data_2f1e_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2f1e _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 120.594 0.235 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.411 ' CE2' HG23 ' A' ' 109' ' ' THR . 37.8 m-85 -118.65 112.07 19.35 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.406 -0.808 . . . . 31.93 110.338 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 45.2 mtm-85 -153.48 134.23 13.78 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.509 0.671 . . . . 0.0 110.28 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.0 t -151.74 115.8 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 121.466 0.65 . . . . 0.0 109.57 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -106.19 128.86 54.23 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.542 0.687 . . . . 0.0 109.78 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.3 t -118.02 138.84 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.815 -0.553 . . . . 28.210000000000001 109.702 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -122.41 136.32 54.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.444 -0.785 . . . . 0.0 109.944 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.7 t -128.29 136.1 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.605 -0.684 . . . . 27.949999999999999 110.33 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 65.3 p -126.37 105.66 24.47 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.689 -0.632 . . . . 0.0 110.526 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.413 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 49.8 Cg_endo -83.46 165.25 14.34 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 O-C-N 123.831 1.438 . . . . 33.0 110.991 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -157.78 131.67 8.03 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.51 0.671 . . . . 54.100000000000001 109.793 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -62.28 138.68 58.47 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.767 -0.583 . . . . 0.0 111.55 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.7 mt -115.4 79.62 1.31 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.903 0.859 . . . . 0.0 110.309 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.03 -35.32 79.63 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.222 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -69.54 -25.17 63.89 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.288 -0.882 . . . . 0.0 111.003 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -119.07 31.18 6.76 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.363 -0.835 . . . . 52.369999999999997 110.927 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.1 p -152.05 146.51 25.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.368 -0.832 . . . . 55.189999999999998 110.996 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.8 t -122.5 93.2 48.65 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.447 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 50.2 Cg_endo -66.2 -22.51 53.75 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 O-C-N 123.715 1.376 . . . . 51.57 111.804 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -64.87 -24.31 67.5 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.333 -0.855 . . . . 0.0 110.951 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -105.75 23.72 13.44 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.336 -0.853 . . . . 0.0 110.76 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.21 29.44 72.06 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -121.02 93.7 4.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.643 -0.916 . . . . 0.0 110.18 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.447 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 67.4 m-85 -104.84 131.28 52.51 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.924 -0.769 . . . . 46.07 108.924 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -118.43 120.9 38.94 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.528 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.423 ' CD1' HD12 ' A' ' 90' ' ' LEU . 75.4 m-85 -116.74 134.63 54.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.651 -0.656 . . . . 38.880000000000003 109.711 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.41 132.54 54.37 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.623 -0.881 . . . . 34.060000000000002 108.623 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 86' ' ' SER . 24.8 p90 -127.59 144.04 51.11 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.216 -0.994 . . . . 29.030000000000001 111.447 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.5 m -103.93 139.7 38.73 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.703 -0.623 . . . . 0.0 109.549 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.443 ' CG2' ' CE1' ' A' ' 84' ' ' TYR . 41.8 mm -105.69 132.42 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.784 0.802 . . . . 0.0 111.755 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -122.9 97.89 5.65 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.452 0.644 . . . . 40.240000000000002 109.644 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.3 mt -91.98 117.22 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.735 -0.603 . . . . 20.73 110.55 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -117.71 134.96 54.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.44 -0.787 . . . . 0.0 109.47 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -93.35 117.68 30.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.736 -0.602 . . . . 21.34 110.652 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.52 11.58 15.96 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.517 -0.739 . . . . 0.0 110.489 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.34 176.02 51.32 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.429 -1.469 . . . . 29.100000000000001 109.429 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.52 -39.36 16.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.482 -1.01 . . . . 0.0 110.214 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.408 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 87.9 t -99.32 140.41 21.64 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.923 -0.486 . . . . 0.0 109.805 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.408 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 40.6 Cg_endo -53.74 144.63 53.22 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 O-C-N 123.786 1.414 . . . . 21.949999999999999 111.722 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.55 151.9 46.46 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.548 0.69 . . . . 20.91 110.953 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.417 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 21.6 ptt-85 -128.11 158.11 38.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.78 -0.575 . . . . 0.0 109.855 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.4 tt -99.0 116.86 32.19 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.472 -0.767 . . . . 0.0 109.123 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.7 t -99.13 -29.63 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.495 -0.753 . . . . 0.0 111.461 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.87 163.72 31.9 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.048 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -142.79 141.45 31.68 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.588 0.708 . . . . 29.050000000000001 110.637 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -144.55 112.36 6.25 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.365 0.603 . . . . 27.969999999999999 109.403 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -99.44 136.16 39.79 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.559 0.695 . . . . 25.25 111.248 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -114.83 80.87 1.47 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 54' ' ' ILE . 12.3 pt -83.15 127.71 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-O 121.784 0.802 . . . . 36.109999999999999 111.59 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.8 m -120.78 129.25 53.51 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.21 -1.033 . . . . 33.979999999999997 108.21 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -91.64 171.21 9.32 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.706 0.765 . . . . 45.039999999999999 111.217 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.92 -6.37 9.38 Favored Glycine 0 N--CA 1.493 2.482 0 O-C-N 121.688 -0.632 . . . . 39.469999999999999 112.214 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.6 p30 -101.87 5.88 41.2 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 119.46 1.63 . . . . 0.0 110.94 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.36 -32.0 5.73 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.204 -0.935 . . . . 0.0 111.23 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.05 142.71 53.57 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.128 -1.219 . . . . 62.780000000000001 109.845 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 60.9 p -132.5 151.16 52.0 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.816 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -123.31 125.12 44.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.579 -0.701 . . . . 0.0 109.865 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -101.68 135.01 43.93 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.554 -0.716 . . . . 0.0 110.763 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.0 t -129.18 133.49 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.582 -0.699 . . . . 37.939999999999998 110.021 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -125.2 127.1 46.26 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.923 -0.486 . . . . 0.0 110.533 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.55 -174.16 14.25 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 108.757 -1.737 . . . . 31.82 108.757 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -66.42 -158.28 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.278 -1.131 . . . . 0.0 109.816 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -51.76 -88.6 0.01 OUTLIER Glycine 0 N--CA 1.498 2.824 0 N-CA-C 110.504 -1.039 . . . . 22.620000000000001 110.504 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.0 m -140.17 128.15 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.382 -1.069 . . . . 17.510000000000002 110.159 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.4 m 40.86 35.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 CA-C-O 121.313 0.577 . . . . 20.550000000000001 112.248 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.58 21.53 57.93 Favored Glycine 0 N--CA 1.499 2.851 0 O-C-N 121.433 -0.792 . . . . 18.289999999999999 112.794 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -139.38 151.73 46.55 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 119.101 1.45 . . . . 0.0 111.197 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -113.51 74.65 2.28 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 109.278 -0.638 . . . . 18.210000000000001 109.278 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -57.58 141.98 95.44 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 O-C-N 123.838 1.441 . . . . 17.609999999999999 111.668 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.417 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 1.4 t90 -103.09 77.33 1.54 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 tp -62.24 118.18 7.06 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.612 -0.68 . . . . 20.57 111.285 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -86.8 158.73 53.26 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -53.67 127.24 24.65 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 O-C-N 123.564 1.297 . . . . 27.039999999999999 110.972 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.64 -18.3 43.83 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.843 -0.903 . . . . 24.739999999999998 110.843 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -88.85 165.64 14.52 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.109 -1.23 . . . . 29.379999999999999 110.239 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.21 151.08 37.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.498 -0.751 . . . . 0.0 110.43 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -118.12 144.96 45.23 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.906 -0.775 . . . . 18.559999999999999 108.906 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.6 p80 -142.65 140.39 31.58 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.117 -0.989 . . . . 0.0 111.258 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.443 ' CE1' ' CG2' ' A' ' 35' ' ' ILE . 52.8 p90 -150.93 159.93 44.24 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.57 -0.706 . . . . 26.649999999999999 109.732 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.6 m -102.58 136.73 41.87 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.422 -0.799 . . . . 28.140000000000001 110.923 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 16.2 t -124.9 168.99 12.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.62 -0.675 . . . . 33.880000000000003 110.146 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.2 124.6 2.57 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.885 -1.15 . . . . 31.800000000000001 110.364 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 79.9 t -129.83 150.64 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.671 -0.899 . . . . 0.0 109.352 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.4 tt -111.08 143.58 41.56 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.529 -0.732 . . . . 0.0 110.577 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.423 HD12 ' CD1' ' A' ' 31' ' ' PHE . 84.0 mt -121.9 145.27 48.26 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.576 -0.703 . . . . 38.68 109.978 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -72.88 -24.22 60.82 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.373 -0.829 . . . . 0.0 111.157 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.3 p -124.3 171.27 10.02 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.342 -0.849 . . . . 31.629999999999999 110.755 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 32.1 tt0 -85.73 6.69 26.66 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.668 -0.645 . . . . 0.0 111.692 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -140.08 149.09 42.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.992 -1.068 . . . . 0.0 109.815 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.62 160.75 23.81 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 118.808 -1.663 . . . . 28.050000000000001 112.178 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -121.97 131.66 54.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 122.185 -0.597 . . . . 0.0 109.401 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 54.6 ttm -127.21 123.68 37.16 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.304 -0.872 . . . . 0.0 111.36 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -123.8 148.21 46.89 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.76 176.21 39.86 Favored Glycine 0 N--CA 1.501 2.991 0 C-N-CA 118.565 -1.779 . . . . 29.620000000000001 111.132 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -140.87 157.6 45.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.804 -0.821 . . . . 0.0 110.663 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -117.07 128.82 55.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.677 -0.639 . . . . 27.050000000000001 110.007 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -81.75 123.59 28.89 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.967 -1.083 . . . . 0.0 109.11 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.432 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 47.4 mtt -122.58 162.6 21.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.887 -0.508 . . . . 0.0 110.491 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.3 m -141.85 128.72 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.516 -0.74 . . . . 23.280000000000001 110.251 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.96 167.55 21.27 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.489 -0.757 . . . . 0.0 109.684 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -64.33 -30.78 71.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.497 -0.752 . . . . 0.0 110.059 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -72.38 -11.7 60.8 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.519 -0.738 . . . . 0.0 110.959 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.23 -7.41 47.6 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.398 -1.081 . . . . 30.43 110.398 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.411 HG23 ' CE2' ' A' ' 7' ' ' TYR . 69.3 m -57.2 135.02 56.4 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.048 -1.266 . . . . 0.0 110.036 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -101.19 139.94 36.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.384 -0.823 . . . . 0.0 110.827 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.432 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 49.8 p90 -167.38 146.92 5.16 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.704 -0.622 . . . . 28.030000000000001 110.077 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.3 pt -103.18 159.12 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.675 -0.641 . . . . 0.0 110.954 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.3 96.61 50.04 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -59.23 143.79 99.62 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 O-C-N 123.907 1.477 . . . . 33.310000000000002 112.269 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 71.4 mt -107.77 122.15 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.68 -0.859 . . . . 30.59 108.68 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.82 155.69 0.83 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.264 0.554 . . . . 30.780000000000001 111.577 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -91.05 119.99 31.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.724 -0.61 . . . . 0.0 110.675 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.413 ' CD1' ' HG3' ' A' ' 15' ' ' PRO . 51.5 p90 -111.02 162.66 14.64 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.487 -0.931 . . . . 30.66 108.487 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.3 p -115.98 154.67 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.204 -0.935 . . . . 0.0 110.882 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.453 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.3 mp -114.07 132.12 56.14 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.32 -0.622 . . . . 39.149999999999999 109.32 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.654 -0.654 . . . . 0.0 110.137 -179.814 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 120.823 0.344 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.456 ' CE1' ' CB ' ' A' ' 105' ' ' ALA . 21.4 m-85 -123.55 101.44 7.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.355 -0.841 . . . . 31.93 110.207 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -144.1 139.19 28.75 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.665 0.745 . . . . 0.0 109.99 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 70.7 t -150.94 114.98 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -105.97 129.55 54.08 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.538 0.685 . . . . 0.0 109.836 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.6 t -118.23 139.79 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.869 -0.519 . . . . 28.210000000000001 109.754 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -120.67 136.65 54.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.438 -0.789 . . . . 0.0 109.817 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.9 t -128.87 137.77 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.586 -0.697 . . . . 27.949999999999999 110.219 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.7 m -125.07 105.07 29.12 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.717 -0.614 . . . . 0.0 110.638 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -84.3 165.56 12.69 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 O-C-N 123.85 1.447 . . . . 33.0 110.797 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -157.46 132.06 8.56 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.541 0.686 . . . . 54.100000000000001 110.064 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -59.73 139.98 56.84 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.852 -0.53 . . . . 0.0 111.315 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 91.2 mt -115.98 80.16 1.41 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.904 0.859 . . . . 0.0 110.397 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.02 -35.84 81.65 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.912 -0.492 . . . . 0.0 111.063 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -69.77 -23.71 63.4 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.415 -0.803 . . . . 0.0 110.947 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -121.05 34.65 5.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.36 -0.837 . . . . 52.369999999999997 111.08 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.4 p -156.47 147.91 22.5 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.312 -0.868 . . . . 55.189999999999998 111.109 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.9 t -118.9 92.17 44.36 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.442 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 51.3 Cg_endo -65.74 -23.51 55.86 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 O-C-N 123.853 1.449 . . . . 51.57 111.627 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.83 -22.41 66.55 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.398 -0.813 . . . . 0.0 110.833 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -106.13 23.56 13.85 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.25 -0.906 . . . . 0.0 110.684 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.37 28.0 73.6 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.2 mtm-85 -121.46 94.13 4.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.591 -0.947 . . . . 0.0 110.175 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.442 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 63.8 m-85 -104.15 135.4 45.71 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.54 -0.725 . . . . 46.07 109.22 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.59 120.54 40.53 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.524 -0.735 . . . . 0.0 111.174 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -116.14 131.56 56.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.555 -0.715 . . . . 38.880000000000003 109.795 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.01 131.96 56.16 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.287 -0.883 . . . . 34.060000000000002 108.658 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.421 ' CE1' ' HB3' ' A' ' 86' ' ' SER . 54.6 p90 -128.22 145.98 50.87 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 119.17 -1.012 . . . . 29.030000000000001 111.544 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.6 t -101.97 140.88 35.66 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.435 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 48.1 mm -105.47 132.29 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.819 0.819 . . . . 0.0 111.772 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -123.49 98.97 6.09 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.399 0.619 . . . . 40.240000000000002 109.826 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 80.3 mt -91.23 117.27 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.711 -0.618 . . . . 20.73 110.735 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -117.99 134.06 55.32 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.578 -0.701 . . . . 0.0 109.421 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -94.5 117.36 30.0 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 120.178 -0.609 . . . . 21.34 110.781 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.25 13.37 17.89 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.415 -0.803 . . . . 0.0 110.442 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.89 -176.26 51.17 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.515 -1.434 . . . . 29.100000000000001 109.515 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.28 -33.74 10.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.561 -0.964 . . . . 0.0 109.846 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.421 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 87.6 t -104.56 141.51 22.68 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.421 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 39.6 Cg_endo -53.13 144.5 46.9 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 O-C-N 123.693 1.365 . . . . 21.949999999999999 111.619 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -136.79 151.37 49.09 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.732 0.777 . . . . 20.91 111.232 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.414 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 47.2 ttp180 -126.6 152.08 47.11 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.1 tt -98.02 117.85 33.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 109.441 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.6 p -100.69 -25.21 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.55 -0.719 . . . . 0.0 110.947 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.12 164.27 30.62 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.039 -1.064 . . . . 0.0 112.034 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -141.69 139.08 32.87 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.334 0.588 . . . . 29.050000000000001 109.993 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -142.46 113.84 7.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.703 -0.623 . . . . 27.969999999999999 110.016 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.428 ' CH2' HD12 ' A' ' 115' ' ' ILE . 87.8 m95 -101.47 132.66 46.97 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.745 -0.597 . . . . 25.25 110.753 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -116.88 77.42 1.11 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.642 -0.661 . . . . 0.0 109.572 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.413 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.5 pt -83.59 130.07 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.789 0.804 . . . . 36.109999999999999 112.211 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.6 m -119.28 129.59 54.98 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.266 -1.013 . . . . 33.979999999999997 108.266 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -91.63 170.32 10.02 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.734 0.778 . . . . 45.039999999999999 111.364 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.28 -7.21 12.82 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 121.791 -0.568 . . . . 39.469999999999999 112.149 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -102.23 5.69 40.23 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 119.431 1.616 . . . . 0.0 110.733 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.3 -29.49 8.2 Favored Glycine 0 N--CA 1.495 2.585 0 O-C-N 121.213 -0.929 . . . . 0.0 110.898 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -61.86 142.28 57.46 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.323 -1.104 . . . . 62.780000000000001 109.747 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.9 p -134.29 151.69 51.4 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.476 -0.765 . . . . 0.0 110.434 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -121.65 122.12 38.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.509 -0.745 . . . . 0.0 110.074 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -104.19 135.15 46.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.567 -0.708 . . . . 0.0 110.634 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.4 t -128.07 131.75 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.545 -0.722 . . . . 37.939999999999998 109.888 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -125.12 127.55 47.05 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.747 -0.596 . . . . 0.0 110.554 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.88 164.82 30.92 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.215 -1.554 . . . . 31.82 109.215 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -106.08 158.31 16.9 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.351 -1.088 . . . . 0.0 110.086 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.96 96.43 0.01 OUTLIER Glycine 0 N--CA 1.5 2.929 0 O-C-N 121.454 -0.778 . . . . 22.620000000000001 111.628 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.1 m -45.39 132.89 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.519 0 O-C-N 121.403 -1.057 . . . . 17.510000000000002 111.534 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.428 HG22 ' HG2' ' A' ' 72' ' ' GLU . 11.0 m 41.63 36.01 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 CA-C-O 121.631 0.729 . . . . 20.550000000000001 111.413 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.0 21.46 59.16 Favored Glycine 0 N--CA 1.496 2.688 0 O-C-N 121.762 -0.586 . . . . 18.289999999999999 112.436 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.428 ' HG2' HG22 ' A' ' 70' ' ' VAL . 4.9 pt-20 -147.6 154.32 40.51 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-N 119.128 1.464 . . . . 0.0 112.457 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -117.55 72.97 7.88 Favored Pre-proline 0 N--CA 1.491 1.6 0 N-CA-C 108.558 -0.904 . . . . 18.210000000000001 108.558 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -53.99 139.78 70.1 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 O-C-N 123.735 1.387 . . . . 17.609999999999999 112.286 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.414 ' CD1' ' HB2' ' A' ' 46' ' ' ARG . 3.4 t90 -101.45 76.03 1.65 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.5 tp -62.33 117.22 5.82 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.585 -0.697 . . . . 20.57 111.339 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 -85.59 158.71 56.72 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -53.96 126.02 20.64 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 O-C-N 123.537 1.283 . . . . 27.039999999999999 110.905 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.94 -18.37 44.69 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.732 -0.947 . . . . 24.739999999999998 110.732 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -88.96 164.9 14.91 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.133 -1.216 . . . . 29.379999999999999 110.263 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.98 150.4 35.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.541 -0.724 . . . . 0.0 110.331 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.404 ' CZ ' ' OE2' ' A' ' 72' ' ' GLU . 64.7 t80 -117.86 145.58 44.5 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.864 -0.791 . . . . 18.559999999999999 108.864 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -143.57 140.48 30.23 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.119 -0.988 . . . . 0.0 111.37 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.435 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 51.1 p90 -150.14 160.02 43.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.647 -0.658 . . . . 26.649999999999999 109.34 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.5 m -102.62 139.08 38.67 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.29 -0.881 . . . . 28.140000000000001 110.928 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.421 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 16.8 t -124.06 166.07 16.41 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.647 -0.658 . . . . 33.880000000000003 109.97 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -144.53 120.3 1.4 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.076 -1.21 . . . . 31.800000000000001 110.076 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.51 152.93 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.686 -0.89 . . . . 0.0 109.927 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.98 142.85 39.03 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.521 -0.737 . . . . 0.0 110.508 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 24.1 mt -124.02 143.08 50.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.542 -0.724 . . . . 38.68 110.291 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -82.23 -22.77 35.71 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.217 -0.927 . . . . 0.0 110.087 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.2 m -99.55 134.25 42.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.671 -0.643 . . . . 31.629999999999999 109.991 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.416 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 58.2 tt0 -75.39 -7.9 55.26 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.171 -0.956 . . . . 0.0 110.833 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -138.3 147.28 43.41 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.21 -0.931 . . . . 0.0 108.952 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.7 169.64 38.97 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 118.265 -1.922 . . . . 28.050000000000001 112.706 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -115.82 130.23 56.75 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 98.3 mtp -126.73 121.27 31.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.349 -0.844 . . . . 0.0 111.316 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.408 ' CG ' ' CB ' ' A' ' 117' ' ' ALA . 55.8 mt-30 -124.39 152.12 43.6 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.27 175.92 36.99 Favored Glycine 0 N--CA 1.499 2.86 0 C-N-CA 118.792 -1.671 . . . . 29.620000000000001 111.05 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.423 ' CD2' ' HA ' ' A' ' 114' ' ' PRO . 69.4 m80 -137.61 157.85 45.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.8 -0.824 . . . . 0.0 109.678 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.452 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 10.1 m-85 -116.64 127.31 54.32 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.577 -0.702 . . . . 27.050000000000001 110.009 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -85.63 119.13 25.62 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.992 -1.068 . . . . 0.0 108.723 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 111' ' ' PHE . 2.5 tpt -122.49 160.7 25.03 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.141 0.496 . . . . 0.0 110.348 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.0 m -139.08 129.5 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.639 -0.663 . . . . 23.280000000000001 110.105 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.456 ' CB ' ' CE1' ' A' ' 7' ' ' TYR . . . -70.01 164.81 23.14 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.571 -0.706 . . . . 0.0 109.633 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -63.76 -28.17 69.69 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.537 -0.727 . . . . 0.0 110.131 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -79.0 -7.6 58.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.487 -0.758 . . . . 0.0 111.294 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.7 -7.63 45.94 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 120.104 -1.046 . . . . 30.43 110.515 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.4 m -57.82 134.98 56.76 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.046 -1.267 . . . . 0.0 109.98 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -101.84 139.38 37.55 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.346 -0.846 . . . . 0.0 110.891 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.416 ' CZ ' ' HB3' ' A' ' 103' ' ' MET . 43.0 p90 -165.1 143.61 6.42 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.732 -0.605 . . . . 28.030000000000001 109.685 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 85.0 mt -101.62 157.69 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.646 -0.659 . . . . 0.0 110.81 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.15 97.33 49.25 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.423 ' HA ' ' CD2' ' A' ' 100' ' ' HIS . 46.5 Cg_endo -58.7 143.78 98.44 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 O-C-N 123.847 1.446 . . . . 33.310000000000002 112.292 -178.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.452 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 52.7 mt -108.71 122.83 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.739 -0.837 . . . . 30.59 108.739 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.42 171.29 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.29 0.567 . . . . 30.780000000000001 111.465 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.408 ' CB ' ' CG ' ' A' ' 98' ' ' GLN . . . -101.72 122.01 43.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.657 -0.652 . . . . 0.0 110.825 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 97' ' ' MET . 49.1 p90 -110.94 156.45 21.19 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.162 -1.051 . . . . 30.66 108.162 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.8 t -115.87 154.95 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.174 -0.954 . . . . 0.0 110.587 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.452 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.6 mp -112.49 132.23 55.18 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.099 -0.704 . . . . 39.149999999999999 109.099 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 34.7 t . . . . . 0 N--CA 1.493 1.716 0 O-C-N 121.779 -0.576 . . . . 0.0 110.041 -179.782 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 120.781 0.324 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -121.42 101.95 7.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.437 -0.79 . . . . 31.93 110.16 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.79 131.53 15.98 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.554 -0.716 . . . . 0.0 110.065 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.0 t -152.11 117.09 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.613 0.72 . . . . 0.0 109.808 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -105.27 129.66 53.58 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.537 0.684 . . . . 0.0 109.825 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.2 t -117.97 139.03 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.842 -0.536 . . . . 28.210000000000001 109.76 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -121.65 136.93 54.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.456 -0.777 . . . . 0.0 110.116 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.5 t -129.28 136.57 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.581 -0.699 . . . . 27.949999999999999 110.139 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.0 m -125.44 103.96 28.57 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.737 -0.602 . . . . 0.0 110.659 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.74 165.05 15.85 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 O-C-N 123.874 1.46 . . . . 33.0 110.835 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -157.85 132.92 8.69 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.661 0.743 . . . . 54.100000000000001 110.111 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -60.01 140.1 57.0 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.27 0.557 . . . . 0.0 111.629 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.4 mt -117.11 83.44 1.98 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.019 0.914 . . . . 0.0 110.247 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.97 -35.11 76.37 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.317 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -69.92 -22.69 63.18 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.427 -0.795 . . . . 0.0 111.099 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -121.87 34.31 5.22 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.232 -0.918 . . . . 52.369999999999997 110.897 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.8 p -154.46 148.8 26.09 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.308 -0.87 . . . . 55.189999999999998 110.979 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.2 t -121.97 93.84 48.43 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.457 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 50.4 Cg_endo -66.86 -23.2 47.94 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 O-C-N 123.786 1.414 . . . . 51.57 112.068 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -66.05 -22.36 66.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.253 -0.904 . . . . 0.0 111.032 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -106.47 23.22 14.55 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.207 -0.933 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.52 29.16 72.89 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -121.4 94.18 4.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.551 -0.97 . . . . 0.0 110.178 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.457 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 58.8 m-85 -105.6 133.8 49.75 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.503 -0.748 . . . . 46.07 109.143 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -115.77 120.64 39.97 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.354 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -116.68 131.04 57.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.553 -0.717 . . . . 38.880000000000003 109.642 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.77 131.77 56.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.255 -0.903 . . . . 34.060000000000002 109.048 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 86' ' ' SER . 53.1 p90 -128.08 148.13 50.55 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.338 -0.945 . . . . 29.030000000000001 111.308 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 m -101.27 140.21 35.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.667 -0.646 . . . . 0.0 109.411 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.436 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 46.0 mm -103.69 132.39 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-O 121.841 0.829 . . . . 0.0 111.677 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.0 mmm-85 -124.05 97.22 5.25 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.471 0.653 . . . . 40.240000000000002 109.797 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 80.1 mt -92.21 118.17 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.704 -0.623 . . . . 20.73 110.751 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -117.36 132.81 56.52 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.508 -0.745 . . . . 0.0 109.21 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -93.96 117.89 30.73 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.786 -0.571 . . . . 21.34 110.632 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.81 14.12 16.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.527 -0.733 . . . . 0.0 110.539 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.52 -171.89 46.09 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.215 -1.554 . . . . 29.100000000000001 109.215 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.64 -29.99 10.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.463 -1.021 . . . . 0.0 110.343 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.422 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 88.0 t -108.82 141.36 23.16 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.836 -0.54 . . . . 0.0 110.016 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.434 ' CB ' ' CH2' ' A' ' 75' ' ' TRP . 39.1 Cg_endo -52.52 142.33 49.18 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 O-C-N 123.772 1.406 . . . . 21.949999999999999 111.749 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.41 151.69 48.82 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.875 0.845 . . . . 20.91 111.418 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.412 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 54.5 ttp180 -125.89 153.45 44.18 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.0 tt -97.53 119.19 35.63 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.574 -0.704 . . . . 0.0 109.464 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.3 t -101.17 -27.15 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.539 -0.726 . . . . 0.0 110.983 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.13 165.06 28.47 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 119.1 -1.04 . . . . 0.0 112.162 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.7 ptt-85 -141.12 139.59 33.99 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.368 0.604 . . . . 29.050000000000001 110.214 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -142.79 112.84 7.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.775 -0.578 . . . . 27.969999999999999 109.873 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -102.19 134.27 45.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.642 -0.661 . . . . 25.25 111.168 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -116.09 79.15 1.27 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.75 -0.594 . . . . 0.0 109.405 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.414 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.0 pt -86.75 129.24 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 121.833 0.825 . . . . 36.109999999999999 111.826 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.1 m -120.69 130.38 54.06 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.441 -0.948 . . . . 33.979999999999997 108.441 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -89.93 170.5 10.32 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.748 0.785 . . . . 45.039999999999999 111.251 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.83 -7.06 14.07 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 121.75 -0.594 . . . . 39.469999999999999 112.138 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -101.62 6.3 41.99 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 119.344 1.572 . . . . 0.0 110.667 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.61 -26.19 15.23 Favored Glycine 0 N--CA 1.494 2.566 0 O-C-N 121.208 -0.933 . . . . 0.0 110.966 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -62.16 141.28 58.25 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.184 -1.186 . . . . 62.780000000000001 109.6 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.3 p -131.54 148.79 52.65 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.402 -0.812 . . . . 0.0 110.574 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -122.3 120.53 34.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.445 -0.785 . . . . 0.0 109.872 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -103.06 135.0 45.55 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.747 -0.596 . . . . 0.0 110.499 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.2 t -128.29 130.31 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.614 0.721 . . . . 37.939999999999998 110.031 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -126.17 126.53 44.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.895 -0.503 . . . . 0.0 109.946 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.78 151.03 23.18 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.555 -1.418 . . . . 31.82 109.555 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -77.38 155.22 32.03 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.431 -1.04 . . . . 0.0 110.241 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.62 -174.52 0.23 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 110.99 -0.844 . . . . 22.620000000000001 110.99 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.1 m -128.81 127.43 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.838 -0.801 . . . . 17.510000000000002 109.625 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.413 HG22 ' HG2' ' A' ' 72' ' ' GLU . 13.2 m 41.32 36.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 CA-C-O 121.603 0.715 . . . . 20.550000000000001 111.831 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.37 16.03 70.03 Favored Glycine 0 N--CA 1.499 2.841 0 O-C-N 121.588 -0.695 . . . . 18.289999999999999 112.869 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.413 ' HG2' HG22 ' A' ' 70' ' ' VAL . 10.1 pt-20 -146.43 151.67 37.81 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 119.158 1.479 . . . . 0.0 112.147 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -115.42 75.55 4.76 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 108.746 -0.835 . . . . 18.210000000000001 108.746 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -57.85 137.65 82.12 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 O-C-N 123.811 1.427 . . . . 17.609999999999999 112.194 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.434 ' CH2' ' CB ' ' A' ' 44' ' ' PRO . 7.4 t90 -101.34 75.98 1.67 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.1 mt -60.3 118.37 6.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.566 -0.709 . . . . 20.57 112.013 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.6 mtp85 -86.59 158.87 53.69 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -54.62 129.14 33.38 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 O-C-N 123.466 1.246 . . . . 27.039999999999999 111.126 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.02 -18.3 48.62 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 111.012 -0.835 . . . . 24.739999999999998 111.012 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -88.28 166.01 14.62 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.041 -1.27 . . . . 29.379999999999999 110.69 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.1 148.68 33.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.594 -0.691 . . . . 0.0 110.024 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.401 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 64.6 t80 -117.57 144.67 44.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.466 -0.771 . . . . 18.559999999999999 109.13 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -143.62 140.42 30.13 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.234 -0.916 . . . . 0.0 111.279 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.436 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 49.5 p90 -150.89 159.96 44.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.591 -0.693 . . . . 26.649999999999999 109.62 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.5 m -101.67 137.5 39.9 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.389 -0.819 . . . . 28.140000000000001 111.005 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.431 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 15.0 t -124.49 167.63 14.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.641 -0.662 . . . . 33.880000000000003 109.918 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.89 124.41 2.45 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.811 -1.185 . . . . 31.800000000000001 110.466 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.71 153.5 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.653 -0.91 . . . . 0.0 109.896 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 mp -108.84 144.86 36.15 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.559 -0.713 . . . . 0.0 111.071 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.09 147.23 45.83 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.685 -0.634 . . . . 38.68 109.591 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.41 ' O ' ' CE1' ' A' ' 29' ' ' TYR . 74.7 tt0 -77.9 -26.6 49.2 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.248 -0.908 . . . . 0.0 111.25 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.8 p -124.99 172.78 9.14 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.268 -0.895 . . . . 31.629999999999999 110.936 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.457 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 50.4 mt-10 -86.62 11.55 12.6 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.653 -0.654 . . . . 0.0 111.469 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -139.99 144.38 36.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.037 -1.039 . . . . 0.0 109.69 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.98 157.03 17.9 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 118.795 -1.669 . . . . 28.050000000000001 112.237 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -121.36 131.37 54.15 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 98.1 mtp -127.24 120.7 29.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.326 -0.859 . . . . 0.0 111.386 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -126.41 151.4 47.74 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.12 177.8 39.02 Favored Glycine 0 N--CA 1.499 2.871 0 C-N-CA 118.946 -1.597 . . . . 29.620000000000001 110.962 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.426 ' CD2' ' HA ' ' A' ' 114' ' ' PRO . 66.9 m80 -136.17 156.92 47.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.715 -0.874 . . . . 0.0 110.139 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.453 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 4.7 m-85 -115.37 127.93 55.73 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.759 -0.588 . . . . 27.050000000000001 109.932 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -83.71 121.92 27.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.965 -1.084 . . . . 0.0 108.532 177.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 54.6 ttm -123.92 161.59 25.07 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.297 0.57 . . . . 0.0 110.781 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.5 m -139.99 129.93 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.741 -0.599 . . . . 23.280000000000001 110.17 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.3 166.29 23.84 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.509 -0.744 . . . . 0.0 109.811 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -65.33 -31.05 71.98 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.52 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -74.57 -7.73 54.05 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.433 -0.792 . . . . 0.0 111.272 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.0 -9.33 54.92 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 120.091 -1.052 . . . . 30.43 110.636 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.4 m -57.55 134.79 56.43 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.021 -1.282 . . . . 0.0 109.935 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -101.92 140.83 35.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.432 -0.792 . . . . 0.0 110.931 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -168.61 146.12 3.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.666 -0.646 . . . . 28.030000000000001 109.851 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.434 HD12 HG23 ' A' ' 112' ' ' ILE . 84.9 mt -101.23 157.52 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.707 -0.621 . . . . 0.0 110.66 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.27 98.7 50.57 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.426 ' HA ' ' CD2' ' A' ' 100' ' ' HIS . 45.4 Cg_endo -58.08 142.84 97.16 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 O-C-N 123.932 1.491 . . . . 33.310000000000002 112.254 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.453 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 48.6 mt -109.31 124.28 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.741 -0.837 . . . . 30.59 108.741 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.66 149.99 3.02 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.861 -0.525 . . . . 30.780000000000001 111.271 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -92.86 124.26 36.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.66 -0.65 . . . . 0.0 110.047 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -108.8 164.67 12.18 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.046 -0.724 . . . . 30.66 109.046 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.5 p -116.0 155.41 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.349 -0.845 . . . . 0.0 110.495 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.462 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.2 mp -112.13 133.07 54.49 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.281 -0.637 . . . . 39.149999999999999 109.281 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.627 -0.671 . . . . 0.0 110.094 -179.796 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 120.678 0.275 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -118.23 108.1 14.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.452 -0.78 . . . . 31.93 110.336 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 23.5 mtm180 -151.01 132.12 14.37 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.61 -0.681 . . . . 0.0 110.092 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.9 t -151.67 114.45 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.543 -0.723 . . . . 0.0 109.548 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -106.7 130.36 54.44 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.628 0.727 . . . . 0.0 110.246 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.6 t -117.73 139.23 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.585 -0.524 . . . . 28.210000000000001 109.585 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -121.24 138.44 54.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.367 -0.833 . . . . 0.0 110.193 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.56 135.84 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.61 -0.681 . . . . 27.949999999999999 110.445 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.6 t -126.61 105.53 23.72 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.694 -0.629 . . . . 0.0 110.474 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -82.95 164.8 15.45 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 O-C-N 123.832 1.438 . . . . 33.0 111.15 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -157.87 131.63 7.92 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.572 0.701 . . . . 54.100000000000001 109.697 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -62.13 138.55 58.41 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.651 -0.656 . . . . 0.0 111.691 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 86.0 mt -116.66 83.15 1.91 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 122.009 0.909 . . . . 0.0 110.269 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.45 -35.55 77.74 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.303 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -69.8 -23.71 63.37 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.309 -0.869 . . . . 0.0 111.076 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -121.77 43.06 2.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.263 -0.898 . . . . 52.369999999999997 110.717 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -162.64 143.93 10.17 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.399 -0.813 . . . . 55.189999999999998 110.883 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.9 m -116.58 92.69 38.21 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.44 -0.787 . . . . 0.0 109.124 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.458 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 47.5 Cg_endo -66.05 -25.16 51.63 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 O-C-N 123.932 1.49 . . . . 51.57 111.553 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -68.49 -22.95 64.51 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.298 -0.876 . . . . 0.0 111.038 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -105.06 22.82 14.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.235 -0.915 . . . . 0.0 110.912 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.41 28.62 73.15 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -120.63 93.59 4.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.652 -0.91 . . . . 0.0 109.804 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.458 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 65.2 m-85 -105.62 130.89 53.56 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.361 -0.837 . . . . 46.07 109.017 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.3 121.14 41.13 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.554 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -116.75 134.3 54.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.624 -0.672 . . . . 38.880000000000003 109.459 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -110.9 132.63 54.04 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.171 -0.956 . . . . 34.060000000000002 108.839 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 86' ' ' SER . 25.8 p90 -126.98 143.55 51.26 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.376 -0.929 . . . . 29.030000000000001 111.294 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.0 t -103.92 139.57 38.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.707 -0.621 . . . . 0.0 109.417 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.431 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 40.9 mm -105.06 132.6 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.811 0.815 . . . . 0.0 111.532 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -123.02 95.74 4.73 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.46 0.647 . . . . 40.240000000000002 109.563 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.7 mt -90.23 117.5 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.766 -0.583 . . . . 20.73 110.535 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -117.36 134.4 54.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.515 -0.741 . . . . 0.0 109.434 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -92.24 117.43 29.87 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.282 -0.567 . . . . 21.34 110.524 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.85 10.44 16.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.471 -0.768 . . . . 0.0 110.584 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.32 179.55 53.3 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.216 -1.554 . . . . 29.100000000000001 109.216 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.11 -30.93 13.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.516 -0.991 . . . . 0.0 110.29 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.411 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 84.0 t -106.29 140.15 21.0 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.791 -0.568 . . . . 0.0 109.984 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.411 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 38.7 Cg_endo -51.53 141.28 42.74 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 O-C-N 123.8 1.421 . . . . 21.949999999999999 112.038 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.34 152.2 45.63 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.709 0.766 . . . . 20.91 111.09 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.2 ptt-85 -127.66 159.46 34.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.706 -0.621 . . . . 0.0 109.471 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.409 HD12 ' CD1' ' A' ' 101' ' ' TYR . 7.1 tt -96.62 117.56 31.24 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.418 -0.801 . . . . 0.0 109.794 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.6 t -99.48 -28.46 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.519 -0.738 . . . . 0.0 110.636 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.61 162.82 34.46 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.83 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -143.5 142.12 31.02 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.612 0.72 . . . . 29.050000000000001 110.712 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.404 ' CG ' ' OD1' ' A' ' 65' ' ' ASP . 21.6 t-160 -145.27 114.79 7.2 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.289 0.566 . . . . 27.969999999999999 109.701 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -100.13 136.67 39.69 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.652 -0.655 . . . . 25.25 111.36 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -116.13 78.28 1.18 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.661 -0.649 . . . . 0.0 109.258 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' ' 54' ' ' ILE . 29.9 pt -88.15 131.67 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.771 0.796 . . . . 36.109999999999999 112.279 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 93.5 m -119.63 133.23 55.73 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.395 -0.965 . . . . 33.979999999999997 108.395 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -85.89 169.16 13.55 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.693 0.759 . . . . 45.039999999999999 111.265 -178.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.93 -9.35 13.66 Favored Glycine 0 N--CA 1.496 2.644 0 O-C-N 121.827 -0.546 . . . . 39.469999999999999 112.078 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -100.78 9.23 42.64 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 119.26 1.53 . . . . 0.0 110.761 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.7 -21.0 38.3 Favored Glycine 0 N--CA 1.495 2.621 0 O-C-N 121.2 -0.938 . . . . 0.0 111.018 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.02 142.33 54.12 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.064 -1.257 . . . . 62.780000000000001 109.884 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.4 p -125.32 140.24 52.99 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.515 -0.741 . . . . 0.0 110.808 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -123.18 117.88 26.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.525 -0.734 . . . . 0.0 109.829 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -103.75 135.32 45.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.717 -0.614 . . . . 0.0 110.768 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.0 t -128.75 130.89 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.657 -0.652 . . . . 37.939999999999998 109.947 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.404 ' OD1' ' CG ' ' A' ' 51' ' ' HIS . 64.7 m-20 -124.07 126.77 46.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.929 -0.482 . . . . 0.0 109.959 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.9 145.67 14.26 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.527 -1.429 . . . . 31.82 109.527 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -67.29 153.57 43.36 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.462 -1.022 . . . . 0.0 110.099 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 46.97 -164.73 0.12 Allowed Glycine 0 N--CA 1.501 3.009 0 O-C-N 121.487 -0.758 . . . . 22.620000000000001 111.793 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.9 m -130.98 129.37 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.89 -0.771 . . . . 17.510000000000002 109.633 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.429 HG21 ' HG2' ' A' ' 72' ' ' GLU . 12.5 m 40.98 34.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 CA-C-O 121.513 0.673 . . . . 20.550000000000001 111.822 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.57 17.16 66.75 Favored Glycine 0 N--CA 1.499 2.839 0 O-C-N 121.668 -0.645 . . . . 18.289999999999999 112.952 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.429 ' HG2' HG21 ' A' ' 70' ' ' VAL . 10.7 pt-20 -144.53 150.0 36.81 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 119.2 1.5 . . . . 0.0 111.95 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -116.08 74.92 5.62 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.989 -0.745 . . . . 18.210000000000001 108.989 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -56.37 141.32 89.34 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 O-C-N 123.852 1.449 . . . . 17.609999999999999 112.06 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -100.34 77.33 1.94 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.1 mt -62.88 118.04 7.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.575 -0.703 . . . . 20.57 111.987 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -86.92 159.18 52.23 Favored Pre-proline 0 N--CA 1.489 1.508 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -54.65 128.73 31.53 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 O-C-N 123.512 1.27 . . . . 27.039999999999999 111.013 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.49 -17.39 52.49 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.955 -0.858 . . . . 24.739999999999998 110.955 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -87.41 166.1 15.08 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.995 -1.297 . . . . 29.379999999999999 110.635 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.34 150.08 35.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.659 -0.651 . . . . 0.0 110.112 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -118.94 147.69 43.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.505 -0.747 . . . . 18.559999999999999 109.081 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.5 p80 -144.75 140.84 28.79 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.146 -0.971 . . . . 0.0 111.243 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.431 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 52.1 p90 -150.95 160.02 44.19 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.633 -0.667 . . . . 26.649999999999999 109.812 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.4 m -101.34 137.01 40.24 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.431 -0.793 . . . . 28.140000000000001 110.911 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 26.6 t -125.23 169.35 12.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.616 -0.677 . . . . 33.880000000000003 110.132 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.39 123.33 2.15 Favored Glycine 0 N--CA 1.497 2.725 0 C-N-CA 119.914 -1.136 . . . . 31.800000000000001 110.461 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 80.4 t -130.18 152.44 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.532 -0.981 . . . . 0.0 109.48 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 tt -110.56 143.81 40.37 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.532 -0.73 . . . . 0.0 110.508 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 70.8 mt -122.28 147.57 46.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.578 -0.702 . . . . 38.68 110.193 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -74.74 -25.91 59.43 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.28 -0.887 . . . . 0.0 110.805 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.2 p -125.52 172.9 9.32 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.429 -0.794 . . . . 31.629999999999999 110.857 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.447 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 94.0 mt-10 -86.33 11.91 11.21 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.683 -0.636 . . . . 0.0 111.635 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -139.93 147.39 40.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.113 -0.992 . . . . 0.0 109.895 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.48 158.88 21.51 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 118.889 -1.624 . . . . 28.050000000000001 112.28 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -119.47 129.72 54.88 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 122.108 -0.642 . . . . 0.0 109.357 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 98.0 mtp -125.61 116.42 21.69 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.371 -0.83 . . . . 0.0 111.124 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -130.15 151.1 51.05 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -168.77 -177.18 39.5 Favored Glycine 0 N--CA 1.5 2.93 0 C-N-CA 119.017 -1.564 . . . . 29.620000000000001 110.748 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -140.16 157.99 44.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.682 -0.893 . . . . 0.0 110.958 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.417 ' CD2' HD11 ' A' ' 115' ' ' ILE . 5.6 m-85 -115.77 128.21 55.68 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.68 -0.637 . . . . 27.050000000000001 109.647 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -80.78 124.83 29.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.927 -1.108 . . . . 0.0 109.184 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.41 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 29.5 mtp -124.63 162.37 24.25 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.249 0.547 . . . . 0.0 110.543 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.8 m -139.73 128.15 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.654 -0.654 . . . . 23.280000000000001 110.285 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.46 168.99 18.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.538 -0.726 . . . . 0.0 109.861 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.61 -31.74 72.63 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.834 -0.747 . . . . 0.0 110.271 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -70.02 -15.67 63.05 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.491 -0.755 . . . . 0.0 110.942 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.9 -5.74 47.01 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.42 -1.072 . . . . 30.43 110.42 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.4 m -57.72 135.6 56.78 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.061 -1.258 . . . . 0.0 110.052 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -98.63 139.98 33.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.443 -0.786 . . . . 0.0 110.612 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.41 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 48.0 p90 -168.39 148.88 4.75 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.703 -0.623 . . . . 28.030000000000001 110.121 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.6 pt -102.64 157.9 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.707 -0.621 . . . . 0.0 110.833 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -118.54 99.08 51.51 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -58.68 142.76 98.82 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 O-C-N 123.928 1.489 . . . . 33.310000000000002 112.356 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.417 HD11 ' CD2' ' A' ' 101' ' ' TYR . 70.2 mt -108.82 123.6 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.45 -0.945 . . . . 30.59 108.45 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.74 143.98 8.93 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.191 0.52 . . . . 30.780000000000001 111.362 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -85.98 121.6 28.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.619 -0.675 . . . . 0.0 110.186 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 97' ' ' MET . 42.4 p90 -109.46 163.95 12.95 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.796 -0.816 . . . . 30.66 108.796 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.8 p -115.4 154.53 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.186 -0.946 . . . . 0.0 110.476 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.457 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 6.9 mp -113.63 133.47 55.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.733 -0.604 . . . . 39.149999999999999 109.384 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.702 -0.624 . . . . 0.0 110.046 -179.792 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 61.6 mtt180 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.656 0.265 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.421 ' CE2' HG22 ' A' ' 109' ' ' THR . 31.4 m-85 -119.98 108.07 13.87 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.44 -0.788 . . . . 31.93 110.306 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.4 mtt85 -149.06 132.85 16.97 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.661 -0.65 . . . . 0.0 109.986 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.0 t -150.61 113.48 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.687 -0.633 . . . . 0.0 109.455 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -107.41 129.19 54.96 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.616 -0.677 . . . . 0.0 109.809 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.4 t -118.75 139.56 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.88 -0.512 . . . . 28.210000000000001 109.969 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -121.26 137.07 54.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.401 -0.812 . . . . 0.0 109.905 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.1 t -128.81 136.67 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.709 -0.619 . . . . 27.949999999999999 110.23 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.9 p -125.38 104.8 28.23 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.719 -0.613 . . . . 0.0 110.55 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -83.7 164.39 14.08 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 O-C-N 123.95 1.5 . . . . 33.0 110.902 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.6 ptt-85 -157.37 132.5 8.9 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.522 0.677 . . . . 54.100000000000001 109.843 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -59.43 138.56 57.62 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.337 0.589 . . . . 0.0 111.305 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.3 tp -116.18 79.79 1.36 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.983 0.897 . . . . 0.0 110.386 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.59 -35.58 73.09 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.567 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -68.43 -25.05 64.82 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.279 -0.888 . . . . 0.0 111.117 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -120.08 45.85 2.09 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.27 -0.894 . . . . 52.369999999999997 110.63 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.8 p -165.76 150.03 8.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.374 -0.829 . . . . 55.189999999999998 110.974 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.5 t -120.98 93.24 48.81 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.456 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 49.3 Cg_endo -66.89 -23.21 47.73 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 O-C-N 123.761 1.401 . . . . 51.57 111.965 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.09 -23.02 67.04 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.287 -0.883 . . . . 0.0 110.927 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -106.39 24.0 13.25 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.295 -0.878 . . . . 0.0 110.641 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.76 29.17 72.68 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -121.85 93.94 4.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.592 -0.946 . . . . 0.0 110.152 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.456 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 58.4 m-85 -104.95 133.8 49.14 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.559 -0.713 . . . . 46.07 109.103 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -115.04 119.78 37.62 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.163 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.421 ' CD1' HD13 ' A' ' 90' ' ' LEU . 83.2 m-85 -114.73 134.83 54.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.564 -0.71 . . . . 38.880000000000003 109.786 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.4 131.54 55.49 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.52 -0.919 . . . . 34.060000000000002 108.52 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 86' ' ' SER . 21.9 p90 -128.43 144.76 51.19 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.273 -0.971 . . . . 29.030000000000001 111.435 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -104.42 139.6 39.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.752 -0.592 . . . . 0.0 109.886 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.441 ' CG2' ' CE1' ' A' ' 84' ' ' TYR . 44.7 mm -107.28 133.04 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.707 0.765 . . . . 0.0 111.416 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.13 98.52 5.81 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.394 0.616 . . . . 40.240000000000002 109.738 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.411 ' CG2' ' CD1' ' A' ' 76' ' ' LEU . 77.3 mt -90.27 117.75 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.749 -0.595 . . . . 20.73 110.597 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -118.09 133.45 55.89 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.451 -0.781 . . . . 0.0 109.615 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.41 117.12 29.79 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.822 -0.549 . . . . 21.34 110.434 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.82 14.39 17.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.319 -0.863 . . . . 0.0 110.717 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.58 -177.03 51.5 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.349 -1.501 . . . . 29.100000000000001 109.349 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.98 -33.5 12.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.598 -0.943 . . . . 0.0 109.915 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.413 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 84.9 t -104.7 140.82 21.45 Favored Pre-proline 0 N--CA 1.494 1.772 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.413 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 39.1 Cg_endo -52.51 142.24 49.4 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 O-C-N 123.777 1.409 . . . . 21.949999999999999 111.711 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.03 152.73 46.47 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.716 0.77 . . . . 20.91 111.101 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.419 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 24.0 ptt-85 -127.88 157.75 39.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.708 -0.62 . . . . 0.0 109.634 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.4 tt -97.46 117.85 32.62 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.381 -0.824 . . . . 0.0 109.084 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.9 t -100.22 -29.32 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.56 -0.712 . . . . 0.0 111.616 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.06 164.47 29.94 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.126 -1.029 . . . . 0.0 112.151 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -142.85 141.14 31.53 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.559 0.695 . . . . 29.050000000000001 110.906 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -143.37 113.06 7.0 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.309 -0.626 . . . . 27.969999999999999 109.309 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.421 ' CH2' HD13 ' A' ' 115' ' ' ILE . 88.3 m95 -100.05 134.69 42.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.607 -0.683 . . . . 25.25 111.099 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -116.54 77.19 1.08 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.574 -0.704 . . . . 0.0 109.57 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.422 ' O ' HG13 ' A' ' 54' ' ' ILE . 27.6 pt -86.68 130.27 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.416 -0.803 . . . . 36.109999999999999 111.855 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.8 m -119.48 132.67 55.83 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.374 -0.973 . . . . 33.979999999999997 108.374 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -88.13 169.57 11.81 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.717 0.77 . . . . 45.039999999999999 111.417 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.67 -7.69 12.2 Favored Glycine 0 N--CA 1.495 2.57 0 O-C-N 121.786 -0.571 . . . . 39.469999999999999 112.16 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -101.25 7.59 42.89 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 119.307 1.554 . . . . 0.0 110.682 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.13 -29.32 8.26 Favored Glycine 0 N--CA 1.495 2.631 0 O-C-N 121.211 -0.931 . . . . 0.0 110.798 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -63.6 142.45 58.39 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.205 -1.173 . . . . 62.780000000000001 109.755 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.9 t -134.49 152.76 52.0 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.846 -0.741 . . . . 0.0 110.683 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -122.53 125.23 45.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.623 -0.673 . . . . 0.0 110.267 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -102.47 134.72 45.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.671 -0.643 . . . . 0.0 110.512 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.8 t -128.38 132.6 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.548 -0.72 . . . . 37.939999999999998 110.038 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -125.49 127.18 46.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.874 -0.516 . . . . 0.0 110.338 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.3 -174.57 15.68 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 108.711 -1.756 . . . . 31.82 108.711 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.24 -157.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.186 -1.185 . . . . 0.0 109.813 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -51.03 -91.25 0.01 OUTLIER Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.563 -1.015 . . . . 22.620000000000001 110.563 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.4 m -140.22 129.13 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.402 -1.057 . . . . 17.510000000000002 110.143 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.0 m 40.81 33.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 CA-C-O 121.268 0.556 . . . . 20.550000000000001 112.122 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.97 22.29 55.5 Favored Glycine 0 N--CA 1.499 2.837 0 O-C-N 121.533 -0.729 . . . . 18.289999999999999 112.782 177.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -139.83 150.75 45.05 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 119.142 1.471 . . . . 0.0 111.354 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -113.84 74.83 2.62 Favored Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 109.117 -0.697 . . . . 18.210000000000001 109.117 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -57.36 141.7 94.85 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 O-C-N 123.858 1.452 . . . . 17.609999999999999 111.887 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.419 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -103.8 76.36 1.37 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.411 ' CD1' ' CG2' ' A' ' 37' ' ' ILE . 19.0 mt -63.67 121.48 14.04 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.634 -0.666 . . . . 20.57 111.947 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -86.31 158.44 54.99 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -53.6 128.75 30.69 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 O-C-N 123.517 1.272 . . . . 27.039999999999999 111.132 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.01 -17.3 54.07 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.805 -0.918 . . . . 24.739999999999998 110.805 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -88.62 164.85 15.16 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.121 -1.223 . . . . 29.379999999999999 110.585 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.19 150.04 35.08 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.649 -0.657 . . . . 0.0 110.165 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -117.93 144.51 45.41 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.503 -0.748 . . . . 18.559999999999999 109.126 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -142.76 140.4 31.4 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.24 -0.912 . . . . 0.0 111.25 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.441 ' CE1' ' CG2' ' A' ' 35' ' ' ILE . 52.1 p90 -150.65 159.92 44.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.672 -0.642 . . . . 26.649999999999999 109.781 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 60.3 m -102.78 136.73 42.07 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.431 -0.793 . . . . 28.140000000000001 110.76 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 15.7 t -125.25 169.95 11.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.643 -0.661 . . . . 33.880000000000003 110.133 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -139.83 125.87 3.1 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 119.934 -1.127 . . . . 31.800000000000001 110.38 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.2 t -130.08 152.47 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.594 -0.945 . . . . 0.0 109.462 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.1 tt -110.51 142.64 42.01 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.642 -0.661 . . . . 0.0 110.488 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.421 HD13 ' CD1' ' A' ' 31' ' ' PHE . 86.1 mt -122.12 145.8 47.83 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.543 -0.723 . . . . 38.68 109.971 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -81.49 -26.3 35.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.299 -0.876 . . . . 0.0 111.036 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.0 m -123.69 169.34 11.59 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.306 -0.871 . . . . 31.629999999999999 110.66 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.453 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 50.6 mt-10 -86.22 11.09 12.8 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.637 -0.664 . . . . 0.0 111.603 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -140.72 145.31 36.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.16 -0.963 . . . . 0.0 109.853 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.51 157.02 17.52 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 118.747 -1.692 . . . . 28.050000000000001 112.315 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -117.28 129.28 55.8 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 99.6 mtp -126.08 117.77 23.88 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.314 -0.866 . . . . 0.0 111.431 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -126.3 149.18 49.3 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -155.46 -178.91 30.16 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 118.8 -1.667 . . . . 29.620000000000001 111.078 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.433 ' CE1' ' HB3' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -136.92 155.74 49.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.769 -0.842 . . . . 0.0 109.494 179.506 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.444 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 6.6 m-85 -118.09 126.95 53.27 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.419 -0.801 . . . . 27.050000000000001 110.163 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -85.49 120.36 26.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.113 -0.992 . . . . 0.0 108.761 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 111' ' ' PHE . 14.2 tpp -123.93 160.67 27.03 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.109 0.48 . . . . 0.0 110.403 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.1 m -140.69 130.04 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.654 -0.654 . . . . 23.280000000000001 110.176 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.39 166.62 23.18 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.494 -0.754 . . . . 0.0 109.732 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -65.37 -29.77 70.53 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.546 -0.721 . . . . 0.0 110.153 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -74.64 -6.43 48.59 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.437 -0.789 . . . . 0.0 111.139 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.26 -9.41 59.38 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 120.082 -1.056 . . . . 30.43 110.581 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.421 HG22 ' CE2' ' A' ' 7' ' ' TYR . 27.4 m -57.89 135.01 56.81 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.009 -1.289 . . . . 0.0 110.023 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -101.13 138.86 37.61 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.359 -0.838 . . . . 0.0 110.726 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.423 ' CZ ' ' HB3' ' A' ' 103' ' ' MET . 41.9 p90 -162.69 143.8 10.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.664 -0.648 . . . . 28.030000000000001 109.942 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.422 ' HB ' ' CD2' ' A' ' 100' ' ' HIS . 30.5 pt -101.01 156.78 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 121.331 0.586 . . . . 0.0 110.877 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -121.66 100.19 44.19 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.617 -0.677 . . . . 0.0 109.421 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.433 ' HB3' ' CE1' ' A' ' 100' ' ' HIS . 45.3 Cg_endo -58.02 142.85 96.99 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 O-C-N 123.862 1.454 . . . . 33.310000000000002 112.176 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.444 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 66.9 mt -107.88 123.05 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.677 -0.861 . . . . 30.59 108.677 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.83 145.45 7.08 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.848 -0.532 . . . . 30.780000000000001 111.352 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -93.61 120.36 33.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.745 -0.597 . . . . 0.0 110.012 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -108.55 167.75 9.82 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.907 -0.775 . . . . 30.66 108.907 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.8 p -113.7 154.1 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.349 -0.844 . . . . 0.0 110.498 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.46 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.1 mp -113.72 132.93 55.63 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.37 -0.604 . . . . 39.149999999999999 109.37 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.672 -0.642 . . . . 0.0 110.069 -179.808 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.4 ' CD ' ' CB ' ' A' ' 42' ' ' ALA . 28.5 mmt85 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 120.669 0.271 . . . . 0.0 110.741 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -121.22 113.34 19.82 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.412 -0.805 . . . . 31.93 110.383 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 41.0 mtp85 -152.14 135.93 16.3 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.589 0.709 . . . . 0.0 110.092 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.7 t -151.28 114.4 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 CA-C-O 121.442 0.639 . . . . 0.0 109.426 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -106.79 129.0 54.72 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.516 0.674 . . . . 0.0 109.907 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.19 138.4 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 109.694 -0.484 . . . . 28.210000000000001 109.694 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -121.8 136.66 54.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.416 -0.802 . . . . 0.0 109.931 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.4 t -129.39 136.4 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.484 -0.76 . . . . 27.949999999999999 110.375 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -125.71 104.57 27.26 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.732 -0.605 . . . . 0.0 110.443 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.422 ' HG3' ' CE1' ' A' ' 118' ' ' PHE . 49.9 Cg_endo -84.41 165.25 12.57 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 O-C-N 123.843 1.444 . . . . 33.0 110.929 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -158.03 132.61 8.33 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.562 0.696 . . . . 54.100000000000001 109.982 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -58.66 138.25 57.09 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.833 -0.542 . . . . 0.0 111.198 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.6 tp -115.47 80.53 1.45 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.028 0.918 . . . . 0.0 110.359 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.12 -35.97 71.95 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.494 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -68.8 -24.2 64.37 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.374 -0.829 . . . . 0.0 111.002 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -121.34 46.82 1.97 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.382 -0.824 . . . . 52.369999999999997 110.389 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.3 t -166.05 149.85 7.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.456 -0.777 . . . . 55.189999999999998 110.894 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.7 t -122.04 92.94 48.81 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.456 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 49.5 Cg_endo -66.72 -23.1 49.13 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.761 1.401 . . . . 51.57 111.986 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -65.81 -22.68 66.58 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.267 -0.896 . . . . 0.0 110.947 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -105.97 23.59 13.74 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.251 -0.905 . . . . 0.0 110.734 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.33 28.85 73.08 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.8 mmt85 -121.72 94.19 4.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.599 -0.942 . . . . 0.0 110.154 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.456 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 57.6 m-85 -105.33 131.66 52.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.538 -0.726 . . . . 46.07 109.122 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.7 120.56 40.53 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.609 -0.837 . . . . 0.0 111.043 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.427 ' CD1' HD11 ' A' ' 90' ' ' LEU . 86.8 m-85 -114.59 135.75 53.8 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.578 -0.701 . . . . 38.880000000000003 109.581 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.72 131.61 55.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.198 -0.939 . . . . 34.060000000000002 108.483 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 86' ' ' SER . 20.9 p90 -128.55 144.58 51.17 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.276 -0.969 . . . . 29.030000000000001 111.45 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.8 p -104.18 141.1 36.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.647 -0.658 . . . . 0.0 109.877 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.443 ' CG2' ' CE1' ' A' ' 84' ' ' TYR . 44.3 mm -106.89 132.24 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.728 0.775 . . . . 0.0 111.352 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -122.95 97.88 5.64 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.427 0.632 . . . . 40.240000000000002 109.578 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.409 ' CG2' ' CD1' ' A' ' 76' ' ' LEU . 77.6 mt -91.65 116.99 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.771 -0.581 . . . . 20.73 110.598 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -118.02 133.5 55.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.437 -0.789 . . . . 0.0 109.468 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -95.5 117.83 31.11 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.225 -0.59 . . . . 21.34 110.634 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.96 14.28 17.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.423 -0.798 . . . . 0.0 110.5 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.68 179.79 53.31 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.316 -1.514 . . . . 29.100000000000001 109.316 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.4 ' CB ' ' CD ' ' A' ' 6' ' ' ARG . . . -92.42 -33.81 14.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.536 -0.979 . . . . 0.0 110.056 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.409 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 84.3 t -104.6 139.61 20.27 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.965 -0.46 . . . . 0.0 109.771 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.409 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 39.5 Cg_endo -51.26 146.2 24.7 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 O-C-N 123.709 1.373 . . . . 21.949999999999999 111.613 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.49 151.08 48.07 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.861 0.838 . . . . 20.91 111.524 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.423 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 52.6 ttp180 -126.02 153.35 44.51 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.2 tt -96.93 116.97 30.11 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.541 -0.724 . . . . 0.0 109.705 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.3 t -100.51 -27.0 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.607 -0.683 . . . . 0.0 110.516 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.69 162.4 35.49 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.132 -1.027 . . . . 0.0 112.124 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 32.6 ptt85 -140.76 139.0 34.54 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.322 0.582 . . . . 29.050000000000001 109.858 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.407 ' NE2' ' CG ' ' A' ' 63' ' ' GLN . 20.0 t-160 -143.32 111.45 6.15 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.653 -0.654 . . . . 27.969999999999999 110.264 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -105.64 135.85 46.31 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.33 0.586 . . . . 25.25 111.135 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -115.87 82.26 1.74 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.703 -0.623 . . . . 0.0 109.348 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 54' ' ' ILE . 16.3 pt -84.47 128.38 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.43 -0.794 . . . . 36.109999999999999 111.668 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.6 m -120.57 132.13 55.0 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.492 -0.929 . . . . 33.979999999999997 108.492 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -88.69 169.89 11.28 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.664 0.745 . . . . 45.039999999999999 111.271 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.14 -7.48 13.47 Favored Glycine 0 N--CA 1.495 2.604 0 O-C-N 121.82 -0.55 . . . . 39.469999999999999 112.148 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -101.41 7.66 42.5 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 119.369 1.585 . . . . 0.0 110.682 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.07 -28.75 8.99 Favored Glycine 0 N--CA 1.493 2.457 0 O-C-N 121.193 -0.942 . . . . 0.0 110.892 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.26 141.24 58.84 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.232 -1.158 . . . . 62.780000000000001 109.617 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.8 t -135.58 153.18 51.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.446 -0.784 . . . . 0.0 110.745 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -120.98 123.36 42.23 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.536 -0.728 . . . . 0.0 109.735 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.407 ' CG ' ' NE2' ' A' ' 51' ' ' HIS . 50.7 tt0 -99.15 136.6 38.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.659 -0.651 . . . . 0.0 110.827 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.94 131.68 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 CA-C-O 121.681 0.753 . . . . 37.939999999999998 110.352 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -126.91 127.45 44.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.955 -0.466 . . . . 0.0 110.055 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.11 172.63 32.74 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.304 -1.518 . . . . 31.82 109.304 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -115.61 159.18 21.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.403 -1.057 . . . . 0.0 110.085 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.65 96.55 0.01 OUTLIER Glycine 0 N--CA 1.501 2.98 0 O-C-N 121.424 -0.797 . . . . 22.620000000000001 111.531 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.7 m -45.56 133.31 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 O-C-N 121.338 -1.095 . . . . 17.510000000000002 111.589 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.421 HG21 ' HG2' ' A' ' 72' ' ' GLU . 11.1 m 41.6 35.97 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 CA-C-O 121.619 0.723 . . . . 20.550000000000001 111.408 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.4 21.5 58.34 Favored Glycine 0 N--CA 1.495 2.584 0 O-C-N 121.753 -0.592 . . . . 18.289999999999999 112.398 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.421 ' HG2' HG21 ' A' ' 70' ' ' VAL . 3.6 pt-20 -146.21 152.85 39.88 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 119.111 1.455 . . . . 0.0 112.473 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -118.56 72.95 10.81 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 108.449 -0.945 . . . . 18.210000000000001 108.449 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -55.01 139.64 79.8 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 O-C-N 123.781 1.411 . . . . 17.609999999999999 112.284 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.424 ' CZ3' ' HG2' ' A' ' 77' ' ' ARG . 5.2 t90 -99.56 75.54 1.95 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.409 ' CD1' ' CG2' ' A' ' 37' ' ' ILE . 12.4 mt -61.03 119.77 8.95 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.682 -0.636 . . . . 20.57 112.084 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.424 ' HG2' ' CZ3' ' A' ' 75' ' ' TRP . 18.1 mtm180 -86.48 157.86 55.2 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -53.84 128.28 29.0 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 O-C-N 123.492 1.259 . . . . 27.039999999999999 111.093 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.68 -16.59 56.16 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.769 -0.933 . . . . 24.739999999999998 110.769 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -88.17 164.75 15.52 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.133 -1.216 . . . . 29.379999999999999 110.533 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.18 149.82 34.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.586 -0.696 . . . . 0.0 110.124 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -118.65 147.54 43.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.49 -0.756 . . . . 18.559999999999999 109.17 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -143.34 139.85 30.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.168 -0.957 . . . . 0.0 111.124 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.443 ' CE1' ' CG2' ' A' ' 35' ' ' ILE . 53.2 p90 -150.92 159.73 44.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.614 -0.679 . . . . 26.649999999999999 109.716 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.2 m -102.12 136.64 41.6 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.363 -0.836 . . . . 28.140000000000001 110.92 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 17.9 t -124.95 170.25 11.29 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.681 -0.637 . . . . 33.880000000000003 109.912 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -140.54 125.34 2.85 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.827 -1.177 . . . . 31.800000000000001 110.495 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 76.2 t -129.98 152.26 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.592 -0.946 . . . . 0.0 109.293 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.1 tt -111.01 142.91 42.52 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.627 -0.671 . . . . 0.0 110.712 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.427 HD11 ' CD1' ' A' ' 31' ' ' PHE . 89.4 mt -121.67 145.21 48.24 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.576 -0.703 . . . . 38.68 109.893 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -79.16 -26.73 42.72 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.211 -0.93 . . . . 0.0 110.939 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.9 p -124.43 172.29 9.27 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.361 -0.837 . . . . 31.629999999999999 110.729 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.456 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 48.8 mt-10 -86.56 12.38 10.59 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.62 -0.675 . . . . 0.0 111.58 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -141.47 144.89 34.63 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.039 -1.038 . . . . 0.0 109.78 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 178.77 158.89 22.15 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 118.74 -1.695 . . . . 28.050000000000001 112.275 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -119.71 129.42 54.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 122.117 -0.637 . . . . 0.0 109.322 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 49.2 ttm -125.14 121.18 33.49 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.249 -0.907 . . . . 0.0 111.155 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -123.82 150.15 44.87 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.56 171.28 36.69 Favored Glycine 0 N--CA 1.5 2.931 0 C-N-CA 118.337 -1.887 . . . . 29.620000000000001 111.605 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 114' ' ' PRO . 51.6 m80 -135.3 153.97 51.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.895 -0.767 . . . . 0.0 109.685 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.437 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 5.3 m-85 -119.16 126.1 50.78 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.519 -0.738 . . . . 27.050000000000001 109.74 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -80.98 121.93 26.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.898 -1.126 . . . . 0.0 109.359 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.423 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 91.6 mmm -119.68 161.47 20.65 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.112 0.482 . . . . 0.0 110.066 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.5 m -140.86 127.62 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.551 -0.718 . . . . 23.280000000000001 110.335 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.88 167.47 21.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.585 -0.697 . . . . 0.0 109.581 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -64.06 -29.63 70.76 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.136 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -73.3 -11.19 60.41 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.534 -0.729 . . . . 0.0 111.136 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.91 -7.2 52.56 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 120.075 -1.059 . . . . 30.43 110.54 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 41.2 m -57.47 136.28 56.66 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.015 -1.285 . . . . 0.0 110.106 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -101.57 141.19 34.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.433 -0.792 . . . . 0.0 110.959 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 46.8 p90 -168.54 146.7 4.13 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.677 -0.639 . . . . 28.030000000000001 109.883 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.3 pt -102.63 159.27 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.673 -0.642 . . . . 0.0 111.222 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.02 97.13 50.64 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.429 ' HB3' ' CD2' ' A' ' 100' ' ' HIS . 46.0 Cg_endo -59.75 143.44 99.63 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 O-C-N 123.962 1.506 . . . . 33.310000000000002 112.332 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.437 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 72.7 mt -108.13 120.72 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.301 -0.999 . . . . 30.59 108.301 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -47.36 161.23 0.08 Allowed 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.304 0.573 . . . . 30.780000000000001 111.818 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -99.93 118.05 35.53 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.78 -0.575 . . . . 0.0 110.778 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.422 ' CE1' ' HG3' ' A' ' 15' ' ' PRO . 50.5 p90 -110.68 166.24 11.18 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.359 -0.978 . . . . 30.66 108.359 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.2 t -113.18 153.98 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.172 -0.955 . . . . 0.0 110.48 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.46 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.4 mp -113.35 130.57 56.25 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.169 -0.678 . . . . 39.149999999999999 109.169 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.4 m . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.668 -0.645 . . . . 0.0 110.062 -179.801 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 60.0 mtt180 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 120.734 0.302 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.418 ' CE2' HG23 ' A' ' 109' ' ' THR . 44.6 m-85 -123.77 119.56 30.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.505 -0.747 . . . . 31.93 110.501 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -156.86 132.89 9.65 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.43 0.633 . . . . 0.0 110.081 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.5 t -151.74 115.45 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.618 -0.676 . . . . 0.0 109.755 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -106.15 128.8 54.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.667 -0.646 . . . . 0.0 109.82 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.8 t -118.9 138.99 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.92 -0.487 . . . . 28.210000000000001 109.896 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -122.5 135.82 54.74 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.39 -0.818 . . . . 0.0 109.935 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.9 t -129.29 136.88 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.639 -0.663 . . . . 27.949999999999999 110.36 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -126.79 105.08 23.21 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.687 -0.633 . . . . 0.0 110.758 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -82.9 165.01 15.5 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 O-C-N 123.796 1.419 . . . . 33.0 110.808 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -157.69 131.62 8.07 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.725 0.774 . . . . 54.100000000000001 110.219 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -61.22 140.12 58.0 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.718 -0.614 . . . . 0.0 111.507 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 88.7 mt -116.95 82.39 1.8 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.944 0.878 . . . . 0.0 110.373 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.99 -34.64 75.62 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.137 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -69.9 -23.37 63.23 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.315 -0.865 . . . . 0.0 111.15 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -121.46 39.12 3.92 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.274 -0.892 . . . . 52.369999999999997 110.983 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.1 p -158.92 149.78 20.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.292 -0.88 . . . . 55.189999999999998 111.015 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.8 t -120.33 92.9 47.83 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.46 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 48.6 Cg_endo -66.23 -23.05 52.82 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 O-C-N 123.913 1.481 . . . . 51.57 111.894 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -67.25 -22.15 65.69 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.257 -0.902 . . . . 0.0 111.141 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -105.6 23.22 14.18 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.261 -0.9 . . . . 0.0 110.937 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.08 27.38 73.43 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.6 mtt85 -121.0 94.48 4.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.533 -0.98 . . . . 0.0 110.023 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.46 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 61.3 m-85 -105.24 134.91 47.56 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.498 -0.751 . . . . 46.07 109.26 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -115.51 121.18 41.9 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.082 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.442 ' CD1' ' CD1' ' A' ' 90' ' ' LEU . 87.8 m-85 -116.64 133.3 56.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.509 -0.744 . . . . 38.880000000000003 109.727 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.51 131.66 55.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.279 -0.888 . . . . 34.060000000000002 108.619 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 86' ' ' SER . 25.0 p90 -127.05 144.47 51.02 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.307 -0.957 . . . . 29.030000000000001 111.386 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.3 t -104.21 139.04 39.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.695 -0.628 . . . . 0.0 109.388 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.446 ' CD1' ' CZ ' ' A' ' 84' ' ' TYR . 79.3 mt -108.4 133.94 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.714 0.768 . . . . 0.0 111.493 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -123.91 99.01 6.05 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.526 0.679 . . . . 40.240000000000002 109.718 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 83.9 mt -91.15 117.73 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.875 -0.515 . . . . 20.73 110.492 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -117.32 131.5 56.79 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.442 -0.786 . . . . 0.0 109.35 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -96.43 117.61 31.24 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 120.261 -0.575 . . . . 21.34 110.235 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -118.0 17.42 14.12 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.318 -0.864 . . . . 0.0 110.525 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.3 178.28 53.95 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.519 -1.432 . . . . 29.100000000000001 109.519 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.96 -42.55 13.06 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.572 -0.958 . . . . 0.0 110.282 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.406 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 86.4 t -98.69 139.96 21.46 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.954 -0.466 . . . . 0.0 109.982 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.406 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 40.3 Cg_endo -53.03 145.65 40.86 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 O-C-N 123.805 1.423 . . . . 21.949999999999999 111.67 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.56 152.24 45.36 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.687 0.756 . . . . 20.91 111.22 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.426 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 18.2 ptt-85 -127.76 153.85 46.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.803 -0.561 . . . . 0.0 109.665 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.5 tt -94.66 117.05 29.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.384 -0.823 . . . . 0.0 109.247 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.7 m -100.93 -24.44 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.732 -0.605 . . . . 0.0 111.194 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.44 163.1 33.76 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.19 -1.004 . . . . 0.0 112.081 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -142.06 140.05 32.46 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.542 0.687 . . . . 29.050000000000001 110.517 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.406 ' CD2' ' OD1' ' A' ' 65' ' ' ASP . 20.8 t-160 -144.39 112.93 6.59 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.42 0.628 . . . . 27.969999999999999 109.809 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -103.61 135.93 44.28 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.499 0.666 . . . . 25.25 111.532 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -115.8 82.31 1.74 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 54' ' ' ILE . 13.1 pt -83.1 127.11 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 121.75 0.786 . . . . 36.109999999999999 111.567 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.4 m -122.0 130.03 52.96 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.732 -0.84 . . . . 33.979999999999997 108.732 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -91.56 169.77 10.48 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.757 0.789 . . . . 45.039999999999999 111.493 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.98 -5.91 16.52 Favored Glycine 0 N--CA 1.496 2.683 0 O-C-N 121.856 -0.527 . . . . 39.469999999999999 112.345 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -100.26 5.58 44.61 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 119.501 1.65 . . . . 0.0 110.636 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.91 -27.34 10.2 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.48 141.43 58.77 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.164 -1.198 . . . . 62.780000000000001 109.228 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.8 p -133.73 150.06 51.49 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.664 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -121.93 121.86 38.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.498 -0.751 . . . . 0.0 109.601 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.401 ' CG ' ' NE2' ' A' ' 51' ' ' HIS . 51.9 tt0 -100.53 134.86 42.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.667 -0.646 . . . . 0.0 110.705 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.7 t -128.93 129.97 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.714 0.768 . . . . 37.939999999999998 110.214 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.406 ' OD1' ' CD2' ' A' ' 51' ' ' HIS . 58.9 m-20 -125.58 126.87 45.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.86 -0.525 . . . . 0.0 109.808 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.03 146.27 15.49 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.51 -1.436 . . . . 31.82 109.51 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -71.84 154.26 41.38 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.607 -0.937 . . . . 0.0 110.196 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 50.05 -170.63 0.17 Allowed Glycine 0 N--CA 1.497 2.762 0 O-C-N 121.373 -0.829 . . . . 22.620000000000001 111.268 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.3 m -129.92 128.0 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.89 -0.77 . . . . 17.510000000000002 109.155 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.41 HG21 ' HG2' ' A' ' 72' ' ' GLU . 11.5 m 41.49 33.48 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 CA-C-O 121.649 0.738 . . . . 20.550000000000001 111.397 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.59 18.76 61.32 Favored Glycine 0 N--CA 1.498 2.767 0 O-C-N 121.769 -0.582 . . . . 18.289999999999999 113.101 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.41 ' HG2' HG21 ' A' ' 70' ' ' VAL . 9.8 pt-20 -146.59 150.2 35.02 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 119.386 1.593 . . . . 0.0 112.618 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -116.14 72.85 4.85 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.257 -1.016 . . . . 18.210000000000001 108.257 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -55.1 142.49 77.3 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 O-C-N 123.761 1.401 . . . . 17.609999999999999 112.331 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.426 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 3.1 t90 -101.87 76.54 1.63 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.4 mt -61.84 117.87 6.45 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.612 -0.68 . . . . 20.57 111.921 -178.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -87.83 159.04 49.8 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -54.0 129.07 32.45 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 O-C-N 123.579 1.305 . . . . 27.039999999999999 111.119 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.62 -18.03 49.0 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.929 -0.868 . . . . 24.739999999999998 110.929 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -87.33 165.07 15.89 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.005 -1.291 . . . . 29.379999999999999 110.458 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.22 148.69 33.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.586 -0.696 . . . . 0.0 110.289 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.403 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 89.4 t80 -117.71 143.47 46.17 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.085 -0.709 . . . . 18.559999999999999 109.085 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -146.99 140.89 25.89 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.2 -0.938 . . . . 0.0 111.314 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.446 ' CZ ' ' CD1' ' A' ' 35' ' ' ILE . 42.7 p90 -152.8 162.3 41.45 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.539 -0.725 . . . . 26.649999999999999 109.653 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 54.2 m -98.61 136.63 38.42 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.439 -0.788 . . . . 28.140000000000001 111.248 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 15.2 t -125.06 169.11 12.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.639 -0.663 . . . . 33.880000000000003 109.774 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -139.85 126.3 3.22 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.769 -1.205 . . . . 31.800000000000001 110.487 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 77.9 t -131.28 151.7 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.63 -0.923 . . . . 0.0 109.31 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.18 144.39 40.41 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.582 -0.699 . . . . 0.0 110.862 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.442 ' CD1' ' CD1' ' A' ' 31' ' ' PHE . 94.6 mt -122.33 148.07 45.49 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.621 -0.674 . . . . 38.68 110.026 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.408 ' O ' ' CE1' ' A' ' 29' ' ' TYR . 38.6 tp10 -79.01 -26.4 43.24 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.39 -0.819 . . . . 0.0 110.757 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.2 p -124.09 172.1 9.26 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.336 -0.853 . . . . 31.629999999999999 110.621 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.457 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 50.4 mt-10 -85.42 10.67 12.18 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.607 -0.683 . . . . 0.0 111.63 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -141.39 145.49 35.42 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.125 -0.984 . . . . 0.0 109.811 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.6 155.46 15.24 Favored Glycine 0 N--CA 1.496 2.682 0 C-N-CA 118.871 -1.633 . . . . 28.050000000000001 112.219 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -120.47 130.2 54.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 122.125 -0.632 . . . . 0.0 109.374 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 56.1 ttm -126.82 123.77 38.1 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.37 -0.831 . . . . 0.0 111.533 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -123.1 148.93 45.13 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.67 175.52 41.33 Favored Glycine 0 N--CA 1.499 2.842 0 C-N-CA 118.738 -1.696 . . . . 29.620000000000001 111.05 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -140.04 157.79 45.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.828 -0.807 . . . . 0.0 110.675 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -114.62 130.01 56.74 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.673 -0.642 . . . . 27.050000000000001 109.787 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -82.02 121.81 27.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 108.928 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.418 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 2.0 ttm -121.93 161.92 21.98 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.204 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.5 m -141.65 130.34 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.639 -0.663 . . . . 23.280000000000001 110.486 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.14 166.73 21.73 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.51 -0.744 . . . . 0.0 109.609 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -66.92 -29.36 69.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.533 -0.729 . . . . 0.0 110.284 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -77.36 -4.29 44.43 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.426 -0.796 . . . . 0.0 111.359 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.27 -9.7 54.02 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.087 -1.054 . . . . 30.43 110.519 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.418 HG23 ' CE2' ' A' ' 7' ' ' TYR . 57.6 m -57.02 133.61 55.09 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.045 -1.268 . . . . 0.0 110.093 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -102.32 139.44 37.93 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -0.866 . . . . 0.0 110.668 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.418 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 38.9 p90 -165.26 144.05 6.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.705 -0.622 . . . . 28.030000000000001 109.886 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.8 pt -101.85 158.89 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.636 -0.665 . . . . 0.0 110.874 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.01 95.12 49.1 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -60.48 144.73 99.54 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 O-C-N 123.958 1.504 . . . . 33.310000000000002 112.24 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 71.7 mt -108.65 121.55 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.698 -0.852 . . . . 30.59 108.698 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.61 167.05 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.258 0.552 . . . . 30.780000000000001 111.578 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -95.03 118.92 32.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.65 -0.656 . . . . 0.0 110.759 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -112.59 160.34 17.95 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.343 -0.984 . . . . 30.66 108.343 178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.1 t -116.86 152.98 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.169 -0.957 . . . . 0.0 110.753 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.459 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.3 mp -114.16 131.26 56.5 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.098 -0.704 . . . . 39.149999999999999 109.098 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 40.4 p . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.607 -0.683 . . . . 0.0 110.033 -179.831 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.9 0.381 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.413 ' CE2' HG22 ' A' ' 109' ' ' THR . 37.1 m-85 -112.24 104.65 12.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.546 -0.721 . . . . 31.93 110.158 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.29 131.58 14.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.655 -0.653 . . . . 0.0 109.982 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.2 t -151.98 114.53 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.519 -0.738 . . . . 0.0 109.522 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -107.58 129.88 54.94 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.636 0.731 . . . . 0.0 109.954 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.3 t -117.35 139.69 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 109.562 -0.533 . . . . 28.210000000000001 109.562 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -120.49 137.19 54.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.409 -0.807 . . . . 0.0 110.017 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.7 t -127.46 135.99 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.304 0.573 . . . . 27.949999999999999 110.056 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.2 m -125.0 104.03 30.07 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.77 -0.581 . . . . 0.0 110.392 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -84.16 164.31 13.21 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 O-C-N 123.927 1.488 . . . . 33.0 110.907 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -156.62 131.86 9.22 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.592 0.711 . . . . 54.100000000000001 109.723 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -60.1 138.99 57.77 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.279 0.562 . . . . 0.0 111.146 -178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.8 tp -116.01 78.05 1.15 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 122.075 0.941 . . . . 0.0 110.476 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.82 -35.45 69.93 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.119 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -68.01 -24.05 65.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.358 -0.839 . . . . 0.0 110.895 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -121.77 41.66 3.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.365 -0.835 . . . . 52.369999999999997 110.416 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.7 t -163.69 150.98 12.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.506 -0.747 . . . . 55.189999999999998 110.789 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.2 t -122.49 94.52 47.65 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.593 -0.692 . . . . 0.0 109.246 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.45 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 49.8 Cg_endo -66.17 -22.91 53.39 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.773 1.407 . . . . 51.57 111.466 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.59 -23.95 67.43 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.341 -0.849 . . . . 0.0 110.819 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -105.96 23.13 14.48 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.357 -0.84 . . . . 0.0 110.705 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.33 29.44 73.15 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.9 ttt85 -121.5 93.05 3.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.634 -0.921 . . . . 0.0 110.13 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.45 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 56.6 m-85 -104.53 133.19 49.81 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.035 -0.728 . . . . 46.07 109.035 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.0 118.87 34.11 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.938 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -114.05 134.25 54.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.629 -0.669 . . . . 38.880000000000003 109.72 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.91 132.08 55.47 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.228 -0.92 . . . . 34.060000000000002 108.563 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 86' ' ' SER . 22.9 p90 -129.06 144.56 51.24 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.175 -1.01 . . . . 29.030000000000001 111.476 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.2 m -104.4 139.95 38.62 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.717 -0.614 . . . . 0.0 109.788 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.432 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 43.7 mm -105.55 132.29 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.735 0.779 . . . . 0.0 111.535 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -123.49 98.02 5.66 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.482 0.658 . . . . 40.240000000000002 109.722 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.8 mt -91.18 117.27 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.762 -0.586 . . . . 20.73 110.458 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -117.99 135.56 54.07 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.512 -0.742 . . . . 0.0 109.453 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -92.67 117.76 30.33 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.721 -0.612 . . . . 21.34 110.867 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.16 9.34 17.14 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.435 -0.79 . . . . 0.0 110.456 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.9 173.71 49.13 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.348 -1.501 . . . . 29.100000000000001 109.348 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.38 -31.01 21.71 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.583 -0.951 . . . . 0.0 110.216 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.414 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 87.2 t -106.71 140.6 21.51 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.853 -0.529 . . . . 0.0 110.076 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.414 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 40.3 Cg_endo -53.52 148.38 34.82 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 O-C-N 123.752 1.396 . . . . 21.949999999999999 111.673 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.29 151.12 47.3 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.68 0.752 . . . . 20.91 111.377 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.416 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 45.5 ttp180 -126.06 155.31 41.75 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.0 tt -99.29 117.78 34.5 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.554 -0.716 . . . . 0.0 109.711 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.3 t -100.48 -29.4 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.547 -0.72 . . . . 0.0 111.015 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.27 164.76 29.27 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 118.981 -1.088 . . . . 0.0 112.42 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -142.72 140.54 31.53 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.425 0.631 . . . . 29.050000000000001 110.223 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -142.92 114.06 7.76 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.315 0.578 . . . . 27.969999999999999 109.759 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.419 ' CE3' ' HA3' ' A' ' 99' ' ' GLY . 86.6 m95 -100.38 133.4 44.85 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.676 -0.64 . . . . 25.25 110.971 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -115.51 77.14 1.05 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.589 -0.694 . . . . 0.0 109.139 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 54' ' ' ILE . 17.1 pt -82.85 127.99 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.468 -0.77 . . . . 36.109999999999999 111.881 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.5 m -120.79 130.09 53.85 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.329 -0.989 . . . . 33.979999999999997 108.329 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -89.06 169.98 11.04 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.701 0.762 . . . . 45.039999999999999 111.553 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.06 -5.74 8.37 Favored Glycine 0 N--CA 1.495 2.588 0 O-C-N 121.88 -0.513 . . . . 39.469999999999999 112.246 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -101.54 6.58 42.3 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 119.417 1.608 . . . . 0.0 110.516 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.75 -31.13 6.74 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -62.99 141.95 58.56 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.316 -1.108 . . . . 62.780000000000001 110.019 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.1 t -135.31 153.2 51.95 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.574 -0.704 . . . . 0.0 110.653 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -121.97 124.36 43.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.535 -0.728 . . . . 0.0 110.184 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -102.27 134.79 44.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.674 -0.641 . . . . 0.0 110.593 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.2 t -128.49 131.57 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.587 -0.696 . . . . 37.939999999999998 110.086 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -125.59 126.72 45.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.813 -0.554 . . . . 0.0 110.137 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.12 148.84 20.71 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.463 -1.455 . . . . 31.82 109.463 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -75.27 154.7 37.31 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.528 -0.984 . . . . 0.0 110.505 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.09 -170.38 0.1 Allowed Glycine 0 N--CA 1.499 2.896 0 O-C-N 121.46 -0.775 . . . . 22.620000000000001 111.454 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.85 128.88 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.862 -0.787 . . . . 17.510000000000002 109.331 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.424 HG22 ' HG2' ' A' ' 72' ' ' GLU . 10.9 m 41.14 33.77 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 CA-C-O 121.485 0.66 . . . . 20.550000000000001 111.844 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.93 17.45 67.52 Favored Glycine 0 N--CA 1.498 2.799 0 O-C-N 121.456 -0.777 . . . . 18.289999999999999 112.957 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.424 ' HG2' HG22 ' A' ' 70' ' ' VAL . 15.4 pt-20 -145.23 150.45 36.71 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-N 119.275 1.537 . . . . 0.0 111.856 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -115.37 75.57 4.68 Favored Pre-proline 0 N--CA 1.492 1.637 0 N-CA-C 108.932 -0.766 . . . . 18.210000000000001 108.932 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -57.49 138.07 84.42 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 O-C-N 123.885 1.466 . . . . 17.609999999999999 112.043 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.416 ' CD1' ' HB2' ' A' ' 46' ' ' ARG . 4.3 t90 -100.82 75.89 1.74 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.95 116.56 3.87 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.545 -0.722 . . . . 20.57 111.239 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.405 ' HG2' ' CZ3' ' A' ' 75' ' ' TRP . 4.5 mtt180 -86.83 159.25 52.3 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -54.39 125.87 20.36 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 O-C-N 123.585 1.308 . . . . 27.039999999999999 110.75 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.51 -18.21 43.8 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.732 -0.947 . . . . 24.739999999999998 110.732 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -89.24 165.64 14.3 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.996 -1.297 . . . . 29.379999999999999 110.243 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.27 151.79 36.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.494 -0.753 . . . . 0.0 110.5 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -118.17 147.53 43.26 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.479 -0.763 . . . . 18.559999999999999 109.042 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -144.42 140.73 29.17 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.192 -0.943 . . . . 0.0 111.082 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.432 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 47.2 p90 -150.16 160.0 44.0 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.653 -0.654 . . . . 26.649999999999999 109.671 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 62.8 m -100.37 136.54 40.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.464 -0.772 . . . . 28.140000000000001 110.651 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 29.2 t -124.04 167.9 13.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.578 -0.701 . . . . 33.880000000000003 110.033 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.15 122.46 2.09 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.876 -1.154 . . . . 31.800000000000001 110.274 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 80.3 t -129.72 148.19 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.575 -0.956 . . . . 0.0 109.352 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.0 mt -107.97 144.49 35.19 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.522 -0.736 . . . . 0.0 110.408 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.2 tp -121.57 144.07 48.94 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.581 -0.699 . . . . 38.68 109.787 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -105.15 -2.19 24.55 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.329 -0.857 . . . . 0.0 111.332 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.51 ' O ' ' CB ' ' A' ' 93' ' ' GLU . 29.6 m -109.29 -35.96 6.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.068 -1.02 . . . . 31.629999999999999 110.931 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.51 ' CB ' ' O ' ' A' ' 92' ' ' THR . 33.3 tt0 87.72 -14.07 0.44 Allowed 'General case' 0 N--CA 1.524 3.266 0 C-N-CA 123.196 0.598 . . . . 0.0 111.059 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -139.97 146.41 39.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.119 -0.988 . . . . 0.0 109.832 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 160.79 179.85 35.81 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 118.421 -1.847 . . . . 28.050000000000001 112.643 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -121.66 130.79 53.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 122.237 -0.567 . . . . 0.0 109.668 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.411 ' CG ' ' CG2' ' A' ' 54' ' ' ILE . 0.5 OUTLIER -126.58 124.61 40.36 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.314 -0.866 . . . . 0.0 111.543 -178.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -118.05 151.4 37.59 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.419 ' HA3' ' CE3' ' A' ' 52' ' ' TRP . . . -156.02 167.58 33.31 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 118.873 -1.632 . . . . 29.620000000000001 110.902 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.423 ' CD2' ' HA ' ' A' ' 114' ' ' PRO . 68.9 m80 -137.75 156.87 47.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.73 -0.865 . . . . 0.0 109.846 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.45 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 12.2 m-85 -117.94 127.21 53.62 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.546 -0.721 . . . . 27.050000000000001 110.154 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -85.64 121.45 28.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.929 -1.107 . . . . 0.0 108.732 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.43 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 76.8 mtp -123.87 164.06 20.01 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.239 0.543 . . . . 0.0 110.672 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.1 m -142.8 129.21 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.678 -0.639 . . . . 23.280000000000001 110.377 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.52 166.85 22.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.431 -0.793 . . . . 0.0 109.229 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -63.65 -28.94 70.26 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.108 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -74.01 -12.96 60.79 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.455 -0.778 . . . . 0.0 111.044 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.06 -6.34 43.09 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.351 -1.099 . . . . 30.43 110.351 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.413 HG22 ' CE2' ' A' ' 7' ' ' TYR . 48.0 m -58.62 137.36 57.56 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.082 -1.246 . . . . 0.0 109.952 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -101.42 139.77 36.63 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.362 -0.836 . . . . 0.0 110.947 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.43 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 45.1 p90 -163.02 141.81 8.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.715 -0.616 . . . . 28.030000000000001 109.782 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.4 HG21 HD12 ' A' ' 112' ' ' ILE . 84.9 mt -101.74 157.92 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.738 -0.601 . . . . 0.0 110.813 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.01 95.82 49.22 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.423 ' HA ' ' CD2' ' A' ' 100' ' ' HIS . 46.5 Cg_endo -60.14 146.14 96.9 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 O-C-N 124.013 1.533 . . . . 33.310000000000002 112.201 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.45 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 69.0 mt -111.43 121.55 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.731 -0.84 . . . . 30.59 108.731 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -47.58 161.66 0.08 Allowed 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 121.199 0.524 . . . . 30.780000000000001 111.641 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -98.71 122.95 42.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.584 -0.698 . . . . 0.0 110.807 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -109.86 162.91 14.03 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.409 -0.959 . . . . 30.66 108.409 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.0 t -114.22 155.34 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.338 -0.851 . . . . 0.0 110.253 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.452 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.9 mp -110.63 131.98 54.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.684 -0.635 . . . . 39.149999999999999 109.422 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.8 p . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.807 -0.558 . . . . 0.0 110.126 -179.772 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 120.833 0.349 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -115.42 109.13 17.42 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.566 -0.709 . . . . 31.93 110.154 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 58.8 mtp85 -151.89 135.63 16.3 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.666 0.746 . . . . 0.0 110.347 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.4 t -150.68 116.08 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.478 0.656 . . . . 0.0 109.415 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -107.07 128.93 54.81 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.551 0.691 . . . . 0.0 109.916 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.5 t -118.93 137.27 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.813 -0.554 . . . . 28.210000000000001 109.844 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -123.6 136.61 54.61 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.351 -0.843 . . . . 0.0 109.649 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.9 t -129.05 137.67 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.621 -0.674 . . . . 27.949999999999999 110.688 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.3 t -126.34 105.66 24.59 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.77 -0.581 . . . . 0.0 110.44 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.433 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 51.1 Cg_endo -83.8 166.89 13.18 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 O-C-N 123.799 1.42 . . . . 33.0 111.236 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -157.77 130.19 7.24 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.474 0.654 . . . . 54.100000000000001 109.732 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -60.54 140.03 57.51 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.788 -0.57 . . . . 0.0 111.407 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.6 mt -116.46 81.39 1.61 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.9 0.857 . . . . 0.0 110.462 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.58 -36.08 81.77 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.968 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -69.98 -22.99 63.09 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.366 -0.834 . . . . 0.0 111.127 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -121.33 38.42 4.09 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.218 -0.926 . . . . 52.369999999999997 111.258 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.4 p -160.09 146.47 15.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.269 -0.895 . . . . 55.189999999999998 111.161 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.2 m -117.7 92.09 40.34 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.517 -0.739 . . . . 0.0 109.043 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.43 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 49.3 Cg_endo -66.91 -25.36 45.09 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 O-C-N 123.925 1.487 . . . . 51.57 111.374 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -66.35 -23.93 66.43 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.552 -0.717 . . . . 0.0 110.846 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -106.84 24.51 12.63 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.334 -0.854 . . . . 0.0 110.581 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.5 30.57 73.17 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -120.02 92.37 3.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.602 -0.94 . . . . 0.0 110.111 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.43 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 81.2 m-85 -105.06 131.21 52.87 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.47 -0.769 . . . . 46.07 109.296 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -118.32 120.76 38.59 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.406 -0.809 . . . . 0.0 111.34 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.414 ' CD1' HD11 ' A' ' 90' ' ' LEU . 67.2 m-85 -116.44 134.6 54.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.459 -0.776 . . . . 38.880000000000003 109.819 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -110.92 131.42 55.06 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.379 -0.971 . . . . 34.060000000000002 108.379 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 86' ' ' SER . 23.9 p90 -127.58 143.69 51.15 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.112 -1.035 . . . . 29.030000000000001 111.559 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.2 m -103.25 139.24 38.97 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.403 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 40.6 mm -106.66 133.75 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.626 0.727 . . . . 0.0 111.488 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -123.25 98.78 6.03 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.422 0.63 . . . . 40.240000000000002 109.751 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.3 mt -90.33 116.11 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.653 -0.654 . . . . 20.73 110.408 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -117.91 134.76 54.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.517 -0.739 . . . . 0.0 109.53 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -92.82 117.64 30.23 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 120.234 -0.586 . . . . 21.34 110.503 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.1 11.06 17.53 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.404 -0.81 . . . . 0.0 110.482 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.27 171.62 48.25 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.907 -1.677 . . . . 29.100000000000001 108.907 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.53 -31.89 24.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.442 -1.034 . . . . 0.0 110.09 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.404 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 87.1 t -103.15 139.67 20.33 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.813 -0.555 . . . . 0.0 109.873 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.404 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 40.1 Cg_endo -53.21 145.09 45.32 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 O-C-N 123.891 1.469 . . . . 21.949999999999999 111.748 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.02 151.8 45.74 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.674 0.75 . . . . 20.91 111.112 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.425 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 2.1 ptt85 -127.36 158.68 36.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.768 -0.583 . . . . 0.0 109.596 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.4 tt -96.68 118.06 32.34 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.486 -0.759 . . . . 0.0 109.5 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.1 p -101.2 -24.41 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.589 -0.695 . . . . 0.0 111.071 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.3 163.88 31.65 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.213 -0.929 . . . . 0.0 111.901 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.5 ptt85 -138.16 137.65 37.85 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.437 0.636 . . . . 29.050000000000001 110.201 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.403 ' CD2' ' OD1' ' A' ' 65' ' ' ASP . 20.4 t-160 -142.11 111.29 6.41 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.417 0.627 . . . . 27.969999999999999 109.852 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -103.35 133.8 47.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.682 -0.637 . . . . 25.25 111.396 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -115.77 80.76 1.49 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.416 ' O ' HG13 ' A' ' 54' ' ' ILE . 17.2 pt -86.0 129.14 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.49 -0.756 . . . . 36.109999999999999 111.755 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 86.6 m -120.04 129.96 54.48 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.362 -0.977 . . . . 33.979999999999997 108.362 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -91.15 169.99 10.39 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.582 0.706 . . . . 45.039999999999999 111.309 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.12 -6.72 14.24 Favored Glycine 0 N--CA 1.495 2.633 0 O-C-N 121.848 -0.533 . . . . 39.469999999999999 112.066 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -101.71 6.84 42.04 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 119.357 1.579 . . . . 0.0 110.771 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.75 -33.11 5.18 Favored Glycine 0 N--CA 1.496 2.644 0 C-N-CA 120.329 -0.939 . . . . 0.0 110.983 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.29 142.34 54.82 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.146 -1.208 . . . . 62.780000000000001 109.835 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.3 p -133.49 152.4 51.9 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.599 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -121.15 121.89 38.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.584 -0.698 . . . . 0.0 109.833 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.403 ' CG ' ' NE2' ' A' ' 51' ' ' HIS . 46.9 tt0 -102.4 135.3 44.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.577 -0.702 . . . . 0.0 110.658 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.2 t -129.52 130.44 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.705 0.764 . . . . 37.939999999999998 110.484 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.403 ' OD1' ' CD2' ' A' ' 51' ' ' HIS . 77.9 m-20 -127.41 126.46 42.46 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.06 148.53 20.0 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.806 -1.318 . . . . 31.82 109.806 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -71.09 152.31 43.61 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.447 -1.031 . . . . 0.0 110.22 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 50.52 -172.17 0.14 Allowed Glycine 0 N--CA 1.498 2.812 0 O-C-N 121.403 -0.811 . . . . 22.620000000000001 111.345 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.4 m -129.79 128.53 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.87 -0.782 . . . . 17.510000000000002 109.631 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.426 HG22 ' HG2' ' A' ' 72' ' ' GLU . 10.6 m 41.32 34.62 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 CA-C-O 121.578 0.704 . . . . 20.550000000000001 111.733 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.51 17.06 67.12 Favored Glycine 0 N--CA 1.499 2.837 0 O-C-N 121.658 -0.651 . . . . 18.289999999999999 112.991 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.426 ' HG2' HG22 ' A' ' 70' ' ' VAL . 11.6 pt-20 -145.67 150.36 36.16 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 119.179 1.489 . . . . 0.0 112.118 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -115.75 73.15 4.33 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.85 -0.796 . . . . 18.210000000000001 108.85 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -55.87 141.37 85.57 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 O-C-N 123.876 1.461 . . . . 17.609999999999999 112.281 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.425 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 2.9 t90 -103.43 77.17 1.48 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 tp -61.4 117.68 5.97 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.553 -0.717 . . . . 20.57 111.857 -178.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.4 mtm180 -88.12 159.63 47.68 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -54.69 129.2 33.74 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 O-C-N 123.549 1.289 . . . . 27.039999999999999 111.185 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.11 -19.21 40.03 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 111.045 -0.822 . . . . 24.739999999999998 111.045 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -89.13 166.42 13.85 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.098 -1.236 . . . . 29.379999999999999 110.53 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -147.0 149.88 34.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.556 -0.715 . . . . 0.0 110.384 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -117.27 148.16 41.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.471 -0.768 . . . . 18.559999999999999 109.221 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -144.37 139.77 28.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.229 -0.919 . . . . 0.0 111.258 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.403 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 43.3 p90 -150.6 159.98 44.12 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.549 -0.719 . . . . 26.649999999999999 109.667 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.0 m -102.44 136.79 41.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.388 -0.82 . . . . 28.140000000000001 110.846 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 21.3 t -125.35 169.47 12.29 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.586 -0.696 . . . . 33.880000000000003 110.081 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.16 124.71 2.6 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.834 -1.174 . . . . 31.800000000000001 110.433 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 75.6 t -129.46 150.83 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.699 -0.883 . . . . 0.0 109.272 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 48.3 mt -110.35 143.73 40.14 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.526 -0.734 . . . . 0.0 110.729 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.414 HD11 ' CD1' ' A' ' 31' ' ' PHE . 98.1 mt -122.13 146.12 47.52 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.644 -0.66 . . . . 38.68 109.941 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -73.19 -25.96 60.98 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.379 -0.826 . . . . 0.0 110.773 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.7 t -123.81 173.04 8.42 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.461 -0.774 . . . . 31.629999999999999 110.618 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 37.2 tt0 -85.72 10.28 13.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.665 -0.647 . . . . 0.0 111.576 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -142.12 150.04 40.61 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.125 -0.984 . . . . 0.0 109.919 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.05 165.52 31.45 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 118.868 -1.634 . . . . 28.050000000000001 112.244 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -119.08 129.86 55.3 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 122.173 -0.604 . . . . 0.0 109.444 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 48.4 ttm -125.29 116.44 21.94 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.314 -0.866 . . . . 0.0 111.055 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -129.5 150.58 50.78 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -162.2 178.51 37.99 Favored Glycine 0 N--CA 1.499 2.889 0 C-N-CA 118.743 -1.694 . . . . 29.620000000000001 111.104 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.422 ' CD2' ' HA ' ' A' ' 114' ' ' PRO . 50.9 m80 -134.72 154.0 51.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.73 -0.865 . . . . 0.0 109.972 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.441 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 4.4 m-85 -117.9 127.69 54.1 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.599 -0.688 . . . . 27.050000000000001 109.718 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -81.26 122.11 27.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.971 -1.08 . . . . 0.0 109.053 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.424 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 13.1 tpp -121.61 159.82 25.65 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.078 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.1 m -140.54 129.06 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.517 -0.74 . . . . 23.280000000000001 110.269 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.32 167.34 21.43 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.568 -0.708 . . . . 0.0 109.618 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -64.03 -29.61 70.75 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.95 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -72.39 -12.04 60.95 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.607 -0.683 . . . . 0.0 111.059 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.5 -7.34 50.48 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.415 -1.074 . . . . 30.43 110.415 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.4 m -57.55 135.99 56.7 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.098 -1.236 . . . . 0.0 110.038 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -101.74 141.48 34.53 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.412 -0.805 . . . . 0.0 110.985 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 42.7 p90 -169.39 148.78 3.9 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.65 -0.656 . . . . 28.030000000000001 109.865 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.2 pt -101.98 157.71 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.597 -0.69 . . . . 0.0 111.252 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -118.92 96.89 50.52 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.422 ' HA ' ' CD2' ' A' ' 100' ' ' HIS . 46.3 Cg_endo -58.1 143.3 96.81 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 O-C-N 123.939 1.494 . . . . 33.310000000000002 112.453 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.441 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 70.4 mt -107.51 121.89 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.352 -0.981 . . . . 30.59 108.352 178.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.17 144.61 6.9 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.157 0.503 . . . . 30.780000000000001 111.441 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -91.08 119.4 31.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.718 -0.613 . . . . 0.0 110.313 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.433 ' CD1' ' HG3' ' A' ' 15' ' ' PRO . 34.2 p90 -109.11 168.44 9.37 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.717 -0.845 . . . . 30.66 108.717 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.9 t -114.21 154.67 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.304 -0.873 . . . . 0.0 110.542 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.448 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.4 mp -112.4 133.64 54.38 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.342 -0.614 . . . . 39.149999999999999 109.342 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 95.6 p . . . . . 0 N--CA 1.494 1.754 0 O-C-N 121.681 -0.637 . . . . 0.0 110.046 -179.719 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 82.7 mtt85 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.024 0.44 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.419 ' CE2' HG21 ' A' ' 109' ' ' THR . 29.2 m-85 -114.82 98.96 7.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.56 -0.713 . . . . 31.93 110.109 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 80.2 mtt85 -146.59 137.19 23.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.602 0.715 . . . . 0.0 110.216 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.6 t -152.94 114.12 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.433 0.635 . . . . 0.0 109.305 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -109.06 130.16 55.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.539 -0.726 . . . . 0.0 109.981 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.2 t -118.34 141.55 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.811 -0.556 . . . . 28.210000000000001 109.97 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -120.1 137.66 54.01 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.465 -0.772 . . . . 0.0 109.817 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.1 t -128.65 137.4 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.607 -0.683 . . . . 27.949999999999999 110.45 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -125.97 106.11 25.67 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.778 -0.576 . . . . 0.0 110.624 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -84.52 165.83 12.22 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 O-C-N 123.923 1.486 . . . . 33.0 111.091 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -158.14 131.09 7.36 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.52 0.676 . . . . 54.100000000000001 109.953 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -61.5 139.97 58.15 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.766 -0.584 . . . . 0.0 111.563 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 73.8 mt -116.32 80.81 1.51 Allowed 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.912 0.863 . . . . 0.0 110.349 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.03 -35.88 81.75 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.901 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -69.93 -22.83 63.16 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.375 -0.828 . . . . 0.0 111.107 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -122.23 43.38 2.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.382 -0.824 . . . . 52.369999999999997 110.959 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.6 p -164.98 147.42 8.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.299 -0.876 . . . . 55.189999999999998 111.043 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.3 m -116.37 91.43 33.16 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.43 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.0 Cg_endo -65.09 -24.85 59.04 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 O-C-N 123.877 1.462 . . . . 51.57 111.229 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -67.94 -22.82 65.03 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.381 -0.824 . . . . 0.0 110.834 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -106.51 23.34 14.37 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.265 -0.897 . . . . 0.0 110.615 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.98 29.28 73.44 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -120.41 94.07 4.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.596 -0.943 . . . . 0.0 110.171 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.43 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 77.3 m-85 -105.48 132.18 51.97 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.495 -0.753 . . . . 46.07 109.278 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.72 120.62 40.7 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.093 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.423 ' CG ' HD23 ' A' ' 120' ' ' LEU . 87.7 m-85 -116.01 134.78 54.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.55 -0.718 . . . . 38.880000000000003 109.784 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.62 132.02 54.86 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.436 -0.95 . . . . 34.060000000000002 108.436 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 86' ' ' SER . 20.2 p90 -127.72 142.85 51.21 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.083 -1.047 . . . . 29.030000000000001 111.262 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.5 p -105.2 140.65 38.03 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.438 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 44.6 mm -105.3 131.8 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.841 0.829 . . . . 0.0 111.604 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -122.46 95.74 4.76 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.183 -0.673 . . . . 40.240000000000002 109.183 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.412 ' CG2' ' CD1' ' A' ' 76' ' ' LEU . 75.4 mt -90.84 117.81 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.792 -0.567 . . . . 20.73 110.657 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -117.06 135.72 53.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.543 -0.723 . . . . 0.0 109.398 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -91.46 117.23 29.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.801 -0.562 . . . . 21.34 110.651 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.51 9.29 18.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.536 -0.728 . . . . 0.0 110.579 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.27 -177.08 51.7 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.182 -1.567 . . . . 29.100000000000001 109.182 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.39 -30.99 11.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.492 -1.005 . . . . 0.0 110.063 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.42 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 86.2 t -105.4 140.56 21.27 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.8 -0.563 . . . . 0.0 109.545 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.42 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 39.2 Cg_endo -51.4 141.89 39.64 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 O-C-N 123.731 1.385 . . . . 21.949999999999999 111.9 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.7 151.73 46.12 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.488 0.661 . . . . 20.91 110.937 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -127.57 158.89 36.26 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.827 -0.546 . . . . 0.0 109.844 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.7 tt -97.88 117.12 31.48 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.449 -0.782 . . . . 0.0 109.404 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -100.69 -27.76 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.666 -0.646 . . . . 0.0 110.569 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.11 162.83 34.3 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.833 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.7 ptt85 -142.41 139.97 31.83 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.44 0.638 . . . . 29.050000000000001 110.206 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -142.24 113.67 7.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.72 -0.613 . . . . 27.969999999999999 109.699 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.424 ' CH2' HD11 ' A' ' 115' ' ' ILE . 92.4 m95 -101.92 133.5 46.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.74 -0.6 . . . . 25.25 110.792 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -116.33 77.33 1.09 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.633 -0.667 . . . . 0.0 109.338 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.42 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.4 pt -84.17 129.19 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.922 0.868 . . . . 36.109999999999999 112.149 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.5 m -121.0 130.99 54.02 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.325 -0.991 . . . . 33.979999999999997 108.325 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -88.64 170.59 10.69 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.725 0.774 . . . . 45.039999999999999 111.427 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.55 -7.67 8.18 Favored Glycine 0 N--CA 1.494 2.542 0 O-C-N 121.823 -0.548 . . . . 39.469999999999999 112.299 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -101.21 6.92 43.21 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 119.411 1.605 . . . . 0.0 110.691 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.77 -28.33 9.47 Favored Glycine 0 N--CA 1.495 2.587 0 O-C-N 121.204 -0.935 . . . . 0.0 110.955 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.76 142.0 58.56 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.256 -1.143 . . . . 62.780000000000001 109.779 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.7 t -135.06 153.16 52.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.489 -0.757 . . . . 0.0 110.756 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -121.51 123.33 41.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.535 -0.728 . . . . 0.0 110.076 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -102.36 135.61 43.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.75 -0.594 . . . . 0.0 110.742 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.9 t -128.67 132.9 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.628 -0.67 . . . . 37.939999999999998 109.85 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -124.64 127.48 47.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.828 -0.545 . . . . 0.0 110.452 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -153.94 170.32 32.56 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.215 -1.554 . . . . 31.82 109.215 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -114.99 159.98 20.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.374 -1.074 . . . . 0.0 110.141 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.44 96.25 0.01 OUTLIER Glycine 0 N--CA 1.5 2.957 0 O-C-N 121.328 -0.857 . . . . 22.620000000000001 111.444 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.4 m -46.32 133.37 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.453 0 O-C-N 121.365 -1.079 . . . . 17.510000000000002 111.425 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.0 m 41.45 34.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 CA-C-O 121.587 0.708 . . . . 20.550000000000001 111.312 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.62 23.14 54.42 Favored Glycine 0 N--CA 1.495 2.603 0 O-C-N 121.714 -0.616 . . . . 18.289999999999999 112.301 178.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -144.21 151.25 39.22 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 119.125 1.463 . . . . 0.0 112.335 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -117.86 72.19 8.33 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.152 -1.055 . . . . 18.210000000000001 108.152 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -54.8 141.79 75.78 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 O-C-N 123.757 1.399 . . . . 17.609999999999999 112.385 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -103.75 75.32 1.3 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.412 ' CD1' ' CG2' ' A' ' 37' ' ' ILE . 15.0 mt -60.43 119.66 8.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.706 -0.621 . . . . 20.57 111.915 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -86.05 158.45 55.72 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -53.48 127.4 25.16 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 O-C-N 123.539 1.284 . . . . 27.039999999999999 111.167 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.76 -16.48 56.55 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.74 -0.944 . . . . 24.739999999999998 110.74 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -87.25 164.36 16.36 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.089 -1.242 . . . . 29.379999999999999 110.427 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.45 149.33 34.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.568 -0.708 . . . . 0.0 110.199 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -119.2 144.63 46.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.499 -0.751 . . . . 18.559999999999999 109.212 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 -144.14 140.93 29.67 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.163 -0.96 . . . . 0.0 111.236 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.438 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 51.0 p90 -150.8 160.05 44.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.646 -0.659 . . . . 26.649999999999999 109.74 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 60.3 m -100.8 136.08 41.23 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.445 -0.785 . . . . 28.140000000000001 110.848 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 23.3 t -126.38 168.08 14.65 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.554 -0.716 . . . . 33.880000000000003 110.115 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -135.67 129.11 4.88 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.926 -1.13 . . . . 31.800000000000001 110.496 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.2 t -133.01 148.76 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.592 -0.946 . . . . 0.0 109.248 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.9 tp -109.81 143.79 39.18 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.552 -0.718 . . . . 0.0 110.542 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.4 tp -121.49 144.26 48.8 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.574 -0.704 . . . . 38.68 109.767 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -75.98 -25.41 55.79 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.25 -0.906 . . . . 0.0 111.096 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.8 m -124.04 171.97 9.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.332 -0.855 . . . . 31.629999999999999 110.512 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.41 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 52.6 tt0 -86.28 11.45 12.13 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.612 -0.68 . . . . 0.0 111.592 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -142.89 142.98 31.86 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.2 -0.937 . . . . 0.0 109.626 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -177.47 152.73 12.29 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 118.751 -1.69 . . . . 28.050000000000001 112.198 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -118.05 130.33 56.1 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 90.7 mtp -128.0 124.02 36.18 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.457 -0.777 . . . . 0.0 111.597 -178.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.41 ' CG ' ' CB ' ' A' ' 117' ' ' ALA . 62.8 mt-30 -125.49 152.19 45.29 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.89 179.88 38.59 Favored Glycine 0 N--CA 1.5 2.958 0 C-N-CA 118.665 -1.731 . . . . 29.620000000000001 111.211 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.433 ' CD2' ' HA ' ' A' ' 114' ' ' PRO . 44.4 m80 -134.62 159.07 42.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.843 -0.798 . . . . 0.0 110.031 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.453 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 8.2 m-85 -116.71 127.35 54.31 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.589 -0.694 . . . . 27.050000000000001 109.959 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -85.99 118.51 25.51 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.06 -1.025 . . . . 0.0 108.815 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.419 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 18.3 tpp -124.73 160.78 27.83 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.294 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.2 m -140.93 131.19 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.614 -0.679 . . . . 23.280000000000001 110.328 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.04 166.86 22.28 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.437 -0.789 . . . . 0.0 109.606 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -64.64 -29.45 70.45 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.94 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -73.72 -11.24 60.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.519 -0.738 . . . . 0.0 111.059 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.24 -7.3 47.43 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.411 -1.076 . . . . 30.43 110.411 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.419 HG21 ' CE2' ' A' ' 7' ' ' TYR . 24.3 m -57.68 135.47 56.74 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.026 -1.279 . . . . 0.0 110.056 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -101.14 139.61 36.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.441 -0.787 . . . . 0.0 110.69 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.419 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 43.8 p90 -165.78 145.05 6.26 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.75 -0.594 . . . . 28.030000000000001 109.902 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 24.9 pt -102.21 158.11 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.716 -0.615 . . . . 0.0 111.16 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.86 97.6 49.59 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.433 ' HA ' ' CD2' ' A' ' 100' ' ' HIS . 45.7 Cg_endo -58.15 143.82 96.19 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 O-C-N 123.835 1.439 . . . . 33.310000000000002 112.166 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.453 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 68.7 mt -108.81 122.52 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-N 115.368 -0.833 . . . . 30.59 108.954 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.61 172.81 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.255 0.55 . . . . 30.780000000000001 111.429 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.41 ' CB ' ' CG ' ' A' ' 98' ' ' GLN . . . -100.29 119.93 39.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.583 -0.698 . . . . 0.0 110.753 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 97' ' ' MET . 41.9 p90 -111.99 156.02 22.83 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.244 -1.021 . . . . 30.66 108.244 178.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.2 t -116.95 153.45 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.177 -0.952 . . . . 0.0 110.886 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.462 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.9 mp -114.52 130.16 56.72 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.141 -0.689 . . . . 39.149999999999999 109.141 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.606 -0.684 . . . . 0.0 110.156 -179.802 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.1 mtm-85 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.772 0.32 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.411 ' CZ ' HG21 ' A' ' 109' ' ' THR . 90.9 m-85 -119.18 105.96 11.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.52 -0.738 . . . . 31.93 110.141 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -149.03 134.82 18.84 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.615 -0.678 . . . . 0.0 110.07 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.0 t -151.58 116.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-O 121.554 0.692 . . . . 0.0 109.609 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -105.63 131.24 53.25 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.652 0.739 . . . . 0.0 110.385 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 63.4 t -118.75 136.12 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 109.303 -0.628 . . . . 28.210000000000001 109.303 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -124.02 137.24 54.62 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.306 -0.871 . . . . 0.0 110.136 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 75.8 t -129.22 136.95 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.679 -0.638 . . . . 27.949999999999999 110.523 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.1 m -125.12 105.55 28.72 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.785 -0.572 . . . . 0.0 110.302 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 49.8 Cg_endo -82.33 164.66 16.87 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.859 1.452 . . . . 33.0 111.255 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -157.47 130.63 7.71 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.667 0.746 . . . . 54.100000000000001 109.722 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -63.95 139.87 58.81 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.663 -0.648 . . . . 0.0 111.585 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.0 mt -116.04 80.7 1.49 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.947 0.88 . . . . 0.0 110.453 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.46 -35.75 78.01 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.793 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -69.54 -24.02 63.67 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.447 -0.783 . . . . 0.0 110.734 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -120.84 43.1 2.86 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.431 -0.793 . . . . 52.369999999999997 110.735 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -164.68 146.67 8.32 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.365 -0.834 . . . . 55.189999999999998 110.974 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 t -120.38 93.12 48.07 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.552 -0.718 . . . . 0.0 109.146 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.438 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 50.1 Cg_endo -65.94 -23.09 54.83 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 O-C-N 123.89 1.469 . . . . 51.57 111.573 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -65.61 -23.69 66.88 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.378 -0.826 . . . . 0.0 111.047 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -105.59 23.99 12.93 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.347 -0.845 . . . . 0.0 110.815 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.24 27.82 73.57 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -120.79 94.2 4.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.503 -0.998 . . . . 0.0 110.169 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.438 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 68.2 m-85 -104.45 132.68 50.42 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.601 -0.687 . . . . 46.07 109.313 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.64 120.56 40.58 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.338 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.42 ' CG ' HD23 ' A' ' 120' ' ' LEU . 89.4 m-85 -116.26 134.5 54.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.529 -0.732 . . . . 38.880000000000003 109.841 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.16 132.71 54.73 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.442 -0.947 . . . . 34.060000000000002 108.442 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 86' ' ' SER . 20.1 p90 -128.05 143.28 51.07 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.078 -1.049 . . . . 29.030000000000001 111.611 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.9 m -106.71 139.69 40.75 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.452 ' CD1' ' CZ ' ' A' ' 84' ' ' TYR . 87.3 mt -108.8 134.55 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 121.668 0.747 . . . . 0.0 111.671 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.3 mtm105 -124.82 98.65 5.8 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.642 0.734 . . . . 40.240000000000002 109.796 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 85.4 mt -94.13 118.26 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.818 -0.551 . . . . 20.73 110.726 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -116.43 138.61 51.22 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.267 -0.896 . . . . 0.0 109.231 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -90.61 117.97 29.69 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.78 -0.575 . . . . 21.34 110.856 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.51 9.92 15.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.477 -0.765 . . . . 0.0 110.603 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.2 -178.97 52.4 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.417 -1.473 . . . . 29.100000000000001 109.417 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.69 -33.89 12.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.441 -1.034 . . . . 0.0 110.326 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.41 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 87.4 t -103.78 139.6 20.26 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.846 -0.533 . . . . 0.0 109.946 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 39.9 Cg_endo -52.35 143.22 44.55 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 O-C-N 123.883 1.465 . . . . 21.949999999999999 111.845 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.88 151.92 46.03 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.498 0.666 . . . . 20.91 110.99 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.422 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 19.6 ptt-85 -128.05 158.96 36.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.824 -0.547 . . . . 0.0 110.017 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.406 HD12 ' CD1' ' A' ' 101' ' ' TYR . 6.4 tt -97.7 115.28 27.66 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.446 -0.784 . . . . 0.0 109.246 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.1 m -100.54 -26.18 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.632 -0.667 . . . . 0.0 111.175 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.4 163.05 33.9 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.196 -0.94 . . . . 0.0 111.734 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 -145.39 142.26 29.18 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.644 0.735 . . . . 29.050000000000001 110.858 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -144.89 115.17 7.54 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.324 -0.621 . . . . 27.969999999999999 109.324 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -98.05 135.6 39.51 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.558 -0.713 . . . . 25.25 111.747 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -115.48 75.98 0.98 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.402 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.8 pt -86.98 131.3 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.412 -0.805 . . . . 36.109999999999999 112.14 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.3 m -119.85 132.93 55.72 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.35 -0.982 . . . . 33.979999999999997 108.35 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -87.19 169.48 12.31 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.638 0.732 . . . . 45.039999999999999 111.308 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.32 -8.36 12.4 Favored Glycine 0 N--CA 1.494 2.549 0 O-C-N 121.828 -0.545 . . . . 39.469999999999999 112.124 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -101.01 8.15 43.14 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 119.402 1.601 . . . . 0.0 110.859 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.34 -23.07 29.26 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.196 -0.94 . . . . 0.0 110.952 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -60.4 142.16 55.35 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.187 -1.184 . . . . 62.780000000000001 109.806 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 74.3 p -126.05 142.0 51.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.407 -0.808 . . . . 0.0 110.669 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -122.87 119.95 32.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.411 -0.806 . . . . 0.0 109.948 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -104.79 134.47 47.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.657 -0.652 . . . . 0.0 110.7 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.9 t -127.93 130.85 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.625 -0.672 . . . . 37.939999999999998 109.81 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -123.41 126.6 47.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.84 -0.537 . . . . 0.0 110.299 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -147.84 147.45 18.13 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.223 -1.551 . . . . 31.82 109.223 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -72.59 155.63 39.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.51 -0.994 . . . . 0.0 110.15 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.59 -170.65 0.08 OUTLIER Glycine 0 N--CA 1.498 2.824 0 O-C-N 121.49 -0.756 . . . . 22.620000000000001 111.357 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.0 m -129.74 127.96 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.835 -0.803 . . . . 17.510000000000002 108.957 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.3 m 41.75 34.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 CA-C-O 121.7 0.762 . . . . 20.550000000000001 111.448 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.4 18.83 61.53 Favored Glycine 0 N--CA 1.497 2.751 0 O-C-N 121.714 -0.616 . . . . 18.289999999999999 113.041 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -147.58 150.67 34.9 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 119.449 1.625 . . . . 0.0 112.675 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -115.24 73.05 3.47 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 108.257 -1.016 . . . . 18.210000000000001 108.257 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -55.5 141.49 82.63 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 O-C-N 123.842 1.443 . . . . 17.609999999999999 112.426 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.422 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 4.7 t90 -102.39 76.88 1.59 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.3 mt -60.89 117.49 5.49 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.636 -0.665 . . . . 20.57 111.783 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -88.39 159.12 47.94 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -54.25 129.58 35.3 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 O-C-N 123.535 1.281 . . . . 27.039999999999999 111.134 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.91 -18.9 44.95 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 111.003 -0.839 . . . . 24.739999999999998 111.003 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.93 166.62 14.39 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.117 -1.225 . . . . 29.379999999999999 110.446 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -144.55 146.16 32.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.672 -0.643 . . . . 0.0 110.415 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -114.58 141.24 48.01 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.049 -0.722 . . . . 18.559999999999999 109.049 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -147.95 140.98 24.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.298 -0.876 . . . . 0.0 111.101 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.452 ' CZ ' ' CD1' ' A' ' 35' ' ' ILE . 46.3 p90 -153.33 162.5 41.22 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.621 -0.674 . . . . 26.649999999999999 109.775 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.1 m -99.01 135.78 39.92 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.468 -0.77 . . . . 28.140000000000001 111.211 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 17.2 t -125.16 166.65 16.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.642 -0.661 . . . . 33.880000000000003 109.688 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.26 130.33 5.69 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 119.779 -1.201 . . . . 31.800000000000001 110.536 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.2 t -132.77 147.01 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.695 -0.885 . . . . 0.0 109.118 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.2 tp -110.27 143.74 40.0 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.559 -0.713 . . . . 0.0 110.33 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.4 144.97 48.7 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.491 -0.756 . . . . 38.68 109.936 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -78.24 -26.09 47.17 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.425 -0.797 . . . . 0.0 110.641 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.5 m -123.41 171.22 9.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.42 -0.8 . . . . 31.629999999999999 110.2 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.414 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 56.8 tt0 -86.21 12.54 9.59 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.415 -0.803 . . . . 0.0 111.579 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -140.99 144.99 35.38 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.044 -1.035 . . . . 0.0 109.698 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.51 158.94 21.66 Favored Glycine 0 N--CA 1.496 2.673 0 C-N-CA 118.766 -1.683 . . . . 28.050000000000001 112.321 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -119.66 129.96 54.83 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 122.128 -0.631 . . . . 0.0 109.578 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 90.0 mtp -125.48 117.42 23.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.275 -0.89 . . . . 0.0 111.075 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -129.21 150.04 50.76 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.36 -177.83 38.04 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 119.108 -1.52 . . . . 29.620000000000001 110.514 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 -140.26 159.93 41.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.698 -0.883 . . . . 0.0 110.676 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.444 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 5.2 m-85 -115.3 128.38 56.07 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.753 -0.592 . . . . 27.050000000000001 109.944 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -83.4 122.3 28.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.006 -1.059 . . . . 0.0 108.739 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.43 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 43.0 mtp -123.51 161.93 23.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.878 -0.513 . . . . 0.0 110.507 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.4 m -140.32 129.47 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.719 -0.613 . . . . 23.280000000000001 110.23 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.21 166.53 22.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.507 -0.745 . . . . 0.0 109.649 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -65.86 -29.27 69.7 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.198 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -76.74 -4.89 45.7 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.395 -0.816 . . . . 0.0 111.347 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.33 -9.52 57.61 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.045 -1.074 . . . . 30.43 110.627 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.411 HG21 ' CZ ' ' A' ' 7' ' ' TYR . 23.9 m -57.42 134.57 56.16 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.047 -1.266 . . . . 0.0 110.104 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -101.68 139.61 37.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.37 -0.831 . . . . 0.0 110.724 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.43 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 45.2 p90 -164.08 143.75 7.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.664 -0.648 . . . . 28.030000000000001 109.856 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.9 mm -98.69 156.11 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.661 -0.649 . . . . 0.0 110.61 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.53 96.92 48.93 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -59.44 141.53 97.63 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.911 1.479 . . . . 33.310000000000002 112.222 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.444 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 68.0 mt -107.08 124.05 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.627 -0.879 . . . . 30.59 108.627 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.92 147.52 3.82 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.234 0.54 . . . . 30.780000000000001 111.48 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -89.65 122.33 32.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.597 -0.689 . . . . 0.0 110.179 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 97' ' ' MET . 45.0 p90 -109.1 164.69 12.2 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.934 -0.765 . . . . 30.66 108.934 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.8 t -114.48 155.4 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.333 -0.854 . . . . 0.0 110.28 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.462 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.0 mp -114.11 132.17 56.15 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.264 -0.643 . . . . 39.149999999999999 109.264 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.687 -0.633 . . . . 0.0 110.104 -179.852 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 120.906 0.384 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -115.83 107.18 14.71 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.559 -0.713 . . . . 31.93 110.167 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.8 ttt85 -153.44 135.2 14.52 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.561 0.696 . . . . 0.0 110.413 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.0 t -152.29 116.08 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-O 121.448 0.642 . . . . 0.0 109.499 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -107.36 130.07 54.83 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.622 0.725 . . . . 0.0 110.049 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.0 t -118.1 139.46 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.848 -0.532 . . . . 28.210000000000001 109.817 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -121.81 137.81 54.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.386 -0.822 . . . . 0.0 110.014 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.7 t -128.7 137.11 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.59 -0.694 . . . . 27.949999999999999 110.379 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -125.3 106.9 27.54 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.738 -0.601 . . . . 0.0 110.485 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.431 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 51.0 Cg_endo -82.76 165.66 15.54 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 O-C-N 123.816 1.43 . . . . 33.0 111.119 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -158.05 129.59 6.72 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.595 0.712 . . . . 54.100000000000001 109.588 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -62.98 139.95 58.82 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.753 -0.592 . . . . 0.0 111.543 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 88.9 mt -115.85 81.2 1.56 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.907 0.861 . . . . 0.0 110.381 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.44 -35.77 78.08 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.893 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -69.94 -23.18 63.16 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.415 -0.803 . . . . 0.0 110.823 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -121.23 38.97 3.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.364 -0.835 . . . . 52.369999999999997 110.757 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.9 t -160.01 145.75 15.48 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.335 -0.853 . . . . 55.189999999999998 111.117 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.0 t -120.02 92.76 47.24 Favored Pre-proline 0 N--CA 1.496 1.848 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.439 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.8 Cg_endo -66.32 -23.0 52.17 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 O-C-N 123.86 1.453 . . . . 51.57 111.718 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -65.28 -23.45 67.04 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.357 -0.839 . . . . 0.0 110.994 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -105.62 24.15 12.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.306 -0.871 . . . . 0.0 110.846 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.99 28.13 73.68 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -120.98 94.0 4.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.642 -0.916 . . . . 0.0 110.23 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 69.8 m-85 -104.14 133.56 48.87 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.607 -0.683 . . . . 46.07 109.359 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -115.21 120.19 38.87 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 119.754 -0.779 . . . . 0.0 111.075 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.423 ' CD1' HD11 ' A' ' 90' ' ' LEU . 91.4 m-85 -115.92 135.26 54.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.512 -0.742 . . . . 38.880000000000003 109.782 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.38 132.24 55.12 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.542 -0.91 . . . . 34.060000000000002 108.542 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.423 ' CZ ' ' HB3' ' A' ' 86' ' ' SER . 18.5 p90 -128.4 143.26 50.97 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.214 -0.995 . . . . 29.030000000000001 111.429 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.5 t -105.77 140.57 38.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.724 -0.61 . . . . 0.0 109.494 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.436 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 45.6 mm -105.11 131.84 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.727 0.775 . . . . 0.0 111.63 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -122.91 96.93 5.21 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.532 0.682 . . . . 40.240000000000002 109.381 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 79.9 mt -92.48 117.83 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.759 -0.588 . . . . 20.73 110.592 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -116.82 134.16 55.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.496 -0.753 . . . . 0.0 109.248 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -92.79 117.57 30.16 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 120.204 -0.598 . . . . 21.34 110.565 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.35 11.96 16.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.49 -0.756 . . . . 0.0 110.575 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.25 -179.26 52.76 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.086 -1.605 . . . . 29.100000000000001 109.086 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.99 -32.89 12.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.479 -1.012 . . . . 0.0 110.32 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.417 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 85.3 t -104.6 141.2 22.05 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.83 -0.544 . . . . 0.0 109.883 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.417 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 40.1 Cg_endo -53.53 143.26 56.82 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 O-C-N 123.809 1.426 . . . . 21.949999999999999 111.91 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.7 151.69 46.09 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.604 0.716 . . . . 20.91 110.861 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.421 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 18.4 ptt180 -127.96 159.76 33.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.751 -0.593 . . . . 0.0 109.723 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.9 tt -98.14 117.28 32.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.432 -0.792 . . . . 0.0 109.699 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.5 t -99.85 -29.45 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.514 -0.741 . . . . 0.0 110.677 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.38 162.66 34.95 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.949 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.6 ptt85 -143.7 141.59 30.58 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.673 0.749 . . . . 29.050000000000001 110.323 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -144.51 113.97 7.09 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.405 0.622 . . . . 27.969999999999999 109.507 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -98.45 135.2 40.35 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.65 -0.656 . . . . 25.25 111.488 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -115.38 75.85 0.97 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.41 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.3 pt -85.7 130.5 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 121.85 0.833 . . . . 36.109999999999999 111.975 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 86.1 m -121.22 132.93 55.11 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.351 -0.981 . . . . 33.979999999999997 108.351 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -87.32 169.74 12.03 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.717 0.77 . . . . 45.039999999999999 111.477 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.29 -7.88 15.93 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 121.819 -0.551 . . . . 39.469999999999999 112.06 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -100.57 8.12 43.63 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 119.345 1.573 . . . . 0.0 110.578 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.7 -21.3 36.77 Favored Glycine 0 N--CA 1.493 2.49 0 O-C-N 121.233 -0.917 . . . . 0.0 111.011 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.19 141.03 56.6 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.169 -1.195 . . . . 62.780000000000001 109.806 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 82.1 p -125.87 140.09 52.94 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.447 -0.783 . . . . 0.0 110.668 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -123.73 120.0 31.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.41 -0.806 . . . . 0.0 110.014 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -104.85 135.26 46.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.686 -0.634 . . . . 0.0 110.859 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.26 130.62 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.58 -0.7 . . . . 37.939999999999998 109.848 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.65 127.57 47.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.817 -0.552 . . . . 0.0 110.42 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.79 150.92 23.06 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.289 -1.524 . . . . 31.82 109.289 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -79.43 156.76 27.75 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.559 -0.965 . . . . 0.0 110.25 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 51.57 -173.49 0.18 Allowed Glycine 0 N--CA 1.497 2.752 0 N-CA-C 111.008 -0.837 . . . . 22.620000000000001 111.008 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.2 m -130.1 127.98 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.793 -0.828 . . . . 17.510000000000002 109.606 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.415 HG23 ' HG2' ' A' ' 72' ' ' GLU . 11.6 m 41.12 36.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 CA-C-O 121.514 0.673 . . . . 20.550000000000001 111.853 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.13 16.65 68.99 Favored Glycine 0 N--CA 1.499 2.857 0 O-C-N 121.683 -0.636 . . . . 18.289999999999999 113.002 177.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.415 ' HG2' HG23 ' A' ' 70' ' ' VAL . 9.9 pt-20 -145.64 150.9 37.19 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 119.164 1.482 . . . . 0.0 112.018 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -115.22 75.12 4.18 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.915 -0.772 . . . . 18.210000000000001 108.915 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -57.67 140.06 92.28 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 O-C-N 123.861 1.453 . . . . 17.609999999999999 112.149 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.421 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 4.1 t90 -103.14 77.57 1.55 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.3 mt -60.14 118.31 6.18 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.462 0.649 . . . . 20.57 111.953 -178.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 -85.8 157.19 57.93 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -53.49 128.1 27.99 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 O-C-N 123.561 1.295 . . . . 27.039999999999999 111.15 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.66 -17.13 54.39 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.727 -0.949 . . . . 24.739999999999998 110.727 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -86.89 165.71 15.71 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.058 -1.26 . . . . 29.379999999999999 110.537 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.02 149.1 34.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.66 -0.65 . . . . 0.0 110.041 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.4 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 79.6 t80 -118.9 146.27 45.05 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.47 -0.769 . . . . 18.559999999999999 109.179 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -146.05 141.03 27.22 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.213 -0.929 . . . . 0.0 111.13 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.436 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 50.6 p90 -151.09 160.02 44.14 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.59 -0.693 . . . . 26.649999999999999 109.837 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.2 m -100.04 135.58 41.25 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.391 -0.818 . . . . 28.140000000000001 110.646 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 28.4 t -125.06 167.41 14.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.592 -0.693 . . . . 33.880000000000003 110.048 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.87 129.97 5.48 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.841 -1.171 . . . . 31.800000000000001 110.481 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.75 148.61 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.695 -0.885 . . . . 0.0 109.821 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 mp -112.93 144.28 42.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.57 -0.706 . . . . 0.0 110.569 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.423 HD11 ' CD1' ' A' ' 31' ' ' PHE . 31.8 mt -121.98 146.57 47.02 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.639 -0.663 . . . . 38.68 110.004 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -77.6 -26.16 50.45 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.405 -0.809 . . . . 0.0 110.765 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.5 p -122.95 171.33 9.31 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.47 -0.769 . . . . 31.629999999999999 110.522 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -86.13 11.06 12.65 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.636 -0.665 . . . . 0.0 111.549 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -140.72 146.18 37.42 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.016 -1.053 . . . . 0.0 109.638 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.42 153.21 10.72 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 118.921 -1.609 . . . . 28.050000000000001 112.264 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -118.2 129.84 55.73 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 94.3 mtp -126.8 122.45 34.8 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.39 -0.819 . . . . 0.0 111.63 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -127.34 149.45 50.04 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.86 -177.68 36.85 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 118.931 -1.604 . . . . 29.620000000000001 110.844 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -142.81 158.81 43.26 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.795 -0.826 . . . . 0.0 110.626 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.417 ' CE2' HD12 ' A' ' 115' ' ' ILE . 4.5 m-85 -116.68 129.18 55.98 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.656 -0.652 . . . . 27.050000000000001 110.076 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -83.06 122.65 28.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.014 -1.054 . . . . 0.0 109.095 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.423 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 63.3 mtp -123.12 163.01 21.36 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.108 0.48 . . . . 0.0 110.457 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 m -142.54 131.55 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.65 -0.656 . . . . 23.280000000000001 110.432 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.2 165.03 23.02 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.398 -0.814 . . . . 0.0 109.508 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -65.71 -27.21 68.16 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.519 -0.738 . . . . 0.0 110.46 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -79.93 -1.29 38.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.321 -0.862 . . . . 0.0 111.312 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.03 -10.07 56.79 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.962 -1.113 . . . . 30.43 110.581 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.6 m -57.46 134.02 55.71 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.086 -1.244 . . . . 0.0 110.059 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -102.64 139.24 38.48 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.311 -0.868 . . . . 0.0 110.782 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 43.1 p90 -162.82 141.68 8.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.759 -0.588 . . . . 28.030000000000001 110.002 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.8 pt -98.43 156.8 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.715 -0.615 . . . . 0.0 110.77 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -121.33 97.98 46.95 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -59.31 142.11 98.67 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 O-C-N 123.907 1.477 . . . . 33.310000000000002 112.039 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.417 HD12 ' CE2' ' A' ' 101' ' ' TYR . 70.9 mt -107.68 124.13 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.791 -0.818 . . . . 30.59 108.791 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.59 151.18 2.41 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.264 0.554 . . . . 30.780000000000001 111.356 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -98.67 118.19 34.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.675 -0.641 . . . . 0.0 110.159 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.431 ' CD1' ' HG3' ' A' ' 15' ' ' PRO . 41.6 p90 -107.95 168.94 8.92 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.944 -0.761 . . . . 30.66 108.944 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.5 t -114.23 154.14 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.251 -0.906 . . . . 0.0 110.509 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.454 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.0 mp -113.65 132.4 55.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.676 -0.64 . . . . 39.149999999999999 109.357 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 79.8 p . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.636 -0.665 . . . . 0.0 110.1 -179.808 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 120.951 0.405 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -109.97 100.59 9.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.785 -0.572 . . . . 31.93 109.908 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 64.7 mtp85 -149.0 137.21 20.86 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.754 0.788 . . . . 0.0 110.314 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.2 t -151.31 114.79 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -107.55 130.26 54.89 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.574 0.702 . . . . 0.0 110.109 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.9 t -118.53 138.89 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.883 -0.511 . . . . 28.210000000000001 109.639 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -121.24 137.36 54.72 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.477 -0.764 . . . . 0.0 109.85 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.2 t -129.16 136.58 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.555 -0.715 . . . . 27.949999999999999 110.502 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.6 t -125.24 104.43 28.98 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.714 -0.616 . . . . 0.0 110.226 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 50.2 Cg_endo -83.86 165.81 13.41 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 O-C-N 123.815 1.429 . . . . 33.0 111.095 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -158.02 131.5 7.7 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.527 0.679 . . . . 54.100000000000001 109.737 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -59.29 138.49 57.6 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.737 -0.602 . . . . 0.0 111.2 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.1 tp -115.01 80.72 1.46 Allowed 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 122.014 0.912 . . . . 0.0 110.269 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.07 -35.63 74.35 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.366 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -69.22 -22.6 63.86 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.366 -0.834 . . . . 0.0 111.03 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 34.1 tp60 -121.75 36.87 4.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.283 -0.885 . . . . 52.369999999999997 110.596 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.8 t -156.95 146.02 20.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.451 -0.781 . . . . 55.189999999999998 111.02 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.2 t -122.03 92.83 48.82 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.439 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.1 Cg_endo -65.98 -22.39 55.46 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 O-C-N 123.711 1.374 . . . . 51.57 111.928 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -64.87 -23.52 67.26 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.258 -0.901 . . . . 0.0 110.879 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.59 23.48 14.17 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.289 -0.882 . . . . 0.0 110.705 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.61 29.94 72.89 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.2 mmm-85 -120.87 93.59 4.08 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.596 -0.943 . . . . 0.0 110.181 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 68.4 m-85 -104.58 130.4 52.56 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.571 -0.705 . . . . 46.07 109.126 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -117.76 120.31 37.57 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.571 -0.851 . . . . 0.0 111.185 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.424 ' CD1' HD12 ' A' ' 90' ' ' LEU . 68.1 m-85 -115.0 137.28 52.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.583 -0.698 . . . . 38.880000000000003 109.815 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.78 131.61 55.21 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.293 -1.002 . . . . 34.060000000000002 108.293 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.417 ' CZ ' ' HB3' ' A' ' 86' ' ' SER . 20.6 p90 -128.21 144.08 51.09 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.19 -1.004 . . . . 29.030000000000001 111.534 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.5 t -104.39 141.06 37.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.68 -0.638 . . . . 0.0 109.851 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.442 ' CG2' ' CE1' ' A' ' 84' ' ' TYR . 45.6 mm -106.35 132.23 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.822 0.82 . . . . 0.0 111.618 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.7 mtp85 -121.47 96.6 5.14 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.418 0.628 . . . . 40.240000000000002 109.526 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.406 ' CG2' ' CD1' ' A' ' 76' ' ' LEU . 78.1 mt -92.53 115.74 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.736 -0.603 . . . . 20.73 110.352 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -117.66 136.49 53.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.563 -0.711 . . . . 0.0 109.472 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -91.47 116.11 28.59 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 120.179 -0.608 . . . . 21.34 110.541 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -112.26 9.38 19.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.441 -0.787 . . . . 0.0 110.683 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.96 -176.15 50.96 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.002 -1.639 . . . . 29.100000000000001 109.002 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.75 -30.0 12.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.463 -1.021 . . . . 0.0 110.137 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.42 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 84.2 t -105.57 139.83 20.57 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.78 -0.575 . . . . 0.0 109.714 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.42 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 39.9 Cg_endo -51.18 144.84 28.22 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 O-C-N 123.684 1.36 . . . . 21.949999999999999 111.685 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.5 150.08 49.68 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.736 0.779 . . . . 20.91 111.212 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.5 ttt-85 -125.81 153.08 44.58 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.5 tt -97.57 117.16 31.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.494 -0.754 . . . . 0.0 109.997 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.7 t -100.85 -29.45 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.613 -0.68 . . . . 0.0 110.436 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.2 163.7 32.24 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.13 -1.028 . . . . 0.0 112.007 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.6 ptt85 -143.55 141.19 30.59 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.337 0.589 . . . . 29.050000000000001 110.16 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -144.0 114.14 7.38 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.396 0.617 . . . . 27.969999999999999 110.15 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -102.05 135.25 43.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.658 -0.651 . . . . 25.25 111.241 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -116.24 81.05 1.55 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.403 ' O ' HG13 ' A' ' 54' ' ' ILE . 17.3 pt -86.04 129.99 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 121.671 0.748 . . . . 36.109999999999999 111.748 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.3 m -119.32 130.16 55.24 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.397 -0.964 . . . . 33.979999999999997 108.397 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -89.18 169.9 11.07 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.666 0.746 . . . . 45.039999999999999 111.26 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.25 -7.9 15.8 Favored Glycine 0 N--CA 1.495 2.579 0 O-C-N 121.791 -0.568 . . . . 39.469999999999999 112.071 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -102.15 6.95 41.06 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 119.336 1.568 . . . . 0.0 110.805 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.1 -27.94 10.5 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 121.159 -0.963 . . . . 0.0 110.933 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -61.6 141.81 57.54 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.19 -1.182 . . . . 62.780000000000001 109.707 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 57.9 p -132.36 150.24 52.2 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.429 -0.794 . . . . 0.0 110.69 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -122.26 122.26 38.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.562 -0.711 . . . . 0.0 109.792 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -102.63 136.04 43.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.613 -0.679 . . . . 0.0 110.83 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.2 t -128.51 131.85 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.504 0.669 . . . . 37.939999999999998 109.925 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -125.02 127.48 47.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.79 -0.569 . . . . 0.0 110.3 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -153.91 173.5 32.54 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.101 -1.599 . . . . 31.82 109.101 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -115.78 159.64 21.18 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.362 -1.081 . . . . 0.0 110.047 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.66 95.35 0.01 OUTLIER Glycine 0 N--CA 1.5 2.94 0 O-C-N 121.423 -0.798 . . . . 22.620000000000001 111.355 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.1 m -46.36 134.02 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.505 0 O-C-N 121.399 -1.059 . . . . 17.510000000000002 111.553 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.429 HG22 ' HG2' ' A' ' 72' ' ' GLU . 12.4 m 41.55 37.13 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-O 121.634 0.73 . . . . 20.550000000000001 111.344 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.7 20.02 62.49 Favored Glycine 0 N--CA 1.495 2.598 0 O-C-N 121.752 -0.592 . . . . 18.289999999999999 112.428 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.429 ' HG2' HG22 ' A' ' 70' ' ' VAL . 5.2 pt-20 -146.73 151.81 37.8 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 119.191 1.496 . . . . 0.0 112.57 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -119.06 72.24 11.91 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 108.336 -0.987 . . . . 18.210000000000001 108.336 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -54.31 141.07 72.26 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 O-C-N 123.83 1.437 . . . . 17.609999999999999 112.517 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -99.14 74.4 1.96 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.406 ' CD1' ' CG2' ' A' ' 37' ' ' ILE . 12.0 mt -60.02 120.2 9.24 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.427 0.632 . . . . 20.57 112.045 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -85.42 157.8 58.29 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -53.81 127.03 23.89 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 O-C-N 123.584 1.307 . . . . 27.039999999999999 110.882 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.89 -15.69 57.02 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.735 -0.946 . . . . 24.739999999999998 110.735 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -87.02 164.27 16.57 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.086 -1.244 . . . . 29.379999999999999 110.435 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.83 151.33 36.93 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.45 -0.781 . . . . 0.0 110.333 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.401 ' CZ ' ' OE2' ' A' ' 72' ' ' GLU . 72.4 t80 -119.2 149.3 41.98 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.868 -0.79 . . . . 18.559999999999999 108.868 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -139.34 137.39 35.73 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.104 -0.997 . . . . 0.0 111.013 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.442 ' CE1' ' CG2' ' A' ' 35' ' ' ILE . 51.7 p90 -151.57 159.74 43.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.664 -0.648 . . . . 26.649999999999999 109.793 178.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.9 m -104.47 138.59 40.63 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.394 -0.816 . . . . 28.140000000000001 111.107 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 28.3 t -124.79 169.92 11.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.577 -0.702 . . . . 33.880000000000003 109.896 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.43 123.22 2.12 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.798 -1.191 . . . . 31.800000000000001 110.544 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 74.9 t -129.63 148.86 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.61 -0.935 . . . . 0.0 109.272 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.1 tp -109.74 143.82 39.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.487 -0.758 . . . . 0.0 110.496 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.424 HD12 ' CD1' ' A' ' 31' ' ' PHE . 84.8 mt -121.62 145.25 48.18 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.516 -0.74 . . . . 38.68 109.963 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.402 ' O ' ' CE1' ' A' ' 29' ' ' TYR . 29.9 tp10 -73.88 -26.06 60.35 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.407 -0.808 . . . . 0.0 110.782 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.1 p -123.34 171.74 9.19 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.39 -0.818 . . . . 31.629999999999999 110.579 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.409 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 54.9 tt0 -87.02 12.38 11.45 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.679 -0.638 . . . . 0.0 111.552 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -142.27 148.64 38.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.099 -1.0 . . . . 0.0 109.912 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.26 162.61 26.86 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 118.908 -1.615 . . . . 28.050000000000001 112.137 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -119.11 129.46 55.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.083 -0.657 . . . . 0.0 109.335 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 54.0 ttm -125.02 117.74 24.66 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.279 -0.888 . . . . 0.0 111.205 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -129.5 150.34 50.89 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.08 -179.44 38.32 Favored Glycine 0 N--CA 1.499 2.886 0 C-N-CA 118.787 -1.673 . . . . 29.620000000000001 111.017 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.429 ' CD2' ' HA ' ' A' ' 114' ' ' PRO . 63.3 m80 -137.12 155.36 49.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.808 -0.819 . . . . 0.0 110.118 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.433 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 4.4 m-85 -117.65 127.06 53.58 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.61 -0.681 . . . . 27.050000000000001 109.668 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -81.88 122.11 27.32 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.935 -1.103 . . . . 0.0 109.335 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.42 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 91.8 mmm -120.53 162.84 18.91 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.189 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.9 m -142.51 128.76 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.672 -0.643 . . . . 23.280000000000001 110.503 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.38 167.97 20.16 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.557 -0.714 . . . . 0.0 109.469 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -62.15 -28.14 69.45 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.522 -0.736 . . . . 0.0 110.4 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -72.29 -11.29 60.64 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 111.111 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.45 -6.49 59.29 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.099 -1.048 . . . . 30.43 110.667 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.5 m -59.93 139.5 57.35 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.108 -1.23 . . . . 0.0 109.963 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -99.56 140.48 33.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.463 -0.773 . . . . 0.0 110.892 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 33.5 p90 -163.64 146.33 9.8 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.376 -0.601 . . . . 28.030000000000001 109.376 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.457 HD11 HG22 ' A' ' 112' ' ' ILE . 79.9 mt -100.78 155.43 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.61 0.719 . . . . 0.0 111.104 -178.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.92 98.12 47.8 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.429 ' HA ' ' CD2' ' A' ' 100' ' ' HIS . 46.3 Cg_endo -59.14 144.17 99.48 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 O-C-N 123.869 1.457 . . . . 33.310000000000002 112.554 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.433 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 66.2 mt -108.78 122.63 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.451 -0.944 . . . . 30.59 108.451 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.92 144.97 5.98 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.199 0.523 . . . . 30.780000000000001 111.615 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -92.65 119.43 32.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.795 -0.565 . . . . 0.0 110.394 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.428 ' CD1' ' HG3' ' A' ' 15' ' ' PRO . 43.2 p90 -108.92 169.32 8.75 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.815 -0.809 . . . . 30.66 108.815 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.8 p -113.35 154.66 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.29 -0.881 . . . . 0.0 110.54 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.453 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.5 mp -113.25 131.91 55.73 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.426 -0.583 . . . . 39.149999999999999 109.426 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 96.6 p . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.654 -0.654 . . . . 0.0 110.092 -179.877 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.1 mtt-85 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 120.807 0.337 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -116.14 108.6 16.37 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.503 -0.748 . . . . 31.93 110.313 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -152.17 134.56 15.22 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.574 0.702 . . . . 0.0 110.192 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 80.0 t -151.42 113.84 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -107.85 129.04 55.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.636 -0.665 . . . . 0.0 109.767 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.5 t -119.41 139.75 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.863 -0.523 . . . . 28.210000000000001 109.968 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -121.51 136.51 54.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.409 -0.807 . . . . 0.0 109.673 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.0 t -129.47 137.64 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.513 -0.742 . . . . 27.949999999999999 110.434 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.6 t -125.62 104.51 27.6 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.733 -0.605 . . . . 0.0 110.583 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -83.61 165.14 14.1 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 O-C-N 123.851 1.448 . . . . 33.0 110.996 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -157.53 132.84 8.96 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.505 0.669 . . . . 54.100000000000001 109.999 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -59.96 139.47 57.38 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.812 -0.555 . . . . 0.0 111.298 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 77.0 mt -116.34 80.52 1.47 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.901 0.858 . . . . 0.0 110.524 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.01 -33.28 71.81 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.998 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -68.98 -25.97 64.8 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.271 -0.893 . . . . 0.0 111.875 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -120.01 29.61 7.44 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.093 -1.004 . . . . 52.369999999999997 111.191 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.1 p -148.07 150.59 34.18 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.316 -0.865 . . . . 55.189999999999998 110.821 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.5 m -117.9 92.52 42.09 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.584 -0.697 . . . . 0.0 109.361 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.459 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 48.3 Cg_endo -65.58 -25.46 54.9 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 O-C-N 123.951 1.5 . . . . 51.57 111.241 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.79 -23.22 65.18 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.462 -0.773 . . . . 0.0 110.843 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.39 23.4 14.22 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.326 -0.859 . . . . 0.0 110.716 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.84 30.03 72.54 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -120.86 92.59 3.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.543 -0.975 . . . . 0.0 110.036 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.459 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 72.3 m-85 -105.68 132.84 51.32 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.405 -0.809 . . . . 46.07 109.247 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -115.05 119.62 37.07 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.43 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -115.93 129.31 56.34 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.533 -0.729 . . . . 38.880000000000003 109.492 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.84 131.18 57.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.139 -0.976 . . . . 34.060000000000002 108.982 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 86' ' ' SER . 54.8 p90 -126.99 146.99 50.14 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.293 -0.963 . . . . 29.030000000000001 111.021 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.3 m -100.34 140.18 34.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.646 -0.659 . . . . 0.0 109.378 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.439 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 42.1 mm -104.39 132.01 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 121.734 0.778 . . . . 0.0 111.562 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -123.23 97.4 5.4 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.454 0.645 . . . . 40.240000000000002 109.664 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 75.7 mt -91.68 117.33 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.777 -0.577 . . . . 20.73 110.504 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -117.54 136.01 53.56 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.548 -0.72 . . . . 0.0 109.554 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -91.72 117.43 29.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.73 -0.606 . . . . 21.34 110.715 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.13 9.51 17.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.451 -0.78 . . . . 0.0 110.679 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.61 -178.22 51.25 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.136 -1.586 . . . . 29.100000000000001 109.136 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.05 -31.81 13.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.427 -1.043 . . . . 0.0 110.057 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.415 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 85.7 t -104.79 141.16 21.96 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.415 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 39.9 Cg_endo -53.98 147.17 43.98 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 O-C-N 123.74 1.39 . . . . 21.949999999999999 111.541 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.41 150.94 48.02 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.776 0.798 . . . . 20.91 111.203 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.429 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 3.0 ttt180 -126.46 154.76 43.26 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.9 tt -98.19 118.17 34.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.444 -0.785 . . . . 0.0 109.755 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.5 t -101.53 -26.73 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.715 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.45 162.83 34.54 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.146 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -142.93 139.4 30.71 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.34 0.59 . . . . 29.050000000000001 110.159 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -143.12 114.1 7.7 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.4 0.619 . . . . 27.969999999999999 109.815 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.42 ' CH2' HD12 ' A' ' 115' ' ' ILE . 88.0 m95 -102.49 134.47 45.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.669 -0.644 . . . . 25.25 110.881 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -115.75 78.76 1.21 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.522 -0.736 . . . . 0.0 109.092 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 54' ' ' ILE . 13.1 pt -83.45 128.63 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.515 -0.741 . . . . 36.109999999999999 111.741 -178.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.6 m -120.03 131.08 55.0 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.469 -0.937 . . . . 33.979999999999997 108.469 178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -88.54 170.01 11.24 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.619 0.723 . . . . 45.039999999999999 111.205 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.4 -6.93 12.08 Favored Glycine 0 N--CA 1.496 2.661 0 O-C-N 121.831 -0.543 . . . . 39.469999999999999 112.188 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.35 7.69 42.63 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 119.322 1.561 . . . . 0.0 110.576 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.59 -31.31 6.56 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -62.09 142.72 57.42 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.202 -1.175 . . . . 62.780000000000001 109.778 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.6 t -135.82 153.3 51.55 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.531 -0.731 . . . . 0.0 110.613 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -121.68 122.95 40.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.635 -0.665 . . . . 0.0 110.02 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -100.55 135.06 42.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.699 -0.625 . . . . 0.0 110.547 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.2 t -128.12 130.59 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.613 0.72 . . . . 37.939999999999998 110.065 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -126.44 127.09 44.86 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.801 -0.562 . . . . 0.0 110.147 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -150.5 154.85 25.88 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.494 -1.442 . . . . 31.82 109.494 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -78.16 154.74 30.92 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.51 -0.994 . . . . 0.0 110.367 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.46 -168.38 0.21 Allowed Glycine 0 N--CA 1.498 2.787 0 O-C-N 121.412 -0.805 . . . . 22.620000000000001 111.598 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.0 m -129.86 129.2 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.864 -0.786 . . . . 17.510000000000002 109.72 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.417 HG23 ' HG2' ' A' ' 72' ' ' GLU . 11.3 m 41.13 36.77 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 CA-C-O 121.44 0.638 . . . . 20.550000000000001 111.86 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.08 16.47 69.59 Favored Glycine 0 N--CA 1.499 2.893 0 O-C-N 121.645 -0.659 . . . . 18.289999999999999 112.833 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.417 ' HG2' HG23 ' A' ' 70' ' ' VAL . 10.6 pt-20 -145.98 151.72 38.25 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-N 119.145 1.472 . . . . 0.0 112.014 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -114.9 75.7 3.98 Favored Pre-proline 0 N--CA 1.492 1.625 0 N-CA-C 109.006 -0.739 . . . . 18.210000000000001 109.006 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -57.66 139.81 91.46 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 O-C-N 123.769 1.405 . . . . 17.609999999999999 111.951 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.429 ' CD1' ' HB2' ' A' ' 46' ' ' ARG . 2.3 t90 -103.36 76.53 1.44 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 tp -59.97 117.83 5.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.648 -0.658 . . . . 20.57 111.51 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -86.46 157.99 55.1 Favored Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -53.79 127.57 26.07 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 O-C-N 123.56 1.295 . . . . 27.039999999999999 111.054 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.88 -19.08 39.87 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.761 -0.936 . . . . 24.739999999999998 110.761 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 71.3 tt0 -88.87 166.48 13.95 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.1 -1.235 . . . . 29.379999999999999 110.162 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.28 150.62 36.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.49 -0.756 . . . . 0.0 110.464 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -117.71 147.84 42.57 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.044 -0.725 . . . . 18.559999999999999 109.044 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -144.29 140.19 29.03 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.109 -0.994 . . . . 0.0 111.338 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.439 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 47.9 p90 -150.78 160.28 43.97 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.653 -0.655 . . . . 26.649999999999999 109.577 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.7 m -102.63 137.67 40.55 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.424 -0.798 . . . . 28.140000000000001 110.949 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.426 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 15.0 t -124.11 167.06 14.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.595 -0.69 . . . . 33.880000000000003 109.957 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -139.83 128.65 3.99 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.882 -1.151 . . . . 31.800000000000001 110.503 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.5 m -134.19 154.27 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.651 -0.911 . . . . 0.0 110.009 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 mp -109.83 144.69 37.93 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.566 -0.709 . . . . 0.0 110.95 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.6 tp -121.43 146.55 46.78 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.656 -0.653 . . . . 38.68 109.762 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -83.9 -27.46 28.6 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.321 -0.862 . . . . 0.0 111.053 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.9 p -123.44 171.26 9.6 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.341 -0.849 . . . . 31.629999999999999 110.774 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.453 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 96.6 mt-10 -86.48 11.64 12.12 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.646 -0.659 . . . . 0.0 111.609 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -144.05 143.13 31.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.044 -1.035 . . . . 0.0 109.893 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.7 160.37 25.18 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 118.615 -1.755 . . . . 28.050000000000001 112.537 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -118.91 129.79 55.37 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.425 ' HB3' ' CE1' ' A' ' 118' ' ' PHE . 15.5 ttt -128.69 122.86 31.7 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.306 -0.871 . . . . 0.0 111.641 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -120.27 150.79 40.14 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -151.62 172.21 31.07 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 118.677 -1.725 . . . . 29.620000000000001 111.325 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.428 ' CE1' ' HB3' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -138.95 154.3 48.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.761 -0.847 . . . . 0.0 109.373 179.121 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.454 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 10.3 m-85 -118.98 126.09 50.94 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.404 -0.81 . . . . 27.050000000000001 110.244 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -86.31 120.25 27.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.899 -1.125 . . . . 0.0 108.777 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.43 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 86.8 mmm -121.87 163.04 19.9 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.228 0.537 . . . . 0.0 110.537 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 m -142.17 128.7 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.693 -0.629 . . . . 23.280000000000001 110.421 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.5 166.36 22.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.358 -0.838 . . . . 0.0 109.378 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -63.95 -27.73 69.34 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.324 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -76.41 -10.31 59.3 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.444 -0.785 . . . . 0.0 111.181 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.9 -7.34 48.85 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.45 -1.06 . . . . 30.43 110.45 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.3 m -58.32 135.76 57.23 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.052 -1.263 . . . . 0.0 109.966 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -100.51 139.03 36.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.434 -0.791 . . . . 0.0 110.783 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.43 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 37.8 p90 -161.2 141.46 10.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.702 -0.624 . . . . 28.030000000000001 109.889 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.409 ' HB ' ' CD2' ' A' ' 100' ' ' HIS . 29.9 pt -99.88 156.17 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.661 -0.649 . . . . 0.0 110.923 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -121.69 98.77 45.41 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.648 -0.658 . . . . 0.0 109.391 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.428 ' HB3' ' CE1' ' A' ' 100' ' ' HIS . 46.3 Cg_endo -59.03 144.0 99.56 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 O-C-N 123.901 1.474 . . . . 33.310000000000002 112.154 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.454 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 64.1 mt -108.8 121.71 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.426 -0.953 . . . . 30.59 108.426 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.3 159.13 0.22 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.176 0.512 . . . . 30.780000000000001 111.533 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -91.12 124.3 35.24 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.738 -0.601 . . . . 0.0 110.874 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.425 ' CE1' ' HB3' ' A' ' 97' ' ' MET . 38.5 p90 -113.64 158.35 20.95 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.347 -0.982 . . . . 30.66 108.347 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.1 t -116.15 154.89 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.27 -0.894 . . . . 0.0 110.387 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.455 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.9 mp -114.64 130.51 56.81 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.229 -0.656 . . . . 39.149999999999999 109.229 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.744 -0.598 . . . . 0.0 110.069 -179.652 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 120.762 0.315 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.418 ' CE2' HG23 ' A' ' 109' ' ' THR . 49.9 m-85 -118.51 108.42 14.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.433 -0.792 . . . . 31.93 110.209 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 66.9 mtt85 -150.15 134.95 17.62 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.57 0.7 . . . . 0.0 110.12 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 63.3 t -150.21 116.01 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.507 0.67 . . . . 0.0 109.365 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -107.25 130.69 54.71 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.592 0.711 . . . . 0.0 110.279 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.7 t -118.89 137.02 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.809 -0.557 . . . . 28.210000000000001 109.501 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -123.85 137.7 54.61 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.404 -0.81 . . . . 0.0 109.94 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.2 t -128.97 137.02 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.484 0.659 . . . . 27.949999999999999 110.583 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -124.59 105.19 30.47 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.754 -0.591 . . . . 0.0 110.116 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 50.7 Cg_endo -82.58 163.39 16.62 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 O-C-N 123.869 1.457 . . . . 33.0 111.323 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -156.98 130.77 8.22 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.613 0.721 . . . . 54.100000000000001 109.602 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -61.55 138.48 58.29 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.344 0.592 . . . . 0.0 111.444 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.9 tp -114.96 82.65 1.77 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.961 0.886 . . . . 0.0 110.014 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.19 -36.17 83.38 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.575 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -68.89 -22.39 64.18 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.355 -0.84 . . . . 0.0 110.871 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -119.54 23.55 11.13 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.345 -0.847 . . . . 52.369999999999997 110.702 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.1 m -136.11 137.95 41.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.301 -0.875 . . . . 55.189999999999998 111.16 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.2 m -119.19 90.44 41.8 Favored Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.424 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 48.3 Cg_endo -63.74 -26.83 68.14 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 O-C-N 123.933 1.491 . . . . 51.57 111.686 -178.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -69.04 -22.83 64.02 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.327 -0.858 . . . . 0.0 110.829 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -107.11 19.27 20.64 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.295 -0.878 . . . . 0.0 110.998 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.18 30.37 73.73 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -119.61 94.37 4.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.667 -0.902 . . . . 0.0 110.247 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.426 ' CE2' ' HB2' ' A' ' 93' ' ' GLU . 79.0 m-85 -106.51 129.01 54.54 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.391 -0.818 . . . . 46.07 109.386 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -119.42 120.07 35.76 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.31 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.404 ' CD1' HD13 ' A' ' 90' ' ' LEU . 61.9 m-85 -115.79 136.84 52.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.644 -0.66 . . . . 38.880000000000003 109.597 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.27 131.82 54.85 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.727 -0.842 . . . . 34.060000000000002 108.727 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 86' ' ' SER . 26.4 p90 -126.54 143.37 51.23 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.212 -0.995 . . . . 29.030000000000001 111.303 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 t -102.81 139.12 38.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.682 -0.636 . . . . 0.0 109.286 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.443 ' CD1' ' CE2' ' A' ' 84' ' ' TYR . 5.2 mp -104.78 132.04 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.81 0.814 . . . . 0.0 111.247 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.6 mtm180 -122.08 97.35 5.44 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.467 0.651 . . . . 40.240000000000002 109.63 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 80.2 mt -94.2 116.47 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.765 -0.584 . . . . 20.73 110.507 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -117.46 138.68 51.7 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.486 -0.759 . . . . 0.0 109.455 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -91.61 118.12 30.33 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.67 -0.644 . . . . 21.34 110.851 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.1 9.04 14.63 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.428 -0.795 . . . . 0.0 110.479 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.23 176.63 52.95 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.544 -1.423 . . . . 29.100000000000001 109.544 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.12 -35.71 17.3 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.585 -0.95 . . . . 0.0 110.271 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.411 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 86.9 t -102.96 140.31 20.93 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.802 -0.561 . . . . 0.0 110.033 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.411 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 39.5 Cg_endo -52.87 144.14 45.73 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 O-C-N 123.775 1.408 . . . . 21.949999999999999 111.68 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.09 151.4 46.69 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.659 0.742 . . . . 20.91 111.092 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.42 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 1.1 ptt85 -127.73 159.79 33.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.697 -0.627 . . . . 0.0 109.715 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.8 tt -98.04 116.4 30.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.463 -0.773 . . . . 0.0 109.583 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.6 t -98.43 -28.21 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.541 -0.724 . . . . 0.0 110.515 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.62 162.38 35.63 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.439 -0.905 . . . . 0.0 111.758 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.0 ptt85 -142.89 141.56 31.55 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.579 0.704 . . . . 29.050000000000001 110.298 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -144.23 114.86 7.67 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.288 0.566 . . . . 27.969999999999999 109.581 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -95.9 133.68 39.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.646 -0.659 . . . . 25.25 111.037 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -115.84 78.49 1.19 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.415 ' O ' HG13 ' A' ' 54' ' ' ILE . 13.3 pt -86.29 129.24 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-O 121.748 0.785 . . . . 36.109999999999999 111.758 -178.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.6 m -120.19 129.98 54.35 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.097 -1.075 . . . . 33.979999999999997 108.097 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -91.04 170.32 10.14 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.771 0.796 . . . . 45.039999999999999 111.504 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.62 -6.62 11.97 Favored Glycine 0 N--CA 1.494 2.555 0 O-C-N 121.8 -0.562 . . . . 39.469999999999999 112.122 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -101.73 5.56 41.38 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 119.429 1.614 . . . . 0.0 110.62 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.77 -28.5 9.2 Favored Glycine 0 N--CA 1.495 2.613 0 O-C-N 121.25 -0.906 . . . . 0.0 110.894 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.6 142.44 58.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.191 -1.182 . . . . 62.780000000000001 109.621 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 71.5 p -132.23 149.99 52.26 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.455 -0.778 . . . . 0.0 110.67 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -122.4 122.12 38.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.47 -0.769 . . . . 0.0 109.962 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -105.44 136.39 45.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.579 -0.701 . . . . 0.0 110.984 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.6 t -129.23 131.35 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.546 -0.722 . . . . 37.939999999999998 109.818 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.29 127.45 47.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.711 -0.618 . . . . 0.0 110.429 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.24 149.23 21.17 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.412 -1.475 . . . . 31.82 109.412 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -74.42 155.68 37.81 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.448 -1.031 . . . . 0.0 110.274 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 50.4 -171.94 0.14 Allowed Glycine 0 N--CA 1.498 2.817 0 O-C-N 121.336 -0.853 . . . . 22.620000000000001 111.253 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.8 m -129.41 128.11 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.78 -0.835 . . . . 17.510000000000002 109.57 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.413 HG23 ' HG2' ' A' ' 72' ' ' GLU . 12.0 m 41.17 36.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 CA-C-O 121.603 0.716 . . . . 20.550000000000001 111.796 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.25 16.25 69.75 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 121.627 -0.67 . . . . 18.289999999999999 112.93 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.413 ' HG2' HG23 ' A' ' 70' ' ' VAL . 10.0 pt-20 -145.79 150.76 36.8 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 119.163 1.481 . . . . 0.0 112.028 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -114.97 74.15 3.43 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.895 -0.78 . . . . 18.210000000000001 108.895 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -57.25 140.51 93.11 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 O-C-N 123.793 1.417 . . . . 17.609999999999999 112.225 -178.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.42 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 5.9 t90 -102.11 77.17 1.65 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 tp -59.66 117.3 4.77 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.553 -0.717 . . . . 20.57 111.621 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -86.35 156.86 56.66 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -52.76 126.72 22.02 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 O-C-N 123.678 1.357 . . . . 27.039999999999999 110.931 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.6 -17.44 49.25 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.701 -0.96 . . . . 24.739999999999998 110.701 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -88.16 165.5 15.05 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.053 -1.263 . . . . 29.379999999999999 110.196 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -147.81 152.8 38.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.513 -0.742 . . . . 0.0 110.372 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.4 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 66.9 t80 -119.34 147.89 43.81 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.93 -0.767 . . . . 18.559999999999999 108.93 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.5 m80 -138.95 138.31 37.21 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.094 -1.004 . . . . 0.0 110.824 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.443 ' CE2' ' CD1' ' A' ' 35' ' ' ILE . 50.5 p90 -151.0 159.72 44.39 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.527 -0.733 . . . . 26.649999999999999 109.993 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.1 m -104.36 137.61 41.99 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.444 -0.785 . . . . 28.140000000000001 110.811 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 14.6 t -125.14 166.86 15.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.578 -0.701 . . . . 33.880000000000003 110.091 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.43 127.24 4.07 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.886 -1.15 . . . . 31.800000000000001 110.413 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 79.4 t -131.51 148.43 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.577 -0.955 . . . . 0.0 109.375 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.9 tp -110.13 143.54 40.06 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.561 -0.712 . . . . 0.0 110.275 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.404 HD13 ' CD1' ' A' ' 31' ' ' PHE . 84.5 mt -122.97 148.38 45.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.474 -0.766 . . . . 38.68 110.358 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -76.21 -26.41 56.09 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.376 -0.828 . . . . 0.0 110.63 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.4 m -122.55 171.27 9.24 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.453 -0.78 . . . . 31.629999999999999 110.545 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.426 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 58.0 tt0 -85.87 8.15 21.3 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.678 -0.639 . . . . 0.0 111.754 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -140.71 150.11 43.03 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.059 -1.026 . . . . 0.0 110.064 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.06 164.46 29.14 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 118.867 -1.635 . . . . 28.050000000000001 112.097 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -121.89 131.69 54.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 122.067 -0.667 . . . . 0.0 109.545 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 118' ' ' PHE . 27.1 ttt -127.27 121.05 30.09 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.256 -0.902 . . . . 0.0 111.424 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -128.66 147.75 50.76 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.84 -179.86 35.86 Favored Glycine 0 N--CA 1.5 2.945 0 C-N-CA 119.072 -1.537 . . . . 29.620000000000001 110.72 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -140.84 157.97 44.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.697 -0.884 . . . . 0.0 110.75 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.451 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 6.9 m-85 -116.72 129.28 56.03 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.606 -0.684 . . . . 27.050000000000001 110.193 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -83.9 122.98 29.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.959 -1.088 . . . . 0.0 109.149 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.422 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 24.1 mtp -124.23 162.75 23.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.9 -0.5 . . . . 0.0 110.572 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.6 m -140.45 130.24 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.69 -0.631 . . . . 23.280000000000001 110.208 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.9 166.61 22.66 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.407 -0.808 . . . . 0.0 109.473 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -63.93 -29.97 71.09 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.127 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -74.19 -10.34 59.51 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.524 -0.735 . . . . 0.0 111.129 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.14 -7.43 47.99 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 120.072 -1.061 . . . . 30.43 110.454 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.418 HG23 ' CE2' ' A' ' 7' ' ' TYR . 65.8 m -57.45 136.05 56.63 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.108 -1.231 . . . . 0.0 109.988 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -101.92 140.85 35.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.334 -0.854 . . . . 0.0 110.955 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.422 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 46.5 p90 -167.45 147.03 5.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.678 -0.639 . . . . 28.030000000000001 110.06 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.2 pt -102.43 157.53 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.685 -0.634 . . . . 0.0 110.846 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.77 98.33 49.65 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -59.25 142.19 98.84 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 O-C-N 123.935 1.492 . . . . 33.310000000000002 112.236 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.451 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 67.3 mt -106.83 123.3 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.52 -0.918 . . . . 30.59 108.52 178.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.18 144.09 7.56 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.243 0.544 . . . . 30.780000000000001 111.365 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -88.53 121.22 30.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.659 -0.651 . . . . 0.0 110.103 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.428 ' CD1' ' HG3' ' A' ' 15' ' ' PRO . 36.3 p90 -107.5 165.14 11.62 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.037 -0.727 . . . . 30.66 109.037 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.94 155.63 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.377 -0.827 . . . . 0.0 110.274 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.452 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.2 mp -114.06 132.49 56.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.709 -0.619 . . . . 39.149999999999999 109.6 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.657 -0.652 . . . . 0.0 110.138 -179.796 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.034 0.445 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -112.68 79.57 1.24 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.702 -0.624 . . . . 31.93 109.9 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 45.9 mtm180 -138.29 142.87 39.79 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.966 0.889 . . . . 0.0 110.333 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.5 t -150.56 115.75 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.537 0.684 . . . . 0.0 109.215 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -106.02 129.61 54.1 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.557 0.694 . . . . 0.0 109.779 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.5 t -116.93 138.87 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.92 -0.487 . . . . 28.210000000000001 109.694 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -121.02 136.6 54.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.466 -0.771 . . . . 0.0 109.798 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.1 t -128.42 136.38 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.669 -0.644 . . . . 27.949999999999999 110.173 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.9 m -124.81 105.05 29.9 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.617 -0.677 . . . . 0.0 110.509 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -82.22 165.06 17.0 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 O-C-N 123.893 1.47 . . . . 33.0 110.768 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -158.01 130.67 7.27 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.587 0.708 . . . . 54.100000000000001 109.844 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -61.16 138.21 58.22 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.761 -0.587 . . . . 0.0 111.327 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.1 mt -116.62 80.94 1.54 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.086 0.946 . . . . 0.0 110.333 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.37 -35.67 79.82 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.136 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -68.8 -23.25 64.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.275 -0.891 . . . . 0.0 110.818 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -121.96 46.87 2.0 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.36 -0.838 . . . . 52.369999999999997 110.64 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.3 p -167.46 148.74 5.57 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.236 -0.915 . . . . 55.189999999999998 111.112 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.8 t -122.02 93.27 48.67 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.439 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.0 Cg_endo -67.26 -22.81 45.86 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 O-C-N 123.673 1.354 . . . . 51.57 111.949 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -65.15 -23.27 67.07 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.283 -0.886 . . . . 0.0 110.961 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -106.14 24.45 12.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.285 -0.884 . . . . 0.0 110.709 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.84 28.91 73.39 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -120.87 93.81 4.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.641 -0.917 . . . . 0.0 110.178 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 67.8 m-85 -104.26 133.95 48.31 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.533 -0.729 . . . . 46.07 109.126 179.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.28 120.93 42.08 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.107 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -116.12 134.02 55.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.694 -0.629 . . . . 38.880000000000003 109.788 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.43 132.04 55.25 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.463 -0.939 . . . . 34.060000000000002 108.463 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.451 ' CZ ' ' CB ' ' A' ' 86' ' ' SER . 38.2 p90 -127.67 144.39 51.08 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.073 -1.051 . . . . 29.030000000000001 111.708 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.6 t -104.82 139.98 38.79 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.442 ' CG2' ' CE1' ' A' ' 84' ' ' TYR . 41.4 mm -105.77 132.63 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.77 0.795 . . . . 0.0 111.725 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.3 mtp180 -124.04 97.02 5.16 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.49 0.662 . . . . 40.240000000000002 109.799 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.416 ' CG2' ' CD1' ' A' ' 76' ' ' LEU . 74.1 mt -92.78 116.92 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.706 -0.621 . . . . 20.73 110.433 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -119.77 144.69 47.15 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.455 -0.778 . . . . 0.0 109.919 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.06 113.84 22.46 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.514 -0.741 . . . . 21.34 109.47 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.32 -18.79 26.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.788 -0.57 . . . . 0.0 111.715 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.59 -163.93 37.2 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.305 -0.95 . . . . 29.100000000000001 110.942 -178.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -113.89 -17.02 12.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.964 -0.727 . . . . 0.0 111.013 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.411 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 95.5 t -103.31 135.59 19.36 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.316 -0.865 . . . . 0.0 109.566 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.434 ' CB ' ' CH2' ' A' ' 75' ' ' TRP . 41.2 Cg_endo -48.84 140.54 23.09 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 O-C-N 123.757 1.399 . . . . 21.949999999999999 112.219 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -134.23 149.52 50.98 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.703 0.764 . . . . 20.91 110.873 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.421 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 43.2 ttt180 -125.91 151.45 46.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.832 -0.542 . . . . 0.0 109.547 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.2 tt -98.68 117.21 32.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.464 -0.773 . . . . 0.0 109.973 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.4 t -100.98 -30.49 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.6 -0.687 . . . . 0.0 110.649 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.4 162.54 35.25 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.08 -1.048 . . . . 0.0 112.334 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -143.25 140.98 30.91 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.482 0.658 . . . . 29.050000000000001 110.201 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.417 ' HB3' ' CE1' ' A' ' 100' ' ' HIS . 21.7 t-160 -145.86 114.69 6.9 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.353 0.597 . . . . 27.969999999999999 109.987 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.421 ' CE3' ' HA3' ' A' ' 99' ' ' GLY . 63.2 m95 -100.21 135.97 40.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.579 -0.701 . . . . 25.25 111.42 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -117.06 79.17 1.3 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.711 -0.618 . . . . 0.0 109.417 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 54' ' ' ILE . 28.2 pt -83.31 130.27 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.375 -0.828 . . . . 36.109999999999999 112.208 -178.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.3 m -119.48 130.05 55.03 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.209 -1.034 . . . . 33.979999999999997 108.209 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -91.39 170.03 10.31 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.657 0.741 . . . . 45.039999999999999 111.352 -178.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.81 -6.72 12.85 Favored Glycine 0 N--CA 1.495 2.609 0 O-C-N 121.866 -0.521 . . . . 39.469999999999999 112.086 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -102.05 5.83 40.74 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 119.367 1.584 . . . . 0.0 110.6 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.27 -28.47 9.71 Favored Glycine 0 N--CA 1.495 2.596 0 C-N-CA 120.352 -0.927 . . . . 0.0 110.859 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.1 141.4 58.15 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.277 -1.131 . . . . 62.780000000000001 109.77 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 66.4 p -132.38 150.05 52.23 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.438 -0.788 . . . . 0.0 110.488 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -122.32 122.29 38.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.566 -0.709 . . . . 0.0 109.903 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -103.28 134.66 46.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.696 -0.627 . . . . 0.0 110.59 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.3 t -128.04 130.07 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.558 0.694 . . . . 37.939999999999998 109.942 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -124.24 126.82 46.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.822 -0.549 . . . . 0.0 110.111 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.96 149.6 21.62 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.35 -1.5 . . . . 31.82 109.35 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -76.72 154.72 33.86 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.492 -1.004 . . . . 0.0 110.078 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.77 -169.48 0.19 Allowed Glycine 0 N--CA 1.498 2.808 0 O-C-N 121.378 -0.826 . . . . 22.620000000000001 111.337 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.9 m -131.05 129.24 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.834 -0.803 . . . . 17.510000000000002 109.648 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.429 HG21 ' HG2' ' A' ' 72' ' ' GLU . 11.1 m 40.95 35.22 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.456 0 CA-C-O 121.445 0.64 . . . . 20.550000000000001 111.918 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.06 17.13 67.95 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 121.676 -0.64 . . . . 18.289999999999999 112.85 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.429 ' HG2' HG21 ' A' ' 70' ' ' VAL . 11.9 pt-20 -144.97 150.33 36.75 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 119.131 1.466 . . . . 0.0 111.902 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -116.3 75.57 6.37 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 109.019 -0.734 . . . . 18.210000000000001 109.019 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -58.1 142.17 96.83 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 O-C-N 123.956 1.503 . . . . 17.609999999999999 112.411 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.434 ' CH2' ' CB ' ' A' ' 44' ' ' PRO . 5.0 t90 -103.88 75.54 1.3 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.416 ' CD1' ' CG2' ' A' ' 37' ' ' ILE . 9.7 mt -60.82 121.34 12.08 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.563 -0.711 . . . . 20.57 112.35 -178.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -87.44 158.44 51.72 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -54.22 129.21 33.32 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 O-C-N 123.529 1.279 . . . . 27.039999999999999 111.309 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.92 -16.75 49.8 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 120.481 -0.866 . . . . 24.739999999999998 111.023 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -87.96 166.07 14.77 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.973 -1.31 . . . . 29.379999999999999 110.393 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.33 149.56 35.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.516 -0.74 . . . . 0.0 110.283 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.404 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 65.1 t80 -118.99 147.79 43.7 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.846 -0.798 . . . . 18.559999999999999 108.846 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -143.95 140.19 29.53 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.13 -0.981 . . . . 0.0 111.552 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.442 ' CE1' ' CG2' ' A' ' 35' ' ' ILE . 52.1 p90 -150.45 159.97 44.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.707 -0.621 . . . . 26.649999999999999 109.526 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.5 m -104.83 138.78 40.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.283 -0.885 . . . . 28.140000000000001 111.353 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.451 ' CB ' ' CZ ' ' A' ' 33' ' ' TYR . 25.2 t -123.95 166.18 16.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.714 -0.616 . . . . 33.880000000000003 109.762 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -143.06 118.89 1.28 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.202 -1.159 . . . . 31.800000000000001 110.202 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 68.2 t -132.57 149.42 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.66 -0.906 . . . . 0.0 109.763 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 pp -107.34 142.36 37.25 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.505 -0.747 . . . . 0.0 110.205 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.0 mt -124.57 143.3 50.77 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.486 -0.759 . . . . 38.68 110.502 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.56 -19.26 38.88 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.281 -0.887 . . . . 0.0 110.232 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 m -101.67 133.17 46.79 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.443 -0.786 . . . . 31.629999999999999 109.978 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.421 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 67.9 tt0 -75.7 -4.89 42.85 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.119 -0.988 . . . . 0.0 110.623 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -138.68 143.31 39.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.207 -0.933 . . . . 0.0 108.803 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -178.05 167.35 38.04 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 118.303 -1.903 . . . . 28.050000000000001 112.639 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -117.71 130.63 56.45 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 122.192 -0.593 . . . . 0.0 109.711 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 98.1 mtp -127.11 121.28 31.01 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.325 -0.859 . . . . 0.0 111.337 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -123.06 152.7 40.76 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.421 ' HA3' ' CE3' ' A' ' 52' ' ' TRP . . . -168.41 174.96 43.18 Favored Glycine 0 N--CA 1.499 2.879 0 C-N-CA 118.561 -1.78 . . . . 29.620000000000001 111.366 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.417 ' CE1' ' HB3' ' A' ' 51' ' ' HIS . 40.7 p-80 -142.86 156.17 44.89 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.876 -0.779 . . . . 0.0 110.078 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.418 ' CD2' HD11 ' A' ' 115' ' ' ILE . 4.8 m-85 -116.82 127.81 54.67 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.503 -0.748 . . . . 27.050000000000001 109.796 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -78.88 123.17 26.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.914 -1.116 . . . . 0.0 109.298 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.428 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 92.3 mmm -119.69 163.07 17.96 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.174 0.512 . . . . 0.0 110.062 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.6 m -142.42 129.16 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.588 -0.695 . . . . 23.280000000000001 110.453 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.73 166.03 23.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.492 -0.755 . . . . 0.0 109.408 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -64.36 -28.39 69.67 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.383 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 47.0 p-10 -76.29 -4.44 42.04 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.467 -0.77 . . . . 0.0 111.505 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.7 -9.91 60.57 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.056 -1.069 . . . . 30.43 110.915 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 89.7 m -57.5 135.08 56.59 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.03 -1.276 . . . . 0.0 109.985 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -101.36 140.8 35.15 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.335 -0.853 . . . . 0.0 110.877 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.428 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 44.0 p90 -165.9 144.87 6.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.712 -0.618 . . . . 28.030000000000001 109.603 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 84.8 mt -99.15 157.41 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.699 -0.626 . . . . 0.0 110.712 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.82 96.07 49.39 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -60.1 144.88 99.45 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 O-C-N 123.946 1.498 . . . . 33.310000000000002 112.376 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.418 HD11 ' CD2' ' A' ' 101' ' ' TYR . 68.8 mt -111.56 123.32 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.749 -0.834 . . . . 30.59 108.749 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -47.87 170.56 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.246 0.545 . . . . 30.780000000000001 111.636 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -99.41 123.14 43.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.699 -0.626 . . . . 0.0 110.766 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 97' ' ' MET . 48.4 p90 -111.36 156.83 20.97 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.262 -1.014 . . . . 30.66 108.262 178.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.9 p -115.65 155.31 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.245 -0.909 . . . . 0.0 110.602 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.8 mp -112.81 132.34 55.3 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.286 -0.635 . . . . 39.149999999999999 109.286 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.735 -0.603 . . . . 0.0 110.114 -179.722 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.3 ttm-85 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.011 0.434 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -122.47 84.59 2.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.77 -0.581 . . . . 31.93 110.348 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.404 ' HG2' ' HA2' ' A' ' 41' ' ' GLY . 11.9 ptp180 -148.3 144.26 27.47 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.133 0.968 . . . . 0.0 110.737 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.3 t -151.02 120.61 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -108.07 134.18 51.32 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.615 0.721 . . . . 0.0 110.127 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.5 t -119.28 138.55 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.915 -0.491 . . . . 28.210000000000001 109.921 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -122.92 139.71 53.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.502 -0.749 . . . . 0.0 109.422 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.3 t -128.56 140.25 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.645 -0.659 . . . . 27.949999999999999 110.717 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.6 t -122.83 104.04 36.52 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.844 -0.535 . . . . 0.0 109.963 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.423 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 50.0 Cg_endo -82.74 165.79 15.53 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 O-C-N 123.901 1.474 . . . . 33.0 111.26 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 -157.61 132.8 8.86 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.511 0.672 . . . . 54.100000000000001 109.557 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -60.0 137.77 58.01 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.287 0.565 . . . . 0.0 111.206 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.6 tp -114.95 78.71 1.19 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.979 0.895 . . . . 0.0 110.211 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.89 -35.32 72.27 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.567 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -68.14 -25.18 65.16 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.339 -0.851 . . . . 0.0 111.02 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -119.38 33.7 5.53 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.375 -0.828 . . . . 52.369999999999997 110.38 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -152.39 143.91 23.43 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.537 -0.727 . . . . 55.189999999999998 110.705 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.0 t -121.05 95.56 48.79 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.449 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 49.5 Cg_endo -66.46 -23.17 50.92 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 O-C-N 123.79 1.416 . . . . 51.57 112.106 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -65.13 -24.15 67.33 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.295 -0.878 . . . . 0.0 110.995 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -105.4 21.8 16.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.197 -0.939 . . . . 0.0 110.944 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.89 30.3 70.35 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -121.14 93.13 3.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.619 -0.93 . . . . 0.0 109.943 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.458 ' CE2' ' CG ' ' A' ' 93' ' ' GLU . 54.8 m-85 -105.56 130.77 53.54 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.955 -0.757 . . . . 46.07 108.955 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -117.98 119.62 35.36 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.635 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.415 ' CD1' HD12 ' A' ' 90' ' ' LEU . 79.2 m-85 -114.59 131.39 56.7 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.134 -0.691 . . . . 38.880000000000003 109.134 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.69 131.01 56.32 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.142 -0.974 . . . . 34.060000000000002 109.021 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.422 ' CE1' ' HB3' ' A' ' 86' ' ' SER . 52.3 p90 -128.51 147.46 50.69 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.237 -0.985 . . . . 29.030000000000001 111.161 -179.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.7 m -101.07 139.44 36.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.697 -0.627 . . . . 0.0 109.691 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.44 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 47.4 mm -103.22 132.74 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.661 0.743 . . . . 0.0 111.317 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 62.7 mtt85 -126.0 97.77 5.24 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.577 0.703 . . . . 40.240000000000002 110.182 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.405 ' CG2' ' CD1' ' A' ' 76' ' ' LEU . 81.7 mt -93.5 118.05 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.882 -0.511 . . . . 20.73 110.656 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -117.0 135.73 53.47 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.428 -0.795 . . . . 0.0 109.507 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -90.69 118.73 30.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.879 -0.513 . . . . 21.34 110.833 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.56 8.91 17.85 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.558 -0.714 . . . . 0.0 110.706 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.404 ' HA2' ' HG2' ' A' ' 8' ' ' ARG . . . -82.94 178.68 53.13 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.216 -1.554 . . . . 29.100000000000001 109.216 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.62 -30.45 14.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.446 -1.032 . . . . 0.0 110.198 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.415 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 86.7 t -103.82 139.89 20.54 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.855 -0.528 . . . . 0.0 109.764 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.421 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . 39.9 Cg_endo -52.75 142.69 50.28 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 O-C-N 123.818 1.43 . . . . 21.949999999999999 111.827 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.4 151.44 46.3 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.53 0.681 . . . . 20.91 110.926 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.412 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 19.3 ptt-85 -127.76 159.14 35.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.721 -0.612 . . . . 0.0 109.893 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.6 tt -97.75 116.22 29.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.449 -0.782 . . . . 0.0 109.737 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.08 -27.54 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.517 -0.739 . . . . 0.0 110.497 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.46 163.61 32.36 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.822 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -143.18 140.65 30.85 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.306 0.574 . . . . 29.050000000000001 110.226 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -145.1 113.46 6.61 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.433 0.635 . . . . 27.969999999999999 110.15 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -101.1 136.66 40.59 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.635 -0.666 . . . . 25.25 110.996 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -116.8 78.52 1.22 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.717 -0.614 . . . . 0.0 109.751 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.403 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.0 pt -86.42 131.89 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.361 -0.837 . . . . 36.109999999999999 111.963 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.3 m -118.76 132.51 56.14 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.549 -0.908 . . . . 33.979999999999997 108.549 178.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -87.91 169.81 11.69 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.556 0.694 . . . . 45.039999999999999 111.244 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.48 -8.67 20.77 Favored Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.81 -0.556 . . . . 39.469999999999999 112.016 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -101.98 8.29 41.07 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 119.301 1.551 . . . . 0.0 110.797 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.78 -25.61 18.36 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 121.264 -0.898 . . . . 0.0 110.966 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.3 mpp_? -62.0 141.71 57.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.219 -1.165 . . . . 62.780000000000001 109.619 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.7 p -129.3 147.83 51.17 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.614 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -122.1 120.49 34.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.549 -0.72 . . . . 0.0 109.809 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -103.92 136.13 44.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.66 -0.65 . . . . 0.0 110.668 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.5 t -128.12 131.11 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.454 0.645 . . . . 37.939999999999998 109.781 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.99 127.85 47.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.827 -0.546 . . . . 0.0 110.472 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -153.0 170.18 31.99 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.165 -1.574 . . . . 31.82 109.165 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -111.13 160.32 17.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.411 -1.052 . . . . 0.0 109.896 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.77 93.81 0.01 OUTLIER Glycine 0 N--CA 1.5 2.919 0 O-C-N 121.284 -0.885 . . . . 22.620000000000001 111.239 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.6 m -44.54 132.53 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.528 0 O-C-N 121.431 -1.041 . . . . 17.510000000000002 111.774 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.404 HG21 ' HG2' ' A' ' 72' ' ' GLU . 11.9 m 41.77 38.45 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 CA-C-N 115.592 -0.731 . . . . 20.550000000000001 111.605 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.08 18.79 64.19 Favored Glycine 0 N--CA 1.495 2.618 0 O-C-N 121.789 -0.569 . . . . 18.289999999999999 112.521 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 82' ' ' PHE . 5.5 pt-20 -147.41 153.07 39.16 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 119.045 1.422 . . . . 0.0 112.477 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -117.39 73.31 7.58 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.555 -0.906 . . . . 18.210000000000001 108.555 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -54.88 141.39 77.75 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 O-C-N 123.715 1.376 . . . . 17.609999999999999 112.174 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.421 ' CZ3' ' HB2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -100.62 76.93 1.86 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.405 ' CD1' ' CG2' ' A' ' 37' ' ' ILE . 11.2 mt -60.68 118.18 6.28 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.618 -0.676 . . . . 20.57 111.736 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.08 157.5 56.79 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -53.17 127.6 25.74 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 O-C-N 123.491 1.258 . . . . 27.039999999999999 111.089 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.14 -16.58 55.33 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.799 -0.92 . . . . 24.739999999999998 110.799 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -86.81 165.36 16.06 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.078 -1.248 . . . . 29.379999999999999 110.489 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.14 149.62 35.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.517 -0.739 . . . . 0.0 110.015 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.407 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 64.7 t80 -119.75 148.25 43.64 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.414 -0.804 . . . . 18.559999999999999 109.141 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.8 p80 -143.46 140.23 30.27 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.125 -0.985 . . . . 0.0 111.293 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.44 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 51.7 p90 -151.52 160.38 43.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.664 -0.648 . . . . 26.649999999999999 109.618 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.2 m -102.82 137.64 40.75 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.402 -0.812 . . . . 28.140000000000001 111.058 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.422 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 17.0 t -123.99 167.28 14.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.595 -0.691 . . . . 33.880000000000003 109.886 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -143.97 124.35 2.23 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.813 -1.184 . . . . 31.800000000000001 110.572 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.5 m -131.36 154.19 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.632 -0.923 . . . . 0.0 109.939 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.6 tp -109.18 144.64 36.99 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.553 -0.717 . . . . 0.0 110.832 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.415 HD12 ' CD1' ' A' ' 31' ' ' PHE . 74.7 mt -122.14 146.34 47.32 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.597 -0.689 . . . . 38.68 110.314 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.403 ' O ' ' CE1' ' A' ' 29' ' ' TYR . 75.4 tt0 -76.2 -25.62 55.33 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.353 -0.842 . . . . 0.0 110.782 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 68.0 p -125.2 172.06 9.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.361 -0.837 . . . . 31.629999999999999 110.782 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.458 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 50.1 mt-10 -86.81 11.72 12.58 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.593 -0.692 . . . . 0.0 111.654 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -140.85 148.22 40.2 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.06 -1.025 . . . . 0.0 110.057 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.31 160.82 23.78 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 118.907 -1.616 . . . . 28.050000000000001 112.086 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -119.73 129.64 54.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 122.14 -0.624 . . . . 0.0 109.335 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 97.7 mtp -125.3 116.24 21.62 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.344 -0.848 . . . . 0.0 111.116 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -129.26 149.79 50.91 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.7 -178.49 38.72 Favored Glycine 0 N--CA 1.498 2.822 0 C-N-CA 118.916 -1.611 . . . . 29.620000000000001 110.76 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -140.54 157.96 44.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.703 -0.881 . . . . 0.0 110.752 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.436 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 6.3 m-85 -116.79 128.58 55.43 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.645 -0.66 . . . . 27.050000000000001 109.885 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -81.35 123.18 28.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.978 -1.076 . . . . 0.0 109.136 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.428 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 51.7 mtp -122.19 162.35 21.52 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.118 0.485 . . . . 0.0 110.339 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.0 m -142.91 129.73 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.613 -0.679 . . . . 23.280000000000001 110.325 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.04 167.66 20.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.513 -0.742 . . . . 0.0 109.45 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -64.29 -28.44 69.72 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.142 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -72.92 -12.26 60.89 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.567 -0.708 . . . . 0.0 111.026 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.25 -7.05 47.05 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.484 -1.046 . . . . 30.43 110.484 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 91.3 m -57.66 135.2 56.7 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.051 -1.264 . . . . 0.0 110.049 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -101.29 140.03 36.14 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.457 -0.777 . . . . 0.0 110.796 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.428 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 47.5 p90 -167.16 147.23 5.43 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.781 -0.574 . . . . 28.030000000000001 109.854 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.7 pt -102.55 158.12 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.596 -0.69 . . . . 0.0 111.087 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.63 97.59 49.91 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -59.25 143.13 99.86 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 O-C-N 123.895 1.471 . . . . 33.310000000000002 112.432 -178.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.436 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 72.2 mt -108.33 123.24 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.658 -0.867 . . . . 30.59 108.658 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.05 144.21 7.13 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.217 0.532 . . . . 30.780000000000001 111.551 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -87.37 121.03 29.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.638 -0.664 . . . . 0.0 110.242 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.423 ' CD1' ' HG3' ' A' ' 15' ' ' PRO . 41.9 p90 -109.42 165.89 11.3 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.879 -0.785 . . . . 30.66 108.879 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.1 t -114.81 154.0 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.284 -0.885 . . . . 0.0 110.326 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.453 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.0 mp -113.2 133.23 55.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.788 -0.57 . . . . 39.149999999999999 109.514 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.673 -0.642 . . . . 0.0 110.071 -179.838 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.961 0.41 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.416 ' CE2' HG23 ' A' ' 109' ' ' THR . 34.3 m-85 -115.93 107.41 14.96 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.542 -0.724 . . . . 31.93 110.029 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -155.87 135.05 12.17 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.588 0.708 . . . . 0.0 110.594 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.2 t -152.42 116.23 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -108.95 132.6 53.93 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.675 0.75 . . . . 0.0 110.62 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.7 t -119.41 139.08 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.891 -0.506 . . . . 28.210000000000001 109.712 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -119.96 137.92 53.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.505 -0.747 . . . . 0.0 109.709 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.409 HG12 ' CD1' ' A' ' 33' ' ' TYR . 62.6 t -129.26 136.62 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.539 -0.725 . . . . 27.949999999999999 110.509 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.6 p -124.17 103.89 32.65 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.72 -0.612 . . . . 0.0 110.281 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -82.89 165.97 15.13 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 123.841 1.443 . . . . 33.0 111.063 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -157.59 132.12 8.47 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.539 0.685 . . . . 54.100000000000001 109.801 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -60.29 139.52 57.57 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.257 0.551 . . . . 0.0 111.471 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 93.7 mt -115.58 79.15 1.25 Allowed 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.879 0.847 . . . . 0.0 110.279 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.89 -35.62 81.15 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.17 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -69.96 -23.45 63.18 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.365 -0.835 . . . . 0.0 110.985 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -121.07 29.97 7.08 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.366 -0.834 . . . . 52.369999999999997 110.976 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.7 p -152.17 146.37 25.42 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.265 -0.897 . . . . 55.189999999999998 111.099 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 t -119.45 92.79 46.45 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.443 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.3 Cg_endo -66.08 -23.15 53.75 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 O-C-N 123.912 1.48 . . . . 51.57 111.566 -178.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.04 -23.19 67.12 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.4 -0.812 . . . . 0.0 110.882 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -105.77 23.83 13.27 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.357 -0.839 . . . . 0.0 110.693 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.43 28.71 73.66 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.1 mtt180 -121.52 93.9 4.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.646 -0.914 . . . . 0.0 110.311 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 66.4 m-85 -104.59 134.32 47.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.644 -0.66 . . . . 46.07 109.325 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -117.17 120.68 39.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.444 -0.785 . . . . 0.0 111.273 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.423 ' CD1' HD12 ' A' ' 90' ' ' LEU . 91.1 m-85 -116.36 133.67 55.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.505 -0.747 . . . . 38.880000000000003 109.853 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.74 132.42 56.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.205 -0.934 . . . . 34.060000000000002 108.74 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 86' ' ' SER . 34.0 p90 -127.63 145.99 50.7 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 119.19 -1.004 . . . . 29.030000000000001 111.747 -178.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 53.8 m -104.46 134.15 48.14 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.445 ' CG2' ' CE2' ' A' ' 84' ' ' TYR . 18.8 tt -105.94 135.76 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 121.807 0.813 . . . . 0.0 112.111 -178.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -124.64 100.88 6.85 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.548 0.689 . . . . 40.240000000000002 109.897 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.6 mt -90.72 118.56 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.808 -0.558 . . . . 20.73 110.69 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -117.35 139.5 50.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.392 -0.817 . . . . 0.0 109.497 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -88.55 117.23 27.36 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.672 -0.642 . . . . 21.34 110.848 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.68 3.31 15.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.551 -0.718 . . . . 0.0 110.633 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.8 -174.88 49.92 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.02 -1.632 . . . . 29.100000000000001 109.02 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.02 -30.67 11.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.439 -1.036 . . . . 0.0 110.277 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.419 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 86.3 t -105.33 140.65 21.35 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.796 -0.565 . . . . 0.0 109.646 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.419 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 39.5 Cg_endo -52.1 141.12 48.93 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 O-C-N 123.718 1.378 . . . . 21.949999999999999 111.991 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.84 151.56 45.8 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.627 0.727 . . . . 20.91 110.883 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.416 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 0.5 OUTLIER -127.68 160.5 31.48 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.72 -0.612 . . . . 0.0 109.794 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.1 tt -97.27 117.88 32.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.379 -0.826 . . . . 0.0 109.451 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.8 t -101.32 -27.05 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.542 -0.724 . . . . 0.0 110.627 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.41 162.82 34.4 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.226 -0.989 . . . . 0.0 111.558 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -141.29 138.67 33.34 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.345 0.593 . . . . 29.050000000000001 110.434 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -142.86 113.31 7.32 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.327 0.584 . . . . 27.969999999999999 109.723 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -101.15 133.63 45.4 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.632 -0.668 . . . . 25.25 111.049 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -116.28 76.48 1.02 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.635 -0.666 . . . . 0.0 109.345 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.422 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.0 pt -85.59 129.21 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-O 121.776 0.798 . . . . 36.109999999999999 111.774 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.0 m -120.57 131.8 54.84 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.429 -0.952 . . . . 33.979999999999997 108.429 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -88.55 169.99 11.25 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.85 0.833 . . . . 45.039999999999999 111.474 -178.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.04 -7.12 11.57 Favored Glycine 0 N--CA 1.495 2.616 0 O-C-N 121.757 -0.589 . . . . 39.469999999999999 112.205 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -101.0 7.02 43.71 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 119.434 1.617 . . . . 0.0 110.6 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.04 -29.05 8.47 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.79 141.49 58.75 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.23 -1.159 . . . . 62.780000000000001 109.674 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.8 t -134.84 152.96 52.18 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.618 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -121.32 122.08 39.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.542 -0.723 . . . . 0.0 110.155 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -102.82 134.72 45.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.705 -0.622 . . . . 0.0 110.439 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.4 t -128.01 130.82 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.578 -0.701 . . . . 37.939999999999998 110.062 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -125.82 126.87 45.2 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.849 -0.532 . . . . 0.0 110.041 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -151.13 158.37 27.66 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.264 -1.534 . . . . 31.82 109.264 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -80.7 154.35 27.34 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.428 -1.042 . . . . 0.0 110.374 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.88 -167.09 0.2 Allowed Glycine 0 N--CA 1.498 2.767 0 O-C-N 121.493 -0.754 . . . . 22.620000000000001 111.605 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.0 m -131.8 129.61 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.96 -0.729 . . . . 17.510000000000002 109.537 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.42 HG21 ' HG2' ' A' ' 72' ' ' GLU . 11.4 m 40.91 35.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 CA-C-O 121.517 0.675 . . . . 20.550000000000001 111.779 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.28 17.8 65.98 Favored Glycine 0 N--CA 1.498 2.813 0 O-C-N 121.598 -0.689 . . . . 18.289999999999999 112.988 177.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.42 ' HG2' HG21 ' A' ' 70' ' ' VAL . 11.1 pt-20 -145.13 150.59 37.06 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 119.211 1.505 . . . . 0.0 112.025 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -115.21 74.75 4.03 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.923 -0.769 . . . . 18.210000000000001 108.923 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -56.94 140.8 93.12 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 O-C-N 123.785 1.413 . . . . 17.609999999999999 112.189 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.416 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 6.3 t90 -104.03 77.55 1.45 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 tp -61.38 118.17 6.6 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.516 -0.74 . . . . 20.57 111.623 -178.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.416 ' HG2' ' CZ3' ' A' ' 75' ' ' TRP . 16.0 mtm180 -86.31 159.18 53.98 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -54.61 126.71 23.28 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 O-C-N 123.628 1.331 . . . . 27.039999999999999 111.002 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.64 -18.53 42.34 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.903 -0.879 . . . . 24.739999999999998 110.903 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -87.89 165.77 15.02 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.079 -1.248 . . . . 29.379999999999999 110.255 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.74 150.45 36.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.545 -0.722 . . . . 0.0 110.388 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.402 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 90.7 t80 -118.59 145.68 45.21 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.031 -0.729 . . . . 18.559999999999999 109.031 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.6 p80 -146.14 141.19 27.26 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.226 -0.922 . . . . 0.0 111.367 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.445 ' CE2' ' CG2' ' A' ' 35' ' ' ILE . 44.9 p90 -151.89 163.28 39.57 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.655 -0.653 . . . . 26.649999999999999 109.557 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.9 m -99.0 138.42 36.12 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.167 -0.958 . . . . 28.140000000000001 111.137 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 15.2 t -125.91 166.35 17.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.615 -0.678 . . . . 33.880000000000003 109.912 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -143.88 124.52 2.27 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 119.774 -1.203 . . . . 31.800000000000001 110.675 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.5 m -132.13 152.8 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.667 -0.902 . . . . 0.0 109.809 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.5 mt -111.56 145.15 39.63 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.559 -0.713 . . . . 0.0 110.977 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.423 HD12 ' CD1' ' A' ' 31' ' ' PHE . 78.7 mt -121.2 145.95 47.3 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.691 -0.631 . . . . 38.68 109.886 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -73.39 -25.69 60.67 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.306 -0.871 . . . . 0.0 111.165 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.8 p -123.47 171.71 9.27 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.354 -0.841 . . . . 31.629999999999999 110.756 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.418 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 32.6 tt0 -86.31 7.37 25.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.692 -0.63 . . . . 0.0 111.506 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -138.62 148.62 44.31 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.097 -1.002 . . . . 0.0 109.526 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.62 156.77 14.57 Favored Glycine 0 N--CA 1.496 2.661 0 C-N-CA 118.755 -1.688 . . . . 28.050000000000001 112.254 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -118.41 130.02 55.74 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 94.8 mtp -126.29 120.77 30.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.38 -0.825 . . . . 0.0 111.4 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -130.6 151.83 50.64 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.73 -173.67 33.63 Favored Glycine 0 N--CA 1.5 2.951 0 C-N-CA 118.973 -1.584 . . . . 29.620000000000001 110.806 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.427 ' CD2' ' HA ' ' A' ' 114' ' ' PRO . 68.2 m80 -137.13 160.18 39.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.654 -0.909 . . . . 0.0 110.557 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.453 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 8.7 m-85 -116.98 128.42 55.17 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.771 -0.581 . . . . 27.050000000000001 110.181 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -87.15 121.31 29.43 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.021 -1.05 . . . . 0.0 108.846 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.43 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 55.1 mtp -126.4 162.76 24.82 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.21 0.529 . . . . 0.0 110.624 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.6 m -140.65 131.23 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.551 -0.718 . . . . 23.280000000000001 110.287 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.406 ' HB1' ' CE1' ' A' ' 7' ' ' TYR . . . -73.45 165.58 24.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.35 -0.844 . . . . 0.0 109.402 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -63.7 -29.37 70.6 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.024 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -75.34 -9.69 58.78 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.493 -0.754 . . . . 0.0 111.202 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.99 -7.98 49.29 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.061 -1.066 . . . . 30.43 110.469 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.416 HG23 ' CE2' ' A' ' 7' ' ' TYR . 33.6 m -57.69 135.38 56.74 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.036 -1.273 . . . . 0.0 109.964 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -101.34 139.77 36.56 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.347 -0.845 . . . . 0.0 110.723 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.43 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 47.8 p90 -163.76 143.24 8.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.684 -0.635 . . . . 28.030000000000001 109.993 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.4 HG21 HD11 ' A' ' 112' ' ' ILE . 84.3 mt -101.09 156.79 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.424 0.631 . . . . 0.0 110.43 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.86 98.91 47.45 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.427 ' HA ' ' CD2' ' A' ' 100' ' ' HIS . 45.9 Cg_endo -58.36 143.22 97.8 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 O-C-N 123.93 1.49 . . . . 33.310000000000002 112.066 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.453 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 70.9 mt -107.97 123.28 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-N 115.375 -0.829 . . . . 30.59 108.907 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -51.84 149.63 4.7 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.175 0.512 . . . . 30.780000000000001 111.207 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -91.29 120.87 32.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.586 -0.696 . . . . 0.0 110.113 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -110.29 165.01 12.11 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.678 -0.86 . . . . 30.66 108.678 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.2 t -116.01 153.13 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.159 -0.963 . . . . 0.0 110.677 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.455 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.0 mp -113.32 134.35 54.66 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.283 -0.636 . . . . 39.149999999999999 109.283 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 51.9 m . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.62 -0.675 . . . . 0.0 110.081 -179.819 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.703 0.287 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.414 ' CE2' HG22 ' A' ' 109' ' ' THR . 39.9 m-85 -118.62 105.36 11.53 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.484 -0.76 . . . . 31.93 110.331 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -147.08 132.57 18.67 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.603 -0.685 . . . . 0.0 109.839 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.4 t -152.1 115.41 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.501 -0.75 . . . . 0.0 109.896 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -105.7 128.42 53.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.662 -0.649 . . . . 0.0 109.823 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.4 t -119.32 138.3 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.757 -0.59 . . . . 28.210000000000001 109.793 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -123.57 136.73 54.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.316 -0.865 . . . . 0.0 110.148 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.4 t -129.61 137.11 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.57 -0.706 . . . . 27.949999999999999 110.18 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.4 t -125.61 105.28 27.17 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.688 -0.633 . . . . 0.0 110.887 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.88 165.13 15.51 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.794 1.418 . . . . 33.0 110.886 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.8 ptt-85 -157.98 132.01 8.04 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.664 0.745 . . . . 54.100000000000001 109.947 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -60.02 139.97 57.1 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.725 -0.609 . . . . 0.0 111.604 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 84.5 mt -116.49 80.76 1.51 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.903 0.858 . . . . 0.0 110.422 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.8 -35.74 81.55 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.065 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -69.96 -24.45 63.34 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.282 -0.886 . . . . 0.0 110.881 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.2 tp60 -121.36 49.56 1.5 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.331 -0.856 . . . . 52.369999999999997 110.779 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 52.5 p -169.59 149.12 3.84 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.228 -0.92 . . . . 55.189999999999998 110.916 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 t -118.88 92.42 44.77 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.452 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 49.0 Cg_endo -66.86 -24.92 45.88 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 O-C-N 123.818 1.43 . . . . 51.57 112.064 -178.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -66.7 -20.77 66.04 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.236 -0.915 . . . . 0.0 111.022 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -105.6 23.58 13.61 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.145 -0.972 . . . . 0.0 110.739 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.72 27.43 73.27 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.8 mtt85 -122.08 94.38 4.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.643 -0.916 . . . . 0.0 110.082 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.456 ' CE2' ' CG ' ' A' ' 93' ' ' GLU . 63.8 m-85 -104.41 137.15 42.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.582 -0.699 . . . . 46.07 109.209 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.03 120.4 40.47 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.162 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -116.5 131.38 56.96 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.608 -0.683 . . . . 38.880000000000003 109.653 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.39 131.5 55.97 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.282 -0.886 . . . . 34.060000000000002 108.849 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.42 ' CE2' ' HB3' ' A' ' 86' ' ' SER . 53.7 p90 -126.52 145.57 50.46 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.331 -0.948 . . . . 29.030000000000001 111.326 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.5 t -102.41 140.27 36.91 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.437 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 48.5 mm -105.68 132.46 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.783 0.802 . . . . 0.0 111.715 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -123.58 97.77 5.54 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.522 0.677 . . . . 40.240000000000002 109.718 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.401 ' CG2' ' CD1' ' A' ' 76' ' ' LEU . 81.8 mt -93.17 117.75 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.773 -0.58 . . . . 20.73 110.583 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -117.18 133.72 55.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.439 -0.788 . . . . 0.0 109.319 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -94.59 117.44 30.13 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 120.212 -0.595 . . . . 21.34 110.523 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.27 15.89 15.86 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.39 -0.819 . . . . 0.0 110.45 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.83 -179.72 52.78 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.332 -1.507 . . . . 29.100000000000001 109.332 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.31 -33.26 13.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.56 -0.964 . . . . 0.0 110.267 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.419 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 87.2 t -106.45 142.02 24.03 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 122.022 -0.424 . . . . 0.0 109.937 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.419 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 38.7 Cg_endo -53.66 146.84 42.28 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 O-C-N 123.792 1.417 . . . . 21.949999999999999 111.428 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.5 151.28 47.23 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.794 0.807 . . . . 20.91 111.506 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.427 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 8.1 ttt180 -126.85 152.32 47.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.865 -0.522 . . . . 0.0 109.595 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.0 tt -98.03 118.73 35.28 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.382 -0.824 . . . . 0.0 109.728 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.0 t -100.27 -29.66 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.61 -0.681 . . . . 0.0 111.073 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.68 165.58 27.1 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.078 -1.049 . . . . 0.0 112.296 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.5 ptt85 -142.72 140.69 31.57 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.519 0.676 . . . . 29.050000000000001 110.352 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -143.09 114.59 8.0 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.777 -0.577 . . . . 27.969999999999999 109.628 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.416 ' CH2' HD11 ' A' ' 115' ' ' ILE . 91.6 m95 -99.95 132.92 45.01 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.578 -0.701 . . . . 25.25 111.2 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -116.15 76.05 0.99 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.604 -0.685 . . . . 0.0 109.402 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.421 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.2 pt -85.17 130.13 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.789 0.805 . . . . 36.109999999999999 112.275 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.9 m -118.64 130.89 56.11 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.983 -1.117 . . . . 33.979999999999997 107.983 178.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -88.5 169.72 11.51 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.644 0.735 . . . . 45.039999999999999 111.144 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.57 -6.84 12.41 Favored Glycine 0 N--CA 1.496 2.636 0 O-C-N 121.754 -0.591 . . . . 39.469999999999999 112.13 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -101.47 7.69 42.36 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 119.337 1.569 . . . . 0.0 110.596 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.67 -31.63 6.37 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.51 142.72 57.81 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.387 -1.067 . . . . 62.780000000000001 109.944 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.7 t -134.36 152.93 52.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.531 -0.731 . . . . 0.0 110.451 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -121.92 123.35 41.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.545 -0.722 . . . . 0.0 110.335 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -103.23 134.24 46.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.671 -0.643 . . . . 0.0 110.496 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.8 t -128.37 131.78 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.538 -0.727 . . . . 37.939999999999998 110.043 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -124.86 126.21 45.2 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.822 -0.549 . . . . 0.0 110.148 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.35 149.01 21.0 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.363 -1.495 . . . . 31.82 109.363 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -77.88 155.24 31.07 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.474 -1.015 . . . . 0.0 110.439 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.56 -175.13 0.18 Allowed Glycine 0 N--CA 1.497 2.7 0 N-CA-C 111.049 -0.82 . . . . 22.620000000000001 111.049 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.3 m -128.24 127.52 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.8 -0.824 . . . . 17.510000000000002 109.576 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.419 HG23 ' HG2' ' A' ' 72' ' ' GLU . 11.4 m 41.21 36.95 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-O 121.599 0.714 . . . . 20.550000000000001 111.809 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.97 15.77 71.7 Favored Glycine 0 N--CA 1.499 2.854 0 O-C-N 121.571 -0.705 . . . . 18.289999999999999 112.957 177.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.419 ' HG2' HG23 ' A' ' 70' ' ' VAL . 10.8 pt-20 -146.3 151.33 37.36 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-N 119.136 1.468 . . . . 0.0 112.15 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -115.5 75.36 4.82 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.887 -0.783 . . . . 18.210000000000001 108.887 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -57.71 139.04 88.96 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 O-C-N 123.847 1.446 . . . . 17.609999999999999 112.084 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.427 ' CD1' ' HB2' ' A' ' 46' ' ' ARG . 4.0 t90 -101.68 76.22 1.64 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.401 ' CD1' ' CG2' ' A' ' 37' ' ' ILE . 10.1 mt -60.25 118.17 6.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.582 -0.699 . . . . 20.57 112.039 -178.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.415 ' HG2' ' CZ3' ' A' ' 75' ' ' TRP . 15.2 mtm180 -86.91 158.45 53.28 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -54.25 129.37 34.2 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 O-C-N 123.461 1.243 . . . . 27.039999999999999 111.227 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.01 -18.59 47.03 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 111.068 -0.813 . . . . 24.739999999999998 111.068 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -88.05 166.17 14.64 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.058 -1.26 . . . . 29.379999999999999 110.618 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.04 147.66 32.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.621 -0.674 . . . . 0.0 110.231 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.402 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 84.6 t80 -116.21 144.24 44.45 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.525 -0.734 . . . . 18.559999999999999 109.08 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -144.18 140.58 29.42 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.278 -0.889 . . . . 0.0 111.141 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.437 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 51.3 p90 -150.15 159.99 44.01 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.758 -0.589 . . . . 26.649999999999999 109.528 178.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.9 m -103.51 138.77 39.75 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.43 -0.794 . . . . 28.140000000000001 110.875 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.42 ' HB3' ' CE2' ' A' ' 33' ' ' TYR . 15.3 t -124.21 167.36 14.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.689 -0.632 . . . . 33.880000000000003 109.937 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -144.03 119.36 1.29 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 110.136 -1.186 . . . . 31.800000000000001 110.136 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.35 152.83 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.591 -0.947 . . . . 0.0 110.1 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -108.71 142.99 38.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.53 -0.731 . . . . 0.0 110.666 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 36.4 mt -124.64 144.79 49.99 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.484 -0.76 . . . . 38.68 110.38 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -88.71 -19.84 25.59 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.129 -0.982 . . . . 0.0 110.395 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.6 p -103.05 134.88 45.74 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.403 -0.811 . . . . 31.629999999999999 110.481 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.456 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 51.3 mt-10 -77.38 -2.88 37.32 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.239 -0.913 . . . . 0.0 110.66 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -138.59 140.63 39.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.179 -0.951 . . . . 0.0 108.834 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.91 166.57 35.76 Favored Glycine 0 N--CA 1.499 2.885 0 C-N-CA 118.409 -1.853 . . . . 28.050000000000001 112.585 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -117.77 129.98 56.02 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.154 -0.615 . . . . 0.0 109.465 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 98.0 mtp -126.33 119.97 28.69 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.308 -0.87 . . . . 0.0 111.281 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.407 ' CG ' ' CB ' ' A' ' 117' ' ' ALA . 69.4 mt-30 -122.54 152.16 40.65 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.93 173.43 36.61 Favored Glycine 0 N--CA 1.498 2.813 0 C-N-CA 118.783 -1.675 . . . . 29.620000000000001 111.107 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.421 ' CD2' ' HA ' ' A' ' 114' ' ' PRO . 67.5 m80 -136.98 156.77 48.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.702 -0.881 . . . . 0.0 109.892 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.45 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 9.1 m-85 -116.66 127.48 54.47 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.683 -0.635 . . . . 27.050000000000001 109.938 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -84.07 119.89 25.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.962 -1.086 . . . . 0.0 108.414 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.427 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 4.8 ttm -123.48 162.34 23.08 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.065 0.46 . . . . 0.0 110.685 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.8 m -141.42 129.84 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.699 -0.626 . . . . 23.280000000000001 110.52 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.7 166.45 23.26 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.474 -0.766 . . . . 0.0 109.521 179.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -66.45 -30.55 70.93 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.484 -0.76 . . . . 0.0 110.291 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -74.98 -4.59 39.15 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.494 -0.754 . . . . 0.0 111.233 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.8 -9.99 58.68 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.139 -1.029 . . . . 30.43 110.537 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.414 HG22 ' CE2' ' A' ' 7' ' ' TYR . 43.5 m -57.57 134.59 56.27 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.124 -1.221 . . . . 0.0 109.982 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -101.42 140.02 36.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.354 -0.841 . . . . 0.0 110.776 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 42.8 p90 -164.41 142.98 7.09 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.644 -0.66 . . . . 28.030000000000001 109.822 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 85.7 mt -101.23 158.01 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.633 -0.667 . . . . 0.0 110.495 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.01 95.43 49.35 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.421 ' HA ' ' CD2' ' A' ' 100' ' ' HIS . 46.6 Cg_endo -59.56 146.6 94.72 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 O-C-N 123.933 1.491 . . . . 33.310000000000002 112.082 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.45 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 66.5 mt -111.19 120.92 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.594 -0.891 . . . . 30.59 108.594 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.05 168.77 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.152 0.501 . . . . 30.780000000000001 111.467 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.407 ' CB ' ' CG ' ' A' ' 98' ' ' GLN . . . -96.98 122.17 39.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.584 -0.698 . . . . 0.0 110.765 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 97' ' ' MET . 47.4 p90 -112.01 157.99 20.07 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.183 -1.043 . . . . 30.66 108.183 178.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.3 t -114.93 153.73 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.241 -0.912 . . . . 0.0 110.494 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.462 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.3 mp -113.12 131.57 55.78 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.175 -0.676 . . . . 39.149999999999999 109.175 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.836 -0.54 . . . . 0.0 110.068 -179.754 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.1 mtt180 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.864 0.364 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.407 ' CE1' HG23 ' A' ' 109' ' ' THR . 91.9 m-85 -120.63 98.09 5.86 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.553 -0.717 . . . . 31.93 110.199 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.4 mtm-85 -142.66 135.11 27.75 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.62 -0.675 . . . . 0.0 109.754 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.4 t -151.75 117.01 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 121.621 0.724 . . . . 0.0 109.784 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -106.56 128.03 53.79 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.63 -0.669 . . . . 0.0 109.687 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.7 t -121.1 136.01 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.759 -0.588 . . . . 28.210000000000001 109.926 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -126.89 137.56 53.17 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.341 -0.85 . . . . 0.0 109.869 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 67.2 t -128.01 139.81 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.641 -0.662 . . . . 27.949999999999999 110.123 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -123.82 105.39 32.48 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.726 -0.609 . . . . 0.0 110.627 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.406 ' HG3' ' CE1' ' A' ' 118' ' ' PHE . 49.1 Cg_endo -83.69 165.82 13.72 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 O-C-N 123.898 1.473 . . . . 33.0 110.734 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -157.93 132.47 8.35 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.598 0.713 . . . . 54.100000000000001 109.917 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -60.03 138.43 57.86 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.797 -0.565 . . . . 0.0 111.197 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.8 tp -115.5 79.68 1.32 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 122.039 0.923 . . . . 0.0 110.402 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.17 -35.65 69.07 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.465 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -68.42 -25.75 65.19 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.274 -0.891 . . . . 0.0 110.941 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -119.42 43.66 2.56 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.379 -0.826 . . . . 52.369999999999997 110.313 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.6 t -162.87 150.27 13.34 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.532 -0.73 . . . . 55.189999999999998 110.93 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.7 t -121.25 93.98 48.78 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.458 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 49.7 Cg_endo -67.12 -22.85 46.65 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 O-C-N 123.748 1.394 . . . . 51.57 112.004 -178.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -65.44 -22.98 66.82 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.289 -0.882 . . . . 0.0 110.947 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -106.22 23.49 14.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.209 -0.932 . . . . 0.0 110.786 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.97 28.85 73.32 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -120.72 93.93 4.19 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.636 -0.92 . . . . 0.0 110.076 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.458 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 54.1 m-85 -105.45 134.1 49.11 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.542 -0.724 . . . . 46.07 109.202 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.67 119.48 37.56 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.02 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.403 ' CD1' HD11 ' A' ' 90' ' ' LEU . 83.0 m-85 -114.73 133.3 56.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.595 -0.69 . . . . 38.880000000000003 109.614 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.44 130.25 56.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.218 -0.926 . . . . 34.060000000000002 108.726 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.431 ' CZ ' ' HB3' ' A' ' 86' ' ' SER . 35.7 p90 -126.05 144.27 50.79 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.263 -0.975 . . . . 29.030000000000001 111.176 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.5 m -103.91 137.82 41.35 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.609 -0.682 . . . . 0.0 109.834 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.424 HG21 ' CE2' ' A' ' 84' ' ' TYR . 43.2 mm -104.62 130.79 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-O 121.696 0.76 . . . . 0.0 111.37 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -122.85 98.81 6.07 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.528 0.68 . . . . 40.240000000000002 109.716 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.412 ' CG2' ' CD1' ' A' ' 76' ' ' LEU . 82.5 mt -91.82 116.9 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.715 -0.616 . . . . 20.73 110.411 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -117.87 133.29 56.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.536 -0.727 . . . . 0.0 109.486 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.4 117.51 30.23 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 120.217 -0.593 . . . . 21.34 110.423 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.72 15.25 17.58 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.358 -0.839 . . . . 0.0 110.534 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.25 -171.36 47.42 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.237 -1.545 . . . . 29.100000000000001 109.237 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.53 -30.17 11.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.497 -1.002 . . . . 0.0 110.169 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.407 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 91.5 t -106.18 139.55 20.39 Favored Pre-proline 0 N--CA 1.498 1.951 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.082 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.407 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 40.4 Cg_endo -53.2 144.65 47.02 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 O-C-N 123.837 1.441 . . . . 21.949999999999999 111.796 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.06 152.21 44.65 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.701 0.762 . . . . 20.91 111.296 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.416 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 22.3 ptt180 -127.42 155.74 43.18 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.5 tt -94.27 118.3 31.39 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.339 -0.851 . . . . 0.0 109.767 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.3 t -100.31 -28.53 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.563 -0.71 . . . . 0.0 110.851 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.13 165.26 27.94 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.098 -1.041 . . . . 0.0 112.24 -179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -141.62 139.88 33.17 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.463 0.649 . . . . 29.050000000000001 110.251 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -142.62 114.52 8.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.782 -0.574 . . . . 27.969999999999999 109.605 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -99.71 132.17 45.22 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.643 -0.66 . . . . 25.25 111.398 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -115.12 78.25 1.15 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 54' ' ' ILE . 15.2 pt -87.02 128.81 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-O 121.609 0.718 . . . . 36.109999999999999 111.8 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.6 m -118.6 130.14 55.72 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.874 -1.158 . . . . 33.979999999999997 107.874 177.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -89.23 169.82 11.12 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.86 0.838 . . . . 45.039999999999999 111.636 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.11 -7.63 13.97 Favored Glycine 0 N--CA 1.495 2.63 0 O-C-N 121.837 -0.54 . . . . 39.469999999999999 112.043 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -101.41 6.98 42.78 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 119.334 1.567 . . . . 0.0 110.561 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.99 -30.25 7.77 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -63.27 142.36 58.42 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.224 -1.163 . . . . 62.780000000000001 109.928 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.9 t -133.98 151.92 51.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.509 -0.744 . . . . 0.0 110.456 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -121.89 123.61 42.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.565 -0.709 . . . . 0.0 110.409 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -104.47 135.71 45.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.724 -0.61 . . . . 0.0 110.684 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.9 t -129.47 132.43 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.437 -0.789 . . . . 37.939999999999998 110.118 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.76 126.17 45.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.83 -0.544 . . . . 0.0 110.172 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.65 148.26 19.54 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.454 -1.459 . . . . 31.82 109.454 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -78.73 154.83 29.72 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.434 -1.039 . . . . 0.0 110.463 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 54.97 -178.86 0.27 Allowed Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.855 -0.898 . . . . 22.620000000000001 110.855 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.4 m -128.14 127.26 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.749 -0.854 . . . . 17.510000000000002 109.679 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.416 HG22 ' HG2' ' A' ' 72' ' ' GLU . 10.9 m 41.4 36.79 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 CA-C-O 121.636 0.732 . . . . 20.550000000000001 111.744 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.06 15.27 72.77 Favored Glycine 0 N--CA 1.499 2.856 0 O-C-N 121.563 -0.71 . . . . 18.289999999999999 112.935 177.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.416 ' HG2' HG22 ' A' ' 70' ' ' VAL . 10.1 pt-20 -145.5 150.01 35.68 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 119.131 1.465 . . . . 0.0 112.157 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -116.15 74.52 5.58 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.625 -0.88 . . . . 18.210000000000001 108.625 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -57.49 140.81 94.39 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.904 1.476 . . . . 17.609999999999999 112.229 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.416 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 1.6 t90 -101.81 76.91 1.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.412 ' CD1' ' CG2' ' A' ' 37' ' ' ILE . 11.1 mt -60.19 117.89 5.7 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.663 -0.648 . . . . 20.57 111.969 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -86.29 157.62 56.04 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -53.41 128.31 28.79 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 O-C-N 123.5 1.263 . . . . 27.039999999999999 111.126 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.97 -16.97 55.68 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.751 -0.94 . . . . 24.739999999999998 110.751 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -87.13 165.18 15.94 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.074 -1.251 . . . . 29.379999999999999 110.555 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.81 150.52 36.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.58 -0.7 . . . . 0.0 110.154 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -118.03 147.59 43.07 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.417 -0.802 . . . . 18.559999999999999 109.11 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -142.73 137.45 29.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.238 -0.914 . . . . 0.0 110.878 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.424 ' CE2' HG21 ' A' ' 35' ' ' ILE . 51.6 p90 -150.95 160.21 44.06 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.613 -0.679 . . . . 26.649999999999999 109.709 178.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.9 m -105.16 139.23 40.13 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.43 -0.794 . . . . 28.140000000000001 111.035 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 16.9 t -124.46 166.68 15.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.62 -0.675 . . . . 33.880000000000003 109.834 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.03 120.15 1.58 Allowed Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.923 -1.132 . . . . 31.800000000000001 110.38 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 80.8 t -130.77 152.2 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.628 -0.925 . . . . 0.0 109.862 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 mp -108.41 142.63 38.47 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.556 -0.715 . . . . 0.0 110.177 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.403 HD11 ' CD1' ' A' ' 31' ' ' PHE . 67.0 mt -124.63 145.14 49.8 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.489 -0.757 . . . . 38.68 110.565 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -90.74 -21.63 21.48 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.138 -0.976 . . . . 0.0 110.124 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.3 p -102.71 137.0 41.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.525 -0.735 . . . . 31.629999999999999 110.447 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.447 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 66.6 mt-10 -77.66 -1.77 32.69 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.29 -0.881 . . . . 0.0 110.753 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -138.53 141.05 39.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.048 -1.033 . . . . 0.0 108.911 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.54 168.66 38.78 Favored Glycine 0 N--CA 1.498 2.83 0 C-N-CA 118.577 -1.773 . . . . 28.050000000000001 112.308 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -118.83 130.2 55.63 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.056 -0.673 . . . . 0.0 109.665 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 35.9 ttm -124.9 117.15 23.44 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.236 -0.915 . . . . 0.0 111.01 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -127.82 151.31 49.19 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.88 176.67 37.47 Favored Glycine 0 N--CA 1.499 2.873 0 C-N-CA 119.087 -1.53 . . . . 29.620000000000001 110.895 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.419 ' CD2' ' HA ' ' A' ' 114' ' ' PRO . 66.3 m80 -136.41 156.41 48.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.704 -0.88 . . . . 0.0 110.193 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.445 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 5.9 m-85 -117.03 128.12 54.85 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.57 -0.706 . . . . 27.050000000000001 109.972 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -83.71 120.31 25.85 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.083 -1.011 . . . . 0.0 108.835 177.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.42 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 7.8 ttm -122.88 161.46 24.06 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.028 0.442 . . . . 0.0 110.222 -179.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.1 m -142.74 130.53 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.554 -0.716 . . . . 23.280000000000001 110.546 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.45 168.14 19.84 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.468 -0.77 . . . . 0.0 109.649 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -67.77 -28.81 67.93 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.516 -0.74 . . . . 0.0 110.374 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 46.9 p-10 -76.07 -3.69 37.29 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.338 -0.851 . . . . 0.0 111.422 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.89 -10.51 60.48 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.022 -1.085 . . . . 30.43 110.892 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.407 HG23 ' CE1' ' A' ' 7' ' ' TYR . 76.5 m -57.9 134.66 56.53 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.998 -1.295 . . . . 0.0 110.053 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -101.16 140.09 35.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.355 -0.841 . . . . 0.0 110.809 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.42 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 37.2 p90 -164.56 143.87 7.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.709 -0.62 . . . . 28.030000000000001 109.708 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 85.5 mt -101.36 157.49 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.714 -0.617 . . . . 0.0 110.556 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.5 96.07 49.58 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.419 ' HA ' ' CD2' ' A' ' 100' ' ' HIS . 46.6 Cg_endo -58.98 142.93 99.85 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 O-C-N 123.966 1.509 . . . . 33.310000000000002 112.147 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.445 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 51.7 mt -107.94 122.31 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.465 -0.939 . . . . 30.59 108.465 178.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.01 153.76 0.85 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.894 -0.504 . . . . 30.780000000000001 111.389 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -99.76 117.58 34.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.727 -0.608 . . . . 0.0 110.278 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.406 ' CE1' ' HG3' ' A' ' 15' ' ' PRO . 41.4 p90 -106.18 169.13 8.68 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.822 -0.807 . . . . 30.66 108.822 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.5 t -111.95 154.37 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.254 -0.904 . . . . 0.0 110.231 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.459 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.4 mp -112.21 132.48 54.89 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.259 -0.645 . . . . 39.149999999999999 109.259 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.687 -0.633 . . . . 0.0 110.089 -179.735 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 120.594 0.235 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.411 ' CE2' HG23 ' A' ' 109' ' ' THR . 37.8 m-85 -118.65 112.07 19.35 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.406 -0.808 . . . . 31.93 110.338 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 45.2 mtm-85 -153.48 134.23 13.78 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.509 0.671 . . . . 0.0 110.28 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.0 t -151.74 115.8 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 121.466 0.65 . . . . 0.0 109.57 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -106.19 128.86 54.23 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.542 0.687 . . . . 0.0 109.78 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.3 t -118.02 138.84 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.815 -0.553 . . . . 28.210000000000001 109.702 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -122.41 136.32 54.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.444 -0.785 . . . . 0.0 109.944 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.7 t -128.29 136.1 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.605 -0.684 . . . . 27.949999999999999 110.33 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 65.3 p -126.37 105.66 24.47 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.689 -0.632 . . . . 0.0 110.526 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.413 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 49.8 Cg_endo -83.46 165.25 14.34 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 O-C-N 123.831 1.438 . . . . 33.0 110.991 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -157.78 131.67 8.03 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.51 0.671 . . . . 54.100000000000001 109.793 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -62.28 138.68 58.47 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.767 -0.583 . . . . 0.0 111.55 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.7 mt -115.4 79.62 1.31 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.903 0.859 . . . . 0.0 110.309 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.03 -35.32 79.63 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.222 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -69.54 -25.17 63.89 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.288 -0.882 . . . . 0.0 111.003 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -119.07 31.18 6.76 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.363 -0.835 . . . . 52.369999999999997 110.927 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.1 p -152.05 146.51 25.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.368 -0.832 . . . . 55.189999999999998 110.996 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.8 t -122.5 93.2 48.65 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.447 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 50.2 Cg_endo -66.2 -22.51 53.75 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 O-C-N 123.715 1.376 . . . . 51.57 111.804 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -64.87 -24.31 67.5 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.333 -0.855 . . . . 0.0 110.951 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -105.75 23.72 13.44 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.336 -0.853 . . . . 0.0 110.76 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.21 29.44 72.06 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -121.02 93.7 4.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.643 -0.916 . . . . 0.0 110.18 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.447 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 67.4 m-85 -104.84 131.28 52.51 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.924 -0.769 . . . . 46.07 108.924 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -118.43 120.9 38.94 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.528 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.423 ' CD1' HD12 ' A' ' 90' ' ' LEU . 75.4 m-85 -116.74 134.63 54.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.651 -0.656 . . . . 38.880000000000003 109.711 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.41 132.54 54.37 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.623 -0.881 . . . . 34.060000000000002 108.623 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 86' ' ' SER . 24.8 p90 -127.59 144.04 51.11 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.216 -0.994 . . . . 29.030000000000001 111.447 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.5 m -103.93 139.7 38.73 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.703 -0.623 . . . . 0.0 109.549 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.443 ' CG2' ' CE1' ' A' ' 84' ' ' TYR . 41.8 mm -105.69 132.42 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.784 0.802 . . . . 0.0 111.755 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -122.9 97.89 5.65 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.452 0.644 . . . . 40.240000000000002 109.644 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.3 mt -91.98 117.22 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.735 -0.603 . . . . 20.73 110.55 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -117.71 134.96 54.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.44 -0.787 . . . . 0.0 109.47 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -93.35 117.68 30.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.736 -0.602 . . . . 21.34 110.652 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.52 11.58 15.96 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.517 -0.739 . . . . 0.0 110.489 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.34 176.02 51.32 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.429 -1.469 . . . . 29.100000000000001 109.429 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.52 -39.36 16.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.482 -1.01 . . . . 0.0 110.214 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.408 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 87.9 t -99.32 140.41 21.64 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.923 -0.486 . . . . 0.0 109.805 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.408 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 40.6 Cg_endo -53.74 144.63 53.22 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 O-C-N 123.786 1.414 . . . . 21.949999999999999 111.722 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.55 151.9 46.46 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.548 0.69 . . . . 20.91 110.953 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.417 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 21.6 ptt-85 -128.11 158.11 38.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.78 -0.575 . . . . 0.0 109.855 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.4 tt -99.0 116.86 32.19 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.472 -0.767 . . . . 0.0 109.123 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.7 t -99.13 -29.63 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.495 -0.753 . . . . 0.0 111.461 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.87 163.72 31.9 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.048 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -142.79 141.45 31.68 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.588 0.708 . . . . 29.050000000000001 110.637 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -144.55 112.36 6.25 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.365 0.603 . . . . 27.969999999999999 109.403 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -99.44 136.16 39.79 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.559 0.695 . . . . 25.25 111.248 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -114.83 80.87 1.47 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 54' ' ' ILE . 12.3 pt -83.15 127.71 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-O 121.784 0.802 . . . . 36.109999999999999 111.59 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.8 m -120.78 129.25 53.51 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.21 -1.033 . . . . 33.979999999999997 108.21 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -91.64 171.21 9.32 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.706 0.765 . . . . 45.039999999999999 111.217 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.92 -6.37 9.38 Favored Glycine 0 N--CA 1.493 2.482 0 O-C-N 121.688 -0.632 . . . . 39.469999999999999 112.214 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.6 p30 -101.87 5.88 41.2 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 119.46 1.63 . . . . 0.0 110.94 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.36 -32.0 5.73 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.204 -0.935 . . . . 0.0 111.23 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.05 142.71 53.57 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.128 -1.219 . . . . 62.780000000000001 109.845 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 60.9 p -132.5 151.16 52.0 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.816 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -123.31 125.12 44.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.579 -0.701 . . . . 0.0 109.865 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -101.68 135.01 43.93 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.554 -0.716 . . . . 0.0 110.763 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.0 t -129.18 133.49 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.582 -0.699 . . . . 37.939999999999998 110.021 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -125.2 127.1 46.26 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.923 -0.486 . . . . 0.0 110.533 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.55 -174.16 14.25 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 108.757 -1.737 . . . . 31.82 108.757 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -66.42 -158.28 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.278 -1.131 . . . . 0.0 109.816 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -51.76 -88.6 0.01 OUTLIER Glycine 0 N--CA 1.498 2.824 0 N-CA-C 110.504 -1.039 . . . . 22.620000000000001 110.504 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.0 m -140.17 128.15 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.382 -1.069 . . . . 17.510000000000002 110.159 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.4 m 40.86 35.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 CA-C-O 121.313 0.577 . . . . 20.550000000000001 112.248 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.58 21.53 57.93 Favored Glycine 0 N--CA 1.499 2.851 0 O-C-N 121.433 -0.792 . . . . 18.289999999999999 112.794 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -139.38 151.73 46.55 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 119.101 1.45 . . . . 0.0 111.197 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -113.51 74.65 2.28 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 109.278 -0.638 . . . . 18.210000000000001 109.278 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -57.58 141.98 95.44 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 O-C-N 123.838 1.441 . . . . 17.609999999999999 111.668 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.417 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 1.4 t90 -103.09 77.33 1.54 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 tp -62.24 118.18 7.06 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.612 -0.68 . . . . 20.57 111.285 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -86.8 158.73 53.26 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -53.67 127.24 24.65 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 O-C-N 123.564 1.297 . . . . 27.039999999999999 110.972 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.64 -18.3 43.83 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.843 -0.903 . . . . 24.739999999999998 110.843 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -88.85 165.64 14.52 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.109 -1.23 . . . . 29.379999999999999 110.239 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.21 151.08 37.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.498 -0.751 . . . . 0.0 110.43 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -118.12 144.96 45.23 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.906 -0.775 . . . . 18.559999999999999 108.906 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.6 p80 -142.65 140.39 31.58 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.117 -0.989 . . . . 0.0 111.258 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.443 ' CE1' ' CG2' ' A' ' 35' ' ' ILE . 52.8 p90 -150.93 159.93 44.24 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.57 -0.706 . . . . 26.649999999999999 109.732 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.6 m -102.58 136.73 41.87 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.422 -0.799 . . . . 28.140000000000001 110.923 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 16.2 t -124.9 168.99 12.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.62 -0.675 . . . . 33.880000000000003 110.146 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.2 124.6 2.57 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.885 -1.15 . . . . 31.800000000000001 110.364 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 79.9 t -129.83 150.64 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.671 -0.899 . . . . 0.0 109.352 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.4 tt -111.08 143.58 41.56 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.529 -0.732 . . . . 0.0 110.577 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.423 HD12 ' CD1' ' A' ' 31' ' ' PHE . 84.0 mt -121.9 145.27 48.26 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.576 -0.703 . . . . 38.68 109.978 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -72.88 -24.22 60.82 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.373 -0.829 . . . . 0.0 111.157 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.3 p -124.3 171.27 10.02 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.342 -0.849 . . . . 31.629999999999999 110.755 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 32.1 tt0 -85.73 6.69 26.66 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.668 -0.645 . . . . 0.0 111.692 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -140.08 149.09 42.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.992 -1.068 . . . . 0.0 109.815 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.62 160.75 23.81 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 118.808 -1.663 . . . . 28.050000000000001 112.178 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -121.97 131.66 54.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 122.185 -0.597 . . . . 0.0 109.401 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 54.6 ttm -127.21 123.68 37.16 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.304 -0.872 . . . . 0.0 111.36 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -123.8 148.21 46.89 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.76 176.21 39.86 Favored Glycine 0 N--CA 1.501 2.991 0 C-N-CA 118.565 -1.779 . . . . 29.620000000000001 111.132 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -140.87 157.6 45.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.804 -0.821 . . . . 0.0 110.663 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -117.07 128.82 55.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.677 -0.639 . . . . 27.050000000000001 110.007 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -81.75 123.59 28.89 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.967 -1.083 . . . . 0.0 109.11 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.432 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 47.4 mtt -122.58 162.6 21.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.887 -0.508 . . . . 0.0 110.491 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.3 m -141.85 128.72 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.516 -0.74 . . . . 23.280000000000001 110.251 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.96 167.55 21.27 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.489 -0.757 . . . . 0.0 109.684 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -64.33 -30.78 71.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.497 -0.752 . . . . 0.0 110.059 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -72.38 -11.7 60.8 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.519 -0.738 . . . . 0.0 110.959 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.23 -7.41 47.6 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.398 -1.081 . . . . 30.43 110.398 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.411 HG23 ' CE2' ' A' ' 7' ' ' TYR . 69.3 m -57.2 135.02 56.4 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.048 -1.266 . . . . 0.0 110.036 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -101.19 139.94 36.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.384 -0.823 . . . . 0.0 110.827 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.432 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 49.8 p90 -167.38 146.92 5.16 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.704 -0.622 . . . . 28.030000000000001 110.077 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.3 pt -103.18 159.12 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.675 -0.641 . . . . 0.0 110.954 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.3 96.61 50.04 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -59.23 143.79 99.62 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 O-C-N 123.907 1.477 . . . . 33.310000000000002 112.269 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 71.4 mt -107.77 122.15 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.68 -0.859 . . . . 30.59 108.68 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.82 155.69 0.83 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.264 0.554 . . . . 30.780000000000001 111.577 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -91.05 119.99 31.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.724 -0.61 . . . . 0.0 110.675 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.413 ' CD1' ' HG3' ' A' ' 15' ' ' PRO . 51.5 p90 -111.02 162.66 14.64 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.487 -0.931 . . . . 30.66 108.487 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.3 p -115.98 154.67 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.204 -0.935 . . . . 0.0 110.882 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.453 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.3 mp -114.07 132.12 56.14 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.32 -0.622 . . . . 39.149999999999999 109.32 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.654 -0.654 . . . . 0.0 110.137 -179.814 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 120.823 0.344 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.456 ' CE1' ' CB ' ' A' ' 105' ' ' ALA . 21.4 m-85 -123.55 101.44 7.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.355 -0.841 . . . . 31.93 110.207 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -144.1 139.19 28.75 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.665 0.745 . . . . 0.0 109.99 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 70.7 t -150.94 114.98 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -105.97 129.55 54.08 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.538 0.685 . . . . 0.0 109.836 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.6 t -118.23 139.79 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.869 -0.519 . . . . 28.210000000000001 109.754 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -120.67 136.65 54.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.438 -0.789 . . . . 0.0 109.817 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.9 t -128.87 137.77 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.586 -0.697 . . . . 27.949999999999999 110.219 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.7 m -125.07 105.07 29.12 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.717 -0.614 . . . . 0.0 110.638 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -84.3 165.56 12.69 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 O-C-N 123.85 1.447 . . . . 33.0 110.797 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -157.46 132.06 8.56 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.541 0.686 . . . . 54.100000000000001 110.064 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -59.73 139.98 56.84 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.852 -0.53 . . . . 0.0 111.315 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 91.2 mt -115.98 80.16 1.41 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.904 0.859 . . . . 0.0 110.397 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.02 -35.84 81.65 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.912 -0.492 . . . . 0.0 111.063 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -69.77 -23.71 63.4 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.415 -0.803 . . . . 0.0 110.947 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -121.05 34.65 5.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.36 -0.837 . . . . 52.369999999999997 111.08 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.4 p -156.47 147.91 22.5 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.312 -0.868 . . . . 55.189999999999998 111.109 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.9 t -118.9 92.17 44.36 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.442 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 51.3 Cg_endo -65.74 -23.51 55.86 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 O-C-N 123.853 1.449 . . . . 51.57 111.627 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.83 -22.41 66.55 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.398 -0.813 . . . . 0.0 110.833 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -106.13 23.56 13.85 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.25 -0.906 . . . . 0.0 110.684 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.37 28.0 73.6 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.2 mtm-85 -121.46 94.13 4.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.591 -0.947 . . . . 0.0 110.175 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.442 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 63.8 m-85 -104.15 135.4 45.71 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.54 -0.725 . . . . 46.07 109.22 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.59 120.54 40.53 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.524 -0.735 . . . . 0.0 111.174 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -116.14 131.56 56.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.555 -0.715 . . . . 38.880000000000003 109.795 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.01 131.96 56.16 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.287 -0.883 . . . . 34.060000000000002 108.658 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.421 ' CE1' ' HB3' ' A' ' 86' ' ' SER . 54.6 p90 -128.22 145.98 50.87 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 119.17 -1.012 . . . . 29.030000000000001 111.544 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.6 t -101.97 140.88 35.66 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.435 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 48.1 mm -105.47 132.29 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.819 0.819 . . . . 0.0 111.772 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -123.49 98.97 6.09 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.399 0.619 . . . . 40.240000000000002 109.826 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 80.3 mt -91.23 117.27 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.711 -0.618 . . . . 20.73 110.735 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -117.99 134.06 55.32 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.578 -0.701 . . . . 0.0 109.421 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -94.5 117.36 30.0 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 120.178 -0.609 . . . . 21.34 110.781 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.25 13.37 17.89 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.415 -0.803 . . . . 0.0 110.442 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.89 -176.26 51.17 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.515 -1.434 . . . . 29.100000000000001 109.515 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.28 -33.74 10.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.561 -0.964 . . . . 0.0 109.846 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.421 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 87.6 t -104.56 141.51 22.68 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.421 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 39.6 Cg_endo -53.13 144.5 46.9 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 O-C-N 123.693 1.365 . . . . 21.949999999999999 111.619 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -136.79 151.37 49.09 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.732 0.777 . . . . 20.91 111.232 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.414 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 47.2 ttp180 -126.6 152.08 47.11 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.1 tt -98.02 117.85 33.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 109.441 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.6 p -100.69 -25.21 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.55 -0.719 . . . . 0.0 110.947 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.12 164.27 30.62 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.039 -1.064 . . . . 0.0 112.034 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -141.69 139.08 32.87 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.334 0.588 . . . . 29.050000000000001 109.993 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -142.46 113.84 7.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.703 -0.623 . . . . 27.969999999999999 110.016 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.428 ' CH2' HD12 ' A' ' 115' ' ' ILE . 87.8 m95 -101.47 132.66 46.97 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.745 -0.597 . . . . 25.25 110.753 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -116.88 77.42 1.11 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.642 -0.661 . . . . 0.0 109.572 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.413 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.5 pt -83.59 130.07 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.789 0.804 . . . . 36.109999999999999 112.211 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.6 m -119.28 129.59 54.98 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.266 -1.013 . . . . 33.979999999999997 108.266 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -91.63 170.32 10.02 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.734 0.778 . . . . 45.039999999999999 111.364 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.28 -7.21 12.82 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 121.791 -0.568 . . . . 39.469999999999999 112.149 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -102.23 5.69 40.23 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 119.431 1.616 . . . . 0.0 110.733 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.3 -29.49 8.2 Favored Glycine 0 N--CA 1.495 2.585 0 O-C-N 121.213 -0.929 . . . . 0.0 110.898 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -61.86 142.28 57.46 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.323 -1.104 . . . . 62.780000000000001 109.747 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.9 p -134.29 151.69 51.4 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.476 -0.765 . . . . 0.0 110.434 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -121.65 122.12 38.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.509 -0.745 . . . . 0.0 110.074 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -104.19 135.15 46.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.567 -0.708 . . . . 0.0 110.634 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.4 t -128.07 131.75 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.545 -0.722 . . . . 37.939999999999998 109.888 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -125.12 127.55 47.05 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.747 -0.596 . . . . 0.0 110.554 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.88 164.82 30.92 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.215 -1.554 . . . . 31.82 109.215 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -106.08 158.31 16.9 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.351 -1.088 . . . . 0.0 110.086 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.96 96.43 0.01 OUTLIER Glycine 0 N--CA 1.5 2.929 0 O-C-N 121.454 -0.778 . . . . 22.620000000000001 111.628 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.1 m -45.39 132.89 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.519 0 O-C-N 121.403 -1.057 . . . . 17.510000000000002 111.534 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.428 HG22 ' HG2' ' A' ' 72' ' ' GLU . 11.0 m 41.63 36.01 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 CA-C-O 121.631 0.729 . . . . 20.550000000000001 111.413 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.0 21.46 59.16 Favored Glycine 0 N--CA 1.496 2.688 0 O-C-N 121.762 -0.586 . . . . 18.289999999999999 112.436 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.428 ' HG2' HG22 ' A' ' 70' ' ' VAL . 4.9 pt-20 -147.6 154.32 40.51 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-N 119.128 1.464 . . . . 0.0 112.457 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -117.55 72.97 7.88 Favored Pre-proline 0 N--CA 1.491 1.6 0 N-CA-C 108.558 -0.904 . . . . 18.210000000000001 108.558 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -53.99 139.78 70.1 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 O-C-N 123.735 1.387 . . . . 17.609999999999999 112.286 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.414 ' CD1' ' HB2' ' A' ' 46' ' ' ARG . 3.4 t90 -101.45 76.03 1.65 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.5 tp -62.33 117.22 5.82 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.585 -0.697 . . . . 20.57 111.339 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 -85.59 158.71 56.72 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -53.96 126.02 20.64 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 O-C-N 123.537 1.283 . . . . 27.039999999999999 110.905 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.94 -18.37 44.69 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.732 -0.947 . . . . 24.739999999999998 110.732 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -88.96 164.9 14.91 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.133 -1.216 . . . . 29.379999999999999 110.263 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.98 150.4 35.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.541 -0.724 . . . . 0.0 110.331 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.404 ' CZ ' ' OE2' ' A' ' 72' ' ' GLU . 64.7 t80 -117.86 145.58 44.5 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.864 -0.791 . . . . 18.559999999999999 108.864 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -143.57 140.48 30.23 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.119 -0.988 . . . . 0.0 111.37 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.435 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 51.1 p90 -150.14 160.02 43.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.647 -0.658 . . . . 26.649999999999999 109.34 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.5 m -102.62 139.08 38.67 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.29 -0.881 . . . . 28.140000000000001 110.928 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.421 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 16.8 t -124.06 166.07 16.41 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.647 -0.658 . . . . 33.880000000000003 109.97 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -144.53 120.3 1.4 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.076 -1.21 . . . . 31.800000000000001 110.076 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.51 152.93 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.686 -0.89 . . . . 0.0 109.927 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.98 142.85 39.03 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.521 -0.737 . . . . 0.0 110.508 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 24.1 mt -124.02 143.08 50.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.542 -0.724 . . . . 38.68 110.291 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -82.23 -22.77 35.71 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.217 -0.927 . . . . 0.0 110.087 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.2 m -99.55 134.25 42.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.671 -0.643 . . . . 31.629999999999999 109.991 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.416 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 58.2 tt0 -75.39 -7.9 55.26 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.171 -0.956 . . . . 0.0 110.833 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -138.3 147.28 43.41 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.21 -0.931 . . . . 0.0 108.952 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.7 169.64 38.97 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 118.265 -1.922 . . . . 28.050000000000001 112.706 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -115.82 130.23 56.75 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 98.3 mtp -126.73 121.27 31.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.349 -0.844 . . . . 0.0 111.316 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.408 ' CG ' ' CB ' ' A' ' 117' ' ' ALA . 55.8 mt-30 -124.39 152.12 43.6 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.27 175.92 36.99 Favored Glycine 0 N--CA 1.499 2.86 0 C-N-CA 118.792 -1.671 . . . . 29.620000000000001 111.05 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.423 ' CD2' ' HA ' ' A' ' 114' ' ' PRO . 69.4 m80 -137.61 157.85 45.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.8 -0.824 . . . . 0.0 109.678 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.452 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 10.1 m-85 -116.64 127.31 54.32 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.577 -0.702 . . . . 27.050000000000001 110.009 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -85.63 119.13 25.62 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.992 -1.068 . . . . 0.0 108.723 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 111' ' ' PHE . 2.5 tpt -122.49 160.7 25.03 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.141 0.496 . . . . 0.0 110.348 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.0 m -139.08 129.5 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.639 -0.663 . . . . 23.280000000000001 110.105 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.456 ' CB ' ' CE1' ' A' ' 7' ' ' TYR . . . -70.01 164.81 23.14 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.571 -0.706 . . . . 0.0 109.633 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -63.76 -28.17 69.69 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.537 -0.727 . . . . 0.0 110.131 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -79.0 -7.6 58.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.487 -0.758 . . . . 0.0 111.294 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.7 -7.63 45.94 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 120.104 -1.046 . . . . 30.43 110.515 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.4 m -57.82 134.98 56.76 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.046 -1.267 . . . . 0.0 109.98 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -101.84 139.38 37.55 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.346 -0.846 . . . . 0.0 110.891 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.416 ' CZ ' ' HB3' ' A' ' 103' ' ' MET . 43.0 p90 -165.1 143.61 6.42 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.732 -0.605 . . . . 28.030000000000001 109.685 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 85.0 mt -101.62 157.69 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.646 -0.659 . . . . 0.0 110.81 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.15 97.33 49.25 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.423 ' HA ' ' CD2' ' A' ' 100' ' ' HIS . 46.5 Cg_endo -58.7 143.78 98.44 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 O-C-N 123.847 1.446 . . . . 33.310000000000002 112.292 -178.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.452 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 52.7 mt -108.71 122.83 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.739 -0.837 . . . . 30.59 108.739 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.42 171.29 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.29 0.567 . . . . 30.780000000000001 111.465 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.408 ' CB ' ' CG ' ' A' ' 98' ' ' GLN . . . -101.72 122.01 43.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.657 -0.652 . . . . 0.0 110.825 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 97' ' ' MET . 49.1 p90 -110.94 156.45 21.19 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.162 -1.051 . . . . 30.66 108.162 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.8 t -115.87 154.95 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.174 -0.954 . . . . 0.0 110.587 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.452 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.6 mp -112.49 132.23 55.18 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.099 -0.704 . . . . 39.149999999999999 109.099 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 34.7 t . . . . . 0 N--CA 1.493 1.716 0 O-C-N 121.779 -0.576 . . . . 0.0 110.041 -179.782 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 120.781 0.324 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -121.42 101.95 7.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.437 -0.79 . . . . 31.93 110.16 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.79 131.53 15.98 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.554 -0.716 . . . . 0.0 110.065 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.0 t -152.11 117.09 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.613 0.72 . . . . 0.0 109.808 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -105.27 129.66 53.58 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.537 0.684 . . . . 0.0 109.825 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.2 t -117.97 139.03 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.842 -0.536 . . . . 28.210000000000001 109.76 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -121.65 136.93 54.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.456 -0.777 . . . . 0.0 110.116 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.5 t -129.28 136.57 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.581 -0.699 . . . . 27.949999999999999 110.139 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.0 m -125.44 103.96 28.57 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.737 -0.602 . . . . 0.0 110.659 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.74 165.05 15.85 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 O-C-N 123.874 1.46 . . . . 33.0 110.835 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -157.85 132.92 8.69 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.661 0.743 . . . . 54.100000000000001 110.111 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -60.01 140.1 57.0 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.27 0.557 . . . . 0.0 111.629 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.4 mt -117.11 83.44 1.98 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.019 0.914 . . . . 0.0 110.247 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.97 -35.11 76.37 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.317 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -69.92 -22.69 63.18 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.427 -0.795 . . . . 0.0 111.099 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -121.87 34.31 5.22 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.232 -0.918 . . . . 52.369999999999997 110.897 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.8 p -154.46 148.8 26.09 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.308 -0.87 . . . . 55.189999999999998 110.979 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.2 t -121.97 93.84 48.43 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.457 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 50.4 Cg_endo -66.86 -23.2 47.94 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 O-C-N 123.786 1.414 . . . . 51.57 112.068 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -66.05 -22.36 66.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.253 -0.904 . . . . 0.0 111.032 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -106.47 23.22 14.55 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.207 -0.933 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.52 29.16 72.89 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -121.4 94.18 4.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.551 -0.97 . . . . 0.0 110.178 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.457 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 58.8 m-85 -105.6 133.8 49.75 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.503 -0.748 . . . . 46.07 109.143 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -115.77 120.64 39.97 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.354 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -116.68 131.04 57.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.553 -0.717 . . . . 38.880000000000003 109.642 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.77 131.77 56.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.255 -0.903 . . . . 34.060000000000002 109.048 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 86' ' ' SER . 53.1 p90 -128.08 148.13 50.55 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.338 -0.945 . . . . 29.030000000000001 111.308 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 m -101.27 140.21 35.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.667 -0.646 . . . . 0.0 109.411 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.436 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 46.0 mm -103.69 132.39 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-O 121.841 0.829 . . . . 0.0 111.677 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.0 mmm-85 -124.05 97.22 5.25 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.471 0.653 . . . . 40.240000000000002 109.797 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 80.1 mt -92.21 118.17 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.704 -0.623 . . . . 20.73 110.751 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -117.36 132.81 56.52 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.508 -0.745 . . . . 0.0 109.21 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -93.96 117.89 30.73 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.786 -0.571 . . . . 21.34 110.632 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.81 14.12 16.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.527 -0.733 . . . . 0.0 110.539 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.52 -171.89 46.09 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.215 -1.554 . . . . 29.100000000000001 109.215 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.64 -29.99 10.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.463 -1.021 . . . . 0.0 110.343 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.422 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 88.0 t -108.82 141.36 23.16 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.836 -0.54 . . . . 0.0 110.016 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.434 ' CB ' ' CH2' ' A' ' 75' ' ' TRP . 39.1 Cg_endo -52.52 142.33 49.18 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 O-C-N 123.772 1.406 . . . . 21.949999999999999 111.749 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.41 151.69 48.82 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.875 0.845 . . . . 20.91 111.418 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.412 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 54.5 ttp180 -125.89 153.45 44.18 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.0 tt -97.53 119.19 35.63 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.574 -0.704 . . . . 0.0 109.464 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.3 t -101.17 -27.15 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.539 -0.726 . . . . 0.0 110.983 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.13 165.06 28.47 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 119.1 -1.04 . . . . 0.0 112.162 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.7 ptt-85 -141.12 139.59 33.99 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.368 0.604 . . . . 29.050000000000001 110.214 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -142.79 112.84 7.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.775 -0.578 . . . . 27.969999999999999 109.873 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -102.19 134.27 45.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.642 -0.661 . . . . 25.25 111.168 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -116.09 79.15 1.27 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.75 -0.594 . . . . 0.0 109.405 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.414 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.0 pt -86.75 129.24 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 121.833 0.825 . . . . 36.109999999999999 111.826 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.1 m -120.69 130.38 54.06 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.441 -0.948 . . . . 33.979999999999997 108.441 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -89.93 170.5 10.32 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.748 0.785 . . . . 45.039999999999999 111.251 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.83 -7.06 14.07 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 121.75 -0.594 . . . . 39.469999999999999 112.138 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -101.62 6.3 41.99 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 119.344 1.572 . . . . 0.0 110.667 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.61 -26.19 15.23 Favored Glycine 0 N--CA 1.494 2.566 0 O-C-N 121.208 -0.933 . . . . 0.0 110.966 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -62.16 141.28 58.25 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.184 -1.186 . . . . 62.780000000000001 109.6 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.3 p -131.54 148.79 52.65 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.402 -0.812 . . . . 0.0 110.574 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -122.3 120.53 34.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.445 -0.785 . . . . 0.0 109.872 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -103.06 135.0 45.55 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.747 -0.596 . . . . 0.0 110.499 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.2 t -128.29 130.31 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.614 0.721 . . . . 37.939999999999998 110.031 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -126.17 126.53 44.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.895 -0.503 . . . . 0.0 109.946 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.78 151.03 23.18 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.555 -1.418 . . . . 31.82 109.555 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -77.38 155.22 32.03 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.431 -1.04 . . . . 0.0 110.241 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.62 -174.52 0.23 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 110.99 -0.844 . . . . 22.620000000000001 110.99 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.1 m -128.81 127.43 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.838 -0.801 . . . . 17.510000000000002 109.625 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.413 HG22 ' HG2' ' A' ' 72' ' ' GLU . 13.2 m 41.32 36.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 CA-C-O 121.603 0.715 . . . . 20.550000000000001 111.831 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.37 16.03 70.03 Favored Glycine 0 N--CA 1.499 2.841 0 O-C-N 121.588 -0.695 . . . . 18.289999999999999 112.869 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.413 ' HG2' HG22 ' A' ' 70' ' ' VAL . 10.1 pt-20 -146.43 151.67 37.81 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 119.158 1.479 . . . . 0.0 112.147 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -115.42 75.55 4.76 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 108.746 -0.835 . . . . 18.210000000000001 108.746 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -57.85 137.65 82.12 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 O-C-N 123.811 1.427 . . . . 17.609999999999999 112.194 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.434 ' CH2' ' CB ' ' A' ' 44' ' ' PRO . 7.4 t90 -101.34 75.98 1.67 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.1 mt -60.3 118.37 6.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.566 -0.709 . . . . 20.57 112.013 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.6 mtp85 -86.59 158.87 53.69 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -54.62 129.14 33.38 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 O-C-N 123.466 1.246 . . . . 27.039999999999999 111.126 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.02 -18.3 48.62 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 111.012 -0.835 . . . . 24.739999999999998 111.012 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -88.28 166.01 14.62 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.041 -1.27 . . . . 29.379999999999999 110.69 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.1 148.68 33.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.594 -0.691 . . . . 0.0 110.024 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.401 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 64.6 t80 -117.57 144.67 44.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.466 -0.771 . . . . 18.559999999999999 109.13 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -143.62 140.42 30.13 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.234 -0.916 . . . . 0.0 111.279 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.436 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 49.5 p90 -150.89 159.96 44.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.591 -0.693 . . . . 26.649999999999999 109.62 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.5 m -101.67 137.5 39.9 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.389 -0.819 . . . . 28.140000000000001 111.005 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.431 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 15.0 t -124.49 167.63 14.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.641 -0.662 . . . . 33.880000000000003 109.918 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.89 124.41 2.45 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.811 -1.185 . . . . 31.800000000000001 110.466 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.71 153.5 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.653 -0.91 . . . . 0.0 109.896 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 mp -108.84 144.86 36.15 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.559 -0.713 . . . . 0.0 111.071 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.09 147.23 45.83 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.685 -0.634 . . . . 38.68 109.591 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.41 ' O ' ' CE1' ' A' ' 29' ' ' TYR . 74.7 tt0 -77.9 -26.6 49.2 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.248 -0.908 . . . . 0.0 111.25 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.8 p -124.99 172.78 9.14 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.268 -0.895 . . . . 31.629999999999999 110.936 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.457 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 50.4 mt-10 -86.62 11.55 12.6 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.653 -0.654 . . . . 0.0 111.469 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -139.99 144.38 36.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.037 -1.039 . . . . 0.0 109.69 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.98 157.03 17.9 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 118.795 -1.669 . . . . 28.050000000000001 112.237 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -121.36 131.37 54.15 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 98.1 mtp -127.24 120.7 29.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.326 -0.859 . . . . 0.0 111.386 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -126.41 151.4 47.74 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.12 177.8 39.02 Favored Glycine 0 N--CA 1.499 2.871 0 C-N-CA 118.946 -1.597 . . . . 29.620000000000001 110.962 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.426 ' CD2' ' HA ' ' A' ' 114' ' ' PRO . 66.9 m80 -136.17 156.92 47.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.715 -0.874 . . . . 0.0 110.139 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.453 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 4.7 m-85 -115.37 127.93 55.73 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.759 -0.588 . . . . 27.050000000000001 109.932 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -83.71 121.92 27.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.965 -1.084 . . . . 0.0 108.532 177.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 54.6 ttm -123.92 161.59 25.07 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.297 0.57 . . . . 0.0 110.781 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.5 m -139.99 129.93 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.741 -0.599 . . . . 23.280000000000001 110.17 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.3 166.29 23.84 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.509 -0.744 . . . . 0.0 109.811 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -65.33 -31.05 71.98 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.52 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -74.57 -7.73 54.05 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.433 -0.792 . . . . 0.0 111.272 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.0 -9.33 54.92 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 120.091 -1.052 . . . . 30.43 110.636 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.4 m -57.55 134.79 56.43 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.021 -1.282 . . . . 0.0 109.935 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -101.92 140.83 35.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.432 -0.792 . . . . 0.0 110.931 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -168.61 146.12 3.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.666 -0.646 . . . . 28.030000000000001 109.851 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.434 HD12 HG23 ' A' ' 112' ' ' ILE . 84.9 mt -101.23 157.52 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.707 -0.621 . . . . 0.0 110.66 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.27 98.7 50.57 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.426 ' HA ' ' CD2' ' A' ' 100' ' ' HIS . 45.4 Cg_endo -58.08 142.84 97.16 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 O-C-N 123.932 1.491 . . . . 33.310000000000002 112.254 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.453 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 48.6 mt -109.31 124.28 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.741 -0.837 . . . . 30.59 108.741 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.66 149.99 3.02 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.861 -0.525 . . . . 30.780000000000001 111.271 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -92.86 124.26 36.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.66 -0.65 . . . . 0.0 110.047 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -108.8 164.67 12.18 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.046 -0.724 . . . . 30.66 109.046 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.5 p -116.0 155.41 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.349 -0.845 . . . . 0.0 110.495 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.462 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.2 mp -112.13 133.07 54.49 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.281 -0.637 . . . . 39.149999999999999 109.281 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.627 -0.671 . . . . 0.0 110.094 -179.796 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 120.678 0.275 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -118.23 108.1 14.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.452 -0.78 . . . . 31.93 110.336 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 23.5 mtm180 -151.01 132.12 14.37 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.61 -0.681 . . . . 0.0 110.092 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.9 t -151.67 114.45 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.543 -0.723 . . . . 0.0 109.548 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -106.7 130.36 54.44 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.628 0.727 . . . . 0.0 110.246 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.6 t -117.73 139.23 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.585 -0.524 . . . . 28.210000000000001 109.585 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -121.24 138.44 54.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.367 -0.833 . . . . 0.0 110.193 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.56 135.84 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.61 -0.681 . . . . 27.949999999999999 110.445 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.6 t -126.61 105.53 23.72 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.694 -0.629 . . . . 0.0 110.474 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -82.95 164.8 15.45 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 O-C-N 123.832 1.438 . . . . 33.0 111.15 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -157.87 131.63 7.92 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.572 0.701 . . . . 54.100000000000001 109.697 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -62.13 138.55 58.41 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.651 -0.656 . . . . 0.0 111.691 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 86.0 mt -116.66 83.15 1.91 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 122.009 0.909 . . . . 0.0 110.269 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.45 -35.55 77.74 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.303 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -69.8 -23.71 63.37 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.309 -0.869 . . . . 0.0 111.076 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -121.77 43.06 2.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.263 -0.898 . . . . 52.369999999999997 110.717 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -162.64 143.93 10.17 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.399 -0.813 . . . . 55.189999999999998 110.883 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.9 m -116.58 92.69 38.21 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.44 -0.787 . . . . 0.0 109.124 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.458 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 47.5 Cg_endo -66.05 -25.16 51.63 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 O-C-N 123.932 1.49 . . . . 51.57 111.553 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -68.49 -22.95 64.51 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.298 -0.876 . . . . 0.0 111.038 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -105.06 22.82 14.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.235 -0.915 . . . . 0.0 110.912 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.41 28.62 73.15 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -120.63 93.59 4.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.652 -0.91 . . . . 0.0 109.804 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.458 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 65.2 m-85 -105.62 130.89 53.56 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.361 -0.837 . . . . 46.07 109.017 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.3 121.14 41.13 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.554 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -116.75 134.3 54.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.624 -0.672 . . . . 38.880000000000003 109.459 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -110.9 132.63 54.04 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.171 -0.956 . . . . 34.060000000000002 108.839 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 86' ' ' SER . 25.8 p90 -126.98 143.55 51.26 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.376 -0.929 . . . . 29.030000000000001 111.294 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.0 t -103.92 139.57 38.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.707 -0.621 . . . . 0.0 109.417 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.431 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 40.9 mm -105.06 132.6 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.811 0.815 . . . . 0.0 111.532 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -123.02 95.74 4.73 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.46 0.647 . . . . 40.240000000000002 109.563 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.7 mt -90.23 117.5 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.766 -0.583 . . . . 20.73 110.535 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -117.36 134.4 54.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.515 -0.741 . . . . 0.0 109.434 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -92.24 117.43 29.87 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.282 -0.567 . . . . 21.34 110.524 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.85 10.44 16.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.471 -0.768 . . . . 0.0 110.584 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.32 179.55 53.3 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.216 -1.554 . . . . 29.100000000000001 109.216 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.11 -30.93 13.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.516 -0.991 . . . . 0.0 110.29 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.411 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 84.0 t -106.29 140.15 21.0 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.791 -0.568 . . . . 0.0 109.984 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.411 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 38.7 Cg_endo -51.53 141.28 42.74 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 O-C-N 123.8 1.421 . . . . 21.949999999999999 112.038 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.34 152.2 45.63 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.709 0.766 . . . . 20.91 111.09 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.2 ptt-85 -127.66 159.46 34.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.706 -0.621 . . . . 0.0 109.471 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.409 HD12 ' CD1' ' A' ' 101' ' ' TYR . 7.1 tt -96.62 117.56 31.24 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.418 -0.801 . . . . 0.0 109.794 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.6 t -99.48 -28.46 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.519 -0.738 . . . . 0.0 110.636 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.61 162.82 34.46 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.83 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -143.5 142.12 31.02 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.612 0.72 . . . . 29.050000000000001 110.712 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.404 ' CG ' ' OD1' ' A' ' 65' ' ' ASP . 21.6 t-160 -145.27 114.79 7.2 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.289 0.566 . . . . 27.969999999999999 109.701 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -100.13 136.67 39.69 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.652 -0.655 . . . . 25.25 111.36 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -116.13 78.28 1.18 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.661 -0.649 . . . . 0.0 109.258 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' ' 54' ' ' ILE . 29.9 pt -88.15 131.67 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.771 0.796 . . . . 36.109999999999999 112.279 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 93.5 m -119.63 133.23 55.73 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.395 -0.965 . . . . 33.979999999999997 108.395 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -85.89 169.16 13.55 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.693 0.759 . . . . 45.039999999999999 111.265 -178.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.93 -9.35 13.66 Favored Glycine 0 N--CA 1.496 2.644 0 O-C-N 121.827 -0.546 . . . . 39.469999999999999 112.078 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -100.78 9.23 42.64 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 119.26 1.53 . . . . 0.0 110.761 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.7 -21.0 38.3 Favored Glycine 0 N--CA 1.495 2.621 0 O-C-N 121.2 -0.938 . . . . 0.0 111.018 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.02 142.33 54.12 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.064 -1.257 . . . . 62.780000000000001 109.884 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.4 p -125.32 140.24 52.99 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.515 -0.741 . . . . 0.0 110.808 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -123.18 117.88 26.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.525 -0.734 . . . . 0.0 109.829 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -103.75 135.32 45.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.717 -0.614 . . . . 0.0 110.768 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.0 t -128.75 130.89 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.657 -0.652 . . . . 37.939999999999998 109.947 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.404 ' OD1' ' CG ' ' A' ' 51' ' ' HIS . 64.7 m-20 -124.07 126.77 46.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.929 -0.482 . . . . 0.0 109.959 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.9 145.67 14.26 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.527 -1.429 . . . . 31.82 109.527 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -67.29 153.57 43.36 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.462 -1.022 . . . . 0.0 110.099 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 46.97 -164.73 0.12 Allowed Glycine 0 N--CA 1.501 3.009 0 O-C-N 121.487 -0.758 . . . . 22.620000000000001 111.793 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.9 m -130.98 129.37 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.89 -0.771 . . . . 17.510000000000002 109.633 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.429 HG21 ' HG2' ' A' ' 72' ' ' GLU . 12.5 m 40.98 34.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 CA-C-O 121.513 0.673 . . . . 20.550000000000001 111.822 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.57 17.16 66.75 Favored Glycine 0 N--CA 1.499 2.839 0 O-C-N 121.668 -0.645 . . . . 18.289999999999999 112.952 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.429 ' HG2' HG21 ' A' ' 70' ' ' VAL . 10.7 pt-20 -144.53 150.0 36.81 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 119.2 1.5 . . . . 0.0 111.95 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -116.08 74.92 5.62 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.989 -0.745 . . . . 18.210000000000001 108.989 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -56.37 141.32 89.34 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 O-C-N 123.852 1.449 . . . . 17.609999999999999 112.06 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -100.34 77.33 1.94 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.1 mt -62.88 118.04 7.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.575 -0.703 . . . . 20.57 111.987 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -86.92 159.18 52.23 Favored Pre-proline 0 N--CA 1.489 1.508 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -54.65 128.73 31.53 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 O-C-N 123.512 1.27 . . . . 27.039999999999999 111.013 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.49 -17.39 52.49 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.955 -0.858 . . . . 24.739999999999998 110.955 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -87.41 166.1 15.08 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.995 -1.297 . . . . 29.379999999999999 110.635 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.34 150.08 35.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.659 -0.651 . . . . 0.0 110.112 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -118.94 147.69 43.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.505 -0.747 . . . . 18.559999999999999 109.081 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.5 p80 -144.75 140.84 28.79 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.146 -0.971 . . . . 0.0 111.243 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.431 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 52.1 p90 -150.95 160.02 44.19 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.633 -0.667 . . . . 26.649999999999999 109.812 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.4 m -101.34 137.01 40.24 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.431 -0.793 . . . . 28.140000000000001 110.911 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 26.6 t -125.23 169.35 12.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.616 -0.677 . . . . 33.880000000000003 110.132 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.39 123.33 2.15 Favored Glycine 0 N--CA 1.497 2.725 0 C-N-CA 119.914 -1.136 . . . . 31.800000000000001 110.461 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 80.4 t -130.18 152.44 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.532 -0.981 . . . . 0.0 109.48 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 tt -110.56 143.81 40.37 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.532 -0.73 . . . . 0.0 110.508 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 70.8 mt -122.28 147.57 46.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.578 -0.702 . . . . 38.68 110.193 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -74.74 -25.91 59.43 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.28 -0.887 . . . . 0.0 110.805 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.2 p -125.52 172.9 9.32 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.429 -0.794 . . . . 31.629999999999999 110.857 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.447 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 94.0 mt-10 -86.33 11.91 11.21 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.683 -0.636 . . . . 0.0 111.635 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -139.93 147.39 40.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.113 -0.992 . . . . 0.0 109.895 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.48 158.88 21.51 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 118.889 -1.624 . . . . 28.050000000000001 112.28 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -119.47 129.72 54.88 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 122.108 -0.642 . . . . 0.0 109.357 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 98.0 mtp -125.61 116.42 21.69 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.371 -0.83 . . . . 0.0 111.124 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -130.15 151.1 51.05 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -168.77 -177.18 39.5 Favored Glycine 0 N--CA 1.5 2.93 0 C-N-CA 119.017 -1.564 . . . . 29.620000000000001 110.748 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -140.16 157.99 44.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.682 -0.893 . . . . 0.0 110.958 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.417 ' CD2' HD11 ' A' ' 115' ' ' ILE . 5.6 m-85 -115.77 128.21 55.68 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.68 -0.637 . . . . 27.050000000000001 109.647 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -80.78 124.83 29.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.927 -1.108 . . . . 0.0 109.184 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.41 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 29.5 mtp -124.63 162.37 24.25 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.249 0.547 . . . . 0.0 110.543 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.8 m -139.73 128.15 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.654 -0.654 . . . . 23.280000000000001 110.285 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.46 168.99 18.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.538 -0.726 . . . . 0.0 109.861 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.61 -31.74 72.63 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.834 -0.747 . . . . 0.0 110.271 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -70.02 -15.67 63.05 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.491 -0.755 . . . . 0.0 110.942 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.9 -5.74 47.01 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.42 -1.072 . . . . 30.43 110.42 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.4 m -57.72 135.6 56.78 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.061 -1.258 . . . . 0.0 110.052 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -98.63 139.98 33.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.443 -0.786 . . . . 0.0 110.612 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.41 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 48.0 p90 -168.39 148.88 4.75 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.703 -0.623 . . . . 28.030000000000001 110.121 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.6 pt -102.64 157.9 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.707 -0.621 . . . . 0.0 110.833 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -118.54 99.08 51.51 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -58.68 142.76 98.82 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 O-C-N 123.928 1.489 . . . . 33.310000000000002 112.356 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.417 HD11 ' CD2' ' A' ' 101' ' ' TYR . 70.2 mt -108.82 123.6 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.45 -0.945 . . . . 30.59 108.45 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.74 143.98 8.93 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.191 0.52 . . . . 30.780000000000001 111.362 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -85.98 121.6 28.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.619 -0.675 . . . . 0.0 110.186 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 97' ' ' MET . 42.4 p90 -109.46 163.95 12.95 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.796 -0.816 . . . . 30.66 108.796 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.8 p -115.4 154.53 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.186 -0.946 . . . . 0.0 110.476 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.457 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 6.9 mp -113.63 133.47 55.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.733 -0.604 . . . . 39.149999999999999 109.384 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.702 -0.624 . . . . 0.0 110.046 -179.792 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 61.6 mtt180 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.656 0.265 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.421 ' CE2' HG22 ' A' ' 109' ' ' THR . 31.4 m-85 -119.98 108.07 13.87 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.44 -0.788 . . . . 31.93 110.306 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.4 mtt85 -149.06 132.85 16.97 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.661 -0.65 . . . . 0.0 109.986 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.0 t -150.61 113.48 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.687 -0.633 . . . . 0.0 109.455 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -107.41 129.19 54.96 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.616 -0.677 . . . . 0.0 109.809 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.4 t -118.75 139.56 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.88 -0.512 . . . . 28.210000000000001 109.969 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -121.26 137.07 54.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.401 -0.812 . . . . 0.0 109.905 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.1 t -128.81 136.67 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.709 -0.619 . . . . 27.949999999999999 110.23 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.9 p -125.38 104.8 28.23 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.719 -0.613 . . . . 0.0 110.55 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -83.7 164.39 14.08 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 O-C-N 123.95 1.5 . . . . 33.0 110.902 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.6 ptt-85 -157.37 132.5 8.9 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.522 0.677 . . . . 54.100000000000001 109.843 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -59.43 138.56 57.62 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.337 0.589 . . . . 0.0 111.305 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.3 tp -116.18 79.79 1.36 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.983 0.897 . . . . 0.0 110.386 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.59 -35.58 73.09 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.567 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -68.43 -25.05 64.82 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.279 -0.888 . . . . 0.0 111.117 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -120.08 45.85 2.09 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.27 -0.894 . . . . 52.369999999999997 110.63 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.8 p -165.76 150.03 8.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.374 -0.829 . . . . 55.189999999999998 110.974 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.5 t -120.98 93.24 48.81 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.456 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 49.3 Cg_endo -66.89 -23.21 47.73 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 O-C-N 123.761 1.401 . . . . 51.57 111.965 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.09 -23.02 67.04 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.287 -0.883 . . . . 0.0 110.927 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -106.39 24.0 13.25 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.295 -0.878 . . . . 0.0 110.641 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.76 29.17 72.68 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -121.85 93.94 4.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.592 -0.946 . . . . 0.0 110.152 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.456 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 58.4 m-85 -104.95 133.8 49.14 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.559 -0.713 . . . . 46.07 109.103 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -115.04 119.78 37.62 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.163 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.421 ' CD1' HD13 ' A' ' 90' ' ' LEU . 83.2 m-85 -114.73 134.83 54.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.564 -0.71 . . . . 38.880000000000003 109.786 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.4 131.54 55.49 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.52 -0.919 . . . . 34.060000000000002 108.52 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 86' ' ' SER . 21.9 p90 -128.43 144.76 51.19 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.273 -0.971 . . . . 29.030000000000001 111.435 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -104.42 139.6 39.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.752 -0.592 . . . . 0.0 109.886 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.441 ' CG2' ' CE1' ' A' ' 84' ' ' TYR . 44.7 mm -107.28 133.04 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.707 0.765 . . . . 0.0 111.416 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.13 98.52 5.81 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.394 0.616 . . . . 40.240000000000002 109.738 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.411 ' CG2' ' CD1' ' A' ' 76' ' ' LEU . 77.3 mt -90.27 117.75 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.749 -0.595 . . . . 20.73 110.597 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -118.09 133.45 55.89 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.451 -0.781 . . . . 0.0 109.615 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.41 117.12 29.79 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.822 -0.549 . . . . 21.34 110.434 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.82 14.39 17.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.319 -0.863 . . . . 0.0 110.717 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.58 -177.03 51.5 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.349 -1.501 . . . . 29.100000000000001 109.349 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.98 -33.5 12.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.598 -0.943 . . . . 0.0 109.915 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.413 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 84.9 t -104.7 140.82 21.45 Favored Pre-proline 0 N--CA 1.494 1.772 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.413 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 39.1 Cg_endo -52.51 142.24 49.4 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 O-C-N 123.777 1.409 . . . . 21.949999999999999 111.711 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.03 152.73 46.47 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.716 0.77 . . . . 20.91 111.101 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.419 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 24.0 ptt-85 -127.88 157.75 39.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.708 -0.62 . . . . 0.0 109.634 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.4 tt -97.46 117.85 32.62 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.381 -0.824 . . . . 0.0 109.084 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.9 t -100.22 -29.32 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.56 -0.712 . . . . 0.0 111.616 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.06 164.47 29.94 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.126 -1.029 . . . . 0.0 112.151 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -142.85 141.14 31.53 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.559 0.695 . . . . 29.050000000000001 110.906 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -143.37 113.06 7.0 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.309 -0.626 . . . . 27.969999999999999 109.309 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.421 ' CH2' HD13 ' A' ' 115' ' ' ILE . 88.3 m95 -100.05 134.69 42.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.607 -0.683 . . . . 25.25 111.099 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -116.54 77.19 1.08 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.574 -0.704 . . . . 0.0 109.57 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.422 ' O ' HG13 ' A' ' 54' ' ' ILE . 27.6 pt -86.68 130.27 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.416 -0.803 . . . . 36.109999999999999 111.855 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.8 m -119.48 132.67 55.83 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.374 -0.973 . . . . 33.979999999999997 108.374 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -88.13 169.57 11.81 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.717 0.77 . . . . 45.039999999999999 111.417 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.67 -7.69 12.2 Favored Glycine 0 N--CA 1.495 2.57 0 O-C-N 121.786 -0.571 . . . . 39.469999999999999 112.16 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -101.25 7.59 42.89 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 119.307 1.554 . . . . 0.0 110.682 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.13 -29.32 8.26 Favored Glycine 0 N--CA 1.495 2.631 0 O-C-N 121.211 -0.931 . . . . 0.0 110.798 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -63.6 142.45 58.39 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.205 -1.173 . . . . 62.780000000000001 109.755 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.9 t -134.49 152.76 52.0 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.846 -0.741 . . . . 0.0 110.683 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -122.53 125.23 45.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.623 -0.673 . . . . 0.0 110.267 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -102.47 134.72 45.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.671 -0.643 . . . . 0.0 110.512 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.8 t -128.38 132.6 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.548 -0.72 . . . . 37.939999999999998 110.038 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -125.49 127.18 46.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.874 -0.516 . . . . 0.0 110.338 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.3 -174.57 15.68 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 108.711 -1.756 . . . . 31.82 108.711 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.24 -157.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.186 -1.185 . . . . 0.0 109.813 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -51.03 -91.25 0.01 OUTLIER Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.563 -1.015 . . . . 22.620000000000001 110.563 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.4 m -140.22 129.13 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.402 -1.057 . . . . 17.510000000000002 110.143 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.0 m 40.81 33.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 CA-C-O 121.268 0.556 . . . . 20.550000000000001 112.122 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.97 22.29 55.5 Favored Glycine 0 N--CA 1.499 2.837 0 O-C-N 121.533 -0.729 . . . . 18.289999999999999 112.782 177.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -139.83 150.75 45.05 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 119.142 1.471 . . . . 0.0 111.354 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -113.84 74.83 2.62 Favored Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 109.117 -0.697 . . . . 18.210000000000001 109.117 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -57.36 141.7 94.85 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 O-C-N 123.858 1.452 . . . . 17.609999999999999 111.887 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.419 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -103.8 76.36 1.37 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.411 ' CD1' ' CG2' ' A' ' 37' ' ' ILE . 19.0 mt -63.67 121.48 14.04 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.634 -0.666 . . . . 20.57 111.947 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -86.31 158.44 54.99 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -53.6 128.75 30.69 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 O-C-N 123.517 1.272 . . . . 27.039999999999999 111.132 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.01 -17.3 54.07 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.805 -0.918 . . . . 24.739999999999998 110.805 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -88.62 164.85 15.16 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.121 -1.223 . . . . 29.379999999999999 110.585 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.19 150.04 35.08 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.649 -0.657 . . . . 0.0 110.165 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -117.93 144.51 45.41 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.503 -0.748 . . . . 18.559999999999999 109.126 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -142.76 140.4 31.4 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.24 -0.912 . . . . 0.0 111.25 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.441 ' CE1' ' CG2' ' A' ' 35' ' ' ILE . 52.1 p90 -150.65 159.92 44.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.672 -0.642 . . . . 26.649999999999999 109.781 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 60.3 m -102.78 136.73 42.07 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.431 -0.793 . . . . 28.140000000000001 110.76 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 15.7 t -125.25 169.95 11.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.643 -0.661 . . . . 33.880000000000003 110.133 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -139.83 125.87 3.1 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 119.934 -1.127 . . . . 31.800000000000001 110.38 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.2 t -130.08 152.47 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.594 -0.945 . . . . 0.0 109.462 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.1 tt -110.51 142.64 42.01 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.642 -0.661 . . . . 0.0 110.488 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.421 HD13 ' CD1' ' A' ' 31' ' ' PHE . 86.1 mt -122.12 145.8 47.83 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.543 -0.723 . . . . 38.68 109.971 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -81.49 -26.3 35.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.299 -0.876 . . . . 0.0 111.036 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.0 m -123.69 169.34 11.59 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.306 -0.871 . . . . 31.629999999999999 110.66 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.453 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 50.6 mt-10 -86.22 11.09 12.8 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.637 -0.664 . . . . 0.0 111.603 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -140.72 145.31 36.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.16 -0.963 . . . . 0.0 109.853 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.51 157.02 17.52 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 118.747 -1.692 . . . . 28.050000000000001 112.315 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -117.28 129.28 55.8 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 99.6 mtp -126.08 117.77 23.88 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.314 -0.866 . . . . 0.0 111.431 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -126.3 149.18 49.3 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -155.46 -178.91 30.16 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 118.8 -1.667 . . . . 29.620000000000001 111.078 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.433 ' CE1' ' HB3' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -136.92 155.74 49.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.769 -0.842 . . . . 0.0 109.494 179.506 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.444 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 6.6 m-85 -118.09 126.95 53.27 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.419 -0.801 . . . . 27.050000000000001 110.163 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -85.49 120.36 26.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.113 -0.992 . . . . 0.0 108.761 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 111' ' ' PHE . 14.2 tpp -123.93 160.67 27.03 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.109 0.48 . . . . 0.0 110.403 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.1 m -140.69 130.04 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.654 -0.654 . . . . 23.280000000000001 110.176 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.39 166.62 23.18 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.494 -0.754 . . . . 0.0 109.732 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -65.37 -29.77 70.53 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.546 -0.721 . . . . 0.0 110.153 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -74.64 -6.43 48.59 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.437 -0.789 . . . . 0.0 111.139 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.26 -9.41 59.38 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 120.082 -1.056 . . . . 30.43 110.581 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.421 HG22 ' CE2' ' A' ' 7' ' ' TYR . 27.4 m -57.89 135.01 56.81 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.009 -1.289 . . . . 0.0 110.023 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -101.13 138.86 37.61 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.359 -0.838 . . . . 0.0 110.726 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.423 ' CZ ' ' HB3' ' A' ' 103' ' ' MET . 41.9 p90 -162.69 143.8 10.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.664 -0.648 . . . . 28.030000000000001 109.942 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.422 ' HB ' ' CD2' ' A' ' 100' ' ' HIS . 30.5 pt -101.01 156.78 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 121.331 0.586 . . . . 0.0 110.877 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -121.66 100.19 44.19 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.617 -0.677 . . . . 0.0 109.421 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.433 ' HB3' ' CE1' ' A' ' 100' ' ' HIS . 45.3 Cg_endo -58.02 142.85 96.99 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 O-C-N 123.862 1.454 . . . . 33.310000000000002 112.176 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.444 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 66.9 mt -107.88 123.05 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.677 -0.861 . . . . 30.59 108.677 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.83 145.45 7.08 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.848 -0.532 . . . . 30.780000000000001 111.352 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -93.61 120.36 33.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.745 -0.597 . . . . 0.0 110.012 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -108.55 167.75 9.82 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.907 -0.775 . . . . 30.66 108.907 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.8 p -113.7 154.1 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.349 -0.844 . . . . 0.0 110.498 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.46 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.1 mp -113.72 132.93 55.63 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.37 -0.604 . . . . 39.149999999999999 109.37 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.672 -0.642 . . . . 0.0 110.069 -179.808 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.4 ' CD ' ' CB ' ' A' ' 42' ' ' ALA . 28.5 mmt85 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 120.669 0.271 . . . . 0.0 110.741 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -121.22 113.34 19.82 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.412 -0.805 . . . . 31.93 110.383 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 41.0 mtp85 -152.14 135.93 16.3 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.589 0.709 . . . . 0.0 110.092 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.7 t -151.28 114.4 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 CA-C-O 121.442 0.639 . . . . 0.0 109.426 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -106.79 129.0 54.72 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.516 0.674 . . . . 0.0 109.907 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.19 138.4 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 109.694 -0.484 . . . . 28.210000000000001 109.694 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -121.8 136.66 54.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.416 -0.802 . . . . 0.0 109.931 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.4 t -129.39 136.4 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.484 -0.76 . . . . 27.949999999999999 110.375 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -125.71 104.57 27.26 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.732 -0.605 . . . . 0.0 110.443 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.422 ' HG3' ' CE1' ' A' ' 118' ' ' PHE . 49.9 Cg_endo -84.41 165.25 12.57 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 O-C-N 123.843 1.444 . . . . 33.0 110.929 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -158.03 132.61 8.33 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.562 0.696 . . . . 54.100000000000001 109.982 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -58.66 138.25 57.09 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.833 -0.542 . . . . 0.0 111.198 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.6 tp -115.47 80.53 1.45 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.028 0.918 . . . . 0.0 110.359 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.12 -35.97 71.95 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.494 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -68.8 -24.2 64.37 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.374 -0.829 . . . . 0.0 111.002 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -121.34 46.82 1.97 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.382 -0.824 . . . . 52.369999999999997 110.389 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.3 t -166.05 149.85 7.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.456 -0.777 . . . . 55.189999999999998 110.894 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.7 t -122.04 92.94 48.81 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.456 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 49.5 Cg_endo -66.72 -23.1 49.13 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.761 1.401 . . . . 51.57 111.986 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -65.81 -22.68 66.58 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.267 -0.896 . . . . 0.0 110.947 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -105.97 23.59 13.74 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.251 -0.905 . . . . 0.0 110.734 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.33 28.85 73.08 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.8 mmt85 -121.72 94.19 4.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.599 -0.942 . . . . 0.0 110.154 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.456 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 57.6 m-85 -105.33 131.66 52.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.538 -0.726 . . . . 46.07 109.122 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.7 120.56 40.53 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.609 -0.837 . . . . 0.0 111.043 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.427 ' CD1' HD11 ' A' ' 90' ' ' LEU . 86.8 m-85 -114.59 135.75 53.8 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.578 -0.701 . . . . 38.880000000000003 109.581 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.72 131.61 55.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.198 -0.939 . . . . 34.060000000000002 108.483 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 86' ' ' SER . 20.9 p90 -128.55 144.58 51.17 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.276 -0.969 . . . . 29.030000000000001 111.45 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.8 p -104.18 141.1 36.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.647 -0.658 . . . . 0.0 109.877 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.443 ' CG2' ' CE1' ' A' ' 84' ' ' TYR . 44.3 mm -106.89 132.24 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.728 0.775 . . . . 0.0 111.352 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -122.95 97.88 5.64 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.427 0.632 . . . . 40.240000000000002 109.578 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.409 ' CG2' ' CD1' ' A' ' 76' ' ' LEU . 77.6 mt -91.65 116.99 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.771 -0.581 . . . . 20.73 110.598 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -118.02 133.5 55.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.437 -0.789 . . . . 0.0 109.468 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -95.5 117.83 31.11 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.225 -0.59 . . . . 21.34 110.634 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.96 14.28 17.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.423 -0.798 . . . . 0.0 110.5 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.68 179.79 53.31 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.316 -1.514 . . . . 29.100000000000001 109.316 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.4 ' CB ' ' CD ' ' A' ' 6' ' ' ARG . . . -92.42 -33.81 14.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.536 -0.979 . . . . 0.0 110.056 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.409 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 84.3 t -104.6 139.61 20.27 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.965 -0.46 . . . . 0.0 109.771 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.409 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 39.5 Cg_endo -51.26 146.2 24.7 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 O-C-N 123.709 1.373 . . . . 21.949999999999999 111.613 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.49 151.08 48.07 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.861 0.838 . . . . 20.91 111.524 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.423 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 52.6 ttp180 -126.02 153.35 44.51 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.2 tt -96.93 116.97 30.11 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.541 -0.724 . . . . 0.0 109.705 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.3 t -100.51 -27.0 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.607 -0.683 . . . . 0.0 110.516 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.69 162.4 35.49 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.132 -1.027 . . . . 0.0 112.124 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 32.6 ptt85 -140.76 139.0 34.54 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.322 0.582 . . . . 29.050000000000001 109.858 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.407 ' NE2' ' CG ' ' A' ' 63' ' ' GLN . 20.0 t-160 -143.32 111.45 6.15 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.653 -0.654 . . . . 27.969999999999999 110.264 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -105.64 135.85 46.31 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.33 0.586 . . . . 25.25 111.135 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -115.87 82.26 1.74 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.703 -0.623 . . . . 0.0 109.348 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 54' ' ' ILE . 16.3 pt -84.47 128.38 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.43 -0.794 . . . . 36.109999999999999 111.668 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.6 m -120.57 132.13 55.0 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.492 -0.929 . . . . 33.979999999999997 108.492 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -88.69 169.89 11.28 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.664 0.745 . . . . 45.039999999999999 111.271 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.14 -7.48 13.47 Favored Glycine 0 N--CA 1.495 2.604 0 O-C-N 121.82 -0.55 . . . . 39.469999999999999 112.148 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -101.41 7.66 42.5 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 119.369 1.585 . . . . 0.0 110.682 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.07 -28.75 8.99 Favored Glycine 0 N--CA 1.493 2.457 0 O-C-N 121.193 -0.942 . . . . 0.0 110.892 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.26 141.24 58.84 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.232 -1.158 . . . . 62.780000000000001 109.617 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.8 t -135.58 153.18 51.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.446 -0.784 . . . . 0.0 110.745 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -120.98 123.36 42.23 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.536 -0.728 . . . . 0.0 109.735 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.407 ' CG ' ' NE2' ' A' ' 51' ' ' HIS . 50.7 tt0 -99.15 136.6 38.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.659 -0.651 . . . . 0.0 110.827 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.94 131.68 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 CA-C-O 121.681 0.753 . . . . 37.939999999999998 110.352 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -126.91 127.45 44.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.955 -0.466 . . . . 0.0 110.055 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.11 172.63 32.74 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.304 -1.518 . . . . 31.82 109.304 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -115.61 159.18 21.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.403 -1.057 . . . . 0.0 110.085 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.65 96.55 0.01 OUTLIER Glycine 0 N--CA 1.501 2.98 0 O-C-N 121.424 -0.797 . . . . 22.620000000000001 111.531 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.7 m -45.56 133.31 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 O-C-N 121.338 -1.095 . . . . 17.510000000000002 111.589 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.421 HG21 ' HG2' ' A' ' 72' ' ' GLU . 11.1 m 41.6 35.97 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 CA-C-O 121.619 0.723 . . . . 20.550000000000001 111.408 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.4 21.5 58.34 Favored Glycine 0 N--CA 1.495 2.584 0 O-C-N 121.753 -0.592 . . . . 18.289999999999999 112.398 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.421 ' HG2' HG21 ' A' ' 70' ' ' VAL . 3.6 pt-20 -146.21 152.85 39.88 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 119.111 1.455 . . . . 0.0 112.473 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -118.56 72.95 10.81 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 108.449 -0.945 . . . . 18.210000000000001 108.449 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -55.01 139.64 79.8 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 O-C-N 123.781 1.411 . . . . 17.609999999999999 112.284 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.424 ' CZ3' ' HG2' ' A' ' 77' ' ' ARG . 5.2 t90 -99.56 75.54 1.95 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.409 ' CD1' ' CG2' ' A' ' 37' ' ' ILE . 12.4 mt -61.03 119.77 8.95 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.682 -0.636 . . . . 20.57 112.084 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.424 ' HG2' ' CZ3' ' A' ' 75' ' ' TRP . 18.1 mtm180 -86.48 157.86 55.2 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -53.84 128.28 29.0 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 O-C-N 123.492 1.259 . . . . 27.039999999999999 111.093 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.68 -16.59 56.16 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.769 -0.933 . . . . 24.739999999999998 110.769 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -88.17 164.75 15.52 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.133 -1.216 . . . . 29.379999999999999 110.533 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.18 149.82 34.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.586 -0.696 . . . . 0.0 110.124 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -118.65 147.54 43.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.49 -0.756 . . . . 18.559999999999999 109.17 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -143.34 139.85 30.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.168 -0.957 . . . . 0.0 111.124 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.443 ' CE1' ' CG2' ' A' ' 35' ' ' ILE . 53.2 p90 -150.92 159.73 44.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.614 -0.679 . . . . 26.649999999999999 109.716 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.2 m -102.12 136.64 41.6 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.363 -0.836 . . . . 28.140000000000001 110.92 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 17.9 t -124.95 170.25 11.29 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.681 -0.637 . . . . 33.880000000000003 109.912 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -140.54 125.34 2.85 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.827 -1.177 . . . . 31.800000000000001 110.495 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 76.2 t -129.98 152.26 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.592 -0.946 . . . . 0.0 109.293 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.1 tt -111.01 142.91 42.52 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.627 -0.671 . . . . 0.0 110.712 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.427 HD11 ' CD1' ' A' ' 31' ' ' PHE . 89.4 mt -121.67 145.21 48.24 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.576 -0.703 . . . . 38.68 109.893 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -79.16 -26.73 42.72 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.211 -0.93 . . . . 0.0 110.939 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.9 p -124.43 172.29 9.27 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.361 -0.837 . . . . 31.629999999999999 110.729 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.456 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 48.8 mt-10 -86.56 12.38 10.59 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.62 -0.675 . . . . 0.0 111.58 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -141.47 144.89 34.63 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.039 -1.038 . . . . 0.0 109.78 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 178.77 158.89 22.15 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 118.74 -1.695 . . . . 28.050000000000001 112.275 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -119.71 129.42 54.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 122.117 -0.637 . . . . 0.0 109.322 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 49.2 ttm -125.14 121.18 33.49 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.249 -0.907 . . . . 0.0 111.155 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -123.82 150.15 44.87 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.56 171.28 36.69 Favored Glycine 0 N--CA 1.5 2.931 0 C-N-CA 118.337 -1.887 . . . . 29.620000000000001 111.605 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 114' ' ' PRO . 51.6 m80 -135.3 153.97 51.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.895 -0.767 . . . . 0.0 109.685 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.437 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 5.3 m-85 -119.16 126.1 50.78 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.519 -0.738 . . . . 27.050000000000001 109.74 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -80.98 121.93 26.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.898 -1.126 . . . . 0.0 109.359 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.423 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 91.6 mmm -119.68 161.47 20.65 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.112 0.482 . . . . 0.0 110.066 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.5 m -140.86 127.62 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.551 -0.718 . . . . 23.280000000000001 110.335 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.88 167.47 21.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.585 -0.697 . . . . 0.0 109.581 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -64.06 -29.63 70.76 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.136 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -73.3 -11.19 60.41 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.534 -0.729 . . . . 0.0 111.136 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.91 -7.2 52.56 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 120.075 -1.059 . . . . 30.43 110.54 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 41.2 m -57.47 136.28 56.66 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.015 -1.285 . . . . 0.0 110.106 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -101.57 141.19 34.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.433 -0.792 . . . . 0.0 110.959 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 46.8 p90 -168.54 146.7 4.13 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.677 -0.639 . . . . 28.030000000000001 109.883 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.3 pt -102.63 159.27 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.673 -0.642 . . . . 0.0 111.222 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.02 97.13 50.64 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.429 ' HB3' ' CD2' ' A' ' 100' ' ' HIS . 46.0 Cg_endo -59.75 143.44 99.63 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 O-C-N 123.962 1.506 . . . . 33.310000000000002 112.332 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.437 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 72.7 mt -108.13 120.72 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.301 -0.999 . . . . 30.59 108.301 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -47.36 161.23 0.08 Allowed 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.304 0.573 . . . . 30.780000000000001 111.818 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -99.93 118.05 35.53 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.78 -0.575 . . . . 0.0 110.778 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.422 ' CE1' ' HG3' ' A' ' 15' ' ' PRO . 50.5 p90 -110.68 166.24 11.18 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.359 -0.978 . . . . 30.66 108.359 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.2 t -113.18 153.98 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.172 -0.955 . . . . 0.0 110.48 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.46 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.4 mp -113.35 130.57 56.25 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.169 -0.678 . . . . 39.149999999999999 109.169 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.4 m . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.668 -0.645 . . . . 0.0 110.062 -179.801 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 60.0 mtt180 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 120.734 0.302 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.418 ' CE2' HG23 ' A' ' 109' ' ' THR . 44.6 m-85 -123.77 119.56 30.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.505 -0.747 . . . . 31.93 110.501 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -156.86 132.89 9.65 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.43 0.633 . . . . 0.0 110.081 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.5 t -151.74 115.45 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.618 -0.676 . . . . 0.0 109.755 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -106.15 128.8 54.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.667 -0.646 . . . . 0.0 109.82 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.8 t -118.9 138.99 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.92 -0.487 . . . . 28.210000000000001 109.896 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -122.5 135.82 54.74 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.39 -0.818 . . . . 0.0 109.935 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.9 t -129.29 136.88 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.639 -0.663 . . . . 27.949999999999999 110.36 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -126.79 105.08 23.21 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.687 -0.633 . . . . 0.0 110.758 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -82.9 165.01 15.5 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 O-C-N 123.796 1.419 . . . . 33.0 110.808 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -157.69 131.62 8.07 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.725 0.774 . . . . 54.100000000000001 110.219 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -61.22 140.12 58.0 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.718 -0.614 . . . . 0.0 111.507 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 88.7 mt -116.95 82.39 1.8 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.944 0.878 . . . . 0.0 110.373 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.99 -34.64 75.62 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.137 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -69.9 -23.37 63.23 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.315 -0.865 . . . . 0.0 111.15 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -121.46 39.12 3.92 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.274 -0.892 . . . . 52.369999999999997 110.983 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.1 p -158.92 149.78 20.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.292 -0.88 . . . . 55.189999999999998 111.015 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.8 t -120.33 92.9 47.83 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.46 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 48.6 Cg_endo -66.23 -23.05 52.82 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 O-C-N 123.913 1.481 . . . . 51.57 111.894 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -67.25 -22.15 65.69 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.257 -0.902 . . . . 0.0 111.141 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -105.6 23.22 14.18 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.261 -0.9 . . . . 0.0 110.937 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.08 27.38 73.43 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.6 mtt85 -121.0 94.48 4.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.533 -0.98 . . . . 0.0 110.023 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.46 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 61.3 m-85 -105.24 134.91 47.56 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.498 -0.751 . . . . 46.07 109.26 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -115.51 121.18 41.9 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.082 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.442 ' CD1' ' CD1' ' A' ' 90' ' ' LEU . 87.8 m-85 -116.64 133.3 56.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.509 -0.744 . . . . 38.880000000000003 109.727 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.51 131.66 55.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.279 -0.888 . . . . 34.060000000000002 108.619 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 86' ' ' SER . 25.0 p90 -127.05 144.47 51.02 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.307 -0.957 . . . . 29.030000000000001 111.386 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.3 t -104.21 139.04 39.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.695 -0.628 . . . . 0.0 109.388 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.446 ' CD1' ' CZ ' ' A' ' 84' ' ' TYR . 79.3 mt -108.4 133.94 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.714 0.768 . . . . 0.0 111.493 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -123.91 99.01 6.05 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.526 0.679 . . . . 40.240000000000002 109.718 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 83.9 mt -91.15 117.73 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.875 -0.515 . . . . 20.73 110.492 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -117.32 131.5 56.79 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.442 -0.786 . . . . 0.0 109.35 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -96.43 117.61 31.24 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 120.261 -0.575 . . . . 21.34 110.235 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -118.0 17.42 14.12 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.318 -0.864 . . . . 0.0 110.525 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.3 178.28 53.95 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.519 -1.432 . . . . 29.100000000000001 109.519 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.96 -42.55 13.06 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.572 -0.958 . . . . 0.0 110.282 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.406 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 86.4 t -98.69 139.96 21.46 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.954 -0.466 . . . . 0.0 109.982 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.406 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 40.3 Cg_endo -53.03 145.65 40.86 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 O-C-N 123.805 1.423 . . . . 21.949999999999999 111.67 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.56 152.24 45.36 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.687 0.756 . . . . 20.91 111.22 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.426 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 18.2 ptt-85 -127.76 153.85 46.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.803 -0.561 . . . . 0.0 109.665 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.5 tt -94.66 117.05 29.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.384 -0.823 . . . . 0.0 109.247 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.7 m -100.93 -24.44 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.732 -0.605 . . . . 0.0 111.194 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.44 163.1 33.76 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.19 -1.004 . . . . 0.0 112.081 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -142.06 140.05 32.46 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.542 0.687 . . . . 29.050000000000001 110.517 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.406 ' CD2' ' OD1' ' A' ' 65' ' ' ASP . 20.8 t-160 -144.39 112.93 6.59 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.42 0.628 . . . . 27.969999999999999 109.809 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -103.61 135.93 44.28 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.499 0.666 . . . . 25.25 111.532 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -115.8 82.31 1.74 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 54' ' ' ILE . 13.1 pt -83.1 127.11 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 121.75 0.786 . . . . 36.109999999999999 111.567 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.4 m -122.0 130.03 52.96 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.732 -0.84 . . . . 33.979999999999997 108.732 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -91.56 169.77 10.48 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.757 0.789 . . . . 45.039999999999999 111.493 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.98 -5.91 16.52 Favored Glycine 0 N--CA 1.496 2.683 0 O-C-N 121.856 -0.527 . . . . 39.469999999999999 112.345 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -100.26 5.58 44.61 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 119.501 1.65 . . . . 0.0 110.636 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.91 -27.34 10.2 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.48 141.43 58.77 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.164 -1.198 . . . . 62.780000000000001 109.228 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.8 p -133.73 150.06 51.49 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.664 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -121.93 121.86 38.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.498 -0.751 . . . . 0.0 109.601 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.401 ' CG ' ' NE2' ' A' ' 51' ' ' HIS . 51.9 tt0 -100.53 134.86 42.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.667 -0.646 . . . . 0.0 110.705 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.7 t -128.93 129.97 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.714 0.768 . . . . 37.939999999999998 110.214 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.406 ' OD1' ' CD2' ' A' ' 51' ' ' HIS . 58.9 m-20 -125.58 126.87 45.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.86 -0.525 . . . . 0.0 109.808 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.03 146.27 15.49 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.51 -1.436 . . . . 31.82 109.51 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -71.84 154.26 41.38 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.607 -0.937 . . . . 0.0 110.196 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 50.05 -170.63 0.17 Allowed Glycine 0 N--CA 1.497 2.762 0 O-C-N 121.373 -0.829 . . . . 22.620000000000001 111.268 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.3 m -129.92 128.0 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.89 -0.77 . . . . 17.510000000000002 109.155 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.41 HG21 ' HG2' ' A' ' 72' ' ' GLU . 11.5 m 41.49 33.48 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 CA-C-O 121.649 0.738 . . . . 20.550000000000001 111.397 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.59 18.76 61.32 Favored Glycine 0 N--CA 1.498 2.767 0 O-C-N 121.769 -0.582 . . . . 18.289999999999999 113.101 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.41 ' HG2' HG21 ' A' ' 70' ' ' VAL . 9.8 pt-20 -146.59 150.2 35.02 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 119.386 1.593 . . . . 0.0 112.618 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -116.14 72.85 4.85 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.257 -1.016 . . . . 18.210000000000001 108.257 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -55.1 142.49 77.3 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 O-C-N 123.761 1.401 . . . . 17.609999999999999 112.331 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.426 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 3.1 t90 -101.87 76.54 1.63 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.4 mt -61.84 117.87 6.45 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.612 -0.68 . . . . 20.57 111.921 -178.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -87.83 159.04 49.8 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -54.0 129.07 32.45 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 O-C-N 123.579 1.305 . . . . 27.039999999999999 111.119 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.62 -18.03 49.0 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.929 -0.868 . . . . 24.739999999999998 110.929 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -87.33 165.07 15.89 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.005 -1.291 . . . . 29.379999999999999 110.458 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.22 148.69 33.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.586 -0.696 . . . . 0.0 110.289 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.403 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 89.4 t80 -117.71 143.47 46.17 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.085 -0.709 . . . . 18.559999999999999 109.085 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -146.99 140.89 25.89 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.2 -0.938 . . . . 0.0 111.314 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.446 ' CZ ' ' CD1' ' A' ' 35' ' ' ILE . 42.7 p90 -152.8 162.3 41.45 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.539 -0.725 . . . . 26.649999999999999 109.653 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 54.2 m -98.61 136.63 38.42 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.439 -0.788 . . . . 28.140000000000001 111.248 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 15.2 t -125.06 169.11 12.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.639 -0.663 . . . . 33.880000000000003 109.774 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -139.85 126.3 3.22 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.769 -1.205 . . . . 31.800000000000001 110.487 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 77.9 t -131.28 151.7 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.63 -0.923 . . . . 0.0 109.31 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.18 144.39 40.41 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.582 -0.699 . . . . 0.0 110.862 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.442 ' CD1' ' CD1' ' A' ' 31' ' ' PHE . 94.6 mt -122.33 148.07 45.49 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.621 -0.674 . . . . 38.68 110.026 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.408 ' O ' ' CE1' ' A' ' 29' ' ' TYR . 38.6 tp10 -79.01 -26.4 43.24 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.39 -0.819 . . . . 0.0 110.757 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.2 p -124.09 172.1 9.26 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.336 -0.853 . . . . 31.629999999999999 110.621 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.457 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 50.4 mt-10 -85.42 10.67 12.18 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.607 -0.683 . . . . 0.0 111.63 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -141.39 145.49 35.42 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.125 -0.984 . . . . 0.0 109.811 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.6 155.46 15.24 Favored Glycine 0 N--CA 1.496 2.682 0 C-N-CA 118.871 -1.633 . . . . 28.050000000000001 112.219 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -120.47 130.2 54.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 122.125 -0.632 . . . . 0.0 109.374 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 56.1 ttm -126.82 123.77 38.1 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.37 -0.831 . . . . 0.0 111.533 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -123.1 148.93 45.13 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.67 175.52 41.33 Favored Glycine 0 N--CA 1.499 2.842 0 C-N-CA 118.738 -1.696 . . . . 29.620000000000001 111.05 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -140.04 157.79 45.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.828 -0.807 . . . . 0.0 110.675 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -114.62 130.01 56.74 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.673 -0.642 . . . . 27.050000000000001 109.787 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -82.02 121.81 27.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 108.928 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.418 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 2.0 ttm -121.93 161.92 21.98 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.204 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.5 m -141.65 130.34 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.639 -0.663 . . . . 23.280000000000001 110.486 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.14 166.73 21.73 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.51 -0.744 . . . . 0.0 109.609 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -66.92 -29.36 69.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.533 -0.729 . . . . 0.0 110.284 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -77.36 -4.29 44.43 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.426 -0.796 . . . . 0.0 111.359 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.27 -9.7 54.02 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.087 -1.054 . . . . 30.43 110.519 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.418 HG23 ' CE2' ' A' ' 7' ' ' TYR . 57.6 m -57.02 133.61 55.09 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.045 -1.268 . . . . 0.0 110.093 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -102.32 139.44 37.93 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -0.866 . . . . 0.0 110.668 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.418 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 38.9 p90 -165.26 144.05 6.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.705 -0.622 . . . . 28.030000000000001 109.886 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.8 pt -101.85 158.89 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.636 -0.665 . . . . 0.0 110.874 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.01 95.12 49.1 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -60.48 144.73 99.54 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 O-C-N 123.958 1.504 . . . . 33.310000000000002 112.24 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 71.7 mt -108.65 121.55 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.698 -0.852 . . . . 30.59 108.698 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.61 167.05 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.258 0.552 . . . . 30.780000000000001 111.578 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -95.03 118.92 32.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.65 -0.656 . . . . 0.0 110.759 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -112.59 160.34 17.95 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.343 -0.984 . . . . 30.66 108.343 178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.1 t -116.86 152.98 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.169 -0.957 . . . . 0.0 110.753 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.459 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.3 mp -114.16 131.26 56.5 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.098 -0.704 . . . . 39.149999999999999 109.098 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 40.4 p . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.607 -0.683 . . . . 0.0 110.033 -179.831 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.9 0.381 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.413 ' CE2' HG22 ' A' ' 109' ' ' THR . 37.1 m-85 -112.24 104.65 12.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.546 -0.721 . . . . 31.93 110.158 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.29 131.58 14.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.655 -0.653 . . . . 0.0 109.982 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.2 t -151.98 114.53 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.519 -0.738 . . . . 0.0 109.522 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -107.58 129.88 54.94 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.636 0.731 . . . . 0.0 109.954 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.3 t -117.35 139.69 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 109.562 -0.533 . . . . 28.210000000000001 109.562 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -120.49 137.19 54.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.409 -0.807 . . . . 0.0 110.017 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.7 t -127.46 135.99 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.304 0.573 . . . . 27.949999999999999 110.056 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.2 m -125.0 104.03 30.07 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.77 -0.581 . . . . 0.0 110.392 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -84.16 164.31 13.21 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 O-C-N 123.927 1.488 . . . . 33.0 110.907 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -156.62 131.86 9.22 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.592 0.711 . . . . 54.100000000000001 109.723 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -60.1 138.99 57.77 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.279 0.562 . . . . 0.0 111.146 -178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.8 tp -116.01 78.05 1.15 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 122.075 0.941 . . . . 0.0 110.476 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.82 -35.45 69.93 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.119 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -68.01 -24.05 65.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.358 -0.839 . . . . 0.0 110.895 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -121.77 41.66 3.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.365 -0.835 . . . . 52.369999999999997 110.416 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.7 t -163.69 150.98 12.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.506 -0.747 . . . . 55.189999999999998 110.789 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.2 t -122.49 94.52 47.65 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.593 -0.692 . . . . 0.0 109.246 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.45 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 49.8 Cg_endo -66.17 -22.91 53.39 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.773 1.407 . . . . 51.57 111.466 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.59 -23.95 67.43 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.341 -0.849 . . . . 0.0 110.819 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -105.96 23.13 14.48 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.357 -0.84 . . . . 0.0 110.705 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.33 29.44 73.15 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.9 ttt85 -121.5 93.05 3.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.634 -0.921 . . . . 0.0 110.13 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.45 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 56.6 m-85 -104.53 133.19 49.81 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.035 -0.728 . . . . 46.07 109.035 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.0 118.87 34.11 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.938 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -114.05 134.25 54.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.629 -0.669 . . . . 38.880000000000003 109.72 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.91 132.08 55.47 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.228 -0.92 . . . . 34.060000000000002 108.563 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 86' ' ' SER . 22.9 p90 -129.06 144.56 51.24 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.175 -1.01 . . . . 29.030000000000001 111.476 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.2 m -104.4 139.95 38.62 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.717 -0.614 . . . . 0.0 109.788 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.432 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 43.7 mm -105.55 132.29 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.735 0.779 . . . . 0.0 111.535 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -123.49 98.02 5.66 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.482 0.658 . . . . 40.240000000000002 109.722 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.8 mt -91.18 117.27 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.762 -0.586 . . . . 20.73 110.458 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -117.99 135.56 54.07 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.512 -0.742 . . . . 0.0 109.453 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -92.67 117.76 30.33 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.721 -0.612 . . . . 21.34 110.867 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.16 9.34 17.14 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.435 -0.79 . . . . 0.0 110.456 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.9 173.71 49.13 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.348 -1.501 . . . . 29.100000000000001 109.348 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.38 -31.01 21.71 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.583 -0.951 . . . . 0.0 110.216 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.414 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 87.2 t -106.71 140.6 21.51 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.853 -0.529 . . . . 0.0 110.076 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.414 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 40.3 Cg_endo -53.52 148.38 34.82 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 O-C-N 123.752 1.396 . . . . 21.949999999999999 111.673 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.29 151.12 47.3 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.68 0.752 . . . . 20.91 111.377 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.416 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 45.5 ttp180 -126.06 155.31 41.75 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.0 tt -99.29 117.78 34.5 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.554 -0.716 . . . . 0.0 109.711 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.3 t -100.48 -29.4 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.547 -0.72 . . . . 0.0 111.015 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.27 164.76 29.27 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 118.981 -1.088 . . . . 0.0 112.42 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -142.72 140.54 31.53 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.425 0.631 . . . . 29.050000000000001 110.223 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -142.92 114.06 7.76 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.315 0.578 . . . . 27.969999999999999 109.759 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.419 ' CE3' ' HA3' ' A' ' 99' ' ' GLY . 86.6 m95 -100.38 133.4 44.85 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.676 -0.64 . . . . 25.25 110.971 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -115.51 77.14 1.05 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.589 -0.694 . . . . 0.0 109.139 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 54' ' ' ILE . 17.1 pt -82.85 127.99 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.468 -0.77 . . . . 36.109999999999999 111.881 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.5 m -120.79 130.09 53.85 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.329 -0.989 . . . . 33.979999999999997 108.329 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -89.06 169.98 11.04 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.701 0.762 . . . . 45.039999999999999 111.553 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.06 -5.74 8.37 Favored Glycine 0 N--CA 1.495 2.588 0 O-C-N 121.88 -0.513 . . . . 39.469999999999999 112.246 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -101.54 6.58 42.3 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 119.417 1.608 . . . . 0.0 110.516 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.75 -31.13 6.74 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -62.99 141.95 58.56 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.316 -1.108 . . . . 62.780000000000001 110.019 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.1 t -135.31 153.2 51.95 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.574 -0.704 . . . . 0.0 110.653 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -121.97 124.36 43.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.535 -0.728 . . . . 0.0 110.184 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -102.27 134.79 44.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.674 -0.641 . . . . 0.0 110.593 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.2 t -128.49 131.57 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.587 -0.696 . . . . 37.939999999999998 110.086 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -125.59 126.72 45.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.813 -0.554 . . . . 0.0 110.137 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.12 148.84 20.71 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.463 -1.455 . . . . 31.82 109.463 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -75.27 154.7 37.31 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.528 -0.984 . . . . 0.0 110.505 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.09 -170.38 0.1 Allowed Glycine 0 N--CA 1.499 2.896 0 O-C-N 121.46 -0.775 . . . . 22.620000000000001 111.454 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.85 128.88 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.862 -0.787 . . . . 17.510000000000002 109.331 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.424 HG22 ' HG2' ' A' ' 72' ' ' GLU . 10.9 m 41.14 33.77 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 CA-C-O 121.485 0.66 . . . . 20.550000000000001 111.844 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.93 17.45 67.52 Favored Glycine 0 N--CA 1.498 2.799 0 O-C-N 121.456 -0.777 . . . . 18.289999999999999 112.957 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.424 ' HG2' HG22 ' A' ' 70' ' ' VAL . 15.4 pt-20 -145.23 150.45 36.71 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-N 119.275 1.537 . . . . 0.0 111.856 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -115.37 75.57 4.68 Favored Pre-proline 0 N--CA 1.492 1.637 0 N-CA-C 108.932 -0.766 . . . . 18.210000000000001 108.932 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -57.49 138.07 84.42 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 O-C-N 123.885 1.466 . . . . 17.609999999999999 112.043 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.416 ' CD1' ' HB2' ' A' ' 46' ' ' ARG . 4.3 t90 -100.82 75.89 1.74 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.95 116.56 3.87 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.545 -0.722 . . . . 20.57 111.239 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.405 ' HG2' ' CZ3' ' A' ' 75' ' ' TRP . 4.5 mtt180 -86.83 159.25 52.3 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -54.39 125.87 20.36 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 O-C-N 123.585 1.308 . . . . 27.039999999999999 110.75 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.51 -18.21 43.8 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.732 -0.947 . . . . 24.739999999999998 110.732 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -89.24 165.64 14.3 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.996 -1.297 . . . . 29.379999999999999 110.243 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.27 151.79 36.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.494 -0.753 . . . . 0.0 110.5 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -118.17 147.53 43.26 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.479 -0.763 . . . . 18.559999999999999 109.042 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -144.42 140.73 29.17 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.192 -0.943 . . . . 0.0 111.082 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.432 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 47.2 p90 -150.16 160.0 44.0 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.653 -0.654 . . . . 26.649999999999999 109.671 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 62.8 m -100.37 136.54 40.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.464 -0.772 . . . . 28.140000000000001 110.651 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 29.2 t -124.04 167.9 13.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.578 -0.701 . . . . 33.880000000000003 110.033 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.15 122.46 2.09 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.876 -1.154 . . . . 31.800000000000001 110.274 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 80.3 t -129.72 148.19 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.575 -0.956 . . . . 0.0 109.352 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.0 mt -107.97 144.49 35.19 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.522 -0.736 . . . . 0.0 110.408 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.2 tp -121.57 144.07 48.94 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.581 -0.699 . . . . 38.68 109.787 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -105.15 -2.19 24.55 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.329 -0.857 . . . . 0.0 111.332 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.51 ' O ' ' CB ' ' A' ' 93' ' ' GLU . 29.6 m -109.29 -35.96 6.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.068 -1.02 . . . . 31.629999999999999 110.931 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.51 ' CB ' ' O ' ' A' ' 92' ' ' THR . 33.3 tt0 87.72 -14.07 0.44 Allowed 'General case' 0 N--CA 1.524 3.266 0 C-N-CA 123.196 0.598 . . . . 0.0 111.059 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -139.97 146.41 39.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.119 -0.988 . . . . 0.0 109.832 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 160.79 179.85 35.81 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 118.421 -1.847 . . . . 28.050000000000001 112.643 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -121.66 130.79 53.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 122.237 -0.567 . . . . 0.0 109.668 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.411 ' CG ' ' CG2' ' A' ' 54' ' ' ILE . 0.5 OUTLIER -126.58 124.61 40.36 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.314 -0.866 . . . . 0.0 111.543 -178.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -118.05 151.4 37.59 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.419 ' HA3' ' CE3' ' A' ' 52' ' ' TRP . . . -156.02 167.58 33.31 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 118.873 -1.632 . . . . 29.620000000000001 110.902 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.423 ' CD2' ' HA ' ' A' ' 114' ' ' PRO . 68.9 m80 -137.75 156.87 47.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.73 -0.865 . . . . 0.0 109.846 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.45 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 12.2 m-85 -117.94 127.21 53.62 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.546 -0.721 . . . . 27.050000000000001 110.154 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -85.64 121.45 28.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.929 -1.107 . . . . 0.0 108.732 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.43 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 76.8 mtp -123.87 164.06 20.01 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.239 0.543 . . . . 0.0 110.672 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.1 m -142.8 129.21 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.678 -0.639 . . . . 23.280000000000001 110.377 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.52 166.85 22.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.431 -0.793 . . . . 0.0 109.229 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -63.65 -28.94 70.26 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.108 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -74.01 -12.96 60.79 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.455 -0.778 . . . . 0.0 111.044 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.06 -6.34 43.09 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.351 -1.099 . . . . 30.43 110.351 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.413 HG22 ' CE2' ' A' ' 7' ' ' TYR . 48.0 m -58.62 137.36 57.56 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.082 -1.246 . . . . 0.0 109.952 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -101.42 139.77 36.63 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.362 -0.836 . . . . 0.0 110.947 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.43 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 45.1 p90 -163.02 141.81 8.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.715 -0.616 . . . . 28.030000000000001 109.782 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.4 HG21 HD12 ' A' ' 112' ' ' ILE . 84.9 mt -101.74 157.92 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.738 -0.601 . . . . 0.0 110.813 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.01 95.82 49.22 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.423 ' HA ' ' CD2' ' A' ' 100' ' ' HIS . 46.5 Cg_endo -60.14 146.14 96.9 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 O-C-N 124.013 1.533 . . . . 33.310000000000002 112.201 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.45 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 69.0 mt -111.43 121.55 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.731 -0.84 . . . . 30.59 108.731 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -47.58 161.66 0.08 Allowed 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 121.199 0.524 . . . . 30.780000000000001 111.641 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -98.71 122.95 42.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.584 -0.698 . . . . 0.0 110.807 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -109.86 162.91 14.03 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.409 -0.959 . . . . 30.66 108.409 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.0 t -114.22 155.34 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.338 -0.851 . . . . 0.0 110.253 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.452 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.9 mp -110.63 131.98 54.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.684 -0.635 . . . . 39.149999999999999 109.422 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.8 p . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.807 -0.558 . . . . 0.0 110.126 -179.772 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 120.833 0.349 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -115.42 109.13 17.42 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.566 -0.709 . . . . 31.93 110.154 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 58.8 mtp85 -151.89 135.63 16.3 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.666 0.746 . . . . 0.0 110.347 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.4 t -150.68 116.08 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.478 0.656 . . . . 0.0 109.415 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -107.07 128.93 54.81 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.551 0.691 . . . . 0.0 109.916 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.5 t -118.93 137.27 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.813 -0.554 . . . . 28.210000000000001 109.844 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -123.6 136.61 54.61 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.351 -0.843 . . . . 0.0 109.649 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.9 t -129.05 137.67 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.621 -0.674 . . . . 27.949999999999999 110.688 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.3 t -126.34 105.66 24.59 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.77 -0.581 . . . . 0.0 110.44 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.433 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 51.1 Cg_endo -83.8 166.89 13.18 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 O-C-N 123.799 1.42 . . . . 33.0 111.236 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -157.77 130.19 7.24 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.474 0.654 . . . . 54.100000000000001 109.732 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -60.54 140.03 57.51 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.788 -0.57 . . . . 0.0 111.407 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.6 mt -116.46 81.39 1.61 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.9 0.857 . . . . 0.0 110.462 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.58 -36.08 81.77 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.968 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -69.98 -22.99 63.09 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.366 -0.834 . . . . 0.0 111.127 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -121.33 38.42 4.09 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.218 -0.926 . . . . 52.369999999999997 111.258 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.4 p -160.09 146.47 15.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.269 -0.895 . . . . 55.189999999999998 111.161 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.2 m -117.7 92.09 40.34 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.517 -0.739 . . . . 0.0 109.043 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.43 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 49.3 Cg_endo -66.91 -25.36 45.09 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 O-C-N 123.925 1.487 . . . . 51.57 111.374 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -66.35 -23.93 66.43 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.552 -0.717 . . . . 0.0 110.846 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -106.84 24.51 12.63 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.334 -0.854 . . . . 0.0 110.581 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.5 30.57 73.17 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -120.02 92.37 3.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.602 -0.94 . . . . 0.0 110.111 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.43 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 81.2 m-85 -105.06 131.21 52.87 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.47 -0.769 . . . . 46.07 109.296 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -118.32 120.76 38.59 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.406 -0.809 . . . . 0.0 111.34 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.414 ' CD1' HD11 ' A' ' 90' ' ' LEU . 67.2 m-85 -116.44 134.6 54.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.459 -0.776 . . . . 38.880000000000003 109.819 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -110.92 131.42 55.06 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.379 -0.971 . . . . 34.060000000000002 108.379 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 86' ' ' SER . 23.9 p90 -127.58 143.69 51.15 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.112 -1.035 . . . . 29.030000000000001 111.559 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.2 m -103.25 139.24 38.97 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.403 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 40.6 mm -106.66 133.75 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.626 0.727 . . . . 0.0 111.488 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -123.25 98.78 6.03 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.422 0.63 . . . . 40.240000000000002 109.751 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.3 mt -90.33 116.11 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.653 -0.654 . . . . 20.73 110.408 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -117.91 134.76 54.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.517 -0.739 . . . . 0.0 109.53 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -92.82 117.64 30.23 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 120.234 -0.586 . . . . 21.34 110.503 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.1 11.06 17.53 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.404 -0.81 . . . . 0.0 110.482 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.27 171.62 48.25 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.907 -1.677 . . . . 29.100000000000001 108.907 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.53 -31.89 24.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.442 -1.034 . . . . 0.0 110.09 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.404 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 87.1 t -103.15 139.67 20.33 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.813 -0.555 . . . . 0.0 109.873 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.404 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 40.1 Cg_endo -53.21 145.09 45.32 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 O-C-N 123.891 1.469 . . . . 21.949999999999999 111.748 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.02 151.8 45.74 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.674 0.75 . . . . 20.91 111.112 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.425 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 2.1 ptt85 -127.36 158.68 36.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.768 -0.583 . . . . 0.0 109.596 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.4 tt -96.68 118.06 32.34 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.486 -0.759 . . . . 0.0 109.5 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.1 p -101.2 -24.41 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.589 -0.695 . . . . 0.0 111.071 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.3 163.88 31.65 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.213 -0.929 . . . . 0.0 111.901 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.5 ptt85 -138.16 137.65 37.85 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.437 0.636 . . . . 29.050000000000001 110.201 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.403 ' CD2' ' OD1' ' A' ' 65' ' ' ASP . 20.4 t-160 -142.11 111.29 6.41 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.417 0.627 . . . . 27.969999999999999 109.852 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -103.35 133.8 47.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.682 -0.637 . . . . 25.25 111.396 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -115.77 80.76 1.49 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.416 ' O ' HG13 ' A' ' 54' ' ' ILE . 17.2 pt -86.0 129.14 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.49 -0.756 . . . . 36.109999999999999 111.755 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 86.6 m -120.04 129.96 54.48 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.362 -0.977 . . . . 33.979999999999997 108.362 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -91.15 169.99 10.39 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.582 0.706 . . . . 45.039999999999999 111.309 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.12 -6.72 14.24 Favored Glycine 0 N--CA 1.495 2.633 0 O-C-N 121.848 -0.533 . . . . 39.469999999999999 112.066 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -101.71 6.84 42.04 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 119.357 1.579 . . . . 0.0 110.771 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.75 -33.11 5.18 Favored Glycine 0 N--CA 1.496 2.644 0 C-N-CA 120.329 -0.939 . . . . 0.0 110.983 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.29 142.34 54.82 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.146 -1.208 . . . . 62.780000000000001 109.835 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.3 p -133.49 152.4 51.9 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.599 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -121.15 121.89 38.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.584 -0.698 . . . . 0.0 109.833 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.403 ' CG ' ' NE2' ' A' ' 51' ' ' HIS . 46.9 tt0 -102.4 135.3 44.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.577 -0.702 . . . . 0.0 110.658 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.2 t -129.52 130.44 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.705 0.764 . . . . 37.939999999999998 110.484 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.403 ' OD1' ' CD2' ' A' ' 51' ' ' HIS . 77.9 m-20 -127.41 126.46 42.46 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.06 148.53 20.0 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.806 -1.318 . . . . 31.82 109.806 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -71.09 152.31 43.61 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.447 -1.031 . . . . 0.0 110.22 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 50.52 -172.17 0.14 Allowed Glycine 0 N--CA 1.498 2.812 0 O-C-N 121.403 -0.811 . . . . 22.620000000000001 111.345 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.4 m -129.79 128.53 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.87 -0.782 . . . . 17.510000000000002 109.631 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.426 HG22 ' HG2' ' A' ' 72' ' ' GLU . 10.6 m 41.32 34.62 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 CA-C-O 121.578 0.704 . . . . 20.550000000000001 111.733 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.51 17.06 67.12 Favored Glycine 0 N--CA 1.499 2.837 0 O-C-N 121.658 -0.651 . . . . 18.289999999999999 112.991 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.426 ' HG2' HG22 ' A' ' 70' ' ' VAL . 11.6 pt-20 -145.67 150.36 36.16 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 119.179 1.489 . . . . 0.0 112.118 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -115.75 73.15 4.33 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.85 -0.796 . . . . 18.210000000000001 108.85 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -55.87 141.37 85.57 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 O-C-N 123.876 1.461 . . . . 17.609999999999999 112.281 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.425 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 2.9 t90 -103.43 77.17 1.48 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 tp -61.4 117.68 5.97 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.553 -0.717 . . . . 20.57 111.857 -178.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.4 mtm180 -88.12 159.63 47.68 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -54.69 129.2 33.74 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 O-C-N 123.549 1.289 . . . . 27.039999999999999 111.185 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.11 -19.21 40.03 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 111.045 -0.822 . . . . 24.739999999999998 111.045 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -89.13 166.42 13.85 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.098 -1.236 . . . . 29.379999999999999 110.53 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -147.0 149.88 34.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.556 -0.715 . . . . 0.0 110.384 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -117.27 148.16 41.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.471 -0.768 . . . . 18.559999999999999 109.221 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -144.37 139.77 28.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.229 -0.919 . . . . 0.0 111.258 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.403 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 43.3 p90 -150.6 159.98 44.12 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.549 -0.719 . . . . 26.649999999999999 109.667 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.0 m -102.44 136.79 41.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.388 -0.82 . . . . 28.140000000000001 110.846 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 21.3 t -125.35 169.47 12.29 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.586 -0.696 . . . . 33.880000000000003 110.081 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.16 124.71 2.6 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.834 -1.174 . . . . 31.800000000000001 110.433 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 75.6 t -129.46 150.83 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.699 -0.883 . . . . 0.0 109.272 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 48.3 mt -110.35 143.73 40.14 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.526 -0.734 . . . . 0.0 110.729 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.414 HD11 ' CD1' ' A' ' 31' ' ' PHE . 98.1 mt -122.13 146.12 47.52 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.644 -0.66 . . . . 38.68 109.941 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -73.19 -25.96 60.98 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.379 -0.826 . . . . 0.0 110.773 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.7 t -123.81 173.04 8.42 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.461 -0.774 . . . . 31.629999999999999 110.618 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 37.2 tt0 -85.72 10.28 13.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.665 -0.647 . . . . 0.0 111.576 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -142.12 150.04 40.61 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.125 -0.984 . . . . 0.0 109.919 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.05 165.52 31.45 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 118.868 -1.634 . . . . 28.050000000000001 112.244 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -119.08 129.86 55.3 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 122.173 -0.604 . . . . 0.0 109.444 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 48.4 ttm -125.29 116.44 21.94 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.314 -0.866 . . . . 0.0 111.055 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -129.5 150.58 50.78 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -162.2 178.51 37.99 Favored Glycine 0 N--CA 1.499 2.889 0 C-N-CA 118.743 -1.694 . . . . 29.620000000000001 111.104 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.422 ' CD2' ' HA ' ' A' ' 114' ' ' PRO . 50.9 m80 -134.72 154.0 51.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.73 -0.865 . . . . 0.0 109.972 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.441 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 4.4 m-85 -117.9 127.69 54.1 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.599 -0.688 . . . . 27.050000000000001 109.718 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -81.26 122.11 27.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.971 -1.08 . . . . 0.0 109.053 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.424 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 13.1 tpp -121.61 159.82 25.65 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.078 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.1 m -140.54 129.06 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.517 -0.74 . . . . 23.280000000000001 110.269 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.32 167.34 21.43 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.568 -0.708 . . . . 0.0 109.618 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -64.03 -29.61 70.75 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.95 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -72.39 -12.04 60.95 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.607 -0.683 . . . . 0.0 111.059 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.5 -7.34 50.48 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.415 -1.074 . . . . 30.43 110.415 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.4 m -57.55 135.99 56.7 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.098 -1.236 . . . . 0.0 110.038 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -101.74 141.48 34.53 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.412 -0.805 . . . . 0.0 110.985 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 42.7 p90 -169.39 148.78 3.9 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.65 -0.656 . . . . 28.030000000000001 109.865 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.2 pt -101.98 157.71 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.597 -0.69 . . . . 0.0 111.252 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -118.92 96.89 50.52 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.422 ' HA ' ' CD2' ' A' ' 100' ' ' HIS . 46.3 Cg_endo -58.1 143.3 96.81 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 O-C-N 123.939 1.494 . . . . 33.310000000000002 112.453 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.441 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 70.4 mt -107.51 121.89 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.352 -0.981 . . . . 30.59 108.352 178.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.17 144.61 6.9 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.157 0.503 . . . . 30.780000000000001 111.441 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -91.08 119.4 31.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.718 -0.613 . . . . 0.0 110.313 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.433 ' CD1' ' HG3' ' A' ' 15' ' ' PRO . 34.2 p90 -109.11 168.44 9.37 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.717 -0.845 . . . . 30.66 108.717 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.9 t -114.21 154.67 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.304 -0.873 . . . . 0.0 110.542 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.448 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.4 mp -112.4 133.64 54.38 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.342 -0.614 . . . . 39.149999999999999 109.342 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 95.6 p . . . . . 0 N--CA 1.494 1.754 0 O-C-N 121.681 -0.637 . . . . 0.0 110.046 -179.719 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 82.7 mtt85 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.024 0.44 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.419 ' CE2' HG21 ' A' ' 109' ' ' THR . 29.2 m-85 -114.82 98.96 7.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.56 -0.713 . . . . 31.93 110.109 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 80.2 mtt85 -146.59 137.19 23.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.602 0.715 . . . . 0.0 110.216 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.6 t -152.94 114.12 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.433 0.635 . . . . 0.0 109.305 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -109.06 130.16 55.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.539 -0.726 . . . . 0.0 109.981 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.2 t -118.34 141.55 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.811 -0.556 . . . . 28.210000000000001 109.97 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -120.1 137.66 54.01 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.465 -0.772 . . . . 0.0 109.817 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.1 t -128.65 137.4 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.607 -0.683 . . . . 27.949999999999999 110.45 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -125.97 106.11 25.67 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.778 -0.576 . . . . 0.0 110.624 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -84.52 165.83 12.22 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 O-C-N 123.923 1.486 . . . . 33.0 111.091 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -158.14 131.09 7.36 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.52 0.676 . . . . 54.100000000000001 109.953 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -61.5 139.97 58.15 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.766 -0.584 . . . . 0.0 111.563 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 73.8 mt -116.32 80.81 1.51 Allowed 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.912 0.863 . . . . 0.0 110.349 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.03 -35.88 81.75 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.901 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -69.93 -22.83 63.16 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.375 -0.828 . . . . 0.0 111.107 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -122.23 43.38 2.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.382 -0.824 . . . . 52.369999999999997 110.959 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.6 p -164.98 147.42 8.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.299 -0.876 . . . . 55.189999999999998 111.043 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.3 m -116.37 91.43 33.16 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.43 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.0 Cg_endo -65.09 -24.85 59.04 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 O-C-N 123.877 1.462 . . . . 51.57 111.229 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -67.94 -22.82 65.03 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.381 -0.824 . . . . 0.0 110.834 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -106.51 23.34 14.37 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.265 -0.897 . . . . 0.0 110.615 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.98 29.28 73.44 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -120.41 94.07 4.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.596 -0.943 . . . . 0.0 110.171 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.43 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 77.3 m-85 -105.48 132.18 51.97 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.495 -0.753 . . . . 46.07 109.278 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.72 120.62 40.7 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.093 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.423 ' CG ' HD23 ' A' ' 120' ' ' LEU . 87.7 m-85 -116.01 134.78 54.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.55 -0.718 . . . . 38.880000000000003 109.784 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.62 132.02 54.86 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.436 -0.95 . . . . 34.060000000000002 108.436 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 86' ' ' SER . 20.2 p90 -127.72 142.85 51.21 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.083 -1.047 . . . . 29.030000000000001 111.262 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.5 p -105.2 140.65 38.03 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.438 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 44.6 mm -105.3 131.8 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.841 0.829 . . . . 0.0 111.604 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -122.46 95.74 4.76 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.183 -0.673 . . . . 40.240000000000002 109.183 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.412 ' CG2' ' CD1' ' A' ' 76' ' ' LEU . 75.4 mt -90.84 117.81 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.792 -0.567 . . . . 20.73 110.657 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -117.06 135.72 53.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.543 -0.723 . . . . 0.0 109.398 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -91.46 117.23 29.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.801 -0.562 . . . . 21.34 110.651 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.51 9.29 18.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.536 -0.728 . . . . 0.0 110.579 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.27 -177.08 51.7 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.182 -1.567 . . . . 29.100000000000001 109.182 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.39 -30.99 11.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.492 -1.005 . . . . 0.0 110.063 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.42 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 86.2 t -105.4 140.56 21.27 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.8 -0.563 . . . . 0.0 109.545 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.42 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 39.2 Cg_endo -51.4 141.89 39.64 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 O-C-N 123.731 1.385 . . . . 21.949999999999999 111.9 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.7 151.73 46.12 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.488 0.661 . . . . 20.91 110.937 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -127.57 158.89 36.26 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.827 -0.546 . . . . 0.0 109.844 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.7 tt -97.88 117.12 31.48 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.449 -0.782 . . . . 0.0 109.404 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -100.69 -27.76 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.666 -0.646 . . . . 0.0 110.569 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.11 162.83 34.3 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.833 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.7 ptt85 -142.41 139.97 31.83 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.44 0.638 . . . . 29.050000000000001 110.206 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -142.24 113.67 7.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.72 -0.613 . . . . 27.969999999999999 109.699 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.424 ' CH2' HD11 ' A' ' 115' ' ' ILE . 92.4 m95 -101.92 133.5 46.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.74 -0.6 . . . . 25.25 110.792 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -116.33 77.33 1.09 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.633 -0.667 . . . . 0.0 109.338 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.42 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.4 pt -84.17 129.19 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.922 0.868 . . . . 36.109999999999999 112.149 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.5 m -121.0 130.99 54.02 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.325 -0.991 . . . . 33.979999999999997 108.325 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -88.64 170.59 10.69 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.725 0.774 . . . . 45.039999999999999 111.427 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.55 -7.67 8.18 Favored Glycine 0 N--CA 1.494 2.542 0 O-C-N 121.823 -0.548 . . . . 39.469999999999999 112.299 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -101.21 6.92 43.21 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 119.411 1.605 . . . . 0.0 110.691 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.77 -28.33 9.47 Favored Glycine 0 N--CA 1.495 2.587 0 O-C-N 121.204 -0.935 . . . . 0.0 110.955 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.76 142.0 58.56 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.256 -1.143 . . . . 62.780000000000001 109.779 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.7 t -135.06 153.16 52.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.489 -0.757 . . . . 0.0 110.756 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -121.51 123.33 41.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.535 -0.728 . . . . 0.0 110.076 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -102.36 135.61 43.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.75 -0.594 . . . . 0.0 110.742 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.9 t -128.67 132.9 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.628 -0.67 . . . . 37.939999999999998 109.85 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -124.64 127.48 47.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.828 -0.545 . . . . 0.0 110.452 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -153.94 170.32 32.56 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.215 -1.554 . . . . 31.82 109.215 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -114.99 159.98 20.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.374 -1.074 . . . . 0.0 110.141 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.44 96.25 0.01 OUTLIER Glycine 0 N--CA 1.5 2.957 0 O-C-N 121.328 -0.857 . . . . 22.620000000000001 111.444 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.4 m -46.32 133.37 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.453 0 O-C-N 121.365 -1.079 . . . . 17.510000000000002 111.425 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.0 m 41.45 34.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 CA-C-O 121.587 0.708 . . . . 20.550000000000001 111.312 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.62 23.14 54.42 Favored Glycine 0 N--CA 1.495 2.603 0 O-C-N 121.714 -0.616 . . . . 18.289999999999999 112.301 178.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -144.21 151.25 39.22 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 119.125 1.463 . . . . 0.0 112.335 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -117.86 72.19 8.33 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.152 -1.055 . . . . 18.210000000000001 108.152 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -54.8 141.79 75.78 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 O-C-N 123.757 1.399 . . . . 17.609999999999999 112.385 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -103.75 75.32 1.3 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.412 ' CD1' ' CG2' ' A' ' 37' ' ' ILE . 15.0 mt -60.43 119.66 8.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.706 -0.621 . . . . 20.57 111.915 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -86.05 158.45 55.72 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -53.48 127.4 25.16 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 O-C-N 123.539 1.284 . . . . 27.039999999999999 111.167 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.76 -16.48 56.55 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.74 -0.944 . . . . 24.739999999999998 110.74 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -87.25 164.36 16.36 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.089 -1.242 . . . . 29.379999999999999 110.427 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.45 149.33 34.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.568 -0.708 . . . . 0.0 110.199 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -119.2 144.63 46.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.499 -0.751 . . . . 18.559999999999999 109.212 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 -144.14 140.93 29.67 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.163 -0.96 . . . . 0.0 111.236 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.438 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 51.0 p90 -150.8 160.05 44.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.646 -0.659 . . . . 26.649999999999999 109.74 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 60.3 m -100.8 136.08 41.23 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.445 -0.785 . . . . 28.140000000000001 110.848 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 23.3 t -126.38 168.08 14.65 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.554 -0.716 . . . . 33.880000000000003 110.115 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -135.67 129.11 4.88 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.926 -1.13 . . . . 31.800000000000001 110.496 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.2 t -133.01 148.76 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.592 -0.946 . . . . 0.0 109.248 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.9 tp -109.81 143.79 39.18 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.552 -0.718 . . . . 0.0 110.542 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.4 tp -121.49 144.26 48.8 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.574 -0.704 . . . . 38.68 109.767 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -75.98 -25.41 55.79 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.25 -0.906 . . . . 0.0 111.096 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.8 m -124.04 171.97 9.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.332 -0.855 . . . . 31.629999999999999 110.512 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.41 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 52.6 tt0 -86.28 11.45 12.13 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.612 -0.68 . . . . 0.0 111.592 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -142.89 142.98 31.86 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.2 -0.937 . . . . 0.0 109.626 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -177.47 152.73 12.29 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 118.751 -1.69 . . . . 28.050000000000001 112.198 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -118.05 130.33 56.1 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 90.7 mtp -128.0 124.02 36.18 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.457 -0.777 . . . . 0.0 111.597 -178.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.41 ' CG ' ' CB ' ' A' ' 117' ' ' ALA . 62.8 mt-30 -125.49 152.19 45.29 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.89 179.88 38.59 Favored Glycine 0 N--CA 1.5 2.958 0 C-N-CA 118.665 -1.731 . . . . 29.620000000000001 111.211 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.433 ' CD2' ' HA ' ' A' ' 114' ' ' PRO . 44.4 m80 -134.62 159.07 42.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.843 -0.798 . . . . 0.0 110.031 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.453 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 8.2 m-85 -116.71 127.35 54.31 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.589 -0.694 . . . . 27.050000000000001 109.959 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -85.99 118.51 25.51 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.06 -1.025 . . . . 0.0 108.815 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.419 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 18.3 tpp -124.73 160.78 27.83 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.294 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.2 m -140.93 131.19 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.614 -0.679 . . . . 23.280000000000001 110.328 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.04 166.86 22.28 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.437 -0.789 . . . . 0.0 109.606 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -64.64 -29.45 70.45 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.94 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -73.72 -11.24 60.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.519 -0.738 . . . . 0.0 111.059 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.24 -7.3 47.43 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.411 -1.076 . . . . 30.43 110.411 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.419 HG21 ' CE2' ' A' ' 7' ' ' TYR . 24.3 m -57.68 135.47 56.74 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.026 -1.279 . . . . 0.0 110.056 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -101.14 139.61 36.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.441 -0.787 . . . . 0.0 110.69 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.419 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 43.8 p90 -165.78 145.05 6.26 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.75 -0.594 . . . . 28.030000000000001 109.902 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 24.9 pt -102.21 158.11 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.716 -0.615 . . . . 0.0 111.16 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.86 97.6 49.59 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.433 ' HA ' ' CD2' ' A' ' 100' ' ' HIS . 45.7 Cg_endo -58.15 143.82 96.19 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 O-C-N 123.835 1.439 . . . . 33.310000000000002 112.166 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.453 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 68.7 mt -108.81 122.52 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-N 115.368 -0.833 . . . . 30.59 108.954 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.61 172.81 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.255 0.55 . . . . 30.780000000000001 111.429 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.41 ' CB ' ' CG ' ' A' ' 98' ' ' GLN . . . -100.29 119.93 39.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.583 -0.698 . . . . 0.0 110.753 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 97' ' ' MET . 41.9 p90 -111.99 156.02 22.83 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.244 -1.021 . . . . 30.66 108.244 178.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.2 t -116.95 153.45 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.177 -0.952 . . . . 0.0 110.886 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.462 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.9 mp -114.52 130.16 56.72 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.141 -0.689 . . . . 39.149999999999999 109.141 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.606 -0.684 . . . . 0.0 110.156 -179.802 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.1 mtm-85 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.772 0.32 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.411 ' CZ ' HG21 ' A' ' 109' ' ' THR . 90.9 m-85 -119.18 105.96 11.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.52 -0.738 . . . . 31.93 110.141 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -149.03 134.82 18.84 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.615 -0.678 . . . . 0.0 110.07 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.0 t -151.58 116.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-O 121.554 0.692 . . . . 0.0 109.609 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -105.63 131.24 53.25 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.652 0.739 . . . . 0.0 110.385 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 63.4 t -118.75 136.12 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 109.303 -0.628 . . . . 28.210000000000001 109.303 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -124.02 137.24 54.62 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.306 -0.871 . . . . 0.0 110.136 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 75.8 t -129.22 136.95 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.679 -0.638 . . . . 27.949999999999999 110.523 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.1 m -125.12 105.55 28.72 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.785 -0.572 . . . . 0.0 110.302 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 49.8 Cg_endo -82.33 164.66 16.87 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.859 1.452 . . . . 33.0 111.255 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -157.47 130.63 7.71 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.667 0.746 . . . . 54.100000000000001 109.722 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -63.95 139.87 58.81 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.663 -0.648 . . . . 0.0 111.585 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.0 mt -116.04 80.7 1.49 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.947 0.88 . . . . 0.0 110.453 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.46 -35.75 78.01 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.793 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -69.54 -24.02 63.67 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.447 -0.783 . . . . 0.0 110.734 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -120.84 43.1 2.86 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.431 -0.793 . . . . 52.369999999999997 110.735 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -164.68 146.67 8.32 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.365 -0.834 . . . . 55.189999999999998 110.974 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 t -120.38 93.12 48.07 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.552 -0.718 . . . . 0.0 109.146 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.438 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 50.1 Cg_endo -65.94 -23.09 54.83 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 O-C-N 123.89 1.469 . . . . 51.57 111.573 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -65.61 -23.69 66.88 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.378 -0.826 . . . . 0.0 111.047 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -105.59 23.99 12.93 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.347 -0.845 . . . . 0.0 110.815 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.24 27.82 73.57 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -120.79 94.2 4.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.503 -0.998 . . . . 0.0 110.169 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.438 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 68.2 m-85 -104.45 132.68 50.42 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.601 -0.687 . . . . 46.07 109.313 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.64 120.56 40.58 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.338 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.42 ' CG ' HD23 ' A' ' 120' ' ' LEU . 89.4 m-85 -116.26 134.5 54.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.529 -0.732 . . . . 38.880000000000003 109.841 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.16 132.71 54.73 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.442 -0.947 . . . . 34.060000000000002 108.442 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 86' ' ' SER . 20.1 p90 -128.05 143.28 51.07 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.078 -1.049 . . . . 29.030000000000001 111.611 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.9 m -106.71 139.69 40.75 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.452 ' CD1' ' CZ ' ' A' ' 84' ' ' TYR . 87.3 mt -108.8 134.55 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 121.668 0.747 . . . . 0.0 111.671 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.3 mtm105 -124.82 98.65 5.8 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.642 0.734 . . . . 40.240000000000002 109.796 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 85.4 mt -94.13 118.26 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.818 -0.551 . . . . 20.73 110.726 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -116.43 138.61 51.22 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.267 -0.896 . . . . 0.0 109.231 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -90.61 117.97 29.69 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.78 -0.575 . . . . 21.34 110.856 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.51 9.92 15.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.477 -0.765 . . . . 0.0 110.603 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.2 -178.97 52.4 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.417 -1.473 . . . . 29.100000000000001 109.417 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.69 -33.89 12.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.441 -1.034 . . . . 0.0 110.326 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.41 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 87.4 t -103.78 139.6 20.26 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.846 -0.533 . . . . 0.0 109.946 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 39.9 Cg_endo -52.35 143.22 44.55 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 O-C-N 123.883 1.465 . . . . 21.949999999999999 111.845 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.88 151.92 46.03 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.498 0.666 . . . . 20.91 110.99 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.422 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 19.6 ptt-85 -128.05 158.96 36.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.824 -0.547 . . . . 0.0 110.017 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.406 HD12 ' CD1' ' A' ' 101' ' ' TYR . 6.4 tt -97.7 115.28 27.66 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.446 -0.784 . . . . 0.0 109.246 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.1 m -100.54 -26.18 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.632 -0.667 . . . . 0.0 111.175 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.4 163.05 33.9 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.196 -0.94 . . . . 0.0 111.734 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 -145.39 142.26 29.18 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.644 0.735 . . . . 29.050000000000001 110.858 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -144.89 115.17 7.54 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.324 -0.621 . . . . 27.969999999999999 109.324 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -98.05 135.6 39.51 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.558 -0.713 . . . . 25.25 111.747 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -115.48 75.98 0.98 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.402 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.8 pt -86.98 131.3 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.412 -0.805 . . . . 36.109999999999999 112.14 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.3 m -119.85 132.93 55.72 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.35 -0.982 . . . . 33.979999999999997 108.35 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -87.19 169.48 12.31 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.638 0.732 . . . . 45.039999999999999 111.308 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.32 -8.36 12.4 Favored Glycine 0 N--CA 1.494 2.549 0 O-C-N 121.828 -0.545 . . . . 39.469999999999999 112.124 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -101.01 8.15 43.14 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 119.402 1.601 . . . . 0.0 110.859 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.34 -23.07 29.26 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.196 -0.94 . . . . 0.0 110.952 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -60.4 142.16 55.35 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.187 -1.184 . . . . 62.780000000000001 109.806 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 74.3 p -126.05 142.0 51.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.407 -0.808 . . . . 0.0 110.669 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -122.87 119.95 32.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.411 -0.806 . . . . 0.0 109.948 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -104.79 134.47 47.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.657 -0.652 . . . . 0.0 110.7 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.9 t -127.93 130.85 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.625 -0.672 . . . . 37.939999999999998 109.81 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -123.41 126.6 47.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.84 -0.537 . . . . 0.0 110.299 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -147.84 147.45 18.13 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.223 -1.551 . . . . 31.82 109.223 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -72.59 155.63 39.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.51 -0.994 . . . . 0.0 110.15 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.59 -170.65 0.08 OUTLIER Glycine 0 N--CA 1.498 2.824 0 O-C-N 121.49 -0.756 . . . . 22.620000000000001 111.357 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.0 m -129.74 127.96 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.835 -0.803 . . . . 17.510000000000002 108.957 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.3 m 41.75 34.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 CA-C-O 121.7 0.762 . . . . 20.550000000000001 111.448 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.4 18.83 61.53 Favored Glycine 0 N--CA 1.497 2.751 0 O-C-N 121.714 -0.616 . . . . 18.289999999999999 113.041 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -147.58 150.67 34.9 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 119.449 1.625 . . . . 0.0 112.675 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -115.24 73.05 3.47 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 108.257 -1.016 . . . . 18.210000000000001 108.257 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -55.5 141.49 82.63 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 O-C-N 123.842 1.443 . . . . 17.609999999999999 112.426 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.422 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 4.7 t90 -102.39 76.88 1.59 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.3 mt -60.89 117.49 5.49 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.636 -0.665 . . . . 20.57 111.783 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -88.39 159.12 47.94 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -54.25 129.58 35.3 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 O-C-N 123.535 1.281 . . . . 27.039999999999999 111.134 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.91 -18.9 44.95 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 111.003 -0.839 . . . . 24.739999999999998 111.003 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.93 166.62 14.39 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.117 -1.225 . . . . 29.379999999999999 110.446 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -144.55 146.16 32.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.672 -0.643 . . . . 0.0 110.415 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -114.58 141.24 48.01 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.049 -0.722 . . . . 18.559999999999999 109.049 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -147.95 140.98 24.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.298 -0.876 . . . . 0.0 111.101 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.452 ' CZ ' ' CD1' ' A' ' 35' ' ' ILE . 46.3 p90 -153.33 162.5 41.22 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.621 -0.674 . . . . 26.649999999999999 109.775 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.1 m -99.01 135.78 39.92 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.468 -0.77 . . . . 28.140000000000001 111.211 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 17.2 t -125.16 166.65 16.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.642 -0.661 . . . . 33.880000000000003 109.688 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.26 130.33 5.69 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 119.779 -1.201 . . . . 31.800000000000001 110.536 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.2 t -132.77 147.01 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.695 -0.885 . . . . 0.0 109.118 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.2 tp -110.27 143.74 40.0 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.559 -0.713 . . . . 0.0 110.33 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.4 144.97 48.7 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.491 -0.756 . . . . 38.68 109.936 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -78.24 -26.09 47.17 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.425 -0.797 . . . . 0.0 110.641 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.5 m -123.41 171.22 9.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.42 -0.8 . . . . 31.629999999999999 110.2 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.414 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 56.8 tt0 -86.21 12.54 9.59 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.415 -0.803 . . . . 0.0 111.579 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -140.99 144.99 35.38 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.044 -1.035 . . . . 0.0 109.698 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.51 158.94 21.66 Favored Glycine 0 N--CA 1.496 2.673 0 C-N-CA 118.766 -1.683 . . . . 28.050000000000001 112.321 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -119.66 129.96 54.83 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 122.128 -0.631 . . . . 0.0 109.578 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 90.0 mtp -125.48 117.42 23.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.275 -0.89 . . . . 0.0 111.075 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -129.21 150.04 50.76 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.36 -177.83 38.04 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 119.108 -1.52 . . . . 29.620000000000001 110.514 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 -140.26 159.93 41.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.698 -0.883 . . . . 0.0 110.676 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.444 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 5.2 m-85 -115.3 128.38 56.07 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.753 -0.592 . . . . 27.050000000000001 109.944 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -83.4 122.3 28.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.006 -1.059 . . . . 0.0 108.739 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.43 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 43.0 mtp -123.51 161.93 23.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.878 -0.513 . . . . 0.0 110.507 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.4 m -140.32 129.47 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.719 -0.613 . . . . 23.280000000000001 110.23 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.21 166.53 22.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.507 -0.745 . . . . 0.0 109.649 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -65.86 -29.27 69.7 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.198 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -76.74 -4.89 45.7 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.395 -0.816 . . . . 0.0 111.347 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.33 -9.52 57.61 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.045 -1.074 . . . . 30.43 110.627 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.411 HG21 ' CZ ' ' A' ' 7' ' ' TYR . 23.9 m -57.42 134.57 56.16 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.047 -1.266 . . . . 0.0 110.104 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -101.68 139.61 37.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.37 -0.831 . . . . 0.0 110.724 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.43 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 45.2 p90 -164.08 143.75 7.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.664 -0.648 . . . . 28.030000000000001 109.856 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.9 mm -98.69 156.11 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.661 -0.649 . . . . 0.0 110.61 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.53 96.92 48.93 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -59.44 141.53 97.63 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.911 1.479 . . . . 33.310000000000002 112.222 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.444 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 68.0 mt -107.08 124.05 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.627 -0.879 . . . . 30.59 108.627 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.92 147.52 3.82 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.234 0.54 . . . . 30.780000000000001 111.48 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -89.65 122.33 32.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.597 -0.689 . . . . 0.0 110.179 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 97' ' ' MET . 45.0 p90 -109.1 164.69 12.2 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.934 -0.765 . . . . 30.66 108.934 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.8 t -114.48 155.4 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.333 -0.854 . . . . 0.0 110.28 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.462 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.0 mp -114.11 132.17 56.15 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.264 -0.643 . . . . 39.149999999999999 109.264 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.687 -0.633 . . . . 0.0 110.104 -179.852 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 120.906 0.384 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -115.83 107.18 14.71 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.559 -0.713 . . . . 31.93 110.167 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.8 ttt85 -153.44 135.2 14.52 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.561 0.696 . . . . 0.0 110.413 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.0 t -152.29 116.08 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-O 121.448 0.642 . . . . 0.0 109.499 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -107.36 130.07 54.83 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.622 0.725 . . . . 0.0 110.049 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.0 t -118.1 139.46 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.848 -0.532 . . . . 28.210000000000001 109.817 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -121.81 137.81 54.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.386 -0.822 . . . . 0.0 110.014 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.7 t -128.7 137.11 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.59 -0.694 . . . . 27.949999999999999 110.379 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -125.3 106.9 27.54 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.738 -0.601 . . . . 0.0 110.485 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.431 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 51.0 Cg_endo -82.76 165.66 15.54 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 O-C-N 123.816 1.43 . . . . 33.0 111.119 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -158.05 129.59 6.72 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.595 0.712 . . . . 54.100000000000001 109.588 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -62.98 139.95 58.82 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.753 -0.592 . . . . 0.0 111.543 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 88.9 mt -115.85 81.2 1.56 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.907 0.861 . . . . 0.0 110.381 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.44 -35.77 78.08 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.893 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -69.94 -23.18 63.16 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.415 -0.803 . . . . 0.0 110.823 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -121.23 38.97 3.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.364 -0.835 . . . . 52.369999999999997 110.757 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.9 t -160.01 145.75 15.48 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.335 -0.853 . . . . 55.189999999999998 111.117 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.0 t -120.02 92.76 47.24 Favored Pre-proline 0 N--CA 1.496 1.848 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.439 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.8 Cg_endo -66.32 -23.0 52.17 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 O-C-N 123.86 1.453 . . . . 51.57 111.718 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -65.28 -23.45 67.04 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.357 -0.839 . . . . 0.0 110.994 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -105.62 24.15 12.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.306 -0.871 . . . . 0.0 110.846 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.99 28.13 73.68 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -120.98 94.0 4.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.642 -0.916 . . . . 0.0 110.23 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 69.8 m-85 -104.14 133.56 48.87 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.607 -0.683 . . . . 46.07 109.359 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -115.21 120.19 38.87 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 119.754 -0.779 . . . . 0.0 111.075 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.423 ' CD1' HD11 ' A' ' 90' ' ' LEU . 91.4 m-85 -115.92 135.26 54.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.512 -0.742 . . . . 38.880000000000003 109.782 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.38 132.24 55.12 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.542 -0.91 . . . . 34.060000000000002 108.542 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.423 ' CZ ' ' HB3' ' A' ' 86' ' ' SER . 18.5 p90 -128.4 143.26 50.97 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.214 -0.995 . . . . 29.030000000000001 111.429 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.5 t -105.77 140.57 38.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.724 -0.61 . . . . 0.0 109.494 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.436 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 45.6 mm -105.11 131.84 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.727 0.775 . . . . 0.0 111.63 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -122.91 96.93 5.21 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.532 0.682 . . . . 40.240000000000002 109.381 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 79.9 mt -92.48 117.83 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.759 -0.588 . . . . 20.73 110.592 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -116.82 134.16 55.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.496 -0.753 . . . . 0.0 109.248 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -92.79 117.57 30.16 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 120.204 -0.598 . . . . 21.34 110.565 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.35 11.96 16.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.49 -0.756 . . . . 0.0 110.575 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.25 -179.26 52.76 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.086 -1.605 . . . . 29.100000000000001 109.086 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.99 -32.89 12.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.479 -1.012 . . . . 0.0 110.32 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.417 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 85.3 t -104.6 141.2 22.05 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.83 -0.544 . . . . 0.0 109.883 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.417 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 40.1 Cg_endo -53.53 143.26 56.82 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 O-C-N 123.809 1.426 . . . . 21.949999999999999 111.91 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.7 151.69 46.09 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.604 0.716 . . . . 20.91 110.861 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.421 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 18.4 ptt180 -127.96 159.76 33.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.751 -0.593 . . . . 0.0 109.723 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.9 tt -98.14 117.28 32.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.432 -0.792 . . . . 0.0 109.699 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.5 t -99.85 -29.45 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.514 -0.741 . . . . 0.0 110.677 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.38 162.66 34.95 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.949 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.6 ptt85 -143.7 141.59 30.58 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.673 0.749 . . . . 29.050000000000001 110.323 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -144.51 113.97 7.09 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.405 0.622 . . . . 27.969999999999999 109.507 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -98.45 135.2 40.35 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.65 -0.656 . . . . 25.25 111.488 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -115.38 75.85 0.97 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.41 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.3 pt -85.7 130.5 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 121.85 0.833 . . . . 36.109999999999999 111.975 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 86.1 m -121.22 132.93 55.11 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.351 -0.981 . . . . 33.979999999999997 108.351 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -87.32 169.74 12.03 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.717 0.77 . . . . 45.039999999999999 111.477 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.29 -7.88 15.93 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 121.819 -0.551 . . . . 39.469999999999999 112.06 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -100.57 8.12 43.63 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 119.345 1.573 . . . . 0.0 110.578 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.7 -21.3 36.77 Favored Glycine 0 N--CA 1.493 2.49 0 O-C-N 121.233 -0.917 . . . . 0.0 111.011 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.19 141.03 56.6 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.169 -1.195 . . . . 62.780000000000001 109.806 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 82.1 p -125.87 140.09 52.94 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.447 -0.783 . . . . 0.0 110.668 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -123.73 120.0 31.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.41 -0.806 . . . . 0.0 110.014 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -104.85 135.26 46.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.686 -0.634 . . . . 0.0 110.859 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.26 130.62 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.58 -0.7 . . . . 37.939999999999998 109.848 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.65 127.57 47.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.817 -0.552 . . . . 0.0 110.42 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.79 150.92 23.06 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.289 -1.524 . . . . 31.82 109.289 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -79.43 156.76 27.75 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.559 -0.965 . . . . 0.0 110.25 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 51.57 -173.49 0.18 Allowed Glycine 0 N--CA 1.497 2.752 0 N-CA-C 111.008 -0.837 . . . . 22.620000000000001 111.008 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.2 m -130.1 127.98 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.793 -0.828 . . . . 17.510000000000002 109.606 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.415 HG23 ' HG2' ' A' ' 72' ' ' GLU . 11.6 m 41.12 36.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 CA-C-O 121.514 0.673 . . . . 20.550000000000001 111.853 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.13 16.65 68.99 Favored Glycine 0 N--CA 1.499 2.857 0 O-C-N 121.683 -0.636 . . . . 18.289999999999999 113.002 177.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.415 ' HG2' HG23 ' A' ' 70' ' ' VAL . 9.9 pt-20 -145.64 150.9 37.19 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 119.164 1.482 . . . . 0.0 112.018 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -115.22 75.12 4.18 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.915 -0.772 . . . . 18.210000000000001 108.915 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -57.67 140.06 92.28 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 O-C-N 123.861 1.453 . . . . 17.609999999999999 112.149 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.421 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 4.1 t90 -103.14 77.57 1.55 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.3 mt -60.14 118.31 6.18 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.462 0.649 . . . . 20.57 111.953 -178.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 -85.8 157.19 57.93 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -53.49 128.1 27.99 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 O-C-N 123.561 1.295 . . . . 27.039999999999999 111.15 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.66 -17.13 54.39 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.727 -0.949 . . . . 24.739999999999998 110.727 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -86.89 165.71 15.71 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.058 -1.26 . . . . 29.379999999999999 110.537 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.02 149.1 34.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.66 -0.65 . . . . 0.0 110.041 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.4 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 79.6 t80 -118.9 146.27 45.05 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.47 -0.769 . . . . 18.559999999999999 109.179 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -146.05 141.03 27.22 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.213 -0.929 . . . . 0.0 111.13 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.436 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 50.6 p90 -151.09 160.02 44.14 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.59 -0.693 . . . . 26.649999999999999 109.837 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.2 m -100.04 135.58 41.25 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.391 -0.818 . . . . 28.140000000000001 110.646 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 28.4 t -125.06 167.41 14.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.592 -0.693 . . . . 33.880000000000003 110.048 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.87 129.97 5.48 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.841 -1.171 . . . . 31.800000000000001 110.481 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.75 148.61 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.695 -0.885 . . . . 0.0 109.821 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 mp -112.93 144.28 42.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.57 -0.706 . . . . 0.0 110.569 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.423 HD11 ' CD1' ' A' ' 31' ' ' PHE . 31.8 mt -121.98 146.57 47.02 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.639 -0.663 . . . . 38.68 110.004 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -77.6 -26.16 50.45 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.405 -0.809 . . . . 0.0 110.765 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.5 p -122.95 171.33 9.31 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.47 -0.769 . . . . 31.629999999999999 110.522 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -86.13 11.06 12.65 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.636 -0.665 . . . . 0.0 111.549 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -140.72 146.18 37.42 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.016 -1.053 . . . . 0.0 109.638 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.42 153.21 10.72 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 118.921 -1.609 . . . . 28.050000000000001 112.264 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -118.2 129.84 55.73 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 94.3 mtp -126.8 122.45 34.8 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.39 -0.819 . . . . 0.0 111.63 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -127.34 149.45 50.04 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.86 -177.68 36.85 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 118.931 -1.604 . . . . 29.620000000000001 110.844 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -142.81 158.81 43.26 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.795 -0.826 . . . . 0.0 110.626 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.417 ' CE2' HD12 ' A' ' 115' ' ' ILE . 4.5 m-85 -116.68 129.18 55.98 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.656 -0.652 . . . . 27.050000000000001 110.076 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -83.06 122.65 28.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.014 -1.054 . . . . 0.0 109.095 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.423 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 63.3 mtp -123.12 163.01 21.36 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.108 0.48 . . . . 0.0 110.457 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 m -142.54 131.55 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.65 -0.656 . . . . 23.280000000000001 110.432 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.2 165.03 23.02 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.398 -0.814 . . . . 0.0 109.508 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -65.71 -27.21 68.16 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.519 -0.738 . . . . 0.0 110.46 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -79.93 -1.29 38.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.321 -0.862 . . . . 0.0 111.312 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.03 -10.07 56.79 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.962 -1.113 . . . . 30.43 110.581 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.6 m -57.46 134.02 55.71 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.086 -1.244 . . . . 0.0 110.059 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -102.64 139.24 38.48 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.311 -0.868 . . . . 0.0 110.782 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 43.1 p90 -162.82 141.68 8.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.759 -0.588 . . . . 28.030000000000001 110.002 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.8 pt -98.43 156.8 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.715 -0.615 . . . . 0.0 110.77 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -121.33 97.98 46.95 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -59.31 142.11 98.67 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 O-C-N 123.907 1.477 . . . . 33.310000000000002 112.039 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.417 HD12 ' CE2' ' A' ' 101' ' ' TYR . 70.9 mt -107.68 124.13 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.791 -0.818 . . . . 30.59 108.791 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.59 151.18 2.41 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.264 0.554 . . . . 30.780000000000001 111.356 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -98.67 118.19 34.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.675 -0.641 . . . . 0.0 110.159 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.431 ' CD1' ' HG3' ' A' ' 15' ' ' PRO . 41.6 p90 -107.95 168.94 8.92 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.944 -0.761 . . . . 30.66 108.944 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.5 t -114.23 154.14 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.251 -0.906 . . . . 0.0 110.509 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.454 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.0 mp -113.65 132.4 55.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.676 -0.64 . . . . 39.149999999999999 109.357 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 79.8 p . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.636 -0.665 . . . . 0.0 110.1 -179.808 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 120.951 0.405 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -109.97 100.59 9.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.785 -0.572 . . . . 31.93 109.908 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 64.7 mtp85 -149.0 137.21 20.86 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.754 0.788 . . . . 0.0 110.314 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.2 t -151.31 114.79 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -107.55 130.26 54.89 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.574 0.702 . . . . 0.0 110.109 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.9 t -118.53 138.89 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.883 -0.511 . . . . 28.210000000000001 109.639 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -121.24 137.36 54.72 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.477 -0.764 . . . . 0.0 109.85 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.2 t -129.16 136.58 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.555 -0.715 . . . . 27.949999999999999 110.502 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.6 t -125.24 104.43 28.98 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.714 -0.616 . . . . 0.0 110.226 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 50.2 Cg_endo -83.86 165.81 13.41 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 O-C-N 123.815 1.429 . . . . 33.0 111.095 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -158.02 131.5 7.7 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.527 0.679 . . . . 54.100000000000001 109.737 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -59.29 138.49 57.6 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.737 -0.602 . . . . 0.0 111.2 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.1 tp -115.01 80.72 1.46 Allowed 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 122.014 0.912 . . . . 0.0 110.269 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.07 -35.63 74.35 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.366 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -69.22 -22.6 63.86 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.366 -0.834 . . . . 0.0 111.03 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 34.1 tp60 -121.75 36.87 4.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.283 -0.885 . . . . 52.369999999999997 110.596 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.8 t -156.95 146.02 20.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.451 -0.781 . . . . 55.189999999999998 111.02 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.2 t -122.03 92.83 48.82 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.439 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.1 Cg_endo -65.98 -22.39 55.46 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 O-C-N 123.711 1.374 . . . . 51.57 111.928 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -64.87 -23.52 67.26 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.258 -0.901 . . . . 0.0 110.879 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.59 23.48 14.17 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.289 -0.882 . . . . 0.0 110.705 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.61 29.94 72.89 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.2 mmm-85 -120.87 93.59 4.08 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.596 -0.943 . . . . 0.0 110.181 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 68.4 m-85 -104.58 130.4 52.56 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.571 -0.705 . . . . 46.07 109.126 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -117.76 120.31 37.57 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.571 -0.851 . . . . 0.0 111.185 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.424 ' CD1' HD12 ' A' ' 90' ' ' LEU . 68.1 m-85 -115.0 137.28 52.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.583 -0.698 . . . . 38.880000000000003 109.815 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.78 131.61 55.21 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.293 -1.002 . . . . 34.060000000000002 108.293 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.417 ' CZ ' ' HB3' ' A' ' 86' ' ' SER . 20.6 p90 -128.21 144.08 51.09 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.19 -1.004 . . . . 29.030000000000001 111.534 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.5 t -104.39 141.06 37.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.68 -0.638 . . . . 0.0 109.851 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.442 ' CG2' ' CE1' ' A' ' 84' ' ' TYR . 45.6 mm -106.35 132.23 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.822 0.82 . . . . 0.0 111.618 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.7 mtp85 -121.47 96.6 5.14 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.418 0.628 . . . . 40.240000000000002 109.526 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.406 ' CG2' ' CD1' ' A' ' 76' ' ' LEU . 78.1 mt -92.53 115.74 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.736 -0.603 . . . . 20.73 110.352 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -117.66 136.49 53.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.563 -0.711 . . . . 0.0 109.472 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -91.47 116.11 28.59 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 120.179 -0.608 . . . . 21.34 110.541 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -112.26 9.38 19.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.441 -0.787 . . . . 0.0 110.683 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.96 -176.15 50.96 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.002 -1.639 . . . . 29.100000000000001 109.002 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.75 -30.0 12.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.463 -1.021 . . . . 0.0 110.137 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.42 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 84.2 t -105.57 139.83 20.57 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.78 -0.575 . . . . 0.0 109.714 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.42 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 39.9 Cg_endo -51.18 144.84 28.22 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 O-C-N 123.684 1.36 . . . . 21.949999999999999 111.685 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.5 150.08 49.68 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.736 0.779 . . . . 20.91 111.212 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.5 ttt-85 -125.81 153.08 44.58 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.5 tt -97.57 117.16 31.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.494 -0.754 . . . . 0.0 109.997 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.7 t -100.85 -29.45 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.613 -0.68 . . . . 0.0 110.436 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.2 163.7 32.24 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.13 -1.028 . . . . 0.0 112.007 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.6 ptt85 -143.55 141.19 30.59 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.337 0.589 . . . . 29.050000000000001 110.16 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -144.0 114.14 7.38 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.396 0.617 . . . . 27.969999999999999 110.15 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -102.05 135.25 43.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.658 -0.651 . . . . 25.25 111.241 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -116.24 81.05 1.55 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.403 ' O ' HG13 ' A' ' 54' ' ' ILE . 17.3 pt -86.04 129.99 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 121.671 0.748 . . . . 36.109999999999999 111.748 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.3 m -119.32 130.16 55.24 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.397 -0.964 . . . . 33.979999999999997 108.397 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -89.18 169.9 11.07 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.666 0.746 . . . . 45.039999999999999 111.26 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.25 -7.9 15.8 Favored Glycine 0 N--CA 1.495 2.579 0 O-C-N 121.791 -0.568 . . . . 39.469999999999999 112.071 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -102.15 6.95 41.06 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 119.336 1.568 . . . . 0.0 110.805 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.1 -27.94 10.5 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 121.159 -0.963 . . . . 0.0 110.933 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -61.6 141.81 57.54 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.19 -1.182 . . . . 62.780000000000001 109.707 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 57.9 p -132.36 150.24 52.2 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.429 -0.794 . . . . 0.0 110.69 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -122.26 122.26 38.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.562 -0.711 . . . . 0.0 109.792 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -102.63 136.04 43.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.613 -0.679 . . . . 0.0 110.83 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.2 t -128.51 131.85 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.504 0.669 . . . . 37.939999999999998 109.925 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -125.02 127.48 47.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.79 -0.569 . . . . 0.0 110.3 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -153.91 173.5 32.54 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.101 -1.599 . . . . 31.82 109.101 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -115.78 159.64 21.18 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.362 -1.081 . . . . 0.0 110.047 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.66 95.35 0.01 OUTLIER Glycine 0 N--CA 1.5 2.94 0 O-C-N 121.423 -0.798 . . . . 22.620000000000001 111.355 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.1 m -46.36 134.02 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.505 0 O-C-N 121.399 -1.059 . . . . 17.510000000000002 111.553 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.429 HG22 ' HG2' ' A' ' 72' ' ' GLU . 12.4 m 41.55 37.13 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-O 121.634 0.73 . . . . 20.550000000000001 111.344 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.7 20.02 62.49 Favored Glycine 0 N--CA 1.495 2.598 0 O-C-N 121.752 -0.592 . . . . 18.289999999999999 112.428 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.429 ' HG2' HG22 ' A' ' 70' ' ' VAL . 5.2 pt-20 -146.73 151.81 37.8 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 119.191 1.496 . . . . 0.0 112.57 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -119.06 72.24 11.91 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 108.336 -0.987 . . . . 18.210000000000001 108.336 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -54.31 141.07 72.26 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 O-C-N 123.83 1.437 . . . . 17.609999999999999 112.517 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -99.14 74.4 1.96 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.406 ' CD1' ' CG2' ' A' ' 37' ' ' ILE . 12.0 mt -60.02 120.2 9.24 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.427 0.632 . . . . 20.57 112.045 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -85.42 157.8 58.29 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -53.81 127.03 23.89 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 O-C-N 123.584 1.307 . . . . 27.039999999999999 110.882 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.89 -15.69 57.02 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.735 -0.946 . . . . 24.739999999999998 110.735 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -87.02 164.27 16.57 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.086 -1.244 . . . . 29.379999999999999 110.435 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.83 151.33 36.93 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.45 -0.781 . . . . 0.0 110.333 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.401 ' CZ ' ' OE2' ' A' ' 72' ' ' GLU . 72.4 t80 -119.2 149.3 41.98 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.868 -0.79 . . . . 18.559999999999999 108.868 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -139.34 137.39 35.73 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.104 -0.997 . . . . 0.0 111.013 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.442 ' CE1' ' CG2' ' A' ' 35' ' ' ILE . 51.7 p90 -151.57 159.74 43.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.664 -0.648 . . . . 26.649999999999999 109.793 178.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.9 m -104.47 138.59 40.63 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.394 -0.816 . . . . 28.140000000000001 111.107 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 28.3 t -124.79 169.92 11.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.577 -0.702 . . . . 33.880000000000003 109.896 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.43 123.22 2.12 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.798 -1.191 . . . . 31.800000000000001 110.544 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 74.9 t -129.63 148.86 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.61 -0.935 . . . . 0.0 109.272 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.1 tp -109.74 143.82 39.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.487 -0.758 . . . . 0.0 110.496 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.424 HD12 ' CD1' ' A' ' 31' ' ' PHE . 84.8 mt -121.62 145.25 48.18 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.516 -0.74 . . . . 38.68 109.963 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.402 ' O ' ' CE1' ' A' ' 29' ' ' TYR . 29.9 tp10 -73.88 -26.06 60.35 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.407 -0.808 . . . . 0.0 110.782 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.1 p -123.34 171.74 9.19 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.39 -0.818 . . . . 31.629999999999999 110.579 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.409 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 54.9 tt0 -87.02 12.38 11.45 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.679 -0.638 . . . . 0.0 111.552 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -142.27 148.64 38.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.099 -1.0 . . . . 0.0 109.912 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.26 162.61 26.86 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 118.908 -1.615 . . . . 28.050000000000001 112.137 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -119.11 129.46 55.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.083 -0.657 . . . . 0.0 109.335 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 54.0 ttm -125.02 117.74 24.66 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.279 -0.888 . . . . 0.0 111.205 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -129.5 150.34 50.89 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.08 -179.44 38.32 Favored Glycine 0 N--CA 1.499 2.886 0 C-N-CA 118.787 -1.673 . . . . 29.620000000000001 111.017 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.429 ' CD2' ' HA ' ' A' ' 114' ' ' PRO . 63.3 m80 -137.12 155.36 49.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.808 -0.819 . . . . 0.0 110.118 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.433 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 4.4 m-85 -117.65 127.06 53.58 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.61 -0.681 . . . . 27.050000000000001 109.668 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -81.88 122.11 27.32 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.935 -1.103 . . . . 0.0 109.335 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.42 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 91.8 mmm -120.53 162.84 18.91 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.189 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.9 m -142.51 128.76 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.672 -0.643 . . . . 23.280000000000001 110.503 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.38 167.97 20.16 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.557 -0.714 . . . . 0.0 109.469 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -62.15 -28.14 69.45 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.522 -0.736 . . . . 0.0 110.4 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -72.29 -11.29 60.64 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 111.111 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.45 -6.49 59.29 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.099 -1.048 . . . . 30.43 110.667 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.5 m -59.93 139.5 57.35 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.108 -1.23 . . . . 0.0 109.963 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -99.56 140.48 33.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.463 -0.773 . . . . 0.0 110.892 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 33.5 p90 -163.64 146.33 9.8 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.376 -0.601 . . . . 28.030000000000001 109.376 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.457 HD11 HG22 ' A' ' 112' ' ' ILE . 79.9 mt -100.78 155.43 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.61 0.719 . . . . 0.0 111.104 -178.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.92 98.12 47.8 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.429 ' HA ' ' CD2' ' A' ' 100' ' ' HIS . 46.3 Cg_endo -59.14 144.17 99.48 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 O-C-N 123.869 1.457 . . . . 33.310000000000002 112.554 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.433 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 66.2 mt -108.78 122.63 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.451 -0.944 . . . . 30.59 108.451 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.92 144.97 5.98 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.199 0.523 . . . . 30.780000000000001 111.615 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -92.65 119.43 32.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.795 -0.565 . . . . 0.0 110.394 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.428 ' CD1' ' HG3' ' A' ' 15' ' ' PRO . 43.2 p90 -108.92 169.32 8.75 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.815 -0.809 . . . . 30.66 108.815 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.8 p -113.35 154.66 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.29 -0.881 . . . . 0.0 110.54 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.453 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.5 mp -113.25 131.91 55.73 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.426 -0.583 . . . . 39.149999999999999 109.426 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 96.6 p . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.654 -0.654 . . . . 0.0 110.092 -179.877 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.1 mtt-85 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 120.807 0.337 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -116.14 108.6 16.37 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.503 -0.748 . . . . 31.93 110.313 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -152.17 134.56 15.22 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.574 0.702 . . . . 0.0 110.192 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 80.0 t -151.42 113.84 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -107.85 129.04 55.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.636 -0.665 . . . . 0.0 109.767 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.5 t -119.41 139.75 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.863 -0.523 . . . . 28.210000000000001 109.968 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -121.51 136.51 54.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.409 -0.807 . . . . 0.0 109.673 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.0 t -129.47 137.64 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.513 -0.742 . . . . 27.949999999999999 110.434 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.6 t -125.62 104.51 27.6 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.733 -0.605 . . . . 0.0 110.583 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -83.61 165.14 14.1 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 O-C-N 123.851 1.448 . . . . 33.0 110.996 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -157.53 132.84 8.96 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.505 0.669 . . . . 54.100000000000001 109.999 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -59.96 139.47 57.38 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.812 -0.555 . . . . 0.0 111.298 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 77.0 mt -116.34 80.52 1.47 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.901 0.858 . . . . 0.0 110.524 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.01 -33.28 71.81 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.998 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -68.98 -25.97 64.8 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.271 -0.893 . . . . 0.0 111.875 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -120.01 29.61 7.44 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.093 -1.004 . . . . 52.369999999999997 111.191 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.1 p -148.07 150.59 34.18 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.316 -0.865 . . . . 55.189999999999998 110.821 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.5 m -117.9 92.52 42.09 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.584 -0.697 . . . . 0.0 109.361 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.459 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 48.3 Cg_endo -65.58 -25.46 54.9 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 O-C-N 123.951 1.5 . . . . 51.57 111.241 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.79 -23.22 65.18 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.462 -0.773 . . . . 0.0 110.843 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.39 23.4 14.22 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.326 -0.859 . . . . 0.0 110.716 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.84 30.03 72.54 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -120.86 92.59 3.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.543 -0.975 . . . . 0.0 110.036 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.459 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 72.3 m-85 -105.68 132.84 51.32 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.405 -0.809 . . . . 46.07 109.247 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -115.05 119.62 37.07 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.43 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -115.93 129.31 56.34 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.533 -0.729 . . . . 38.880000000000003 109.492 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.84 131.18 57.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.139 -0.976 . . . . 34.060000000000002 108.982 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 86' ' ' SER . 54.8 p90 -126.99 146.99 50.14 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.293 -0.963 . . . . 29.030000000000001 111.021 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.3 m -100.34 140.18 34.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.646 -0.659 . . . . 0.0 109.378 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.439 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 42.1 mm -104.39 132.01 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 121.734 0.778 . . . . 0.0 111.562 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -123.23 97.4 5.4 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.454 0.645 . . . . 40.240000000000002 109.664 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 75.7 mt -91.68 117.33 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.777 -0.577 . . . . 20.73 110.504 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -117.54 136.01 53.56 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.548 -0.72 . . . . 0.0 109.554 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -91.72 117.43 29.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.73 -0.606 . . . . 21.34 110.715 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.13 9.51 17.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.451 -0.78 . . . . 0.0 110.679 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.61 -178.22 51.25 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.136 -1.586 . . . . 29.100000000000001 109.136 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.05 -31.81 13.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.427 -1.043 . . . . 0.0 110.057 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.415 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 85.7 t -104.79 141.16 21.96 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.415 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 39.9 Cg_endo -53.98 147.17 43.98 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 O-C-N 123.74 1.39 . . . . 21.949999999999999 111.541 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.41 150.94 48.02 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.776 0.798 . . . . 20.91 111.203 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.429 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 3.0 ttt180 -126.46 154.76 43.26 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.9 tt -98.19 118.17 34.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.444 -0.785 . . . . 0.0 109.755 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.5 t -101.53 -26.73 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.715 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.45 162.83 34.54 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.146 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -142.93 139.4 30.71 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.34 0.59 . . . . 29.050000000000001 110.159 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -143.12 114.1 7.7 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.4 0.619 . . . . 27.969999999999999 109.815 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.42 ' CH2' HD12 ' A' ' 115' ' ' ILE . 88.0 m95 -102.49 134.47 45.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.669 -0.644 . . . . 25.25 110.881 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -115.75 78.76 1.21 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.522 -0.736 . . . . 0.0 109.092 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 54' ' ' ILE . 13.1 pt -83.45 128.63 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.515 -0.741 . . . . 36.109999999999999 111.741 -178.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.6 m -120.03 131.08 55.0 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.469 -0.937 . . . . 33.979999999999997 108.469 178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -88.54 170.01 11.24 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.619 0.723 . . . . 45.039999999999999 111.205 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.4 -6.93 12.08 Favored Glycine 0 N--CA 1.496 2.661 0 O-C-N 121.831 -0.543 . . . . 39.469999999999999 112.188 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.35 7.69 42.63 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 119.322 1.561 . . . . 0.0 110.576 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.59 -31.31 6.56 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -62.09 142.72 57.42 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.202 -1.175 . . . . 62.780000000000001 109.778 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.6 t -135.82 153.3 51.55 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.531 -0.731 . . . . 0.0 110.613 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -121.68 122.95 40.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.635 -0.665 . . . . 0.0 110.02 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -100.55 135.06 42.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.699 -0.625 . . . . 0.0 110.547 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.2 t -128.12 130.59 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.613 0.72 . . . . 37.939999999999998 110.065 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -126.44 127.09 44.86 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.801 -0.562 . . . . 0.0 110.147 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -150.5 154.85 25.88 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.494 -1.442 . . . . 31.82 109.494 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -78.16 154.74 30.92 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.51 -0.994 . . . . 0.0 110.367 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.46 -168.38 0.21 Allowed Glycine 0 N--CA 1.498 2.787 0 O-C-N 121.412 -0.805 . . . . 22.620000000000001 111.598 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.0 m -129.86 129.2 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.864 -0.786 . . . . 17.510000000000002 109.72 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.417 HG23 ' HG2' ' A' ' 72' ' ' GLU . 11.3 m 41.13 36.77 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 CA-C-O 121.44 0.638 . . . . 20.550000000000001 111.86 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.08 16.47 69.59 Favored Glycine 0 N--CA 1.499 2.893 0 O-C-N 121.645 -0.659 . . . . 18.289999999999999 112.833 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.417 ' HG2' HG23 ' A' ' 70' ' ' VAL . 10.6 pt-20 -145.98 151.72 38.25 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-N 119.145 1.472 . . . . 0.0 112.014 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -114.9 75.7 3.98 Favored Pre-proline 0 N--CA 1.492 1.625 0 N-CA-C 109.006 -0.739 . . . . 18.210000000000001 109.006 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -57.66 139.81 91.46 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 O-C-N 123.769 1.405 . . . . 17.609999999999999 111.951 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.429 ' CD1' ' HB2' ' A' ' 46' ' ' ARG . 2.3 t90 -103.36 76.53 1.44 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 tp -59.97 117.83 5.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.648 -0.658 . . . . 20.57 111.51 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -86.46 157.99 55.1 Favored Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -53.79 127.57 26.07 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 O-C-N 123.56 1.295 . . . . 27.039999999999999 111.054 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.88 -19.08 39.87 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.761 -0.936 . . . . 24.739999999999998 110.761 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 71.3 tt0 -88.87 166.48 13.95 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.1 -1.235 . . . . 29.379999999999999 110.162 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.28 150.62 36.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.49 -0.756 . . . . 0.0 110.464 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -117.71 147.84 42.57 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.044 -0.725 . . . . 18.559999999999999 109.044 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -144.29 140.19 29.03 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.109 -0.994 . . . . 0.0 111.338 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.439 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 47.9 p90 -150.78 160.28 43.97 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.653 -0.655 . . . . 26.649999999999999 109.577 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.7 m -102.63 137.67 40.55 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.424 -0.798 . . . . 28.140000000000001 110.949 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.426 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 15.0 t -124.11 167.06 14.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.595 -0.69 . . . . 33.880000000000003 109.957 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -139.83 128.65 3.99 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.882 -1.151 . . . . 31.800000000000001 110.503 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.5 m -134.19 154.27 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.651 -0.911 . . . . 0.0 110.009 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 mp -109.83 144.69 37.93 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.566 -0.709 . . . . 0.0 110.95 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.6 tp -121.43 146.55 46.78 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.656 -0.653 . . . . 38.68 109.762 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -83.9 -27.46 28.6 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.321 -0.862 . . . . 0.0 111.053 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.9 p -123.44 171.26 9.6 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.341 -0.849 . . . . 31.629999999999999 110.774 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.453 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 96.6 mt-10 -86.48 11.64 12.12 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.646 -0.659 . . . . 0.0 111.609 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -144.05 143.13 31.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.044 -1.035 . . . . 0.0 109.893 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.7 160.37 25.18 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 118.615 -1.755 . . . . 28.050000000000001 112.537 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -118.91 129.79 55.37 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.425 ' HB3' ' CE1' ' A' ' 118' ' ' PHE . 15.5 ttt -128.69 122.86 31.7 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.306 -0.871 . . . . 0.0 111.641 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -120.27 150.79 40.14 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -151.62 172.21 31.07 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 118.677 -1.725 . . . . 29.620000000000001 111.325 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.428 ' CE1' ' HB3' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -138.95 154.3 48.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.761 -0.847 . . . . 0.0 109.373 179.121 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.454 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 10.3 m-85 -118.98 126.09 50.94 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.404 -0.81 . . . . 27.050000000000001 110.244 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -86.31 120.25 27.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.899 -1.125 . . . . 0.0 108.777 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.43 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 86.8 mmm -121.87 163.04 19.9 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.228 0.537 . . . . 0.0 110.537 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 m -142.17 128.7 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.693 -0.629 . . . . 23.280000000000001 110.421 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.5 166.36 22.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.358 -0.838 . . . . 0.0 109.378 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -63.95 -27.73 69.34 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.324 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -76.41 -10.31 59.3 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.444 -0.785 . . . . 0.0 111.181 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.9 -7.34 48.85 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.45 -1.06 . . . . 30.43 110.45 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.3 m -58.32 135.76 57.23 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.052 -1.263 . . . . 0.0 109.966 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -100.51 139.03 36.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.434 -0.791 . . . . 0.0 110.783 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.43 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 37.8 p90 -161.2 141.46 10.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.702 -0.624 . . . . 28.030000000000001 109.889 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.409 ' HB ' ' CD2' ' A' ' 100' ' ' HIS . 29.9 pt -99.88 156.17 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.661 -0.649 . . . . 0.0 110.923 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -121.69 98.77 45.41 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.648 -0.658 . . . . 0.0 109.391 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.428 ' HB3' ' CE1' ' A' ' 100' ' ' HIS . 46.3 Cg_endo -59.03 144.0 99.56 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 O-C-N 123.901 1.474 . . . . 33.310000000000002 112.154 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.454 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 64.1 mt -108.8 121.71 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.426 -0.953 . . . . 30.59 108.426 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.3 159.13 0.22 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.176 0.512 . . . . 30.780000000000001 111.533 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -91.12 124.3 35.24 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.738 -0.601 . . . . 0.0 110.874 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.425 ' CE1' ' HB3' ' A' ' 97' ' ' MET . 38.5 p90 -113.64 158.35 20.95 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.347 -0.982 . . . . 30.66 108.347 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.1 t -116.15 154.89 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.27 -0.894 . . . . 0.0 110.387 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.455 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.9 mp -114.64 130.51 56.81 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.229 -0.656 . . . . 39.149999999999999 109.229 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.744 -0.598 . . . . 0.0 110.069 -179.652 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 120.762 0.315 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.418 ' CE2' HG23 ' A' ' 109' ' ' THR . 49.9 m-85 -118.51 108.42 14.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.433 -0.792 . . . . 31.93 110.209 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 66.9 mtt85 -150.15 134.95 17.62 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.57 0.7 . . . . 0.0 110.12 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 63.3 t -150.21 116.01 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.507 0.67 . . . . 0.0 109.365 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -107.25 130.69 54.71 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.592 0.711 . . . . 0.0 110.279 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.7 t -118.89 137.02 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.809 -0.557 . . . . 28.210000000000001 109.501 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -123.85 137.7 54.61 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.404 -0.81 . . . . 0.0 109.94 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.2 t -128.97 137.02 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.484 0.659 . . . . 27.949999999999999 110.583 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -124.59 105.19 30.47 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.754 -0.591 . . . . 0.0 110.116 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 50.7 Cg_endo -82.58 163.39 16.62 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 O-C-N 123.869 1.457 . . . . 33.0 111.323 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -156.98 130.77 8.22 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.613 0.721 . . . . 54.100000000000001 109.602 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -61.55 138.48 58.29 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.344 0.592 . . . . 0.0 111.444 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.9 tp -114.96 82.65 1.77 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.961 0.886 . . . . 0.0 110.014 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.19 -36.17 83.38 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.575 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -68.89 -22.39 64.18 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.355 -0.84 . . . . 0.0 110.871 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -119.54 23.55 11.13 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.345 -0.847 . . . . 52.369999999999997 110.702 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.1 m -136.11 137.95 41.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.301 -0.875 . . . . 55.189999999999998 111.16 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.2 m -119.19 90.44 41.8 Favored Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.424 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 48.3 Cg_endo -63.74 -26.83 68.14 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 O-C-N 123.933 1.491 . . . . 51.57 111.686 -178.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -69.04 -22.83 64.02 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.327 -0.858 . . . . 0.0 110.829 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -107.11 19.27 20.64 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.295 -0.878 . . . . 0.0 110.998 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.18 30.37 73.73 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -119.61 94.37 4.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.667 -0.902 . . . . 0.0 110.247 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.426 ' CE2' ' HB2' ' A' ' 93' ' ' GLU . 79.0 m-85 -106.51 129.01 54.54 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.391 -0.818 . . . . 46.07 109.386 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -119.42 120.07 35.76 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.31 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.404 ' CD1' HD13 ' A' ' 90' ' ' LEU . 61.9 m-85 -115.79 136.84 52.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.644 -0.66 . . . . 38.880000000000003 109.597 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.27 131.82 54.85 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.727 -0.842 . . . . 34.060000000000002 108.727 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 86' ' ' SER . 26.4 p90 -126.54 143.37 51.23 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.212 -0.995 . . . . 29.030000000000001 111.303 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 t -102.81 139.12 38.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.682 -0.636 . . . . 0.0 109.286 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.443 ' CD1' ' CE2' ' A' ' 84' ' ' TYR . 5.2 mp -104.78 132.04 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.81 0.814 . . . . 0.0 111.247 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.6 mtm180 -122.08 97.35 5.44 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.467 0.651 . . . . 40.240000000000002 109.63 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 80.2 mt -94.2 116.47 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.765 -0.584 . . . . 20.73 110.507 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -117.46 138.68 51.7 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.486 -0.759 . . . . 0.0 109.455 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -91.61 118.12 30.33 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.67 -0.644 . . . . 21.34 110.851 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.1 9.04 14.63 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.428 -0.795 . . . . 0.0 110.479 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.23 176.63 52.95 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.544 -1.423 . . . . 29.100000000000001 109.544 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.12 -35.71 17.3 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.585 -0.95 . . . . 0.0 110.271 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.411 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 86.9 t -102.96 140.31 20.93 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.802 -0.561 . . . . 0.0 110.033 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.411 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 39.5 Cg_endo -52.87 144.14 45.73 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 O-C-N 123.775 1.408 . . . . 21.949999999999999 111.68 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.09 151.4 46.69 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.659 0.742 . . . . 20.91 111.092 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.42 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 1.1 ptt85 -127.73 159.79 33.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.697 -0.627 . . . . 0.0 109.715 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.8 tt -98.04 116.4 30.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.463 -0.773 . . . . 0.0 109.583 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.6 t -98.43 -28.21 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.541 -0.724 . . . . 0.0 110.515 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.62 162.38 35.63 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.439 -0.905 . . . . 0.0 111.758 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.0 ptt85 -142.89 141.56 31.55 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.579 0.704 . . . . 29.050000000000001 110.298 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -144.23 114.86 7.67 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.288 0.566 . . . . 27.969999999999999 109.581 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -95.9 133.68 39.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.646 -0.659 . . . . 25.25 111.037 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -115.84 78.49 1.19 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.415 ' O ' HG13 ' A' ' 54' ' ' ILE . 13.3 pt -86.29 129.24 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-O 121.748 0.785 . . . . 36.109999999999999 111.758 -178.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.6 m -120.19 129.98 54.35 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.097 -1.075 . . . . 33.979999999999997 108.097 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -91.04 170.32 10.14 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.771 0.796 . . . . 45.039999999999999 111.504 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.62 -6.62 11.97 Favored Glycine 0 N--CA 1.494 2.555 0 O-C-N 121.8 -0.562 . . . . 39.469999999999999 112.122 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -101.73 5.56 41.38 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 119.429 1.614 . . . . 0.0 110.62 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.77 -28.5 9.2 Favored Glycine 0 N--CA 1.495 2.613 0 O-C-N 121.25 -0.906 . . . . 0.0 110.894 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.6 142.44 58.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.191 -1.182 . . . . 62.780000000000001 109.621 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 71.5 p -132.23 149.99 52.26 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.455 -0.778 . . . . 0.0 110.67 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -122.4 122.12 38.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.47 -0.769 . . . . 0.0 109.962 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -105.44 136.39 45.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.579 -0.701 . . . . 0.0 110.984 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.6 t -129.23 131.35 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.546 -0.722 . . . . 37.939999999999998 109.818 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.29 127.45 47.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.711 -0.618 . . . . 0.0 110.429 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.24 149.23 21.17 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.412 -1.475 . . . . 31.82 109.412 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -74.42 155.68 37.81 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.448 -1.031 . . . . 0.0 110.274 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 50.4 -171.94 0.14 Allowed Glycine 0 N--CA 1.498 2.817 0 O-C-N 121.336 -0.853 . . . . 22.620000000000001 111.253 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.8 m -129.41 128.11 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.78 -0.835 . . . . 17.510000000000002 109.57 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.413 HG23 ' HG2' ' A' ' 72' ' ' GLU . 12.0 m 41.17 36.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 CA-C-O 121.603 0.716 . . . . 20.550000000000001 111.796 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.25 16.25 69.75 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 121.627 -0.67 . . . . 18.289999999999999 112.93 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.413 ' HG2' HG23 ' A' ' 70' ' ' VAL . 10.0 pt-20 -145.79 150.76 36.8 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 119.163 1.481 . . . . 0.0 112.028 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -114.97 74.15 3.43 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.895 -0.78 . . . . 18.210000000000001 108.895 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -57.25 140.51 93.11 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 O-C-N 123.793 1.417 . . . . 17.609999999999999 112.225 -178.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.42 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 5.9 t90 -102.11 77.17 1.65 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 tp -59.66 117.3 4.77 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.553 -0.717 . . . . 20.57 111.621 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -86.35 156.86 56.66 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -52.76 126.72 22.02 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 O-C-N 123.678 1.357 . . . . 27.039999999999999 110.931 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.6 -17.44 49.25 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.701 -0.96 . . . . 24.739999999999998 110.701 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -88.16 165.5 15.05 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.053 -1.263 . . . . 29.379999999999999 110.196 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -147.81 152.8 38.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.513 -0.742 . . . . 0.0 110.372 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.4 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 66.9 t80 -119.34 147.89 43.81 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.93 -0.767 . . . . 18.559999999999999 108.93 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.5 m80 -138.95 138.31 37.21 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.094 -1.004 . . . . 0.0 110.824 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.443 ' CE2' ' CD1' ' A' ' 35' ' ' ILE . 50.5 p90 -151.0 159.72 44.39 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.527 -0.733 . . . . 26.649999999999999 109.993 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.1 m -104.36 137.61 41.99 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.444 -0.785 . . . . 28.140000000000001 110.811 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 14.6 t -125.14 166.86 15.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.578 -0.701 . . . . 33.880000000000003 110.091 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.43 127.24 4.07 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.886 -1.15 . . . . 31.800000000000001 110.413 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 79.4 t -131.51 148.43 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.577 -0.955 . . . . 0.0 109.375 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.9 tp -110.13 143.54 40.06 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.561 -0.712 . . . . 0.0 110.275 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.404 HD13 ' CD1' ' A' ' 31' ' ' PHE . 84.5 mt -122.97 148.38 45.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.474 -0.766 . . . . 38.68 110.358 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -76.21 -26.41 56.09 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.376 -0.828 . . . . 0.0 110.63 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.4 m -122.55 171.27 9.24 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.453 -0.78 . . . . 31.629999999999999 110.545 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.426 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 58.0 tt0 -85.87 8.15 21.3 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.678 -0.639 . . . . 0.0 111.754 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -140.71 150.11 43.03 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.059 -1.026 . . . . 0.0 110.064 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.06 164.46 29.14 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 118.867 -1.635 . . . . 28.050000000000001 112.097 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -121.89 131.69 54.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 122.067 -0.667 . . . . 0.0 109.545 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 118' ' ' PHE . 27.1 ttt -127.27 121.05 30.09 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.256 -0.902 . . . . 0.0 111.424 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -128.66 147.75 50.76 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.84 -179.86 35.86 Favored Glycine 0 N--CA 1.5 2.945 0 C-N-CA 119.072 -1.537 . . . . 29.620000000000001 110.72 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -140.84 157.97 44.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.697 -0.884 . . . . 0.0 110.75 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.451 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 6.9 m-85 -116.72 129.28 56.03 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.606 -0.684 . . . . 27.050000000000001 110.193 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -83.9 122.98 29.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.959 -1.088 . . . . 0.0 109.149 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.422 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 24.1 mtp -124.23 162.75 23.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.9 -0.5 . . . . 0.0 110.572 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.6 m -140.45 130.24 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.69 -0.631 . . . . 23.280000000000001 110.208 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.9 166.61 22.66 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.407 -0.808 . . . . 0.0 109.473 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -63.93 -29.97 71.09 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.127 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -74.19 -10.34 59.51 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.524 -0.735 . . . . 0.0 111.129 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.14 -7.43 47.99 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 120.072 -1.061 . . . . 30.43 110.454 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.418 HG23 ' CE2' ' A' ' 7' ' ' TYR . 65.8 m -57.45 136.05 56.63 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.108 -1.231 . . . . 0.0 109.988 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -101.92 140.85 35.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.334 -0.854 . . . . 0.0 110.955 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.422 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 46.5 p90 -167.45 147.03 5.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.678 -0.639 . . . . 28.030000000000001 110.06 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.2 pt -102.43 157.53 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.685 -0.634 . . . . 0.0 110.846 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.77 98.33 49.65 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -59.25 142.19 98.84 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 O-C-N 123.935 1.492 . . . . 33.310000000000002 112.236 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.451 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 67.3 mt -106.83 123.3 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.52 -0.918 . . . . 30.59 108.52 178.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.18 144.09 7.56 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.243 0.544 . . . . 30.780000000000001 111.365 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -88.53 121.22 30.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.659 -0.651 . . . . 0.0 110.103 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.428 ' CD1' ' HG3' ' A' ' 15' ' ' PRO . 36.3 p90 -107.5 165.14 11.62 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.037 -0.727 . . . . 30.66 109.037 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.94 155.63 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.377 -0.827 . . . . 0.0 110.274 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.452 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.2 mp -114.06 132.49 56.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.709 -0.619 . . . . 39.149999999999999 109.6 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.657 -0.652 . . . . 0.0 110.138 -179.796 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.034 0.445 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -112.68 79.57 1.24 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.702 -0.624 . . . . 31.93 109.9 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 45.9 mtm180 -138.29 142.87 39.79 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.966 0.889 . . . . 0.0 110.333 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.5 t -150.56 115.75 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.537 0.684 . . . . 0.0 109.215 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -106.02 129.61 54.1 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.557 0.694 . . . . 0.0 109.779 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.5 t -116.93 138.87 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.92 -0.487 . . . . 28.210000000000001 109.694 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -121.02 136.6 54.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.466 -0.771 . . . . 0.0 109.798 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.1 t -128.42 136.38 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.669 -0.644 . . . . 27.949999999999999 110.173 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.9 m -124.81 105.05 29.9 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.617 -0.677 . . . . 0.0 110.509 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -82.22 165.06 17.0 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 O-C-N 123.893 1.47 . . . . 33.0 110.768 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -158.01 130.67 7.27 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.587 0.708 . . . . 54.100000000000001 109.844 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -61.16 138.21 58.22 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.761 -0.587 . . . . 0.0 111.327 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.1 mt -116.62 80.94 1.54 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.086 0.946 . . . . 0.0 110.333 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.37 -35.67 79.82 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.136 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -68.8 -23.25 64.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.275 -0.891 . . . . 0.0 110.818 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -121.96 46.87 2.0 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.36 -0.838 . . . . 52.369999999999997 110.64 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.3 p -167.46 148.74 5.57 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.236 -0.915 . . . . 55.189999999999998 111.112 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.8 t -122.02 93.27 48.67 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.439 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.0 Cg_endo -67.26 -22.81 45.86 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 O-C-N 123.673 1.354 . . . . 51.57 111.949 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -65.15 -23.27 67.07 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.283 -0.886 . . . . 0.0 110.961 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -106.14 24.45 12.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.285 -0.884 . . . . 0.0 110.709 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.84 28.91 73.39 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -120.87 93.81 4.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.641 -0.917 . . . . 0.0 110.178 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 67.8 m-85 -104.26 133.95 48.31 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.533 -0.729 . . . . 46.07 109.126 179.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.28 120.93 42.08 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.107 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -116.12 134.02 55.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.694 -0.629 . . . . 38.880000000000003 109.788 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.43 132.04 55.25 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.463 -0.939 . . . . 34.060000000000002 108.463 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.451 ' CZ ' ' CB ' ' A' ' 86' ' ' SER . 38.2 p90 -127.67 144.39 51.08 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.073 -1.051 . . . . 29.030000000000001 111.708 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.6 t -104.82 139.98 38.79 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.442 ' CG2' ' CE1' ' A' ' 84' ' ' TYR . 41.4 mm -105.77 132.63 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.77 0.795 . . . . 0.0 111.725 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.3 mtp180 -124.04 97.02 5.16 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.49 0.662 . . . . 40.240000000000002 109.799 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.416 ' CG2' ' CD1' ' A' ' 76' ' ' LEU . 74.1 mt -92.78 116.92 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.706 -0.621 . . . . 20.73 110.433 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -119.77 144.69 47.15 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.455 -0.778 . . . . 0.0 109.919 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.06 113.84 22.46 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.514 -0.741 . . . . 21.34 109.47 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.32 -18.79 26.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.788 -0.57 . . . . 0.0 111.715 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.59 -163.93 37.2 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.305 -0.95 . . . . 29.100000000000001 110.942 -178.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -113.89 -17.02 12.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.964 -0.727 . . . . 0.0 111.013 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.411 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 95.5 t -103.31 135.59 19.36 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.316 -0.865 . . . . 0.0 109.566 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.434 ' CB ' ' CH2' ' A' ' 75' ' ' TRP . 41.2 Cg_endo -48.84 140.54 23.09 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 O-C-N 123.757 1.399 . . . . 21.949999999999999 112.219 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -134.23 149.52 50.98 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.703 0.764 . . . . 20.91 110.873 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.421 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 43.2 ttt180 -125.91 151.45 46.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.832 -0.542 . . . . 0.0 109.547 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.2 tt -98.68 117.21 32.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.464 -0.773 . . . . 0.0 109.973 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.4 t -100.98 -30.49 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.6 -0.687 . . . . 0.0 110.649 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.4 162.54 35.25 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.08 -1.048 . . . . 0.0 112.334 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -143.25 140.98 30.91 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.482 0.658 . . . . 29.050000000000001 110.201 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.417 ' HB3' ' CE1' ' A' ' 100' ' ' HIS . 21.7 t-160 -145.86 114.69 6.9 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.353 0.597 . . . . 27.969999999999999 109.987 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.421 ' CE3' ' HA3' ' A' ' 99' ' ' GLY . 63.2 m95 -100.21 135.97 40.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.579 -0.701 . . . . 25.25 111.42 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -117.06 79.17 1.3 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.711 -0.618 . . . . 0.0 109.417 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 54' ' ' ILE . 28.2 pt -83.31 130.27 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.375 -0.828 . . . . 36.109999999999999 112.208 -178.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.3 m -119.48 130.05 55.03 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.209 -1.034 . . . . 33.979999999999997 108.209 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -91.39 170.03 10.31 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.657 0.741 . . . . 45.039999999999999 111.352 -178.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.81 -6.72 12.85 Favored Glycine 0 N--CA 1.495 2.609 0 O-C-N 121.866 -0.521 . . . . 39.469999999999999 112.086 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -102.05 5.83 40.74 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 119.367 1.584 . . . . 0.0 110.6 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.27 -28.47 9.71 Favored Glycine 0 N--CA 1.495 2.596 0 C-N-CA 120.352 -0.927 . . . . 0.0 110.859 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.1 141.4 58.15 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.277 -1.131 . . . . 62.780000000000001 109.77 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 66.4 p -132.38 150.05 52.23 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.438 -0.788 . . . . 0.0 110.488 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -122.32 122.29 38.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.566 -0.709 . . . . 0.0 109.903 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -103.28 134.66 46.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.696 -0.627 . . . . 0.0 110.59 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.3 t -128.04 130.07 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.558 0.694 . . . . 37.939999999999998 109.942 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -124.24 126.82 46.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.822 -0.549 . . . . 0.0 110.111 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.96 149.6 21.62 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.35 -1.5 . . . . 31.82 109.35 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -76.72 154.72 33.86 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.492 -1.004 . . . . 0.0 110.078 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.77 -169.48 0.19 Allowed Glycine 0 N--CA 1.498 2.808 0 O-C-N 121.378 -0.826 . . . . 22.620000000000001 111.337 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.9 m -131.05 129.24 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.834 -0.803 . . . . 17.510000000000002 109.648 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.429 HG21 ' HG2' ' A' ' 72' ' ' GLU . 11.1 m 40.95 35.22 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.456 0 CA-C-O 121.445 0.64 . . . . 20.550000000000001 111.918 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.06 17.13 67.95 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 121.676 -0.64 . . . . 18.289999999999999 112.85 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.429 ' HG2' HG21 ' A' ' 70' ' ' VAL . 11.9 pt-20 -144.97 150.33 36.75 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 119.131 1.466 . . . . 0.0 111.902 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -116.3 75.57 6.37 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 109.019 -0.734 . . . . 18.210000000000001 109.019 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -58.1 142.17 96.83 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 O-C-N 123.956 1.503 . . . . 17.609999999999999 112.411 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.434 ' CH2' ' CB ' ' A' ' 44' ' ' PRO . 5.0 t90 -103.88 75.54 1.3 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.416 ' CD1' ' CG2' ' A' ' 37' ' ' ILE . 9.7 mt -60.82 121.34 12.08 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.563 -0.711 . . . . 20.57 112.35 -178.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -87.44 158.44 51.72 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -54.22 129.21 33.32 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 O-C-N 123.529 1.279 . . . . 27.039999999999999 111.309 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.92 -16.75 49.8 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 120.481 -0.866 . . . . 24.739999999999998 111.023 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -87.96 166.07 14.77 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.973 -1.31 . . . . 29.379999999999999 110.393 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.33 149.56 35.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.516 -0.74 . . . . 0.0 110.283 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.404 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 65.1 t80 -118.99 147.79 43.7 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.846 -0.798 . . . . 18.559999999999999 108.846 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -143.95 140.19 29.53 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.13 -0.981 . . . . 0.0 111.552 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.442 ' CE1' ' CG2' ' A' ' 35' ' ' ILE . 52.1 p90 -150.45 159.97 44.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.707 -0.621 . . . . 26.649999999999999 109.526 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.5 m -104.83 138.78 40.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.283 -0.885 . . . . 28.140000000000001 111.353 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.451 ' CB ' ' CZ ' ' A' ' 33' ' ' TYR . 25.2 t -123.95 166.18 16.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.714 -0.616 . . . . 33.880000000000003 109.762 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -143.06 118.89 1.28 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.202 -1.159 . . . . 31.800000000000001 110.202 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 68.2 t -132.57 149.42 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.66 -0.906 . . . . 0.0 109.763 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 pp -107.34 142.36 37.25 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.505 -0.747 . . . . 0.0 110.205 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.0 mt -124.57 143.3 50.77 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.486 -0.759 . . . . 38.68 110.502 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.56 -19.26 38.88 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.281 -0.887 . . . . 0.0 110.232 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 m -101.67 133.17 46.79 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.443 -0.786 . . . . 31.629999999999999 109.978 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.421 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 67.9 tt0 -75.7 -4.89 42.85 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.119 -0.988 . . . . 0.0 110.623 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -138.68 143.31 39.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.207 -0.933 . . . . 0.0 108.803 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -178.05 167.35 38.04 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 118.303 -1.903 . . . . 28.050000000000001 112.639 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -117.71 130.63 56.45 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 122.192 -0.593 . . . . 0.0 109.711 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 98.1 mtp -127.11 121.28 31.01 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.325 -0.859 . . . . 0.0 111.337 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -123.06 152.7 40.76 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.421 ' HA3' ' CE3' ' A' ' 52' ' ' TRP . . . -168.41 174.96 43.18 Favored Glycine 0 N--CA 1.499 2.879 0 C-N-CA 118.561 -1.78 . . . . 29.620000000000001 111.366 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.417 ' CE1' ' HB3' ' A' ' 51' ' ' HIS . 40.7 p-80 -142.86 156.17 44.89 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.876 -0.779 . . . . 0.0 110.078 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.418 ' CD2' HD11 ' A' ' 115' ' ' ILE . 4.8 m-85 -116.82 127.81 54.67 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.503 -0.748 . . . . 27.050000000000001 109.796 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -78.88 123.17 26.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.914 -1.116 . . . . 0.0 109.298 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.428 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 92.3 mmm -119.69 163.07 17.96 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.174 0.512 . . . . 0.0 110.062 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.6 m -142.42 129.16 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.588 -0.695 . . . . 23.280000000000001 110.453 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.73 166.03 23.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.492 -0.755 . . . . 0.0 109.408 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -64.36 -28.39 69.67 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.383 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 47.0 p-10 -76.29 -4.44 42.04 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.467 -0.77 . . . . 0.0 111.505 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.7 -9.91 60.57 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.056 -1.069 . . . . 30.43 110.915 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 89.7 m -57.5 135.08 56.59 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.03 -1.276 . . . . 0.0 109.985 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -101.36 140.8 35.15 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.335 -0.853 . . . . 0.0 110.877 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.428 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 44.0 p90 -165.9 144.87 6.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.712 -0.618 . . . . 28.030000000000001 109.603 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 84.8 mt -99.15 157.41 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.699 -0.626 . . . . 0.0 110.712 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.82 96.07 49.39 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -60.1 144.88 99.45 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 O-C-N 123.946 1.498 . . . . 33.310000000000002 112.376 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.418 HD11 ' CD2' ' A' ' 101' ' ' TYR . 68.8 mt -111.56 123.32 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.749 -0.834 . . . . 30.59 108.749 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -47.87 170.56 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.246 0.545 . . . . 30.780000000000001 111.636 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -99.41 123.14 43.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.699 -0.626 . . . . 0.0 110.766 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 97' ' ' MET . 48.4 p90 -111.36 156.83 20.97 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.262 -1.014 . . . . 30.66 108.262 178.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.9 p -115.65 155.31 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.245 -0.909 . . . . 0.0 110.602 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.8 mp -112.81 132.34 55.3 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.286 -0.635 . . . . 39.149999999999999 109.286 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.735 -0.603 . . . . 0.0 110.114 -179.722 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.3 ttm-85 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.011 0.434 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -122.47 84.59 2.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.77 -0.581 . . . . 31.93 110.348 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.404 ' HG2' ' HA2' ' A' ' 41' ' ' GLY . 11.9 ptp180 -148.3 144.26 27.47 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.133 0.968 . . . . 0.0 110.737 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.3 t -151.02 120.61 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -108.07 134.18 51.32 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.615 0.721 . . . . 0.0 110.127 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.5 t -119.28 138.55 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.915 -0.491 . . . . 28.210000000000001 109.921 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -122.92 139.71 53.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.502 -0.749 . . . . 0.0 109.422 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.3 t -128.56 140.25 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.645 -0.659 . . . . 27.949999999999999 110.717 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.6 t -122.83 104.04 36.52 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.844 -0.535 . . . . 0.0 109.963 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.423 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 50.0 Cg_endo -82.74 165.79 15.53 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 O-C-N 123.901 1.474 . . . . 33.0 111.26 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 -157.61 132.8 8.86 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.511 0.672 . . . . 54.100000000000001 109.557 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -60.0 137.77 58.01 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.287 0.565 . . . . 0.0 111.206 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.6 tp -114.95 78.71 1.19 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.979 0.895 . . . . 0.0 110.211 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.89 -35.32 72.27 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.567 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -68.14 -25.18 65.16 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.339 -0.851 . . . . 0.0 111.02 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -119.38 33.7 5.53 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.375 -0.828 . . . . 52.369999999999997 110.38 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -152.39 143.91 23.43 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.537 -0.727 . . . . 55.189999999999998 110.705 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.0 t -121.05 95.56 48.79 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.449 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 49.5 Cg_endo -66.46 -23.17 50.92 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 O-C-N 123.79 1.416 . . . . 51.57 112.106 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -65.13 -24.15 67.33 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.295 -0.878 . . . . 0.0 110.995 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -105.4 21.8 16.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.197 -0.939 . . . . 0.0 110.944 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.89 30.3 70.35 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -121.14 93.13 3.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.619 -0.93 . . . . 0.0 109.943 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.458 ' CE2' ' CG ' ' A' ' 93' ' ' GLU . 54.8 m-85 -105.56 130.77 53.54 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.955 -0.757 . . . . 46.07 108.955 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -117.98 119.62 35.36 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.635 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.415 ' CD1' HD12 ' A' ' 90' ' ' LEU . 79.2 m-85 -114.59 131.39 56.7 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.134 -0.691 . . . . 38.880000000000003 109.134 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.69 131.01 56.32 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.142 -0.974 . . . . 34.060000000000002 109.021 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.422 ' CE1' ' HB3' ' A' ' 86' ' ' SER . 52.3 p90 -128.51 147.46 50.69 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.237 -0.985 . . . . 29.030000000000001 111.161 -179.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.7 m -101.07 139.44 36.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.697 -0.627 . . . . 0.0 109.691 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.44 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 47.4 mm -103.22 132.74 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.661 0.743 . . . . 0.0 111.317 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 62.7 mtt85 -126.0 97.77 5.24 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.577 0.703 . . . . 40.240000000000002 110.182 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.405 ' CG2' ' CD1' ' A' ' 76' ' ' LEU . 81.7 mt -93.5 118.05 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.882 -0.511 . . . . 20.73 110.656 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -117.0 135.73 53.47 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.428 -0.795 . . . . 0.0 109.507 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -90.69 118.73 30.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.879 -0.513 . . . . 21.34 110.833 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.56 8.91 17.85 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.558 -0.714 . . . . 0.0 110.706 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.404 ' HA2' ' HG2' ' A' ' 8' ' ' ARG . . . -82.94 178.68 53.13 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.216 -1.554 . . . . 29.100000000000001 109.216 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.62 -30.45 14.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.446 -1.032 . . . . 0.0 110.198 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.415 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 86.7 t -103.82 139.89 20.54 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.855 -0.528 . . . . 0.0 109.764 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.421 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . 39.9 Cg_endo -52.75 142.69 50.28 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 O-C-N 123.818 1.43 . . . . 21.949999999999999 111.827 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.4 151.44 46.3 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.53 0.681 . . . . 20.91 110.926 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.412 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 19.3 ptt-85 -127.76 159.14 35.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.721 -0.612 . . . . 0.0 109.893 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.6 tt -97.75 116.22 29.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.449 -0.782 . . . . 0.0 109.737 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.08 -27.54 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.517 -0.739 . . . . 0.0 110.497 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.46 163.61 32.36 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.822 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -143.18 140.65 30.85 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.306 0.574 . . . . 29.050000000000001 110.226 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -145.1 113.46 6.61 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.433 0.635 . . . . 27.969999999999999 110.15 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -101.1 136.66 40.59 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.635 -0.666 . . . . 25.25 110.996 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -116.8 78.52 1.22 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.717 -0.614 . . . . 0.0 109.751 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.403 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.0 pt -86.42 131.89 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.361 -0.837 . . . . 36.109999999999999 111.963 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.3 m -118.76 132.51 56.14 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.549 -0.908 . . . . 33.979999999999997 108.549 178.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -87.91 169.81 11.69 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.556 0.694 . . . . 45.039999999999999 111.244 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.48 -8.67 20.77 Favored Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.81 -0.556 . . . . 39.469999999999999 112.016 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -101.98 8.29 41.07 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 119.301 1.551 . . . . 0.0 110.797 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.78 -25.61 18.36 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 121.264 -0.898 . . . . 0.0 110.966 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.3 mpp_? -62.0 141.71 57.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.219 -1.165 . . . . 62.780000000000001 109.619 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.7 p -129.3 147.83 51.17 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.614 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -122.1 120.49 34.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.549 -0.72 . . . . 0.0 109.809 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -103.92 136.13 44.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.66 -0.65 . . . . 0.0 110.668 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.5 t -128.12 131.11 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.454 0.645 . . . . 37.939999999999998 109.781 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.99 127.85 47.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.827 -0.546 . . . . 0.0 110.472 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -153.0 170.18 31.99 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.165 -1.574 . . . . 31.82 109.165 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -111.13 160.32 17.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.411 -1.052 . . . . 0.0 109.896 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.77 93.81 0.01 OUTLIER Glycine 0 N--CA 1.5 2.919 0 O-C-N 121.284 -0.885 . . . . 22.620000000000001 111.239 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.6 m -44.54 132.53 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.528 0 O-C-N 121.431 -1.041 . . . . 17.510000000000002 111.774 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.404 HG21 ' HG2' ' A' ' 72' ' ' GLU . 11.9 m 41.77 38.45 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 CA-C-N 115.592 -0.731 . . . . 20.550000000000001 111.605 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.08 18.79 64.19 Favored Glycine 0 N--CA 1.495 2.618 0 O-C-N 121.789 -0.569 . . . . 18.289999999999999 112.521 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 82' ' ' PHE . 5.5 pt-20 -147.41 153.07 39.16 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 119.045 1.422 . . . . 0.0 112.477 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -117.39 73.31 7.58 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.555 -0.906 . . . . 18.210000000000001 108.555 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -54.88 141.39 77.75 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 O-C-N 123.715 1.376 . . . . 17.609999999999999 112.174 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.421 ' CZ3' ' HB2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -100.62 76.93 1.86 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.405 ' CD1' ' CG2' ' A' ' 37' ' ' ILE . 11.2 mt -60.68 118.18 6.28 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.618 -0.676 . . . . 20.57 111.736 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.08 157.5 56.79 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -53.17 127.6 25.74 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 O-C-N 123.491 1.258 . . . . 27.039999999999999 111.089 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.14 -16.58 55.33 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.799 -0.92 . . . . 24.739999999999998 110.799 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -86.81 165.36 16.06 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.078 -1.248 . . . . 29.379999999999999 110.489 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.14 149.62 35.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.517 -0.739 . . . . 0.0 110.015 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.407 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 64.7 t80 -119.75 148.25 43.64 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.414 -0.804 . . . . 18.559999999999999 109.141 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.8 p80 -143.46 140.23 30.27 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.125 -0.985 . . . . 0.0 111.293 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.44 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 51.7 p90 -151.52 160.38 43.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.664 -0.648 . . . . 26.649999999999999 109.618 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.2 m -102.82 137.64 40.75 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.402 -0.812 . . . . 28.140000000000001 111.058 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.422 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 17.0 t -123.99 167.28 14.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.595 -0.691 . . . . 33.880000000000003 109.886 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -143.97 124.35 2.23 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.813 -1.184 . . . . 31.800000000000001 110.572 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.5 m -131.36 154.19 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.632 -0.923 . . . . 0.0 109.939 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.6 tp -109.18 144.64 36.99 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.553 -0.717 . . . . 0.0 110.832 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.415 HD12 ' CD1' ' A' ' 31' ' ' PHE . 74.7 mt -122.14 146.34 47.32 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.597 -0.689 . . . . 38.68 110.314 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.403 ' O ' ' CE1' ' A' ' 29' ' ' TYR . 75.4 tt0 -76.2 -25.62 55.33 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.353 -0.842 . . . . 0.0 110.782 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 68.0 p -125.2 172.06 9.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.361 -0.837 . . . . 31.629999999999999 110.782 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.458 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 50.1 mt-10 -86.81 11.72 12.58 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.593 -0.692 . . . . 0.0 111.654 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -140.85 148.22 40.2 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.06 -1.025 . . . . 0.0 110.057 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.31 160.82 23.78 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 118.907 -1.616 . . . . 28.050000000000001 112.086 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -119.73 129.64 54.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 122.14 -0.624 . . . . 0.0 109.335 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 97.7 mtp -125.3 116.24 21.62 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.344 -0.848 . . . . 0.0 111.116 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -129.26 149.79 50.91 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.7 -178.49 38.72 Favored Glycine 0 N--CA 1.498 2.822 0 C-N-CA 118.916 -1.611 . . . . 29.620000000000001 110.76 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -140.54 157.96 44.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.703 -0.881 . . . . 0.0 110.752 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.436 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 6.3 m-85 -116.79 128.58 55.43 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.645 -0.66 . . . . 27.050000000000001 109.885 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -81.35 123.18 28.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.978 -1.076 . . . . 0.0 109.136 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.428 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 51.7 mtp -122.19 162.35 21.52 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.118 0.485 . . . . 0.0 110.339 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.0 m -142.91 129.73 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.613 -0.679 . . . . 23.280000000000001 110.325 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.04 167.66 20.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.513 -0.742 . . . . 0.0 109.45 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -64.29 -28.44 69.72 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.142 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -72.92 -12.26 60.89 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.567 -0.708 . . . . 0.0 111.026 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.25 -7.05 47.05 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.484 -1.046 . . . . 30.43 110.484 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 91.3 m -57.66 135.2 56.7 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.051 -1.264 . . . . 0.0 110.049 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -101.29 140.03 36.14 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.457 -0.777 . . . . 0.0 110.796 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.428 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 47.5 p90 -167.16 147.23 5.43 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.781 -0.574 . . . . 28.030000000000001 109.854 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.7 pt -102.55 158.12 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.596 -0.69 . . . . 0.0 111.087 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.63 97.59 49.91 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -59.25 143.13 99.86 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 O-C-N 123.895 1.471 . . . . 33.310000000000002 112.432 -178.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.436 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 72.2 mt -108.33 123.24 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.658 -0.867 . . . . 30.59 108.658 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.05 144.21 7.13 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.217 0.532 . . . . 30.780000000000001 111.551 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -87.37 121.03 29.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.638 -0.664 . . . . 0.0 110.242 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.423 ' CD1' ' HG3' ' A' ' 15' ' ' PRO . 41.9 p90 -109.42 165.89 11.3 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.879 -0.785 . . . . 30.66 108.879 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.1 t -114.81 154.0 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.284 -0.885 . . . . 0.0 110.326 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.453 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.0 mp -113.2 133.23 55.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.788 -0.57 . . . . 39.149999999999999 109.514 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.673 -0.642 . . . . 0.0 110.071 -179.838 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.961 0.41 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.416 ' CE2' HG23 ' A' ' 109' ' ' THR . 34.3 m-85 -115.93 107.41 14.96 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.542 -0.724 . . . . 31.93 110.029 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -155.87 135.05 12.17 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.588 0.708 . . . . 0.0 110.594 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.2 t -152.42 116.23 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -108.95 132.6 53.93 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.675 0.75 . . . . 0.0 110.62 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.7 t -119.41 139.08 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.891 -0.506 . . . . 28.210000000000001 109.712 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -119.96 137.92 53.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.505 -0.747 . . . . 0.0 109.709 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.409 HG12 ' CD1' ' A' ' 33' ' ' TYR . 62.6 t -129.26 136.62 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.539 -0.725 . . . . 27.949999999999999 110.509 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.6 p -124.17 103.89 32.65 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.72 -0.612 . . . . 0.0 110.281 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -82.89 165.97 15.13 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 123.841 1.443 . . . . 33.0 111.063 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -157.59 132.12 8.47 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.539 0.685 . . . . 54.100000000000001 109.801 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -60.29 139.52 57.57 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.257 0.551 . . . . 0.0 111.471 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 93.7 mt -115.58 79.15 1.25 Allowed 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.879 0.847 . . . . 0.0 110.279 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.89 -35.62 81.15 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.17 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -69.96 -23.45 63.18 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.365 -0.835 . . . . 0.0 110.985 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -121.07 29.97 7.08 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.366 -0.834 . . . . 52.369999999999997 110.976 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.7 p -152.17 146.37 25.42 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.265 -0.897 . . . . 55.189999999999998 111.099 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 t -119.45 92.79 46.45 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.443 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.3 Cg_endo -66.08 -23.15 53.75 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 O-C-N 123.912 1.48 . . . . 51.57 111.566 -178.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.04 -23.19 67.12 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.4 -0.812 . . . . 0.0 110.882 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -105.77 23.83 13.27 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.357 -0.839 . . . . 0.0 110.693 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.43 28.71 73.66 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.1 mtt180 -121.52 93.9 4.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.646 -0.914 . . . . 0.0 110.311 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 66.4 m-85 -104.59 134.32 47.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.644 -0.66 . . . . 46.07 109.325 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -117.17 120.68 39.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.444 -0.785 . . . . 0.0 111.273 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.423 ' CD1' HD12 ' A' ' 90' ' ' LEU . 91.1 m-85 -116.36 133.67 55.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.505 -0.747 . . . . 38.880000000000003 109.853 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.74 132.42 56.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.205 -0.934 . . . . 34.060000000000002 108.74 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 86' ' ' SER . 34.0 p90 -127.63 145.99 50.7 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 119.19 -1.004 . . . . 29.030000000000001 111.747 -178.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 53.8 m -104.46 134.15 48.14 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.445 ' CG2' ' CE2' ' A' ' 84' ' ' TYR . 18.8 tt -105.94 135.76 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 121.807 0.813 . . . . 0.0 112.111 -178.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -124.64 100.88 6.85 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.548 0.689 . . . . 40.240000000000002 109.897 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.6 mt -90.72 118.56 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.808 -0.558 . . . . 20.73 110.69 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -117.35 139.5 50.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.392 -0.817 . . . . 0.0 109.497 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -88.55 117.23 27.36 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.672 -0.642 . . . . 21.34 110.848 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.68 3.31 15.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.551 -0.718 . . . . 0.0 110.633 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.8 -174.88 49.92 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.02 -1.632 . . . . 29.100000000000001 109.02 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.02 -30.67 11.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.439 -1.036 . . . . 0.0 110.277 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.419 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 86.3 t -105.33 140.65 21.35 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.796 -0.565 . . . . 0.0 109.646 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.419 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 39.5 Cg_endo -52.1 141.12 48.93 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 O-C-N 123.718 1.378 . . . . 21.949999999999999 111.991 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.84 151.56 45.8 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.627 0.727 . . . . 20.91 110.883 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.416 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 0.5 OUTLIER -127.68 160.5 31.48 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.72 -0.612 . . . . 0.0 109.794 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.1 tt -97.27 117.88 32.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.379 -0.826 . . . . 0.0 109.451 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.8 t -101.32 -27.05 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.542 -0.724 . . . . 0.0 110.627 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.41 162.82 34.4 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.226 -0.989 . . . . 0.0 111.558 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -141.29 138.67 33.34 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.345 0.593 . . . . 29.050000000000001 110.434 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -142.86 113.31 7.32 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.327 0.584 . . . . 27.969999999999999 109.723 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -101.15 133.63 45.4 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.632 -0.668 . . . . 25.25 111.049 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -116.28 76.48 1.02 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.635 -0.666 . . . . 0.0 109.345 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.422 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.0 pt -85.59 129.21 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-O 121.776 0.798 . . . . 36.109999999999999 111.774 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.0 m -120.57 131.8 54.84 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.429 -0.952 . . . . 33.979999999999997 108.429 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -88.55 169.99 11.25 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.85 0.833 . . . . 45.039999999999999 111.474 -178.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.04 -7.12 11.57 Favored Glycine 0 N--CA 1.495 2.616 0 O-C-N 121.757 -0.589 . . . . 39.469999999999999 112.205 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -101.0 7.02 43.71 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 119.434 1.617 . . . . 0.0 110.6 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.04 -29.05 8.47 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.79 141.49 58.75 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.23 -1.159 . . . . 62.780000000000001 109.674 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.8 t -134.84 152.96 52.18 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.618 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -121.32 122.08 39.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.542 -0.723 . . . . 0.0 110.155 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -102.82 134.72 45.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.705 -0.622 . . . . 0.0 110.439 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.4 t -128.01 130.82 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.578 -0.701 . . . . 37.939999999999998 110.062 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -125.82 126.87 45.2 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.849 -0.532 . . . . 0.0 110.041 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -151.13 158.37 27.66 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.264 -1.534 . . . . 31.82 109.264 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -80.7 154.35 27.34 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.428 -1.042 . . . . 0.0 110.374 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.88 -167.09 0.2 Allowed Glycine 0 N--CA 1.498 2.767 0 O-C-N 121.493 -0.754 . . . . 22.620000000000001 111.605 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.0 m -131.8 129.61 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.96 -0.729 . . . . 17.510000000000002 109.537 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.42 HG21 ' HG2' ' A' ' 72' ' ' GLU . 11.4 m 40.91 35.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 CA-C-O 121.517 0.675 . . . . 20.550000000000001 111.779 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.28 17.8 65.98 Favored Glycine 0 N--CA 1.498 2.813 0 O-C-N 121.598 -0.689 . . . . 18.289999999999999 112.988 177.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.42 ' HG2' HG21 ' A' ' 70' ' ' VAL . 11.1 pt-20 -145.13 150.59 37.06 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 119.211 1.505 . . . . 0.0 112.025 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -115.21 74.75 4.03 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.923 -0.769 . . . . 18.210000000000001 108.923 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -56.94 140.8 93.12 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 O-C-N 123.785 1.413 . . . . 17.609999999999999 112.189 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.416 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 6.3 t90 -104.03 77.55 1.45 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 tp -61.38 118.17 6.6 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.516 -0.74 . . . . 20.57 111.623 -178.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.416 ' HG2' ' CZ3' ' A' ' 75' ' ' TRP . 16.0 mtm180 -86.31 159.18 53.98 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -54.61 126.71 23.28 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 O-C-N 123.628 1.331 . . . . 27.039999999999999 111.002 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.64 -18.53 42.34 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.903 -0.879 . . . . 24.739999999999998 110.903 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -87.89 165.77 15.02 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.079 -1.248 . . . . 29.379999999999999 110.255 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.74 150.45 36.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.545 -0.722 . . . . 0.0 110.388 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.402 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 90.7 t80 -118.59 145.68 45.21 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.031 -0.729 . . . . 18.559999999999999 109.031 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.6 p80 -146.14 141.19 27.26 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.226 -0.922 . . . . 0.0 111.367 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.445 ' CE2' ' CG2' ' A' ' 35' ' ' ILE . 44.9 p90 -151.89 163.28 39.57 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.655 -0.653 . . . . 26.649999999999999 109.557 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.9 m -99.0 138.42 36.12 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.167 -0.958 . . . . 28.140000000000001 111.137 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 15.2 t -125.91 166.35 17.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.615 -0.678 . . . . 33.880000000000003 109.912 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -143.88 124.52 2.27 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 119.774 -1.203 . . . . 31.800000000000001 110.675 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.5 m -132.13 152.8 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.667 -0.902 . . . . 0.0 109.809 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.5 mt -111.56 145.15 39.63 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.559 -0.713 . . . . 0.0 110.977 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.423 HD12 ' CD1' ' A' ' 31' ' ' PHE . 78.7 mt -121.2 145.95 47.3 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.691 -0.631 . . . . 38.68 109.886 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -73.39 -25.69 60.67 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.306 -0.871 . . . . 0.0 111.165 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.8 p -123.47 171.71 9.27 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.354 -0.841 . . . . 31.629999999999999 110.756 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.418 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 32.6 tt0 -86.31 7.37 25.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.692 -0.63 . . . . 0.0 111.506 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -138.62 148.62 44.31 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.097 -1.002 . . . . 0.0 109.526 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.62 156.77 14.57 Favored Glycine 0 N--CA 1.496 2.661 0 C-N-CA 118.755 -1.688 . . . . 28.050000000000001 112.254 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -118.41 130.02 55.74 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 94.8 mtp -126.29 120.77 30.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.38 -0.825 . . . . 0.0 111.4 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -130.6 151.83 50.64 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.73 -173.67 33.63 Favored Glycine 0 N--CA 1.5 2.951 0 C-N-CA 118.973 -1.584 . . . . 29.620000000000001 110.806 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.427 ' CD2' ' HA ' ' A' ' 114' ' ' PRO . 68.2 m80 -137.13 160.18 39.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.654 -0.909 . . . . 0.0 110.557 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.453 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 8.7 m-85 -116.98 128.42 55.17 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.771 -0.581 . . . . 27.050000000000001 110.181 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -87.15 121.31 29.43 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.021 -1.05 . . . . 0.0 108.846 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.43 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 55.1 mtp -126.4 162.76 24.82 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.21 0.529 . . . . 0.0 110.624 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.6 m -140.65 131.23 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.551 -0.718 . . . . 23.280000000000001 110.287 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.406 ' HB1' ' CE1' ' A' ' 7' ' ' TYR . . . -73.45 165.58 24.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.35 -0.844 . . . . 0.0 109.402 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -63.7 -29.37 70.6 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.024 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -75.34 -9.69 58.78 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.493 -0.754 . . . . 0.0 111.202 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.99 -7.98 49.29 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.061 -1.066 . . . . 30.43 110.469 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.416 HG23 ' CE2' ' A' ' 7' ' ' TYR . 33.6 m -57.69 135.38 56.74 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.036 -1.273 . . . . 0.0 109.964 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -101.34 139.77 36.56 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.347 -0.845 . . . . 0.0 110.723 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.43 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 47.8 p90 -163.76 143.24 8.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.684 -0.635 . . . . 28.030000000000001 109.993 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.4 HG21 HD11 ' A' ' 112' ' ' ILE . 84.3 mt -101.09 156.79 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.424 0.631 . . . . 0.0 110.43 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.86 98.91 47.45 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.427 ' HA ' ' CD2' ' A' ' 100' ' ' HIS . 45.9 Cg_endo -58.36 143.22 97.8 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 O-C-N 123.93 1.49 . . . . 33.310000000000002 112.066 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.453 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 70.9 mt -107.97 123.28 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-N 115.375 -0.829 . . . . 30.59 108.907 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -51.84 149.63 4.7 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.175 0.512 . . . . 30.780000000000001 111.207 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -91.29 120.87 32.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.586 -0.696 . . . . 0.0 110.113 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -110.29 165.01 12.11 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.678 -0.86 . . . . 30.66 108.678 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.2 t -116.01 153.13 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.159 -0.963 . . . . 0.0 110.677 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.455 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.0 mp -113.32 134.35 54.66 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.283 -0.636 . . . . 39.149999999999999 109.283 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 51.9 m . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.62 -0.675 . . . . 0.0 110.081 -179.819 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.703 0.287 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.414 ' CE2' HG22 ' A' ' 109' ' ' THR . 39.9 m-85 -118.62 105.36 11.53 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.484 -0.76 . . . . 31.93 110.331 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -147.08 132.57 18.67 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.603 -0.685 . . . . 0.0 109.839 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.4 t -152.1 115.41 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.501 -0.75 . . . . 0.0 109.896 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -105.7 128.42 53.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.662 -0.649 . . . . 0.0 109.823 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.4 t -119.32 138.3 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.757 -0.59 . . . . 28.210000000000001 109.793 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -123.57 136.73 54.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.316 -0.865 . . . . 0.0 110.148 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.4 t -129.61 137.11 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.57 -0.706 . . . . 27.949999999999999 110.18 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.4 t -125.61 105.28 27.17 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.688 -0.633 . . . . 0.0 110.887 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.88 165.13 15.51 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.794 1.418 . . . . 33.0 110.886 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.8 ptt-85 -157.98 132.01 8.04 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.664 0.745 . . . . 54.100000000000001 109.947 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -60.02 139.97 57.1 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.725 -0.609 . . . . 0.0 111.604 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 84.5 mt -116.49 80.76 1.51 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.903 0.858 . . . . 0.0 110.422 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.8 -35.74 81.55 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.065 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -69.96 -24.45 63.34 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.282 -0.886 . . . . 0.0 110.881 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.2 tp60 -121.36 49.56 1.5 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.331 -0.856 . . . . 52.369999999999997 110.779 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 52.5 p -169.59 149.12 3.84 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.228 -0.92 . . . . 55.189999999999998 110.916 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 t -118.88 92.42 44.77 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.452 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 49.0 Cg_endo -66.86 -24.92 45.88 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 O-C-N 123.818 1.43 . . . . 51.57 112.064 -178.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -66.7 -20.77 66.04 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.236 -0.915 . . . . 0.0 111.022 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -105.6 23.58 13.61 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.145 -0.972 . . . . 0.0 110.739 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.72 27.43 73.27 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.8 mtt85 -122.08 94.38 4.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.643 -0.916 . . . . 0.0 110.082 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.456 ' CE2' ' CG ' ' A' ' 93' ' ' GLU . 63.8 m-85 -104.41 137.15 42.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.582 -0.699 . . . . 46.07 109.209 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.03 120.4 40.47 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.162 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -116.5 131.38 56.96 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.608 -0.683 . . . . 38.880000000000003 109.653 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.39 131.5 55.97 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.282 -0.886 . . . . 34.060000000000002 108.849 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.42 ' CE2' ' HB3' ' A' ' 86' ' ' SER . 53.7 p90 -126.52 145.57 50.46 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.331 -0.948 . . . . 29.030000000000001 111.326 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.5 t -102.41 140.27 36.91 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.437 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 48.5 mm -105.68 132.46 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.783 0.802 . . . . 0.0 111.715 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -123.58 97.77 5.54 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.522 0.677 . . . . 40.240000000000002 109.718 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.401 ' CG2' ' CD1' ' A' ' 76' ' ' LEU . 81.8 mt -93.17 117.75 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.773 -0.58 . . . . 20.73 110.583 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -117.18 133.72 55.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.439 -0.788 . . . . 0.0 109.319 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -94.59 117.44 30.13 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 120.212 -0.595 . . . . 21.34 110.523 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.27 15.89 15.86 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.39 -0.819 . . . . 0.0 110.45 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.83 -179.72 52.78 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.332 -1.507 . . . . 29.100000000000001 109.332 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.31 -33.26 13.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.56 -0.964 . . . . 0.0 110.267 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.419 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 87.2 t -106.45 142.02 24.03 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 122.022 -0.424 . . . . 0.0 109.937 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.419 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 38.7 Cg_endo -53.66 146.84 42.28 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 O-C-N 123.792 1.417 . . . . 21.949999999999999 111.428 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.5 151.28 47.23 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.794 0.807 . . . . 20.91 111.506 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.427 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 8.1 ttt180 -126.85 152.32 47.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.865 -0.522 . . . . 0.0 109.595 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.0 tt -98.03 118.73 35.28 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.382 -0.824 . . . . 0.0 109.728 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.0 t -100.27 -29.66 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.61 -0.681 . . . . 0.0 111.073 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.68 165.58 27.1 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.078 -1.049 . . . . 0.0 112.296 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.5 ptt85 -142.72 140.69 31.57 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.519 0.676 . . . . 29.050000000000001 110.352 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -143.09 114.59 8.0 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.777 -0.577 . . . . 27.969999999999999 109.628 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.416 ' CH2' HD11 ' A' ' 115' ' ' ILE . 91.6 m95 -99.95 132.92 45.01 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.578 -0.701 . . . . 25.25 111.2 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -116.15 76.05 0.99 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.604 -0.685 . . . . 0.0 109.402 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.421 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.2 pt -85.17 130.13 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.789 0.805 . . . . 36.109999999999999 112.275 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.9 m -118.64 130.89 56.11 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.983 -1.117 . . . . 33.979999999999997 107.983 178.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -88.5 169.72 11.51 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.644 0.735 . . . . 45.039999999999999 111.144 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.57 -6.84 12.41 Favored Glycine 0 N--CA 1.496 2.636 0 O-C-N 121.754 -0.591 . . . . 39.469999999999999 112.13 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -101.47 7.69 42.36 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 119.337 1.569 . . . . 0.0 110.596 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.67 -31.63 6.37 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.51 142.72 57.81 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.387 -1.067 . . . . 62.780000000000001 109.944 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.7 t -134.36 152.93 52.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.531 -0.731 . . . . 0.0 110.451 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -121.92 123.35 41.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.545 -0.722 . . . . 0.0 110.335 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -103.23 134.24 46.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.671 -0.643 . . . . 0.0 110.496 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.8 t -128.37 131.78 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.538 -0.727 . . . . 37.939999999999998 110.043 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -124.86 126.21 45.2 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.822 -0.549 . . . . 0.0 110.148 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.35 149.01 21.0 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.363 -1.495 . . . . 31.82 109.363 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -77.88 155.24 31.07 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.474 -1.015 . . . . 0.0 110.439 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.56 -175.13 0.18 Allowed Glycine 0 N--CA 1.497 2.7 0 N-CA-C 111.049 -0.82 . . . . 22.620000000000001 111.049 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.3 m -128.24 127.52 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.8 -0.824 . . . . 17.510000000000002 109.576 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.419 HG23 ' HG2' ' A' ' 72' ' ' GLU . 11.4 m 41.21 36.95 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-O 121.599 0.714 . . . . 20.550000000000001 111.809 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.97 15.77 71.7 Favored Glycine 0 N--CA 1.499 2.854 0 O-C-N 121.571 -0.705 . . . . 18.289999999999999 112.957 177.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.419 ' HG2' HG23 ' A' ' 70' ' ' VAL . 10.8 pt-20 -146.3 151.33 37.36 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-N 119.136 1.468 . . . . 0.0 112.15 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -115.5 75.36 4.82 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.887 -0.783 . . . . 18.210000000000001 108.887 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -57.71 139.04 88.96 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 O-C-N 123.847 1.446 . . . . 17.609999999999999 112.084 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.427 ' CD1' ' HB2' ' A' ' 46' ' ' ARG . 4.0 t90 -101.68 76.22 1.64 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.401 ' CD1' ' CG2' ' A' ' 37' ' ' ILE . 10.1 mt -60.25 118.17 6.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.582 -0.699 . . . . 20.57 112.039 -178.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.415 ' HG2' ' CZ3' ' A' ' 75' ' ' TRP . 15.2 mtm180 -86.91 158.45 53.28 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -54.25 129.37 34.2 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 O-C-N 123.461 1.243 . . . . 27.039999999999999 111.227 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.01 -18.59 47.03 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 111.068 -0.813 . . . . 24.739999999999998 111.068 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -88.05 166.17 14.64 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.058 -1.26 . . . . 29.379999999999999 110.618 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.04 147.66 32.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.621 -0.674 . . . . 0.0 110.231 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.402 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 84.6 t80 -116.21 144.24 44.45 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.525 -0.734 . . . . 18.559999999999999 109.08 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -144.18 140.58 29.42 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.278 -0.889 . . . . 0.0 111.141 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.437 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 51.3 p90 -150.15 159.99 44.01 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.758 -0.589 . . . . 26.649999999999999 109.528 178.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.9 m -103.51 138.77 39.75 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.43 -0.794 . . . . 28.140000000000001 110.875 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.42 ' HB3' ' CE2' ' A' ' 33' ' ' TYR . 15.3 t -124.21 167.36 14.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.689 -0.632 . . . . 33.880000000000003 109.937 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -144.03 119.36 1.29 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 110.136 -1.186 . . . . 31.800000000000001 110.136 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.35 152.83 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.591 -0.947 . . . . 0.0 110.1 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -108.71 142.99 38.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.53 -0.731 . . . . 0.0 110.666 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 36.4 mt -124.64 144.79 49.99 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.484 -0.76 . . . . 38.68 110.38 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -88.71 -19.84 25.59 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.129 -0.982 . . . . 0.0 110.395 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.6 p -103.05 134.88 45.74 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.403 -0.811 . . . . 31.629999999999999 110.481 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.456 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 51.3 mt-10 -77.38 -2.88 37.32 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.239 -0.913 . . . . 0.0 110.66 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -138.59 140.63 39.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.179 -0.951 . . . . 0.0 108.834 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.91 166.57 35.76 Favored Glycine 0 N--CA 1.499 2.885 0 C-N-CA 118.409 -1.853 . . . . 28.050000000000001 112.585 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -117.77 129.98 56.02 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.154 -0.615 . . . . 0.0 109.465 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 98.0 mtp -126.33 119.97 28.69 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.308 -0.87 . . . . 0.0 111.281 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.407 ' CG ' ' CB ' ' A' ' 117' ' ' ALA . 69.4 mt-30 -122.54 152.16 40.65 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.93 173.43 36.61 Favored Glycine 0 N--CA 1.498 2.813 0 C-N-CA 118.783 -1.675 . . . . 29.620000000000001 111.107 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.421 ' CD2' ' HA ' ' A' ' 114' ' ' PRO . 67.5 m80 -136.98 156.77 48.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.702 -0.881 . . . . 0.0 109.892 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.45 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 9.1 m-85 -116.66 127.48 54.47 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.683 -0.635 . . . . 27.050000000000001 109.938 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -84.07 119.89 25.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.962 -1.086 . . . . 0.0 108.414 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.427 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 4.8 ttm -123.48 162.34 23.08 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.065 0.46 . . . . 0.0 110.685 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.8 m -141.42 129.84 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.699 -0.626 . . . . 23.280000000000001 110.52 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.7 166.45 23.26 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.474 -0.766 . . . . 0.0 109.521 179.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -66.45 -30.55 70.93 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.484 -0.76 . . . . 0.0 110.291 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -74.98 -4.59 39.15 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.494 -0.754 . . . . 0.0 111.233 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.8 -9.99 58.68 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.139 -1.029 . . . . 30.43 110.537 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.414 HG22 ' CE2' ' A' ' 7' ' ' TYR . 43.5 m -57.57 134.59 56.27 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.124 -1.221 . . . . 0.0 109.982 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -101.42 140.02 36.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.354 -0.841 . . . . 0.0 110.776 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 42.8 p90 -164.41 142.98 7.09 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.644 -0.66 . . . . 28.030000000000001 109.822 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 85.7 mt -101.23 158.01 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.633 -0.667 . . . . 0.0 110.495 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.01 95.43 49.35 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.421 ' HA ' ' CD2' ' A' ' 100' ' ' HIS . 46.6 Cg_endo -59.56 146.6 94.72 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 O-C-N 123.933 1.491 . . . . 33.310000000000002 112.082 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.45 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 66.5 mt -111.19 120.92 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.594 -0.891 . . . . 30.59 108.594 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.05 168.77 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.152 0.501 . . . . 30.780000000000001 111.467 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.407 ' CB ' ' CG ' ' A' ' 98' ' ' GLN . . . -96.98 122.17 39.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.584 -0.698 . . . . 0.0 110.765 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 97' ' ' MET . 47.4 p90 -112.01 157.99 20.07 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.183 -1.043 . . . . 30.66 108.183 178.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.3 t -114.93 153.73 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.241 -0.912 . . . . 0.0 110.494 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.462 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.3 mp -113.12 131.57 55.78 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.175 -0.676 . . . . 39.149999999999999 109.175 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.836 -0.54 . . . . 0.0 110.068 -179.754 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.1 mtt180 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.864 0.364 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.407 ' CE1' HG23 ' A' ' 109' ' ' THR . 91.9 m-85 -120.63 98.09 5.86 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.553 -0.717 . . . . 31.93 110.199 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.4 mtm-85 -142.66 135.11 27.75 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.62 -0.675 . . . . 0.0 109.754 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.4 t -151.75 117.01 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 121.621 0.724 . . . . 0.0 109.784 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -106.56 128.03 53.79 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.63 -0.669 . . . . 0.0 109.687 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.7 t -121.1 136.01 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.759 -0.588 . . . . 28.210000000000001 109.926 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -126.89 137.56 53.17 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.341 -0.85 . . . . 0.0 109.869 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 67.2 t -128.01 139.81 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.641 -0.662 . . . . 27.949999999999999 110.123 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -123.82 105.39 32.48 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.726 -0.609 . . . . 0.0 110.627 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.406 ' HG3' ' CE1' ' A' ' 118' ' ' PHE . 49.1 Cg_endo -83.69 165.82 13.72 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 O-C-N 123.898 1.473 . . . . 33.0 110.734 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -157.93 132.47 8.35 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.598 0.713 . . . . 54.100000000000001 109.917 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -60.03 138.43 57.86 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.797 -0.565 . . . . 0.0 111.197 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.8 tp -115.5 79.68 1.32 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 122.039 0.923 . . . . 0.0 110.402 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.17 -35.65 69.07 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.465 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -68.42 -25.75 65.19 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.274 -0.891 . . . . 0.0 110.941 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -119.42 43.66 2.56 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.379 -0.826 . . . . 52.369999999999997 110.313 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.6 t -162.87 150.27 13.34 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.532 -0.73 . . . . 55.189999999999998 110.93 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.7 t -121.25 93.98 48.78 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.458 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 49.7 Cg_endo -67.12 -22.85 46.65 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 O-C-N 123.748 1.394 . . . . 51.57 112.004 -178.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -65.44 -22.98 66.82 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.289 -0.882 . . . . 0.0 110.947 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -106.22 23.49 14.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.209 -0.932 . . . . 0.0 110.786 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.97 28.85 73.32 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -120.72 93.93 4.19 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.636 -0.92 . . . . 0.0 110.076 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.458 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 54.1 m-85 -105.45 134.1 49.11 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.542 -0.724 . . . . 46.07 109.202 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.67 119.48 37.56 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.02 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.403 ' CD1' HD11 ' A' ' 90' ' ' LEU . 83.0 m-85 -114.73 133.3 56.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.595 -0.69 . . . . 38.880000000000003 109.614 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.44 130.25 56.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.218 -0.926 . . . . 34.060000000000002 108.726 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.431 ' CZ ' ' HB3' ' A' ' 86' ' ' SER . 35.7 p90 -126.05 144.27 50.79 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.263 -0.975 . . . . 29.030000000000001 111.176 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.5 m -103.91 137.82 41.35 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.609 -0.682 . . . . 0.0 109.834 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.424 HG21 ' CE2' ' A' ' 84' ' ' TYR . 43.2 mm -104.62 130.79 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-O 121.696 0.76 . . . . 0.0 111.37 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -122.85 98.81 6.07 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.528 0.68 . . . . 40.240000000000002 109.716 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.412 ' CG2' ' CD1' ' A' ' 76' ' ' LEU . 82.5 mt -91.82 116.9 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.715 -0.616 . . . . 20.73 110.411 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -117.87 133.29 56.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.536 -0.727 . . . . 0.0 109.486 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.4 117.51 30.23 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 120.217 -0.593 . . . . 21.34 110.423 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.72 15.25 17.58 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.358 -0.839 . . . . 0.0 110.534 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.25 -171.36 47.42 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.237 -1.545 . . . . 29.100000000000001 109.237 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.53 -30.17 11.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.497 -1.002 . . . . 0.0 110.169 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.407 ' CG1' ' HD2' ' A' ' 44' ' ' PRO . 91.5 t -106.18 139.55 20.39 Favored Pre-proline 0 N--CA 1.498 1.951 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.082 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.407 ' HD2' ' CG1' ' A' ' 43' ' ' VAL . 40.4 Cg_endo -53.2 144.65 47.02 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 O-C-N 123.837 1.441 . . . . 21.949999999999999 111.796 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.06 152.21 44.65 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.701 0.762 . . . . 20.91 111.296 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.416 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 22.3 ptt180 -127.42 155.74 43.18 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.5 tt -94.27 118.3 31.39 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.339 -0.851 . . . . 0.0 109.767 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.3 t -100.31 -28.53 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.563 -0.71 . . . . 0.0 110.851 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.13 165.26 27.94 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.098 -1.041 . . . . 0.0 112.24 -179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -141.62 139.88 33.17 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.463 0.649 . . . . 29.050000000000001 110.251 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -142.62 114.52 8.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.782 -0.574 . . . . 27.969999999999999 109.605 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -99.71 132.17 45.22 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.643 -0.66 . . . . 25.25 111.398 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -115.12 78.25 1.15 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 54' ' ' ILE . 15.2 pt -87.02 128.81 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-O 121.609 0.718 . . . . 36.109999999999999 111.8 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.6 m -118.6 130.14 55.72 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.874 -1.158 . . . . 33.979999999999997 107.874 177.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -89.23 169.82 11.12 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.86 0.838 . . . . 45.039999999999999 111.636 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.11 -7.63 13.97 Favored Glycine 0 N--CA 1.495 2.63 0 O-C-N 121.837 -0.54 . . . . 39.469999999999999 112.043 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -101.41 6.98 42.78 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 119.334 1.567 . . . . 0.0 110.561 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.99 -30.25 7.77 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -63.27 142.36 58.42 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.224 -1.163 . . . . 62.780000000000001 109.928 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.9 t -133.98 151.92 51.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.509 -0.744 . . . . 0.0 110.456 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -121.89 123.61 42.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.565 -0.709 . . . . 0.0 110.409 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -104.47 135.71 45.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.724 -0.61 . . . . 0.0 110.684 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.9 t -129.47 132.43 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.437 -0.789 . . . . 37.939999999999998 110.118 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.76 126.17 45.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.83 -0.544 . . . . 0.0 110.172 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.65 148.26 19.54 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.454 -1.459 . . . . 31.82 109.454 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -78.73 154.83 29.72 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.434 -1.039 . . . . 0.0 110.463 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 54.97 -178.86 0.27 Allowed Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.855 -0.898 . . . . 22.620000000000001 110.855 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.4 m -128.14 127.26 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.749 -0.854 . . . . 17.510000000000002 109.679 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.416 HG22 ' HG2' ' A' ' 72' ' ' GLU . 10.9 m 41.4 36.79 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 CA-C-O 121.636 0.732 . . . . 20.550000000000001 111.744 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.06 15.27 72.77 Favored Glycine 0 N--CA 1.499 2.856 0 O-C-N 121.563 -0.71 . . . . 18.289999999999999 112.935 177.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.416 ' HG2' HG22 ' A' ' 70' ' ' VAL . 10.1 pt-20 -145.5 150.01 35.68 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 119.131 1.465 . . . . 0.0 112.157 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -116.15 74.52 5.58 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.625 -0.88 . . . . 18.210000000000001 108.625 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -57.49 140.81 94.39 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.904 1.476 . . . . 17.609999999999999 112.229 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.416 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 1.6 t90 -101.81 76.91 1.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.412 ' CD1' ' CG2' ' A' ' 37' ' ' ILE . 11.1 mt -60.19 117.89 5.7 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.663 -0.648 . . . . 20.57 111.969 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -86.29 157.62 56.04 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -53.41 128.31 28.79 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 O-C-N 123.5 1.263 . . . . 27.039999999999999 111.126 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.97 -16.97 55.68 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.751 -0.94 . . . . 24.739999999999998 110.751 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -87.13 165.18 15.94 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.074 -1.251 . . . . 29.379999999999999 110.555 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.81 150.52 36.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.58 -0.7 . . . . 0.0 110.154 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -118.03 147.59 43.07 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.417 -0.802 . . . . 18.559999999999999 109.11 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -142.73 137.45 29.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.238 -0.914 . . . . 0.0 110.878 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.424 ' CE2' HG21 ' A' ' 35' ' ' ILE . 51.6 p90 -150.95 160.21 44.06 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.613 -0.679 . . . . 26.649999999999999 109.709 178.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.9 m -105.16 139.23 40.13 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.43 -0.794 . . . . 28.140000000000001 111.035 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 16.9 t -124.46 166.68 15.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.62 -0.675 . . . . 33.880000000000003 109.834 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.03 120.15 1.58 Allowed Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.923 -1.132 . . . . 31.800000000000001 110.38 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 80.8 t -130.77 152.2 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.628 -0.925 . . . . 0.0 109.862 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 mp -108.41 142.63 38.47 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.556 -0.715 . . . . 0.0 110.177 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.403 HD11 ' CD1' ' A' ' 31' ' ' PHE . 67.0 mt -124.63 145.14 49.8 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.489 -0.757 . . . . 38.68 110.565 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -90.74 -21.63 21.48 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.138 -0.976 . . . . 0.0 110.124 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.3 p -102.71 137.0 41.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.525 -0.735 . . . . 31.629999999999999 110.447 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.447 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 66.6 mt-10 -77.66 -1.77 32.69 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.29 -0.881 . . . . 0.0 110.753 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -138.53 141.05 39.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.048 -1.033 . . . . 0.0 108.911 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.54 168.66 38.78 Favored Glycine 0 N--CA 1.498 2.83 0 C-N-CA 118.577 -1.773 . . . . 28.050000000000001 112.308 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -118.83 130.2 55.63 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.056 -0.673 . . . . 0.0 109.665 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 35.9 ttm -124.9 117.15 23.44 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.236 -0.915 . . . . 0.0 111.01 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -127.82 151.31 49.19 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.88 176.67 37.47 Favored Glycine 0 N--CA 1.499 2.873 0 C-N-CA 119.087 -1.53 . . . . 29.620000000000001 110.895 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.419 ' CD2' ' HA ' ' A' ' 114' ' ' PRO . 66.3 m80 -136.41 156.41 48.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.704 -0.88 . . . . 0.0 110.193 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.445 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 5.9 m-85 -117.03 128.12 54.85 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.57 -0.706 . . . . 27.050000000000001 109.972 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -83.71 120.31 25.85 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.083 -1.011 . . . . 0.0 108.835 177.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.42 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 7.8 ttm -122.88 161.46 24.06 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.028 0.442 . . . . 0.0 110.222 -179.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.1 m -142.74 130.53 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.554 -0.716 . . . . 23.280000000000001 110.546 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.45 168.14 19.84 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.468 -0.77 . . . . 0.0 109.649 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -67.77 -28.81 67.93 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.516 -0.74 . . . . 0.0 110.374 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 46.9 p-10 -76.07 -3.69 37.29 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.338 -0.851 . . . . 0.0 111.422 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.89 -10.51 60.48 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.022 -1.085 . . . . 30.43 110.892 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.407 HG23 ' CE1' ' A' ' 7' ' ' TYR . 76.5 m -57.9 134.66 56.53 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.998 -1.295 . . . . 0.0 110.053 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -101.16 140.09 35.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.355 -0.841 . . . . 0.0 110.809 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.42 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 37.2 p90 -164.56 143.87 7.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.709 -0.62 . . . . 28.030000000000001 109.708 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 85.5 mt -101.36 157.49 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.714 -0.617 . . . . 0.0 110.556 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.5 96.07 49.58 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.419 ' HA ' ' CD2' ' A' ' 100' ' ' HIS . 46.6 Cg_endo -58.98 142.93 99.85 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 O-C-N 123.966 1.509 . . . . 33.310000000000002 112.147 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.445 ' CD1' ' CE2' ' A' ' 101' ' ' TYR . 51.7 mt -107.94 122.31 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.465 -0.939 . . . . 30.59 108.465 178.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.01 153.76 0.85 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.894 -0.504 . . . . 30.780000000000001 111.389 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -99.76 117.58 34.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.727 -0.608 . . . . 0.0 110.278 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.406 ' CE1' ' HG3' ' A' ' 15' ' ' PRO . 41.4 p90 -106.18 169.13 8.68 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.822 -0.807 . . . . 30.66 108.822 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.5 t -111.95 154.37 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.254 -0.904 . . . . 0.0 110.231 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.459 ' N ' ' CD1' ' A' ' 120' ' ' LEU . 7.4 mp -112.21 132.48 54.89 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.259 -0.645 . . . . 39.149999999999999 109.259 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.687 -0.633 . . . . 0.0 110.089 -179.735 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 120.594 0.235 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.567 ' CE2' HG21 ' A' ' 109' ' ' THR . 37.8 m-85 -118.65 112.07 19.35 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.406 -0.808 . . . . 31.93 110.338 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.479 ' C ' HG23 ' A' ' 9' ' ' VAL . 45.2 mtm-85 -153.48 134.23 13.78 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.509 0.671 . . . . 0.0 110.28 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.786 HG11 ' CE ' ' A' ' 103' ' ' MET . 97.0 t -151.74 115.8 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 121.466 0.65 . . . . 0.0 109.57 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -106.19 128.86 54.23 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.542 0.687 . . . . 0.0 109.78 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.3 t -118.02 138.84 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.815 -0.553 . . . . 28.210000000000001 109.702 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -122.41 136.32 54.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.444 -0.785 . . . . 0.0 109.944 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.806 HG22 HD13 ' A' ' 35' ' ' ILE . 62.7 t -128.29 136.1 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.605 -0.684 . . . . 27.949999999999999 110.33 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 65.3 p -126.37 105.66 24.47 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.689 -0.632 . . . . 0.0 110.526 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.423 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 49.8 Cg_endo -83.46 165.25 14.34 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 O-C-N 123.831 1.438 . . . . 33.0 110.991 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -157.78 131.67 8.03 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.51 0.671 . . . . 54.100000000000001 109.793 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.512 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 76.3 t80 -62.28 138.68 58.47 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.767 -0.583 . . . . 0.0 111.55 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.944 HD11 ' HB2' ' A' ' 32' ' ' ALA . 85.7 mt -115.4 79.62 1.31 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.903 0.859 . . . . 0.0 110.309 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.512 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -67.03 -35.32 79.63 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.222 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -69.54 -25.17 63.89 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.288 -0.882 . . . . 0.0 111.003 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -119.07 31.18 6.76 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.363 -0.835 . . . . 52.369999999999997 110.927 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.547 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 22.1 p -152.05 146.51 25.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.368 -0.832 . . . . 55.189999999999998 110.996 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.601 HG23 ' HB2' ' A' ' 28' ' ' ARG . 8.8 t -122.5 93.2 48.65 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.465 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.2 Cg_endo -66.2 -22.51 53.75 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 O-C-N 123.715 1.376 . . . . 51.57 111.804 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -64.87 -24.31 67.5 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.333 -0.855 . . . . 0.0 110.951 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -105.75 23.72 13.44 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.336 -0.853 . . . . 0.0 110.76 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.21 29.44 72.06 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.601 ' HB2' HG23 ' A' ' 23' ' ' THR . 84.2 mtt-85 -121.02 93.7 4.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.643 -0.916 . . . . 0.0 110.18 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.465 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 67.4 m-85 -104.84 131.28 52.51 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.924 -0.769 . . . . 46.07 108.924 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.547 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -118.43 120.9 38.94 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.528 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.657 ' CD1' HD12 ' A' ' 90' ' ' LEU . 75.4 m-85 -116.74 134.63 54.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.651 -0.656 . . . . 38.880000000000003 109.711 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.944 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -111.41 132.54 54.37 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.623 -0.881 . . . . 34.060000000000002 108.623 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.594 ' HE1' HG23 ' A' ' 88' ' ' VAL . 24.8 p90 -127.59 144.04 51.11 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.216 -0.994 . . . . 29.030000000000001 111.447 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.5 m -103.93 139.7 38.73 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.703 -0.623 . . . . 0.0 109.549 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.806 HD13 HG22 ' A' ' 13' ' ' VAL . 41.8 mm -105.69 132.42 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.784 0.802 . . . . 0.0 111.755 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -122.9 97.89 5.65 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.452 0.644 . . . . 40.240000000000002 109.644 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.761 HG22 HD22 ' A' ' 76' ' ' LEU . 78.3 mt -91.98 117.22 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.735 -0.603 . . . . 20.73 110.55 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -117.71 134.96 54.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.44 -0.787 . . . . 0.0 109.47 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.614 ' HB2' HD23 ' A' ' 76' ' ' LEU . 51.7 t-20 -93.35 117.68 30.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.736 -0.602 . . . . 21.34 110.652 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.52 11.58 15.96 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.517 -0.739 . . . . 0.0 110.489 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.34 176.02 51.32 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.429 -1.469 . . . . 29.100000000000001 109.429 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.52 -39.36 16.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.482 -1.01 . . . . 0.0 110.214 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.506 HG13 ' HD2' ' A' ' 44' ' ' PRO . 87.9 t -99.32 140.41 21.64 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.923 -0.486 . . . . 0.0 109.805 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.506 ' HD2' HG13 ' A' ' 43' ' ' VAL . 40.6 Cg_endo -53.74 144.63 53.22 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 O-C-N 123.786 1.414 . . . . 21.949999999999999 111.722 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.55 151.9 46.46 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.548 0.69 . . . . 20.91 110.953 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.429 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 21.6 ptt-85 -128.11 158.11 38.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.78 -0.575 . . . . 0.0 109.855 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.681 HD22 HG13 ' A' ' 69' ' ' VAL . 6.4 tt -99.0 116.86 32.19 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.472 -0.767 . . . . 0.0 109.123 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.411 HG23 HG22 ' A' ' 104' ' ' VAL . 58.7 t -99.13 -29.63 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.495 -0.753 . . . . 0.0 111.461 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.653 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -139.87 163.72 31.9 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.048 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -142.79 141.45 31.68 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.588 0.708 . . . . 29.050000000000001 110.637 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -144.55 112.36 6.25 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.365 0.603 . . . . 27.969999999999999 109.403 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -99.44 136.16 39.79 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.559 0.695 . . . . 25.25 111.248 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -114.83 80.87 1.47 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.848 HG22 ' HG3' ' A' ' 97' ' ' MET . 12.3 pt -83.15 127.71 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-O 121.784 0.802 . . . . 36.109999999999999 111.59 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.634 HG23 HG22 ' A' ' 61' ' ' THR . 95.8 m -120.78 129.25 53.51 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.21 -1.033 . . . . 33.979999999999997 108.21 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -91.64 171.21 9.32 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.706 0.765 . . . . 45.039999999999999 111.217 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.92 -6.37 9.38 Favored Glycine 0 N--CA 1.493 2.482 0 O-C-N 121.688 -0.632 . . . . 39.469999999999999 112.214 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.6 p30 -101.87 5.88 41.2 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 119.46 1.63 . . . . 0.0 110.94 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 61' ' ' THR . . . 92.36 -32.0 5.73 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.204 -0.935 . . . . 0.0 111.23 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.05 142.71 53.57 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.128 -1.219 . . . . 62.780000000000001 109.845 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.634 HG22 HG23 ' A' ' 55' ' ' THR . 60.9 p -132.5 151.16 52.0 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.816 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -123.31 125.12 44.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.579 -0.701 . . . . 0.0 109.865 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -101.68 135.01 43.93 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.554 -0.716 . . . . 0.0 110.763 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.0 t -129.18 133.49 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.582 -0.699 . . . . 37.939999999999998 110.021 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -125.2 127.1 46.26 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.923 -0.486 . . . . 0.0 110.533 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.55 -174.16 14.25 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 108.757 -1.737 . . . . 31.82 108.757 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -66.42 -158.28 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.278 -1.131 . . . . 0.0 109.816 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.403 ' HA2' ' CD2' ' A' ' 47' ' ' LEU . . . -51.76 -88.6 0.01 OUTLIER Glycine 0 N--CA 1.498 2.824 0 N-CA-C 110.504 -1.039 . . . . 22.620000000000001 110.504 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.681 HG13 HD22 ' A' ' 47' ' ' LEU . 25.0 m -140.17 128.15 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.382 -1.069 . . . . 17.510000000000002 110.159 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 69' ' ' VAL . 12.4 m 40.86 35.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 CA-C-O 121.313 0.577 . . . . 20.550000000000001 112.248 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.58 21.53 57.93 Favored Glycine 0 N--CA 1.499 2.851 0 O-C-N 121.433 -0.792 . . . . 18.289999999999999 112.794 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.664 ' HG3' HG23 ' A' ' 69' ' ' VAL . 1.7 pt-20 -139.38 151.73 46.55 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 119.101 1.45 . . . . 0.0 111.197 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -113.51 74.65 2.28 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 109.278 -0.638 . . . . 18.210000000000001 109.278 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -57.58 141.98 95.44 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 O-C-N 123.838 1.441 . . . . 17.609999999999999 111.668 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.429 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 1.4 t90 -103.09 77.33 1.54 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.761 HD22 HG22 ' A' ' 37' ' ' ILE . 5.6 tp -62.24 118.18 7.06 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.612 -0.68 . . . . 20.57 111.285 -178.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -86.8 158.73 53.26 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -53.67 127.24 24.65 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 O-C-N 123.564 1.297 . . . . 27.039999999999999 110.972 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.64 -18.3 43.83 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.843 -0.903 . . . . 24.739999999999998 110.843 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -88.85 165.64 14.52 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.109 -1.23 . . . . 29.379999999999999 110.239 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.597 ' C ' HD11 ' A' ' 76' ' ' LEU . . . -146.21 151.08 37.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.498 -0.751 . . . . 0.0 110.43 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.491 ' N ' HD11 ' A' ' 76' ' ' LEU . 64.8 t80 -118.12 144.96 45.23 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.906 -0.775 . . . . 18.559999999999999 108.906 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.6 p80 -142.65 140.39 31.58 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.117 -0.989 . . . . 0.0 111.258 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.577 ' CE1' HG21 ' A' ' 35' ' ' ILE . 52.8 p90 -150.93 159.93 44.24 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.57 -0.706 . . . . 26.649999999999999 109.732 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.6 m -102.58 136.73 41.87 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.422 -0.799 . . . . 28.140000000000001 110.923 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 16.2 t -124.9 168.99 12.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.62 -0.675 . . . . 33.880000000000003 110.146 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.2 124.6 2.57 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.885 -1.15 . . . . 31.800000000000001 110.364 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.594 HG23 ' HE1' ' A' ' 33' ' ' TYR . 79.9 t -129.83 150.64 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.671 -0.899 . . . . 0.0 109.352 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.532 HD23 ' N ' ' A' ' 90' ' ' LEU . 9.4 tt -111.08 143.58 41.56 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.529 -0.732 . . . . 0.0 110.577 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.657 HD12 ' CD1' ' A' ' 31' ' ' PHE . 84.0 mt -121.9 145.27 48.26 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.576 -0.703 . . . . 38.68 109.978 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.658 ' HG3' HG23 ' A' ' 92' ' ' THR . 7.8 pt-20 -72.88 -24.22 60.82 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.373 -0.829 . . . . 0.0 111.157 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.658 HG23 ' HG3' ' A' ' 91' ' ' GLU . 57.3 p -124.3 171.27 10.02 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.342 -0.849 . . . . 31.629999999999999 110.755 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 32.1 tt0 -85.73 6.69 26.66 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.668 -0.645 . . . . 0.0 111.692 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -140.08 149.09 42.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.992 -1.068 . . . . 0.0 109.815 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.62 160.75 23.81 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 118.808 -1.663 . . . . 28.050000000000001 112.178 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -121.97 131.66 54.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 122.185 -0.597 . . . . 0.0 109.401 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.848 ' HG3' HG22 ' A' ' 54' ' ' ILE . 54.6 ttm -127.21 123.68 37.16 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.304 -0.872 . . . . 0.0 111.36 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.505 ' HG2' ' HB2' ' A' ' 117' ' ' ALA . 1.8 mp0 -123.8 148.21 46.89 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.76 176.21 39.86 Favored Glycine 0 N--CA 1.501 2.991 0 C-N-CA 118.565 -1.779 . . . . 29.620000000000001 111.132 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -140.87 157.6 45.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.804 -0.821 . . . . 0.0 110.663 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.615 ' CE2' HD11 ' A' ' 115' ' ' ILE . 7.2 m-85 -117.07 128.82 55.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.677 -0.639 . . . . 27.050000000000001 110.007 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.653 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 26.1 t0 -81.75 123.59 28.89 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.967 -1.083 . . . . 0.0 109.11 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.786 ' CE ' HG11 ' A' ' 9' ' ' VAL . 47.4 mtt -122.58 162.6 21.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.887 -0.508 . . . . 0.0 110.491 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.411 HG22 HG23 ' A' ' 48' ' ' VAL . 11.3 m -141.85 128.72 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.516 -0.74 . . . . 23.280000000000001 110.251 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.96 167.55 21.27 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.489 -0.757 . . . . 0.0 109.684 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -64.33 -30.78 71.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.497 -0.752 . . . . 0.0 110.059 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -72.38 -11.7 60.8 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.519 -0.738 . . . . 0.0 110.959 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.23 -7.41 47.6 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.398 -1.081 . . . . 30.43 110.398 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.567 HG21 ' CE2' ' A' ' 7' ' ' TYR . 69.3 m -57.2 135.02 56.4 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.048 -1.266 . . . . 0.0 110.036 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -101.19 139.94 36.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.384 -0.823 . . . . 0.0 110.827 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.458 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 49.8 p90 -167.38 146.92 5.16 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.704 -0.622 . . . . 28.030000000000001 110.077 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.3 pt -103.18 159.12 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.675 -0.641 . . . . 0.0 110.954 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.41 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -119.3 96.61 50.04 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -59.23 143.79 99.62 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 O-C-N 123.907 1.477 . . . . 33.310000000000002 112.269 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.615 HD11 ' CE2' ' A' ' 101' ' ' TYR . 71.4 mt -107.77 122.15 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.68 -0.859 . . . . 30.59 108.68 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.82 155.69 0.83 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.264 0.554 . . . . 30.780000000000001 111.577 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.505 ' HB2' ' HG2' ' A' ' 98' ' ' GLN . . . -91.05 119.99 31.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.724 -0.61 . . . . 0.0 110.675 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.678 ' CE1' HD11 ' A' ' 120' ' ' LEU . 51.5 p90 -111.02 162.66 14.64 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.487 -0.931 . . . . 30.66 108.487 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.625 ' C ' HD12 ' A' ' 120' ' ' LEU . 9.3 p -115.98 154.67 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.204 -0.935 . . . . 0.0 110.882 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.678 HD11 ' CE1' ' A' ' 118' ' ' PHE . 7.3 mp -114.07 132.12 56.14 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.32 -0.622 . . . . 39.149999999999999 109.32 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.654 -0.654 . . . . 0.0 110.137 -179.814 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 120.823 0.344 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.456 ' CE1' ' CB ' ' A' ' 105' ' ' ALA . 21.4 m-85 -123.55 101.44 7.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.355 -0.841 . . . . 31.93 110.207 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.458 ' C ' HG23 ' A' ' 9' ' ' VAL . 27.6 mmt180 -144.1 139.19 28.75 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.665 0.745 . . . . 0.0 109.99 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.458 HG23 ' C ' ' A' ' 8' ' ' ARG . 70.7 t -150.94 114.98 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -105.97 129.55 54.08 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.538 0.685 . . . . 0.0 109.836 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.512 HG22 ' HA ' ' A' ' 37' ' ' ILE . 57.6 t -118.23 139.79 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.869 -0.519 . . . . 28.210000000000001 109.754 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -120.67 136.65 54.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.438 -0.789 . . . . 0.0 109.817 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.649 HG22 HD13 ' A' ' 35' ' ' ILE . 60.9 t -128.87 137.77 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.586 -0.697 . . . . 27.949999999999999 110.219 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.7 m -125.07 105.07 29.12 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.717 -0.614 . . . . 0.0 110.638 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -84.3 165.56 12.69 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 O-C-N 123.85 1.447 . . . . 33.0 110.797 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -157.46 132.06 8.56 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.541 0.686 . . . . 54.100000000000001 110.064 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.482 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 80.5 t80 -59.73 139.98 56.84 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.852 -0.53 . . . . 0.0 111.315 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.915 HD11 ' HB2' ' A' ' 32' ' ' ALA . 91.2 mt -115.98 80.16 1.41 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.904 0.859 . . . . 0.0 110.397 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.482 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -66.02 -35.84 81.65 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.912 -0.492 . . . . 0.0 111.063 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -69.77 -23.71 63.4 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.415 -0.803 . . . . 0.0 110.947 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -121.05 34.65 5.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.36 -0.837 . . . . 52.369999999999997 111.08 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.654 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 24.4 p -156.47 147.91 22.5 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.312 -0.868 . . . . 55.189999999999998 111.109 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.579 ' O ' HG23 ' A' ' 23' ' ' THR . 4.9 t -118.9 92.17 44.36 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.475 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 51.3 Cg_endo -65.74 -23.51 55.86 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 O-C-N 123.853 1.449 . . . . 51.57 111.627 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.83 -22.41 66.55 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.398 -0.813 . . . . 0.0 110.833 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -106.13 23.56 13.85 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.25 -0.906 . . . . 0.0 110.684 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.37 28.0 73.6 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.549 ' HB2' HG23 ' A' ' 23' ' ' THR . 3.2 mtm-85 -121.46 94.13 4.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.591 -0.947 . . . . 0.0 110.175 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.475 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 63.8 m-85 -104.15 135.4 45.71 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.54 -0.725 . . . . 46.07 109.22 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.654 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -114.59 120.54 40.53 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.524 -0.735 . . . . 0.0 111.174 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.459 ' CD1' HD12 ' A' ' 90' ' ' LEU . 89.0 m-85 -116.14 131.56 56.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.555 -0.715 . . . . 38.880000000000003 109.795 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.915 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -114.01 131.96 56.16 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.287 -0.883 . . . . 34.060000000000002 108.658 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.475 ' CE1' HD11 ' A' ' 35' ' ' ILE . 54.6 p90 -128.22 145.98 50.87 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 119.17 -1.012 . . . . 29.030000000000001 111.544 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.6 t -101.97 140.88 35.66 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.649 HD13 HG22 ' A' ' 13' ' ' VAL . 48.1 mm -105.47 132.29 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.819 0.819 . . . . 0.0 111.772 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -123.49 98.97 6.09 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.399 0.619 . . . . 40.240000000000002 109.826 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.886 HG22 HD22 ' A' ' 76' ' ' LEU . 80.3 mt -91.23 117.27 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.711 -0.618 . . . . 20.73 110.735 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -117.99 134.06 55.32 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.578 -0.701 . . . . 0.0 109.421 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.466 ' HB2' HD23 ' A' ' 76' ' ' LEU . 42.9 t-20 -94.5 117.36 30.0 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 120.178 -0.609 . . . . 21.34 110.781 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.25 13.37 17.89 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.415 -0.803 . . . . 0.0 110.442 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.89 -176.26 51.17 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.515 -1.434 . . . . 29.100000000000001 109.515 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.28 -33.74 10.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.561 -0.964 . . . . 0.0 109.846 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.511 HG13 ' HD2' ' A' ' 44' ' ' PRO . 87.6 t -104.56 141.51 22.68 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.511 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.6 Cg_endo -53.13 144.5 46.9 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 O-C-N 123.693 1.365 . . . . 21.949999999999999 111.619 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -136.79 151.37 49.09 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.732 0.777 . . . . 20.91 111.232 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.426 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 47.2 ttp180 -126.6 152.08 47.11 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.775 HD22 HG13 ' A' ' 69' ' ' VAL . 7.1 tt -98.02 117.85 33.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 109.441 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.6 p -100.69 -25.21 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.55 -0.719 . . . . 0.0 110.947 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.665 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -142.12 164.27 30.62 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.039 -1.064 . . . . 0.0 112.034 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -141.69 139.08 32.87 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.334 0.588 . . . . 29.050000000000001 109.993 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -142.46 113.84 7.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.703 -0.623 . . . . 27.969999999999999 110.016 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.543 ' CH2' HD13 ' A' ' 115' ' ' ILE . 87.8 m95 -101.47 132.66 46.97 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.745 -0.597 . . . . 25.25 110.753 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -116.88 77.42 1.11 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.642 -0.661 . . . . 0.0 109.572 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.459 HD11 ' HB2' ' A' ' 62' ' ' GLU . 28.5 pt -83.59 130.07 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.789 0.804 . . . . 36.109999999999999 112.211 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.906 HG23 HG22 ' A' ' 61' ' ' THR . 25.6 m -119.28 129.59 54.98 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.266 -1.013 . . . . 33.979999999999997 108.266 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -91.63 170.32 10.02 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.734 0.778 . . . . 45.039999999999999 111.364 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.28 -7.21 12.82 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 121.791 -0.568 . . . . 39.469999999999999 112.149 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -102.23 5.69 40.23 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 119.431 1.616 . . . . 0.0 110.733 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 61' ' ' THR . . . 93.3 -29.49 8.2 Favored Glycine 0 N--CA 1.495 2.585 0 O-C-N 121.213 -0.929 . . . . 0.0 110.898 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -61.86 142.28 57.46 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.323 -1.104 . . . . 62.780000000000001 109.747 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.906 HG22 HG23 ' A' ' 55' ' ' THR . 69.9 p -134.29 151.69 51.4 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.476 -0.765 . . . . 0.0 110.434 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.459 ' HB2' HD11 ' A' ' 54' ' ' ILE . 96.6 mt-10 -121.65 122.12 38.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.509 -0.745 . . . . 0.0 110.074 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -104.19 135.15 46.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.567 -0.708 . . . . 0.0 110.634 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.4 t -128.07 131.75 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.545 -0.722 . . . . 37.939999999999998 109.888 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -125.12 127.55 47.05 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.747 -0.596 . . . . 0.0 110.554 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.88 164.82 30.92 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.215 -1.554 . . . . 31.82 109.215 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -106.08 158.31 16.9 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.351 -1.088 . . . . 0.0 110.086 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.96 96.43 0.01 OUTLIER Glycine 0 N--CA 1.5 2.929 0 O-C-N 121.454 -0.778 . . . . 22.620000000000001 111.628 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.775 HG13 HD22 ' A' ' 47' ' ' LEU . 25.1 m -45.39 132.89 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.519 0 O-C-N 121.403 -1.057 . . . . 17.510000000000002 111.534 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.0 m 41.63 36.01 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 CA-C-O 121.631 0.729 . . . . 20.550000000000001 111.413 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.0 21.46 59.16 Favored Glycine 0 N--CA 1.496 2.688 0 O-C-N 121.762 -0.586 . . . . 18.289999999999999 112.436 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.421 ' HG3' HG23 ' A' ' 69' ' ' VAL . 4.9 pt-20 -147.6 154.32 40.51 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-N 119.128 1.464 . . . . 0.0 112.457 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -117.55 72.97 7.88 Favored Pre-proline 0 N--CA 1.491 1.6 0 N-CA-C 108.558 -0.904 . . . . 18.210000000000001 108.558 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -53.99 139.78 70.1 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 O-C-N 123.735 1.387 . . . . 17.609999999999999 112.286 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.426 ' CD1' ' HB2' ' A' ' 46' ' ' ARG . 3.4 t90 -101.45 76.03 1.65 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.886 HD22 HG22 ' A' ' 37' ' ' ILE . 2.5 tp -62.33 117.22 5.82 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.585 -0.697 . . . . 20.57 111.339 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 -85.59 158.71 56.72 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -53.96 126.02 20.64 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 O-C-N 123.537 1.283 . . . . 27.039999999999999 110.905 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.94 -18.37 44.69 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.732 -0.947 . . . . 24.739999999999998 110.732 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -88.96 164.9 14.91 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.133 -1.216 . . . . 29.379999999999999 110.263 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.451 ' C ' HD11 ' A' ' 76' ' ' LEU . . . -146.98 150.4 35.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.541 -0.724 . . . . 0.0 110.331 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.608 ' N ' HD11 ' A' ' 76' ' ' LEU . 64.7 t80 -117.86 145.58 44.5 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.864 -0.791 . . . . 18.559999999999999 108.864 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -143.57 140.48 30.23 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.119 -0.988 . . . . 0.0 111.37 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.512 ' CE1' HG21 ' A' ' 35' ' ' ILE . 51.1 p90 -150.14 160.02 43.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.647 -0.658 . . . . 26.649999999999999 109.34 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.5 m -102.62 139.08 38.67 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.29 -0.881 . . . . 28.140000000000001 110.928 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.437 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 16.8 t -124.06 166.07 16.41 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.647 -0.658 . . . . 33.880000000000003 109.97 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -144.53 120.3 1.4 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.076 -1.21 . . . . 31.800000000000001 110.076 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.51 152.93 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.686 -0.89 . . . . 0.0 109.927 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.98 142.85 39.03 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.521 -0.737 . . . . 0.0 110.508 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.459 HD12 ' CD1' ' A' ' 31' ' ' PHE . 24.1 mt -124.02 143.08 50.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.542 -0.724 . . . . 38.68 110.291 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -82.23 -22.77 35.71 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.217 -0.927 . . . . 0.0 110.087 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.429 HG22 ' H ' ' A' ' 94' ' ' GLN . 7.2 m -99.55 134.25 42.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.671 -0.643 . . . . 31.629999999999999 109.991 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.413 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 58.2 tt0 -75.39 -7.9 55.26 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.171 -0.956 . . . . 0.0 110.833 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.429 ' H ' HG22 ' A' ' 92' ' ' THR . 14.5 pt20 -138.3 147.28 43.41 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.21 -0.931 . . . . 0.0 108.952 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.7 169.64 38.97 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 118.265 -1.922 . . . . 28.050000000000001 112.706 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -115.82 130.23 56.75 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 98.3 mtp -126.73 121.27 31.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.349 -0.844 . . . . 0.0 111.316 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.612 ' HG2' ' HB2' ' A' ' 117' ' ' ALA . 55.8 mt-30 -124.39 152.12 43.6 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.27 175.92 36.99 Favored Glycine 0 N--CA 1.499 2.86 0 C-N-CA 118.792 -1.671 . . . . 29.620000000000001 111.05 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -137.61 157.85 45.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.8 -0.824 . . . . 0.0 109.678 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.593 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 10.1 m-85 -116.64 127.31 54.32 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.577 -0.702 . . . . 27.050000000000001 110.009 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.665 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 42.8 t0 -85.63 119.13 25.62 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.992 -1.068 . . . . 0.0 108.723 177.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.425 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 2.5 tpt -122.49 160.7 25.03 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.141 0.496 . . . . 0.0 110.348 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.0 m -139.08 129.5 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.639 -0.663 . . . . 23.280000000000001 110.105 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.456 ' CB ' ' CE1' ' A' ' 7' ' ' TYR . . . -70.01 164.81 23.14 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.571 -0.706 . . . . 0.0 109.633 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -63.76 -28.17 69.69 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.537 -0.727 . . . . 0.0 110.131 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -79.0 -7.6 58.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.487 -0.758 . . . . 0.0 111.294 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.7 -7.63 45.94 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 120.104 -1.046 . . . . 30.43 110.515 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.4 m -57.82 134.98 56.76 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.046 -1.267 . . . . 0.0 109.98 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -101.84 139.38 37.55 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.346 -0.846 . . . . 0.0 110.891 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 43.0 p90 -165.1 143.61 6.42 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.732 -0.605 . . . . 28.030000000000001 109.685 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 85.0 mt -101.62 157.69 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.646 -0.659 . . . . 0.0 110.81 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.593 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -120.15 97.33 49.25 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -58.7 143.78 98.44 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 O-C-N 123.847 1.446 . . . . 33.310000000000002 112.292 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.543 HD13 ' CH2' ' A' ' 52' ' ' TRP . 52.7 mt -108.71 122.83 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.739 -0.837 . . . . 30.59 108.739 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.42 171.29 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.29 0.567 . . . . 30.780000000000001 111.465 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.612 ' HB2' ' HG2' ' A' ' 98' ' ' GLN . . . -101.72 122.01 43.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.657 -0.652 . . . . 0.0 110.825 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.474 ' CE1' HD11 ' A' ' 120' ' ' LEU . 49.1 p90 -110.94 156.45 21.19 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.162 -1.051 . . . . 30.66 108.162 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.613 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.8 t -115.87 154.95 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.174 -0.954 . . . . 0.0 110.587 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.65 ' N ' HD12 ' A' ' 120' ' ' LEU . 7.6 mp -112.49 132.23 55.18 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.099 -0.704 . . . . 39.149999999999999 109.099 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 34.7 t . . . . . 0 N--CA 1.493 1.716 0 O-C-N 121.779 -0.576 . . . . 0.0 110.041 -179.782 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.67 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 90.0 mtt180 . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 120.781 0.324 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -121.42 101.95 7.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.437 -0.79 . . . . 31.93 110.16 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.482 ' C ' HG23 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -148.79 131.53 15.98 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.554 -0.716 . . . . 0.0 110.065 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.482 HG23 ' C ' ' A' ' 8' ' ' ARG . 84.0 t -152.11 117.09 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.613 0.72 . . . . 0.0 109.808 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -105.27 129.66 53.58 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.537 0.684 . . . . 0.0 109.825 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.483 HG11 ' HE2' ' A' ' 101' ' ' TYR . 62.2 t -117.97 139.03 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.842 -0.536 . . . . 28.210000000000001 109.76 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -121.65 136.93 54.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.456 -0.777 . . . . 0.0 110.116 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.714 HG22 HD13 ' A' ' 35' ' ' ILE . 60.5 t -129.28 136.57 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.581 -0.699 . . . . 27.949999999999999 110.139 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.0 m -125.44 103.96 28.57 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.737 -0.602 . . . . 0.0 110.659 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.74 165.05 15.85 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 O-C-N 123.874 1.46 . . . . 33.0 110.835 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -157.85 132.92 8.69 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.661 0.743 . . . . 54.100000000000001 110.111 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.495 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 80.4 t80 -60.01 140.1 57.0 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.27 0.557 . . . . 0.0 111.629 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.873 HD11 ' HB2' ' A' ' 32' ' ' ALA . 85.4 mt -117.11 83.44 1.98 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.019 0.914 . . . . 0.0 110.247 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.495 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -68.97 -35.11 76.37 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.317 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -69.92 -22.69 63.18 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.427 -0.795 . . . . 0.0 111.099 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -121.87 34.31 5.22 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.232 -0.918 . . . . 52.369999999999997 110.897 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.585 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 24.8 p -154.46 148.8 26.09 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.308 -0.87 . . . . 55.189999999999998 110.979 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.619 HG23 ' HB2' ' A' ' 28' ' ' ARG . 8.2 t -121.97 93.84 48.43 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.4 Cg_endo -66.86 -23.2 47.94 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 O-C-N 123.786 1.414 . . . . 51.57 112.068 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -66.05 -22.36 66.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.253 -0.904 . . . . 0.0 111.032 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -106.47 23.22 14.55 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.207 -0.933 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.52 29.16 72.89 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.619 ' HB2' HG23 ' A' ' 23' ' ' THR . 93.6 mtt-85 -121.4 94.18 4.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.551 -0.97 . . . . 0.0 110.178 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.46 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 58.8 m-85 -105.6 133.8 49.75 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.503 -0.748 . . . . 46.07 109.143 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.585 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -115.77 120.64 39.97 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.354 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -116.68 131.04 57.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.553 -0.717 . . . . 38.880000000000003 109.642 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.873 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -114.77 131.77 56.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.255 -0.903 . . . . 34.060000000000002 109.048 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.489 ' CE1' HD11 ' A' ' 35' ' ' ILE . 53.1 p90 -128.08 148.13 50.55 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.338 -0.945 . . . . 29.030000000000001 111.308 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 m -101.27 140.21 35.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.667 -0.646 . . . . 0.0 109.411 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.714 HD13 HG22 ' A' ' 13' ' ' VAL . 46.0 mm -103.69 132.39 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-O 121.841 0.829 . . . . 0.0 111.677 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.0 mmm-85 -124.05 97.22 5.25 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.471 0.653 . . . . 40.240000000000002 109.797 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.499 HG22 ' CD1' ' A' ' 76' ' ' LEU . 80.1 mt -92.21 118.17 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.704 -0.623 . . . . 20.73 110.751 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -117.36 132.81 56.52 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.508 -0.745 . . . . 0.0 109.21 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -93.96 117.89 30.73 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.786 -0.571 . . . . 21.34 110.632 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.81 14.12 16.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.527 -0.733 . . . . 0.0 110.539 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.52 -171.89 46.09 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.215 -1.554 . . . . 29.100000000000001 109.215 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.67 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . . . -104.64 -29.99 10.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.463 -1.021 . . . . 0.0 110.343 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.539 HG13 ' HD2' ' A' ' 44' ' ' PRO . 88.0 t -108.82 141.36 23.16 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.836 -0.54 . . . . 0.0 110.016 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.539 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.1 Cg_endo -52.52 142.33 49.18 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 O-C-N 123.772 1.406 . . . . 21.949999999999999 111.749 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.461 ' HB1' ' SD ' ' A' ' 103' ' ' MET . . . -137.41 151.69 48.82 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.875 0.845 . . . . 20.91 111.418 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.427 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 54.5 ttp180 -125.89 153.45 44.18 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.93 HD22 HG13 ' A' ' 69' ' ' VAL . 7.0 tt -97.53 119.19 35.63 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.574 -0.704 . . . . 0.0 109.464 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.492 HG23 HG22 ' A' ' 104' ' ' VAL . 57.3 t -101.17 -27.15 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.539 -0.726 . . . . 0.0 110.983 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.725 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -142.13 165.06 28.47 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 119.1 -1.04 . . . . 0.0 112.162 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.7 ptt-85 -141.12 139.59 33.99 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.368 0.604 . . . . 29.050000000000001 110.214 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -142.79 112.84 7.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.775 -0.578 . . . . 27.969999999999999 109.873 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -102.19 134.27 45.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.642 -0.661 . . . . 25.25 111.168 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -116.09 79.15 1.27 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.75 -0.594 . . . . 0.0 109.405 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.433 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.0 pt -86.75 129.24 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 121.833 0.825 . . . . 36.109999999999999 111.826 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.722 HG23 HG22 ' A' ' 61' ' ' THR . 99.1 m -120.69 130.38 54.06 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.441 -0.948 . . . . 33.979999999999997 108.441 178.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -89.93 170.5 10.32 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.748 0.785 . . . . 45.039999999999999 111.251 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.83 -7.06 14.07 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 121.75 -0.594 . . . . 39.469999999999999 112.138 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -101.62 6.3 41.99 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 119.344 1.572 . . . . 0.0 110.667 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 61' ' ' THR . . . 92.61 -26.19 15.23 Favored Glycine 0 N--CA 1.494 2.566 0 O-C-N 121.208 -0.933 . . . . 0.0 110.966 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -62.16 141.28 58.25 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.184 -1.186 . . . . 62.780000000000001 109.6 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.722 HG22 HG23 ' A' ' 55' ' ' THR . 58.3 p -131.54 148.79 52.65 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.402 -0.812 . . . . 0.0 110.574 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -122.3 120.53 34.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.445 -0.785 . . . . 0.0 109.872 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -103.06 135.0 45.55 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.747 -0.596 . . . . 0.0 110.499 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.2 t -128.29 130.31 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.614 0.721 . . . . 37.939999999999998 110.031 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -126.17 126.53 44.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.895 -0.503 . . . . 0.0 109.946 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.78 151.03 23.18 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.555 -1.418 . . . . 31.82 109.555 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -77.38 155.22 32.03 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.431 -1.04 . . . . 0.0 110.241 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.62 -174.52 0.23 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 110.99 -0.844 . . . . 22.620000000000001 110.99 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.93 HG13 HD22 ' A' ' 47' ' ' LEU . 13.1 m -128.81 127.43 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.838 -0.801 . . . . 17.510000000000002 109.625 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 69' ' ' VAL . 13.2 m 41.32 36.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 CA-C-O 121.603 0.715 . . . . 20.550000000000001 111.831 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.37 16.03 70.03 Favored Glycine 0 N--CA 1.499 2.841 0 O-C-N 121.588 -0.695 . . . . 18.289999999999999 112.869 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.425 ' O ' HG22 ' A' ' 69' ' ' VAL . 10.1 pt-20 -146.43 151.67 37.81 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 119.158 1.479 . . . . 0.0 112.147 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -115.42 75.55 4.76 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 108.746 -0.835 . . . . 18.210000000000001 108.746 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -57.85 137.65 82.12 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 O-C-N 123.811 1.427 . . . . 17.609999999999999 112.194 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.434 ' CH2' ' CB ' ' A' ' 44' ' ' PRO . 7.4 t90 -101.34 75.98 1.67 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.499 ' CD1' HG22 ' A' ' 37' ' ' ILE . 10.1 mt -60.3 118.37 6.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.566 -0.709 . . . . 20.57 112.013 -178.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.6 mtp85 -86.59 158.87 53.69 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -54.62 129.14 33.38 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 O-C-N 123.466 1.246 . . . . 27.039999999999999 111.126 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.02 -18.3 48.62 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 111.012 -0.835 . . . . 24.739999999999998 111.012 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -88.28 166.01 14.62 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.041 -1.27 . . . . 29.379999999999999 110.69 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.1 148.68 33.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.594 -0.691 . . . . 0.0 110.024 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.435 ' HD1' HD12 ' A' ' 37' ' ' ILE . 64.6 t80 -117.57 144.67 44.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.466 -0.771 . . . . 18.559999999999999 109.13 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -143.62 140.42 30.13 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.234 -0.916 . . . . 0.0 111.279 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.646 ' CE1' HG21 ' A' ' 35' ' ' ILE . 49.5 p90 -150.89 159.96 44.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.591 -0.693 . . . . 26.649999999999999 109.62 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.5 m -101.67 137.5 39.9 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.389 -0.819 . . . . 28.140000000000001 111.005 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.447 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 15.0 t -124.49 167.63 14.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.641 -0.662 . . . . 33.880000000000003 109.918 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.89 124.41 2.45 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.811 -1.185 . . . . 31.800000000000001 110.466 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.71 153.5 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.653 -0.91 . . . . 0.0 109.896 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 89' ' ' LEU . 4.9 mp -108.84 144.86 36.15 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.559 -0.713 . . . . 0.0 111.071 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.692 ' CD1' HD22 ' A' ' 120' ' ' LEU . 0.4 OUTLIER -121.09 147.23 45.83 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.685 -0.634 . . . . 38.68 109.591 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.41 ' O ' ' CE1' ' A' ' 29' ' ' TYR . 74.7 tt0 -77.9 -26.6 49.2 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.248 -0.908 . . . . 0.0 111.25 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.8 p -124.99 172.78 9.14 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.268 -0.895 . . . . 31.629999999999999 110.936 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.457 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 50.4 mt-10 -86.62 11.55 12.6 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.653 -0.654 . . . . 0.0 111.469 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 97.4 mt-30 -139.99 144.38 36.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.037 -1.039 . . . . 0.0 109.69 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.98 157.03 17.9 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 118.795 -1.669 . . . . 28.050000000000001 112.237 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -121.36 131.37 54.15 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.425 ' HB3' ' HE2' ' A' ' 97' ' ' MET . 98.1 mtp -127.24 120.7 29.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.326 -0.859 . . . . 0.0 111.386 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 117' ' ' ALA . 56.0 tt0 -126.41 151.4 47.74 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.12 177.8 39.02 Favored Glycine 0 N--CA 1.499 2.871 0 C-N-CA 118.946 -1.597 . . . . 29.620000000000001 110.962 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.406 ' CD2' ' HB3' ' A' ' 114' ' ' PRO . 66.9 m80 -136.17 156.92 47.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.715 -0.874 . . . . 0.0 110.139 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.624 ' CD2' HD11 ' A' ' 115' ' ' ILE . 4.7 m-85 -115.37 127.93 55.73 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.759 -0.588 . . . . 27.050000000000001 109.932 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.725 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 11.1 t70 -83.71 121.92 27.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.965 -1.084 . . . . 0.0 108.532 177.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.462 ' SD ' HG21 ' A' ' 9' ' ' VAL . 54.6 ttm -123.92 161.59 25.07 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.297 0.57 . . . . 0.0 110.781 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.492 HG22 HG23 ' A' ' 48' ' ' VAL . 10.5 m -139.99 129.93 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.741 -0.599 . . . . 23.280000000000001 110.17 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 107' ' ' ASP . . . -75.3 166.29 23.84 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.509 -0.744 . . . . 0.0 109.811 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -65.33 -31.05 71.98 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.52 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.488 ' OD1' ' HB3' ' A' ' 105' ' ' ALA . 49.4 p-10 -74.57 -7.73 54.05 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.433 -0.792 . . . . 0.0 111.272 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.0 -9.33 54.92 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 120.091 -1.052 . . . . 30.43 110.636 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.4 m -57.55 134.79 56.43 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.021 -1.282 . . . . 0.0 109.935 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -101.92 140.83 35.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.432 -0.792 . . . . 0.0 110.931 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -168.61 146.12 3.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.666 -0.646 . . . . 28.030000000000001 109.851 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 84.9 mt -101.23 157.52 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.707 -0.621 . . . . 0.0 110.66 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.27 98.7 50.57 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.406 ' HB3' ' CD2' ' A' ' 100' ' ' HIS . 45.4 Cg_endo -58.08 142.84 97.16 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 O-C-N 123.932 1.491 . . . . 33.310000000000002 112.254 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.624 HD11 ' CD2' ' A' ' 101' ' ' TYR . 48.6 mt -109.31 124.28 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.741 -0.837 . . . . 30.59 108.741 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.66 149.99 3.02 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.861 -0.525 . . . . 30.780000000000001 111.271 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.438 ' HB2' ' HB2' ' A' ' 98' ' ' GLN . . . -92.86 124.26 36.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.66 -0.65 . . . . 0.0 110.047 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.653 ' HE1' HD11 ' A' ' 120' ' ' LEU . 44.7 p90 -108.8 164.67 12.18 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.046 -0.724 . . . . 30.66 109.046 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.588 ' C ' HD12 ' A' ' 120' ' ' LEU . 8.5 p -116.0 155.41 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.349 -0.845 . . . . 0.0 110.495 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.692 HD22 ' CD1' ' A' ' 90' ' ' LEU . 7.2 mp -112.13 133.07 54.49 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.281 -0.637 . . . . 39.149999999999999 109.281 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.627 -0.671 . . . . 0.0 110.094 -179.796 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 120.678 0.275 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -118.23 108.1 14.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.452 -0.78 . . . . 31.93 110.336 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.48 ' C ' HG23 ' A' ' 9' ' ' VAL . 23.5 mtm180 -151.01 132.12 14.37 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.61 -0.681 . . . . 0.0 110.092 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.599 HG11 ' SD ' ' A' ' 103' ' ' MET . 60.9 t -151.67 114.45 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.543 -0.723 . . . . 0.0 109.548 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -106.7 130.36 54.44 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.628 0.727 . . . . 0.0 110.246 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.6 t -117.73 139.23 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.585 -0.524 . . . . 28.210000000000001 109.585 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -121.24 138.44 54.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.367 -0.833 . . . . 0.0 110.193 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.833 HG22 HD13 ' A' ' 35' ' ' ILE . 61.8 t -128.56 135.84 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.61 -0.681 . . . . 27.949999999999999 110.445 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.6 t -126.61 105.53 23.72 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.694 -0.629 . . . . 0.0 110.474 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -82.95 164.8 15.45 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 O-C-N 123.832 1.438 . . . . 33.0 111.15 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -157.87 131.63 7.92 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.572 0.701 . . . . 54.100000000000001 109.697 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.522 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 80.2 t80 -62.13 138.55 58.41 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.651 -0.656 . . . . 0.0 111.691 -178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.985 HD11 ' HB2' ' A' ' 32' ' ' ALA . 86.0 mt -116.66 83.15 1.91 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 122.009 0.909 . . . . 0.0 110.269 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.522 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -68.45 -35.55 77.74 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.303 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -69.8 -23.71 63.37 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.309 -0.869 . . . . 0.0 111.076 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -121.77 43.06 2.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.263 -0.898 . . . . 52.369999999999997 110.717 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.734 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 37.8 t -162.64 143.93 10.17 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.399 -0.813 . . . . 55.189999999999998 110.883 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.9 m -116.58 92.69 38.21 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.44 -0.787 . . . . 0.0 109.124 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.458 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 47.5 Cg_endo -66.05 -25.16 51.63 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 O-C-N 123.932 1.49 . . . . 51.57 111.553 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -68.49 -22.95 64.51 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.298 -0.876 . . . . 0.0 111.038 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -105.06 22.82 14.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.235 -0.915 . . . . 0.0 110.912 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.41 28.62 73.15 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -120.63 93.59 4.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.652 -0.91 . . . . 0.0 109.804 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.458 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 65.2 m-85 -105.62 130.89 53.56 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.361 -0.837 . . . . 46.07 109.017 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.734 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -116.3 121.14 41.13 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.554 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.653 ' CD1' HD12 ' A' ' 90' ' ' LEU . 85.1 m-85 -116.75 134.3 54.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.624 -0.672 . . . . 38.880000000000003 109.459 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.985 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -110.9 132.63 54.04 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.171 -0.956 . . . . 34.060000000000002 108.839 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.585 ' HE1' HG23 ' A' ' 88' ' ' VAL . 25.8 p90 -126.98 143.55 51.26 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.376 -0.929 . . . . 29.030000000000001 111.294 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.0 t -103.92 139.57 38.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.707 -0.621 . . . . 0.0 109.417 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.833 HD13 HG22 ' A' ' 13' ' ' VAL . 40.9 mm -105.06 132.6 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.811 0.815 . . . . 0.0 111.532 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -123.02 95.74 4.73 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.46 0.647 . . . . 40.240000000000002 109.563 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.53 HG22 ' CD1' ' A' ' 76' ' ' LEU . 78.7 mt -90.23 117.5 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.766 -0.583 . . . . 20.73 110.535 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -117.36 134.4 54.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.515 -0.741 . . . . 0.0 109.434 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -92.24 117.43 29.87 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.282 -0.567 . . . . 21.34 110.524 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.85 10.44 16.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.471 -0.768 . . . . 0.0 110.584 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.32 179.55 53.3 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.216 -1.554 . . . . 29.100000000000001 109.216 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.11 -30.93 13.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.516 -0.991 . . . . 0.0 110.29 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.523 HG13 ' HD2' ' A' ' 44' ' ' PRO . 84.0 t -106.29 140.15 21.0 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.791 -0.568 . . . . 0.0 109.984 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.523 ' HD2' HG13 ' A' ' 43' ' ' VAL . 38.7 Cg_endo -51.53 141.28 42.74 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 O-C-N 123.8 1.421 . . . . 21.949999999999999 112.038 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.34 152.2 45.63 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.709 0.766 . . . . 20.91 111.09 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.2 ptt-85 -127.66 159.46 34.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.706 -0.621 . . . . 0.0 109.471 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.894 HD22 HG13 ' A' ' 69' ' ' VAL . 7.1 tt -96.62 117.56 31.24 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.418 -0.801 . . . . 0.0 109.794 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.444 HG23 HG22 ' A' ' 104' ' ' VAL . 58.6 t -99.48 -28.46 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.519 -0.738 . . . . 0.0 110.636 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.743 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -142.61 162.82 34.46 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.83 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.606 ' HD2' HG12 ' A' ' 69' ' ' VAL . 2.7 ptm180 -143.5 142.12 31.02 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.612 0.72 . . . . 29.050000000000001 110.712 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.409 ' HB3' ' NE2' ' A' ' 100' ' ' HIS . 21.6 t-160 -145.27 114.79 7.2 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.289 0.566 . . . . 27.969999999999999 109.701 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.464 ' CH2' HG21 ' A' ' 115' ' ' ILE . 67.3 m95 -100.13 136.67 39.69 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.652 -0.655 . . . . 25.25 111.36 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -116.13 78.28 1.18 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.661 -0.649 . . . . 0.0 109.258 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.425 ' O ' HG13 ' A' ' 54' ' ' ILE . 29.9 pt -88.15 131.67 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.771 0.796 . . . . 36.109999999999999 112.279 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.449 ' OG1' HG22 ' A' ' 61' ' ' THR . 93.5 m -119.63 133.23 55.73 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.395 -0.965 . . . . 33.979999999999997 108.395 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -85.89 169.16 13.55 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.693 0.759 . . . . 45.039999999999999 111.265 -178.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.93 -9.35 13.66 Favored Glycine 0 N--CA 1.496 2.644 0 O-C-N 121.827 -0.546 . . . . 39.469999999999999 112.078 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -100.78 9.23 42.64 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 119.26 1.53 . . . . 0.0 110.761 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.7 -21.0 38.3 Favored Glycine 0 N--CA 1.495 2.621 0 O-C-N 121.2 -0.938 . . . . 0.0 111.018 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.02 142.33 54.12 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.064 -1.257 . . . . 62.780000000000001 109.884 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.449 HG22 ' OG1' ' A' ' 55' ' ' THR . 73.4 p -125.32 140.24 52.99 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.515 -0.741 . . . . 0.0 110.808 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -123.18 117.88 26.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.525 -0.734 . . . . 0.0 109.829 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -103.75 135.32 45.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.717 -0.614 . . . . 0.0 110.768 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.0 t -128.75 130.89 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.657 -0.652 . . . . 37.939999999999998 109.947 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.404 ' OD1' ' CG ' ' A' ' 51' ' ' HIS . 64.7 m-20 -124.07 126.77 46.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.929 -0.482 . . . . 0.0 109.959 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.9 145.67 14.26 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.527 -1.429 . . . . 31.82 109.527 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -67.29 153.57 43.36 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.462 -1.022 . . . . 0.0 110.099 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 46.97 -164.73 0.12 Allowed Glycine 0 N--CA 1.501 3.009 0 O-C-N 121.487 -0.758 . . . . 22.620000000000001 111.793 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.894 HG13 HD22 ' A' ' 47' ' ' LEU . 15.9 m -130.98 129.37 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.89 -0.771 . . . . 17.510000000000002 109.633 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 69' ' ' VAL . 12.5 m 40.98 34.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 CA-C-O 121.513 0.673 . . . . 20.550000000000001 111.822 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.57 17.16 66.75 Favored Glycine 0 N--CA 1.499 2.839 0 O-C-N 121.668 -0.645 . . . . 18.289999999999999 112.952 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -144.53 150.0 36.81 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 119.2 1.5 . . . . 0.0 111.95 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -116.08 74.92 5.62 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.989 -0.745 . . . . 18.210000000000001 108.989 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -56.37 141.32 89.34 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 O-C-N 123.852 1.449 . . . . 17.609999999999999 112.06 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -100.34 77.33 1.94 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.53 ' CD1' HG22 ' A' ' 37' ' ' ILE . 11.1 mt -62.88 118.04 7.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.575 -0.703 . . . . 20.57 111.987 -178.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -86.92 159.18 52.23 Favored Pre-proline 0 N--CA 1.489 1.508 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -54.65 128.73 31.53 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 O-C-N 123.512 1.27 . . . . 27.039999999999999 111.013 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.49 -17.39 52.49 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.955 -0.858 . . . . 24.739999999999998 110.955 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -87.41 166.1 15.08 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.995 -1.297 . . . . 29.379999999999999 110.635 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.34 150.08 35.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.659 -0.651 . . . . 0.0 110.112 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -118.94 147.69 43.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.505 -0.747 . . . . 18.559999999999999 109.081 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.5 p80 -144.75 140.84 28.79 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.146 -0.971 . . . . 0.0 111.243 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.539 ' CE1' HG21 ' A' ' 35' ' ' ILE . 52.1 p90 -150.95 160.02 44.19 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.633 -0.667 . . . . 26.649999999999999 109.812 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.4 m -101.34 137.01 40.24 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.431 -0.793 . . . . 28.140000000000001 110.911 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.451 ' HG ' ' HH ' ' A' ' 33' ' ' TYR . 26.6 t -125.23 169.35 12.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.616 -0.677 . . . . 33.880000000000003 110.132 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.39 123.33 2.15 Favored Glycine 0 N--CA 1.497 2.725 0 C-N-CA 119.914 -1.136 . . . . 31.800000000000001 110.461 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.585 HG23 ' HE1' ' A' ' 33' ' ' TYR . 80.4 t -130.18 152.44 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.532 -0.981 . . . . 0.0 109.48 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.719 HD23 ' N ' ' A' ' 90' ' ' LEU . 5.6 tt -110.56 143.81 40.37 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.532 -0.73 . . . . 0.0 110.508 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.777 HD11 HD22 ' A' ' 120' ' ' LEU . 70.8 mt -122.28 147.57 46.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.578 -0.702 . . . . 38.68 110.193 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -74.74 -25.91 59.43 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.28 -0.887 . . . . 0.0 110.805 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.2 p -125.52 172.9 9.32 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.429 -0.794 . . . . 31.629999999999999 110.857 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.452 ' HG2' ' CD2' ' A' ' 29' ' ' TYR . 94.0 mt-10 -86.33 11.91 11.21 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.683 -0.636 . . . . 0.0 111.635 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 97.0 mt-30 -139.93 147.39 40.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.113 -0.992 . . . . 0.0 109.895 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.48 158.88 21.51 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 118.889 -1.624 . . . . 28.050000000000001 112.28 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -119.47 129.72 54.88 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 122.108 -0.642 . . . . 0.0 109.357 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.451 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 98.0 mtp -125.61 116.42 21.69 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.371 -0.83 . . . . 0.0 111.124 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.493 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 56.3 tt0 -130.15 151.1 51.05 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -168.77 -177.18 39.5 Favored Glycine 0 N--CA 1.5 2.93 0 C-N-CA 119.017 -1.564 . . . . 29.620000000000001 110.748 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.409 ' NE2' ' HB3' ' A' ' 51' ' ' HIS . 6.0 p-80 -140.16 157.99 44.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.682 -0.893 . . . . 0.0 110.958 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.664 ' CD1' HD11 ' A' ' 47' ' ' LEU . 5.6 m-85 -115.77 128.21 55.68 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.68 -0.637 . . . . 27.050000000000001 109.647 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.743 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 41.4 t0 -80.78 124.83 29.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.927 -1.108 . . . . 0.0 109.184 178.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.599 ' SD ' HG11 ' A' ' 9' ' ' VAL . 29.5 mtp -124.63 162.37 24.25 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.249 0.547 . . . . 0.0 110.543 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.456 HG12 ' OE2' ' A' ' 110' ' ' GLU . 9.8 m -139.73 128.15 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.654 -0.654 . . . . 23.280000000000001 110.285 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.46 168.99 18.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.538 -0.726 . . . . 0.0 109.861 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.61 -31.74 72.63 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.834 -0.747 . . . . 0.0 110.271 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -70.02 -15.67 63.05 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.491 -0.755 . . . . 0.0 110.942 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.9 -5.74 47.01 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.42 -1.072 . . . . 30.43 110.42 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.4 m -57.72 135.6 56.78 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.061 -1.258 . . . . 0.0 110.052 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.456 ' OE2' HG12 ' A' ' 104' ' ' VAL . 77.1 mm-40 -98.63 139.98 33.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.443 -0.786 . . . . 0.0 110.612 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 48.0 p90 -168.39 148.88 4.75 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.703 -0.623 . . . . 28.030000000000001 110.121 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.6 pt -102.64 157.9 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.707 -0.621 . . . . 0.0 110.833 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -118.54 99.08 51.51 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -58.68 142.76 98.82 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 O-C-N 123.928 1.489 . . . . 33.310000000000002 112.356 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.637 HD11 ' CD2' ' A' ' 101' ' ' TYR . 70.2 mt -108.82 123.6 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.45 -0.945 . . . . 30.59 108.45 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.74 143.98 8.93 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.191 0.52 . . . . 30.780000000000001 111.362 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.493 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -85.98 121.6 28.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.619 -0.675 . . . . 0.0 110.186 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.582 ' CE1' HD11 ' A' ' 120' ' ' LEU . 42.4 p90 -109.46 163.95 12.95 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.796 -0.816 . . . . 30.66 108.796 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.606 ' C ' HD12 ' A' ' 120' ' ' LEU . 8.8 p -115.4 154.53 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.186 -0.946 . . . . 0.0 110.476 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.777 HD22 HD11 ' A' ' 90' ' ' LEU . 6.9 mp -113.63 133.47 55.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.733 -0.604 . . . . 39.149999999999999 109.384 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.702 -0.624 . . . . 0.0 110.046 -179.792 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.656 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 61.6 mtt180 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.656 0.265 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.476 ' CE2' HG21 ' A' ' 109' ' ' THR . 31.4 m-85 -119.98 108.07 13.87 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.44 -0.788 . . . . 31.93 110.306 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.464 ' C ' HG23 ' A' ' 9' ' ' VAL . 81.4 mtt85 -149.06 132.85 16.97 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.661 -0.65 . . . . 0.0 109.986 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.588 HG11 ' CE ' ' A' ' 103' ' ' MET . 68.0 t -150.61 113.48 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.687 -0.633 . . . . 0.0 109.455 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -107.41 129.19 54.96 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.616 -0.677 . . . . 0.0 109.809 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.585 HG11 ' HE2' ' A' ' 101' ' ' TYR . 58.4 t -118.75 139.56 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.88 -0.512 . . . . 28.210000000000001 109.969 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -121.26 137.07 54.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.401 -0.812 . . . . 0.0 109.905 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.715 HG22 HD13 ' A' ' 35' ' ' ILE . 59.1 t -128.81 136.67 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.709 -0.619 . . . . 27.949999999999999 110.23 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.9 p -125.38 104.8 28.23 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.719 -0.613 . . . . 0.0 110.55 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.404 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 48.4 Cg_endo -83.7 164.39 14.08 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 O-C-N 123.95 1.5 . . . . 33.0 110.902 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.6 ptt-85 -157.37 132.5 8.9 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.522 0.677 . . . . 54.100000000000001 109.843 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.567 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 75.1 t80 -59.43 138.56 57.62 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.337 0.589 . . . . 0.0 111.305 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.3 tp -116.18 79.79 1.36 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.983 0.897 . . . . 0.0 110.386 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.567 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -70.59 -35.58 73.09 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.567 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -68.43 -25.05 64.82 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.279 -0.888 . . . . 0.0 111.117 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -120.08 45.85 2.09 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.27 -0.894 . . . . 52.369999999999997 110.63 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.735 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 34.8 p -165.76 150.03 8.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.374 -0.829 . . . . 55.189999999999998 110.974 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.628 HG23 ' HB2' ' A' ' 28' ' ' ARG . 9.5 t -120.98 93.24 48.81 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.461 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.3 Cg_endo -66.89 -23.21 47.73 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 O-C-N 123.761 1.401 . . . . 51.57 111.965 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.09 -23.02 67.04 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.287 -0.883 . . . . 0.0 110.927 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -106.39 24.0 13.25 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.295 -0.878 . . . . 0.0 110.641 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.76 29.17 72.68 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.628 ' HB2' HG23 ' A' ' 23' ' ' THR . 99.5 mtt180 -121.85 93.94 4.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.592 -0.946 . . . . 0.0 110.152 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.461 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 58.4 m-85 -104.95 133.8 49.14 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.559 -0.713 . . . . 46.07 109.103 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.735 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -115.04 119.78 37.62 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.163 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.833 ' CD1' HD12 ' A' ' 90' ' ' LEU . 83.2 m-85 -114.73 134.83 54.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.564 -0.71 . . . . 38.880000000000003 109.786 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.4 131.54 55.49 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.52 -0.919 . . . . 34.060000000000002 108.52 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.633 ' HE1' HG23 ' A' ' 88' ' ' VAL . 21.9 p90 -128.43 144.76 51.19 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.273 -0.971 . . . . 29.030000000000001 111.435 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -104.42 139.6 39.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.752 -0.592 . . . . 0.0 109.886 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.715 HD13 HG22 ' A' ' 13' ' ' VAL . 44.7 mm -107.28 133.04 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.707 0.765 . . . . 0.0 111.416 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.13 98.52 5.81 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.394 0.616 . . . . 40.240000000000002 109.738 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.58 HG22 ' CD1' ' A' ' 76' ' ' LEU . 77.3 mt -90.27 117.75 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.749 -0.595 . . . . 20.73 110.597 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -118.09 133.45 55.89 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.451 -0.781 . . . . 0.0 109.615 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -95.41 117.12 29.79 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.822 -0.549 . . . . 21.34 110.434 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.82 14.39 17.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.319 -0.863 . . . . 0.0 110.717 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.58 -177.03 51.5 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.349 -1.501 . . . . 29.100000000000001 109.349 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.656 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . . . -95.98 -33.5 12.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.598 -0.943 . . . . 0.0 109.915 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.514 HG13 ' HD2' ' A' ' 44' ' ' PRO . 84.9 t -104.7 140.82 21.45 Favored Pre-proline 0 N--CA 1.494 1.772 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.514 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.1 Cg_endo -52.51 142.24 49.4 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 O-C-N 123.777 1.409 . . . . 21.949999999999999 111.711 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.03 152.73 46.47 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.716 0.77 . . . . 20.91 111.101 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.431 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 24.0 ptt-85 -127.88 157.75 39.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.708 -0.62 . . . . 0.0 109.634 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.71 HD22 HG13 ' A' ' 69' ' ' VAL . 6.4 tt -97.46 117.85 32.62 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.381 -0.824 . . . . 0.0 109.084 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.454 HG23 HG22 ' A' ' 104' ' ' VAL . 60.9 t -100.22 -29.32 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.56 -0.712 . . . . 0.0 111.616 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.695 ' HB3' ' HB2' ' A' ' 102' ' ' ASP . . . -140.06 164.47 29.94 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.126 -1.029 . . . . 0.0 112.151 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -142.85 141.14 31.53 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.559 0.695 . . . . 29.050000000000001 110.906 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -143.37 113.06 7.0 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.309 -0.626 . . . . 27.969999999999999 109.309 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.501 ' CH2' HD13 ' A' ' 115' ' ' ILE . 88.3 m95 -100.05 134.69 42.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.607 -0.683 . . . . 25.25 111.099 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -116.54 77.19 1.08 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.574 -0.704 . . . . 0.0 109.57 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 54' ' ' ILE . 27.6 pt -86.68 130.27 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.416 -0.803 . . . . 36.109999999999999 111.855 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.59 HG23 ' HB ' ' A' ' 61' ' ' THR . 6.8 m -119.48 132.67 55.83 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.374 -0.973 . . . . 33.979999999999997 108.374 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -88.13 169.57 11.81 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.717 0.77 . . . . 45.039999999999999 111.417 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.67 -7.69 12.2 Favored Glycine 0 N--CA 1.495 2.57 0 O-C-N 121.786 -0.571 . . . . 39.469999999999999 112.16 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -101.25 7.59 42.89 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 119.307 1.554 . . . . 0.0 110.682 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.13 -29.32 8.26 Favored Glycine 0 N--CA 1.495 2.631 0 O-C-N 121.211 -0.931 . . . . 0.0 110.798 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -63.6 142.45 58.39 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.205 -1.173 . . . . 62.780000000000001 109.755 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.59 ' HB ' HG23 ' A' ' 55' ' ' THR . 7.9 t -134.49 152.76 52.0 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.846 -0.741 . . . . 0.0 110.683 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -122.53 125.23 45.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.623 -0.673 . . . . 0.0 110.267 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -102.47 134.72 45.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.671 -0.643 . . . . 0.0 110.512 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.8 t -128.38 132.6 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.548 -0.72 . . . . 37.939999999999998 110.038 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -125.49 127.18 46.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.874 -0.516 . . . . 0.0 110.338 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.3 -174.57 15.68 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 108.711 -1.756 . . . . 31.82 108.711 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.24 -157.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.186 -1.185 . . . . 0.0 109.813 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.405 ' HA2' ' CD2' ' A' ' 47' ' ' LEU . . . -51.03 -91.25 0.01 OUTLIER Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.563 -1.015 . . . . 22.620000000000001 110.563 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.71 HG13 HD22 ' A' ' 47' ' ' LEU . 27.4 m -140.22 129.13 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.402 -1.057 . . . . 17.510000000000002 110.143 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 69' ' ' VAL . 12.0 m 40.81 33.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 CA-C-O 121.268 0.556 . . . . 20.550000000000001 112.122 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.97 22.29 55.5 Favored Glycine 0 N--CA 1.499 2.837 0 O-C-N 121.533 -0.729 . . . . 18.289999999999999 112.782 177.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.656 ' HG3' HG23 ' A' ' 69' ' ' VAL . 1.6 pt-20 -139.83 150.75 45.05 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 119.142 1.471 . . . . 0.0 111.354 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -113.84 74.83 2.62 Favored Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 109.117 -0.697 . . . . 18.210000000000001 109.117 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -57.36 141.7 94.85 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 O-C-N 123.858 1.452 . . . . 17.609999999999999 111.887 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.431 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -103.8 76.36 1.37 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.58 ' CD1' HG22 ' A' ' 37' ' ' ILE . 19.0 mt -63.67 121.48 14.04 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.634 -0.666 . . . . 20.57 111.947 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -86.31 158.44 54.99 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -53.6 128.75 30.69 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 O-C-N 123.517 1.272 . . . . 27.039999999999999 111.132 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.01 -17.3 54.07 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.805 -0.918 . . . . 24.739999999999998 110.805 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -88.62 164.85 15.16 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.121 -1.223 . . . . 29.379999999999999 110.585 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.19 150.04 35.08 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.649 -0.657 . . . . 0.0 110.165 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -117.93 144.51 45.41 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.503 -0.748 . . . . 18.559999999999999 109.126 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -142.76 140.4 31.4 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.24 -0.912 . . . . 0.0 111.25 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.564 ' CE1' HG21 ' A' ' 35' ' ' ILE . 52.1 p90 -150.65 159.92 44.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.672 -0.642 . . . . 26.649999999999999 109.781 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 60.3 m -102.78 136.73 42.07 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.431 -0.793 . . . . 28.140000000000001 110.76 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 15.7 t -125.25 169.95 11.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.643 -0.661 . . . . 33.880000000000003 110.133 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -139.83 125.87 3.1 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 119.934 -1.127 . . . . 31.800000000000001 110.38 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.633 HG23 ' HE1' ' A' ' 33' ' ' TYR . 71.2 t -130.08 152.47 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.594 -0.945 . . . . 0.0 109.462 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.598 HD23 ' N ' ' A' ' 90' ' ' LEU . 8.1 tt -110.51 142.64 42.01 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.642 -0.661 . . . . 0.0 110.488 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.833 HD12 ' CD1' ' A' ' 31' ' ' PHE . 86.1 mt -122.12 145.8 47.83 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.543 -0.723 . . . . 38.68 109.971 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -81.49 -26.3 35.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.299 -0.876 . . . . 0.0 111.036 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 93' ' ' GLU . 27.0 m -123.69 169.34 11.59 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.306 -0.871 . . . . 31.629999999999999 110.66 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.453 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 50.6 mt-10 -86.22 11.09 12.8 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.637 -0.664 . . . . 0.0 111.603 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 96.9 mt-30 -140.72 145.31 36.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.16 -0.963 . . . . 0.0 109.853 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.51 157.02 17.52 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 118.747 -1.692 . . . . 28.050000000000001 112.315 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -117.28 129.28 55.8 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 99.6 mtp -126.08 117.77 23.88 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.314 -0.866 . . . . 0.0 111.431 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.483 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 56.6 tt0 -126.3 149.18 49.3 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -155.46 -178.91 30.16 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 118.8 -1.667 . . . . 29.620000000000001 111.078 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.824 ' CE1' HD12 ' A' ' 112' ' ' ILE . 0.3 OUTLIER -136.92 155.74 49.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.769 -0.842 . . . . 0.0 109.494 179.506 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.585 ' HE2' HG11 ' A' ' 11' ' ' VAL . 6.6 m-85 -118.09 126.95 53.27 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.419 -0.801 . . . . 27.050000000000001 110.163 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.695 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 78.6 m-20 -85.49 120.36 26.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.113 -0.992 . . . . 0.0 108.761 177.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.588 ' CE ' HG11 ' A' ' 9' ' ' VAL . 14.2 tpp -123.93 160.67 27.03 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.109 0.48 . . . . 0.0 110.403 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.454 HG22 HG23 ' A' ' 48' ' ' VAL . 9.1 m -140.69 130.04 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.654 -0.654 . . . . 23.280000000000001 110.176 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.39 166.62 23.18 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.494 -0.754 . . . . 0.0 109.732 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -65.37 -29.77 70.53 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.546 -0.721 . . . . 0.0 110.153 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -74.64 -6.43 48.59 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.437 -0.789 . . . . 0.0 111.139 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.26 -9.41 59.38 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 120.082 -1.056 . . . . 30.43 110.581 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.476 HG21 ' CE2' ' A' ' 7' ' ' TYR . 27.4 m -57.89 135.01 56.81 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.009 -1.289 . . . . 0.0 110.023 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -101.13 138.86 37.61 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.359 -0.838 . . . . 0.0 110.726 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 41.9 p90 -162.69 143.8 10.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.664 -0.648 . . . . 28.030000000000001 109.942 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.824 HD12 ' CE1' ' A' ' 100' ' ' HIS . 30.5 pt -101.01 156.78 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 121.331 0.586 . . . . 0.0 110.877 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.485 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -121.66 100.19 44.19 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.617 -0.677 . . . . 0.0 109.421 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.422 ' HB3' ' CE1' ' A' ' 100' ' ' HIS . 45.3 Cg_endo -58.02 142.85 96.99 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 O-C-N 123.862 1.454 . . . . 33.310000000000002 112.176 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.501 HD13 ' CH2' ' A' ' 52' ' ' TRP . 66.9 mt -107.88 123.05 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.677 -0.861 . . . . 30.59 108.677 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.83 145.45 7.08 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.848 -0.532 . . . . 30.780000000000001 111.352 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.483 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -93.61 120.36 33.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.745 -0.597 . . . . 0.0 110.012 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.725 ' CE1' HD11 ' A' ' 120' ' ' LEU . 46.1 p90 -108.55 167.75 9.82 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.907 -0.775 . . . . 30.66 108.907 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.615 ' C ' HD12 ' A' ' 120' ' ' LEU . 8.8 p -113.7 154.1 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.349 -0.844 . . . . 0.0 110.498 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.725 HD11 ' CE1' ' A' ' 118' ' ' PHE . 7.1 mp -113.72 132.93 55.63 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.37 -0.604 . . . . 39.149999999999999 109.37 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.672 -0.642 . . . . 0.0 110.069 -179.808 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.588 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 28.5 mmt85 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 120.669 0.271 . . . . 0.0 110.741 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.444 ' CE2' HG21 ' A' ' 109' ' ' THR . 40.4 m-85 -121.22 113.34 19.82 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.412 -0.805 . . . . 31.93 110.383 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.461 ' C ' HG23 ' A' ' 9' ' ' VAL . 41.0 mtp85 -152.14 135.93 16.3 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.589 0.709 . . . . 0.0 110.092 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.461 HG23 ' C ' ' A' ' 8' ' ' ARG . 83.7 t -151.28 114.4 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 CA-C-O 121.442 0.639 . . . . 0.0 109.426 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -106.79 129.0 54.72 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.516 0.674 . . . . 0.0 109.907 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.19 138.4 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 109.694 -0.484 . . . . 28.210000000000001 109.694 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -121.8 136.66 54.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.416 -0.802 . . . . 0.0 109.931 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.733 HG22 HD13 ' A' ' 35' ' ' ILE . 62.4 t -129.39 136.4 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.484 -0.76 . . . . 27.949999999999999 110.375 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -125.71 104.57 27.26 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.732 -0.605 . . . . 0.0 110.443 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.425 ' HG3' ' CE1' ' A' ' 118' ' ' PHE . 49.9 Cg_endo -84.41 165.25 12.57 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 O-C-N 123.843 1.444 . . . . 33.0 110.929 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -158.03 132.61 8.33 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.562 0.696 . . . . 54.100000000000001 109.982 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.556 ' CE2' ' HB2' ' A' ' 19' ' ' ALA . 76.8 t80 -58.66 138.25 57.09 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.833 -0.542 . . . . 0.0 111.198 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.438 HD23 ' HB3' ' A' ' 21' ' ' GLN . 8.6 tp -115.47 80.53 1.45 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.028 0.918 . . . . 0.0 110.359 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.556 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -71.12 -35.97 71.95 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.494 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -68.8 -24.2 64.37 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.374 -0.829 . . . . 0.0 111.002 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.438 ' HB3' HD23 ' A' ' 18' ' ' LEU . 54.4 tp60 -121.34 46.82 1.97 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.382 -0.824 . . . . 52.369999999999997 110.389 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.739 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 34.3 t -166.05 149.85 7.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.456 -0.777 . . . . 55.189999999999998 110.894 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.625 HG23 ' HB2' ' A' ' 28' ' ' ARG . 8.7 t -122.04 92.94 48.81 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.457 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.5 Cg_endo -66.72 -23.1 49.13 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.761 1.401 . . . . 51.57 111.986 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -65.81 -22.68 66.58 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.267 -0.896 . . . . 0.0 110.947 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -105.97 23.59 13.74 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.251 -0.905 . . . . 0.0 110.734 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.33 28.85 73.08 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.625 ' HB2' HG23 ' A' ' 23' ' ' THR . 24.8 mmt85 -121.72 94.19 4.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.599 -0.942 . . . . 0.0 110.154 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.457 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 57.6 m-85 -105.33 131.66 52.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.538 -0.726 . . . . 46.07 109.122 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.739 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -114.7 120.56 40.53 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.609 -0.837 . . . . 0.0 111.043 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.788 ' CD1' HD12 ' A' ' 90' ' ' LEU . 86.8 m-85 -114.59 135.75 53.8 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.578 -0.701 . . . . 38.880000000000003 109.581 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.72 131.61 55.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.198 -0.939 . . . . 34.060000000000002 108.483 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.645 ' HE1' HG23 ' A' ' 88' ' ' VAL . 20.9 p90 -128.55 144.58 51.17 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.276 -0.969 . . . . 29.030000000000001 111.45 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.8 p -104.18 141.1 36.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.647 -0.658 . . . . 0.0 109.877 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.733 HD13 HG22 ' A' ' 13' ' ' VAL . 44.3 mm -106.89 132.24 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.728 0.775 . . . . 0.0 111.352 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -122.95 97.88 5.64 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.427 0.632 . . . . 40.240000000000002 109.578 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.608 HG22 ' CD1' ' A' ' 76' ' ' LEU . 77.6 mt -91.65 116.99 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.771 -0.581 . . . . 20.73 110.598 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -118.02 133.5 55.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.437 -0.789 . . . . 0.0 109.468 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -95.5 117.83 31.11 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.225 -0.59 . . . . 21.34 110.634 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.96 14.28 17.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.423 -0.798 . . . . 0.0 110.5 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.68 179.79 53.31 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.316 -1.514 . . . . 29.100000000000001 109.316 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.588 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . . . -92.42 -33.81 14.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.536 -0.979 . . . . 0.0 110.056 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.511 HG13 ' HD2' ' A' ' 44' ' ' PRO . 84.3 t -104.6 139.61 20.27 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.965 -0.46 . . . . 0.0 109.771 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.511 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.5 Cg_endo -51.26 146.2 24.7 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 O-C-N 123.709 1.373 . . . . 21.949999999999999 111.613 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.49 151.08 48.07 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.861 0.838 . . . . 20.91 111.524 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.437 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 52.6 ttp180 -126.02 153.35 44.51 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.641 HD22 HG13 ' A' ' 69' ' ' VAL . 7.2 tt -96.93 116.97 30.11 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.541 -0.724 . . . . 0.0 109.705 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.44 HG23 HG22 ' A' ' 104' ' ' VAL . 57.3 t -100.51 -27.0 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.607 -0.683 . . . . 0.0 110.516 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.727 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -140.69 162.4 35.49 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.132 -1.027 . . . . 0.0 112.124 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 32.6 ptt85 -140.76 139.0 34.54 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.322 0.582 . . . . 29.050000000000001 109.858 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.407 ' NE2' ' CG ' ' A' ' 63' ' ' GLN . 20.0 t-160 -143.32 111.45 6.15 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.653 -0.654 . . . . 27.969999999999999 110.264 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.57 ' CH2' HD13 ' A' ' 115' ' ' ILE . 60.5 m95 -105.64 135.85 46.31 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.33 0.586 . . . . 25.25 111.135 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -115.87 82.26 1.74 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.703 -0.623 . . . . 0.0 109.348 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.908 HG22 ' HG3' ' A' ' 97' ' ' MET . 16.3 pt -84.47 128.38 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.43 -0.794 . . . . 36.109999999999999 111.668 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.477 HG23 ' HB ' ' A' ' 61' ' ' THR . 17.6 m -120.57 132.13 55.0 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.492 -0.929 . . . . 33.979999999999997 108.492 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -88.69 169.89 11.28 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.664 0.745 . . . . 45.039999999999999 111.271 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.14 -7.48 13.47 Favored Glycine 0 N--CA 1.495 2.604 0 O-C-N 121.82 -0.55 . . . . 39.469999999999999 112.148 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -101.41 7.66 42.5 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 119.369 1.585 . . . . 0.0 110.682 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.07 -28.75 8.99 Favored Glycine 0 N--CA 1.493 2.457 0 O-C-N 121.193 -0.942 . . . . 0.0 110.892 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.26 141.24 58.84 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.232 -1.158 . . . . 62.780000000000001 109.617 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.477 ' HB ' HG23 ' A' ' 55' ' ' THR . 7.8 t -135.58 153.18 51.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.446 -0.784 . . . . 0.0 110.745 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -120.98 123.36 42.23 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.536 -0.728 . . . . 0.0 109.735 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.407 ' CG ' ' NE2' ' A' ' 51' ' ' HIS . 12.0 tt0 -99.15 136.6 38.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.659 -0.651 . . . . 0.0 110.827 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.94 131.68 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 CA-C-O 121.681 0.753 . . . . 37.939999999999998 110.352 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -126.91 127.45 44.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.955 -0.466 . . . . 0.0 110.055 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.11 172.63 32.74 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.304 -1.518 . . . . 31.82 109.304 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -115.61 159.18 21.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.403 -1.057 . . . . 0.0 110.085 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.65 96.55 0.01 OUTLIER Glycine 0 N--CA 1.501 2.98 0 O-C-N 121.424 -0.797 . . . . 22.620000000000001 111.531 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.641 HG13 HD22 ' A' ' 47' ' ' LEU . 23.7 m -45.56 133.31 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 O-C-N 121.338 -1.095 . . . . 17.510000000000002 111.589 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.1 m 41.6 35.97 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 CA-C-O 121.619 0.723 . . . . 20.550000000000001 111.408 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.4 21.5 58.34 Favored Glycine 0 N--CA 1.495 2.584 0 O-C-N 121.753 -0.592 . . . . 18.289999999999999 112.398 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.488 ' HG3' HG23 ' A' ' 69' ' ' VAL . 3.6 pt-20 -146.21 152.85 39.88 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 119.111 1.455 . . . . 0.0 112.473 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -118.56 72.95 10.81 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 108.449 -0.945 . . . . 18.210000000000001 108.449 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -55.01 139.64 79.8 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 O-C-N 123.781 1.411 . . . . 17.609999999999999 112.284 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.44 ' CZ3' ' HG2' ' A' ' 77' ' ' ARG . 5.2 t90 -99.56 75.54 1.95 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.608 ' CD1' HG22 ' A' ' 37' ' ' ILE . 12.4 mt -61.03 119.77 8.95 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.682 -0.636 . . . . 20.57 112.084 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.44 ' HG2' ' CZ3' ' A' ' 75' ' ' TRP . 18.1 mtm180 -86.48 157.86 55.2 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -53.84 128.28 29.0 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 O-C-N 123.492 1.259 . . . . 27.039999999999999 111.093 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.68 -16.59 56.16 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.769 -0.933 . . . . 24.739999999999998 110.769 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -88.17 164.75 15.52 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.133 -1.216 . . . . 29.379999999999999 110.533 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.18 149.82 34.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.586 -0.696 . . . . 0.0 110.124 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -118.65 147.54 43.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.49 -0.756 . . . . 18.559999999999999 109.17 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -143.34 139.85 30.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.168 -0.957 . . . . 0.0 111.124 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.556 ' CE1' HG21 ' A' ' 35' ' ' ILE . 53.2 p90 -150.92 159.73 44.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.614 -0.679 . . . . 26.649999999999999 109.716 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.2 m -102.12 136.64 41.6 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.363 -0.836 . . . . 28.140000000000001 110.92 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 17.9 t -124.95 170.25 11.29 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.681 -0.637 . . . . 33.880000000000003 109.912 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -140.54 125.34 2.85 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.827 -1.177 . . . . 31.800000000000001 110.495 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.645 HG23 ' HE1' ' A' ' 33' ' ' TYR . 76.2 t -129.98 152.26 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.592 -0.946 . . . . 0.0 109.293 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.493 HD23 ' N ' ' A' ' 90' ' ' LEU . 7.1 tt -111.01 142.91 42.52 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.627 -0.671 . . . . 0.0 110.712 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.788 HD12 ' CD1' ' A' ' 31' ' ' PHE . 89.4 mt -121.67 145.21 48.24 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.576 -0.703 . . . . 38.68 109.893 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -79.16 -26.73 42.72 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.211 -0.93 . . . . 0.0 110.939 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.9 p -124.43 172.29 9.27 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.361 -0.837 . . . . 31.629999999999999 110.729 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.456 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 48.8 mt-10 -86.56 12.38 10.59 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.62 -0.675 . . . . 0.0 111.58 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 15.1 pt20 -141.47 144.89 34.63 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.039 -1.038 . . . . 0.0 109.78 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 178.77 158.89 22.15 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 118.74 -1.695 . . . . 28.050000000000001 112.275 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -119.71 129.42 54.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 122.117 -0.637 . . . . 0.0 109.322 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.908 ' HG3' HG22 ' A' ' 54' ' ' ILE . 49.2 ttm -125.14 121.18 33.49 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.249 -0.907 . . . . 0.0 111.155 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.449 ' CD ' ' HB2' ' A' ' 117' ' ' ALA . 35.4 mt-30 -123.82 150.15 44.87 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.56 171.28 36.69 Favored Glycine 0 N--CA 1.5 2.931 0 C-N-CA 118.337 -1.887 . . . . 29.620000000000001 111.605 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 114' ' ' PRO . 51.6 m80 -135.3 153.97 51.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.895 -0.767 . . . . 0.0 109.685 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.725 ' CE2' HD11 ' A' ' 115' ' ' ILE . 5.3 m-85 -119.16 126.1 50.78 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.519 -0.738 . . . . 27.050000000000001 109.74 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.727 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 41.5 t0 -80.98 121.93 26.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.898 -1.126 . . . . 0.0 109.359 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.447 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 91.6 mmm -119.68 161.47 20.65 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.112 0.482 . . . . 0.0 110.066 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.44 HG22 HG23 ' A' ' 48' ' ' VAL . 8.5 m -140.86 127.62 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.551 -0.718 . . . . 23.280000000000001 110.335 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.88 167.47 21.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.585 -0.697 . . . . 0.0 109.581 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -64.06 -29.63 70.76 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.136 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -73.3 -11.19 60.41 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.534 -0.729 . . . . 0.0 111.136 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.91 -7.2 52.56 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 120.075 -1.059 . . . . 30.43 110.54 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.444 HG21 ' CE2' ' A' ' 7' ' ' TYR . 41.2 m -57.47 136.28 56.66 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.015 -1.285 . . . . 0.0 110.106 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -101.57 141.19 34.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.433 -0.792 . . . . 0.0 110.959 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 46.8 p90 -168.54 146.7 4.13 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.677 -0.639 . . . . 28.030000000000001 109.883 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.3 pt -102.63 159.27 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.673 -0.642 . . . . 0.0 111.222 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.02 97.13 50.64 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.429 ' HB3' ' CD2' ' A' ' 100' ' ' HIS . 46.0 Cg_endo -59.75 143.44 99.63 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 O-C-N 123.962 1.506 . . . . 33.310000000000002 112.332 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.725 HD11 ' CE2' ' A' ' 101' ' ' TYR . 72.7 mt -108.13 120.72 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.301 -0.999 . . . . 30.59 108.301 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -47.36 161.23 0.08 Allowed 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.304 0.573 . . . . 30.780000000000001 111.818 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.449 ' HB2' ' CD ' ' A' ' 98' ' ' GLN . . . -99.93 118.05 35.53 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.78 -0.575 . . . . 0.0 110.778 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.755 ' CE1' HD11 ' A' ' 120' ' ' LEU . 50.5 p90 -110.68 166.24 11.18 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.359 -0.978 . . . . 30.66 108.359 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.633 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.2 t -113.18 153.98 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.172 -0.955 . . . . 0.0 110.48 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.755 HD11 ' CE1' ' A' ' 118' ' ' PHE . 7.4 mp -113.35 130.57 56.25 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.169 -0.678 . . . . 39.149999999999999 109.169 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.4 m . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.668 -0.645 . . . . 0.0 110.062 -179.801 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.666 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 60.0 mtt180 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 120.734 0.302 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.683 ' CE2' HG21 ' A' ' 109' ' ' THR . 44.6 m-85 -123.77 119.56 30.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.505 -0.747 . . . . 31.93 110.501 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.489 ' C ' HG23 ' A' ' 9' ' ' VAL . 21.3 ttm180 -156.86 132.89 9.65 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.43 0.633 . . . . 0.0 110.081 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.489 HG23 ' C ' ' A' ' 8' ' ' ARG . 95.5 t -151.74 115.45 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.618 -0.676 . . . . 0.0 109.755 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -106.15 128.8 54.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.667 -0.646 . . . . 0.0 109.82 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.487 HG22 ' HA ' ' A' ' 37' ' ' ILE . 61.8 t -118.9 138.99 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.92 -0.487 . . . . 28.210000000000001 109.896 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -122.5 135.82 54.74 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.39 -0.818 . . . . 0.0 109.935 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.9 t -129.29 136.88 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.639 -0.663 . . . . 27.949999999999999 110.36 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -126.79 105.08 23.21 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.687 -0.633 . . . . 0.0 110.758 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -82.9 165.01 15.5 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 O-C-N 123.796 1.419 . . . . 33.0 110.808 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -157.69 131.62 8.07 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.725 0.774 . . . . 54.100000000000001 110.219 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.516 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 79.9 t80 -61.22 140.12 58.0 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.718 -0.614 . . . . 0.0 111.507 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.005 HD11 ' HB2' ' A' ' 32' ' ' ALA . 88.7 mt -116.95 82.39 1.8 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.944 0.878 . . . . 0.0 110.373 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.516 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -68.99 -34.64 75.62 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.137 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -69.9 -23.37 63.23 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.315 -0.865 . . . . 0.0 111.15 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -121.46 39.12 3.92 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.274 -0.892 . . . . 52.369999999999997 110.983 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.613 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 44.1 p -158.92 149.78 20.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.292 -0.88 . . . . 55.189999999999998 111.015 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.603 HG23 ' HB2' ' A' ' 28' ' ' ARG . 4.8 t -120.33 92.9 47.83 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.46 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 48.6 Cg_endo -66.23 -23.05 52.82 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 O-C-N 123.913 1.481 . . . . 51.57 111.894 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -67.25 -22.15 65.69 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.257 -0.902 . . . . 0.0 111.141 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -105.6 23.22 14.18 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.261 -0.9 . . . . 0.0 110.937 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.08 27.38 73.43 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.603 ' HB2' HG23 ' A' ' 23' ' ' THR . 29.6 mtt85 -121.0 94.48 4.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.533 -0.98 . . . . 0.0 110.023 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.46 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 61.3 m-85 -105.24 134.91 47.56 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.498 -0.751 . . . . 46.07 109.26 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -115.51 121.18 41.9 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.082 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.867 ' CD1' HD12 ' A' ' 90' ' ' LEU . 87.8 m-85 -116.64 133.3 56.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.509 -0.744 . . . . 38.880000000000003 109.727 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 1.005 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -112.51 131.66 55.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.279 -0.888 . . . . 34.060000000000002 108.619 178.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.588 ' HE1' HG23 ' A' ' 88' ' ' VAL . 25.0 p90 -127.05 144.47 51.02 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.307 -0.957 . . . . 29.030000000000001 111.386 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.3 t -104.21 139.04 39.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.695 -0.628 . . . . 0.0 109.388 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.831 HD12 ' CZ ' ' A' ' 84' ' ' TYR . 79.3 mt -108.4 133.94 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.714 0.768 . . . . 0.0 111.493 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -123.91 99.01 6.05 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.526 0.679 . . . . 40.240000000000002 109.718 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.559 HG22 ' CD1' ' A' ' 76' ' ' LEU . 83.9 mt -91.15 117.73 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.875 -0.515 . . . . 20.73 110.492 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -117.32 131.5 56.79 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.442 -0.786 . . . . 0.0 109.35 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -96.43 117.61 31.24 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 120.261 -0.575 . . . . 21.34 110.235 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -118.0 17.42 14.12 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.318 -0.864 . . . . 0.0 110.525 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.3 178.28 53.95 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.519 -1.432 . . . . 29.100000000000001 109.519 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.666 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . . . -86.96 -42.55 13.06 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.572 -0.958 . . . . 0.0 110.282 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.515 HG13 ' HD2' ' A' ' 44' ' ' PRO . 86.4 t -98.69 139.96 21.46 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.954 -0.466 . . . . 0.0 109.982 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.515 ' HD2' HG13 ' A' ' 43' ' ' VAL . 40.3 Cg_endo -53.03 145.65 40.86 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 O-C-N 123.805 1.423 . . . . 21.949999999999999 111.67 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.421 ' HB1' ' HG2' ' A' ' 103' ' ' MET . . . -140.56 152.24 45.36 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.687 0.756 . . . . 20.91 111.22 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.444 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 18.2 ptt-85 -127.76 153.85 46.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.803 -0.561 . . . . 0.0 109.665 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.761 HD22 HG13 ' A' ' 69' ' ' VAL . 6.5 tt -94.66 117.05 29.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.384 -0.823 . . . . 0.0 109.247 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.7 m -100.93 -24.44 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.732 -0.605 . . . . 0.0 111.194 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.766 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -142.44 163.1 33.76 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.19 -1.004 . . . . 0.0 112.081 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.499 ' HD2' HG12 ' A' ' 69' ' ' VAL . 1.8 ptm180 -142.06 140.05 32.46 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.542 0.687 . . . . 29.050000000000001 110.517 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.406 ' CD2' ' OD1' ' A' ' 65' ' ' ASP . 20.8 t-160 -144.39 112.93 6.59 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.42 0.628 . . . . 27.969999999999999 109.809 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -103.61 135.93 44.28 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.499 0.666 . . . . 25.25 111.532 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -115.8 82.31 1.74 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.78 HG22 ' HG3' ' A' ' 97' ' ' MET . 13.1 pt -83.1 127.11 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 121.75 0.786 . . . . 36.109999999999999 111.567 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.983 HG23 HG22 ' A' ' 61' ' ' THR . 95.4 m -122.0 130.03 52.96 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.732 -0.84 . . . . 33.979999999999997 108.732 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -91.56 169.77 10.48 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.757 0.789 . . . . 45.039999999999999 111.493 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.98 -5.91 16.52 Favored Glycine 0 N--CA 1.496 2.683 0 O-C-N 121.856 -0.527 . . . . 39.469999999999999 112.345 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -100.26 5.58 44.61 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 119.501 1.65 . . . . 0.0 110.636 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.449 ' O ' HG23 ' A' ' 61' ' ' THR . . . 91.91 -27.34 10.2 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.48 141.43 58.77 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.164 -1.198 . . . . 62.780000000000001 109.228 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.983 HG22 HG23 ' A' ' 55' ' ' THR . 61.8 p -133.73 150.06 51.49 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.664 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -121.93 121.86 38.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.498 -0.751 . . . . 0.0 109.601 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.401 ' CG ' ' NE2' ' A' ' 51' ' ' HIS . 12.6 tt0 -100.53 134.86 42.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.667 -0.646 . . . . 0.0 110.705 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.7 t -128.93 129.97 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.714 0.768 . . . . 37.939999999999998 110.214 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.406 ' OD1' ' CD2' ' A' ' 51' ' ' HIS . 58.9 m-20 -125.58 126.87 45.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.86 -0.525 . . . . 0.0 109.808 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.03 146.27 15.49 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.51 -1.436 . . . . 31.82 109.51 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -71.84 154.26 41.38 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.607 -0.937 . . . . 0.0 110.196 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 50.05 -170.63 0.17 Allowed Glycine 0 N--CA 1.497 2.762 0 O-C-N 121.373 -0.829 . . . . 22.620000000000001 111.268 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.761 HG13 HD22 ' A' ' 47' ' ' LEU . 13.3 m -129.92 128.0 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.89 -0.77 . . . . 17.510000000000002 109.155 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.639 HG11 ' CE2' ' A' ' 84' ' ' TYR . 11.5 m 41.49 33.48 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 CA-C-O 121.649 0.738 . . . . 20.550000000000001 111.397 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.59 18.76 61.32 Favored Glycine 0 N--CA 1.498 2.767 0 O-C-N 121.769 -0.582 . . . . 18.289999999999999 113.101 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.416 ' O ' HG22 ' A' ' 69' ' ' VAL . 9.8 pt-20 -146.59 150.2 35.02 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 119.386 1.593 . . . . 0.0 112.618 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -116.14 72.85 4.85 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.257 -1.016 . . . . 18.210000000000001 108.257 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -55.1 142.49 77.3 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 O-C-N 123.761 1.401 . . . . 17.609999999999999 112.331 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.444 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 3.1 t90 -101.87 76.54 1.63 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.559 ' CD1' HG22 ' A' ' 37' ' ' ILE . 10.4 mt -61.84 117.87 6.45 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.612 -0.68 . . . . 20.57 111.921 -178.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -87.83 159.04 49.8 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -54.0 129.07 32.45 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 O-C-N 123.579 1.305 . . . . 27.039999999999999 111.119 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.62 -18.03 49.0 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.929 -0.868 . . . . 24.739999999999998 110.929 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -87.33 165.07 15.89 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.005 -1.291 . . . . 29.379999999999999 110.458 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.22 148.69 33.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.586 -0.696 . . . . 0.0 110.289 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.506 ' HD2' HD12 ' A' ' 37' ' ' ILE . 89.4 t80 -117.71 143.47 46.17 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.085 -0.709 . . . . 18.559999999999999 109.085 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -146.99 140.89 25.89 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.2 -0.938 . . . . 0.0 111.314 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.831 ' CZ ' HD12 ' A' ' 35' ' ' ILE . 42.7 p90 -152.8 162.3 41.45 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.539 -0.725 . . . . 26.649999999999999 109.653 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 54.2 m -98.61 136.63 38.42 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.439 -0.788 . . . . 28.140000000000001 111.248 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.478 ' HG ' ' HH ' ' A' ' 33' ' ' TYR . 15.2 t -125.06 169.11 12.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.639 -0.663 . . . . 33.880000000000003 109.774 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -139.85 126.3 3.22 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.769 -1.205 . . . . 31.800000000000001 110.487 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.588 HG23 ' HE1' ' A' ' 33' ' ' TYR . 77.9 t -131.28 151.7 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.63 -0.923 . . . . 0.0 109.31 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.18 144.39 40.41 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.582 -0.699 . . . . 0.0 110.862 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.867 HD12 ' CD1' ' A' ' 31' ' ' PHE . 94.6 mt -122.33 148.07 45.49 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.621 -0.674 . . . . 38.68 110.026 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.408 ' O ' ' CE1' ' A' ' 29' ' ' TYR . 38.6 tp10 -79.01 -26.4 43.24 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.39 -0.819 . . . . 0.0 110.757 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.2 p -124.09 172.1 9.26 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.336 -0.853 . . . . 31.629999999999999 110.621 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.457 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 50.4 mt-10 -85.42 10.67 12.18 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.607 -0.683 . . . . 0.0 111.63 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 14.4 pt20 -141.39 145.49 35.42 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.125 -0.984 . . . . 0.0 109.811 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.6 155.46 15.24 Favored Glycine 0 N--CA 1.496 2.682 0 C-N-CA 118.871 -1.633 . . . . 28.050000000000001 112.219 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -120.47 130.2 54.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 122.125 -0.632 . . . . 0.0 109.374 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.78 ' HG3' HG22 ' A' ' 54' ' ' ILE . 56.1 ttm -126.82 123.77 38.1 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.37 -0.831 . . . . 0.0 111.533 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.61 ' CD ' ' HB2' ' A' ' 117' ' ' ALA . 40.7 mt-30 -123.1 148.93 45.13 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.67 175.52 41.33 Favored Glycine 0 N--CA 1.499 2.842 0 C-N-CA 118.738 -1.696 . . . . 29.620000000000001 111.05 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.4 ' NE2' ' HB3' ' A' ' 51' ' ' HIS . 11.7 p-80 -140.04 157.79 45.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.828 -0.807 . . . . 0.0 110.675 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.606 ' CE2' HD11 ' A' ' 115' ' ' ILE . 6.0 m-85 -114.62 130.01 56.74 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.673 -0.642 . . . . 27.050000000000001 109.787 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.766 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 11.2 t70 -82.02 121.81 27.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 108.928 178.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.434 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 2.0 ttm -121.93 161.92 21.98 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.204 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.5 m -141.65 130.34 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.639 -0.663 . . . . 23.280000000000001 110.486 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.479 ' HB3' ' HB ' ' A' ' 109' ' ' THR . . . -72.14 166.73 21.73 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.51 -0.744 . . . . 0.0 109.609 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -66.92 -29.36 69.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.533 -0.729 . . . . 0.0 110.284 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -77.36 -4.29 44.43 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.426 -0.796 . . . . 0.0 111.359 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.27 -9.7 54.02 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.087 -1.054 . . . . 30.43 110.519 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.683 HG21 ' CE2' ' A' ' 7' ' ' TYR . 57.6 m -57.02 133.61 55.09 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.045 -1.268 . . . . 0.0 110.093 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -102.32 139.44 37.93 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -0.866 . . . . 0.0 110.668 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.434 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 38.9 p90 -165.26 144.05 6.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.705 -0.622 . . . . 28.030000000000001 109.886 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.8 pt -101.85 158.89 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.636 -0.665 . . . . 0.0 110.874 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.01 95.12 49.1 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -60.48 144.73 99.54 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 O-C-N 123.958 1.504 . . . . 33.310000000000002 112.24 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.606 HD11 ' CE2' ' A' ' 101' ' ' TYR . 71.7 mt -108.65 121.55 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.698 -0.852 . . . . 30.59 108.698 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.61 167.05 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.258 0.552 . . . . 30.780000000000001 111.578 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.61 ' HB2' ' CD ' ' A' ' 98' ' ' GLN . . . -95.03 118.92 32.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.65 -0.656 . . . . 0.0 110.759 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.45 ' CE1' HD11 ' A' ' 120' ' ' LEU . 38.9 p90 -112.59 160.34 17.95 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.343 -0.984 . . . . 30.66 108.343 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.634 ' C ' HD12 ' A' ' 120' ' ' LEU . 59.1 t -116.86 152.98 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.169 -0.957 . . . . 0.0 110.753 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.747 HD22 HD11 ' A' ' 90' ' ' LEU . 7.3 mp -114.16 131.26 56.5 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.098 -0.704 . . . . 39.149999999999999 109.098 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 40.4 p . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.607 -0.683 . . . . 0.0 110.033 -179.831 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.9 0.381 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.439 ' CE2' HG21 ' A' ' 109' ' ' THR . 37.1 m-85 -112.24 104.65 12.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.546 -0.721 . . . . 31.93 110.158 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.478 ' C ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -150.29 131.58 14.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.655 -0.653 . . . . 0.0 109.982 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.746 HG11 ' SD ' ' A' ' 103' ' ' MET . 69.2 t -151.98 114.53 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.519 -0.738 . . . . 0.0 109.522 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -107.58 129.88 54.94 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.636 0.731 . . . . 0.0 109.954 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.535 HG11 ' HE2' ' A' ' 101' ' ' TYR . 57.3 t -117.35 139.69 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 109.562 -0.533 . . . . 28.210000000000001 109.562 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -120.49 137.19 54.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.409 -0.807 . . . . 0.0 110.017 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.763 HG22 HD13 ' A' ' 35' ' ' ILE . 60.7 t -127.46 135.99 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.304 0.573 . . . . 27.949999999999999 110.056 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.2 m -125.0 104.03 30.07 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.77 -0.581 . . . . 0.0 110.392 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -84.16 164.31 13.21 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 O-C-N 123.927 1.488 . . . . 33.0 110.907 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -156.62 131.86 9.22 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.592 0.711 . . . . 54.100000000000001 109.723 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 19' ' ' ALA . 69.8 t80 -60.1 138.99 57.77 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.279 0.562 . . . . 0.0 111.146 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 18' ' ' LEU . 8.8 tp -116.01 78.05 1.15 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 122.075 0.941 . . . . 0.0 110.476 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.572 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -71.82 -35.45 69.93 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.119 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -68.01 -24.05 65.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.358 -0.839 . . . . 0.0 110.895 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -121.77 41.66 3.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.365 -0.835 . . . . 52.369999999999997 110.416 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.679 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 21.7 t -163.69 150.98 12.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.506 -0.747 . . . . 55.189999999999998 110.789 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.583 ' O ' HG23 ' A' ' 23' ' ' THR . 8.2 t -122.49 94.52 47.65 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.593 -0.692 . . . . 0.0 109.246 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.469 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.8 Cg_endo -66.17 -22.91 53.39 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.773 1.407 . . . . 51.57 111.466 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.59 -23.95 67.43 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.341 -0.849 . . . . 0.0 110.819 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -105.96 23.13 14.48 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.357 -0.84 . . . . 0.0 110.705 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.33 29.44 73.15 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.51 ' HB3' HG23 ' A' ' 23' ' ' THR . 54.9 ttt85 -121.5 93.05 3.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.634 -0.921 . . . . 0.0 110.13 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.469 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 56.6 m-85 -104.53 133.19 49.81 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.035 -0.728 . . . . 46.07 109.035 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.679 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -116.0 118.87 34.11 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.938 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -114.05 134.25 54.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.629 -0.669 . . . . 38.880000000000003 109.72 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.91 132.08 55.47 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.228 -0.92 . . . . 34.060000000000002 108.563 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.586 ' HE1' HG23 ' A' ' 88' ' ' VAL . 22.9 p90 -129.06 144.56 51.24 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.175 -1.01 . . . . 29.030000000000001 111.476 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.2 m -104.4 139.95 38.62 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.717 -0.614 . . . . 0.0 109.788 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.763 HD13 HG22 ' A' ' 13' ' ' VAL . 43.7 mm -105.55 132.29 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.735 0.779 . . . . 0.0 111.535 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -123.49 98.02 5.66 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.482 0.658 . . . . 40.240000000000002 109.722 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.776 HG22 HD22 ' A' ' 76' ' ' LEU . 78.8 mt -91.18 117.27 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.762 -0.586 . . . . 20.73 110.458 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -117.99 135.56 54.07 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.512 -0.742 . . . . 0.0 109.453 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.606 ' HB2' HD23 ' A' ' 76' ' ' LEU . 42.7 t-20 -92.67 117.76 30.33 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.721 -0.612 . . . . 21.34 110.867 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.16 9.34 17.14 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.435 -0.79 . . . . 0.0 110.456 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.9 173.71 49.13 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.348 -1.501 . . . . 29.100000000000001 109.348 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.38 -31.01 21.71 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.583 -0.951 . . . . 0.0 110.216 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.512 HG13 ' HD2' ' A' ' 44' ' ' PRO . 87.2 t -106.71 140.6 21.51 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.853 -0.529 . . . . 0.0 110.076 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.512 ' HD2' HG13 ' A' ' 43' ' ' VAL . 40.3 Cg_endo -53.52 148.38 34.82 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 O-C-N 123.752 1.396 . . . . 21.949999999999999 111.673 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.499 ' HB1' ' HZ ' ' A' ' 111' ' ' PHE . . . -138.29 151.12 47.3 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.68 0.752 . . . . 20.91 111.377 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.429 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 45.5 ttp180 -126.06 155.31 41.75 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.851 HD22 HG13 ' A' ' 69' ' ' VAL . 7.0 tt -99.29 117.78 34.5 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.554 -0.716 . . . . 0.0 109.711 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.558 HG23 HG22 ' A' ' 104' ' ' VAL . 62.3 t -100.48 -29.4 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.547 -0.72 . . . . 0.0 111.015 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 102' ' ' ASP . . . -142.27 164.76 29.27 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 118.981 -1.088 . . . . 0.0 112.42 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -142.72 140.54 31.53 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.425 0.631 . . . . 29.050000000000001 110.223 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -142.92 114.06 7.76 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.315 0.578 . . . . 27.969999999999999 109.759 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.6 ' CH2' HD13 ' A' ' 115' ' ' ILE . 86.6 m95 -100.38 133.4 44.85 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.676 -0.64 . . . . 25.25 110.971 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -115.51 77.14 1.05 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.589 -0.694 . . . . 0.0 109.139 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.811 HG22 ' CG ' ' A' ' 97' ' ' MET . 17.1 pt -82.85 127.99 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.468 -0.77 . . . . 36.109999999999999 111.881 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.5 m -120.79 130.09 53.85 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.329 -0.989 . . . . 33.979999999999997 108.329 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -89.06 169.98 11.04 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.701 0.762 . . . . 45.039999999999999 111.553 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.06 -5.74 8.37 Favored Glycine 0 N--CA 1.495 2.588 0 O-C-N 121.88 -0.513 . . . . 39.469999999999999 112.246 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -101.54 6.58 42.3 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 119.417 1.608 . . . . 0.0 110.516 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.75 -31.13 6.74 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -62.99 141.95 58.56 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.316 -1.108 . . . . 62.780000000000001 110.019 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.1 t -135.31 153.2 51.95 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.574 -0.704 . . . . 0.0 110.653 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -121.97 124.36 43.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.535 -0.728 . . . . 0.0 110.184 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -102.27 134.79 44.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.674 -0.641 . . . . 0.0 110.593 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.2 t -128.49 131.57 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.587 -0.696 . . . . 37.939999999999998 110.086 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -125.59 126.72 45.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.813 -0.554 . . . . 0.0 110.137 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.12 148.84 20.71 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.463 -1.455 . . . . 31.82 109.463 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -75.27 154.7 37.31 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.528 -0.984 . . . . 0.0 110.505 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.09 -170.38 0.1 Allowed Glycine 0 N--CA 1.499 2.896 0 O-C-N 121.46 -0.775 . . . . 22.620000000000001 111.454 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.851 HG13 HD22 ' A' ' 47' ' ' LEU . 15.5 m -130.85 128.88 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.862 -0.787 . . . . 17.510000000000002 109.331 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 69' ' ' VAL . 10.9 m 41.14 33.77 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 CA-C-O 121.485 0.66 . . . . 20.550000000000001 111.844 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.93 17.45 67.52 Favored Glycine 0 N--CA 1.498 2.799 0 O-C-N 121.456 -0.777 . . . . 18.289999999999999 112.957 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 69' ' ' VAL . 15.4 pt-20 -145.23 150.45 36.71 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-N 119.275 1.537 . . . . 0.0 111.856 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -115.37 75.57 4.68 Favored Pre-proline 0 N--CA 1.492 1.637 0 N-CA-C 108.932 -0.766 . . . . 18.210000000000001 108.932 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -57.49 138.07 84.42 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 O-C-N 123.885 1.466 . . . . 17.609999999999999 112.043 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.429 ' CD1' ' HB2' ' A' ' 46' ' ' ARG . 4.3 t90 -100.82 75.89 1.74 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.776 HD22 HG22 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -58.95 116.56 3.87 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.545 -0.722 . . . . 20.57 111.239 -178.459 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.427 ' HG2' ' CZ3' ' A' ' 75' ' ' TRP . 4.5 mtt180 -86.83 159.25 52.3 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -54.39 125.87 20.36 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 O-C-N 123.585 1.308 . . . . 27.039999999999999 110.75 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.51 -18.21 43.8 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.732 -0.947 . . . . 24.739999999999998 110.732 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -89.24 165.64 14.3 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.996 -1.297 . . . . 29.379999999999999 110.243 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 37' ' ' ILE . . . -148.27 151.79 36.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.494 -0.753 . . . . 0.0 110.5 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.494 ' N ' HD11 ' A' ' 76' ' ' LEU . 65.3 t80 -118.17 147.53 43.26 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.479 -0.763 . . . . 18.559999999999999 109.042 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -144.42 140.73 29.17 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.192 -0.943 . . . . 0.0 111.082 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.443 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 47.2 p90 -150.16 160.0 44.0 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.653 -0.654 . . . . 26.649999999999999 109.671 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 62.8 m -100.37 136.54 40.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.464 -0.772 . . . . 28.140000000000001 110.651 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 29.2 t -124.04 167.9 13.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.578 -0.701 . . . . 33.880000000000003 110.033 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.15 122.46 2.09 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.876 -1.154 . . . . 31.800000000000001 110.274 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.586 HG23 ' HE1' ' A' ' 33' ' ' TYR . 80.3 t -129.72 148.19 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.575 -0.956 . . . . 0.0 109.352 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 30' ' ' ALA . 87.0 mt -107.97 144.49 35.19 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.522 -0.736 . . . . 0.0 110.408 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.2 tp -121.57 144.07 48.94 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.581 -0.699 . . . . 38.68 109.787 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -105.15 -2.19 24.55 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.329 -0.857 . . . . 0.0 111.332 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.584 HG22 ' HG2' ' A' ' 94' ' ' GLN . 29.6 m -109.29 -35.96 6.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.068 -1.02 . . . . 31.629999999999999 110.931 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.51 ' CB ' ' O ' ' A' ' 92' ' ' THR . 33.3 tt0 87.72 -14.07 0.44 Allowed 'General case' 0 N--CA 1.524 3.266 0 C-N-CA 123.196 0.598 . . . . 0.0 111.059 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.584 ' HG2' HG22 ' A' ' 92' ' ' THR . 14.3 pt20 -139.97 146.41 39.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.119 -0.988 . . . . 0.0 109.832 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 160.79 179.85 35.81 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 118.421 -1.847 . . . . 28.050000000000001 112.643 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -121.66 130.79 53.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 122.237 -0.567 . . . . 0.0 109.668 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.811 ' CG ' HG22 ' A' ' 54' ' ' ILE . 0.5 OUTLIER -126.58 124.61 40.36 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.314 -0.866 . . . . 0.0 111.543 -178.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.803 ' HG2' ' HB2' ' A' ' 117' ' ' ALA . 88.7 mt-30 -118.05 151.4 37.59 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.434 ' HA3' ' CE3' ' A' ' 52' ' ' TRP . . . -156.02 167.58 33.31 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 118.873 -1.632 . . . . 29.620000000000001 110.902 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -137.75 156.87 47.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.73 -0.865 . . . . 0.0 109.846 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.688 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 12.2 m-85 -117.94 127.21 53.62 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.546 -0.721 . . . . 27.050000000000001 110.154 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.581 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 80.4 m-20 -85.64 121.45 28.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.929 -1.107 . . . . 0.0 108.732 177.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.746 ' SD ' HG11 ' A' ' 9' ' ' VAL . 76.8 mtp -123.87 164.06 20.01 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.239 0.543 . . . . 0.0 110.672 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.558 HG22 HG23 ' A' ' 48' ' ' VAL . 9.1 m -142.8 129.21 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.678 -0.639 . . . . 23.280000000000001 110.377 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.52 166.85 22.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.431 -0.793 . . . . 0.0 109.229 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -63.65 -28.94 70.26 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.108 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -74.01 -12.96 60.79 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.455 -0.778 . . . . 0.0 111.044 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.06 -6.34 43.09 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.351 -1.099 . . . . 30.43 110.351 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.439 HG21 ' CE2' ' A' ' 7' ' ' TYR . 48.0 m -58.62 137.36 57.56 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.082 -1.246 . . . . 0.0 109.952 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -101.42 139.77 36.63 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.362 -0.836 . . . . 0.0 110.947 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.499 ' HZ ' ' HB1' ' A' ' 45' ' ' ALA . 45.1 p90 -163.02 141.81 8.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.715 -0.616 . . . . 28.030000000000001 109.782 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 84.9 mt -101.74 157.92 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.738 -0.601 . . . . 0.0 110.813 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.688 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -120.01 95.82 49.22 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -60.14 146.14 96.9 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 O-C-N 124.013 1.533 . . . . 33.310000000000002 112.201 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.638 HD11 ' CZ ' ' A' ' 101' ' ' TYR . 69.0 mt -111.43 121.55 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.731 -0.84 . . . . 30.59 108.731 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -47.58 161.66 0.08 Allowed 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 121.199 0.524 . . . . 30.780000000000001 111.641 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.803 ' HB2' ' HG2' ' A' ' 98' ' ' GLN . . . -98.71 122.95 42.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.584 -0.698 . . . . 0.0 110.807 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.61 ' HE1' HD11 ' A' ' 120' ' ' LEU . 46.3 p90 -109.86 162.91 14.03 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.409 -0.959 . . . . 30.66 108.409 178.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.583 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.0 t -114.22 155.34 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.338 -0.851 . . . . 0.0 110.253 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.637 ' N ' HD12 ' A' ' 120' ' ' LEU . 7.9 mp -110.63 131.98 54.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.684 -0.635 . . . . 39.149999999999999 109.422 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.8 p . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.807 -0.558 . . . . 0.0 110.126 -179.772 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.463 ' HG3' ' HB3' ' A' ' 42' ' ' ALA . 32.4 ttp180 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 120.833 0.349 . . . . 0.0 110.377 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.475 ' CE2' HG21 ' A' ' 109' ' ' THR . 34.3 m-85 -115.42 109.13 17.42 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.566 -0.709 . . . . 31.93 110.154 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.451 ' C ' HG23 ' A' ' 9' ' ' VAL . 58.8 mtp85 -151.89 135.63 16.3 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.666 0.746 . . . . 0.0 110.347 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.735 HG11 ' CE ' ' A' ' 103' ' ' MET . 62.4 t -150.68 116.08 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.478 0.656 . . . . 0.0 109.415 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -107.07 128.93 54.81 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.551 0.691 . . . . 0.0 109.916 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.5 t -118.93 137.27 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.813 -0.554 . . . . 28.210000000000001 109.844 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -123.6 136.61 54.61 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.351 -0.843 . . . . 0.0 109.649 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.827 HG22 HD13 ' A' ' 35' ' ' ILE . 57.9 t -129.05 137.67 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.621 -0.674 . . . . 27.949999999999999 110.688 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.3 t -126.34 105.66 24.59 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.77 -0.581 . . . . 0.0 110.44 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.442 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 51.1 Cg_endo -83.8 166.89 13.18 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 O-C-N 123.799 1.42 . . . . 33.0 111.236 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -157.77 130.19 7.24 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.474 0.654 . . . . 54.100000000000001 109.732 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.471 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 81.5 t80 -60.54 140.03 57.51 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.788 -0.57 . . . . 0.0 111.407 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.073 HD11 ' HB2' ' A' ' 32' ' ' ALA . 92.6 mt -116.46 81.39 1.61 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.9 0.857 . . . . 0.0 110.462 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.471 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -66.58 -36.08 81.77 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.968 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -69.98 -22.99 63.09 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.366 -0.834 . . . . 0.0 111.127 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -121.33 38.42 4.09 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.218 -0.926 . . . . 52.369999999999997 111.258 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.714 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 45.4 p -160.09 146.47 15.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.269 -0.895 . . . . 55.189999999999998 111.161 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.2 m -117.7 92.09 40.34 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.517 -0.739 . . . . 0.0 109.043 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.454 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.3 Cg_endo -66.91 -25.36 45.09 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 O-C-N 123.925 1.487 . . . . 51.57 111.374 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -66.35 -23.93 66.43 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.552 -0.717 . . . . 0.0 110.846 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -106.84 24.51 12.63 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.334 -0.854 . . . . 0.0 110.581 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.5 30.57 73.17 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -120.02 92.37 3.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.602 -0.94 . . . . 0.0 110.111 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.454 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 81.2 m-85 -105.06 131.21 52.87 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.47 -0.769 . . . . 46.07 109.296 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.714 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -118.32 120.76 38.59 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.406 -0.809 . . . . 0.0 111.34 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.811 ' CD1' HD12 ' A' ' 90' ' ' LEU . 67.2 m-85 -116.44 134.6 54.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.459 -0.776 . . . . 38.880000000000003 109.819 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 1.073 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -110.92 131.42 55.06 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.379 -0.971 . . . . 34.060000000000002 108.379 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.619 ' HE1' HG23 ' A' ' 88' ' ' VAL . 23.9 p90 -127.58 143.69 51.15 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.112 -1.035 . . . . 29.030000000000001 111.559 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.2 m -103.25 139.24 38.97 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.827 HD13 HG22 ' A' ' 13' ' ' VAL . 40.6 mm -106.66 133.75 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.626 0.727 . . . . 0.0 111.488 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -123.25 98.78 6.03 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.422 0.63 . . . . 40.240000000000002 109.751 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.792 HG22 HD22 ' A' ' 76' ' ' LEU . 81.3 mt -90.33 116.11 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.653 -0.654 . . . . 20.73 110.408 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -117.91 134.76 54.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.517 -0.739 . . . . 0.0 109.53 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.569 ' HB2' HD23 ' A' ' 76' ' ' LEU . 22.3 t-20 -92.82 117.64 30.23 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 120.234 -0.586 . . . . 21.34 110.503 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.1 11.06 17.53 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.404 -0.81 . . . . 0.0 110.482 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.27 171.62 48.25 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.907 -1.677 . . . . 29.100000000000001 108.907 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.463 ' HB3' ' HG3' ' A' ' 6' ' ' ARG . . . -84.53 -31.89 24.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.442 -1.034 . . . . 0.0 110.09 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.51 HG13 ' HD2' ' A' ' 44' ' ' PRO . 87.1 t -103.15 139.67 20.33 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.813 -0.555 . . . . 0.0 109.873 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.51 ' HD2' HG13 ' A' ' 43' ' ' VAL . 40.1 Cg_endo -53.21 145.09 45.32 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 O-C-N 123.891 1.469 . . . . 21.949999999999999 111.748 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.02 151.8 45.74 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.674 0.75 . . . . 20.91 111.112 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.439 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 2.1 ptt85 -127.36 158.68 36.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.768 -0.583 . . . . 0.0 109.596 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.908 HD22 HG13 ' A' ' 69' ' ' VAL . 6.4 tt -96.68 118.06 32.34 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.486 -0.759 . . . . 0.0 109.5 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.1 p -101.2 -24.41 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.589 -0.695 . . . . 0.0 111.071 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.794 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -142.3 163.88 31.65 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.213 -0.929 . . . . 0.0 111.901 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.5 ptt85 -138.16 137.65 37.85 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.437 0.636 . . . . 29.050000000000001 110.201 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.403 ' CD2' ' OD1' ' A' ' 65' ' ' ASP . 20.4 t-160 -142.11 111.29 6.41 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.417 0.627 . . . . 27.969999999999999 109.852 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.415 ' CH2' HG21 ' A' ' 115' ' ' ILE . 66.2 m95 -103.35 133.8 47.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.682 -0.637 . . . . 25.25 111.396 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -115.77 80.76 1.49 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.892 HG22 ' HG3' ' A' ' 97' ' ' MET . 17.2 pt -86.0 129.14 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.49 -0.756 . . . . 36.109999999999999 111.755 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.812 HG23 HG22 ' A' ' 61' ' ' THR . 86.6 m -120.04 129.96 54.48 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.362 -0.977 . . . . 33.979999999999997 108.362 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -91.15 169.99 10.39 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.582 0.706 . . . . 45.039999999999999 111.309 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.12 -6.72 14.24 Favored Glycine 0 N--CA 1.495 2.633 0 O-C-N 121.848 -0.533 . . . . 39.469999999999999 112.066 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -101.71 6.84 42.04 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 119.357 1.579 . . . . 0.0 110.771 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 61' ' ' THR . . . 92.75 -33.11 5.18 Favored Glycine 0 N--CA 1.496 2.644 0 C-N-CA 120.329 -0.939 . . . . 0.0 110.983 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.29 142.34 54.82 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.146 -1.208 . . . . 62.780000000000001 109.835 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.812 HG22 HG23 ' A' ' 55' ' ' THR . 69.3 p -133.49 152.4 51.9 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.599 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.415 ' HB2' HD11 ' A' ' 54' ' ' ILE . 49.3 mt-10 -121.15 121.89 38.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.584 -0.698 . . . . 0.0 109.833 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.403 ' CG ' ' NE2' ' A' ' 51' ' ' HIS . 15.4 tt0 -102.4 135.3 44.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.577 -0.702 . . . . 0.0 110.658 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.2 t -129.52 130.44 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.705 0.764 . . . . 37.939999999999998 110.484 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.403 ' OD1' ' CD2' ' A' ' 51' ' ' HIS . 77.9 m-20 -127.41 126.46 42.46 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.06 148.53 20.0 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.806 -1.318 . . . . 31.82 109.806 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -71.09 152.31 43.61 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.447 -1.031 . . . . 0.0 110.22 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 50.52 -172.17 0.14 Allowed Glycine 0 N--CA 1.498 2.812 0 O-C-N 121.403 -0.811 . . . . 22.620000000000001 111.345 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.908 HG13 HD22 ' A' ' 47' ' ' LEU . 14.4 m -129.79 128.53 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.87 -0.782 . . . . 17.510000000000002 109.631 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 69' ' ' VAL . 10.6 m 41.32 34.62 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 CA-C-O 121.578 0.704 . . . . 20.550000000000001 111.733 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.51 17.06 67.12 Favored Glycine 0 N--CA 1.499 2.837 0 O-C-N 121.658 -0.651 . . . . 18.289999999999999 112.991 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -145.67 150.36 36.16 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 119.179 1.489 . . . . 0.0 112.118 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -115.75 73.15 4.33 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.85 -0.796 . . . . 18.210000000000001 108.85 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -55.87 141.37 85.57 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 O-C-N 123.876 1.461 . . . . 17.609999999999999 112.281 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.439 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 2.9 t90 -103.43 77.17 1.48 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.792 HD22 HG22 ' A' ' 37' ' ' ILE . 8.0 tp -61.4 117.68 5.97 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.553 -0.717 . . . . 20.57 111.857 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.4 mtm180 -88.12 159.63 47.68 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -54.69 129.2 33.74 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 O-C-N 123.549 1.289 . . . . 27.039999999999999 111.185 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.11 -19.21 40.03 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 111.045 -0.822 . . . . 24.739999999999998 111.045 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -89.13 166.42 13.85 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.098 -1.236 . . . . 29.379999999999999 110.53 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.543 ' CA ' HD11 ' A' ' 76' ' ' LEU . . . -147.0 149.88 34.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.556 -0.715 . . . . 0.0 110.384 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -117.27 148.16 41.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.471 -0.768 . . . . 18.559999999999999 109.221 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -144.37 139.77 28.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.229 -0.919 . . . . 0.0 111.258 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.513 ' CE1' HG21 ' A' ' 35' ' ' ILE . 43.3 p90 -150.6 159.98 44.12 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.549 -0.719 . . . . 26.649999999999999 109.667 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.0 m -102.44 136.79 41.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.388 -0.82 . . . . 28.140000000000001 110.846 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 21.3 t -125.35 169.47 12.29 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.586 -0.696 . . . . 33.880000000000003 110.081 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.16 124.71 2.6 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.834 -1.174 . . . . 31.800000000000001 110.433 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.619 HG23 ' HE1' ' A' ' 33' ' ' TYR . 75.6 t -129.46 150.83 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.699 -0.883 . . . . 0.0 109.272 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 48.3 mt -110.35 143.73 40.14 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.526 -0.734 . . . . 0.0 110.729 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.811 HD12 ' CD1' ' A' ' 31' ' ' PHE . 98.1 mt -122.13 146.12 47.52 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.644 -0.66 . . . . 38.68 109.941 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -73.19 -25.96 60.98 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.379 -0.826 . . . . 0.0 110.773 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 94' ' ' GLN . 7.7 t -123.81 173.04 8.42 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.461 -0.774 . . . . 31.629999999999999 110.618 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.42 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 37.2 tt0 -85.72 10.28 13.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.665 -0.647 . . . . 0.0 111.576 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.458 ' O ' HG23 ' A' ' 92' ' ' THR . 27.7 pt20 -142.12 150.04 40.61 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.125 -0.984 . . . . 0.0 109.919 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.05 165.52 31.45 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 118.868 -1.634 . . . . 28.050000000000001 112.244 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -119.08 129.86 55.3 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 122.173 -0.604 . . . . 0.0 109.444 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.892 ' HG3' HG22 ' A' ' 54' ' ' ILE . 48.4 ttm -125.29 116.44 21.94 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.314 -0.866 . . . . 0.0 111.055 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.501 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 56.7 tt0 -129.5 150.58 50.78 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -162.2 178.51 37.99 Favored Glycine 0 N--CA 1.499 2.889 0 C-N-CA 118.743 -1.694 . . . . 29.620000000000001 111.104 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.418 ' CD2' ' HB3' ' A' ' 114' ' ' PRO . 50.9 m80 -134.72 154.0 51.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.73 -0.865 . . . . 0.0 109.972 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.655 ' CD2' HD11 ' A' ' 115' ' ' ILE . 4.4 m-85 -117.9 127.69 54.1 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.599 -0.688 . . . . 27.050000000000001 109.718 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.794 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 41.1 t0 -81.26 122.11 27.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.971 -1.08 . . . . 0.0 109.053 178.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.735 ' CE ' HG11 ' A' ' 9' ' ' VAL . 13.1 tpp -121.61 159.82 25.65 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.078 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.403 HG23 ' CG ' ' A' ' 46' ' ' ARG . 11.1 m -140.54 129.06 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.517 -0.74 . . . . 23.280000000000001 110.269 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.32 167.34 21.43 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.568 -0.708 . . . . 0.0 109.618 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -64.03 -29.61 70.75 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.95 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -72.39 -12.04 60.95 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.607 -0.683 . . . . 0.0 111.059 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.5 -7.34 50.48 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.415 -1.074 . . . . 30.43 110.415 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.475 HG21 ' CE2' ' A' ' 7' ' ' TYR . 30.4 m -57.55 135.99 56.7 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.098 -1.236 . . . . 0.0 110.038 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -101.74 141.48 34.53 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.412 -0.805 . . . . 0.0 110.985 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 42.7 p90 -169.39 148.78 3.9 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.65 -0.656 . . . . 28.030000000000001 109.865 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.2 pt -101.98 157.71 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.597 -0.69 . . . . 0.0 111.252 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -118.92 96.89 50.52 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.418 ' HB3' ' CD2' ' A' ' 100' ' ' HIS . 46.3 Cg_endo -58.1 143.3 96.81 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 O-C-N 123.939 1.494 . . . . 33.310000000000002 112.453 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.655 HD11 ' CD2' ' A' ' 101' ' ' TYR . 70.4 mt -107.51 121.89 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.352 -0.981 . . . . 30.59 108.352 178.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.17 144.61 6.9 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.157 0.503 . . . . 30.780000000000001 111.441 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.501 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -91.08 119.4 31.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.718 -0.613 . . . . 0.0 110.313 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.573 ' HE1' HD11 ' A' ' 120' ' ' LEU . 34.2 p90 -109.11 168.44 9.37 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.717 -0.845 . . . . 30.66 108.717 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.594 ' C ' HD12 ' A' ' 120' ' ' LEU . 57.9 t -114.21 154.67 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.304 -0.873 . . . . 0.0 110.542 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 120' ' ' LEU . 7.4 mp -112.4 133.64 54.38 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.342 -0.614 . . . . 39.149999999999999 109.342 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 95.6 p . . . . . 0 N--CA 1.494 1.754 0 O-C-N 121.681 -0.637 . . . . 0.0 110.046 -179.719 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.424 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 82.7 mtt85 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.024 0.44 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.453 ' CE2' HG21 ' A' ' 109' ' ' THR . 29.2 m-85 -114.82 98.96 7.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.56 -0.713 . . . . 31.93 110.109 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.484 ' C ' HG23 ' A' ' 9' ' ' VAL . 80.2 mtt85 -146.59 137.19 23.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.602 0.715 . . . . 0.0 110.216 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.535 HG11 ' CE ' ' A' ' 103' ' ' MET . 97.6 t -152.94 114.12 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.433 0.635 . . . . 0.0 109.305 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -109.06 130.16 55.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.539 -0.726 . . . . 0.0 109.981 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.48 HG22 ' HA ' ' A' ' 37' ' ' ILE . 60.2 t -118.34 141.55 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.811 -0.556 . . . . 28.210000000000001 109.97 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -120.1 137.66 54.01 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.465 -0.772 . . . . 0.0 109.817 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.765 HG22 HD13 ' A' ' 35' ' ' ILE . 61.1 t -128.65 137.4 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.607 -0.683 . . . . 27.949999999999999 110.45 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -125.97 106.11 25.67 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.778 -0.576 . . . . 0.0 110.624 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -84.52 165.83 12.22 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 O-C-N 123.923 1.486 . . . . 33.0 111.091 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -158.14 131.09 7.36 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.52 0.676 . . . . 54.100000000000001 109.953 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.474 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 79.8 t80 -61.5 139.97 58.15 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.766 -0.584 . . . . 0.0 111.563 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.0 HD11 ' HB2' ' A' ' 32' ' ' ALA . 73.8 mt -116.32 80.81 1.51 Allowed 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.912 0.863 . . . . 0.0 110.349 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.474 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -66.03 -35.88 81.75 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.901 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -69.93 -22.83 63.16 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.375 -0.828 . . . . 0.0 111.107 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -122.23 43.38 2.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.382 -0.824 . . . . 52.369999999999997 110.959 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.639 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 51.6 p -164.98 147.42 8.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.299 -0.876 . . . . 55.189999999999998 111.043 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.3 m -116.37 91.43 33.16 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.0 Cg_endo -65.09 -24.85 59.04 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 O-C-N 123.877 1.462 . . . . 51.57 111.229 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -67.94 -22.82 65.03 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.381 -0.824 . . . . 0.0 110.834 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -106.51 23.34 14.37 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.265 -0.897 . . . . 0.0 110.615 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.98 29.28 73.44 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -120.41 94.07 4.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.596 -0.943 . . . . 0.0 110.171 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.46 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 77.3 m-85 -105.48 132.18 51.97 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.495 -0.753 . . . . 46.07 109.278 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.639 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -114.72 120.62 40.7 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.093 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.598 ' CG ' HD23 ' A' ' 120' ' ' LEU . 87.7 m-85 -116.01 134.78 54.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.55 -0.718 . . . . 38.880000000000003 109.784 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 1.0 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -111.62 132.02 54.86 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.436 -0.95 . . . . 34.060000000000002 108.436 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.627 ' HE1' HG23 ' A' ' 88' ' ' VAL . 20.2 p90 -127.72 142.85 51.21 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.083 -1.047 . . . . 29.030000000000001 111.262 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.5 p -105.2 140.65 38.03 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.765 HD13 HG22 ' A' ' 13' ' ' VAL . 44.6 mm -105.3 131.8 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.841 0.829 . . . . 0.0 111.604 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -122.46 95.74 4.76 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.183 -0.673 . . . . 40.240000000000002 109.183 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.535 HG22 ' CD1' ' A' ' 76' ' ' LEU . 75.4 mt -90.84 117.81 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.792 -0.567 . . . . 20.73 110.657 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.556 ' OE1' ' HB2' ' A' ' 81' ' ' ALA . 71.6 tp60 -117.06 135.72 53.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.543 -0.723 . . . . 0.0 109.398 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -91.46 117.23 29.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.801 -0.562 . . . . 21.34 110.651 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.51 9.29 18.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.536 -0.728 . . . . 0.0 110.579 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.27 -177.08 51.7 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.182 -1.567 . . . . 29.100000000000001 109.182 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . . . -100.39 -30.99 11.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.492 -1.005 . . . . 0.0 110.063 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.519 HG13 ' HD2' ' A' ' 44' ' ' PRO . 86.2 t -105.4 140.56 21.27 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.8 -0.563 . . . . 0.0 109.545 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.519 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.2 Cg_endo -51.4 141.89 39.64 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 O-C-N 123.731 1.385 . . . . 21.949999999999999 111.9 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.7 151.73 46.12 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.488 0.661 . . . . 20.91 110.937 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -127.57 158.89 36.26 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.827 -0.546 . . . . 0.0 109.844 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.805 HD22 HG13 ' A' ' 69' ' ' VAL . 7.7 tt -97.88 117.12 31.48 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.449 -0.782 . . . . 0.0 109.404 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.439 HG21 HG21 ' A' ' 104' ' ' VAL . 62.1 t -100.69 -27.76 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.666 -0.646 . . . . 0.0 110.569 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.714 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -140.11 162.83 34.3 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.833 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.7 ptt85 -142.41 139.97 31.83 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.44 0.638 . . . . 29.050000000000001 110.206 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -142.24 113.67 7.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.72 -0.613 . . . . 27.969999999999999 109.699 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.503 ' CH2' HD13 ' A' ' 115' ' ' ILE . 92.4 m95 -101.92 133.5 46.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.74 -0.6 . . . . 25.25 110.792 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -116.33 77.33 1.09 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.633 -0.667 . . . . 0.0 109.338 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 54' ' ' ILE . 28.4 pt -84.17 129.19 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.922 0.868 . . . . 36.109999999999999 112.149 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.5 m -121.0 130.99 54.02 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.325 -0.991 . . . . 33.979999999999997 108.325 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -88.64 170.59 10.69 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.725 0.774 . . . . 45.039999999999999 111.427 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.55 -7.67 8.18 Favored Glycine 0 N--CA 1.494 2.542 0 O-C-N 121.823 -0.548 . . . . 39.469999999999999 112.299 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -101.21 6.92 43.21 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 119.411 1.605 . . . . 0.0 110.691 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.77 -28.33 9.47 Favored Glycine 0 N--CA 1.495 2.587 0 O-C-N 121.204 -0.935 . . . . 0.0 110.955 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.76 142.0 58.56 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.256 -1.143 . . . . 62.780000000000001 109.779 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.7 t -135.06 153.16 52.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.489 -0.757 . . . . 0.0 110.756 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -121.51 123.33 41.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.535 -0.728 . . . . 0.0 110.076 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -102.36 135.61 43.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.75 -0.594 . . . . 0.0 110.742 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.9 t -128.67 132.9 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.628 -0.67 . . . . 37.939999999999998 109.85 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -124.64 127.48 47.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.828 -0.545 . . . . 0.0 110.452 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -153.94 170.32 32.56 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.215 -1.554 . . . . 31.82 109.215 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -114.99 159.98 20.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.374 -1.074 . . . . 0.0 110.141 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.44 96.25 0.01 OUTLIER Glycine 0 N--CA 1.5 2.957 0 O-C-N 121.328 -0.857 . . . . 22.620000000000001 111.444 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.805 HG13 HD22 ' A' ' 47' ' ' LEU . 30.4 m -46.32 133.37 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.453 0 O-C-N 121.365 -1.079 . . . . 17.510000000000002 111.425 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.0 m 41.45 34.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 CA-C-O 121.587 0.708 . . . . 20.550000000000001 111.312 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.62 23.14 54.42 Favored Glycine 0 N--CA 1.495 2.603 0 O-C-N 121.714 -0.616 . . . . 18.289999999999999 112.301 178.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.53 ' HG3' HG23 ' A' ' 69' ' ' VAL . 2.2 pt-20 -144.21 151.25 39.22 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 119.125 1.463 . . . . 0.0 112.335 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -117.86 72.19 8.33 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.152 -1.055 . . . . 18.210000000000001 108.152 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -54.8 141.79 75.78 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 O-C-N 123.757 1.399 . . . . 17.609999999999999 112.385 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -103.75 75.32 1.3 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.535 ' CD1' HG22 ' A' ' 37' ' ' ILE . 15.0 mt -60.43 119.66 8.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.706 -0.621 . . . . 20.57 111.915 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -86.05 158.45 55.72 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -53.48 127.4 25.16 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 O-C-N 123.539 1.284 . . . . 27.039999999999999 111.167 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.76 -16.48 56.55 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.74 -0.944 . . . . 24.739999999999998 110.74 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -87.25 164.36 16.36 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.089 -1.242 . . . . 29.379999999999999 110.427 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.556 ' HB2' ' OE1' ' A' ' 38' ' ' GLN . . . -145.45 149.33 34.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.568 -0.708 . . . . 0.0 110.199 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -119.2 144.63 46.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.499 -0.751 . . . . 18.559999999999999 109.212 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 -144.14 140.93 29.67 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.163 -0.96 . . . . 0.0 111.236 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.462 ' CE1' HG21 ' A' ' 35' ' ' ILE . 51.0 p90 -150.8 160.05 44.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.646 -0.659 . . . . 26.649999999999999 109.74 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 60.3 m -100.8 136.08 41.23 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.445 -0.785 . . . . 28.140000000000001 110.848 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 23.3 t -126.38 168.08 14.65 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.554 -0.716 . . . . 33.880000000000003 110.115 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -135.67 129.11 4.88 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.926 -1.13 . . . . 31.800000000000001 110.496 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.627 HG23 ' HE1' ' A' ' 33' ' ' TYR . 54.2 t -133.01 148.76 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.592 -0.946 . . . . 0.0 109.248 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 29' ' ' TYR . 15.9 tp -109.81 143.79 39.18 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.552 -0.718 . . . . 0.0 110.542 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.746 HD23 ' O ' ' A' ' 92' ' ' THR . 11.4 tp -121.49 144.26 48.8 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.574 -0.704 . . . . 38.68 109.767 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -75.98 -25.41 55.79 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.25 -0.906 . . . . 0.0 111.096 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.746 ' O ' HD23 ' A' ' 90' ' ' LEU . 5.8 m -124.04 171.97 9.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.332 -0.855 . . . . 31.629999999999999 110.512 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.428 ' H ' HG22 ' A' ' 92' ' ' THR . 52.6 tt0 -86.28 11.45 12.13 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.612 -0.68 . . . . 0.0 111.592 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -142.89 142.98 31.86 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.2 -0.937 . . . . 0.0 109.626 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -177.47 152.73 12.29 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 118.751 -1.69 . . . . 28.050000000000001 112.198 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -118.05 130.33 56.1 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 90.7 mtp -128.0 124.02 36.18 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.457 -0.777 . . . . 0.0 111.597 -178.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.546 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 62.8 mt-30 -125.49 152.19 45.29 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.89 179.88 38.59 Favored Glycine 0 N--CA 1.5 2.958 0 C-N-CA 118.665 -1.731 . . . . 29.620000000000001 111.211 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -134.62 159.07 42.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.843 -0.798 . . . . 0.0 110.031 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.674 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 8.2 m-85 -116.71 127.35 54.31 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.589 -0.694 . . . . 27.050000000000001 109.959 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.714 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 40.4 t0 -85.99 118.51 25.51 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.06 -1.025 . . . . 0.0 108.815 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.535 ' CE ' HG11 ' A' ' 9' ' ' VAL . 18.3 tpp -124.73 160.78 27.83 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.294 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.439 HG21 HG21 ' A' ' 48' ' ' VAL . 7.2 m -140.93 131.19 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.614 -0.679 . . . . 23.280000000000001 110.328 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.04 166.86 22.28 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.437 -0.789 . . . . 0.0 109.606 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -64.64 -29.45 70.45 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.94 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -73.72 -11.24 60.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.519 -0.738 . . . . 0.0 111.059 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.24 -7.3 47.43 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.411 -1.076 . . . . 30.43 110.411 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.453 HG21 ' CE2' ' A' ' 7' ' ' TYR . 24.3 m -57.68 135.47 56.74 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.026 -1.279 . . . . 0.0 110.056 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -101.14 139.61 36.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.441 -0.787 . . . . 0.0 110.69 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 43.8 p90 -165.78 145.05 6.26 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.75 -0.594 . . . . 28.030000000000001 109.902 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 24.9 pt -102.21 158.11 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.716 -0.615 . . . . 0.0 111.16 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.674 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -119.86 97.6 49.59 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -58.15 143.82 96.19 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 O-C-N 123.835 1.439 . . . . 33.310000000000002 112.166 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.503 HD13 ' CH2' ' A' ' 52' ' ' TRP . 68.7 mt -108.81 122.52 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-N 115.368 -0.833 . . . . 30.59 108.954 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.61 172.81 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.255 0.55 . . . . 30.780000000000001 111.429 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.546 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -100.29 119.93 39.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.583 -0.698 . . . . 0.0 110.753 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 97' ' ' MET . 41.9 p90 -111.99 156.02 22.83 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.244 -1.021 . . . . 30.66 108.244 178.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.672 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.2 t -116.95 153.45 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.177 -0.952 . . . . 0.0 110.886 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.672 HD12 ' C ' ' A' ' 119' ' ' VAL . 7.9 mp -114.52 130.16 56.72 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.141 -0.689 . . . . 39.149999999999999 109.141 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.606 -0.684 . . . . 0.0 110.156 -179.802 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.665 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 91.1 mtm-85 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.772 0.32 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.53 ' CZ ' HG21 ' A' ' 109' ' ' THR . 90.9 m-85 -119.18 105.96 11.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.52 -0.738 . . . . 31.93 110.141 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.474 ' C ' HG23 ' A' ' 9' ' ' VAL . 93.8 mtt-85 -149.03 134.82 18.84 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.615 -0.678 . . . . 0.0 110.07 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.818 HG11 ' SD ' ' A' ' 103' ' ' MET . 97.0 t -151.58 116.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-O 121.554 0.692 . . . . 0.0 109.609 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -105.63 131.24 53.25 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.652 0.739 . . . . 0.0 110.385 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.577 HG11 ' HE2' ' A' ' 101' ' ' TYR . 63.4 t -118.75 136.12 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 109.303 -0.628 . . . . 28.210000000000001 109.303 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -124.02 137.24 54.62 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.306 -0.871 . . . . 0.0 110.136 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 75.8 t -129.22 136.95 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.679 -0.638 . . . . 27.949999999999999 110.523 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.1 m -125.12 105.55 28.72 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.785 -0.572 . . . . 0.0 110.302 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.406 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 49.8 Cg_endo -82.33 164.66 16.87 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.859 1.452 . . . . 33.0 111.255 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -157.47 130.63 7.71 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.667 0.746 . . . . 54.100000000000001 109.722 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.509 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 76.9 t80 -63.95 139.87 58.81 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.663 -0.648 . . . . 0.0 111.585 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.981 HD11 ' HB2' ' A' ' 32' ' ' ALA . 96.0 mt -116.04 80.7 1.49 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.947 0.88 . . . . 0.0 110.453 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.509 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -68.46 -35.75 78.01 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.793 178.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -69.54 -24.02 63.67 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.447 -0.783 . . . . 0.0 110.734 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -120.84 43.1 2.86 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.431 -0.793 . . . . 52.369999999999997 110.735 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.736 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 32.7 t -164.68 146.67 8.32 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.365 -0.834 . . . . 55.189999999999998 110.974 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.59 ' O ' HG23 ' A' ' 23' ' ' THR . 5.1 t -120.38 93.12 48.07 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.552 -0.718 . . . . 0.0 109.146 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.472 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.1 Cg_endo -65.94 -23.09 54.83 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 O-C-N 123.89 1.469 . . . . 51.57 111.573 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -65.61 -23.69 66.88 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.378 -0.826 . . . . 0.0 111.047 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -105.59 23.99 12.93 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.347 -0.845 . . . . 0.0 110.815 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.24 27.82 73.57 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.565 ' HB2' HG23 ' A' ' 23' ' ' THR . 10.5 mtm180 -120.79 94.2 4.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.503 -0.998 . . . . 0.0 110.169 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.472 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 68.2 m-85 -104.45 132.68 50.42 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.601 -0.687 . . . . 46.07 109.313 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.736 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -114.64 120.56 40.58 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.338 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.578 ' CG ' HD23 ' A' ' 120' ' ' LEU . 89.4 m-85 -116.26 134.5 54.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.529 -0.732 . . . . 38.880000000000003 109.841 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.981 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -112.16 132.71 54.73 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.442 -0.947 . . . . 34.060000000000002 108.442 178.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.605 ' HE1' HG23 ' A' ' 88' ' ' VAL . 20.1 p90 -128.05 143.28 51.07 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.078 -1.049 . . . . 29.030000000000001 111.611 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.9 m -106.71 139.69 40.75 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.818 HD12 ' CZ ' ' A' ' 84' ' ' TYR . 87.3 mt -108.8 134.55 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 121.668 0.747 . . . . 0.0 111.671 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.3 mtm105 -124.82 98.65 5.8 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.642 0.734 . . . . 40.240000000000002 109.796 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.563 HG22 ' CD1' ' A' ' 76' ' ' LEU . 85.4 mt -94.13 118.26 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.818 -0.551 . . . . 20.73 110.726 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -116.43 138.61 51.22 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.267 -0.896 . . . . 0.0 109.231 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -90.61 117.97 29.69 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.78 -0.575 . . . . 21.34 110.856 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.51 9.92 15.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.477 -0.765 . . . . 0.0 110.603 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.2 -178.97 52.4 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.417 -1.473 . . . . 29.100000000000001 109.417 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.665 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . . . -94.69 -33.89 12.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.441 -1.034 . . . . 0.0 110.326 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.516 HG13 ' HD2' ' A' ' 44' ' ' PRO . 87.4 t -103.78 139.6 20.26 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.846 -0.533 . . . . 0.0 109.946 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.516 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.9 Cg_endo -52.35 143.22 44.55 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 O-C-N 123.883 1.465 . . . . 21.949999999999999 111.845 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.452 ' HB1' ' HZ ' ' A' ' 111' ' ' PHE . . . -139.88 151.92 46.03 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.498 0.666 . . . . 20.91 110.99 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.438 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 19.6 ptt-85 -128.05 158.96 36.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.824 -0.547 . . . . 0.0 110.017 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.903 HD22 HG13 ' A' ' 69' ' ' VAL . 6.4 tt -97.7 115.28 27.66 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.446 -0.784 . . . . 0.0 109.246 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.444 HG11 HG21 ' A' ' 104' ' ' VAL . 35.1 m -100.54 -26.18 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.632 -0.667 . . . . 0.0 111.175 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.763 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -142.4 163.05 33.9 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.196 -0.94 . . . . 0.0 111.734 -179.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.463 ' HD3' HG12 ' A' ' 69' ' ' VAL . 39.3 ptt85 -145.39 142.26 29.18 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.644 0.735 . . . . 29.050000000000001 110.858 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.608 ' HB3' ' CE1' ' A' ' 100' ' ' HIS . 22.1 t-160 -144.89 115.17 7.54 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.324 -0.621 . . . . 27.969999999999999 109.324 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -98.05 135.6 39.51 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.558 -0.713 . . . . 25.25 111.747 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -115.48 75.98 0.98 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.427 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.8 pt -86.98 131.3 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.412 -0.805 . . . . 36.109999999999999 112.14 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.966 HG23 HG22 ' A' ' 61' ' ' THR . 12.3 m -119.85 132.93 55.72 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.35 -0.982 . . . . 33.979999999999997 108.35 178.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -87.19 169.48 12.31 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.638 0.732 . . . . 45.039999999999999 111.308 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.32 -8.36 12.4 Favored Glycine 0 N--CA 1.494 2.549 0 O-C-N 121.828 -0.545 . . . . 39.469999999999999 112.124 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -101.01 8.15 43.14 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 119.402 1.601 . . . . 0.0 110.859 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.34 -23.07 29.26 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.196 -0.94 . . . . 0.0 110.952 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -60.4 142.16 55.35 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.187 -1.184 . . . . 62.780000000000001 109.806 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.966 HG22 HG23 ' A' ' 55' ' ' THR . 74.3 p -126.05 142.0 51.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.407 -0.808 . . . . 0.0 110.669 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -122.87 119.95 32.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.411 -0.806 . . . . 0.0 109.948 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -104.79 134.47 47.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.657 -0.652 . . . . 0.0 110.7 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.9 t -127.93 130.85 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.625 -0.672 . . . . 37.939999999999998 109.81 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -123.41 126.6 47.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.84 -0.537 . . . . 0.0 110.299 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -147.84 147.45 18.13 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.223 -1.551 . . . . 31.82 109.223 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -72.59 155.63 39.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.51 -0.994 . . . . 0.0 110.15 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.59 -170.65 0.08 OUTLIER Glycine 0 N--CA 1.498 2.824 0 O-C-N 121.49 -0.756 . . . . 22.620000000000001 111.357 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.903 HG13 HD22 ' A' ' 47' ' ' LEU . 13.0 m -129.74 127.96 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.835 -0.803 . . . . 17.510000000000002 108.957 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.517 HG11 ' CE2' ' A' ' 84' ' ' TYR . 12.3 m 41.75 34.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 CA-C-O 121.7 0.762 . . . . 20.550000000000001 111.448 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.4 18.83 61.53 Favored Glycine 0 N--CA 1.497 2.751 0 O-C-N 121.714 -0.616 . . . . 18.289999999999999 113.041 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.425 ' O ' HG22 ' A' ' 69' ' ' VAL . 8.6 pt-20 -147.58 150.67 34.9 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 119.449 1.625 . . . . 0.0 112.675 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -115.24 73.05 3.47 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 108.257 -1.016 . . . . 18.210000000000001 108.257 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -55.5 141.49 82.63 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 O-C-N 123.842 1.443 . . . . 17.609999999999999 112.426 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.438 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 4.7 t90 -102.39 76.88 1.59 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.563 ' CD1' HG22 ' A' ' 37' ' ' ILE . 9.3 mt -60.89 117.49 5.49 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.636 -0.665 . . . . 20.57 111.783 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -88.39 159.12 47.94 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -54.25 129.58 35.3 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 O-C-N 123.535 1.281 . . . . 27.039999999999999 111.134 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.91 -18.9 44.95 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 111.003 -0.839 . . . . 24.739999999999998 111.003 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.93 166.62 14.39 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.117 -1.225 . . . . 29.379999999999999 110.446 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -144.55 146.16 32.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.672 -0.643 . . . . 0.0 110.415 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.512 ' HD2' HD12 ' A' ' 37' ' ' ILE . 89.5 t80 -114.58 141.24 48.01 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.049 -0.722 . . . . 18.559999999999999 109.049 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -147.95 140.98 24.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.298 -0.876 . . . . 0.0 111.101 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.818 ' CZ ' HD12 ' A' ' 35' ' ' ILE . 46.3 p90 -153.33 162.5 41.22 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.621 -0.674 . . . . 26.649999999999999 109.775 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.1 m -99.01 135.78 39.92 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.468 -0.77 . . . . 28.140000000000001 111.211 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 17.2 t -125.16 166.65 16.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.642 -0.661 . . . . 33.880000000000003 109.688 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.26 130.33 5.69 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 119.779 -1.201 . . . . 31.800000000000001 110.536 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.605 HG23 ' HE1' ' A' ' 33' ' ' TYR . 61.2 t -132.77 147.01 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.695 -0.885 . . . . 0.0 109.118 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.2 tp -110.27 143.74 40.0 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.559 -0.713 . . . . 0.0 110.33 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.75 HD12 HD22 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -122.4 144.97 48.7 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.491 -0.756 . . . . 38.68 109.936 -179.683 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -78.24 -26.09 47.17 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.425 -0.797 . . . . 0.0 110.641 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.446 HG22 ' N ' ' A' ' 93' ' ' GLU . 21.5 m -123.41 171.22 9.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.42 -0.8 . . . . 31.629999999999999 110.2 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.446 ' N ' HG22 ' A' ' 92' ' ' THR . 56.8 tt0 -86.21 12.54 9.59 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.415 -0.803 . . . . 0.0 111.579 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 97.0 mt-30 -140.99 144.99 35.38 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.044 -1.035 . . . . 0.0 109.698 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.51 158.94 21.66 Favored Glycine 0 N--CA 1.496 2.673 0 C-N-CA 118.766 -1.683 . . . . 28.050000000000001 112.321 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -119.66 129.96 54.83 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 122.128 -0.631 . . . . 0.0 109.578 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.478 ' HB3' ' HE2' ' A' ' 97' ' ' MET . 90.0 mtp -125.48 117.42 23.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.275 -0.89 . . . . 0.0 111.075 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.496 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 57.1 tt0 -129.21 150.04 50.76 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.36 -177.83 38.04 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 119.108 -1.52 . . . . 29.620000000000001 110.514 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.608 ' CE1' ' HB3' ' A' ' 51' ' ' HIS . 23.1 p80 -140.26 159.93 41.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.698 -0.883 . . . . 0.0 110.676 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.645 ' CD1' HD11 ' A' ' 47' ' ' LEU . 5.2 m-85 -115.3 128.38 56.07 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.753 -0.592 . . . . 27.050000000000001 109.944 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.763 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 42.9 t0 -83.4 122.3 28.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.006 -1.059 . . . . 0.0 108.739 177.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.818 ' SD ' HG11 ' A' ' 9' ' ' VAL . 43.0 mtp -123.51 161.93 23.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.878 -0.513 . . . . 0.0 110.507 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.444 HG21 HG11 ' A' ' 48' ' ' VAL . 6.4 m -140.32 129.47 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.719 -0.613 . . . . 23.280000000000001 110.23 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.21 166.53 22.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.507 -0.745 . . . . 0.0 109.649 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -65.86 -29.27 69.7 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.198 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -76.74 -4.89 45.7 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.395 -0.816 . . . . 0.0 111.347 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.33 -9.52 57.61 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.045 -1.074 . . . . 30.43 110.627 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.53 HG21 ' CZ ' ' A' ' 7' ' ' TYR . 23.9 m -57.42 134.57 56.16 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.047 -1.266 . . . . 0.0 110.104 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -101.68 139.61 37.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.37 -0.831 . . . . 0.0 110.724 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 45.2 p90 -164.08 143.75 7.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.664 -0.648 . . . . 28.030000000000001 109.856 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 102' ' ' ASP . 50.9 mm -98.69 156.11 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.661 -0.649 . . . . 0.0 110.61 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.53 96.92 48.93 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -59.44 141.53 97.63 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.911 1.479 . . . . 33.310000000000002 112.222 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.613 HD11 ' CD2' ' A' ' 101' ' ' TYR . 68.0 mt -107.08 124.05 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.627 -0.879 . . . . 30.59 108.627 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.92 147.52 3.82 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.234 0.54 . . . . 30.780000000000001 111.48 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.496 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -89.65 122.33 32.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.597 -0.689 . . . . 0.0 110.179 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.637 ' CE1' HD11 ' A' ' 120' ' ' LEU . 45.0 p90 -109.1 164.69 12.2 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.934 -0.765 . . . . 30.66 108.934 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.634 ' C ' HD12 ' A' ' 120' ' ' LEU . 57.8 t -114.48 155.4 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.333 -0.854 . . . . 0.0 110.28 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.75 HD22 HD12 ' A' ' 90' ' ' LEU . 7.0 mp -114.11 132.17 56.15 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.264 -0.643 . . . . 39.149999999999999 109.264 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.687 -0.633 . . . . 0.0 110.104 -179.852 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.42 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 38.7 ttm180 . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 120.906 0.384 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.445 ' CZ ' HG21 ' A' ' 109' ' ' THR . 47.7 m-85 -115.83 107.18 14.71 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.559 -0.713 . . . . 31.93 110.167 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.483 ' C ' HG23 ' A' ' 9' ' ' VAL . 9.8 ttt85 -153.44 135.2 14.52 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.561 0.696 . . . . 0.0 110.413 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.729 HG11 ' SD ' ' A' ' 103' ' ' MET . 97.0 t -152.29 116.08 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-O 121.448 0.642 . . . . 0.0 109.499 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -107.36 130.07 54.83 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.622 0.725 . . . . 0.0 110.049 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.0 t -118.1 139.46 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.848 -0.532 . . . . 28.210000000000001 109.817 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -121.81 137.81 54.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.386 -0.822 . . . . 0.0 110.014 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.724 HG22 HD13 ' A' ' 35' ' ' ILE . 58.7 t -128.7 137.11 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.59 -0.694 . . . . 27.949999999999999 110.379 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -125.3 106.9 27.54 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.738 -0.601 . . . . 0.0 110.485 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.439 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 51.0 Cg_endo -82.76 165.66 15.54 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 O-C-N 123.816 1.43 . . . . 33.0 111.119 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -158.05 129.59 6.72 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.595 0.712 . . . . 54.100000000000001 109.588 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.496 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 78.7 t80 -62.98 139.95 58.82 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.753 -0.592 . . . . 0.0 111.543 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.003 HD11 ' HB2' ' A' ' 32' ' ' ALA . 88.9 mt -115.85 81.2 1.56 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.907 0.861 . . . . 0.0 110.381 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.496 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -68.44 -35.77 78.08 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.893 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -69.94 -23.18 63.16 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.415 -0.803 . . . . 0.0 110.823 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -121.23 38.97 3.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.364 -0.835 . . . . 52.369999999999997 110.757 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.738 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 32.9 t -160.01 145.75 15.48 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.335 -0.853 . . . . 55.189999999999998 111.117 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.59 HG23 ' HB2' ' A' ' 28' ' ' ARG . 5.0 t -120.02 92.76 47.24 Favored Pre-proline 0 N--CA 1.496 1.848 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.476 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.8 Cg_endo -66.32 -23.0 52.17 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 O-C-N 123.86 1.453 . . . . 51.57 111.718 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -65.28 -23.45 67.04 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.357 -0.839 . . . . 0.0 110.994 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -105.62 24.15 12.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.306 -0.871 . . . . 0.0 110.846 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.99 28.13 73.68 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.59 ' HB2' HG23 ' A' ' 23' ' ' THR . 13.3 mtp180 -120.98 94.0 4.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.642 -0.916 . . . . 0.0 110.23 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.476 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 69.8 m-85 -104.14 133.56 48.87 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.607 -0.683 . . . . 46.07 109.359 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.738 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -115.21 120.19 38.87 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 119.754 -0.779 . . . . 0.0 111.075 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.83 ' CD1' HD12 ' A' ' 90' ' ' LEU . 91.4 m-85 -115.92 135.26 54.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.512 -0.742 . . . . 38.880000000000003 109.782 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 1.003 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -112.38 132.24 55.12 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.542 -0.91 . . . . 34.060000000000002 108.542 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.621 ' HE1' HG13 ' A' ' 88' ' ' VAL . 18.5 p90 -128.4 143.26 50.97 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.214 -0.995 . . . . 29.030000000000001 111.429 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.5 t -105.77 140.57 38.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.724 -0.61 . . . . 0.0 109.494 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.724 HD13 HG22 ' A' ' 13' ' ' VAL . 45.6 mm -105.11 131.84 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.727 0.775 . . . . 0.0 111.63 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -122.91 96.93 5.21 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.532 0.682 . . . . 40.240000000000002 109.381 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.513 HG22 ' CD1' ' A' ' 76' ' ' LEU . 79.9 mt -92.48 117.83 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.759 -0.588 . . . . 20.73 110.592 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -116.82 134.16 55.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.496 -0.753 . . . . 0.0 109.248 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -92.79 117.57 30.16 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 120.204 -0.598 . . . . 21.34 110.565 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.35 11.96 16.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.49 -0.756 . . . . 0.0 110.575 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.25 -179.26 52.76 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.086 -1.605 . . . . 29.100000000000001 109.086 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . . . -94.99 -32.89 12.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.479 -1.012 . . . . 0.0 110.32 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.526 HG13 ' HD2' ' A' ' 44' ' ' PRO . 85.3 t -104.6 141.2 22.05 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.83 -0.544 . . . . 0.0 109.883 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.526 ' HD2' HG13 ' A' ' 43' ' ' VAL . 40.1 Cg_endo -53.53 143.26 56.82 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 O-C-N 123.809 1.426 . . . . 21.949999999999999 111.91 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.408 ' HB1' ' HZ ' ' A' ' 111' ' ' PHE . . . -139.7 151.69 46.09 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.604 0.716 . . . . 20.91 110.861 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.436 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 18.4 ptt180 -127.96 159.76 33.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.751 -0.593 . . . . 0.0 109.723 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.923 HD22 HG13 ' A' ' 69' ' ' VAL . 6.9 tt -98.14 117.28 32.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.432 -0.792 . . . . 0.0 109.699 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.46 HG21 HG21 ' A' ' 104' ' ' VAL . 62.5 t -99.85 -29.45 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.514 -0.741 . . . . 0.0 110.677 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.696 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -141.38 162.66 34.95 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.949 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.6 ptt85 -143.7 141.59 30.58 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.673 0.749 . . . . 29.050000000000001 110.323 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -144.51 113.97 7.09 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.405 0.622 . . . . 27.969999999999999 109.507 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -98.45 135.2 40.35 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.65 -0.656 . . . . 25.25 111.488 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -115.38 75.85 0.97 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 54' ' ' ILE . 28.3 pt -85.7 130.5 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 121.85 0.833 . . . . 36.109999999999999 111.975 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.596 HG23 HG22 ' A' ' 61' ' ' THR . 86.1 m -121.22 132.93 55.11 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.351 -0.981 . . . . 33.979999999999997 108.351 178.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -87.32 169.74 12.03 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.717 0.77 . . . . 45.039999999999999 111.477 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.29 -7.88 15.93 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 121.819 -0.551 . . . . 39.469999999999999 112.06 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -100.57 8.12 43.63 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 119.345 1.573 . . . . 0.0 110.578 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.7 -21.3 36.77 Favored Glycine 0 N--CA 1.493 2.49 0 O-C-N 121.233 -0.917 . . . . 0.0 111.011 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.19 141.03 56.6 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.169 -1.195 . . . . 62.780000000000001 109.806 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.596 HG22 HG23 ' A' ' 55' ' ' THR . 82.1 p -125.87 140.09 52.94 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.447 -0.783 . . . . 0.0 110.668 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -123.73 120.0 31.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.41 -0.806 . . . . 0.0 110.014 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -104.85 135.26 46.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.686 -0.634 . . . . 0.0 110.859 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.26 130.62 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.58 -0.7 . . . . 37.939999999999998 109.848 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.65 127.57 47.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.817 -0.552 . . . . 0.0 110.42 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.79 150.92 23.06 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.289 -1.524 . . . . 31.82 109.289 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -79.43 156.76 27.75 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.559 -0.965 . . . . 0.0 110.25 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 51.57 -173.49 0.18 Allowed Glycine 0 N--CA 1.497 2.752 0 N-CA-C 111.008 -0.837 . . . . 22.620000000000001 111.008 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.923 HG13 HD22 ' A' ' 47' ' ' LEU . 15.2 m -130.1 127.98 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.793 -0.828 . . . . 17.510000000000002 109.606 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.6 m 41.12 36.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 CA-C-O 121.514 0.673 . . . . 20.550000000000001 111.853 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.13 16.65 68.99 Favored Glycine 0 N--CA 1.499 2.857 0 O-C-N 121.683 -0.636 . . . . 18.289999999999999 113.002 177.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.409 ' O ' HG22 ' A' ' 69' ' ' VAL . 9.9 pt-20 -145.64 150.9 37.19 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 119.164 1.482 . . . . 0.0 112.018 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -115.22 75.12 4.18 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.915 -0.772 . . . . 18.210000000000001 108.915 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -57.67 140.06 92.28 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 O-C-N 123.861 1.453 . . . . 17.609999999999999 112.149 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.436 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 4.1 t90 -103.14 77.57 1.55 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.513 ' CD1' HG22 ' A' ' 37' ' ' ILE . 11.3 mt -60.14 118.31 6.18 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.462 0.649 . . . . 20.57 111.953 -178.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 -85.8 157.19 57.93 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -53.49 128.1 27.99 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 O-C-N 123.561 1.295 . . . . 27.039999999999999 111.15 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.66 -17.13 54.39 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.727 -0.949 . . . . 24.739999999999998 110.727 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -86.89 165.71 15.71 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.058 -1.26 . . . . 29.379999999999999 110.537 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.02 149.1 34.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.66 -0.65 . . . . 0.0 110.041 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.4 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 79.6 t80 -118.9 146.27 45.05 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.47 -0.769 . . . . 18.559999999999999 109.179 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -146.05 141.03 27.22 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.213 -0.929 . . . . 0.0 111.13 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.447 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 50.6 p90 -151.09 160.02 44.14 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.59 -0.693 . . . . 26.649999999999999 109.837 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.2 m -100.04 135.58 41.25 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.391 -0.818 . . . . 28.140000000000001 110.646 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 28.4 t -125.06 167.41 14.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.592 -0.693 . . . . 33.880000000000003 110.048 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.87 129.97 5.48 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.841 -1.171 . . . . 31.800000000000001 110.481 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.621 HG13 ' HE1' ' A' ' 33' ' ' TYR . 15.6 m -134.75 148.61 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.695 -0.885 . . . . 0.0 109.821 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 89' ' ' LEU . 4.9 mp -112.93 144.28 42.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.57 -0.706 . . . . 0.0 110.569 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.83 HD12 ' CD1' ' A' ' 31' ' ' PHE . 31.8 mt -121.98 146.57 47.02 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.639 -0.663 . . . . 38.68 110.004 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -77.6 -26.16 50.45 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.405 -0.809 . . . . 0.0 110.765 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.5 p -122.95 171.33 9.31 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.47 -0.769 . . . . 31.629999999999999 110.522 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -86.13 11.06 12.65 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.636 -0.665 . . . . 0.0 111.549 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 78.1 mt-30 -140.72 146.18 37.42 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.016 -1.053 . . . . 0.0 109.638 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.42 153.21 10.72 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 118.921 -1.609 . . . . 28.050000000000001 112.264 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -118.2 129.84 55.73 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 94.3 mtp -126.8 122.45 34.8 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.39 -0.819 . . . . 0.0 111.63 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.491 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 57.2 tt0 -127.34 149.45 50.04 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.86 -177.68 36.85 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 118.931 -1.604 . . . . 29.620000000000001 110.844 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -142.81 158.81 43.26 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.795 -0.826 . . . . 0.0 110.626 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.703 ' CD2' HD11 ' A' ' 115' ' ' ILE . 4.5 m-85 -116.68 129.18 55.98 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.656 -0.652 . . . . 27.050000000000001 110.076 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.696 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 11.0 t70 -83.06 122.65 28.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.014 -1.054 . . . . 0.0 109.095 177.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.729 ' SD ' HG11 ' A' ' 9' ' ' VAL . 63.3 mtp -123.12 163.01 21.36 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.108 0.48 . . . . 0.0 110.457 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.46 HG21 HG21 ' A' ' 48' ' ' VAL . 7.5 m -142.54 131.55 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.65 -0.656 . . . . 23.280000000000001 110.432 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.531 ' HB3' ' HB ' ' A' ' 109' ' ' THR . . . -70.2 165.03 23.02 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.398 -0.814 . . . . 0.0 109.508 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -65.71 -27.21 68.16 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.519 -0.738 . . . . 0.0 110.46 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -79.93 -1.29 38.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.321 -0.862 . . . . 0.0 111.312 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.03 -10.07 56.79 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.962 -1.113 . . . . 30.43 110.581 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 25.6 m -57.46 134.02 55.71 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.086 -1.244 . . . . 0.0 110.059 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -102.64 139.24 38.48 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.311 -0.868 . . . . 0.0 110.782 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 43.1 p90 -162.82 141.68 8.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.759 -0.588 . . . . 28.030000000000001 110.002 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.8 pt -98.43 156.8 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.715 -0.615 . . . . 0.0 110.77 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -121.33 97.98 46.95 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -59.31 142.11 98.67 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 O-C-N 123.907 1.477 . . . . 33.310000000000002 112.039 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.703 HD11 ' CD2' ' A' ' 101' ' ' TYR . 70.9 mt -107.68 124.13 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.791 -0.818 . . . . 30.59 108.791 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.59 151.18 2.41 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.264 0.554 . . . . 30.780000000000001 111.356 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.491 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -98.67 118.19 34.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.675 -0.641 . . . . 0.0 110.159 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.7 ' CE1' HD11 ' A' ' 120' ' ' LEU . 41.6 p90 -107.95 168.94 8.92 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.944 -0.761 . . . . 30.66 108.944 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.605 ' C ' HD12 ' A' ' 120' ' ' LEU . 57.5 t -114.23 154.14 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.251 -0.906 . . . . 0.0 110.509 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.804 HD22 HD11 ' A' ' 90' ' ' LEU . 7.0 mp -113.65 132.4 55.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.676 -0.64 . . . . 39.149999999999999 109.357 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 79.8 p . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.636 -0.665 . . . . 0.0 110.1 -179.808 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.457 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 76.9 mtp180 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 120.951 0.405 . . . . 0.0 110.111 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -109.97 100.59 9.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.785 -0.572 . . . . 31.93 109.908 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.467 ' C ' HG23 ' A' ' 9' ' ' VAL . 64.7 mtp85 -149.0 137.21 20.86 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.754 0.788 . . . . 0.0 110.314 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.467 HG23 ' C ' ' A' ' 8' ' ' ARG . 82.2 t -151.31 114.79 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -107.55 130.26 54.89 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.574 0.702 . . . . 0.0 110.109 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.9 t -118.53 138.89 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.883 -0.511 . . . . 28.210000000000001 109.639 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -121.24 137.36 54.72 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.477 -0.764 . . . . 0.0 109.85 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.735 HG22 HD13 ' A' ' 35' ' ' ILE . 62.2 t -129.16 136.58 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.555 -0.715 . . . . 27.949999999999999 110.502 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.6 t -125.24 104.43 28.98 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.714 -0.616 . . . . 0.0 110.226 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.441 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 50.2 Cg_endo -83.86 165.81 13.41 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 O-C-N 123.815 1.429 . . . . 33.0 111.095 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -158.02 131.5 7.7 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.527 0.679 . . . . 54.100000000000001 109.737 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.523 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 78.5 t80 -59.29 138.49 57.6 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.737 -0.602 . . . . 0.0 111.2 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.516 HD23 ' HB3' ' A' ' 21' ' ' GLN . 9.1 tp -115.01 80.72 1.46 Allowed 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 122.014 0.912 . . . . 0.0 110.269 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.523 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -70.07 -35.63 74.35 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.366 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -69.22 -22.6 63.86 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.366 -0.834 . . . . 0.0 111.03 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.516 ' HB3' HD23 ' A' ' 18' ' ' LEU . 34.1 tp60 -121.75 36.87 4.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.283 -0.885 . . . . 52.369999999999997 110.596 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.714 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 32.8 t -156.95 146.02 20.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.451 -0.781 . . . . 55.189999999999998 111.02 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.602 ' O ' HG23 ' A' ' 23' ' ' THR . 9.2 t -122.03 92.83 48.82 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.475 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.1 Cg_endo -65.98 -22.39 55.46 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 O-C-N 123.711 1.374 . . . . 51.57 111.928 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -64.87 -23.52 67.26 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.258 -0.901 . . . . 0.0 110.879 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.59 23.48 14.17 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.289 -0.882 . . . . 0.0 110.705 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.61 29.94 72.89 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.602 ' HB2' HG23 ' A' ' 23' ' ' THR . 42.2 mmm-85 -120.87 93.59 4.08 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.596 -0.943 . . . . 0.0 110.181 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.475 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 68.4 m-85 -104.58 130.4 52.56 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.571 -0.705 . . . . 46.07 109.126 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.714 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -117.76 120.31 37.57 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.571 -0.851 . . . . 0.0 111.185 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.667 ' CD1' HD12 ' A' ' 90' ' ' LEU . 68.1 m-85 -115.0 137.28 52.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.583 -0.698 . . . . 38.880000000000003 109.815 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.78 131.61 55.21 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.293 -1.002 . . . . 34.060000000000002 108.293 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.653 ' HE2' HD11 ' A' ' 35' ' ' ILE . 20.6 p90 -128.21 144.08 51.09 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.19 -1.004 . . . . 29.030000000000001 111.534 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.5 t -104.39 141.06 37.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.68 -0.638 . . . . 0.0 109.851 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.735 HD13 HG22 ' A' ' 13' ' ' VAL . 45.6 mm -106.35 132.23 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.822 0.82 . . . . 0.0 111.618 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.7 mtp85 -121.47 96.6 5.14 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.418 0.628 . . . . 40.240000000000002 109.526 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.619 HG22 ' CD1' ' A' ' 76' ' ' LEU . 78.1 mt -92.53 115.74 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.736 -0.603 . . . . 20.73 110.352 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -117.66 136.49 53.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.563 -0.711 . . . . 0.0 109.472 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -91.47 116.11 28.59 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 120.179 -0.608 . . . . 21.34 110.541 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -112.26 9.38 19.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.441 -0.787 . . . . 0.0 110.683 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.96 -176.15 50.96 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.002 -1.639 . . . . 29.100000000000001 109.002 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.457 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . . . -98.75 -30.0 12.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.463 -1.021 . . . . 0.0 110.137 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.517 HG13 ' HD2' ' A' ' 44' ' ' PRO . 84.2 t -105.57 139.83 20.57 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.78 -0.575 . . . . 0.0 109.714 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.517 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.9 Cg_endo -51.18 144.84 28.22 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 O-C-N 123.684 1.36 . . . . 21.949999999999999 111.685 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.5 150.08 49.68 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.736 0.779 . . . . 20.91 111.212 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.499 ' NH2' HG22 ' A' ' 48' ' ' VAL . 35.5 ttt-85 -125.81 153.08 44.58 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.546 HD23 ' C ' ' A' ' 47' ' ' LEU . 7.5 tt -97.57 117.16 31.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.494 -0.754 . . . . 0.0 109.997 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.499 HG22 ' NH2' ' A' ' 46' ' ' ARG . 64.7 t -100.85 -29.45 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.613 -0.68 . . . . 0.0 110.436 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.675 ' HB3' ' HB2' ' A' ' 102' ' ' ASP . . . -141.2 163.7 32.24 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.13 -1.028 . . . . 0.0 112.007 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.6 ptt85 -143.55 141.19 30.59 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.337 0.589 . . . . 29.050000000000001 110.16 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -144.0 114.14 7.38 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.396 0.617 . . . . 27.969999999999999 110.15 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.415 ' CH2' HG21 ' A' ' 115' ' ' ILE . 58.0 m95 -102.05 135.25 43.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.658 -0.651 . . . . 25.25 111.241 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -116.24 81.05 1.55 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.912 HG22 ' HG3' ' A' ' 97' ' ' MET . 17.3 pt -86.04 129.99 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 121.671 0.748 . . . . 36.109999999999999 111.748 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.693 HG23 HG22 ' A' ' 61' ' ' THR . 94.3 m -119.32 130.16 55.24 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.397 -0.964 . . . . 33.979999999999997 108.397 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -89.18 169.9 11.07 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.666 0.746 . . . . 45.039999999999999 111.26 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.25 -7.9 15.8 Favored Glycine 0 N--CA 1.495 2.579 0 O-C-N 121.791 -0.568 . . . . 39.469999999999999 112.071 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -102.15 6.95 41.06 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 119.336 1.568 . . . . 0.0 110.805 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.418 ' O ' HG23 ' A' ' 61' ' ' THR . . . 93.1 -27.94 10.5 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 121.159 -0.963 . . . . 0.0 110.933 178.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -61.6 141.81 57.54 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.19 -1.182 . . . . 62.780000000000001 109.707 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.693 HG22 HG23 ' A' ' 55' ' ' THR . 57.9 p -132.36 150.24 52.2 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.429 -0.794 . . . . 0.0 110.69 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -122.26 122.26 38.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.562 -0.711 . . . . 0.0 109.792 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -102.63 136.04 43.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.613 -0.679 . . . . 0.0 110.83 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.2 t -128.51 131.85 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.504 0.669 . . . . 37.939999999999998 109.925 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -125.02 127.48 47.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.79 -0.569 . . . . 0.0 110.3 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -153.91 173.5 32.54 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.101 -1.599 . . . . 31.82 109.101 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -115.78 159.64 21.18 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.362 -1.081 . . . . 0.0 110.047 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.66 95.35 0.01 OUTLIER Glycine 0 N--CA 1.5 2.94 0 O-C-N 121.423 -0.798 . . . . 22.620000000000001 111.355 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.493 HG13 HD22 ' A' ' 47' ' ' LEU . 16.1 m -46.36 134.02 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.505 0 O-C-N 121.399 -1.059 . . . . 17.510000000000002 111.553 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 69' ' ' VAL . 12.4 m 41.55 37.13 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-O 121.634 0.73 . . . . 20.550000000000001 111.344 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.7 20.02 62.49 Favored Glycine 0 N--CA 1.495 2.598 0 O-C-N 121.752 -0.592 . . . . 18.289999999999999 112.428 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.401 ' OE2' ' CZ ' ' A' ' 82' ' ' PHE . 5.2 pt-20 -146.73 151.81 37.8 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 119.191 1.496 . . . . 0.0 112.57 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -119.06 72.24 11.91 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 108.336 -0.987 . . . . 18.210000000000001 108.336 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -54.31 141.07 72.26 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 O-C-N 123.83 1.437 . . . . 17.609999999999999 112.517 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -99.14 74.4 1.96 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.619 ' CD1' HG22 ' A' ' 37' ' ' ILE . 12.0 mt -60.02 120.2 9.24 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.427 0.632 . . . . 20.57 112.045 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -85.42 157.8 58.29 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -53.81 127.03 23.89 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 O-C-N 123.584 1.307 . . . . 27.039999999999999 110.882 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.89 -15.69 57.02 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.735 -0.946 . . . . 24.739999999999998 110.735 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -87.02 164.27 16.57 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.086 -1.244 . . . . 29.379999999999999 110.435 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.83 151.33 36.93 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.45 -0.781 . . . . 0.0 110.333 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.401 ' CZ ' ' OE2' ' A' ' 72' ' ' GLU . 72.4 t80 -119.2 149.3 41.98 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.868 -0.79 . . . . 18.559999999999999 108.868 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -139.34 137.39 35.73 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.104 -0.997 . . . . 0.0 111.013 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.514 ' CE1' HG21 ' A' ' 35' ' ' ILE . 51.7 p90 -151.57 159.74 43.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.664 -0.648 . . . . 26.649999999999999 109.793 178.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.9 m -104.47 138.59 40.63 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.394 -0.816 . . . . 28.140000000000001 111.107 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 28.3 t -124.79 169.92 11.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.577 -0.702 . . . . 33.880000000000003 109.896 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.43 123.22 2.12 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.798 -1.191 . . . . 31.800000000000001 110.544 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.625 HG23 ' HE1' ' A' ' 33' ' ' TYR . 74.9 t -129.63 148.86 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.61 -0.935 . . . . 0.0 109.272 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.584 HD12 ' HA ' ' A' ' 30' ' ' ALA . 13.1 tp -109.74 143.82 39.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.487 -0.758 . . . . 0.0 110.496 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.667 HD12 ' CD1' ' A' ' 31' ' ' PHE . 84.8 mt -121.62 145.25 48.18 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.516 -0.74 . . . . 38.68 109.963 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.402 ' O ' ' CE1' ' A' ' 29' ' ' TYR . 29.9 tp10 -73.88 -26.06 60.35 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.407 -0.808 . . . . 0.0 110.782 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.1 p -123.34 171.74 9.19 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.39 -0.818 . . . . 31.629999999999999 110.579 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.41 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 54.9 tt0 -87.02 12.38 11.45 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.679 -0.638 . . . . 0.0 111.552 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -142.27 148.64 38.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.099 -1.0 . . . . 0.0 109.912 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.26 162.61 26.86 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 118.908 -1.615 . . . . 28.050000000000001 112.137 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -119.11 129.46 55.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.083 -0.657 . . . . 0.0 109.335 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.912 ' HG3' HG22 ' A' ' 54' ' ' ILE . 54.0 ttm -125.02 117.74 24.66 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.279 -0.888 . . . . 0.0 111.205 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.494 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 57.1 tt0 -129.5 150.34 50.89 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.08 -179.44 38.32 Favored Glycine 0 N--CA 1.499 2.886 0 C-N-CA 118.787 -1.673 . . . . 29.620000000000001 111.017 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.403 ' HB3' ' CG2' ' A' ' 112' ' ' ILE . 63.3 m80 -137.12 155.36 49.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.808 -0.819 . . . . 0.0 110.118 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.663 ' CD2' HD11 ' A' ' 115' ' ' ILE . 4.4 m-85 -117.65 127.06 53.58 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.61 -0.681 . . . . 27.050000000000001 109.668 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.675 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 71.4 m-20 -81.88 122.11 27.32 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.935 -1.103 . . . . 0.0 109.335 178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.443 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 91.8 mmm -120.53 162.84 18.91 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.189 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.458 HG22 HG23 ' A' ' 48' ' ' VAL . 7.9 m -142.51 128.76 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.672 -0.643 . . . . 23.280000000000001 110.503 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.38 167.97 20.16 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.557 -0.714 . . . . 0.0 109.469 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -62.15 -28.14 69.45 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.522 -0.736 . . . . 0.0 110.4 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -72.29 -11.29 60.64 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 111.111 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.45 -6.49 59.29 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.099 -1.048 . . . . 30.43 110.667 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.5 m -59.93 139.5 57.35 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.108 -1.23 . . . . 0.0 109.963 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -99.56 140.48 33.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.463 -0.773 . . . . 0.0 110.892 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.443 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 33.5 p90 -163.64 146.33 9.8 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.376 -0.601 . . . . 28.030000000000001 109.376 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.403 ' CG2' ' HB3' ' A' ' 100' ' ' HIS . 79.9 mt -100.78 155.43 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.61 0.719 . . . . 0.0 111.104 -178.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.92 98.12 47.8 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -59.14 144.17 99.48 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 O-C-N 123.869 1.457 . . . . 33.310000000000002 112.554 -178.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.663 HD11 ' CD2' ' A' ' 101' ' ' TYR . 66.2 mt -108.78 122.63 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.451 -0.944 . . . . 30.59 108.451 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.92 144.97 5.98 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.199 0.523 . . . . 30.780000000000001 111.615 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.494 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -92.65 119.43 32.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.795 -0.565 . . . . 0.0 110.394 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.705 ' CE1' HD11 ' A' ' 120' ' ' LEU . 43.2 p90 -108.92 169.32 8.75 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.815 -0.809 . . . . 30.66 108.815 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.628 ' C ' HD12 ' A' ' 120' ' ' LEU . 7.8 p -113.35 154.66 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.29 -0.881 . . . . 0.0 110.54 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.705 HD11 ' CE1' ' A' ' 118' ' ' PHE . 7.5 mp -113.25 131.91 55.73 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.426 -0.583 . . . . 39.149999999999999 109.426 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 96.6 p . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.654 -0.654 . . . . 0.0 110.092 -179.877 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.1 mtt-85 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 120.807 0.337 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -116.14 108.6 16.37 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.503 -0.748 . . . . 31.93 110.313 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.473 ' C ' HG23 ' A' ' 9' ' ' VAL . 74.8 mtt85 -152.17 134.56 15.22 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.574 0.702 . . . . 0.0 110.192 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.473 HG23 ' C ' ' A' ' 8' ' ' ARG . 80.0 t -151.42 113.84 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -107.85 129.04 55.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.636 -0.665 . . . . 0.0 109.767 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.551 HG11 ' HE2' ' A' ' 101' ' ' TYR . 59.5 t -119.41 139.75 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.863 -0.523 . . . . 28.210000000000001 109.968 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -121.51 136.51 54.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.409 -0.807 . . . . 0.0 109.673 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.761 HG22 HD13 ' A' ' 35' ' ' ILE . 61.0 t -129.47 137.64 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.513 -0.742 . . . . 27.949999999999999 110.434 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.6 t -125.62 104.51 27.6 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.733 -0.605 . . . . 0.0 110.583 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -83.61 165.14 14.1 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 O-C-N 123.851 1.448 . . . . 33.0 110.996 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -157.53 132.84 8.96 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.505 0.669 . . . . 54.100000000000001 109.999 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.537 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 76.5 t80 -59.96 139.47 57.38 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.812 -0.555 . . . . 0.0 111.298 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.0 HD11 ' HB2' ' A' ' 32' ' ' ALA . 77.0 mt -116.34 80.52 1.47 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.901 0.858 . . . . 0.0 110.524 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.537 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -70.01 -33.28 71.81 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.998 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -68.98 -25.97 64.8 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.271 -0.893 . . . . 0.0 111.875 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.423 ' CG ' ' HB3' ' A' ' 18' ' ' LEU . 15.7 pt20 -120.01 29.61 7.44 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.093 -1.004 . . . . 52.369999999999997 111.191 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.609 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 24.1 p -148.07 150.59 34.18 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.316 -0.865 . . . . 55.189999999999998 110.821 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.5 m -117.9 92.52 42.09 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.584 -0.697 . . . . 0.0 109.361 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.459 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 48.3 Cg_endo -65.58 -25.46 54.9 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 O-C-N 123.951 1.5 . . . . 51.57 111.241 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.79 -23.22 65.18 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.462 -0.773 . . . . 0.0 110.843 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.39 23.4 14.22 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.326 -0.859 . . . . 0.0 110.716 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.84 30.03 72.54 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -120.86 92.59 3.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.543 -0.975 . . . . 0.0 110.036 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.459 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 72.3 m-85 -105.68 132.84 51.32 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.405 -0.809 . . . . 46.07 109.247 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.609 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -115.05 119.62 37.07 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.43 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.453 ' CG ' HD23 ' A' ' 120' ' ' LEU . 83.5 m-85 -115.93 129.31 56.34 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.533 -0.729 . . . . 38.880000000000003 109.492 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 1.0 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -115.84 131.18 57.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.139 -0.976 . . . . 34.060000000000002 108.982 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.552 ' CE1' HD11 ' A' ' 35' ' ' ILE . 54.8 p90 -126.99 146.99 50.14 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.293 -0.963 . . . . 29.030000000000001 111.021 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.3 m -100.34 140.18 34.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.646 -0.659 . . . . 0.0 109.378 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.761 HD13 HG22 ' A' ' 13' ' ' VAL . 42.1 mm -104.39 132.01 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 121.734 0.778 . . . . 0.0 111.562 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -123.23 97.4 5.4 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.454 0.645 . . . . 40.240000000000002 109.664 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.658 HG22 HD22 ' A' ' 76' ' ' LEU . 75.7 mt -91.68 117.33 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.777 -0.577 . . . . 20.73 110.504 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -117.54 136.01 53.56 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.548 -0.72 . . . . 0.0 109.554 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.501 ' HB2' HD23 ' A' ' 76' ' ' LEU . 54.9 t-20 -91.72 117.43 29.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.73 -0.606 . . . . 21.34 110.715 -179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.13 9.51 17.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.451 -0.78 . . . . 0.0 110.679 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.61 -178.22 51.25 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.136 -1.586 . . . . 29.100000000000001 109.136 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.05 -31.81 13.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.427 -1.043 . . . . 0.0 110.057 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.51 HG13 ' HD2' ' A' ' 44' ' ' PRO . 85.7 t -104.79 141.16 21.96 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.51 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.9 Cg_endo -53.98 147.17 43.98 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 O-C-N 123.74 1.39 . . . . 21.949999999999999 111.541 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.438 ' HB1' ' HZ ' ' A' ' 111' ' ' PHE . . . -137.41 150.94 48.02 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.776 0.798 . . . . 20.91 111.203 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.434 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 3.0 ttt180 -126.46 154.76 43.26 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.978 HD22 HG13 ' A' ' 69' ' ' VAL . 6.9 tt -98.19 118.17 34.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.444 -0.785 . . . . 0.0 109.755 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.537 HG23 HG22 ' A' ' 104' ' ' VAL . 63.5 t -101.53 -26.73 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.715 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.655 ' HB3' ' HB2' ' A' ' 102' ' ' ASP . . . -141.45 162.83 34.54 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.146 -179.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -142.93 139.4 30.71 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.34 0.59 . . . . 29.050000000000001 110.159 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -143.12 114.1 7.7 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.4 0.619 . . . . 27.969999999999999 109.815 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.539 ' CH2' HD13 ' A' ' 115' ' ' ILE . 88.0 m95 -102.49 134.47 45.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.669 -0.644 . . . . 25.25 110.881 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -115.75 78.76 1.21 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.522 -0.736 . . . . 0.0 109.092 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.728 HG22 ' HG3' ' A' ' 97' ' ' MET . 13.1 pt -83.45 128.63 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.515 -0.741 . . . . 36.109999999999999 111.741 -178.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.704 HG23 ' HB ' ' A' ' 61' ' ' THR . 3.6 m -120.03 131.08 55.0 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.469 -0.937 . . . . 33.979999999999997 108.469 178.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -88.54 170.01 11.24 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.619 0.723 . . . . 45.039999999999999 111.205 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.4 -6.93 12.08 Favored Glycine 0 N--CA 1.496 2.661 0 O-C-N 121.831 -0.543 . . . . 39.469999999999999 112.188 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.35 7.69 42.63 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 119.322 1.561 . . . . 0.0 110.576 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.59 -31.31 6.56 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -62.09 142.72 57.42 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.202 -1.175 . . . . 62.780000000000001 109.778 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.704 ' HB ' HG23 ' A' ' 55' ' ' THR . 7.6 t -135.82 153.3 51.55 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.531 -0.731 . . . . 0.0 110.613 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -121.68 122.95 40.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.635 -0.665 . . . . 0.0 110.02 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -100.55 135.06 42.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.699 -0.625 . . . . 0.0 110.547 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.2 t -128.12 130.59 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.613 0.72 . . . . 37.939999999999998 110.065 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -126.44 127.09 44.86 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.801 -0.562 . . . . 0.0 110.147 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -150.5 154.85 25.88 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.494 -1.442 . . . . 31.82 109.494 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -78.16 154.74 30.92 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.51 -0.994 . . . . 0.0 110.367 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.46 -168.38 0.21 Allowed Glycine 0 N--CA 1.498 2.787 0 O-C-N 121.412 -0.805 . . . . 22.620000000000001 111.598 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.978 HG13 HD22 ' A' ' 47' ' ' LEU . 16.0 m -129.86 129.2 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.864 -0.786 . . . . 17.510000000000002 109.72 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.3 m 41.13 36.77 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 CA-C-O 121.44 0.638 . . . . 20.550000000000001 111.86 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.08 16.47 69.59 Favored Glycine 0 N--CA 1.499 2.893 0 O-C-N 121.645 -0.659 . . . . 18.289999999999999 112.833 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -145.98 151.72 38.25 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-N 119.145 1.472 . . . . 0.0 112.014 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -114.9 75.7 3.98 Favored Pre-proline 0 N--CA 1.492 1.625 0 N-CA-C 109.006 -0.739 . . . . 18.210000000000001 109.006 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -57.66 139.81 91.46 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 O-C-N 123.769 1.405 . . . . 17.609999999999999 111.951 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 46' ' ' ARG . 2.3 t90 -103.36 76.53 1.44 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.658 HD22 HG22 ' A' ' 37' ' ' ILE . 6.6 tp -59.97 117.83 5.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.648 -0.658 . . . . 20.57 111.51 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -86.46 157.99 55.1 Favored Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -53.79 127.57 26.07 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 O-C-N 123.56 1.295 . . . . 27.039999999999999 111.054 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.88 -19.08 39.87 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.761 -0.936 . . . . 24.739999999999998 110.761 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 71.3 tt0 -88.87 166.48 13.95 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.1 -1.235 . . . . 29.379999999999999 110.162 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.624 ' CA ' HD11 ' A' ' 76' ' ' LEU . . . -146.28 150.62 36.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.49 -0.756 . . . . 0.0 110.464 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.45 ' N ' HD11 ' A' ' 76' ' ' LEU . 66.2 t80 -117.71 147.84 42.57 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.044 -0.725 . . . . 18.559999999999999 109.044 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -144.29 140.19 29.03 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.109 -0.994 . . . . 0.0 111.338 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.66 ' CE1' HG21 ' A' ' 35' ' ' ILE . 47.9 p90 -150.78 160.28 43.97 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.653 -0.655 . . . . 26.649999999999999 109.577 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.7 m -102.63 137.67 40.55 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.424 -0.798 . . . . 28.140000000000001 110.949 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.442 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 15.0 t -124.11 167.06 14.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.595 -0.69 . . . . 33.880000000000003 109.957 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -139.83 128.65 3.99 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.882 -1.151 . . . . 31.800000000000001 110.503 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.5 m -134.19 154.27 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.651 -0.911 . . . . 0.0 110.009 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.424 ' N ' HD12 ' A' ' 89' ' ' LEU . 5.0 mp -109.83 144.69 37.93 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.566 -0.709 . . . . 0.0 110.95 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.712 HD23 ' O ' ' A' ' 92' ' ' THR . 12.6 tp -121.43 146.55 46.78 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.656 -0.653 . . . . 38.68 109.762 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -83.9 -27.46 28.6 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.321 -0.862 . . . . 0.0 111.053 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.712 ' O ' HD23 ' A' ' 90' ' ' LEU . 71.9 p -123.44 171.26 9.6 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.341 -0.849 . . . . 31.629999999999999 110.774 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.453 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 96.6 mt-10 -86.48 11.64 12.12 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.646 -0.659 . . . . 0.0 111.609 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -144.05 143.13 31.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.044 -1.035 . . . . 0.0 109.893 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.7 160.37 25.18 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 118.615 -1.755 . . . . 28.050000000000001 112.537 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -118.91 129.79 55.37 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.728 ' HG3' HG22 ' A' ' 54' ' ' ILE . 15.5 ttt -128.69 122.86 31.7 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.306 -0.871 . . . . 0.0 111.641 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.407 ' HG2' ' CB ' ' A' ' 117' ' ' ALA . 39.3 mt-30 -120.27 150.79 40.14 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -151.62 172.21 31.07 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 118.677 -1.725 . . . . 29.620000000000001 111.325 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.858 ' CE1' HD12 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -138.95 154.3 48.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.761 -0.847 . . . . 0.0 109.373 179.121 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.62 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 10.3 m-85 -118.98 126.09 50.94 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.404 -0.81 . . . . 27.050000000000001 110.244 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.655 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 78.3 m-20 -86.31 120.25 27.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.899 -1.125 . . . . 0.0 108.777 177.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.454 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 86.8 mmm -121.87 163.04 19.9 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.228 0.537 . . . . 0.0 110.537 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.537 HG22 HG23 ' A' ' 48' ' ' VAL . 7.5 m -142.17 128.7 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.693 -0.629 . . . . 23.280000000000001 110.421 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.5 166.36 22.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.358 -0.838 . . . . 0.0 109.378 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -63.95 -27.73 69.34 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.324 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -76.41 -10.31 59.3 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.444 -0.785 . . . . 0.0 111.181 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.9 -7.34 48.85 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.45 -1.06 . . . . 30.43 110.45 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.3 m -58.32 135.76 57.23 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.052 -1.263 . . . . 0.0 109.966 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -100.51 139.03 36.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.434 -0.791 . . . . 0.0 110.783 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 37.8 p90 -161.2 141.46 10.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.702 -0.624 . . . . 28.030000000000001 109.889 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.858 HD12 ' CE1' ' A' ' 100' ' ' HIS . 29.9 pt -99.88 156.17 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.661 -0.649 . . . . 0.0 110.923 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.62 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -121.69 98.77 45.41 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.648 -0.658 . . . . 0.0 109.391 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.415 ' HB3' ' CE1' ' A' ' 100' ' ' HIS . 46.3 Cg_endo -59.03 144.0 99.56 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 O-C-N 123.901 1.474 . . . . 33.310000000000002 112.154 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.539 HD13 ' CH2' ' A' ' 52' ' ' TRP . 64.1 mt -108.8 121.71 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.426 -0.953 . . . . 30.59 108.426 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.3 159.13 0.22 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.176 0.512 . . . . 30.780000000000001 111.533 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.407 ' CB ' ' HG2' ' A' ' 98' ' ' GLN . . . -91.12 124.3 35.24 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.738 -0.601 . . . . 0.0 110.874 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 97' ' ' MET . 38.5 p90 -113.64 158.35 20.95 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.347 -0.982 . . . . 30.66 108.347 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.662 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.1 t -116.15 154.89 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.27 -0.894 . . . . 0.0 110.387 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.662 HD12 ' C ' ' A' ' 119' ' ' VAL . 7.9 mp -114.64 130.51 56.81 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.229 -0.656 . . . . 39.149999999999999 109.229 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.744 -0.598 . . . . 0.0 110.069 -179.652 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 120.762 0.315 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.447 ' CE2' HG21 ' A' ' 109' ' ' THR . 49.9 m-85 -118.51 108.42 14.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.433 -0.792 . . . . 31.93 110.209 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.451 ' C ' HG23 ' A' ' 9' ' ' VAL . 66.9 mtt85 -150.15 134.95 17.62 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.57 0.7 . . . . 0.0 110.12 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.808 HG11 ' SD ' ' A' ' 103' ' ' MET . 63.3 t -150.21 116.01 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.507 0.67 . . . . 0.0 109.365 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -107.25 130.69 54.71 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.592 0.711 . . . . 0.0 110.279 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.648 HG11 ' HE2' ' A' ' 101' ' ' TYR . 62.7 t -118.89 137.02 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.809 -0.557 . . . . 28.210000000000001 109.501 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -123.85 137.7 54.61 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.404 -0.81 . . . . 0.0 109.94 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.2 t -128.97 137.02 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.484 0.659 . . . . 27.949999999999999 110.583 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -124.59 105.19 30.47 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.754 -0.591 . . . . 0.0 110.116 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.433 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 50.7 Cg_endo -82.58 163.39 16.62 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 O-C-N 123.869 1.457 . . . . 33.0 111.323 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -156.98 130.77 8.22 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.613 0.721 . . . . 54.100000000000001 109.602 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.442 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 84.8 t80 -61.55 138.48 58.29 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.344 0.592 . . . . 0.0 111.444 -178.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.705 HD23 ' HB3' ' A' ' 21' ' ' GLN . 8.9 tp -114.96 82.65 1.77 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.961 0.886 . . . . 0.0 110.014 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.442 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -65.19 -36.17 83.38 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.575 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -68.89 -22.39 64.18 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.355 -0.84 . . . . 0.0 110.871 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.705 ' HB3' HD23 ' A' ' 18' ' ' LEU . 44.2 tt0 -119.54 23.55 11.13 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.345 -0.847 . . . . 52.369999999999997 110.702 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.719 ' OG ' ' HB3' ' A' ' 30' ' ' ALA . 73.1 m -136.11 137.95 41.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.301 -0.875 . . . . 55.189999999999998 111.16 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.2 m -119.19 90.44 41.8 Favored Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.447 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 48.3 Cg_endo -63.74 -26.83 68.14 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 O-C-N 123.933 1.491 . . . . 51.57 111.686 -178.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -69.04 -22.83 64.02 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.327 -0.858 . . . . 0.0 110.829 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -107.11 19.27 20.64 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.295 -0.878 . . . . 0.0 110.998 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.18 30.37 73.73 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -119.61 94.37 4.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.667 -0.902 . . . . 0.0 110.247 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.447 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 79.0 m-85 -106.51 129.01 54.54 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.391 -0.818 . . . . 46.07 109.386 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.719 ' HB3' ' OG ' ' A' ' 22' ' ' SER . . . -119.42 120.07 35.76 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.31 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.634 ' CD1' HD12 ' A' ' 90' ' ' LEU . 61.9 m-85 -115.79 136.84 52.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.644 -0.66 . . . . 38.880000000000003 109.597 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.27 131.82 54.85 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.727 -0.842 . . . . 34.060000000000002 108.727 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.561 ' HE1' HG23 ' A' ' 88' ' ' VAL . 26.4 p90 -126.54 143.37 51.23 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.212 -0.995 . . . . 29.030000000000001 111.303 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 t -102.81 139.12 38.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.682 -0.636 . . . . 0.0 109.286 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.9 HD13 ' CE2' ' A' ' 84' ' ' TYR . 5.2 mp -104.78 132.04 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.81 0.814 . . . . 0.0 111.247 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.6 mtm180 -122.08 97.35 5.44 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.467 0.651 . . . . 40.240000000000002 109.63 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.651 HG22 HD22 ' A' ' 76' ' ' LEU . 80.2 mt -94.2 116.47 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.765 -0.584 . . . . 20.73 110.507 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -117.46 138.68 51.7 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.486 -0.759 . . . . 0.0 109.455 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.417 ' HB2' HD23 ' A' ' 76' ' ' LEU . 41.5 t-20 -91.61 118.12 30.33 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.67 -0.644 . . . . 21.34 110.851 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.1 9.04 14.63 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.428 -0.795 . . . . 0.0 110.479 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.23 176.63 52.95 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.544 -1.423 . . . . 29.100000000000001 109.544 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.12 -35.71 17.3 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.585 -0.95 . . . . 0.0 110.271 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.518 HG13 ' HD2' ' A' ' 44' ' ' PRO . 86.9 t -102.96 140.31 20.93 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.802 -0.561 . . . . 0.0 110.033 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.518 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.5 Cg_endo -52.87 144.14 45.73 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 O-C-N 123.775 1.408 . . . . 21.949999999999999 111.68 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.09 151.4 46.69 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.659 0.742 . . . . 20.91 111.092 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 1.1 ptt85 -127.73 159.79 33.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.697 -0.627 . . . . 0.0 109.715 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.953 HD22 HG13 ' A' ' 69' ' ' VAL . 6.8 tt -98.04 116.4 30.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.463 -0.773 . . . . 0.0 109.583 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.482 HG23 HG22 ' A' ' 104' ' ' VAL . 57.6 t -98.43 -28.21 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.541 -0.724 . . . . 0.0 110.515 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.679 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -141.62 162.38 35.63 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.439 -0.905 . . . . 0.0 111.758 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.0 ptt85 -142.89 141.56 31.55 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.579 0.704 . . . . 29.050000000000001 110.298 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -144.23 114.86 7.67 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.288 0.566 . . . . 27.969999999999999 109.581 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -95.9 133.68 39.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.646 -0.659 . . . . 25.25 111.037 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -115.84 78.49 1.19 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.879 HG22 ' HG3' ' A' ' 97' ' ' MET . 13.3 pt -86.29 129.24 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-O 121.748 0.785 . . . . 36.109999999999999 111.758 -178.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.687 HG23 HG22 ' A' ' 61' ' ' THR . 90.6 m -120.19 129.98 54.35 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.097 -1.075 . . . . 33.979999999999997 108.097 178.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -91.04 170.32 10.14 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.771 0.796 . . . . 45.039999999999999 111.504 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.62 -6.62 11.97 Favored Glycine 0 N--CA 1.494 2.555 0 O-C-N 121.8 -0.562 . . . . 39.469999999999999 112.122 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -101.73 5.56 41.38 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 119.429 1.614 . . . . 0.0 110.62 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.4 ' O ' HG23 ' A' ' 61' ' ' THR . . . 92.77 -28.5 9.2 Favored Glycine 0 N--CA 1.495 2.613 0 O-C-N 121.25 -0.906 . . . . 0.0 110.894 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.6 142.44 58.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.191 -1.182 . . . . 62.780000000000001 109.621 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.687 HG22 HG23 ' A' ' 55' ' ' THR . 71.5 p -132.23 149.99 52.26 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.455 -0.778 . . . . 0.0 110.67 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -122.4 122.12 38.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.47 -0.769 . . . . 0.0 109.962 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -105.44 136.39 45.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.579 -0.701 . . . . 0.0 110.984 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.6 t -129.23 131.35 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.546 -0.722 . . . . 37.939999999999998 109.818 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.29 127.45 47.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.711 -0.618 . . . . 0.0 110.429 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.24 149.23 21.17 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.412 -1.475 . . . . 31.82 109.412 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -74.42 155.68 37.81 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.448 -1.031 . . . . 0.0 110.274 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 50.4 -171.94 0.14 Allowed Glycine 0 N--CA 1.498 2.817 0 O-C-N 121.336 -0.853 . . . . 22.620000000000001 111.253 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.953 HG13 HD22 ' A' ' 47' ' ' LEU . 14.8 m -129.41 128.11 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.78 -0.835 . . . . 17.510000000000002 109.57 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 69' ' ' VAL . 12.0 m 41.17 36.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 CA-C-O 121.603 0.716 . . . . 20.550000000000001 111.796 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.25 16.25 69.75 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 121.627 -0.67 . . . . 18.289999999999999 112.93 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.415 ' O ' HG22 ' A' ' 69' ' ' VAL . 10.0 pt-20 -145.79 150.76 36.8 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 119.163 1.481 . . . . 0.0 112.028 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -114.97 74.15 3.43 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.895 -0.78 . . . . 18.210000000000001 108.895 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -57.25 140.51 93.11 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 O-C-N 123.793 1.417 . . . . 17.609999999999999 112.225 -178.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.432 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 5.9 t90 -102.11 77.17 1.65 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.651 HD22 HG22 ' A' ' 37' ' ' ILE . 6.9 tp -59.66 117.3 4.77 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.553 -0.717 . . . . 20.57 111.621 -178.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -86.35 156.86 56.66 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -52.76 126.72 22.02 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 O-C-N 123.678 1.357 . . . . 27.039999999999999 110.931 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.6 -17.44 49.25 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.701 -0.96 . . . . 24.739999999999998 110.701 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -88.16 165.5 15.05 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.053 -1.263 . . . . 29.379999999999999 110.196 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.602 ' CA ' HD11 ' A' ' 76' ' ' LEU . . . -147.81 152.8 38.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.513 -0.742 . . . . 0.0 110.372 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.4 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 66.9 t80 -119.34 147.89 43.81 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.93 -0.767 . . . . 18.559999999999999 108.93 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.5 m80 -138.95 138.31 37.21 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.094 -1.004 . . . . 0.0 110.824 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.9 ' CE2' HD13 ' A' ' 35' ' ' ILE . 50.5 p90 -151.0 159.72 44.39 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.527 -0.733 . . . . 26.649999999999999 109.993 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.1 m -104.36 137.61 41.99 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.444 -0.785 . . . . 28.140000000000001 110.811 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 14.6 t -125.14 166.86 15.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.578 -0.701 . . . . 33.880000000000003 110.091 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.43 127.24 4.07 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.886 -1.15 . . . . 31.800000000000001 110.413 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.561 HG23 ' HE1' ' A' ' 33' ' ' TYR . 79.4 t -131.51 148.43 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.577 -0.955 . . . . 0.0 109.375 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.9 tp -110.13 143.54 40.06 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.561 -0.712 . . . . 0.0 110.275 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.668 ' CD1' HD22 ' A' ' 120' ' ' LEU . 84.5 mt -122.97 148.38 45.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.474 -0.766 . . . . 38.68 110.358 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -76.21 -26.41 56.09 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.376 -0.828 . . . . 0.0 110.63 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 93' ' ' GLU . 6.4 m -122.55 171.27 9.24 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.453 -0.78 . . . . 31.629999999999999 110.545 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.423 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 58.0 tt0 -85.87 8.15 21.3 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.678 -0.639 . . . . 0.0 111.754 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -140.71 150.11 43.03 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.059 -1.026 . . . . 0.0 110.064 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.06 164.46 29.14 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 118.867 -1.635 . . . . 28.050000000000001 112.097 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -121.89 131.69 54.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 122.067 -0.667 . . . . 0.0 109.545 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.879 ' HG3' HG22 ' A' ' 54' ' ' ILE . 27.1 ttt -127.27 121.05 30.09 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.256 -0.902 . . . . 0.0 111.424 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.493 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 56.2 tt0 -128.66 147.75 50.76 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.84 -179.86 35.86 Favored Glycine 0 N--CA 1.5 2.945 0 C-N-CA 119.072 -1.537 . . . . 29.620000000000001 110.72 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -140.84 157.97 44.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.697 -0.884 . . . . 0.0 110.75 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.648 ' HE2' HG11 ' A' ' 11' ' ' VAL . 6.9 m-85 -116.72 129.28 56.03 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.606 -0.684 . . . . 27.050000000000001 110.193 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.679 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 42.6 t0 -83.9 122.98 29.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.959 -1.088 . . . . 0.0 109.149 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.808 ' SD ' HG11 ' A' ' 9' ' ' VAL . 24.1 mtp -124.23 162.75 23.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.9 -0.5 . . . . 0.0 110.572 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.482 HG22 HG23 ' A' ' 48' ' ' VAL . 10.6 m -140.45 130.24 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.69 -0.631 . . . . 23.280000000000001 110.208 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.9 166.61 22.66 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.407 -0.808 . . . . 0.0 109.473 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -63.93 -29.97 71.09 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.127 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -74.19 -10.34 59.51 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.524 -0.735 . . . . 0.0 111.129 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.14 -7.43 47.99 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 120.072 -1.061 . . . . 30.43 110.454 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.447 HG21 ' CE2' ' A' ' 7' ' ' TYR . 65.8 m -57.45 136.05 56.63 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.108 -1.231 . . . . 0.0 109.988 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -101.92 140.85 35.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.334 -0.854 . . . . 0.0 110.955 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 46.5 p90 -167.45 147.03 5.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.678 -0.639 . . . . 28.030000000000001 110.06 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.2 pt -102.43 157.53 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.685 -0.634 . . . . 0.0 110.846 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.77 98.33 49.65 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -59.25 142.19 98.84 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 O-C-N 123.935 1.492 . . . . 33.310000000000002 112.236 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.557 HD11 ' CE2' ' A' ' 101' ' ' TYR . 67.3 mt -106.83 123.3 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.52 -0.918 . . . . 30.59 108.52 178.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.18 144.09 7.56 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.243 0.544 . . . . 30.780000000000001 111.365 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.493 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -88.53 121.22 30.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.659 -0.651 . . . . 0.0 110.103 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.493 ' HE1' HD11 ' A' ' 120' ' ' LEU . 36.3 p90 -107.5 165.14 11.62 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.037 -0.727 . . . . 30.66 109.037 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.607 ' C ' HD12 ' A' ' 120' ' ' LEU . 57.3 t -116.94 155.63 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.377 -0.827 . . . . 0.0 110.274 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.668 HD22 ' CD1' ' A' ' 90' ' ' LEU . 7.2 mp -114.06 132.49 56.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.709 -0.619 . . . . 39.149999999999999 109.6 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.657 -0.652 . . . . 0.0 110.138 -179.796 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.034 0.445 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -112.68 79.57 1.24 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.702 -0.624 . . . . 31.93 109.9 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.458 ' C ' HG23 ' A' ' 9' ' ' VAL . 45.9 mtm180 -138.29 142.87 39.79 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.966 0.889 . . . . 0.0 110.333 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.458 HG23 ' C ' ' A' ' 8' ' ' ARG . 85.5 t -150.56 115.75 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.537 0.684 . . . . 0.0 109.215 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -106.02 129.61 54.1 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.557 0.694 . . . . 0.0 109.779 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.453 HG11 ' HE2' ' A' ' 101' ' ' TYR . 66.5 t -116.93 138.87 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.92 -0.487 . . . . 28.210000000000001 109.694 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -121.02 136.6 54.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.466 -0.771 . . . . 0.0 109.798 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.804 HG22 HD13 ' A' ' 35' ' ' ILE . 62.1 t -128.42 136.38 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.669 -0.644 . . . . 27.949999999999999 110.173 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.9 m -124.81 105.05 29.9 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.617 -0.677 . . . . 0.0 110.509 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -82.22 165.06 17.0 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 O-C-N 123.893 1.47 . . . . 33.0 110.768 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -158.01 130.67 7.27 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.587 0.708 . . . . 54.100000000000001 109.844 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.532 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 77.6 t80 -61.16 138.21 58.22 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.761 -0.587 . . . . 0.0 111.327 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.541 ' CD1' ' HB2' ' A' ' 32' ' ' ALA . 6.1 mt -116.62 80.94 1.54 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.086 0.946 . . . . 0.0 110.333 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.532 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -67.37 -35.67 79.82 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.136 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -68.8 -23.25 64.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.275 -0.891 . . . . 0.0 110.818 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -121.96 46.87 2.0 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.36 -0.838 . . . . 52.369999999999997 110.64 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.743 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 53.3 p -167.46 148.74 5.57 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.236 -0.915 . . . . 55.189999999999998 111.112 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.655 HG23 ' HB2' ' A' ' 28' ' ' ARG . 9.8 t -122.02 93.27 48.67 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.475 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.0 Cg_endo -67.26 -22.81 45.86 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 O-C-N 123.673 1.354 . . . . 51.57 111.949 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -65.15 -23.27 67.07 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.283 -0.886 . . . . 0.0 110.961 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -106.14 24.45 12.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.285 -0.884 . . . . 0.0 110.709 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.84 28.91 73.39 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.655 ' HB2' HG23 ' A' ' 23' ' ' THR . 51.8 mtp180 -120.87 93.81 4.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.641 -0.917 . . . . 0.0 110.178 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.475 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 67.8 m-85 -104.26 133.95 48.31 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.533 -0.729 . . . . 46.07 109.126 179.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.743 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -114.28 120.93 42.08 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.107 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.404 ' CD1' HD12 ' A' ' 90' ' ' LEU . 90.4 m-85 -116.12 134.02 55.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.694 -0.629 . . . . 38.880000000000003 109.788 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.541 ' HB2' ' CD1' ' A' ' 18' ' ' LEU . . . -112.43 132.04 55.25 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.463 -0.939 . . . . 34.060000000000002 108.463 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.502 ' CE2' HD11 ' A' ' 35' ' ' ILE . 38.2 p90 -127.67 144.39 51.08 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.073 -1.051 . . . . 29.030000000000001 111.708 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.6 t -104.82 139.98 38.79 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.804 HD13 HG22 ' A' ' 13' ' ' VAL . 41.4 mm -105.77 132.63 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.77 0.795 . . . . 0.0 111.725 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.3 mtp180 -124.04 97.02 5.16 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.49 0.662 . . . . 40.240000000000002 109.799 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.657 HG22 ' CD1' ' A' ' 76' ' ' LEU . 74.1 mt -92.78 116.92 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.706 -0.621 . . . . 20.73 110.433 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -119.77 144.69 47.15 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.455 -0.778 . . . . 0.0 109.919 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -86.06 113.84 22.46 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.514 -0.741 . . . . 21.34 109.47 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 8' ' ' ARG . . . -89.32 -18.79 26.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.788 -0.57 . . . . 0.0 111.715 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.59 -163.93 37.2 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.305 -0.95 . . . . 29.100000000000001 110.942 -178.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -113.89 -17.02 12.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.964 -0.727 . . . . 0.0 111.013 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.491 HG13 ' HD2' ' A' ' 44' ' ' PRO . 95.5 t -103.31 135.59 19.36 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.316 -0.865 . . . . 0.0 109.566 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.491 ' HD2' HG13 ' A' ' 43' ' ' VAL . 41.2 Cg_endo -48.84 140.54 23.09 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 O-C-N 123.757 1.399 . . . . 21.949999999999999 112.219 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -134.23 149.52 50.98 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.703 0.764 . . . . 20.91 110.873 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.428 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 43.2 ttt180 -125.91 151.45 46.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.832 -0.542 . . . . 0.0 109.547 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.836 HD22 HG13 ' A' ' 69' ' ' VAL . 7.2 tt -98.68 117.21 32.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.464 -0.773 . . . . 0.0 109.973 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.476 HG23 HG22 ' A' ' 104' ' ' VAL . 62.4 t -100.98 -30.49 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.6 -0.687 . . . . 0.0 110.649 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -141.4 162.54 35.25 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.08 -1.048 . . . . 0.0 112.334 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.43 ' HD3' HG12 ' A' ' 69' ' ' VAL . 23.2 ptt180 -143.25 140.98 30.91 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.482 0.658 . . . . 29.050000000000001 110.201 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.412 ' HB3' ' CE1' ' A' ' 100' ' ' HIS . 21.7 t-160 -145.86 114.69 6.9 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.353 0.597 . . . . 27.969999999999999 109.987 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.53 ' CH2' HD13 ' A' ' 115' ' ' ILE . 63.2 m95 -100.21 135.97 40.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.579 -0.701 . . . . 25.25 111.42 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -117.06 79.17 1.3 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.711 -0.618 . . . . 0.0 109.417 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 54' ' ' ILE . 28.2 pt -83.31 130.27 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.375 -0.828 . . . . 36.109999999999999 112.208 -178.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.782 HG23 HG22 ' A' ' 61' ' ' THR . 85.3 m -119.48 130.05 55.03 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.209 -1.034 . . . . 33.979999999999997 108.209 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -91.39 170.03 10.31 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.657 0.741 . . . . 45.039999999999999 111.352 -178.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.81 -6.72 12.85 Favored Glycine 0 N--CA 1.495 2.609 0 O-C-N 121.866 -0.521 . . . . 39.469999999999999 112.086 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -102.05 5.83 40.74 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 119.367 1.584 . . . . 0.0 110.6 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 61' ' ' THR . . . 93.27 -28.47 9.71 Favored Glycine 0 N--CA 1.495 2.596 0 C-N-CA 120.352 -0.927 . . . . 0.0 110.859 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.1 141.4 58.15 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.277 -1.131 . . . . 62.780000000000001 109.77 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.782 HG22 HG23 ' A' ' 55' ' ' THR . 66.4 p -132.38 150.05 52.23 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.438 -0.788 . . . . 0.0 110.488 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -122.32 122.29 38.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.566 -0.709 . . . . 0.0 109.903 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -103.28 134.66 46.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.696 -0.627 . . . . 0.0 110.59 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.3 t -128.04 130.07 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.558 0.694 . . . . 37.939999999999998 109.942 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -124.24 126.82 46.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.822 -0.549 . . . . 0.0 110.111 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.96 149.6 21.62 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.35 -1.5 . . . . 31.82 109.35 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -76.72 154.72 33.86 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.492 -1.004 . . . . 0.0 110.078 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.77 -169.48 0.19 Allowed Glycine 0 N--CA 1.498 2.808 0 O-C-N 121.378 -0.826 . . . . 22.620000000000001 111.337 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.836 HG13 HD22 ' A' ' 47' ' ' LEU . 15.9 m -131.05 129.24 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.834 -0.803 . . . . 17.510000000000002 109.648 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.1 m 40.95 35.22 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.456 0 CA-C-O 121.445 0.64 . . . . 20.550000000000001 111.918 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.06 17.13 67.95 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 121.676 -0.64 . . . . 18.289999999999999 112.85 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.404 ' OE1' ' CZ ' ' A' ' 82' ' ' PHE . 11.9 pt-20 -144.97 150.33 36.75 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 119.131 1.466 . . . . 0.0 111.902 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 46' ' ' ARG . 93.4 mt-30 -116.3 75.57 6.37 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 109.019 -0.734 . . . . 18.210000000000001 109.019 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -58.1 142.17 96.83 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 O-C-N 123.956 1.503 . . . . 17.609999999999999 112.411 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.436 ' CH2' ' HB2' ' A' ' 44' ' ' PRO . 5.0 t90 -103.88 75.54 1.3 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.657 ' CD1' HG22 ' A' ' 37' ' ' ILE . 9.7 mt -60.82 121.34 12.08 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.563 -0.711 . . . . 20.57 112.35 -178.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -87.44 158.44 51.72 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -54.22 129.21 33.32 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 O-C-N 123.529 1.279 . . . . 27.039999999999999 111.309 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.92 -16.75 49.8 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 120.481 -0.866 . . . . 24.739999999999998 111.023 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -87.96 166.07 14.77 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.973 -1.31 . . . . 29.379999999999999 110.393 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.33 149.56 35.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.516 -0.74 . . . . 0.0 110.283 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.404 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 65.1 t80 -118.99 147.79 43.7 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.846 -0.798 . . . . 18.559999999999999 108.846 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -143.95 140.19 29.53 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.13 -0.981 . . . . 0.0 111.552 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.53 ' CE1' HG21 ' A' ' 35' ' ' ILE . 52.1 p90 -150.45 159.97 44.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.707 -0.621 . . . . 26.649999999999999 109.526 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.5 m -104.83 138.78 40.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.283 -0.885 . . . . 28.140000000000001 111.353 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.451 ' CB ' ' CZ ' ' A' ' 33' ' ' TYR . 25.2 t -123.95 166.18 16.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.714 -0.616 . . . . 33.880000000000003 109.762 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -143.06 118.89 1.28 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.202 -1.159 . . . . 31.800000000000001 110.202 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 68.2 t -132.57 149.42 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.66 -0.906 . . . . 0.0 109.763 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 pp -107.34 142.36 37.25 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.505 -0.747 . . . . 0.0 110.205 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.404 HD12 ' CD1' ' A' ' 31' ' ' PHE . 31.0 mt -124.57 143.3 50.77 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.486 -0.759 . . . . 38.68 110.502 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.56 -19.26 38.88 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.281 -0.887 . . . . 0.0 110.232 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.431 HG22 ' H ' ' A' ' 94' ' ' GLN . 5.3 m -101.67 133.17 46.79 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.443 -0.786 . . . . 31.629999999999999 109.978 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.415 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 67.9 tt0 -75.7 -4.89 42.85 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.119 -0.988 . . . . 0.0 110.623 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.431 ' H ' HG22 ' A' ' 92' ' ' THR . 15.5 pt20 -138.68 143.31 39.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.207 -0.933 . . . . 0.0 108.803 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -178.05 167.35 38.04 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 118.303 -1.903 . . . . 28.050000000000001 112.639 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -117.71 130.63 56.45 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 122.192 -0.593 . . . . 0.0 109.711 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 98.1 mtp -127.11 121.28 31.01 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.325 -0.859 . . . . 0.0 111.337 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.72 ' HG2' ' HB2' ' A' ' 117' ' ' ALA . 75.6 mt-30 -123.06 152.7 40.76 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.426 ' HA3' ' CE3' ' A' ' 52' ' ' TRP . . . -168.41 174.96 43.18 Favored Glycine 0 N--CA 1.499 2.879 0 C-N-CA 118.561 -1.78 . . . . 29.620000000000001 111.366 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.412 ' CE1' ' HB3' ' A' ' 51' ' ' HIS . 40.7 p-80 -142.86 156.17 44.89 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.876 -0.779 . . . . 0.0 110.078 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.785 ' CD2' HD11 ' A' ' 115' ' ' ILE . 4.8 m-85 -116.82 127.81 54.67 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.503 -0.748 . . . . 27.050000000000001 109.796 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 10.2 t70 -78.88 123.17 26.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.914 -1.116 . . . . 0.0 109.298 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.452 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 92.3 mmm -119.69 163.07 17.96 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.174 0.512 . . . . 0.0 110.062 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.476 HG22 HG23 ' A' ' 48' ' ' VAL . 8.6 m -142.42 129.16 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.588 -0.695 . . . . 23.280000000000001 110.453 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.564 ' HB3' ' OD1' ' A' ' 107' ' ' ASP . . . -72.73 166.03 23.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.492 -0.755 . . . . 0.0 109.408 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -64.36 -28.39 69.67 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.383 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.564 ' OD1' ' HB3' ' A' ' 105' ' ' ALA . 47.0 p-10 -76.29 -4.44 42.04 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.467 -0.77 . . . . 0.0 111.505 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.7 -9.91 60.57 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.056 -1.069 . . . . 30.43 110.915 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 89.7 m -57.5 135.08 56.59 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.03 -1.276 . . . . 0.0 109.985 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -101.36 140.8 35.15 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.335 -0.853 . . . . 0.0 110.877 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.452 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 44.0 p90 -165.9 144.87 6.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.712 -0.618 . . . . 28.030000000000001 109.603 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 84.8 mt -99.15 157.41 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.699 -0.626 . . . . 0.0 110.712 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.82 96.07 49.39 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -60.1 144.88 99.45 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 O-C-N 123.946 1.498 . . . . 33.310000000000002 112.376 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.785 HD11 ' CD2' ' A' ' 101' ' ' TYR . 68.8 mt -111.56 123.32 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.749 -0.834 . . . . 30.59 108.749 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -47.87 170.56 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.246 0.545 . . . . 30.780000000000001 111.636 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.72 ' HB2' ' HG2' ' A' ' 98' ' ' GLN . . . -99.41 123.14 43.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.699 -0.626 . . . . 0.0 110.766 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.47 ' CE1' HD11 ' A' ' 120' ' ' LEU . 48.4 p90 -111.36 156.83 20.97 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.262 -1.014 . . . . 30.66 108.262 178.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.631 ' C ' HD12 ' A' ' 120' ' ' LEU . 8.9 p -115.65 155.31 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.245 -0.909 . . . . 0.0 110.602 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.653 ' N ' HD12 ' A' ' 120' ' ' LEU . 7.8 mp -112.81 132.34 55.3 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.286 -0.635 . . . . 39.149999999999999 109.286 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.735 -0.603 . . . . 0.0 110.114 -179.722 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.554 ' HG3' ' HB3' ' A' ' 42' ' ' ALA . 29.3 ttm-85 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.011 0.434 . . . . 0.0 110.0 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -122.47 84.59 2.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.77 -0.581 . . . . 31.93 110.348 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.47 ' C ' HG23 ' A' ' 9' ' ' VAL . 11.9 ptp180 -148.3 144.26 27.47 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.133 0.968 . . . . 0.0 110.737 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.641 HG11 ' SD ' ' A' ' 103' ' ' MET . 99.3 t -151.02 120.61 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -108.07 134.18 51.32 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.615 0.721 . . . . 0.0 110.127 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 37' ' ' ILE . 60.5 t -119.28 138.55 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.915 -0.491 . . . . 28.210000000000001 109.921 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.412 ' HG3' ' HB2' ' A' ' 36' ' ' ARG . 13.4 pt-20 -122.92 139.71 53.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.502 -0.749 . . . . 0.0 109.422 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.742 HG22 HD13 ' A' ' 35' ' ' ILE . 59.3 t -128.56 140.25 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.645 -0.659 . . . . 27.949999999999999 110.717 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.6 t -122.83 104.04 36.52 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.844 -0.535 . . . . 0.0 109.963 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.433 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 50.0 Cg_endo -82.74 165.79 15.53 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 O-C-N 123.901 1.474 . . . . 33.0 111.26 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 -157.61 132.8 8.86 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.511 0.672 . . . . 54.100000000000001 109.557 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 19' ' ' ALA . 71.9 t80 -60.0 137.77 58.01 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.287 0.565 . . . . 0.0 111.206 -178.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.545 HD21 ' OE1' ' A' ' 21' ' ' GLN . 5.6 tp -114.95 78.71 1.19 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.979 0.895 . . . . 0.0 110.211 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.577 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -70.89 -35.32 72.27 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.567 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -68.14 -25.18 65.16 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.339 -0.851 . . . . 0.0 111.02 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.545 ' OE1' HD21 ' A' ' 18' ' ' LEU . 97.8 mt-30 -119.38 33.7 5.53 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.375 -0.828 . . . . 52.369999999999997 110.38 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.656 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 23.1 t -152.39 143.91 23.43 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.537 -0.727 . . . . 55.189999999999998 110.705 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.577 ' O ' HG23 ' A' ' 23' ' ' THR . 8.0 t -121.05 95.56 48.79 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.468 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.5 Cg_endo -66.46 -23.17 50.92 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 O-C-N 123.79 1.416 . . . . 51.57 112.106 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -65.13 -24.15 67.33 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.295 -0.878 . . . . 0.0 110.995 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -105.4 21.8 16.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.197 -0.939 . . . . 0.0 110.944 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.89 30.3 70.35 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.718 ' HD2' HD21 ' A' ' 89' ' ' LEU . 9.5 tpt180 -121.14 93.13 3.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.619 -0.93 . . . . 0.0 109.943 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.468 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 54.8 m-85 -105.56 130.77 53.54 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.955 -0.757 . . . . 46.07 108.955 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.656 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -117.98 119.62 35.36 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.635 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.677 ' CD1' HD12 ' A' ' 90' ' ' LEU . 79.2 m-85 -114.59 131.39 56.7 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.134 -0.691 . . . . 38.880000000000003 109.134 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.69 131.01 56.32 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.142 -0.974 . . . . 34.060000000000002 109.021 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.482 ' CE1' HD11 ' A' ' 35' ' ' ILE . 52.3 p90 -128.51 147.46 50.69 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.237 -0.985 . . . . 29.030000000000001 111.161 -179.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.7 m -101.07 139.44 36.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.697 -0.627 . . . . 0.0 109.691 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.742 HD13 HG22 ' A' ' 13' ' ' VAL . 47.4 mm -103.22 132.74 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.661 0.743 . . . . 0.0 111.317 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.412 ' HB2' ' HG3' ' A' ' 12' ' ' GLU . 62.7 mtt85 -126.0 97.77 5.24 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.577 0.703 . . . . 40.240000000000002 110.182 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.557 HG22 ' CD1' ' A' ' 76' ' ' LEU . 81.7 mt -93.5 118.05 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.882 -0.511 . . . . 20.73 110.656 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -117.0 135.73 53.47 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.428 -0.795 . . . . 0.0 109.507 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -90.69 118.73 30.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.879 -0.513 . . . . 21.34 110.833 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.56 8.91 17.85 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.558 -0.714 . . . . 0.0 110.706 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.454 ' HA2' ' HG2' ' A' ' 8' ' ' ARG . . . -82.94 178.68 53.13 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.216 -1.554 . . . . 29.100000000000001 109.216 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.554 ' HB3' ' HG3' ' A' ' 6' ' ' ARG . . . -94.62 -30.45 14.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.446 -1.032 . . . . 0.0 110.198 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.515 HG13 ' HD2' ' A' ' 44' ' ' PRO . 86.7 t -103.82 139.89 20.54 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.855 -0.528 . . . . 0.0 109.764 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.515 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.9 Cg_endo -52.75 142.69 50.28 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 O-C-N 123.818 1.43 . . . . 21.949999999999999 111.827 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.4 151.44 46.3 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.53 0.681 . . . . 20.91 110.926 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.43 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 19.3 ptt-85 -127.76 159.14 35.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.721 -0.612 . . . . 0.0 109.893 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.848 HD22 HG13 ' A' ' 69' ' ' VAL . 7.6 tt -97.75 116.22 29.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.449 -0.782 . . . . 0.0 109.737 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.434 HG23 HG22 ' A' ' 104' ' ' VAL . 57.3 t -98.08 -27.54 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.517 -0.739 . . . . 0.0 110.497 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.725 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -140.46 163.61 32.36 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.822 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -143.18 140.65 30.85 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.306 0.574 . . . . 29.050000000000001 110.226 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -145.1 113.46 6.61 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.433 0.635 . . . . 27.969999999999999 110.15 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.473 ' CH2' HG21 ' A' ' 115' ' ' ILE . 63.0 m95 -101.1 136.66 40.59 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.635 -0.666 . . . . 25.25 110.996 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -116.8 78.52 1.22 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.717 -0.614 . . . . 0.0 109.751 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.421 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.0 pt -86.42 131.89 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.361 -0.837 . . . . 36.109999999999999 111.963 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.717 HG23 HG22 ' A' ' 61' ' ' THR . 94.3 m -118.76 132.51 56.14 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.549 -0.908 . . . . 33.979999999999997 108.549 178.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -87.91 169.81 11.69 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.556 0.694 . . . . 45.039999999999999 111.244 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.48 -8.67 20.77 Favored Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.81 -0.556 . . . . 39.469999999999999 112.016 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -101.98 8.29 41.07 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 119.301 1.551 . . . . 0.0 110.797 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.78 -25.61 18.36 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 121.264 -0.898 . . . . 0.0 110.966 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.3 mpp_? -62.0 141.71 57.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.219 -1.165 . . . . 62.780000000000001 109.619 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.717 HG22 HG23 ' A' ' 55' ' ' THR . 63.7 p -129.3 147.83 51.17 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.614 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -122.1 120.49 34.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.549 -0.72 . . . . 0.0 109.809 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -103.92 136.13 44.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.66 -0.65 . . . . 0.0 110.668 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.5 t -128.12 131.11 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.454 0.645 . . . . 37.939999999999998 109.781 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.99 127.85 47.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.827 -0.546 . . . . 0.0 110.472 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -153.0 170.18 31.99 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.165 -1.574 . . . . 31.82 109.165 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -111.13 160.32 17.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.411 -1.052 . . . . 0.0 109.896 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.77 93.81 0.01 OUTLIER Glycine 0 N--CA 1.5 2.919 0 O-C-N 121.284 -0.885 . . . . 22.620000000000001 111.239 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.848 HG13 HD22 ' A' ' 47' ' ' LEU . 16.6 m -44.54 132.53 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.528 0 O-C-N 121.431 -1.041 . . . . 17.510000000000002 111.774 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.9 m 41.77 38.45 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 CA-C-N 115.592 -0.731 . . . . 20.550000000000001 111.605 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.08 18.79 64.19 Favored Glycine 0 N--CA 1.495 2.618 0 O-C-N 121.789 -0.569 . . . . 18.289999999999999 112.521 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 82' ' ' PHE . 5.5 pt-20 -147.41 153.07 39.16 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 119.045 1.422 . . . . 0.0 112.477 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -117.39 73.31 7.58 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.555 -0.906 . . . . 18.210000000000001 108.555 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -54.88 141.39 77.75 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 O-C-N 123.715 1.376 . . . . 17.609999999999999 112.174 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.444 ' CZ3' ' HB2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -100.62 76.93 1.86 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.956 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.557 ' CD1' HG22 ' A' ' 37' ' ' ILE . 11.2 mt -60.68 118.18 6.28 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.618 -0.676 . . . . 20.57 111.736 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.08 157.5 56.79 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -53.17 127.6 25.74 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 O-C-N 123.491 1.258 . . . . 27.039999999999999 111.089 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.14 -16.58 55.33 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.799 -0.92 . . . . 24.739999999999998 110.799 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -86.81 165.36 16.06 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.078 -1.248 . . . . 29.379999999999999 110.489 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.14 149.62 35.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.517 -0.739 . . . . 0.0 110.015 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.407 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 64.7 t80 -119.75 148.25 43.64 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.414 -0.804 . . . . 18.559999999999999 109.141 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.8 p80 -143.46 140.23 30.27 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.125 -0.985 . . . . 0.0 111.293 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.61 ' CE1' HG21 ' A' ' 35' ' ' ILE . 51.7 p90 -151.52 160.38 43.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.664 -0.648 . . . . 26.649999999999999 109.618 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.2 m -102.82 137.64 40.75 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.402 -0.812 . . . . 28.140000000000001 111.058 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.436 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 17.0 t -123.99 167.28 14.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.595 -0.691 . . . . 33.880000000000003 109.886 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -143.97 124.35 2.23 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.813 -1.184 . . . . 31.800000000000001 110.572 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.5 m -131.36 154.19 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.632 -0.923 . . . . 0.0 109.939 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.718 HD21 ' HD2' ' A' ' 28' ' ' ARG . 10.6 tp -109.18 144.64 36.99 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.553 -0.717 . . . . 0.0 110.832 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.719 HD11 HD22 ' A' ' 120' ' ' LEU . 74.7 mt -122.14 146.34 47.32 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.597 -0.689 . . . . 38.68 110.314 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.403 ' O ' ' CE1' ' A' ' 29' ' ' TYR . 75.4 tt0 -76.2 -25.62 55.33 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.353 -0.842 . . . . 0.0 110.782 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 68.0 p -125.2 172.06 9.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.361 -0.837 . . . . 31.629999999999999 110.782 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.458 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 50.1 mt-10 -86.81 11.72 12.58 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.593 -0.692 . . . . 0.0 111.654 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 14.4 pt20 -140.85 148.22 40.2 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.06 -1.025 . . . . 0.0 110.057 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.31 160.82 23.78 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 118.907 -1.616 . . . . 28.050000000000001 112.086 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -119.73 129.64 54.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 122.14 -0.624 . . . . 0.0 109.335 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 97.7 mtp -125.3 116.24 21.62 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.344 -0.848 . . . . 0.0 111.116 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.49 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 56.6 tt0 -129.26 149.79 50.91 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.7 -178.49 38.72 Favored Glycine 0 N--CA 1.498 2.822 0 C-N-CA 118.916 -1.611 . . . . 29.620000000000001 110.76 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -140.54 157.96 44.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.703 -0.881 . . . . 0.0 110.752 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.669 ' CE2' HD11 ' A' ' 115' ' ' ILE . 6.3 m-85 -116.79 128.58 55.43 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.645 -0.66 . . . . 27.050000000000001 109.885 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.725 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 41.9 t0 -81.35 123.18 28.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.978 -1.076 . . . . 0.0 109.136 178.127 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.641 ' SD ' HG11 ' A' ' 9' ' ' VAL . 51.7 mtp -122.19 162.35 21.52 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.118 0.485 . . . . 0.0 110.339 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.434 HG22 HG23 ' A' ' 48' ' ' VAL . 10.0 m -142.91 129.73 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.613 -0.679 . . . . 23.280000000000001 110.325 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.04 167.66 20.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.513 -0.742 . . . . 0.0 109.45 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -64.29 -28.44 69.72 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.142 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -72.92 -12.26 60.89 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.567 -0.708 . . . . 0.0 111.026 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.25 -7.05 47.05 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.484 -1.046 . . . . 30.43 110.484 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 91.3 m -57.66 135.2 56.7 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.051 -1.264 . . . . 0.0 110.049 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -101.29 140.03 36.14 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.457 -0.777 . . . . 0.0 110.796 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.452 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 47.5 p90 -167.16 147.23 5.43 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.781 -0.574 . . . . 28.030000000000001 109.854 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.7 pt -102.55 158.12 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.596 -0.69 . . . . 0.0 111.087 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.63 97.59 49.91 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -59.25 143.13 99.86 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 O-C-N 123.895 1.471 . . . . 33.310000000000002 112.432 -178.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.669 HD11 ' CE2' ' A' ' 101' ' ' TYR . 72.2 mt -108.33 123.24 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.658 -0.867 . . . . 30.59 108.658 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.05 144.21 7.13 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.217 0.532 . . . . 30.780000000000001 111.551 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.49 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -87.37 121.03 29.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.638 -0.664 . . . . 0.0 110.242 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.616 ' CE1' HD11 ' A' ' 120' ' ' LEU . 41.9 p90 -109.42 165.89 11.3 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.879 -0.785 . . . . 30.66 108.879 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.605 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.1 t -114.81 154.0 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.284 -0.885 . . . . 0.0 110.326 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.719 HD22 HD11 ' A' ' 90' ' ' LEU . 7.0 mp -113.2 133.23 55.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.788 -0.57 . . . . 39.149999999999999 109.514 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.673 -0.642 . . . . 0.0 110.071 -179.838 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.961 0.41 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.424 ' CE2' HG21 ' A' ' 109' ' ' THR . 34.3 m-85 -115.93 107.41 14.96 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.542 -0.724 . . . . 31.93 110.029 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.483 ' C ' HG23 ' A' ' 9' ' ' VAL . 4.1 ttp180 -155.87 135.05 12.17 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.588 0.708 . . . . 0.0 110.594 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.629 HG11 ' SD ' ' A' ' 103' ' ' MET . 98.2 t -152.42 116.23 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -108.95 132.6 53.93 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.675 0.75 . . . . 0.0 110.62 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.7 t -119.41 139.08 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.891 -0.506 . . . . 28.210000000000001 109.712 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -119.96 137.92 53.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.505 -0.747 . . . . 0.0 109.709 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.523 HG13 ' HD1' ' A' ' 33' ' ' TYR . 62.6 t -129.26 136.62 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.539 -0.725 . . . . 27.949999999999999 110.509 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.6 p -124.17 103.89 32.65 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.72 -0.612 . . . . 0.0 110.281 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -82.89 165.97 15.13 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 123.841 1.443 . . . . 33.0 111.063 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -157.59 132.12 8.47 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.539 0.685 . . . . 54.100000000000001 109.801 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.483 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 77.3 t80 -60.29 139.52 57.57 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.257 0.551 . . . . 0.0 111.471 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.914 HD11 ' HB2' ' A' ' 32' ' ' ALA . 93.7 mt -115.58 79.15 1.25 Allowed 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.879 0.847 . . . . 0.0 110.279 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.483 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -65.89 -35.62 81.15 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.17 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -69.96 -23.45 63.18 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.365 -0.835 . . . . 0.0 110.985 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -121.07 29.97 7.08 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.366 -0.834 . . . . 52.369999999999997 110.976 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.608 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 19.7 p -152.17 146.37 25.42 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.265 -0.897 . . . . 55.189999999999998 111.099 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.586 ' O ' HG23 ' A' ' 23' ' ' THR . 5.1 t -119.45 92.79 46.45 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.48 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.3 Cg_endo -66.08 -23.15 53.75 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 O-C-N 123.912 1.48 . . . . 51.57 111.566 -178.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.04 -23.19 67.12 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.4 -0.812 . . . . 0.0 110.882 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -105.77 23.83 13.27 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.357 -0.839 . . . . 0.0 110.693 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.43 28.71 73.66 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.569 ' HB2' HG23 ' A' ' 23' ' ' THR . 33.1 mtt180 -121.52 93.9 4.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.646 -0.914 . . . . 0.0 110.311 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.48 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 66.4 m-85 -104.59 134.32 47.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.644 -0.66 . . . . 46.07 109.325 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.608 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -117.17 120.68 39.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.444 -0.785 . . . . 0.0 111.273 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.755 ' CD1' HD12 ' A' ' 90' ' ' LEU . 91.1 m-85 -116.36 133.67 55.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.505 -0.747 . . . . 38.880000000000003 109.853 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.914 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -114.74 132.42 56.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.205 -0.934 . . . . 34.060000000000002 108.74 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.523 ' HD1' HG13 ' A' ' 13' ' ' VAL . 34.0 p90 -127.63 145.99 50.7 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 119.19 -1.004 . . . . 29.030000000000001 111.747 -178.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 53.8 m -104.46 134.15 48.14 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.872 HG21 ' CE2' ' A' ' 84' ' ' TYR . 18.8 tt -105.94 135.76 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 121.807 0.813 . . . . 0.0 112.111 -178.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -124.64 100.88 6.85 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.548 0.689 . . . . 40.240000000000002 109.897 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.632 HG22 HD22 ' A' ' 76' ' ' LEU . 81.6 mt -90.72 118.56 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.808 -0.558 . . . . 20.73 110.69 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -117.35 139.5 50.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.392 -0.817 . . . . 0.0 109.497 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -88.55 117.23 27.36 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.672 -0.642 . . . . 21.34 110.848 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.68 3.31 15.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.551 -0.718 . . . . 0.0 110.633 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.8 -174.88 49.92 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.02 -1.632 . . . . 29.100000000000001 109.02 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.02 -30.67 11.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.439 -1.036 . . . . 0.0 110.277 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.522 HG13 ' HD2' ' A' ' 44' ' ' PRO . 86.3 t -105.33 140.65 21.35 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.796 -0.565 . . . . 0.0 109.646 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.522 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.5 Cg_endo -52.1 141.12 48.93 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 O-C-N 123.718 1.378 . . . . 21.949999999999999 111.991 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.84 151.56 45.8 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.627 0.727 . . . . 20.91 110.883 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 0.5 OUTLIER -127.68 160.5 31.48 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.72 -0.612 . . . . 0.0 109.794 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.958 HD22 HG13 ' A' ' 69' ' ' VAL . 7.1 tt -97.27 117.88 32.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.379 -0.826 . . . . 0.0 109.451 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.452 HG23 HG22 ' A' ' 104' ' ' VAL . 58.8 t -101.32 -27.05 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.542 -0.724 . . . . 0.0 110.627 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.783 ' HB3' ' HB2' ' A' ' 102' ' ' ASP . . . -140.41 162.82 34.4 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.226 -0.989 . . . . 0.0 111.558 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -141.29 138.67 33.34 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.345 0.593 . . . . 29.050000000000001 110.434 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -142.86 113.31 7.32 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.327 0.584 . . . . 27.969999999999999 109.723 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.427 ' CH2' HD13 ' A' ' 115' ' ' ILE . 82.1 m95 -101.15 133.63 45.4 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.632 -0.668 . . . . 25.25 111.049 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -116.28 76.48 1.02 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.635 -0.666 . . . . 0.0 109.345 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 54' ' ' ILE . 28.0 pt -85.59 129.21 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-O 121.776 0.798 . . . . 36.109999999999999 111.774 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.0 m -120.57 131.8 54.84 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.429 -0.952 . . . . 33.979999999999997 108.429 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -88.55 169.99 11.25 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.85 0.833 . . . . 45.039999999999999 111.474 -178.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.04 -7.12 11.57 Favored Glycine 0 N--CA 1.495 2.616 0 O-C-N 121.757 -0.589 . . . . 39.469999999999999 112.205 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -101.0 7.02 43.71 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 119.434 1.617 . . . . 0.0 110.6 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.04 -29.05 8.47 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.79 141.49 58.75 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.23 -1.159 . . . . 62.780000000000001 109.674 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.8 t -134.84 152.96 52.18 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.618 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -121.32 122.08 39.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.542 -0.723 . . . . 0.0 110.155 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -102.82 134.72 45.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.705 -0.622 . . . . 0.0 110.439 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.4 t -128.01 130.82 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.578 -0.701 . . . . 37.939999999999998 110.062 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -125.82 126.87 45.2 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.849 -0.532 . . . . 0.0 110.041 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -151.13 158.37 27.66 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.264 -1.534 . . . . 31.82 109.264 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -80.7 154.35 27.34 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.428 -1.042 . . . . 0.0 110.374 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.88 -167.09 0.2 Allowed Glycine 0 N--CA 1.498 2.767 0 O-C-N 121.493 -0.754 . . . . 22.620000000000001 111.605 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.958 HG13 HD22 ' A' ' 47' ' ' LEU . 16.0 m -131.8 129.61 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.96 -0.729 . . . . 17.510000000000002 109.537 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.4 m 40.91 35.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 CA-C-O 121.517 0.675 . . . . 20.550000000000001 111.779 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.28 17.8 65.98 Favored Glycine 0 N--CA 1.498 2.813 0 O-C-N 121.598 -0.689 . . . . 18.289999999999999 112.988 177.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 69' ' ' VAL . 11.1 pt-20 -145.13 150.59 37.06 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 119.211 1.505 . . . . 0.0 112.025 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -115.21 74.75 4.03 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.923 -0.769 . . . . 18.210000000000001 108.923 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -56.94 140.8 93.12 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 O-C-N 123.785 1.413 . . . . 17.609999999999999 112.189 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.436 ' CZ3' ' HG2' ' A' ' 77' ' ' ARG . 6.3 t90 -104.03 77.55 1.45 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.632 HD22 HG22 ' A' ' 37' ' ' ILE . 5.8 tp -61.38 118.17 6.6 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.516 -0.74 . . . . 20.57 111.623 -178.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.436 ' HG2' ' CZ3' ' A' ' 75' ' ' TRP . 16.0 mtm180 -86.31 159.18 53.98 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -54.61 126.71 23.28 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 O-C-N 123.628 1.331 . . . . 27.039999999999999 111.002 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.64 -18.53 42.34 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.903 -0.879 . . . . 24.739999999999998 110.903 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -87.89 165.77 15.02 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.079 -1.248 . . . . 29.379999999999999 110.255 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.523 ' CA ' HD11 ' A' ' 76' ' ' LEU . . . -145.74 150.45 36.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.545 -0.722 . . . . 0.0 110.388 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.47 ' HD2' HD12 ' A' ' 37' ' ' ILE . 90.7 t80 -118.59 145.68 45.21 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.031 -0.729 . . . . 18.559999999999999 109.031 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.6 p80 -146.14 141.19 27.26 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.226 -0.922 . . . . 0.0 111.367 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.872 ' CE2' HG21 ' A' ' 35' ' ' ILE . 44.9 p90 -151.89 163.28 39.57 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.655 -0.653 . . . . 26.649999999999999 109.557 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.9 m -99.0 138.42 36.12 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.167 -0.958 . . . . 28.140000000000001 111.137 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 15.2 t -125.91 166.35 17.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.615 -0.678 . . . . 33.880000000000003 109.912 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -143.88 124.52 2.27 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 119.774 -1.203 . . . . 31.800000000000001 110.675 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.5 m -132.13 152.8 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.667 -0.902 . . . . 0.0 109.809 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.548 HD23 ' HA ' ' A' ' 30' ' ' ALA . 81.5 mt -111.56 145.15 39.63 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.559 -0.713 . . . . 0.0 110.977 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.755 HD12 ' CD1' ' A' ' 31' ' ' PHE . 78.7 mt -121.2 145.95 47.3 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.691 -0.631 . . . . 38.68 109.886 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -73.39 -25.69 60.67 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.306 -0.871 . . . . 0.0 111.165 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.8 p -123.47 171.71 9.27 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.354 -0.841 . . . . 31.629999999999999 110.756 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.41 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 32.6 tt0 -86.31 7.37 25.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.692 -0.63 . . . . 0.0 111.506 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -138.62 148.62 44.31 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.097 -1.002 . . . . 0.0 109.526 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.62 156.77 14.57 Favored Glycine 0 N--CA 1.496 2.661 0 C-N-CA 118.755 -1.688 . . . . 28.050000000000001 112.254 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -118.41 130.02 55.74 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 94.8 mtp -126.29 120.77 30.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.38 -0.825 . . . . 0.0 111.4 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -130.6 151.83 50.64 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.73 -173.67 33.63 Favored Glycine 0 N--CA 1.5 2.951 0 C-N-CA 118.973 -1.584 . . . . 29.620000000000001 110.806 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -137.13 160.18 39.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.654 -0.909 . . . . 0.0 110.557 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.61 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 8.7 m-85 -116.98 128.42 55.17 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.771 -0.581 . . . . 27.050000000000001 110.181 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.783 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 78.6 m-20 -87.15 121.31 29.43 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.021 -1.05 . . . . 0.0 108.846 177.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.629 ' SD ' HG11 ' A' ' 9' ' ' VAL . 55.1 mtp -126.4 162.76 24.82 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.21 0.529 . . . . 0.0 110.624 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.514 HG12 ' CD ' ' A' ' 110' ' ' GLU . 12.6 m -140.65 131.23 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.551 -0.718 . . . . 23.280000000000001 110.287 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.45 165.58 24.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.35 -0.844 . . . . 0.0 109.402 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -63.7 -29.37 70.6 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.024 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -75.34 -9.69 58.78 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.493 -0.754 . . . . 0.0 111.202 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.99 -7.98 49.29 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.061 -1.066 . . . . 30.43 110.469 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.424 HG21 ' CE2' ' A' ' 7' ' ' TYR . 33.6 m -57.69 135.38 56.74 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.036 -1.273 . . . . 0.0 109.964 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.514 ' CD ' HG12 ' A' ' 104' ' ' VAL . 79.3 mm-40 -101.34 139.77 36.56 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.347 -0.845 . . . . 0.0 110.723 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 47.8 p90 -163.76 143.24 8.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.684 -0.635 . . . . 28.030000000000001 109.993 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 84.3 mt -101.09 156.79 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.424 0.631 . . . . 0.0 110.43 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.61 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -120.86 98.91 47.45 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -58.36 143.22 97.8 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 O-C-N 123.93 1.49 . . . . 33.310000000000002 112.066 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.464 HD11 ' CZ ' ' A' ' 101' ' ' TYR . 70.9 mt -107.97 123.28 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-N 115.375 -0.829 . . . . 30.59 108.907 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -51.84 149.63 4.7 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.175 0.512 . . . . 30.780000000000001 111.207 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -91.29 120.87 32.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.586 -0.696 . . . . 0.0 110.113 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.72 ' CE1' HD11 ' A' ' 120' ' ' LEU . 51.2 p90 -110.29 165.01 12.11 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.678 -0.86 . . . . 30.66 108.678 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.595 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.2 t -116.01 153.13 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.159 -0.963 . . . . 0.0 110.677 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.74 HD22 HD11 ' A' ' 90' ' ' LEU . 7.0 mp -113.32 134.35 54.66 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.283 -0.636 . . . . 39.149999999999999 109.283 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 51.9 m . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.62 -0.675 . . . . 0.0 110.081 -179.819 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.703 0.287 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.415 ' CE2' HG21 ' A' ' 109' ' ' THR . 39.9 m-85 -118.62 105.36 11.53 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.484 -0.76 . . . . 31.93 110.331 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.49 ' C ' HG23 ' A' ' 9' ' ' VAL . 82.4 mtt85 -147.08 132.57 18.67 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.603 -0.685 . . . . 0.0 109.839 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.49 HG23 ' C ' ' A' ' 8' ' ' ARG . 93.4 t -152.1 115.41 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.501 -0.75 . . . . 0.0 109.896 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -105.7 128.42 53.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.662 -0.649 . . . . 0.0 109.823 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.593 HG11 ' HE2' ' A' ' 101' ' ' TYR . 58.4 t -119.32 138.3 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.757 -0.59 . . . . 28.210000000000001 109.793 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -123.57 136.73 54.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.316 -0.865 . . . . 0.0 110.148 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.633 HG22 HD13 ' A' ' 35' ' ' ILE . 60.4 t -129.61 137.11 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.57 -0.706 . . . . 27.949999999999999 110.18 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.4 t -125.61 105.28 27.17 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.688 -0.633 . . . . 0.0 110.887 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.88 165.13 15.51 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.794 1.418 . . . . 33.0 110.886 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.8 ptt-85 -157.98 132.01 8.04 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.664 0.745 . . . . 54.100000000000001 109.947 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.48 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 79.7 t80 -60.02 139.97 57.1 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.725 -0.609 . . . . 0.0 111.604 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.951 HD11 ' HB2' ' A' ' 32' ' ' ALA . 84.5 mt -116.49 80.76 1.51 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.903 0.858 . . . . 0.0 110.422 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.48 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -65.8 -35.74 81.55 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.065 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -69.96 -24.45 63.34 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.282 -0.886 . . . . 0.0 110.881 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.2 tp60 -121.36 49.56 1.5 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.331 -0.856 . . . . 52.369999999999997 110.779 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.699 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 52.5 p -169.59 149.12 3.84 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.228 -0.92 . . . . 55.189999999999998 110.916 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.604 HG23 ' HB2' ' A' ' 28' ' ' ARG . 5.1 t -118.88 92.42 44.77 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.0 Cg_endo -66.86 -24.92 45.88 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 O-C-N 123.818 1.43 . . . . 51.57 112.064 -178.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -66.7 -20.77 66.04 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.236 -0.915 . . . . 0.0 111.022 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -105.6 23.58 13.61 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.145 -0.972 . . . . 0.0 110.739 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.72 27.43 73.27 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.604 ' HB2' HG23 ' A' ' 23' ' ' THR . 30.8 mtt85 -122.08 94.38 4.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.643 -0.916 . . . . 0.0 110.082 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.46 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 63.8 m-85 -104.41 137.15 42.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.582 -0.699 . . . . 46.07 109.209 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.699 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -114.03 120.4 40.47 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.162 -179.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -116.5 131.38 56.96 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.608 -0.683 . . . . 38.880000000000003 109.653 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.951 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -113.39 131.5 55.97 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.282 -0.886 . . . . 34.060000000000002 108.849 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 86' ' ' SER . 53.7 p90 -126.52 145.57 50.46 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.331 -0.948 . . . . 29.030000000000001 111.326 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.5 t -102.41 140.27 36.91 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.633 HD13 HG22 ' A' ' 13' ' ' VAL . 48.5 mm -105.68 132.46 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.783 0.802 . . . . 0.0 111.715 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -123.58 97.77 5.54 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.522 0.677 . . . . 40.240000000000002 109.718 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.531 HG22 ' CD1' ' A' ' 76' ' ' LEU . 81.8 mt -93.17 117.75 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.773 -0.58 . . . . 20.73 110.583 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -117.18 133.72 55.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.439 -0.788 . . . . 0.0 109.319 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -94.59 117.44 30.13 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 120.212 -0.595 . . . . 21.34 110.523 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.27 15.89 15.86 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.39 -0.819 . . . . 0.0 110.45 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.83 -179.72 52.78 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.332 -1.507 . . . . 29.100000000000001 109.332 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.31 -33.26 13.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.56 -0.964 . . . . 0.0 110.267 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.532 HG13 ' HD2' ' A' ' 44' ' ' PRO . 87.2 t -106.45 142.02 24.03 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 122.022 -0.424 . . . . 0.0 109.937 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.532 ' HD2' HG13 ' A' ' 43' ' ' VAL . 38.7 Cg_endo -53.66 146.84 42.28 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 O-C-N 123.792 1.417 . . . . 21.949999999999999 111.428 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.5 151.28 47.23 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.794 0.807 . . . . 20.91 111.506 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 8.1 ttt180 -126.85 152.32 47.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.865 -0.522 . . . . 0.0 109.595 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.852 HD22 HG13 ' A' ' 69' ' ' VAL . 7.0 tt -98.03 118.73 35.28 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.382 -0.824 . . . . 0.0 109.728 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.501 HG23 HG22 ' A' ' 104' ' ' VAL . 58.0 t -100.27 -29.66 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.61 -0.681 . . . . 0.0 111.073 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.602 ' HB3' ' HB2' ' A' ' 102' ' ' ASP . . . -141.68 165.58 27.1 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.078 -1.049 . . . . 0.0 112.296 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.5 ptt85 -142.72 140.69 31.57 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.519 0.676 . . . . 29.050000000000001 110.352 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -143.09 114.59 8.0 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.777 -0.577 . . . . 27.969999999999999 109.628 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.577 ' CH2' HD13 ' A' ' 115' ' ' ILE . 91.6 m95 -99.95 132.92 45.01 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.578 -0.701 . . . . 25.25 111.2 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -116.15 76.05 0.99 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.604 -0.685 . . . . 0.0 109.402 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 54' ' ' ILE . 28.2 pt -85.17 130.13 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.789 0.805 . . . . 36.109999999999999 112.275 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.562 HG23 ' HB ' ' A' ' 61' ' ' THR . 6.9 m -118.64 130.89 56.11 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.983 -1.117 . . . . 33.979999999999997 107.983 178.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.475 ' OD2' HG21 ' A' ' 92' ' ' THR . 26.3 t0 -88.5 169.72 11.51 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.644 0.735 . . . . 45.039999999999999 111.144 -178.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.57 -6.84 12.41 Favored Glycine 0 N--CA 1.496 2.636 0 O-C-N 121.754 -0.591 . . . . 39.469999999999999 112.13 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -101.47 7.69 42.36 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 119.337 1.569 . . . . 0.0 110.596 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.67 -31.63 6.37 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.51 142.72 57.81 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.387 -1.067 . . . . 62.780000000000001 109.944 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.562 ' HB ' HG23 ' A' ' 55' ' ' THR . 7.7 t -134.36 152.93 52.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.531 -0.731 . . . . 0.0 110.451 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -121.92 123.35 41.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.545 -0.722 . . . . 0.0 110.335 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -103.23 134.24 46.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.671 -0.643 . . . . 0.0 110.496 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.8 t -128.37 131.78 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.538 -0.727 . . . . 37.939999999999998 110.043 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -124.86 126.21 45.2 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.822 -0.549 . . . . 0.0 110.148 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.35 149.01 21.0 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.363 -1.495 . . . . 31.82 109.363 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -77.88 155.24 31.07 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.474 -1.015 . . . . 0.0 110.439 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.56 -175.13 0.18 Allowed Glycine 0 N--CA 1.497 2.7 0 N-CA-C 111.049 -0.82 . . . . 22.620000000000001 111.049 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.852 HG13 HD22 ' A' ' 47' ' ' LEU . 14.3 m -128.24 127.52 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.8 -0.824 . . . . 17.510000000000002 109.576 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.4 m 41.21 36.95 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-O 121.599 0.714 . . . . 20.550000000000001 111.809 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.97 15.77 71.7 Favored Glycine 0 N--CA 1.499 2.854 0 O-C-N 121.571 -0.705 . . . . 18.289999999999999 112.957 177.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.416 ' O ' HG22 ' A' ' 69' ' ' VAL . 10.8 pt-20 -146.3 151.33 37.36 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-N 119.136 1.468 . . . . 0.0 112.15 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -115.5 75.36 4.82 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.887 -0.783 . . . . 18.210000000000001 108.887 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -57.71 139.04 88.96 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 O-C-N 123.847 1.446 . . . . 17.609999999999999 112.084 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.432 ' CD1' ' HB2' ' A' ' 46' ' ' ARG . 4.0 t90 -101.68 76.22 1.64 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.531 ' CD1' HG22 ' A' ' 37' ' ' ILE . 10.1 mt -60.25 118.17 6.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.582 -0.699 . . . . 20.57 112.039 -178.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.429 ' HG2' ' CZ3' ' A' ' 75' ' ' TRP . 15.2 mtm180 -86.91 158.45 53.28 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -54.25 129.37 34.2 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 O-C-N 123.461 1.243 . . . . 27.039999999999999 111.227 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.01 -18.59 47.03 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 111.068 -0.813 . . . . 24.739999999999998 111.068 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -88.05 166.17 14.64 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.058 -1.26 . . . . 29.379999999999999 110.618 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.04 147.66 32.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.621 -0.674 . . . . 0.0 110.231 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.514 ' HD2' HD12 ' A' ' 37' ' ' ILE . 84.6 t80 -116.21 144.24 44.45 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.525 -0.734 . . . . 18.559999999999999 109.08 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -144.18 140.58 29.42 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.278 -0.889 . . . . 0.0 111.141 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.455 ' CE1' HG21 ' A' ' 35' ' ' ILE . 51.3 p90 -150.15 159.99 44.01 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.758 -0.589 . . . . 26.649999999999999 109.528 178.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.9 m -103.51 138.77 39.75 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.43 -0.794 . . . . 28.140000000000001 110.875 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.434 ' HB3' ' CE2' ' A' ' 33' ' ' TYR . 15.3 t -124.21 167.36 14.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.689 -0.632 . . . . 33.880000000000003 109.937 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -144.03 119.36 1.29 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 110.136 -1.186 . . . . 31.800000000000001 110.136 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.35 152.83 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.591 -0.947 . . . . 0.0 110.1 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -108.71 142.99 38.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.53 -0.731 . . . . 0.0 110.666 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.438 ' CD1' HD22 ' A' ' 120' ' ' LEU . 36.4 mt -124.64 144.79 49.99 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.484 -0.76 . . . . 38.68 110.38 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -88.71 -19.84 25.59 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.129 -0.982 . . . . 0.0 110.395 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.475 HG21 ' OD2' ' A' ' 56' ' ' ASP . 2.6 p -103.05 134.88 45.74 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.403 -0.811 . . . . 31.629999999999999 110.481 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.456 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 51.3 mt-10 -77.38 -2.88 37.32 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.239 -0.913 . . . . 0.0 110.66 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 97.1 mt-30 -138.59 140.63 39.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.179 -0.951 . . . . 0.0 108.834 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.91 166.57 35.76 Favored Glycine 0 N--CA 1.499 2.885 0 C-N-CA 118.409 -1.853 . . . . 28.050000000000001 112.585 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -117.77 129.98 56.02 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.154 -0.615 . . . . 0.0 109.465 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.452 ' HB3' ' HE2' ' A' ' 97' ' ' MET . 98.0 mtp -126.33 119.97 28.69 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.308 -0.87 . . . . 0.0 111.281 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.572 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 30.1 mt-30 -122.54 152.16 40.65 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.93 173.43 36.61 Favored Glycine 0 N--CA 1.498 2.813 0 C-N-CA 118.783 -1.675 . . . . 29.620000000000001 111.107 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.432 ' CD2' ' HB3' ' A' ' 114' ' ' PRO . 67.5 m80 -136.98 156.77 48.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.702 -0.881 . . . . 0.0 109.892 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.599 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 9.1 m-85 -116.66 127.48 54.47 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.683 -0.635 . . . . 27.050000000000001 109.938 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.602 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 78.4 m-20 -84.07 119.89 25.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.962 -1.086 . . . . 0.0 108.414 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.44 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 4.8 ttm -123.48 162.34 23.08 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.065 0.46 . . . . 0.0 110.685 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.501 HG22 HG23 ' A' ' 48' ' ' VAL . 10.8 m -141.42 129.84 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.699 -0.626 . . . . 23.280000000000001 110.52 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.7 166.45 23.26 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.474 -0.766 . . . . 0.0 109.521 179.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -66.45 -30.55 70.93 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.484 -0.76 . . . . 0.0 110.291 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -74.98 -4.59 39.15 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.494 -0.754 . . . . 0.0 111.233 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.8 -9.99 58.68 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.139 -1.029 . . . . 30.43 110.537 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.415 HG21 ' CE2' ' A' ' 7' ' ' TYR . 43.5 m -57.57 134.59 56.27 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.124 -1.221 . . . . 0.0 109.982 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -101.42 140.02 36.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.354 -0.841 . . . . 0.0 110.776 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 42.8 p90 -164.41 142.98 7.09 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.644 -0.66 . . . . 28.030000000000001 109.822 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 85.7 mt -101.23 158.01 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.633 -0.667 . . . . 0.0 110.495 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.599 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -119.01 95.43 49.35 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.432 ' HB3' ' CD2' ' A' ' 100' ' ' HIS . 46.6 Cg_endo -59.56 146.6 94.72 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 O-C-N 123.933 1.491 . . . . 33.310000000000002 112.082 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.596 HD11 ' CE2' ' A' ' 101' ' ' TYR . 66.5 mt -111.19 120.92 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.594 -0.891 . . . . 30.59 108.594 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.05 168.77 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.152 0.501 . . . . 30.780000000000001 111.467 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.572 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -96.98 122.17 39.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.584 -0.698 . . . . 0.0 110.765 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.552 ' CE1' HD11 ' A' ' 120' ' ' LEU . 47.4 p90 -112.01 157.99 20.07 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.183 -1.043 . . . . 30.66 108.183 178.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.627 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.3 t -114.93 153.73 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.241 -0.912 . . . . 0.0 110.494 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.669 ' N ' HD12 ' A' ' 120' ' ' LEU . 7.3 mp -113.12 131.57 55.78 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.175 -0.676 . . . . 39.149999999999999 109.175 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.836 -0.54 . . . . 0.0 110.068 -179.754 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.742 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 83.1 mtt180 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.864 0.364 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.527 ' CZ ' HG21 ' A' ' 109' ' ' THR . 91.9 m-85 -120.63 98.09 5.86 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.553 -0.717 . . . . 31.93 110.199 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.469 ' C ' HG23 ' A' ' 9' ' ' VAL . 74.4 mtm-85 -142.66 135.11 27.75 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.62 -0.675 . . . . 0.0 109.754 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.469 HG23 ' C ' ' A' ' 8' ' ' ARG . 73.4 t -151.75 117.01 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 121.621 0.724 . . . . 0.0 109.784 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -106.56 128.03 53.79 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.63 -0.669 . . . . 0.0 109.687 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.518 HG11 ' HE2' ' A' ' 101' ' ' TYR . 62.7 t -121.1 136.01 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.759 -0.588 . . . . 28.210000000000001 109.926 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -126.89 137.56 53.17 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.341 -0.85 . . . . 0.0 109.869 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.735 HG22 HD13 ' A' ' 35' ' ' ILE . 67.2 t -128.01 139.81 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.641 -0.662 . . . . 27.949999999999999 110.123 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -123.82 105.39 32.48 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.726 -0.609 . . . . 0.0 110.627 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HG3' ' CE1' ' A' ' 118' ' ' PHE . 49.1 Cg_endo -83.69 165.82 13.72 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 O-C-N 123.898 1.473 . . . . 33.0 110.734 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -157.93 132.47 8.35 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.598 0.713 . . . . 54.100000000000001 109.917 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.571 ' CE2' ' HB2' ' A' ' 19' ' ' ALA . 73.0 t80 -60.03 138.43 57.86 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.797 -0.565 . . . . 0.0 111.197 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.423 HD21 ' OE1' ' A' ' 21' ' ' GLN . 8.8 tp -115.5 79.68 1.32 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 122.039 0.923 . . . . 0.0 110.402 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.571 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -72.17 -35.65 69.07 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.465 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -68.42 -25.75 65.19 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.274 -0.891 . . . . 0.0 110.941 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.423 ' OE1' HD21 ' A' ' 18' ' ' LEU . 80.9 mt-30 -119.42 43.66 2.56 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.379 -0.826 . . . . 52.369999999999997 110.313 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.675 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 22.6 t -162.87 150.27 13.34 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.532 -0.73 . . . . 55.189999999999998 110.93 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.61 ' O ' HG23 ' A' ' 23' ' ' THR . 9.7 t -121.25 93.98 48.78 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.459 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.7 Cg_endo -67.12 -22.85 46.65 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 O-C-N 123.748 1.394 . . . . 51.57 112.004 -178.278 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -65.44 -22.98 66.82 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.289 -0.882 . . . . 0.0 110.947 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -106.22 23.49 14.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.209 -0.932 . . . . 0.0 110.786 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.97 28.85 73.32 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.608 ' HB2' HG23 ' A' ' 23' ' ' THR . 86.1 mtt180 -120.72 93.93 4.19 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.636 -0.92 . . . . 0.0 110.076 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.459 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 54.1 m-85 -105.45 134.1 49.11 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.542 -0.724 . . . . 46.07 109.202 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.675 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -113.67 119.48 37.56 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.02 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.612 ' CD1' HD12 ' A' ' 90' ' ' LEU . 83.0 m-85 -114.73 133.3 56.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.595 -0.69 . . . . 38.880000000000003 109.614 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.44 130.25 56.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.218 -0.926 . . . . 34.060000000000002 108.726 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.529 ' HE2' HD11 ' A' ' 35' ' ' ILE . 35.7 p90 -126.05 144.27 50.79 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.263 -0.975 . . . . 29.030000000000001 111.176 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.5 m -103.91 137.82 41.35 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.609 -0.682 . . . . 0.0 109.834 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.735 HD13 HG22 ' A' ' 13' ' ' VAL . 43.2 mm -104.62 130.79 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-O 121.696 0.76 . . . . 0.0 111.37 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -122.85 98.81 6.07 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.528 0.68 . . . . 40.240000000000002 109.716 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.577 HG22 ' CD1' ' A' ' 76' ' ' LEU . 82.5 mt -91.82 116.9 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.715 -0.616 . . . . 20.73 110.411 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -117.87 133.29 56.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.536 -0.727 . . . . 0.0 109.486 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -94.4 117.51 30.23 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 120.217 -0.593 . . . . 21.34 110.423 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.72 15.25 17.58 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.358 -0.839 . . . . 0.0 110.534 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.25 -171.36 47.42 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.237 -1.545 . . . . 29.100000000000001 109.237 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.742 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . . . -101.53 -30.17 11.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.497 -1.002 . . . . 0.0 110.169 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.517 HG13 ' HD2' ' A' ' 44' ' ' PRO . 91.5 t -106.18 139.55 20.39 Favored Pre-proline 0 N--CA 1.498 1.951 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.082 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.517 ' HD2' HG13 ' A' ' 43' ' ' VAL . 40.4 Cg_endo -53.2 144.65 47.02 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 O-C-N 123.837 1.441 . . . . 21.949999999999999 111.796 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.489 ' HB1' ' HG2' ' A' ' 103' ' ' MET . . . -141.06 152.21 44.65 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.701 0.762 . . . . 20.91 111.296 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.435 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 22.3 ptt180 -127.42 155.74 43.18 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.898 HD22 HG13 ' A' ' 69' ' ' VAL . 6.5 tt -94.27 118.3 31.39 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.339 -0.851 . . . . 0.0 109.767 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.449 HG23 HG22 ' A' ' 104' ' ' VAL . 58.3 t -100.31 -28.53 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.563 -0.71 . . . . 0.0 110.851 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.692 ' HB3' ' HB2' ' A' ' 102' ' ' ASP . . . -142.13 165.26 27.94 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.098 -1.041 . . . . 0.0 112.24 -179.074 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -141.62 139.88 33.17 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.463 0.649 . . . . 29.050000000000001 110.251 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -142.62 114.52 8.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.782 -0.574 . . . . 27.969999999999999 109.605 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -99.71 132.17 45.22 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.643 -0.66 . . . . 25.25 111.398 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -115.12 78.25 1.15 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.813 HG22 ' HG3' ' A' ' 97' ' ' MET . 15.2 pt -87.02 128.81 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-O 121.609 0.718 . . . . 36.109999999999999 111.8 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.644 HG23 ' HB ' ' A' ' 61' ' ' THR . 3.6 m -118.6 130.14 55.72 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.874 -1.158 . . . . 33.979999999999997 107.874 177.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.613 ' OD2' HG21 ' A' ' 92' ' ' THR . 43.7 t0 -89.23 169.82 11.12 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.86 0.838 . . . . 45.039999999999999 111.636 -178.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.11 -7.63 13.97 Favored Glycine 0 N--CA 1.495 2.63 0 O-C-N 121.837 -0.54 . . . . 39.469999999999999 112.043 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -101.41 6.98 42.78 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 119.334 1.567 . . . . 0.0 110.561 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.99 -30.25 7.77 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -63.27 142.36 58.42 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.224 -1.163 . . . . 62.780000000000001 109.928 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.644 ' HB ' HG23 ' A' ' 55' ' ' THR . 7.9 t -133.98 151.92 51.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.509 -0.744 . . . . 0.0 110.456 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -121.89 123.61 42.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.565 -0.709 . . . . 0.0 110.409 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -104.47 135.71 45.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.724 -0.61 . . . . 0.0 110.684 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.9 t -129.47 132.43 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.437 -0.789 . . . . 37.939999999999998 110.118 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.76 126.17 45.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.83 -0.544 . . . . 0.0 110.172 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.65 148.26 19.54 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.454 -1.459 . . . . 31.82 109.454 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -78.73 154.83 29.72 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.434 -1.039 . . . . 0.0 110.463 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 54.97 -178.86 0.27 Allowed Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.855 -0.898 . . . . 22.620000000000001 110.855 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.898 HG13 HD22 ' A' ' 47' ' ' LEU . 14.4 m -128.14 127.26 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.749 -0.854 . . . . 17.510000000000002 109.679 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 69' ' ' VAL . 10.9 m 41.4 36.79 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 CA-C-O 121.636 0.732 . . . . 20.550000000000001 111.744 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.06 15.27 72.77 Favored Glycine 0 N--CA 1.499 2.856 0 O-C-N 121.563 -0.71 . . . . 18.289999999999999 112.935 177.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.406 ' O ' HG22 ' A' ' 69' ' ' VAL . 10.1 pt-20 -145.5 150.01 35.68 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 119.131 1.465 . . . . 0.0 112.157 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -116.15 74.52 5.58 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.625 -0.88 . . . . 18.210000000000001 108.625 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -57.49 140.81 94.39 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.904 1.476 . . . . 17.609999999999999 112.229 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.435 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 1.6 t90 -101.81 76.91 1.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.577 ' CD1' HG22 ' A' ' 37' ' ' ILE . 11.1 mt -60.19 117.89 5.7 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.663 -0.648 . . . . 20.57 111.969 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -86.29 157.62 56.04 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -53.41 128.31 28.79 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 O-C-N 123.5 1.263 . . . . 27.039999999999999 111.126 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.97 -16.97 55.68 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.751 -0.94 . . . . 24.739999999999998 110.751 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -87.13 165.18 15.94 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.074 -1.251 . . . . 29.379999999999999 110.555 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.81 150.52 36.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.58 -0.7 . . . . 0.0 110.154 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.423 ' HD2' HD12 ' A' ' 37' ' ' ILE . 50.6 t80 -118.03 147.59 43.07 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.417 -0.802 . . . . 18.559999999999999 109.11 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -142.73 137.45 29.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.238 -0.914 . . . . 0.0 110.878 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.495 ' CE2' HG21 ' A' ' 35' ' ' ILE . 51.6 p90 -150.95 160.21 44.06 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.613 -0.679 . . . . 26.649999999999999 109.709 178.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.9 m -105.16 139.23 40.13 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.43 -0.794 . . . . 28.140000000000001 111.035 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 16.9 t -124.46 166.68 15.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.62 -0.675 . . . . 33.880000000000003 109.834 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.03 120.15 1.58 Allowed Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.923 -1.132 . . . . 31.800000000000001 110.38 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.458 HG23 ' HE1' ' A' ' 33' ' ' TYR . 80.8 t -130.77 152.2 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.628 -0.925 . . . . 0.0 109.862 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 89' ' ' LEU . 5.0 mp -108.41 142.63 38.47 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.556 -0.715 . . . . 0.0 110.177 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.612 HD12 ' CD1' ' A' ' 31' ' ' PHE . 67.0 mt -124.63 145.14 49.8 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.489 -0.757 . . . . 38.68 110.565 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -90.74 -21.63 21.48 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.138 -0.976 . . . . 0.0 110.124 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.613 HG21 ' OD2' ' A' ' 56' ' ' ASP . 3.3 p -102.71 137.0 41.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.525 -0.735 . . . . 31.629999999999999 110.447 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.447 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 66.6 mt-10 -77.66 -1.77 32.69 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.29 -0.881 . . . . 0.0 110.753 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 27.9 pt20 -138.53 141.05 39.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.048 -1.033 . . . . 0.0 108.911 179.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.54 168.66 38.78 Favored Glycine 0 N--CA 1.498 2.83 0 C-N-CA 118.577 -1.773 . . . . 28.050000000000001 112.308 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -118.83 130.2 55.63 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.056 -0.673 . . . . 0.0 109.665 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.813 ' HG3' HG22 ' A' ' 54' ' ' ILE . 35.9 ttm -124.9 117.15 23.44 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.236 -0.915 . . . . 0.0 111.01 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.433 ' HB2' ' HB2' ' A' ' 117' ' ' ALA . 60.7 tt0 -127.82 151.31 49.19 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.88 176.67 37.47 Favored Glycine 0 N--CA 1.499 2.873 0 C-N-CA 119.087 -1.53 . . . . 29.620000000000001 110.895 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.42 ' CD2' ' HB3' ' A' ' 114' ' ' PRO . 66.3 m80 -136.41 156.41 48.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.704 -0.88 . . . . 0.0 110.193 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.578 ' CD2' HD11 ' A' ' 115' ' ' ILE . 5.9 m-85 -117.03 128.12 54.85 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.57 -0.706 . . . . 27.050000000000001 109.972 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.692 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 78.6 m-20 -83.71 120.31 25.85 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.083 -1.011 . . . . 0.0 108.835 177.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.489 ' HG2' ' HB1' ' A' ' 45' ' ' ALA . 7.8 ttm -122.88 161.46 24.06 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.028 0.442 . . . . 0.0 110.222 -179.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.449 HG22 HG23 ' A' ' 48' ' ' VAL . 7.1 m -142.74 130.53 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.554 -0.716 . . . . 23.280000000000001 110.546 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.512 ' HB3' ' OD1' ' A' ' 107' ' ' ASP . . . -73.45 168.14 19.84 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.468 -0.77 . . . . 0.0 109.649 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -67.77 -28.81 67.93 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.516 -0.74 . . . . 0.0 110.374 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.512 ' OD1' ' HB3' ' A' ' 105' ' ' ALA . 46.9 p-10 -76.07 -3.69 37.29 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.338 -0.851 . . . . 0.0 111.422 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.89 -10.51 60.48 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.022 -1.085 . . . . 30.43 110.892 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.527 HG21 ' CZ ' ' A' ' 7' ' ' TYR . 76.5 m -57.9 134.66 56.53 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.998 -1.295 . . . . 0.0 110.053 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -101.16 140.09 35.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.355 -0.841 . . . . 0.0 110.809 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.431 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 37.2 p90 -164.56 143.87 7.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.709 -0.62 . . . . 28.030000000000001 109.708 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 85.5 mt -101.36 157.49 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.714 -0.617 . . . . 0.0 110.556 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.5 96.07 49.58 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.42 ' HB3' ' CD2' ' A' ' 100' ' ' HIS . 46.6 Cg_endo -58.98 142.93 99.85 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 O-C-N 123.966 1.509 . . . . 33.310000000000002 112.147 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.578 HD11 ' CD2' ' A' ' 101' ' ' TYR . 51.7 mt -107.94 122.31 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.465 -0.939 . . . . 30.59 108.465 178.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.01 153.76 0.85 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.894 -0.504 . . . . 30.780000000000001 111.389 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' A' ' 98' ' ' GLN . . . -99.76 117.58 34.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.727 -0.608 . . . . 0.0 110.278 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.684 ' CE1' HD11 ' A' ' 120' ' ' LEU . 41.4 p90 -106.18 169.13 8.68 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.822 -0.807 . . . . 30.66 108.822 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.617 ' C ' HD12 ' A' ' 120' ' ' LEU . 57.5 t -111.95 154.37 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.254 -0.904 . . . . 0.0 110.231 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.684 HD11 ' CE1' ' A' ' 118' ' ' PHE . 7.4 mp -112.21 132.48 54.89 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.259 -0.645 . . . . 39.149999999999999 109.259 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.687 -0.633 . . . . 0.0 110.089 -179.735 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 120.594 0.235 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.567 ' CE2' HG21 ' A' ' 109' ' ' THR . 37.8 m-85 -118.65 112.07 19.35 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.406 -0.808 . . . . 31.93 110.338 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.479 ' C ' HG23 ' A' ' 9' ' ' VAL . 45.2 mtm-85 -153.48 134.23 13.78 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.509 0.671 . . . . 0.0 110.28 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.786 HG11 ' CE ' ' A' ' 103' ' ' MET . 97.0 t -151.74 115.8 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 121.466 0.65 . . . . 0.0 109.57 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -106.19 128.86 54.23 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.542 0.687 . . . . 0.0 109.78 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.3 t -118.02 138.84 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.815 -0.553 . . . . 28.210000000000001 109.702 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -122.41 136.32 54.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.444 -0.785 . . . . 0.0 109.944 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.806 HG22 HD13 ' A' ' 35' ' ' ILE . 62.7 t -128.29 136.1 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.605 -0.684 . . . . 27.949999999999999 110.33 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 65.3 p -126.37 105.66 24.47 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.689 -0.632 . . . . 0.0 110.526 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.423 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 49.8 Cg_endo -83.46 165.25 14.34 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 O-C-N 123.831 1.438 . . . . 33.0 110.991 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -157.78 131.67 8.03 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.51 0.671 . . . . 54.100000000000001 109.793 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.512 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 76.3 t80 -62.28 138.68 58.47 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.767 -0.583 . . . . 0.0 111.55 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.944 HD11 ' HB2' ' A' ' 32' ' ' ALA . 85.7 mt -115.4 79.62 1.31 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.903 0.859 . . . . 0.0 110.309 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.512 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -67.03 -35.32 79.63 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.222 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -69.54 -25.17 63.89 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.288 -0.882 . . . . 0.0 111.003 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -119.07 31.18 6.76 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.363 -0.835 . . . . 52.369999999999997 110.927 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.547 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 22.1 p -152.05 146.51 25.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.368 -0.832 . . . . 55.189999999999998 110.996 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.601 HG23 ' HB2' ' A' ' 28' ' ' ARG . 8.8 t -122.5 93.2 48.65 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.465 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.2 Cg_endo -66.2 -22.51 53.75 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 O-C-N 123.715 1.376 . . . . 51.57 111.804 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -64.87 -24.31 67.5 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.333 -0.855 . . . . 0.0 110.951 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -105.75 23.72 13.44 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.336 -0.853 . . . . 0.0 110.76 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.21 29.44 72.06 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.601 ' HB2' HG23 ' A' ' 23' ' ' THR . 84.2 mtt-85 -121.02 93.7 4.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.643 -0.916 . . . . 0.0 110.18 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.465 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 67.4 m-85 -104.84 131.28 52.51 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.924 -0.769 . . . . 46.07 108.924 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.547 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -118.43 120.9 38.94 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.528 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.657 ' CD1' HD12 ' A' ' 90' ' ' LEU . 75.4 m-85 -116.74 134.63 54.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.651 -0.656 . . . . 38.880000000000003 109.711 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.944 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -111.41 132.54 54.37 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.623 -0.881 . . . . 34.060000000000002 108.623 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.594 ' HE1' HG23 ' A' ' 88' ' ' VAL . 24.8 p90 -127.59 144.04 51.11 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.216 -0.994 . . . . 29.030000000000001 111.447 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.5 m -103.93 139.7 38.73 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.703 -0.623 . . . . 0.0 109.549 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.806 HD13 HG22 ' A' ' 13' ' ' VAL . 41.8 mm -105.69 132.42 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.784 0.802 . . . . 0.0 111.755 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -122.9 97.89 5.65 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.452 0.644 . . . . 40.240000000000002 109.644 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.761 HG22 HD22 ' A' ' 76' ' ' LEU . 78.3 mt -91.98 117.22 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.735 -0.603 . . . . 20.73 110.55 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -117.71 134.96 54.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.44 -0.787 . . . . 0.0 109.47 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.614 ' HB2' HD23 ' A' ' 76' ' ' LEU . 51.7 t-20 -93.35 117.68 30.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.736 -0.602 . . . . 21.34 110.652 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.52 11.58 15.96 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.517 -0.739 . . . . 0.0 110.489 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.34 176.02 51.32 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.429 -1.469 . . . . 29.100000000000001 109.429 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.52 -39.36 16.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.482 -1.01 . . . . 0.0 110.214 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.506 HG13 ' HD2' ' A' ' 44' ' ' PRO . 87.9 t -99.32 140.41 21.64 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.923 -0.486 . . . . 0.0 109.805 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.506 ' HD2' HG13 ' A' ' 43' ' ' VAL . 40.6 Cg_endo -53.74 144.63 53.22 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 O-C-N 123.786 1.414 . . . . 21.949999999999999 111.722 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.55 151.9 46.46 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.548 0.69 . . . . 20.91 110.953 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.429 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 21.6 ptt-85 -128.11 158.11 38.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.78 -0.575 . . . . 0.0 109.855 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.681 HD22 HG13 ' A' ' 69' ' ' VAL . 6.4 tt -99.0 116.86 32.19 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.472 -0.767 . . . . 0.0 109.123 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.411 HG23 HG22 ' A' ' 104' ' ' VAL . 58.7 t -99.13 -29.63 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.495 -0.753 . . . . 0.0 111.461 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.653 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -139.87 163.72 31.9 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.048 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -142.79 141.45 31.68 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.588 0.708 . . . . 29.050000000000001 110.637 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -144.55 112.36 6.25 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.365 0.603 . . . . 27.969999999999999 109.403 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -99.44 136.16 39.79 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.559 0.695 . . . . 25.25 111.248 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -114.83 80.87 1.47 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.848 HG22 ' HG3' ' A' ' 97' ' ' MET . 12.3 pt -83.15 127.71 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-O 121.784 0.802 . . . . 36.109999999999999 111.59 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.634 HG23 HG22 ' A' ' 61' ' ' THR . 95.8 m -120.78 129.25 53.51 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.21 -1.033 . . . . 33.979999999999997 108.21 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -91.64 171.21 9.32 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.706 0.765 . . . . 45.039999999999999 111.217 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.92 -6.37 9.38 Favored Glycine 0 N--CA 1.493 2.482 0 O-C-N 121.688 -0.632 . . . . 39.469999999999999 112.214 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.6 p30 -101.87 5.88 41.2 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 119.46 1.63 . . . . 0.0 110.94 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 61' ' ' THR . . . 92.36 -32.0 5.73 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.204 -0.935 . . . . 0.0 111.23 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.05 142.71 53.57 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.128 -1.219 . . . . 62.780000000000001 109.845 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.634 HG22 HG23 ' A' ' 55' ' ' THR . 60.9 p -132.5 151.16 52.0 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.816 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -123.31 125.12 44.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.579 -0.701 . . . . 0.0 109.865 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -101.68 135.01 43.93 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.554 -0.716 . . . . 0.0 110.763 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.0 t -129.18 133.49 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.582 -0.699 . . . . 37.939999999999998 110.021 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -125.2 127.1 46.26 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.923 -0.486 . . . . 0.0 110.533 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.55 -174.16 14.25 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 108.757 -1.737 . . . . 31.82 108.757 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -66.42 -158.28 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.278 -1.131 . . . . 0.0 109.816 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.403 ' HA2' ' CD2' ' A' ' 47' ' ' LEU . . . -51.76 -88.6 0.01 OUTLIER Glycine 0 N--CA 1.498 2.824 0 N-CA-C 110.504 -1.039 . . . . 22.620000000000001 110.504 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.681 HG13 HD22 ' A' ' 47' ' ' LEU . 25.0 m -140.17 128.15 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.382 -1.069 . . . . 17.510000000000002 110.159 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 69' ' ' VAL . 12.4 m 40.86 35.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 CA-C-O 121.313 0.577 . . . . 20.550000000000001 112.248 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.58 21.53 57.93 Favored Glycine 0 N--CA 1.499 2.851 0 O-C-N 121.433 -0.792 . . . . 18.289999999999999 112.794 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.664 ' HG3' HG23 ' A' ' 69' ' ' VAL . 1.7 pt-20 -139.38 151.73 46.55 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 119.101 1.45 . . . . 0.0 111.197 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -113.51 74.65 2.28 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 109.278 -0.638 . . . . 18.210000000000001 109.278 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -57.58 141.98 95.44 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 O-C-N 123.838 1.441 . . . . 17.609999999999999 111.668 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.429 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 1.4 t90 -103.09 77.33 1.54 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.761 HD22 HG22 ' A' ' 37' ' ' ILE . 5.6 tp -62.24 118.18 7.06 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.612 -0.68 . . . . 20.57 111.285 -178.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -86.8 158.73 53.26 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -53.67 127.24 24.65 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 O-C-N 123.564 1.297 . . . . 27.039999999999999 110.972 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.64 -18.3 43.83 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.843 -0.903 . . . . 24.739999999999998 110.843 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -88.85 165.64 14.52 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.109 -1.23 . . . . 29.379999999999999 110.239 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.597 ' C ' HD11 ' A' ' 76' ' ' LEU . . . -146.21 151.08 37.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.498 -0.751 . . . . 0.0 110.43 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.491 ' N ' HD11 ' A' ' 76' ' ' LEU . 64.8 t80 -118.12 144.96 45.23 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.906 -0.775 . . . . 18.559999999999999 108.906 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.6 p80 -142.65 140.39 31.58 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.117 -0.989 . . . . 0.0 111.258 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.577 ' CE1' HG21 ' A' ' 35' ' ' ILE . 52.8 p90 -150.93 159.93 44.24 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.57 -0.706 . . . . 26.649999999999999 109.732 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.6 m -102.58 136.73 41.87 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.422 -0.799 . . . . 28.140000000000001 110.923 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 16.2 t -124.9 168.99 12.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.62 -0.675 . . . . 33.880000000000003 110.146 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.2 124.6 2.57 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.885 -1.15 . . . . 31.800000000000001 110.364 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.594 HG23 ' HE1' ' A' ' 33' ' ' TYR . 79.9 t -129.83 150.64 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.671 -0.899 . . . . 0.0 109.352 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.532 HD23 ' N ' ' A' ' 90' ' ' LEU . 9.4 tt -111.08 143.58 41.56 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.529 -0.732 . . . . 0.0 110.577 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.657 HD12 ' CD1' ' A' ' 31' ' ' PHE . 84.0 mt -121.9 145.27 48.26 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.576 -0.703 . . . . 38.68 109.978 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.658 ' HG3' HG23 ' A' ' 92' ' ' THR . 7.8 pt-20 -72.88 -24.22 60.82 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.373 -0.829 . . . . 0.0 111.157 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.658 HG23 ' HG3' ' A' ' 91' ' ' GLU . 57.3 p -124.3 171.27 10.02 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.342 -0.849 . . . . 31.629999999999999 110.755 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 32.1 tt0 -85.73 6.69 26.66 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.668 -0.645 . . . . 0.0 111.692 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -140.08 149.09 42.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.992 -1.068 . . . . 0.0 109.815 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.62 160.75 23.81 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 118.808 -1.663 . . . . 28.050000000000001 112.178 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -121.97 131.66 54.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 122.185 -0.597 . . . . 0.0 109.401 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.848 ' HG3' HG22 ' A' ' 54' ' ' ILE . 54.6 ttm -127.21 123.68 37.16 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.304 -0.872 . . . . 0.0 111.36 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.505 ' HG2' ' HB2' ' A' ' 117' ' ' ALA . 1.8 mp0 -123.8 148.21 46.89 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.76 176.21 39.86 Favored Glycine 0 N--CA 1.501 2.991 0 C-N-CA 118.565 -1.779 . . . . 29.620000000000001 111.132 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -140.87 157.6 45.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.804 -0.821 . . . . 0.0 110.663 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.615 ' CE2' HD11 ' A' ' 115' ' ' ILE . 7.2 m-85 -117.07 128.82 55.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.677 -0.639 . . . . 27.050000000000001 110.007 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.653 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 26.1 t0 -81.75 123.59 28.89 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.967 -1.083 . . . . 0.0 109.11 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.786 ' CE ' HG11 ' A' ' 9' ' ' VAL . 47.4 mtt -122.58 162.6 21.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.887 -0.508 . . . . 0.0 110.491 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.411 HG22 HG23 ' A' ' 48' ' ' VAL . 11.3 m -141.85 128.72 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.516 -0.74 . . . . 23.280000000000001 110.251 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.96 167.55 21.27 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.489 -0.757 . . . . 0.0 109.684 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -64.33 -30.78 71.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.497 -0.752 . . . . 0.0 110.059 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -72.38 -11.7 60.8 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.519 -0.738 . . . . 0.0 110.959 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.23 -7.41 47.6 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.398 -1.081 . . . . 30.43 110.398 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.567 HG21 ' CE2' ' A' ' 7' ' ' TYR . 69.3 m -57.2 135.02 56.4 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.048 -1.266 . . . . 0.0 110.036 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -101.19 139.94 36.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.384 -0.823 . . . . 0.0 110.827 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.458 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 49.8 p90 -167.38 146.92 5.16 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.704 -0.622 . . . . 28.030000000000001 110.077 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.3 pt -103.18 159.12 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.675 -0.641 . . . . 0.0 110.954 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.41 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -119.3 96.61 50.04 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -59.23 143.79 99.62 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 O-C-N 123.907 1.477 . . . . 33.310000000000002 112.269 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.615 HD11 ' CE2' ' A' ' 101' ' ' TYR . 71.4 mt -107.77 122.15 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.68 -0.859 . . . . 30.59 108.68 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.82 155.69 0.83 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.264 0.554 . . . . 30.780000000000001 111.577 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.505 ' HB2' ' HG2' ' A' ' 98' ' ' GLN . . . -91.05 119.99 31.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.724 -0.61 . . . . 0.0 110.675 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.678 ' CE1' HD11 ' A' ' 120' ' ' LEU . 51.5 p90 -111.02 162.66 14.64 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.487 -0.931 . . . . 30.66 108.487 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.625 ' C ' HD12 ' A' ' 120' ' ' LEU . 9.3 p -115.98 154.67 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.204 -0.935 . . . . 0.0 110.882 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.678 HD11 ' CE1' ' A' ' 118' ' ' PHE . 7.3 mp -114.07 132.12 56.14 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.32 -0.622 . . . . 39.149999999999999 109.32 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.654 -0.654 . . . . 0.0 110.137 -179.814 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 120.823 0.344 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.456 ' CE1' ' CB ' ' A' ' 105' ' ' ALA . 21.4 m-85 -123.55 101.44 7.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.355 -0.841 . . . . 31.93 110.207 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.458 ' C ' HG23 ' A' ' 9' ' ' VAL . 27.6 mmt180 -144.1 139.19 28.75 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.665 0.745 . . . . 0.0 109.99 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.458 HG23 ' C ' ' A' ' 8' ' ' ARG . 70.7 t -150.94 114.98 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -105.97 129.55 54.08 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.538 0.685 . . . . 0.0 109.836 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.512 HG22 ' HA ' ' A' ' 37' ' ' ILE . 57.6 t -118.23 139.79 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.869 -0.519 . . . . 28.210000000000001 109.754 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -120.67 136.65 54.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.438 -0.789 . . . . 0.0 109.817 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.649 HG22 HD13 ' A' ' 35' ' ' ILE . 60.9 t -128.87 137.77 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.586 -0.697 . . . . 27.949999999999999 110.219 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.7 m -125.07 105.07 29.12 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.717 -0.614 . . . . 0.0 110.638 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -84.3 165.56 12.69 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 O-C-N 123.85 1.447 . . . . 33.0 110.797 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -157.46 132.06 8.56 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.541 0.686 . . . . 54.100000000000001 110.064 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.482 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 80.5 t80 -59.73 139.98 56.84 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.852 -0.53 . . . . 0.0 111.315 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.915 HD11 ' HB2' ' A' ' 32' ' ' ALA . 91.2 mt -115.98 80.16 1.41 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.904 0.859 . . . . 0.0 110.397 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.482 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -66.02 -35.84 81.65 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.912 -0.492 . . . . 0.0 111.063 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -69.77 -23.71 63.4 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.415 -0.803 . . . . 0.0 110.947 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -121.05 34.65 5.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.36 -0.837 . . . . 52.369999999999997 111.08 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.654 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 24.4 p -156.47 147.91 22.5 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.312 -0.868 . . . . 55.189999999999998 111.109 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.579 ' O ' HG23 ' A' ' 23' ' ' THR . 4.9 t -118.9 92.17 44.36 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.475 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 51.3 Cg_endo -65.74 -23.51 55.86 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 O-C-N 123.853 1.449 . . . . 51.57 111.627 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.83 -22.41 66.55 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.398 -0.813 . . . . 0.0 110.833 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -106.13 23.56 13.85 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.25 -0.906 . . . . 0.0 110.684 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.37 28.0 73.6 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.549 ' HB2' HG23 ' A' ' 23' ' ' THR . 3.2 mtm-85 -121.46 94.13 4.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.591 -0.947 . . . . 0.0 110.175 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.475 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 63.8 m-85 -104.15 135.4 45.71 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.54 -0.725 . . . . 46.07 109.22 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.654 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -114.59 120.54 40.53 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.524 -0.735 . . . . 0.0 111.174 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.459 ' CD1' HD12 ' A' ' 90' ' ' LEU . 89.0 m-85 -116.14 131.56 56.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.555 -0.715 . . . . 38.880000000000003 109.795 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.915 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -114.01 131.96 56.16 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.287 -0.883 . . . . 34.060000000000002 108.658 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.475 ' CE1' HD11 ' A' ' 35' ' ' ILE . 54.6 p90 -128.22 145.98 50.87 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 119.17 -1.012 . . . . 29.030000000000001 111.544 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.6 t -101.97 140.88 35.66 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.649 HD13 HG22 ' A' ' 13' ' ' VAL . 48.1 mm -105.47 132.29 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.819 0.819 . . . . 0.0 111.772 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -123.49 98.97 6.09 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.399 0.619 . . . . 40.240000000000002 109.826 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.886 HG22 HD22 ' A' ' 76' ' ' LEU . 80.3 mt -91.23 117.27 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.711 -0.618 . . . . 20.73 110.735 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -117.99 134.06 55.32 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.578 -0.701 . . . . 0.0 109.421 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.466 ' HB2' HD23 ' A' ' 76' ' ' LEU . 42.9 t-20 -94.5 117.36 30.0 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 120.178 -0.609 . . . . 21.34 110.781 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.25 13.37 17.89 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.415 -0.803 . . . . 0.0 110.442 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.89 -176.26 51.17 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.515 -1.434 . . . . 29.100000000000001 109.515 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.28 -33.74 10.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.561 -0.964 . . . . 0.0 109.846 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.511 HG13 ' HD2' ' A' ' 44' ' ' PRO . 87.6 t -104.56 141.51 22.68 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.511 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.6 Cg_endo -53.13 144.5 46.9 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 O-C-N 123.693 1.365 . . . . 21.949999999999999 111.619 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -136.79 151.37 49.09 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.732 0.777 . . . . 20.91 111.232 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.426 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 47.2 ttp180 -126.6 152.08 47.11 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.775 HD22 HG13 ' A' ' 69' ' ' VAL . 7.1 tt -98.02 117.85 33.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 109.441 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.6 p -100.69 -25.21 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.55 -0.719 . . . . 0.0 110.947 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.665 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -142.12 164.27 30.62 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.039 -1.064 . . . . 0.0 112.034 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -141.69 139.08 32.87 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.334 0.588 . . . . 29.050000000000001 109.993 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -142.46 113.84 7.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.703 -0.623 . . . . 27.969999999999999 110.016 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.543 ' CH2' HD13 ' A' ' 115' ' ' ILE . 87.8 m95 -101.47 132.66 46.97 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.745 -0.597 . . . . 25.25 110.753 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -116.88 77.42 1.11 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.642 -0.661 . . . . 0.0 109.572 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.459 HD11 ' HB2' ' A' ' 62' ' ' GLU . 28.5 pt -83.59 130.07 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.789 0.804 . . . . 36.109999999999999 112.211 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.906 HG23 HG22 ' A' ' 61' ' ' THR . 25.6 m -119.28 129.59 54.98 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.266 -1.013 . . . . 33.979999999999997 108.266 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -91.63 170.32 10.02 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.734 0.778 . . . . 45.039999999999999 111.364 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.28 -7.21 12.82 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 121.791 -0.568 . . . . 39.469999999999999 112.149 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -102.23 5.69 40.23 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 119.431 1.616 . . . . 0.0 110.733 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 61' ' ' THR . . . 93.3 -29.49 8.2 Favored Glycine 0 N--CA 1.495 2.585 0 O-C-N 121.213 -0.929 . . . . 0.0 110.898 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -61.86 142.28 57.46 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.323 -1.104 . . . . 62.780000000000001 109.747 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.906 HG22 HG23 ' A' ' 55' ' ' THR . 69.9 p -134.29 151.69 51.4 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.476 -0.765 . . . . 0.0 110.434 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.459 ' HB2' HD11 ' A' ' 54' ' ' ILE . 96.6 mt-10 -121.65 122.12 38.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.509 -0.745 . . . . 0.0 110.074 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -104.19 135.15 46.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.567 -0.708 . . . . 0.0 110.634 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.4 t -128.07 131.75 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.545 -0.722 . . . . 37.939999999999998 109.888 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -125.12 127.55 47.05 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.747 -0.596 . . . . 0.0 110.554 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.88 164.82 30.92 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.215 -1.554 . . . . 31.82 109.215 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -106.08 158.31 16.9 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.351 -1.088 . . . . 0.0 110.086 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.96 96.43 0.01 OUTLIER Glycine 0 N--CA 1.5 2.929 0 O-C-N 121.454 -0.778 . . . . 22.620000000000001 111.628 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.775 HG13 HD22 ' A' ' 47' ' ' LEU . 25.1 m -45.39 132.89 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.519 0 O-C-N 121.403 -1.057 . . . . 17.510000000000002 111.534 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.0 m 41.63 36.01 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 CA-C-O 121.631 0.729 . . . . 20.550000000000001 111.413 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.0 21.46 59.16 Favored Glycine 0 N--CA 1.496 2.688 0 O-C-N 121.762 -0.586 . . . . 18.289999999999999 112.436 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.421 ' HG3' HG23 ' A' ' 69' ' ' VAL . 4.9 pt-20 -147.6 154.32 40.51 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-N 119.128 1.464 . . . . 0.0 112.457 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -117.55 72.97 7.88 Favored Pre-proline 0 N--CA 1.491 1.6 0 N-CA-C 108.558 -0.904 . . . . 18.210000000000001 108.558 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -53.99 139.78 70.1 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 O-C-N 123.735 1.387 . . . . 17.609999999999999 112.286 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.426 ' CD1' ' HB2' ' A' ' 46' ' ' ARG . 3.4 t90 -101.45 76.03 1.65 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.886 HD22 HG22 ' A' ' 37' ' ' ILE . 2.5 tp -62.33 117.22 5.82 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.585 -0.697 . . . . 20.57 111.339 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 -85.59 158.71 56.72 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -53.96 126.02 20.64 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 O-C-N 123.537 1.283 . . . . 27.039999999999999 110.905 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.94 -18.37 44.69 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.732 -0.947 . . . . 24.739999999999998 110.732 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -88.96 164.9 14.91 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.133 -1.216 . . . . 29.379999999999999 110.263 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.451 ' C ' HD11 ' A' ' 76' ' ' LEU . . . -146.98 150.4 35.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.541 -0.724 . . . . 0.0 110.331 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.608 ' N ' HD11 ' A' ' 76' ' ' LEU . 64.7 t80 -117.86 145.58 44.5 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.864 -0.791 . . . . 18.559999999999999 108.864 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -143.57 140.48 30.23 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.119 -0.988 . . . . 0.0 111.37 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.512 ' CE1' HG21 ' A' ' 35' ' ' ILE . 51.1 p90 -150.14 160.02 43.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.647 -0.658 . . . . 26.649999999999999 109.34 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.5 m -102.62 139.08 38.67 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.29 -0.881 . . . . 28.140000000000001 110.928 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.437 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 16.8 t -124.06 166.07 16.41 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.647 -0.658 . . . . 33.880000000000003 109.97 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -144.53 120.3 1.4 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.076 -1.21 . . . . 31.800000000000001 110.076 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.51 152.93 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.686 -0.89 . . . . 0.0 109.927 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.98 142.85 39.03 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.521 -0.737 . . . . 0.0 110.508 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.459 HD12 ' CD1' ' A' ' 31' ' ' PHE . 24.1 mt -124.02 143.08 50.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.542 -0.724 . . . . 38.68 110.291 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -82.23 -22.77 35.71 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.217 -0.927 . . . . 0.0 110.087 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.429 HG22 ' H ' ' A' ' 94' ' ' GLN . 7.2 m -99.55 134.25 42.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.671 -0.643 . . . . 31.629999999999999 109.991 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.413 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 58.2 tt0 -75.39 -7.9 55.26 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.171 -0.956 . . . . 0.0 110.833 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.429 ' H ' HG22 ' A' ' 92' ' ' THR . 14.5 pt20 -138.3 147.28 43.41 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.21 -0.931 . . . . 0.0 108.952 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.7 169.64 38.97 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 118.265 -1.922 . . . . 28.050000000000001 112.706 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -115.82 130.23 56.75 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 98.3 mtp -126.73 121.27 31.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.349 -0.844 . . . . 0.0 111.316 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.612 ' HG2' ' HB2' ' A' ' 117' ' ' ALA . 55.8 mt-30 -124.39 152.12 43.6 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.27 175.92 36.99 Favored Glycine 0 N--CA 1.499 2.86 0 C-N-CA 118.792 -1.671 . . . . 29.620000000000001 111.05 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -137.61 157.85 45.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.8 -0.824 . . . . 0.0 109.678 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.593 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 10.1 m-85 -116.64 127.31 54.32 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.577 -0.702 . . . . 27.050000000000001 110.009 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.665 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 42.8 t0 -85.63 119.13 25.62 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.992 -1.068 . . . . 0.0 108.723 177.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.425 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 2.5 tpt -122.49 160.7 25.03 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.141 0.496 . . . . 0.0 110.348 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.0 m -139.08 129.5 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.639 -0.663 . . . . 23.280000000000001 110.105 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.456 ' CB ' ' CE1' ' A' ' 7' ' ' TYR . . . -70.01 164.81 23.14 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.571 -0.706 . . . . 0.0 109.633 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -63.76 -28.17 69.69 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.537 -0.727 . . . . 0.0 110.131 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -79.0 -7.6 58.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.487 -0.758 . . . . 0.0 111.294 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.7 -7.63 45.94 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 120.104 -1.046 . . . . 30.43 110.515 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.4 m -57.82 134.98 56.76 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.046 -1.267 . . . . 0.0 109.98 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -101.84 139.38 37.55 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.346 -0.846 . . . . 0.0 110.891 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 43.0 p90 -165.1 143.61 6.42 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.732 -0.605 . . . . 28.030000000000001 109.685 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 85.0 mt -101.62 157.69 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.646 -0.659 . . . . 0.0 110.81 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.593 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -120.15 97.33 49.25 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -58.7 143.78 98.44 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 O-C-N 123.847 1.446 . . . . 33.310000000000002 112.292 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.543 HD13 ' CH2' ' A' ' 52' ' ' TRP . 52.7 mt -108.71 122.83 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.739 -0.837 . . . . 30.59 108.739 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.42 171.29 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.29 0.567 . . . . 30.780000000000001 111.465 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.612 ' HB2' ' HG2' ' A' ' 98' ' ' GLN . . . -101.72 122.01 43.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.657 -0.652 . . . . 0.0 110.825 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.474 ' CE1' HD11 ' A' ' 120' ' ' LEU . 49.1 p90 -110.94 156.45 21.19 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.162 -1.051 . . . . 30.66 108.162 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.613 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.8 t -115.87 154.95 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.174 -0.954 . . . . 0.0 110.587 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.65 ' N ' HD12 ' A' ' 120' ' ' LEU . 7.6 mp -112.49 132.23 55.18 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.099 -0.704 . . . . 39.149999999999999 109.099 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 34.7 t . . . . . 0 N--CA 1.493 1.716 0 O-C-N 121.779 -0.576 . . . . 0.0 110.041 -179.782 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.67 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 90.0 mtt180 . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 120.781 0.324 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -121.42 101.95 7.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.437 -0.79 . . . . 31.93 110.16 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.482 ' C ' HG23 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -148.79 131.53 15.98 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.554 -0.716 . . . . 0.0 110.065 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.482 HG23 ' C ' ' A' ' 8' ' ' ARG . 84.0 t -152.11 117.09 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.613 0.72 . . . . 0.0 109.808 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -105.27 129.66 53.58 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.537 0.684 . . . . 0.0 109.825 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.483 HG11 ' HE2' ' A' ' 101' ' ' TYR . 62.2 t -117.97 139.03 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.842 -0.536 . . . . 28.210000000000001 109.76 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -121.65 136.93 54.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.456 -0.777 . . . . 0.0 110.116 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.714 HG22 HD13 ' A' ' 35' ' ' ILE . 60.5 t -129.28 136.57 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.581 -0.699 . . . . 27.949999999999999 110.139 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.0 m -125.44 103.96 28.57 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.737 -0.602 . . . . 0.0 110.659 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.74 165.05 15.85 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 O-C-N 123.874 1.46 . . . . 33.0 110.835 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -157.85 132.92 8.69 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.661 0.743 . . . . 54.100000000000001 110.111 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.495 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 80.4 t80 -60.01 140.1 57.0 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.27 0.557 . . . . 0.0 111.629 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.873 HD11 ' HB2' ' A' ' 32' ' ' ALA . 85.4 mt -117.11 83.44 1.98 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.019 0.914 . . . . 0.0 110.247 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.495 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -68.97 -35.11 76.37 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.317 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -69.92 -22.69 63.18 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.427 -0.795 . . . . 0.0 111.099 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -121.87 34.31 5.22 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.232 -0.918 . . . . 52.369999999999997 110.897 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.585 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 24.8 p -154.46 148.8 26.09 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.308 -0.87 . . . . 55.189999999999998 110.979 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.619 HG23 ' HB2' ' A' ' 28' ' ' ARG . 8.2 t -121.97 93.84 48.43 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.4 Cg_endo -66.86 -23.2 47.94 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 O-C-N 123.786 1.414 . . . . 51.57 112.068 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -66.05 -22.36 66.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.253 -0.904 . . . . 0.0 111.032 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -106.47 23.22 14.55 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.207 -0.933 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.52 29.16 72.89 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.619 ' HB2' HG23 ' A' ' 23' ' ' THR . 93.6 mtt-85 -121.4 94.18 4.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.551 -0.97 . . . . 0.0 110.178 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.46 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 58.8 m-85 -105.6 133.8 49.75 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.503 -0.748 . . . . 46.07 109.143 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.585 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -115.77 120.64 39.97 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.354 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -116.68 131.04 57.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.553 -0.717 . . . . 38.880000000000003 109.642 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.873 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -114.77 131.77 56.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.255 -0.903 . . . . 34.060000000000002 109.048 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.489 ' CE1' HD11 ' A' ' 35' ' ' ILE . 53.1 p90 -128.08 148.13 50.55 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.338 -0.945 . . . . 29.030000000000001 111.308 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 m -101.27 140.21 35.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.667 -0.646 . . . . 0.0 109.411 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.714 HD13 HG22 ' A' ' 13' ' ' VAL . 46.0 mm -103.69 132.39 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-O 121.841 0.829 . . . . 0.0 111.677 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.0 mmm-85 -124.05 97.22 5.25 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.471 0.653 . . . . 40.240000000000002 109.797 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.499 HG22 ' CD1' ' A' ' 76' ' ' LEU . 80.1 mt -92.21 118.17 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.704 -0.623 . . . . 20.73 110.751 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -117.36 132.81 56.52 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.508 -0.745 . . . . 0.0 109.21 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -93.96 117.89 30.73 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.786 -0.571 . . . . 21.34 110.632 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.81 14.12 16.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.527 -0.733 . . . . 0.0 110.539 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.52 -171.89 46.09 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.215 -1.554 . . . . 29.100000000000001 109.215 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.67 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . . . -104.64 -29.99 10.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.463 -1.021 . . . . 0.0 110.343 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.539 HG13 ' HD2' ' A' ' 44' ' ' PRO . 88.0 t -108.82 141.36 23.16 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.836 -0.54 . . . . 0.0 110.016 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.539 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.1 Cg_endo -52.52 142.33 49.18 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 O-C-N 123.772 1.406 . . . . 21.949999999999999 111.749 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.461 ' HB1' ' SD ' ' A' ' 103' ' ' MET . . . -137.41 151.69 48.82 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.875 0.845 . . . . 20.91 111.418 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.427 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 54.5 ttp180 -125.89 153.45 44.18 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.93 HD22 HG13 ' A' ' 69' ' ' VAL . 7.0 tt -97.53 119.19 35.63 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.574 -0.704 . . . . 0.0 109.464 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.492 HG23 HG22 ' A' ' 104' ' ' VAL . 57.3 t -101.17 -27.15 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.539 -0.726 . . . . 0.0 110.983 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.725 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -142.13 165.06 28.47 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 119.1 -1.04 . . . . 0.0 112.162 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.7 ptt-85 -141.12 139.59 33.99 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.368 0.604 . . . . 29.050000000000001 110.214 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -142.79 112.84 7.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.775 -0.578 . . . . 27.969999999999999 109.873 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -102.19 134.27 45.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.642 -0.661 . . . . 25.25 111.168 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -116.09 79.15 1.27 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.75 -0.594 . . . . 0.0 109.405 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.433 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.0 pt -86.75 129.24 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 121.833 0.825 . . . . 36.109999999999999 111.826 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.722 HG23 HG22 ' A' ' 61' ' ' THR . 99.1 m -120.69 130.38 54.06 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.441 -0.948 . . . . 33.979999999999997 108.441 178.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -89.93 170.5 10.32 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.748 0.785 . . . . 45.039999999999999 111.251 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.83 -7.06 14.07 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 121.75 -0.594 . . . . 39.469999999999999 112.138 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -101.62 6.3 41.99 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 119.344 1.572 . . . . 0.0 110.667 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 61' ' ' THR . . . 92.61 -26.19 15.23 Favored Glycine 0 N--CA 1.494 2.566 0 O-C-N 121.208 -0.933 . . . . 0.0 110.966 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -62.16 141.28 58.25 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.184 -1.186 . . . . 62.780000000000001 109.6 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.722 HG22 HG23 ' A' ' 55' ' ' THR . 58.3 p -131.54 148.79 52.65 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.402 -0.812 . . . . 0.0 110.574 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -122.3 120.53 34.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.445 -0.785 . . . . 0.0 109.872 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -103.06 135.0 45.55 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.747 -0.596 . . . . 0.0 110.499 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.2 t -128.29 130.31 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.614 0.721 . . . . 37.939999999999998 110.031 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -126.17 126.53 44.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.895 -0.503 . . . . 0.0 109.946 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.78 151.03 23.18 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.555 -1.418 . . . . 31.82 109.555 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -77.38 155.22 32.03 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.431 -1.04 . . . . 0.0 110.241 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.62 -174.52 0.23 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 110.99 -0.844 . . . . 22.620000000000001 110.99 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.93 HG13 HD22 ' A' ' 47' ' ' LEU . 13.1 m -128.81 127.43 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.838 -0.801 . . . . 17.510000000000002 109.625 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 69' ' ' VAL . 13.2 m 41.32 36.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 CA-C-O 121.603 0.715 . . . . 20.550000000000001 111.831 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.37 16.03 70.03 Favored Glycine 0 N--CA 1.499 2.841 0 O-C-N 121.588 -0.695 . . . . 18.289999999999999 112.869 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.425 ' O ' HG22 ' A' ' 69' ' ' VAL . 10.1 pt-20 -146.43 151.67 37.81 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 119.158 1.479 . . . . 0.0 112.147 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -115.42 75.55 4.76 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 108.746 -0.835 . . . . 18.210000000000001 108.746 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -57.85 137.65 82.12 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 O-C-N 123.811 1.427 . . . . 17.609999999999999 112.194 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.434 ' CH2' ' CB ' ' A' ' 44' ' ' PRO . 7.4 t90 -101.34 75.98 1.67 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.499 ' CD1' HG22 ' A' ' 37' ' ' ILE . 10.1 mt -60.3 118.37 6.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.566 -0.709 . . . . 20.57 112.013 -178.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.6 mtp85 -86.59 158.87 53.69 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -54.62 129.14 33.38 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 O-C-N 123.466 1.246 . . . . 27.039999999999999 111.126 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.02 -18.3 48.62 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 111.012 -0.835 . . . . 24.739999999999998 111.012 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -88.28 166.01 14.62 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.041 -1.27 . . . . 29.379999999999999 110.69 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.1 148.68 33.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.594 -0.691 . . . . 0.0 110.024 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.435 ' HD1' HD12 ' A' ' 37' ' ' ILE . 64.6 t80 -117.57 144.67 44.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.466 -0.771 . . . . 18.559999999999999 109.13 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -143.62 140.42 30.13 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.234 -0.916 . . . . 0.0 111.279 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.646 ' CE1' HG21 ' A' ' 35' ' ' ILE . 49.5 p90 -150.89 159.96 44.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.591 -0.693 . . . . 26.649999999999999 109.62 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.5 m -101.67 137.5 39.9 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.389 -0.819 . . . . 28.140000000000001 111.005 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.447 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 15.0 t -124.49 167.63 14.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.641 -0.662 . . . . 33.880000000000003 109.918 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.89 124.41 2.45 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.811 -1.185 . . . . 31.800000000000001 110.466 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.71 153.5 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.653 -0.91 . . . . 0.0 109.896 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 89' ' ' LEU . 4.9 mp -108.84 144.86 36.15 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.559 -0.713 . . . . 0.0 111.071 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.692 ' CD1' HD22 ' A' ' 120' ' ' LEU . 0.4 OUTLIER -121.09 147.23 45.83 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.685 -0.634 . . . . 38.68 109.591 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.41 ' O ' ' CE1' ' A' ' 29' ' ' TYR . 74.7 tt0 -77.9 -26.6 49.2 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.248 -0.908 . . . . 0.0 111.25 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.8 p -124.99 172.78 9.14 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.268 -0.895 . . . . 31.629999999999999 110.936 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.457 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 50.4 mt-10 -86.62 11.55 12.6 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.653 -0.654 . . . . 0.0 111.469 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 97.4 mt-30 -139.99 144.38 36.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.037 -1.039 . . . . 0.0 109.69 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.98 157.03 17.9 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 118.795 -1.669 . . . . 28.050000000000001 112.237 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -121.36 131.37 54.15 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.425 ' HB3' ' HE2' ' A' ' 97' ' ' MET . 98.1 mtp -127.24 120.7 29.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.326 -0.859 . . . . 0.0 111.386 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 117' ' ' ALA . 56.0 tt0 -126.41 151.4 47.74 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.12 177.8 39.02 Favored Glycine 0 N--CA 1.499 2.871 0 C-N-CA 118.946 -1.597 . . . . 29.620000000000001 110.962 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.406 ' CD2' ' HB3' ' A' ' 114' ' ' PRO . 66.9 m80 -136.17 156.92 47.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.715 -0.874 . . . . 0.0 110.139 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.624 ' CD2' HD11 ' A' ' 115' ' ' ILE . 4.7 m-85 -115.37 127.93 55.73 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.759 -0.588 . . . . 27.050000000000001 109.932 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.725 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 11.1 t70 -83.71 121.92 27.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.965 -1.084 . . . . 0.0 108.532 177.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.462 ' SD ' HG21 ' A' ' 9' ' ' VAL . 54.6 ttm -123.92 161.59 25.07 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.297 0.57 . . . . 0.0 110.781 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.492 HG22 HG23 ' A' ' 48' ' ' VAL . 10.5 m -139.99 129.93 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.741 -0.599 . . . . 23.280000000000001 110.17 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 107' ' ' ASP . . . -75.3 166.29 23.84 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.509 -0.744 . . . . 0.0 109.811 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -65.33 -31.05 71.98 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.52 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.488 ' OD1' ' HB3' ' A' ' 105' ' ' ALA . 49.4 p-10 -74.57 -7.73 54.05 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.433 -0.792 . . . . 0.0 111.272 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.0 -9.33 54.92 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 120.091 -1.052 . . . . 30.43 110.636 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.4 m -57.55 134.79 56.43 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.021 -1.282 . . . . 0.0 109.935 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -101.92 140.83 35.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.432 -0.792 . . . . 0.0 110.931 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -168.61 146.12 3.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.666 -0.646 . . . . 28.030000000000001 109.851 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 84.9 mt -101.23 157.52 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.707 -0.621 . . . . 0.0 110.66 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.27 98.7 50.57 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.406 ' HB3' ' CD2' ' A' ' 100' ' ' HIS . 45.4 Cg_endo -58.08 142.84 97.16 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 O-C-N 123.932 1.491 . . . . 33.310000000000002 112.254 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.624 HD11 ' CD2' ' A' ' 101' ' ' TYR . 48.6 mt -109.31 124.28 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.741 -0.837 . . . . 30.59 108.741 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.66 149.99 3.02 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.861 -0.525 . . . . 30.780000000000001 111.271 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.438 ' HB2' ' HB2' ' A' ' 98' ' ' GLN . . . -92.86 124.26 36.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.66 -0.65 . . . . 0.0 110.047 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.653 ' HE1' HD11 ' A' ' 120' ' ' LEU . 44.7 p90 -108.8 164.67 12.18 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.046 -0.724 . . . . 30.66 109.046 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.588 ' C ' HD12 ' A' ' 120' ' ' LEU . 8.5 p -116.0 155.41 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.349 -0.845 . . . . 0.0 110.495 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.692 HD22 ' CD1' ' A' ' 90' ' ' LEU . 7.2 mp -112.13 133.07 54.49 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.281 -0.637 . . . . 39.149999999999999 109.281 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.627 -0.671 . . . . 0.0 110.094 -179.796 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 120.678 0.275 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -118.23 108.1 14.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.452 -0.78 . . . . 31.93 110.336 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.48 ' C ' HG23 ' A' ' 9' ' ' VAL . 23.5 mtm180 -151.01 132.12 14.37 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.61 -0.681 . . . . 0.0 110.092 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.599 HG11 ' SD ' ' A' ' 103' ' ' MET . 60.9 t -151.67 114.45 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.543 -0.723 . . . . 0.0 109.548 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -106.7 130.36 54.44 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.628 0.727 . . . . 0.0 110.246 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.6 t -117.73 139.23 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.585 -0.524 . . . . 28.210000000000001 109.585 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -121.24 138.44 54.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.367 -0.833 . . . . 0.0 110.193 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.833 HG22 HD13 ' A' ' 35' ' ' ILE . 61.8 t -128.56 135.84 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.61 -0.681 . . . . 27.949999999999999 110.445 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.6 t -126.61 105.53 23.72 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.694 -0.629 . . . . 0.0 110.474 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -82.95 164.8 15.45 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 O-C-N 123.832 1.438 . . . . 33.0 111.15 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -157.87 131.63 7.92 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.572 0.701 . . . . 54.100000000000001 109.697 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.522 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 80.2 t80 -62.13 138.55 58.41 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.651 -0.656 . . . . 0.0 111.691 -178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.985 HD11 ' HB2' ' A' ' 32' ' ' ALA . 86.0 mt -116.66 83.15 1.91 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 122.009 0.909 . . . . 0.0 110.269 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.522 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -68.45 -35.55 77.74 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.303 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -69.8 -23.71 63.37 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.309 -0.869 . . . . 0.0 111.076 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -121.77 43.06 2.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.263 -0.898 . . . . 52.369999999999997 110.717 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.734 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 37.8 t -162.64 143.93 10.17 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.399 -0.813 . . . . 55.189999999999998 110.883 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.9 m -116.58 92.69 38.21 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.44 -0.787 . . . . 0.0 109.124 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.458 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 47.5 Cg_endo -66.05 -25.16 51.63 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 O-C-N 123.932 1.49 . . . . 51.57 111.553 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -68.49 -22.95 64.51 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.298 -0.876 . . . . 0.0 111.038 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -105.06 22.82 14.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.235 -0.915 . . . . 0.0 110.912 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.41 28.62 73.15 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -120.63 93.59 4.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.652 -0.91 . . . . 0.0 109.804 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.458 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 65.2 m-85 -105.62 130.89 53.56 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.361 -0.837 . . . . 46.07 109.017 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.734 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -116.3 121.14 41.13 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.554 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.653 ' CD1' HD12 ' A' ' 90' ' ' LEU . 85.1 m-85 -116.75 134.3 54.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.624 -0.672 . . . . 38.880000000000003 109.459 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.985 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -110.9 132.63 54.04 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.171 -0.956 . . . . 34.060000000000002 108.839 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.585 ' HE1' HG23 ' A' ' 88' ' ' VAL . 25.8 p90 -126.98 143.55 51.26 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.376 -0.929 . . . . 29.030000000000001 111.294 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.0 t -103.92 139.57 38.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.707 -0.621 . . . . 0.0 109.417 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.833 HD13 HG22 ' A' ' 13' ' ' VAL . 40.9 mm -105.06 132.6 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.811 0.815 . . . . 0.0 111.532 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -123.02 95.74 4.73 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.46 0.647 . . . . 40.240000000000002 109.563 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.53 HG22 ' CD1' ' A' ' 76' ' ' LEU . 78.7 mt -90.23 117.5 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.766 -0.583 . . . . 20.73 110.535 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -117.36 134.4 54.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.515 -0.741 . . . . 0.0 109.434 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -92.24 117.43 29.87 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.282 -0.567 . . . . 21.34 110.524 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.85 10.44 16.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.471 -0.768 . . . . 0.0 110.584 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.32 179.55 53.3 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.216 -1.554 . . . . 29.100000000000001 109.216 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.11 -30.93 13.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.516 -0.991 . . . . 0.0 110.29 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.523 HG13 ' HD2' ' A' ' 44' ' ' PRO . 84.0 t -106.29 140.15 21.0 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.791 -0.568 . . . . 0.0 109.984 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.523 ' HD2' HG13 ' A' ' 43' ' ' VAL . 38.7 Cg_endo -51.53 141.28 42.74 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 O-C-N 123.8 1.421 . . . . 21.949999999999999 112.038 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.34 152.2 45.63 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.709 0.766 . . . . 20.91 111.09 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.2 ptt-85 -127.66 159.46 34.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.706 -0.621 . . . . 0.0 109.471 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.894 HD22 HG13 ' A' ' 69' ' ' VAL . 7.1 tt -96.62 117.56 31.24 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.418 -0.801 . . . . 0.0 109.794 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.444 HG23 HG22 ' A' ' 104' ' ' VAL . 58.6 t -99.48 -28.46 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.519 -0.738 . . . . 0.0 110.636 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.743 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -142.61 162.82 34.46 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.83 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.606 ' HD2' HG12 ' A' ' 69' ' ' VAL . 2.7 ptm180 -143.5 142.12 31.02 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.612 0.72 . . . . 29.050000000000001 110.712 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.409 ' HB3' ' NE2' ' A' ' 100' ' ' HIS . 21.6 t-160 -145.27 114.79 7.2 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.289 0.566 . . . . 27.969999999999999 109.701 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.464 ' CH2' HG21 ' A' ' 115' ' ' ILE . 67.3 m95 -100.13 136.67 39.69 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.652 -0.655 . . . . 25.25 111.36 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -116.13 78.28 1.18 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.661 -0.649 . . . . 0.0 109.258 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.425 ' O ' HG13 ' A' ' 54' ' ' ILE . 29.9 pt -88.15 131.67 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.771 0.796 . . . . 36.109999999999999 112.279 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.449 ' OG1' HG22 ' A' ' 61' ' ' THR . 93.5 m -119.63 133.23 55.73 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.395 -0.965 . . . . 33.979999999999997 108.395 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -85.89 169.16 13.55 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.693 0.759 . . . . 45.039999999999999 111.265 -178.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.93 -9.35 13.66 Favored Glycine 0 N--CA 1.496 2.644 0 O-C-N 121.827 -0.546 . . . . 39.469999999999999 112.078 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -100.78 9.23 42.64 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 119.26 1.53 . . . . 0.0 110.761 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.7 -21.0 38.3 Favored Glycine 0 N--CA 1.495 2.621 0 O-C-N 121.2 -0.938 . . . . 0.0 111.018 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.02 142.33 54.12 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.064 -1.257 . . . . 62.780000000000001 109.884 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.449 HG22 ' OG1' ' A' ' 55' ' ' THR . 73.4 p -125.32 140.24 52.99 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.515 -0.741 . . . . 0.0 110.808 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -123.18 117.88 26.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.525 -0.734 . . . . 0.0 109.829 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -103.75 135.32 45.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.717 -0.614 . . . . 0.0 110.768 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.0 t -128.75 130.89 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.657 -0.652 . . . . 37.939999999999998 109.947 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.404 ' OD1' ' CG ' ' A' ' 51' ' ' HIS . 64.7 m-20 -124.07 126.77 46.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.929 -0.482 . . . . 0.0 109.959 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.9 145.67 14.26 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.527 -1.429 . . . . 31.82 109.527 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -67.29 153.57 43.36 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.462 -1.022 . . . . 0.0 110.099 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 46.97 -164.73 0.12 Allowed Glycine 0 N--CA 1.501 3.009 0 O-C-N 121.487 -0.758 . . . . 22.620000000000001 111.793 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.894 HG13 HD22 ' A' ' 47' ' ' LEU . 15.9 m -130.98 129.37 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.89 -0.771 . . . . 17.510000000000002 109.633 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 69' ' ' VAL . 12.5 m 40.98 34.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 CA-C-O 121.513 0.673 . . . . 20.550000000000001 111.822 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.57 17.16 66.75 Favored Glycine 0 N--CA 1.499 2.839 0 O-C-N 121.668 -0.645 . . . . 18.289999999999999 112.952 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -144.53 150.0 36.81 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 119.2 1.5 . . . . 0.0 111.95 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -116.08 74.92 5.62 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.989 -0.745 . . . . 18.210000000000001 108.989 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -56.37 141.32 89.34 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 O-C-N 123.852 1.449 . . . . 17.609999999999999 112.06 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -100.34 77.33 1.94 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.53 ' CD1' HG22 ' A' ' 37' ' ' ILE . 11.1 mt -62.88 118.04 7.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.575 -0.703 . . . . 20.57 111.987 -178.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -86.92 159.18 52.23 Favored Pre-proline 0 N--CA 1.489 1.508 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -54.65 128.73 31.53 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 O-C-N 123.512 1.27 . . . . 27.039999999999999 111.013 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.49 -17.39 52.49 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.955 -0.858 . . . . 24.739999999999998 110.955 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -87.41 166.1 15.08 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.995 -1.297 . . . . 29.379999999999999 110.635 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.34 150.08 35.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.659 -0.651 . . . . 0.0 110.112 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -118.94 147.69 43.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.505 -0.747 . . . . 18.559999999999999 109.081 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.5 p80 -144.75 140.84 28.79 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.146 -0.971 . . . . 0.0 111.243 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.539 ' CE1' HG21 ' A' ' 35' ' ' ILE . 52.1 p90 -150.95 160.02 44.19 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.633 -0.667 . . . . 26.649999999999999 109.812 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.4 m -101.34 137.01 40.24 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.431 -0.793 . . . . 28.140000000000001 110.911 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.451 ' HG ' ' HH ' ' A' ' 33' ' ' TYR . 26.6 t -125.23 169.35 12.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.616 -0.677 . . . . 33.880000000000003 110.132 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.39 123.33 2.15 Favored Glycine 0 N--CA 1.497 2.725 0 C-N-CA 119.914 -1.136 . . . . 31.800000000000001 110.461 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.585 HG23 ' HE1' ' A' ' 33' ' ' TYR . 80.4 t -130.18 152.44 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.532 -0.981 . . . . 0.0 109.48 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.719 HD23 ' N ' ' A' ' 90' ' ' LEU . 5.6 tt -110.56 143.81 40.37 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.532 -0.73 . . . . 0.0 110.508 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.777 HD11 HD22 ' A' ' 120' ' ' LEU . 70.8 mt -122.28 147.57 46.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.578 -0.702 . . . . 38.68 110.193 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -74.74 -25.91 59.43 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.28 -0.887 . . . . 0.0 110.805 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.2 p -125.52 172.9 9.32 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.429 -0.794 . . . . 31.629999999999999 110.857 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.452 ' HG2' ' CD2' ' A' ' 29' ' ' TYR . 94.0 mt-10 -86.33 11.91 11.21 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.683 -0.636 . . . . 0.0 111.635 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 97.0 mt-30 -139.93 147.39 40.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.113 -0.992 . . . . 0.0 109.895 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.48 158.88 21.51 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 118.889 -1.624 . . . . 28.050000000000001 112.28 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -119.47 129.72 54.88 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 122.108 -0.642 . . . . 0.0 109.357 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.451 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 98.0 mtp -125.61 116.42 21.69 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.371 -0.83 . . . . 0.0 111.124 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.493 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 56.3 tt0 -130.15 151.1 51.05 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -168.77 -177.18 39.5 Favored Glycine 0 N--CA 1.5 2.93 0 C-N-CA 119.017 -1.564 . . . . 29.620000000000001 110.748 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.409 ' NE2' ' HB3' ' A' ' 51' ' ' HIS . 6.0 p-80 -140.16 157.99 44.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.682 -0.893 . . . . 0.0 110.958 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.664 ' CD1' HD11 ' A' ' 47' ' ' LEU . 5.6 m-85 -115.77 128.21 55.68 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.68 -0.637 . . . . 27.050000000000001 109.647 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.743 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 41.4 t0 -80.78 124.83 29.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.927 -1.108 . . . . 0.0 109.184 178.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.599 ' SD ' HG11 ' A' ' 9' ' ' VAL . 29.5 mtp -124.63 162.37 24.25 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.249 0.547 . . . . 0.0 110.543 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.456 HG12 ' OE2' ' A' ' 110' ' ' GLU . 9.8 m -139.73 128.15 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.654 -0.654 . . . . 23.280000000000001 110.285 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.46 168.99 18.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.538 -0.726 . . . . 0.0 109.861 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.61 -31.74 72.63 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.834 -0.747 . . . . 0.0 110.271 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -70.02 -15.67 63.05 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.491 -0.755 . . . . 0.0 110.942 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.9 -5.74 47.01 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.42 -1.072 . . . . 30.43 110.42 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.4 m -57.72 135.6 56.78 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.061 -1.258 . . . . 0.0 110.052 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.456 ' OE2' HG12 ' A' ' 104' ' ' VAL . 77.1 mm-40 -98.63 139.98 33.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.443 -0.786 . . . . 0.0 110.612 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 48.0 p90 -168.39 148.88 4.75 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.703 -0.623 . . . . 28.030000000000001 110.121 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.6 pt -102.64 157.9 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.707 -0.621 . . . . 0.0 110.833 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -118.54 99.08 51.51 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -58.68 142.76 98.82 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 O-C-N 123.928 1.489 . . . . 33.310000000000002 112.356 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.637 HD11 ' CD2' ' A' ' 101' ' ' TYR . 70.2 mt -108.82 123.6 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.45 -0.945 . . . . 30.59 108.45 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.74 143.98 8.93 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.191 0.52 . . . . 30.780000000000001 111.362 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.493 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -85.98 121.6 28.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.619 -0.675 . . . . 0.0 110.186 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.582 ' CE1' HD11 ' A' ' 120' ' ' LEU . 42.4 p90 -109.46 163.95 12.95 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.796 -0.816 . . . . 30.66 108.796 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.606 ' C ' HD12 ' A' ' 120' ' ' LEU . 8.8 p -115.4 154.53 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.186 -0.946 . . . . 0.0 110.476 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.777 HD22 HD11 ' A' ' 90' ' ' LEU . 6.9 mp -113.63 133.47 55.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.733 -0.604 . . . . 39.149999999999999 109.384 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.702 -0.624 . . . . 0.0 110.046 -179.792 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.656 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 61.6 mtt180 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.656 0.265 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.476 ' CE2' HG21 ' A' ' 109' ' ' THR . 31.4 m-85 -119.98 108.07 13.87 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.44 -0.788 . . . . 31.93 110.306 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.464 ' C ' HG23 ' A' ' 9' ' ' VAL . 81.4 mtt85 -149.06 132.85 16.97 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.661 -0.65 . . . . 0.0 109.986 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.588 HG11 ' CE ' ' A' ' 103' ' ' MET . 68.0 t -150.61 113.48 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.687 -0.633 . . . . 0.0 109.455 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -107.41 129.19 54.96 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.616 -0.677 . . . . 0.0 109.809 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.585 HG11 ' HE2' ' A' ' 101' ' ' TYR . 58.4 t -118.75 139.56 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.88 -0.512 . . . . 28.210000000000001 109.969 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -121.26 137.07 54.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.401 -0.812 . . . . 0.0 109.905 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.715 HG22 HD13 ' A' ' 35' ' ' ILE . 59.1 t -128.81 136.67 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.709 -0.619 . . . . 27.949999999999999 110.23 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.9 p -125.38 104.8 28.23 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.719 -0.613 . . . . 0.0 110.55 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.404 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 48.4 Cg_endo -83.7 164.39 14.08 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 O-C-N 123.95 1.5 . . . . 33.0 110.902 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.6 ptt-85 -157.37 132.5 8.9 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.522 0.677 . . . . 54.100000000000001 109.843 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.567 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 75.1 t80 -59.43 138.56 57.62 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.337 0.589 . . . . 0.0 111.305 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.3 tp -116.18 79.79 1.36 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.983 0.897 . . . . 0.0 110.386 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.567 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -70.59 -35.58 73.09 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.567 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -68.43 -25.05 64.82 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.279 -0.888 . . . . 0.0 111.117 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -120.08 45.85 2.09 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.27 -0.894 . . . . 52.369999999999997 110.63 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.735 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 34.8 p -165.76 150.03 8.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.374 -0.829 . . . . 55.189999999999998 110.974 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.628 HG23 ' HB2' ' A' ' 28' ' ' ARG . 9.5 t -120.98 93.24 48.81 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.461 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.3 Cg_endo -66.89 -23.21 47.73 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 O-C-N 123.761 1.401 . . . . 51.57 111.965 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.09 -23.02 67.04 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.287 -0.883 . . . . 0.0 110.927 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -106.39 24.0 13.25 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.295 -0.878 . . . . 0.0 110.641 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.76 29.17 72.68 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.628 ' HB2' HG23 ' A' ' 23' ' ' THR . 99.5 mtt180 -121.85 93.94 4.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.592 -0.946 . . . . 0.0 110.152 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.461 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 58.4 m-85 -104.95 133.8 49.14 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.559 -0.713 . . . . 46.07 109.103 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.735 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -115.04 119.78 37.62 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.163 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.833 ' CD1' HD12 ' A' ' 90' ' ' LEU . 83.2 m-85 -114.73 134.83 54.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.564 -0.71 . . . . 38.880000000000003 109.786 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.4 131.54 55.49 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.52 -0.919 . . . . 34.060000000000002 108.52 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.633 ' HE1' HG23 ' A' ' 88' ' ' VAL . 21.9 p90 -128.43 144.76 51.19 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.273 -0.971 . . . . 29.030000000000001 111.435 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -104.42 139.6 39.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.752 -0.592 . . . . 0.0 109.886 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.715 HD13 HG22 ' A' ' 13' ' ' VAL . 44.7 mm -107.28 133.04 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.707 0.765 . . . . 0.0 111.416 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.13 98.52 5.81 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.394 0.616 . . . . 40.240000000000002 109.738 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.58 HG22 ' CD1' ' A' ' 76' ' ' LEU . 77.3 mt -90.27 117.75 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.749 -0.595 . . . . 20.73 110.597 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -118.09 133.45 55.89 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.451 -0.781 . . . . 0.0 109.615 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -95.41 117.12 29.79 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.822 -0.549 . . . . 21.34 110.434 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.82 14.39 17.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.319 -0.863 . . . . 0.0 110.717 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.58 -177.03 51.5 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.349 -1.501 . . . . 29.100000000000001 109.349 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.656 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . . . -95.98 -33.5 12.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.598 -0.943 . . . . 0.0 109.915 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.514 HG13 ' HD2' ' A' ' 44' ' ' PRO . 84.9 t -104.7 140.82 21.45 Favored Pre-proline 0 N--CA 1.494 1.772 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.514 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.1 Cg_endo -52.51 142.24 49.4 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 O-C-N 123.777 1.409 . . . . 21.949999999999999 111.711 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.03 152.73 46.47 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.716 0.77 . . . . 20.91 111.101 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.431 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 24.0 ptt-85 -127.88 157.75 39.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.708 -0.62 . . . . 0.0 109.634 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.71 HD22 HG13 ' A' ' 69' ' ' VAL . 6.4 tt -97.46 117.85 32.62 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.381 -0.824 . . . . 0.0 109.084 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.454 HG23 HG22 ' A' ' 104' ' ' VAL . 60.9 t -100.22 -29.32 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.56 -0.712 . . . . 0.0 111.616 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.695 ' HB3' ' HB2' ' A' ' 102' ' ' ASP . . . -140.06 164.47 29.94 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.126 -1.029 . . . . 0.0 112.151 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -142.85 141.14 31.53 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.559 0.695 . . . . 29.050000000000001 110.906 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -143.37 113.06 7.0 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.309 -0.626 . . . . 27.969999999999999 109.309 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.501 ' CH2' HD13 ' A' ' 115' ' ' ILE . 88.3 m95 -100.05 134.69 42.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.607 -0.683 . . . . 25.25 111.099 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -116.54 77.19 1.08 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.574 -0.704 . . . . 0.0 109.57 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 54' ' ' ILE . 27.6 pt -86.68 130.27 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.416 -0.803 . . . . 36.109999999999999 111.855 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.59 HG23 ' HB ' ' A' ' 61' ' ' THR . 6.8 m -119.48 132.67 55.83 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.374 -0.973 . . . . 33.979999999999997 108.374 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -88.13 169.57 11.81 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.717 0.77 . . . . 45.039999999999999 111.417 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.67 -7.69 12.2 Favored Glycine 0 N--CA 1.495 2.57 0 O-C-N 121.786 -0.571 . . . . 39.469999999999999 112.16 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -101.25 7.59 42.89 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 119.307 1.554 . . . . 0.0 110.682 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.13 -29.32 8.26 Favored Glycine 0 N--CA 1.495 2.631 0 O-C-N 121.211 -0.931 . . . . 0.0 110.798 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -63.6 142.45 58.39 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.205 -1.173 . . . . 62.780000000000001 109.755 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.59 ' HB ' HG23 ' A' ' 55' ' ' THR . 7.9 t -134.49 152.76 52.0 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.846 -0.741 . . . . 0.0 110.683 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -122.53 125.23 45.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.623 -0.673 . . . . 0.0 110.267 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -102.47 134.72 45.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.671 -0.643 . . . . 0.0 110.512 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.8 t -128.38 132.6 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.548 -0.72 . . . . 37.939999999999998 110.038 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -125.49 127.18 46.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.874 -0.516 . . . . 0.0 110.338 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.3 -174.57 15.68 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 108.711 -1.756 . . . . 31.82 108.711 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.24 -157.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.186 -1.185 . . . . 0.0 109.813 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.405 ' HA2' ' CD2' ' A' ' 47' ' ' LEU . . . -51.03 -91.25 0.01 OUTLIER Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.563 -1.015 . . . . 22.620000000000001 110.563 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.71 HG13 HD22 ' A' ' 47' ' ' LEU . 27.4 m -140.22 129.13 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.402 -1.057 . . . . 17.510000000000002 110.143 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 69' ' ' VAL . 12.0 m 40.81 33.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 CA-C-O 121.268 0.556 . . . . 20.550000000000001 112.122 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.97 22.29 55.5 Favored Glycine 0 N--CA 1.499 2.837 0 O-C-N 121.533 -0.729 . . . . 18.289999999999999 112.782 177.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.656 ' HG3' HG23 ' A' ' 69' ' ' VAL . 1.6 pt-20 -139.83 150.75 45.05 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 119.142 1.471 . . . . 0.0 111.354 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -113.84 74.83 2.62 Favored Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 109.117 -0.697 . . . . 18.210000000000001 109.117 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -57.36 141.7 94.85 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 O-C-N 123.858 1.452 . . . . 17.609999999999999 111.887 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.431 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -103.8 76.36 1.37 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.58 ' CD1' HG22 ' A' ' 37' ' ' ILE . 19.0 mt -63.67 121.48 14.04 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.634 -0.666 . . . . 20.57 111.947 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -86.31 158.44 54.99 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -53.6 128.75 30.69 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 O-C-N 123.517 1.272 . . . . 27.039999999999999 111.132 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.01 -17.3 54.07 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.805 -0.918 . . . . 24.739999999999998 110.805 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -88.62 164.85 15.16 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.121 -1.223 . . . . 29.379999999999999 110.585 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.19 150.04 35.08 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.649 -0.657 . . . . 0.0 110.165 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -117.93 144.51 45.41 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.503 -0.748 . . . . 18.559999999999999 109.126 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -142.76 140.4 31.4 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.24 -0.912 . . . . 0.0 111.25 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.564 ' CE1' HG21 ' A' ' 35' ' ' ILE . 52.1 p90 -150.65 159.92 44.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.672 -0.642 . . . . 26.649999999999999 109.781 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 60.3 m -102.78 136.73 42.07 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.431 -0.793 . . . . 28.140000000000001 110.76 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 15.7 t -125.25 169.95 11.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.643 -0.661 . . . . 33.880000000000003 110.133 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -139.83 125.87 3.1 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 119.934 -1.127 . . . . 31.800000000000001 110.38 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.633 HG23 ' HE1' ' A' ' 33' ' ' TYR . 71.2 t -130.08 152.47 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.594 -0.945 . . . . 0.0 109.462 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.598 HD23 ' N ' ' A' ' 90' ' ' LEU . 8.1 tt -110.51 142.64 42.01 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.642 -0.661 . . . . 0.0 110.488 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.833 HD12 ' CD1' ' A' ' 31' ' ' PHE . 86.1 mt -122.12 145.8 47.83 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.543 -0.723 . . . . 38.68 109.971 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -81.49 -26.3 35.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.299 -0.876 . . . . 0.0 111.036 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 93' ' ' GLU . 27.0 m -123.69 169.34 11.59 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.306 -0.871 . . . . 31.629999999999999 110.66 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.453 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 50.6 mt-10 -86.22 11.09 12.8 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.637 -0.664 . . . . 0.0 111.603 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 96.9 mt-30 -140.72 145.31 36.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.16 -0.963 . . . . 0.0 109.853 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.51 157.02 17.52 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 118.747 -1.692 . . . . 28.050000000000001 112.315 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -117.28 129.28 55.8 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 99.6 mtp -126.08 117.77 23.88 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.314 -0.866 . . . . 0.0 111.431 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.483 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 56.6 tt0 -126.3 149.18 49.3 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -155.46 -178.91 30.16 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 118.8 -1.667 . . . . 29.620000000000001 111.078 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.824 ' CE1' HD12 ' A' ' 112' ' ' ILE . 0.3 OUTLIER -136.92 155.74 49.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.769 -0.842 . . . . 0.0 109.494 179.506 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.585 ' HE2' HG11 ' A' ' 11' ' ' VAL . 6.6 m-85 -118.09 126.95 53.27 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.419 -0.801 . . . . 27.050000000000001 110.163 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.695 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 78.6 m-20 -85.49 120.36 26.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.113 -0.992 . . . . 0.0 108.761 177.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.588 ' CE ' HG11 ' A' ' 9' ' ' VAL . 14.2 tpp -123.93 160.67 27.03 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.109 0.48 . . . . 0.0 110.403 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.454 HG22 HG23 ' A' ' 48' ' ' VAL . 9.1 m -140.69 130.04 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.654 -0.654 . . . . 23.280000000000001 110.176 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.39 166.62 23.18 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.494 -0.754 . . . . 0.0 109.732 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -65.37 -29.77 70.53 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.546 -0.721 . . . . 0.0 110.153 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -74.64 -6.43 48.59 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.437 -0.789 . . . . 0.0 111.139 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.26 -9.41 59.38 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 120.082 -1.056 . . . . 30.43 110.581 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.476 HG21 ' CE2' ' A' ' 7' ' ' TYR . 27.4 m -57.89 135.01 56.81 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.009 -1.289 . . . . 0.0 110.023 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -101.13 138.86 37.61 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.359 -0.838 . . . . 0.0 110.726 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 41.9 p90 -162.69 143.8 10.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.664 -0.648 . . . . 28.030000000000001 109.942 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.824 HD12 ' CE1' ' A' ' 100' ' ' HIS . 30.5 pt -101.01 156.78 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 121.331 0.586 . . . . 0.0 110.877 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.485 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -121.66 100.19 44.19 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.617 -0.677 . . . . 0.0 109.421 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.422 ' HB3' ' CE1' ' A' ' 100' ' ' HIS . 45.3 Cg_endo -58.02 142.85 96.99 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 O-C-N 123.862 1.454 . . . . 33.310000000000002 112.176 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.501 HD13 ' CH2' ' A' ' 52' ' ' TRP . 66.9 mt -107.88 123.05 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.677 -0.861 . . . . 30.59 108.677 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.83 145.45 7.08 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.848 -0.532 . . . . 30.780000000000001 111.352 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.483 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -93.61 120.36 33.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.745 -0.597 . . . . 0.0 110.012 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.725 ' CE1' HD11 ' A' ' 120' ' ' LEU . 46.1 p90 -108.55 167.75 9.82 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.907 -0.775 . . . . 30.66 108.907 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.615 ' C ' HD12 ' A' ' 120' ' ' LEU . 8.8 p -113.7 154.1 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.349 -0.844 . . . . 0.0 110.498 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.725 HD11 ' CE1' ' A' ' 118' ' ' PHE . 7.1 mp -113.72 132.93 55.63 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.37 -0.604 . . . . 39.149999999999999 109.37 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.672 -0.642 . . . . 0.0 110.069 -179.808 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.588 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 28.5 mmt85 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 120.669 0.271 . . . . 0.0 110.741 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.444 ' CE2' HG21 ' A' ' 109' ' ' THR . 40.4 m-85 -121.22 113.34 19.82 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.412 -0.805 . . . . 31.93 110.383 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.461 ' C ' HG23 ' A' ' 9' ' ' VAL . 41.0 mtp85 -152.14 135.93 16.3 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.589 0.709 . . . . 0.0 110.092 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.461 HG23 ' C ' ' A' ' 8' ' ' ARG . 83.7 t -151.28 114.4 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 CA-C-O 121.442 0.639 . . . . 0.0 109.426 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -106.79 129.0 54.72 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.516 0.674 . . . . 0.0 109.907 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.19 138.4 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 109.694 -0.484 . . . . 28.210000000000001 109.694 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -121.8 136.66 54.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.416 -0.802 . . . . 0.0 109.931 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.733 HG22 HD13 ' A' ' 35' ' ' ILE . 62.4 t -129.39 136.4 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.484 -0.76 . . . . 27.949999999999999 110.375 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -125.71 104.57 27.26 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.732 -0.605 . . . . 0.0 110.443 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.425 ' HG3' ' CE1' ' A' ' 118' ' ' PHE . 49.9 Cg_endo -84.41 165.25 12.57 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 O-C-N 123.843 1.444 . . . . 33.0 110.929 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -158.03 132.61 8.33 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.562 0.696 . . . . 54.100000000000001 109.982 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.556 ' CE2' ' HB2' ' A' ' 19' ' ' ALA . 76.8 t80 -58.66 138.25 57.09 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.833 -0.542 . . . . 0.0 111.198 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.438 HD23 ' HB3' ' A' ' 21' ' ' GLN . 8.6 tp -115.47 80.53 1.45 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.028 0.918 . . . . 0.0 110.359 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.556 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -71.12 -35.97 71.95 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.494 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -68.8 -24.2 64.37 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.374 -0.829 . . . . 0.0 111.002 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.438 ' HB3' HD23 ' A' ' 18' ' ' LEU . 54.4 tp60 -121.34 46.82 1.97 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.382 -0.824 . . . . 52.369999999999997 110.389 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.739 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 34.3 t -166.05 149.85 7.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.456 -0.777 . . . . 55.189999999999998 110.894 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.625 HG23 ' HB2' ' A' ' 28' ' ' ARG . 8.7 t -122.04 92.94 48.81 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.457 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.5 Cg_endo -66.72 -23.1 49.13 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.761 1.401 . . . . 51.57 111.986 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -65.81 -22.68 66.58 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.267 -0.896 . . . . 0.0 110.947 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -105.97 23.59 13.74 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.251 -0.905 . . . . 0.0 110.734 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.33 28.85 73.08 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.625 ' HB2' HG23 ' A' ' 23' ' ' THR . 24.8 mmt85 -121.72 94.19 4.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.599 -0.942 . . . . 0.0 110.154 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.457 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 57.6 m-85 -105.33 131.66 52.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.538 -0.726 . . . . 46.07 109.122 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.739 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -114.7 120.56 40.53 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.609 -0.837 . . . . 0.0 111.043 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.788 ' CD1' HD12 ' A' ' 90' ' ' LEU . 86.8 m-85 -114.59 135.75 53.8 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.578 -0.701 . . . . 38.880000000000003 109.581 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.72 131.61 55.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.198 -0.939 . . . . 34.060000000000002 108.483 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.645 ' HE1' HG23 ' A' ' 88' ' ' VAL . 20.9 p90 -128.55 144.58 51.17 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.276 -0.969 . . . . 29.030000000000001 111.45 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.8 p -104.18 141.1 36.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.647 -0.658 . . . . 0.0 109.877 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.733 HD13 HG22 ' A' ' 13' ' ' VAL . 44.3 mm -106.89 132.24 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.728 0.775 . . . . 0.0 111.352 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -122.95 97.88 5.64 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.427 0.632 . . . . 40.240000000000002 109.578 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.608 HG22 ' CD1' ' A' ' 76' ' ' LEU . 77.6 mt -91.65 116.99 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.771 -0.581 . . . . 20.73 110.598 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -118.02 133.5 55.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.437 -0.789 . . . . 0.0 109.468 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -95.5 117.83 31.11 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.225 -0.59 . . . . 21.34 110.634 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.96 14.28 17.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.423 -0.798 . . . . 0.0 110.5 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.68 179.79 53.31 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.316 -1.514 . . . . 29.100000000000001 109.316 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.588 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . . . -92.42 -33.81 14.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.536 -0.979 . . . . 0.0 110.056 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.511 HG13 ' HD2' ' A' ' 44' ' ' PRO . 84.3 t -104.6 139.61 20.27 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.965 -0.46 . . . . 0.0 109.771 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.511 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.5 Cg_endo -51.26 146.2 24.7 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 O-C-N 123.709 1.373 . . . . 21.949999999999999 111.613 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.49 151.08 48.07 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.861 0.838 . . . . 20.91 111.524 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.437 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 52.6 ttp180 -126.02 153.35 44.51 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.641 HD22 HG13 ' A' ' 69' ' ' VAL . 7.2 tt -96.93 116.97 30.11 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.541 -0.724 . . . . 0.0 109.705 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.44 HG23 HG22 ' A' ' 104' ' ' VAL . 57.3 t -100.51 -27.0 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.607 -0.683 . . . . 0.0 110.516 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.727 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -140.69 162.4 35.49 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.132 -1.027 . . . . 0.0 112.124 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 32.6 ptt85 -140.76 139.0 34.54 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.322 0.582 . . . . 29.050000000000001 109.858 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.407 ' NE2' ' CG ' ' A' ' 63' ' ' GLN . 20.0 t-160 -143.32 111.45 6.15 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.653 -0.654 . . . . 27.969999999999999 110.264 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.57 ' CH2' HD13 ' A' ' 115' ' ' ILE . 60.5 m95 -105.64 135.85 46.31 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.33 0.586 . . . . 25.25 111.135 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -115.87 82.26 1.74 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.703 -0.623 . . . . 0.0 109.348 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.908 HG22 ' HG3' ' A' ' 97' ' ' MET . 16.3 pt -84.47 128.38 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.43 -0.794 . . . . 36.109999999999999 111.668 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.477 HG23 ' HB ' ' A' ' 61' ' ' THR . 17.6 m -120.57 132.13 55.0 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.492 -0.929 . . . . 33.979999999999997 108.492 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -88.69 169.89 11.28 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.664 0.745 . . . . 45.039999999999999 111.271 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.14 -7.48 13.47 Favored Glycine 0 N--CA 1.495 2.604 0 O-C-N 121.82 -0.55 . . . . 39.469999999999999 112.148 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -101.41 7.66 42.5 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 119.369 1.585 . . . . 0.0 110.682 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.07 -28.75 8.99 Favored Glycine 0 N--CA 1.493 2.457 0 O-C-N 121.193 -0.942 . . . . 0.0 110.892 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.26 141.24 58.84 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.232 -1.158 . . . . 62.780000000000001 109.617 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.477 ' HB ' HG23 ' A' ' 55' ' ' THR . 7.8 t -135.58 153.18 51.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.446 -0.784 . . . . 0.0 110.745 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -120.98 123.36 42.23 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.536 -0.728 . . . . 0.0 109.735 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.407 ' CG ' ' NE2' ' A' ' 51' ' ' HIS . 12.0 tt0 -99.15 136.6 38.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.659 -0.651 . . . . 0.0 110.827 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.94 131.68 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 CA-C-O 121.681 0.753 . . . . 37.939999999999998 110.352 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -126.91 127.45 44.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.955 -0.466 . . . . 0.0 110.055 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.11 172.63 32.74 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.304 -1.518 . . . . 31.82 109.304 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -115.61 159.18 21.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.403 -1.057 . . . . 0.0 110.085 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.65 96.55 0.01 OUTLIER Glycine 0 N--CA 1.501 2.98 0 O-C-N 121.424 -0.797 . . . . 22.620000000000001 111.531 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.641 HG13 HD22 ' A' ' 47' ' ' LEU . 23.7 m -45.56 133.31 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 O-C-N 121.338 -1.095 . . . . 17.510000000000002 111.589 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.1 m 41.6 35.97 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 CA-C-O 121.619 0.723 . . . . 20.550000000000001 111.408 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.4 21.5 58.34 Favored Glycine 0 N--CA 1.495 2.584 0 O-C-N 121.753 -0.592 . . . . 18.289999999999999 112.398 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.488 ' HG3' HG23 ' A' ' 69' ' ' VAL . 3.6 pt-20 -146.21 152.85 39.88 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 119.111 1.455 . . . . 0.0 112.473 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -118.56 72.95 10.81 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 108.449 -0.945 . . . . 18.210000000000001 108.449 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -55.01 139.64 79.8 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 O-C-N 123.781 1.411 . . . . 17.609999999999999 112.284 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.44 ' CZ3' ' HG2' ' A' ' 77' ' ' ARG . 5.2 t90 -99.56 75.54 1.95 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.608 ' CD1' HG22 ' A' ' 37' ' ' ILE . 12.4 mt -61.03 119.77 8.95 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.682 -0.636 . . . . 20.57 112.084 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.44 ' HG2' ' CZ3' ' A' ' 75' ' ' TRP . 18.1 mtm180 -86.48 157.86 55.2 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -53.84 128.28 29.0 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 O-C-N 123.492 1.259 . . . . 27.039999999999999 111.093 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.68 -16.59 56.16 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.769 -0.933 . . . . 24.739999999999998 110.769 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -88.17 164.75 15.52 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.133 -1.216 . . . . 29.379999999999999 110.533 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.18 149.82 34.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.586 -0.696 . . . . 0.0 110.124 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -118.65 147.54 43.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.49 -0.756 . . . . 18.559999999999999 109.17 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -143.34 139.85 30.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.168 -0.957 . . . . 0.0 111.124 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.556 ' CE1' HG21 ' A' ' 35' ' ' ILE . 53.2 p90 -150.92 159.73 44.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.614 -0.679 . . . . 26.649999999999999 109.716 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.2 m -102.12 136.64 41.6 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.363 -0.836 . . . . 28.140000000000001 110.92 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 17.9 t -124.95 170.25 11.29 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.681 -0.637 . . . . 33.880000000000003 109.912 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -140.54 125.34 2.85 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.827 -1.177 . . . . 31.800000000000001 110.495 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.645 HG23 ' HE1' ' A' ' 33' ' ' TYR . 76.2 t -129.98 152.26 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.592 -0.946 . . . . 0.0 109.293 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.493 HD23 ' N ' ' A' ' 90' ' ' LEU . 7.1 tt -111.01 142.91 42.52 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.627 -0.671 . . . . 0.0 110.712 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.788 HD12 ' CD1' ' A' ' 31' ' ' PHE . 89.4 mt -121.67 145.21 48.24 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.576 -0.703 . . . . 38.68 109.893 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -79.16 -26.73 42.72 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.211 -0.93 . . . . 0.0 110.939 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.9 p -124.43 172.29 9.27 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.361 -0.837 . . . . 31.629999999999999 110.729 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.456 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 48.8 mt-10 -86.56 12.38 10.59 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.62 -0.675 . . . . 0.0 111.58 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 15.1 pt20 -141.47 144.89 34.63 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.039 -1.038 . . . . 0.0 109.78 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 178.77 158.89 22.15 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 118.74 -1.695 . . . . 28.050000000000001 112.275 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -119.71 129.42 54.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 122.117 -0.637 . . . . 0.0 109.322 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.908 ' HG3' HG22 ' A' ' 54' ' ' ILE . 49.2 ttm -125.14 121.18 33.49 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.249 -0.907 . . . . 0.0 111.155 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.449 ' CD ' ' HB2' ' A' ' 117' ' ' ALA . 35.4 mt-30 -123.82 150.15 44.87 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.56 171.28 36.69 Favored Glycine 0 N--CA 1.5 2.931 0 C-N-CA 118.337 -1.887 . . . . 29.620000000000001 111.605 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 114' ' ' PRO . 51.6 m80 -135.3 153.97 51.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.895 -0.767 . . . . 0.0 109.685 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.725 ' CE2' HD11 ' A' ' 115' ' ' ILE . 5.3 m-85 -119.16 126.1 50.78 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.519 -0.738 . . . . 27.050000000000001 109.74 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.727 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 41.5 t0 -80.98 121.93 26.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.898 -1.126 . . . . 0.0 109.359 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.447 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 91.6 mmm -119.68 161.47 20.65 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.112 0.482 . . . . 0.0 110.066 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.44 HG22 HG23 ' A' ' 48' ' ' VAL . 8.5 m -140.86 127.62 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.551 -0.718 . . . . 23.280000000000001 110.335 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.88 167.47 21.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.585 -0.697 . . . . 0.0 109.581 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -64.06 -29.63 70.76 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.136 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -73.3 -11.19 60.41 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.534 -0.729 . . . . 0.0 111.136 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.91 -7.2 52.56 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 120.075 -1.059 . . . . 30.43 110.54 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.444 HG21 ' CE2' ' A' ' 7' ' ' TYR . 41.2 m -57.47 136.28 56.66 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.015 -1.285 . . . . 0.0 110.106 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -101.57 141.19 34.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.433 -0.792 . . . . 0.0 110.959 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 46.8 p90 -168.54 146.7 4.13 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.677 -0.639 . . . . 28.030000000000001 109.883 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.3 pt -102.63 159.27 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.673 -0.642 . . . . 0.0 111.222 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.02 97.13 50.64 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.429 ' HB3' ' CD2' ' A' ' 100' ' ' HIS . 46.0 Cg_endo -59.75 143.44 99.63 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 O-C-N 123.962 1.506 . . . . 33.310000000000002 112.332 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.725 HD11 ' CE2' ' A' ' 101' ' ' TYR . 72.7 mt -108.13 120.72 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.301 -0.999 . . . . 30.59 108.301 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -47.36 161.23 0.08 Allowed 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.304 0.573 . . . . 30.780000000000001 111.818 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.449 ' HB2' ' CD ' ' A' ' 98' ' ' GLN . . . -99.93 118.05 35.53 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.78 -0.575 . . . . 0.0 110.778 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.755 ' CE1' HD11 ' A' ' 120' ' ' LEU . 50.5 p90 -110.68 166.24 11.18 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.359 -0.978 . . . . 30.66 108.359 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.633 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.2 t -113.18 153.98 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.172 -0.955 . . . . 0.0 110.48 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.755 HD11 ' CE1' ' A' ' 118' ' ' PHE . 7.4 mp -113.35 130.57 56.25 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.169 -0.678 . . . . 39.149999999999999 109.169 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.4 m . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.668 -0.645 . . . . 0.0 110.062 -179.801 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.666 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 60.0 mtt180 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 120.734 0.302 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.683 ' CE2' HG21 ' A' ' 109' ' ' THR . 44.6 m-85 -123.77 119.56 30.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.505 -0.747 . . . . 31.93 110.501 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.489 ' C ' HG23 ' A' ' 9' ' ' VAL . 21.3 ttm180 -156.86 132.89 9.65 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.43 0.633 . . . . 0.0 110.081 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.489 HG23 ' C ' ' A' ' 8' ' ' ARG . 95.5 t -151.74 115.45 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.618 -0.676 . . . . 0.0 109.755 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -106.15 128.8 54.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.667 -0.646 . . . . 0.0 109.82 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.487 HG22 ' HA ' ' A' ' 37' ' ' ILE . 61.8 t -118.9 138.99 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.92 -0.487 . . . . 28.210000000000001 109.896 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -122.5 135.82 54.74 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.39 -0.818 . . . . 0.0 109.935 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.9 t -129.29 136.88 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.639 -0.663 . . . . 27.949999999999999 110.36 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -126.79 105.08 23.21 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.687 -0.633 . . . . 0.0 110.758 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -82.9 165.01 15.5 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 O-C-N 123.796 1.419 . . . . 33.0 110.808 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -157.69 131.62 8.07 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.725 0.774 . . . . 54.100000000000001 110.219 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.516 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 79.9 t80 -61.22 140.12 58.0 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.718 -0.614 . . . . 0.0 111.507 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.005 HD11 ' HB2' ' A' ' 32' ' ' ALA . 88.7 mt -116.95 82.39 1.8 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.944 0.878 . . . . 0.0 110.373 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.516 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -68.99 -34.64 75.62 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.137 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -69.9 -23.37 63.23 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.315 -0.865 . . . . 0.0 111.15 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -121.46 39.12 3.92 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.274 -0.892 . . . . 52.369999999999997 110.983 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.613 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 44.1 p -158.92 149.78 20.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.292 -0.88 . . . . 55.189999999999998 111.015 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.603 HG23 ' HB2' ' A' ' 28' ' ' ARG . 4.8 t -120.33 92.9 47.83 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.46 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 48.6 Cg_endo -66.23 -23.05 52.82 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 O-C-N 123.913 1.481 . . . . 51.57 111.894 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -67.25 -22.15 65.69 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.257 -0.902 . . . . 0.0 111.141 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -105.6 23.22 14.18 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.261 -0.9 . . . . 0.0 110.937 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.08 27.38 73.43 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.603 ' HB2' HG23 ' A' ' 23' ' ' THR . 29.6 mtt85 -121.0 94.48 4.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.533 -0.98 . . . . 0.0 110.023 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.46 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 61.3 m-85 -105.24 134.91 47.56 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.498 -0.751 . . . . 46.07 109.26 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -115.51 121.18 41.9 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.082 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.867 ' CD1' HD12 ' A' ' 90' ' ' LEU . 87.8 m-85 -116.64 133.3 56.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.509 -0.744 . . . . 38.880000000000003 109.727 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 1.005 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -112.51 131.66 55.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.279 -0.888 . . . . 34.060000000000002 108.619 178.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.588 ' HE1' HG23 ' A' ' 88' ' ' VAL . 25.0 p90 -127.05 144.47 51.02 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.307 -0.957 . . . . 29.030000000000001 111.386 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.3 t -104.21 139.04 39.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.695 -0.628 . . . . 0.0 109.388 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.831 HD12 ' CZ ' ' A' ' 84' ' ' TYR . 79.3 mt -108.4 133.94 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.714 0.768 . . . . 0.0 111.493 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -123.91 99.01 6.05 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.526 0.679 . . . . 40.240000000000002 109.718 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.559 HG22 ' CD1' ' A' ' 76' ' ' LEU . 83.9 mt -91.15 117.73 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.875 -0.515 . . . . 20.73 110.492 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -117.32 131.5 56.79 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.442 -0.786 . . . . 0.0 109.35 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -96.43 117.61 31.24 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 120.261 -0.575 . . . . 21.34 110.235 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -118.0 17.42 14.12 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.318 -0.864 . . . . 0.0 110.525 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.3 178.28 53.95 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.519 -1.432 . . . . 29.100000000000001 109.519 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.666 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . . . -86.96 -42.55 13.06 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.572 -0.958 . . . . 0.0 110.282 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.515 HG13 ' HD2' ' A' ' 44' ' ' PRO . 86.4 t -98.69 139.96 21.46 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.954 -0.466 . . . . 0.0 109.982 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.515 ' HD2' HG13 ' A' ' 43' ' ' VAL . 40.3 Cg_endo -53.03 145.65 40.86 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 O-C-N 123.805 1.423 . . . . 21.949999999999999 111.67 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.421 ' HB1' ' HG2' ' A' ' 103' ' ' MET . . . -140.56 152.24 45.36 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.687 0.756 . . . . 20.91 111.22 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.444 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 18.2 ptt-85 -127.76 153.85 46.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.803 -0.561 . . . . 0.0 109.665 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.761 HD22 HG13 ' A' ' 69' ' ' VAL . 6.5 tt -94.66 117.05 29.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.384 -0.823 . . . . 0.0 109.247 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.7 m -100.93 -24.44 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.732 -0.605 . . . . 0.0 111.194 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.766 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -142.44 163.1 33.76 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.19 -1.004 . . . . 0.0 112.081 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.499 ' HD2' HG12 ' A' ' 69' ' ' VAL . 1.8 ptm180 -142.06 140.05 32.46 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.542 0.687 . . . . 29.050000000000001 110.517 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.406 ' CD2' ' OD1' ' A' ' 65' ' ' ASP . 20.8 t-160 -144.39 112.93 6.59 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.42 0.628 . . . . 27.969999999999999 109.809 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -103.61 135.93 44.28 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.499 0.666 . . . . 25.25 111.532 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -115.8 82.31 1.74 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.78 HG22 ' HG3' ' A' ' 97' ' ' MET . 13.1 pt -83.1 127.11 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 121.75 0.786 . . . . 36.109999999999999 111.567 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.983 HG23 HG22 ' A' ' 61' ' ' THR . 95.4 m -122.0 130.03 52.96 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.732 -0.84 . . . . 33.979999999999997 108.732 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -91.56 169.77 10.48 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.757 0.789 . . . . 45.039999999999999 111.493 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.98 -5.91 16.52 Favored Glycine 0 N--CA 1.496 2.683 0 O-C-N 121.856 -0.527 . . . . 39.469999999999999 112.345 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -100.26 5.58 44.61 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 119.501 1.65 . . . . 0.0 110.636 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.449 ' O ' HG23 ' A' ' 61' ' ' THR . . . 91.91 -27.34 10.2 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.48 141.43 58.77 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.164 -1.198 . . . . 62.780000000000001 109.228 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.983 HG22 HG23 ' A' ' 55' ' ' THR . 61.8 p -133.73 150.06 51.49 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.664 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -121.93 121.86 38.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.498 -0.751 . . . . 0.0 109.601 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.401 ' CG ' ' NE2' ' A' ' 51' ' ' HIS . 12.6 tt0 -100.53 134.86 42.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.667 -0.646 . . . . 0.0 110.705 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.7 t -128.93 129.97 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.714 0.768 . . . . 37.939999999999998 110.214 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.406 ' OD1' ' CD2' ' A' ' 51' ' ' HIS . 58.9 m-20 -125.58 126.87 45.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.86 -0.525 . . . . 0.0 109.808 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.03 146.27 15.49 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.51 -1.436 . . . . 31.82 109.51 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -71.84 154.26 41.38 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.607 -0.937 . . . . 0.0 110.196 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 50.05 -170.63 0.17 Allowed Glycine 0 N--CA 1.497 2.762 0 O-C-N 121.373 -0.829 . . . . 22.620000000000001 111.268 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.761 HG13 HD22 ' A' ' 47' ' ' LEU . 13.3 m -129.92 128.0 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.89 -0.77 . . . . 17.510000000000002 109.155 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.639 HG11 ' CE2' ' A' ' 84' ' ' TYR . 11.5 m 41.49 33.48 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 CA-C-O 121.649 0.738 . . . . 20.550000000000001 111.397 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.59 18.76 61.32 Favored Glycine 0 N--CA 1.498 2.767 0 O-C-N 121.769 -0.582 . . . . 18.289999999999999 113.101 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.416 ' O ' HG22 ' A' ' 69' ' ' VAL . 9.8 pt-20 -146.59 150.2 35.02 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 119.386 1.593 . . . . 0.0 112.618 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -116.14 72.85 4.85 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.257 -1.016 . . . . 18.210000000000001 108.257 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -55.1 142.49 77.3 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 O-C-N 123.761 1.401 . . . . 17.609999999999999 112.331 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.444 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 3.1 t90 -101.87 76.54 1.63 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.559 ' CD1' HG22 ' A' ' 37' ' ' ILE . 10.4 mt -61.84 117.87 6.45 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.612 -0.68 . . . . 20.57 111.921 -178.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -87.83 159.04 49.8 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -54.0 129.07 32.45 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 O-C-N 123.579 1.305 . . . . 27.039999999999999 111.119 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.62 -18.03 49.0 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.929 -0.868 . . . . 24.739999999999998 110.929 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -87.33 165.07 15.89 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.005 -1.291 . . . . 29.379999999999999 110.458 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.22 148.69 33.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.586 -0.696 . . . . 0.0 110.289 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.506 ' HD2' HD12 ' A' ' 37' ' ' ILE . 89.4 t80 -117.71 143.47 46.17 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.085 -0.709 . . . . 18.559999999999999 109.085 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -146.99 140.89 25.89 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.2 -0.938 . . . . 0.0 111.314 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.831 ' CZ ' HD12 ' A' ' 35' ' ' ILE . 42.7 p90 -152.8 162.3 41.45 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.539 -0.725 . . . . 26.649999999999999 109.653 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 54.2 m -98.61 136.63 38.42 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.439 -0.788 . . . . 28.140000000000001 111.248 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.478 ' HG ' ' HH ' ' A' ' 33' ' ' TYR . 15.2 t -125.06 169.11 12.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.639 -0.663 . . . . 33.880000000000003 109.774 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -139.85 126.3 3.22 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.769 -1.205 . . . . 31.800000000000001 110.487 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.588 HG23 ' HE1' ' A' ' 33' ' ' TYR . 77.9 t -131.28 151.7 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.63 -0.923 . . . . 0.0 109.31 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.18 144.39 40.41 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.582 -0.699 . . . . 0.0 110.862 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.867 HD12 ' CD1' ' A' ' 31' ' ' PHE . 94.6 mt -122.33 148.07 45.49 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.621 -0.674 . . . . 38.68 110.026 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.408 ' O ' ' CE1' ' A' ' 29' ' ' TYR . 38.6 tp10 -79.01 -26.4 43.24 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.39 -0.819 . . . . 0.0 110.757 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.2 p -124.09 172.1 9.26 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.336 -0.853 . . . . 31.629999999999999 110.621 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.457 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 50.4 mt-10 -85.42 10.67 12.18 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.607 -0.683 . . . . 0.0 111.63 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 14.4 pt20 -141.39 145.49 35.42 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.125 -0.984 . . . . 0.0 109.811 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.6 155.46 15.24 Favored Glycine 0 N--CA 1.496 2.682 0 C-N-CA 118.871 -1.633 . . . . 28.050000000000001 112.219 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -120.47 130.2 54.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 122.125 -0.632 . . . . 0.0 109.374 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.78 ' HG3' HG22 ' A' ' 54' ' ' ILE . 56.1 ttm -126.82 123.77 38.1 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.37 -0.831 . . . . 0.0 111.533 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.61 ' CD ' ' HB2' ' A' ' 117' ' ' ALA . 40.7 mt-30 -123.1 148.93 45.13 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.67 175.52 41.33 Favored Glycine 0 N--CA 1.499 2.842 0 C-N-CA 118.738 -1.696 . . . . 29.620000000000001 111.05 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.4 ' NE2' ' HB3' ' A' ' 51' ' ' HIS . 11.7 p-80 -140.04 157.79 45.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.828 -0.807 . . . . 0.0 110.675 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.606 ' CE2' HD11 ' A' ' 115' ' ' ILE . 6.0 m-85 -114.62 130.01 56.74 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.673 -0.642 . . . . 27.050000000000001 109.787 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.766 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 11.2 t70 -82.02 121.81 27.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 108.928 178.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.434 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 2.0 ttm -121.93 161.92 21.98 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.204 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.5 m -141.65 130.34 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.639 -0.663 . . . . 23.280000000000001 110.486 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.479 ' HB3' ' HB ' ' A' ' 109' ' ' THR . . . -72.14 166.73 21.73 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.51 -0.744 . . . . 0.0 109.609 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -66.92 -29.36 69.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.533 -0.729 . . . . 0.0 110.284 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -77.36 -4.29 44.43 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.426 -0.796 . . . . 0.0 111.359 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.27 -9.7 54.02 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.087 -1.054 . . . . 30.43 110.519 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.683 HG21 ' CE2' ' A' ' 7' ' ' TYR . 57.6 m -57.02 133.61 55.09 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.045 -1.268 . . . . 0.0 110.093 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -102.32 139.44 37.93 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -0.866 . . . . 0.0 110.668 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.434 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 38.9 p90 -165.26 144.05 6.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.705 -0.622 . . . . 28.030000000000001 109.886 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.8 pt -101.85 158.89 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.636 -0.665 . . . . 0.0 110.874 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.01 95.12 49.1 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -60.48 144.73 99.54 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 O-C-N 123.958 1.504 . . . . 33.310000000000002 112.24 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.606 HD11 ' CE2' ' A' ' 101' ' ' TYR . 71.7 mt -108.65 121.55 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.698 -0.852 . . . . 30.59 108.698 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.61 167.05 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.258 0.552 . . . . 30.780000000000001 111.578 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.61 ' HB2' ' CD ' ' A' ' 98' ' ' GLN . . . -95.03 118.92 32.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.65 -0.656 . . . . 0.0 110.759 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.45 ' CE1' HD11 ' A' ' 120' ' ' LEU . 38.9 p90 -112.59 160.34 17.95 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.343 -0.984 . . . . 30.66 108.343 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.634 ' C ' HD12 ' A' ' 120' ' ' LEU . 59.1 t -116.86 152.98 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.169 -0.957 . . . . 0.0 110.753 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.747 HD22 HD11 ' A' ' 90' ' ' LEU . 7.3 mp -114.16 131.26 56.5 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.098 -0.704 . . . . 39.149999999999999 109.098 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 40.4 p . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.607 -0.683 . . . . 0.0 110.033 -179.831 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.9 0.381 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.439 ' CE2' HG21 ' A' ' 109' ' ' THR . 37.1 m-85 -112.24 104.65 12.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.546 -0.721 . . . . 31.93 110.158 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.478 ' C ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -150.29 131.58 14.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.655 -0.653 . . . . 0.0 109.982 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.746 HG11 ' SD ' ' A' ' 103' ' ' MET . 69.2 t -151.98 114.53 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.519 -0.738 . . . . 0.0 109.522 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -107.58 129.88 54.94 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.636 0.731 . . . . 0.0 109.954 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.535 HG11 ' HE2' ' A' ' 101' ' ' TYR . 57.3 t -117.35 139.69 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 109.562 -0.533 . . . . 28.210000000000001 109.562 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -120.49 137.19 54.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.409 -0.807 . . . . 0.0 110.017 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.763 HG22 HD13 ' A' ' 35' ' ' ILE . 60.7 t -127.46 135.99 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.304 0.573 . . . . 27.949999999999999 110.056 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.2 m -125.0 104.03 30.07 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.77 -0.581 . . . . 0.0 110.392 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -84.16 164.31 13.21 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 O-C-N 123.927 1.488 . . . . 33.0 110.907 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -156.62 131.86 9.22 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.592 0.711 . . . . 54.100000000000001 109.723 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 19' ' ' ALA . 69.8 t80 -60.1 138.99 57.77 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.279 0.562 . . . . 0.0 111.146 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 18' ' ' LEU . 8.8 tp -116.01 78.05 1.15 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 122.075 0.941 . . . . 0.0 110.476 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.572 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -71.82 -35.45 69.93 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.119 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -68.01 -24.05 65.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.358 -0.839 . . . . 0.0 110.895 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -121.77 41.66 3.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.365 -0.835 . . . . 52.369999999999997 110.416 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.679 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 21.7 t -163.69 150.98 12.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.506 -0.747 . . . . 55.189999999999998 110.789 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.583 ' O ' HG23 ' A' ' 23' ' ' THR . 8.2 t -122.49 94.52 47.65 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.593 -0.692 . . . . 0.0 109.246 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.469 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.8 Cg_endo -66.17 -22.91 53.39 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.773 1.407 . . . . 51.57 111.466 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.59 -23.95 67.43 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.341 -0.849 . . . . 0.0 110.819 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -105.96 23.13 14.48 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.357 -0.84 . . . . 0.0 110.705 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.33 29.44 73.15 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.51 ' HB3' HG23 ' A' ' 23' ' ' THR . 54.9 ttt85 -121.5 93.05 3.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.634 -0.921 . . . . 0.0 110.13 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.469 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 56.6 m-85 -104.53 133.19 49.81 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.035 -0.728 . . . . 46.07 109.035 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.679 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -116.0 118.87 34.11 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.938 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -114.05 134.25 54.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.629 -0.669 . . . . 38.880000000000003 109.72 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.91 132.08 55.47 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.228 -0.92 . . . . 34.060000000000002 108.563 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.586 ' HE1' HG23 ' A' ' 88' ' ' VAL . 22.9 p90 -129.06 144.56 51.24 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.175 -1.01 . . . . 29.030000000000001 111.476 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.2 m -104.4 139.95 38.62 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.717 -0.614 . . . . 0.0 109.788 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.763 HD13 HG22 ' A' ' 13' ' ' VAL . 43.7 mm -105.55 132.29 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.735 0.779 . . . . 0.0 111.535 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -123.49 98.02 5.66 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.482 0.658 . . . . 40.240000000000002 109.722 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.776 HG22 HD22 ' A' ' 76' ' ' LEU . 78.8 mt -91.18 117.27 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.762 -0.586 . . . . 20.73 110.458 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -117.99 135.56 54.07 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.512 -0.742 . . . . 0.0 109.453 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.606 ' HB2' HD23 ' A' ' 76' ' ' LEU . 42.7 t-20 -92.67 117.76 30.33 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.721 -0.612 . . . . 21.34 110.867 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.16 9.34 17.14 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.435 -0.79 . . . . 0.0 110.456 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.9 173.71 49.13 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.348 -1.501 . . . . 29.100000000000001 109.348 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.38 -31.01 21.71 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.583 -0.951 . . . . 0.0 110.216 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.512 HG13 ' HD2' ' A' ' 44' ' ' PRO . 87.2 t -106.71 140.6 21.51 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.853 -0.529 . . . . 0.0 110.076 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.512 ' HD2' HG13 ' A' ' 43' ' ' VAL . 40.3 Cg_endo -53.52 148.38 34.82 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 O-C-N 123.752 1.396 . . . . 21.949999999999999 111.673 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.499 ' HB1' ' HZ ' ' A' ' 111' ' ' PHE . . . -138.29 151.12 47.3 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.68 0.752 . . . . 20.91 111.377 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.429 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 45.5 ttp180 -126.06 155.31 41.75 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.851 HD22 HG13 ' A' ' 69' ' ' VAL . 7.0 tt -99.29 117.78 34.5 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.554 -0.716 . . . . 0.0 109.711 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.558 HG23 HG22 ' A' ' 104' ' ' VAL . 62.3 t -100.48 -29.4 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.547 -0.72 . . . . 0.0 111.015 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 102' ' ' ASP . . . -142.27 164.76 29.27 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 118.981 -1.088 . . . . 0.0 112.42 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -142.72 140.54 31.53 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.425 0.631 . . . . 29.050000000000001 110.223 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -142.92 114.06 7.76 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.315 0.578 . . . . 27.969999999999999 109.759 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.6 ' CH2' HD13 ' A' ' 115' ' ' ILE . 86.6 m95 -100.38 133.4 44.85 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.676 -0.64 . . . . 25.25 110.971 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -115.51 77.14 1.05 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.589 -0.694 . . . . 0.0 109.139 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.811 HG22 ' CG ' ' A' ' 97' ' ' MET . 17.1 pt -82.85 127.99 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.468 -0.77 . . . . 36.109999999999999 111.881 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.5 m -120.79 130.09 53.85 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.329 -0.989 . . . . 33.979999999999997 108.329 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -89.06 169.98 11.04 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.701 0.762 . . . . 45.039999999999999 111.553 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.06 -5.74 8.37 Favored Glycine 0 N--CA 1.495 2.588 0 O-C-N 121.88 -0.513 . . . . 39.469999999999999 112.246 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -101.54 6.58 42.3 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 119.417 1.608 . . . . 0.0 110.516 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.75 -31.13 6.74 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -62.99 141.95 58.56 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.316 -1.108 . . . . 62.780000000000001 110.019 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.1 t -135.31 153.2 51.95 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.574 -0.704 . . . . 0.0 110.653 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -121.97 124.36 43.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.535 -0.728 . . . . 0.0 110.184 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -102.27 134.79 44.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.674 -0.641 . . . . 0.0 110.593 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.2 t -128.49 131.57 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.587 -0.696 . . . . 37.939999999999998 110.086 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -125.59 126.72 45.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.813 -0.554 . . . . 0.0 110.137 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.12 148.84 20.71 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.463 -1.455 . . . . 31.82 109.463 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -75.27 154.7 37.31 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.528 -0.984 . . . . 0.0 110.505 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.09 -170.38 0.1 Allowed Glycine 0 N--CA 1.499 2.896 0 O-C-N 121.46 -0.775 . . . . 22.620000000000001 111.454 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.851 HG13 HD22 ' A' ' 47' ' ' LEU . 15.5 m -130.85 128.88 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.862 -0.787 . . . . 17.510000000000002 109.331 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 69' ' ' VAL . 10.9 m 41.14 33.77 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 CA-C-O 121.485 0.66 . . . . 20.550000000000001 111.844 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.93 17.45 67.52 Favored Glycine 0 N--CA 1.498 2.799 0 O-C-N 121.456 -0.777 . . . . 18.289999999999999 112.957 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 69' ' ' VAL . 15.4 pt-20 -145.23 150.45 36.71 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-N 119.275 1.537 . . . . 0.0 111.856 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -115.37 75.57 4.68 Favored Pre-proline 0 N--CA 1.492 1.637 0 N-CA-C 108.932 -0.766 . . . . 18.210000000000001 108.932 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -57.49 138.07 84.42 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 O-C-N 123.885 1.466 . . . . 17.609999999999999 112.043 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.429 ' CD1' ' HB2' ' A' ' 46' ' ' ARG . 4.3 t90 -100.82 75.89 1.74 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.776 HD22 HG22 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -58.95 116.56 3.87 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.545 -0.722 . . . . 20.57 111.239 -178.459 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.427 ' HG2' ' CZ3' ' A' ' 75' ' ' TRP . 4.5 mtt180 -86.83 159.25 52.3 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -54.39 125.87 20.36 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 O-C-N 123.585 1.308 . . . . 27.039999999999999 110.75 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.51 -18.21 43.8 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.732 -0.947 . . . . 24.739999999999998 110.732 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -89.24 165.64 14.3 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.996 -1.297 . . . . 29.379999999999999 110.243 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 37' ' ' ILE . . . -148.27 151.79 36.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.494 -0.753 . . . . 0.0 110.5 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.494 ' N ' HD11 ' A' ' 76' ' ' LEU . 65.3 t80 -118.17 147.53 43.26 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.479 -0.763 . . . . 18.559999999999999 109.042 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -144.42 140.73 29.17 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.192 -0.943 . . . . 0.0 111.082 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.443 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 47.2 p90 -150.16 160.0 44.0 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.653 -0.654 . . . . 26.649999999999999 109.671 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 62.8 m -100.37 136.54 40.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.464 -0.772 . . . . 28.140000000000001 110.651 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 29.2 t -124.04 167.9 13.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.578 -0.701 . . . . 33.880000000000003 110.033 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.15 122.46 2.09 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.876 -1.154 . . . . 31.800000000000001 110.274 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.586 HG23 ' HE1' ' A' ' 33' ' ' TYR . 80.3 t -129.72 148.19 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.575 -0.956 . . . . 0.0 109.352 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 30' ' ' ALA . 87.0 mt -107.97 144.49 35.19 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.522 -0.736 . . . . 0.0 110.408 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.2 tp -121.57 144.07 48.94 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.581 -0.699 . . . . 38.68 109.787 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -105.15 -2.19 24.55 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.329 -0.857 . . . . 0.0 111.332 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.584 HG22 ' HG2' ' A' ' 94' ' ' GLN . 29.6 m -109.29 -35.96 6.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.068 -1.02 . . . . 31.629999999999999 110.931 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.51 ' CB ' ' O ' ' A' ' 92' ' ' THR . 33.3 tt0 87.72 -14.07 0.44 Allowed 'General case' 0 N--CA 1.524 3.266 0 C-N-CA 123.196 0.598 . . . . 0.0 111.059 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.584 ' HG2' HG22 ' A' ' 92' ' ' THR . 14.3 pt20 -139.97 146.41 39.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.119 -0.988 . . . . 0.0 109.832 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 160.79 179.85 35.81 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 118.421 -1.847 . . . . 28.050000000000001 112.643 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -121.66 130.79 53.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 122.237 -0.567 . . . . 0.0 109.668 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.811 ' CG ' HG22 ' A' ' 54' ' ' ILE . 0.5 OUTLIER -126.58 124.61 40.36 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.314 -0.866 . . . . 0.0 111.543 -178.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.803 ' HG2' ' HB2' ' A' ' 117' ' ' ALA . 88.7 mt-30 -118.05 151.4 37.59 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.434 ' HA3' ' CE3' ' A' ' 52' ' ' TRP . . . -156.02 167.58 33.31 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 118.873 -1.632 . . . . 29.620000000000001 110.902 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -137.75 156.87 47.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.73 -0.865 . . . . 0.0 109.846 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.688 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 12.2 m-85 -117.94 127.21 53.62 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.546 -0.721 . . . . 27.050000000000001 110.154 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.581 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 80.4 m-20 -85.64 121.45 28.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.929 -1.107 . . . . 0.0 108.732 177.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.746 ' SD ' HG11 ' A' ' 9' ' ' VAL . 76.8 mtp -123.87 164.06 20.01 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.239 0.543 . . . . 0.0 110.672 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.558 HG22 HG23 ' A' ' 48' ' ' VAL . 9.1 m -142.8 129.21 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.678 -0.639 . . . . 23.280000000000001 110.377 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.52 166.85 22.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.431 -0.793 . . . . 0.0 109.229 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -63.65 -28.94 70.26 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.108 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -74.01 -12.96 60.79 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.455 -0.778 . . . . 0.0 111.044 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.06 -6.34 43.09 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.351 -1.099 . . . . 30.43 110.351 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.439 HG21 ' CE2' ' A' ' 7' ' ' TYR . 48.0 m -58.62 137.36 57.56 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.082 -1.246 . . . . 0.0 109.952 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -101.42 139.77 36.63 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.362 -0.836 . . . . 0.0 110.947 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.499 ' HZ ' ' HB1' ' A' ' 45' ' ' ALA . 45.1 p90 -163.02 141.81 8.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.715 -0.616 . . . . 28.030000000000001 109.782 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 84.9 mt -101.74 157.92 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.738 -0.601 . . . . 0.0 110.813 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.688 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -120.01 95.82 49.22 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -60.14 146.14 96.9 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 O-C-N 124.013 1.533 . . . . 33.310000000000002 112.201 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.638 HD11 ' CZ ' ' A' ' 101' ' ' TYR . 69.0 mt -111.43 121.55 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.731 -0.84 . . . . 30.59 108.731 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -47.58 161.66 0.08 Allowed 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 121.199 0.524 . . . . 30.780000000000001 111.641 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.803 ' HB2' ' HG2' ' A' ' 98' ' ' GLN . . . -98.71 122.95 42.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.584 -0.698 . . . . 0.0 110.807 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.61 ' HE1' HD11 ' A' ' 120' ' ' LEU . 46.3 p90 -109.86 162.91 14.03 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.409 -0.959 . . . . 30.66 108.409 178.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.583 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.0 t -114.22 155.34 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.338 -0.851 . . . . 0.0 110.253 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.637 ' N ' HD12 ' A' ' 120' ' ' LEU . 7.9 mp -110.63 131.98 54.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.684 -0.635 . . . . 39.149999999999999 109.422 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.8 p . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.807 -0.558 . . . . 0.0 110.126 -179.772 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.463 ' HG3' ' HB3' ' A' ' 42' ' ' ALA . 32.4 ttp180 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 120.833 0.349 . . . . 0.0 110.377 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.475 ' CE2' HG21 ' A' ' 109' ' ' THR . 34.3 m-85 -115.42 109.13 17.42 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.566 -0.709 . . . . 31.93 110.154 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.451 ' C ' HG23 ' A' ' 9' ' ' VAL . 58.8 mtp85 -151.89 135.63 16.3 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.666 0.746 . . . . 0.0 110.347 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.735 HG11 ' CE ' ' A' ' 103' ' ' MET . 62.4 t -150.68 116.08 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.478 0.656 . . . . 0.0 109.415 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -107.07 128.93 54.81 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.551 0.691 . . . . 0.0 109.916 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.5 t -118.93 137.27 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.813 -0.554 . . . . 28.210000000000001 109.844 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -123.6 136.61 54.61 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.351 -0.843 . . . . 0.0 109.649 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.827 HG22 HD13 ' A' ' 35' ' ' ILE . 57.9 t -129.05 137.67 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.621 -0.674 . . . . 27.949999999999999 110.688 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.3 t -126.34 105.66 24.59 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.77 -0.581 . . . . 0.0 110.44 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.442 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 51.1 Cg_endo -83.8 166.89 13.18 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 O-C-N 123.799 1.42 . . . . 33.0 111.236 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -157.77 130.19 7.24 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.474 0.654 . . . . 54.100000000000001 109.732 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.471 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 81.5 t80 -60.54 140.03 57.51 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.788 -0.57 . . . . 0.0 111.407 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.073 HD11 ' HB2' ' A' ' 32' ' ' ALA . 92.6 mt -116.46 81.39 1.61 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.9 0.857 . . . . 0.0 110.462 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.471 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -66.58 -36.08 81.77 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.968 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -69.98 -22.99 63.09 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.366 -0.834 . . . . 0.0 111.127 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -121.33 38.42 4.09 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.218 -0.926 . . . . 52.369999999999997 111.258 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.714 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 45.4 p -160.09 146.47 15.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.269 -0.895 . . . . 55.189999999999998 111.161 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.2 m -117.7 92.09 40.34 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.517 -0.739 . . . . 0.0 109.043 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.454 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.3 Cg_endo -66.91 -25.36 45.09 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 O-C-N 123.925 1.487 . . . . 51.57 111.374 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -66.35 -23.93 66.43 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.552 -0.717 . . . . 0.0 110.846 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -106.84 24.51 12.63 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.334 -0.854 . . . . 0.0 110.581 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.5 30.57 73.17 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -120.02 92.37 3.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.602 -0.94 . . . . 0.0 110.111 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.454 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 81.2 m-85 -105.06 131.21 52.87 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.47 -0.769 . . . . 46.07 109.296 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.714 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -118.32 120.76 38.59 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.406 -0.809 . . . . 0.0 111.34 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.811 ' CD1' HD12 ' A' ' 90' ' ' LEU . 67.2 m-85 -116.44 134.6 54.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.459 -0.776 . . . . 38.880000000000003 109.819 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 1.073 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -110.92 131.42 55.06 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.379 -0.971 . . . . 34.060000000000002 108.379 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.619 ' HE1' HG23 ' A' ' 88' ' ' VAL . 23.9 p90 -127.58 143.69 51.15 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.112 -1.035 . . . . 29.030000000000001 111.559 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.2 m -103.25 139.24 38.97 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.827 HD13 HG22 ' A' ' 13' ' ' VAL . 40.6 mm -106.66 133.75 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.626 0.727 . . . . 0.0 111.488 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -123.25 98.78 6.03 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.422 0.63 . . . . 40.240000000000002 109.751 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.792 HG22 HD22 ' A' ' 76' ' ' LEU . 81.3 mt -90.33 116.11 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.653 -0.654 . . . . 20.73 110.408 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -117.91 134.76 54.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.517 -0.739 . . . . 0.0 109.53 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.569 ' HB2' HD23 ' A' ' 76' ' ' LEU . 22.3 t-20 -92.82 117.64 30.23 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 120.234 -0.586 . . . . 21.34 110.503 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.1 11.06 17.53 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.404 -0.81 . . . . 0.0 110.482 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.27 171.62 48.25 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.907 -1.677 . . . . 29.100000000000001 108.907 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.463 ' HB3' ' HG3' ' A' ' 6' ' ' ARG . . . -84.53 -31.89 24.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.442 -1.034 . . . . 0.0 110.09 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.51 HG13 ' HD2' ' A' ' 44' ' ' PRO . 87.1 t -103.15 139.67 20.33 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.813 -0.555 . . . . 0.0 109.873 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.51 ' HD2' HG13 ' A' ' 43' ' ' VAL . 40.1 Cg_endo -53.21 145.09 45.32 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 O-C-N 123.891 1.469 . . . . 21.949999999999999 111.748 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.02 151.8 45.74 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.674 0.75 . . . . 20.91 111.112 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.439 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 2.1 ptt85 -127.36 158.68 36.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.768 -0.583 . . . . 0.0 109.596 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.908 HD22 HG13 ' A' ' 69' ' ' VAL . 6.4 tt -96.68 118.06 32.34 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.486 -0.759 . . . . 0.0 109.5 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.1 p -101.2 -24.41 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.589 -0.695 . . . . 0.0 111.071 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.794 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -142.3 163.88 31.65 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.213 -0.929 . . . . 0.0 111.901 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.5 ptt85 -138.16 137.65 37.85 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.437 0.636 . . . . 29.050000000000001 110.201 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.403 ' CD2' ' OD1' ' A' ' 65' ' ' ASP . 20.4 t-160 -142.11 111.29 6.41 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.417 0.627 . . . . 27.969999999999999 109.852 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.415 ' CH2' HG21 ' A' ' 115' ' ' ILE . 66.2 m95 -103.35 133.8 47.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.682 -0.637 . . . . 25.25 111.396 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -115.77 80.76 1.49 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.892 HG22 ' HG3' ' A' ' 97' ' ' MET . 17.2 pt -86.0 129.14 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.49 -0.756 . . . . 36.109999999999999 111.755 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.812 HG23 HG22 ' A' ' 61' ' ' THR . 86.6 m -120.04 129.96 54.48 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.362 -0.977 . . . . 33.979999999999997 108.362 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -91.15 169.99 10.39 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.582 0.706 . . . . 45.039999999999999 111.309 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.12 -6.72 14.24 Favored Glycine 0 N--CA 1.495 2.633 0 O-C-N 121.848 -0.533 . . . . 39.469999999999999 112.066 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -101.71 6.84 42.04 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 119.357 1.579 . . . . 0.0 110.771 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 61' ' ' THR . . . 92.75 -33.11 5.18 Favored Glycine 0 N--CA 1.496 2.644 0 C-N-CA 120.329 -0.939 . . . . 0.0 110.983 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.29 142.34 54.82 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.146 -1.208 . . . . 62.780000000000001 109.835 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.812 HG22 HG23 ' A' ' 55' ' ' THR . 69.3 p -133.49 152.4 51.9 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.599 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.415 ' HB2' HD11 ' A' ' 54' ' ' ILE . 49.3 mt-10 -121.15 121.89 38.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.584 -0.698 . . . . 0.0 109.833 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.403 ' CG ' ' NE2' ' A' ' 51' ' ' HIS . 15.4 tt0 -102.4 135.3 44.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.577 -0.702 . . . . 0.0 110.658 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.2 t -129.52 130.44 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.705 0.764 . . . . 37.939999999999998 110.484 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.403 ' OD1' ' CD2' ' A' ' 51' ' ' HIS . 77.9 m-20 -127.41 126.46 42.46 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.06 148.53 20.0 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.806 -1.318 . . . . 31.82 109.806 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -71.09 152.31 43.61 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.447 -1.031 . . . . 0.0 110.22 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 50.52 -172.17 0.14 Allowed Glycine 0 N--CA 1.498 2.812 0 O-C-N 121.403 -0.811 . . . . 22.620000000000001 111.345 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.908 HG13 HD22 ' A' ' 47' ' ' LEU . 14.4 m -129.79 128.53 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.87 -0.782 . . . . 17.510000000000002 109.631 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 69' ' ' VAL . 10.6 m 41.32 34.62 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 CA-C-O 121.578 0.704 . . . . 20.550000000000001 111.733 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.51 17.06 67.12 Favored Glycine 0 N--CA 1.499 2.837 0 O-C-N 121.658 -0.651 . . . . 18.289999999999999 112.991 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -145.67 150.36 36.16 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 119.179 1.489 . . . . 0.0 112.118 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -115.75 73.15 4.33 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.85 -0.796 . . . . 18.210000000000001 108.85 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -55.87 141.37 85.57 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 O-C-N 123.876 1.461 . . . . 17.609999999999999 112.281 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.439 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 2.9 t90 -103.43 77.17 1.48 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.792 HD22 HG22 ' A' ' 37' ' ' ILE . 8.0 tp -61.4 117.68 5.97 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.553 -0.717 . . . . 20.57 111.857 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.4 mtm180 -88.12 159.63 47.68 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -54.69 129.2 33.74 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 O-C-N 123.549 1.289 . . . . 27.039999999999999 111.185 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.11 -19.21 40.03 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 111.045 -0.822 . . . . 24.739999999999998 111.045 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -89.13 166.42 13.85 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.098 -1.236 . . . . 29.379999999999999 110.53 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.543 ' CA ' HD11 ' A' ' 76' ' ' LEU . . . -147.0 149.88 34.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.556 -0.715 . . . . 0.0 110.384 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -117.27 148.16 41.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.471 -0.768 . . . . 18.559999999999999 109.221 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -144.37 139.77 28.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.229 -0.919 . . . . 0.0 111.258 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.513 ' CE1' HG21 ' A' ' 35' ' ' ILE . 43.3 p90 -150.6 159.98 44.12 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.549 -0.719 . . . . 26.649999999999999 109.667 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.0 m -102.44 136.79 41.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.388 -0.82 . . . . 28.140000000000001 110.846 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 21.3 t -125.35 169.47 12.29 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.586 -0.696 . . . . 33.880000000000003 110.081 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.16 124.71 2.6 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.834 -1.174 . . . . 31.800000000000001 110.433 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.619 HG23 ' HE1' ' A' ' 33' ' ' TYR . 75.6 t -129.46 150.83 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.699 -0.883 . . . . 0.0 109.272 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 48.3 mt -110.35 143.73 40.14 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.526 -0.734 . . . . 0.0 110.729 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.811 HD12 ' CD1' ' A' ' 31' ' ' PHE . 98.1 mt -122.13 146.12 47.52 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.644 -0.66 . . . . 38.68 109.941 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -73.19 -25.96 60.98 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.379 -0.826 . . . . 0.0 110.773 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 94' ' ' GLN . 7.7 t -123.81 173.04 8.42 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.461 -0.774 . . . . 31.629999999999999 110.618 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.42 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 37.2 tt0 -85.72 10.28 13.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.665 -0.647 . . . . 0.0 111.576 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.458 ' O ' HG23 ' A' ' 92' ' ' THR . 27.7 pt20 -142.12 150.04 40.61 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.125 -0.984 . . . . 0.0 109.919 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.05 165.52 31.45 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 118.868 -1.634 . . . . 28.050000000000001 112.244 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -119.08 129.86 55.3 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 122.173 -0.604 . . . . 0.0 109.444 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.892 ' HG3' HG22 ' A' ' 54' ' ' ILE . 48.4 ttm -125.29 116.44 21.94 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.314 -0.866 . . . . 0.0 111.055 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.501 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 56.7 tt0 -129.5 150.58 50.78 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -162.2 178.51 37.99 Favored Glycine 0 N--CA 1.499 2.889 0 C-N-CA 118.743 -1.694 . . . . 29.620000000000001 111.104 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.418 ' CD2' ' HB3' ' A' ' 114' ' ' PRO . 50.9 m80 -134.72 154.0 51.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.73 -0.865 . . . . 0.0 109.972 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.655 ' CD2' HD11 ' A' ' 115' ' ' ILE . 4.4 m-85 -117.9 127.69 54.1 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.599 -0.688 . . . . 27.050000000000001 109.718 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.794 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 41.1 t0 -81.26 122.11 27.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.971 -1.08 . . . . 0.0 109.053 178.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.735 ' CE ' HG11 ' A' ' 9' ' ' VAL . 13.1 tpp -121.61 159.82 25.65 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.078 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.403 HG23 ' CG ' ' A' ' 46' ' ' ARG . 11.1 m -140.54 129.06 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.517 -0.74 . . . . 23.280000000000001 110.269 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.32 167.34 21.43 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.568 -0.708 . . . . 0.0 109.618 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -64.03 -29.61 70.75 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.95 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -72.39 -12.04 60.95 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.607 -0.683 . . . . 0.0 111.059 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.5 -7.34 50.48 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.415 -1.074 . . . . 30.43 110.415 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.475 HG21 ' CE2' ' A' ' 7' ' ' TYR . 30.4 m -57.55 135.99 56.7 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.098 -1.236 . . . . 0.0 110.038 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -101.74 141.48 34.53 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.412 -0.805 . . . . 0.0 110.985 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 42.7 p90 -169.39 148.78 3.9 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.65 -0.656 . . . . 28.030000000000001 109.865 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.2 pt -101.98 157.71 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.597 -0.69 . . . . 0.0 111.252 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -118.92 96.89 50.52 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.418 ' HB3' ' CD2' ' A' ' 100' ' ' HIS . 46.3 Cg_endo -58.1 143.3 96.81 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 O-C-N 123.939 1.494 . . . . 33.310000000000002 112.453 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.655 HD11 ' CD2' ' A' ' 101' ' ' TYR . 70.4 mt -107.51 121.89 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.352 -0.981 . . . . 30.59 108.352 178.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.17 144.61 6.9 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.157 0.503 . . . . 30.780000000000001 111.441 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.501 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -91.08 119.4 31.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.718 -0.613 . . . . 0.0 110.313 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.573 ' HE1' HD11 ' A' ' 120' ' ' LEU . 34.2 p90 -109.11 168.44 9.37 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.717 -0.845 . . . . 30.66 108.717 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.594 ' C ' HD12 ' A' ' 120' ' ' LEU . 57.9 t -114.21 154.67 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.304 -0.873 . . . . 0.0 110.542 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 120' ' ' LEU . 7.4 mp -112.4 133.64 54.38 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.342 -0.614 . . . . 39.149999999999999 109.342 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 95.6 p . . . . . 0 N--CA 1.494 1.754 0 O-C-N 121.681 -0.637 . . . . 0.0 110.046 -179.719 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.424 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 82.7 mtt85 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.024 0.44 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.453 ' CE2' HG21 ' A' ' 109' ' ' THR . 29.2 m-85 -114.82 98.96 7.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.56 -0.713 . . . . 31.93 110.109 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.484 ' C ' HG23 ' A' ' 9' ' ' VAL . 80.2 mtt85 -146.59 137.19 23.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.602 0.715 . . . . 0.0 110.216 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.535 HG11 ' CE ' ' A' ' 103' ' ' MET . 97.6 t -152.94 114.12 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.433 0.635 . . . . 0.0 109.305 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -109.06 130.16 55.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.539 -0.726 . . . . 0.0 109.981 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.48 HG22 ' HA ' ' A' ' 37' ' ' ILE . 60.2 t -118.34 141.55 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.811 -0.556 . . . . 28.210000000000001 109.97 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -120.1 137.66 54.01 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.465 -0.772 . . . . 0.0 109.817 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.765 HG22 HD13 ' A' ' 35' ' ' ILE . 61.1 t -128.65 137.4 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.607 -0.683 . . . . 27.949999999999999 110.45 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -125.97 106.11 25.67 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.778 -0.576 . . . . 0.0 110.624 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -84.52 165.83 12.22 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 O-C-N 123.923 1.486 . . . . 33.0 111.091 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -158.14 131.09 7.36 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.52 0.676 . . . . 54.100000000000001 109.953 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.474 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 79.8 t80 -61.5 139.97 58.15 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.766 -0.584 . . . . 0.0 111.563 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.0 HD11 ' HB2' ' A' ' 32' ' ' ALA . 73.8 mt -116.32 80.81 1.51 Allowed 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.912 0.863 . . . . 0.0 110.349 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.474 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -66.03 -35.88 81.75 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.901 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -69.93 -22.83 63.16 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.375 -0.828 . . . . 0.0 111.107 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -122.23 43.38 2.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.382 -0.824 . . . . 52.369999999999997 110.959 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.639 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 51.6 p -164.98 147.42 8.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.299 -0.876 . . . . 55.189999999999998 111.043 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.3 m -116.37 91.43 33.16 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.0 Cg_endo -65.09 -24.85 59.04 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 O-C-N 123.877 1.462 . . . . 51.57 111.229 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -67.94 -22.82 65.03 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.381 -0.824 . . . . 0.0 110.834 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -106.51 23.34 14.37 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.265 -0.897 . . . . 0.0 110.615 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.98 29.28 73.44 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -120.41 94.07 4.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.596 -0.943 . . . . 0.0 110.171 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.46 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 77.3 m-85 -105.48 132.18 51.97 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.495 -0.753 . . . . 46.07 109.278 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.639 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -114.72 120.62 40.7 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.093 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.598 ' CG ' HD23 ' A' ' 120' ' ' LEU . 87.7 m-85 -116.01 134.78 54.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.55 -0.718 . . . . 38.880000000000003 109.784 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 1.0 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -111.62 132.02 54.86 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.436 -0.95 . . . . 34.060000000000002 108.436 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.627 ' HE1' HG23 ' A' ' 88' ' ' VAL . 20.2 p90 -127.72 142.85 51.21 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.083 -1.047 . . . . 29.030000000000001 111.262 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.5 p -105.2 140.65 38.03 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.765 HD13 HG22 ' A' ' 13' ' ' VAL . 44.6 mm -105.3 131.8 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.841 0.829 . . . . 0.0 111.604 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -122.46 95.74 4.76 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.183 -0.673 . . . . 40.240000000000002 109.183 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.535 HG22 ' CD1' ' A' ' 76' ' ' LEU . 75.4 mt -90.84 117.81 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.792 -0.567 . . . . 20.73 110.657 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.556 ' OE1' ' HB2' ' A' ' 81' ' ' ALA . 71.6 tp60 -117.06 135.72 53.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.543 -0.723 . . . . 0.0 109.398 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -91.46 117.23 29.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.801 -0.562 . . . . 21.34 110.651 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.51 9.29 18.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.536 -0.728 . . . . 0.0 110.579 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.27 -177.08 51.7 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.182 -1.567 . . . . 29.100000000000001 109.182 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . . . -100.39 -30.99 11.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.492 -1.005 . . . . 0.0 110.063 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.519 HG13 ' HD2' ' A' ' 44' ' ' PRO . 86.2 t -105.4 140.56 21.27 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.8 -0.563 . . . . 0.0 109.545 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.519 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.2 Cg_endo -51.4 141.89 39.64 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 O-C-N 123.731 1.385 . . . . 21.949999999999999 111.9 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.7 151.73 46.12 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.488 0.661 . . . . 20.91 110.937 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -127.57 158.89 36.26 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.827 -0.546 . . . . 0.0 109.844 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.805 HD22 HG13 ' A' ' 69' ' ' VAL . 7.7 tt -97.88 117.12 31.48 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.449 -0.782 . . . . 0.0 109.404 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.439 HG21 HG21 ' A' ' 104' ' ' VAL . 62.1 t -100.69 -27.76 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.666 -0.646 . . . . 0.0 110.569 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.714 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -140.11 162.83 34.3 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.833 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.7 ptt85 -142.41 139.97 31.83 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.44 0.638 . . . . 29.050000000000001 110.206 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -142.24 113.67 7.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.72 -0.613 . . . . 27.969999999999999 109.699 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.503 ' CH2' HD13 ' A' ' 115' ' ' ILE . 92.4 m95 -101.92 133.5 46.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.74 -0.6 . . . . 25.25 110.792 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -116.33 77.33 1.09 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.633 -0.667 . . . . 0.0 109.338 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 54' ' ' ILE . 28.4 pt -84.17 129.19 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.922 0.868 . . . . 36.109999999999999 112.149 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.5 m -121.0 130.99 54.02 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.325 -0.991 . . . . 33.979999999999997 108.325 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -88.64 170.59 10.69 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.725 0.774 . . . . 45.039999999999999 111.427 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.55 -7.67 8.18 Favored Glycine 0 N--CA 1.494 2.542 0 O-C-N 121.823 -0.548 . . . . 39.469999999999999 112.299 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -101.21 6.92 43.21 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 119.411 1.605 . . . . 0.0 110.691 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.77 -28.33 9.47 Favored Glycine 0 N--CA 1.495 2.587 0 O-C-N 121.204 -0.935 . . . . 0.0 110.955 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.76 142.0 58.56 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.256 -1.143 . . . . 62.780000000000001 109.779 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.7 t -135.06 153.16 52.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.489 -0.757 . . . . 0.0 110.756 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -121.51 123.33 41.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.535 -0.728 . . . . 0.0 110.076 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -102.36 135.61 43.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.75 -0.594 . . . . 0.0 110.742 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.9 t -128.67 132.9 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.628 -0.67 . . . . 37.939999999999998 109.85 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -124.64 127.48 47.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.828 -0.545 . . . . 0.0 110.452 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -153.94 170.32 32.56 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.215 -1.554 . . . . 31.82 109.215 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -114.99 159.98 20.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.374 -1.074 . . . . 0.0 110.141 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.44 96.25 0.01 OUTLIER Glycine 0 N--CA 1.5 2.957 0 O-C-N 121.328 -0.857 . . . . 22.620000000000001 111.444 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.805 HG13 HD22 ' A' ' 47' ' ' LEU . 30.4 m -46.32 133.37 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.453 0 O-C-N 121.365 -1.079 . . . . 17.510000000000002 111.425 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.0 m 41.45 34.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 CA-C-O 121.587 0.708 . . . . 20.550000000000001 111.312 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.62 23.14 54.42 Favored Glycine 0 N--CA 1.495 2.603 0 O-C-N 121.714 -0.616 . . . . 18.289999999999999 112.301 178.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.53 ' HG3' HG23 ' A' ' 69' ' ' VAL . 2.2 pt-20 -144.21 151.25 39.22 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 119.125 1.463 . . . . 0.0 112.335 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -117.86 72.19 8.33 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.152 -1.055 . . . . 18.210000000000001 108.152 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -54.8 141.79 75.78 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 O-C-N 123.757 1.399 . . . . 17.609999999999999 112.385 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -103.75 75.32 1.3 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.535 ' CD1' HG22 ' A' ' 37' ' ' ILE . 15.0 mt -60.43 119.66 8.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.706 -0.621 . . . . 20.57 111.915 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -86.05 158.45 55.72 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -53.48 127.4 25.16 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 O-C-N 123.539 1.284 . . . . 27.039999999999999 111.167 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.76 -16.48 56.55 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.74 -0.944 . . . . 24.739999999999998 110.74 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -87.25 164.36 16.36 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.089 -1.242 . . . . 29.379999999999999 110.427 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.556 ' HB2' ' OE1' ' A' ' 38' ' ' GLN . . . -145.45 149.33 34.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.568 -0.708 . . . . 0.0 110.199 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -119.2 144.63 46.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.499 -0.751 . . . . 18.559999999999999 109.212 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 -144.14 140.93 29.67 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.163 -0.96 . . . . 0.0 111.236 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.462 ' CE1' HG21 ' A' ' 35' ' ' ILE . 51.0 p90 -150.8 160.05 44.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.646 -0.659 . . . . 26.649999999999999 109.74 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 60.3 m -100.8 136.08 41.23 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.445 -0.785 . . . . 28.140000000000001 110.848 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 23.3 t -126.38 168.08 14.65 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.554 -0.716 . . . . 33.880000000000003 110.115 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -135.67 129.11 4.88 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.926 -1.13 . . . . 31.800000000000001 110.496 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.627 HG23 ' HE1' ' A' ' 33' ' ' TYR . 54.2 t -133.01 148.76 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.592 -0.946 . . . . 0.0 109.248 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 29' ' ' TYR . 15.9 tp -109.81 143.79 39.18 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.552 -0.718 . . . . 0.0 110.542 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.746 HD23 ' O ' ' A' ' 92' ' ' THR . 11.4 tp -121.49 144.26 48.8 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.574 -0.704 . . . . 38.68 109.767 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -75.98 -25.41 55.79 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.25 -0.906 . . . . 0.0 111.096 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.746 ' O ' HD23 ' A' ' 90' ' ' LEU . 5.8 m -124.04 171.97 9.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.332 -0.855 . . . . 31.629999999999999 110.512 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.428 ' H ' HG22 ' A' ' 92' ' ' THR . 52.6 tt0 -86.28 11.45 12.13 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.612 -0.68 . . . . 0.0 111.592 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -142.89 142.98 31.86 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.2 -0.937 . . . . 0.0 109.626 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -177.47 152.73 12.29 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 118.751 -1.69 . . . . 28.050000000000001 112.198 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -118.05 130.33 56.1 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 90.7 mtp -128.0 124.02 36.18 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.457 -0.777 . . . . 0.0 111.597 -178.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.546 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 62.8 mt-30 -125.49 152.19 45.29 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.89 179.88 38.59 Favored Glycine 0 N--CA 1.5 2.958 0 C-N-CA 118.665 -1.731 . . . . 29.620000000000001 111.211 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -134.62 159.07 42.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.843 -0.798 . . . . 0.0 110.031 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.674 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 8.2 m-85 -116.71 127.35 54.31 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.589 -0.694 . . . . 27.050000000000001 109.959 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.714 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 40.4 t0 -85.99 118.51 25.51 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.06 -1.025 . . . . 0.0 108.815 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.535 ' CE ' HG11 ' A' ' 9' ' ' VAL . 18.3 tpp -124.73 160.78 27.83 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.294 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.439 HG21 HG21 ' A' ' 48' ' ' VAL . 7.2 m -140.93 131.19 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.614 -0.679 . . . . 23.280000000000001 110.328 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.04 166.86 22.28 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.437 -0.789 . . . . 0.0 109.606 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -64.64 -29.45 70.45 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.94 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -73.72 -11.24 60.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.519 -0.738 . . . . 0.0 111.059 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.24 -7.3 47.43 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.411 -1.076 . . . . 30.43 110.411 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.453 HG21 ' CE2' ' A' ' 7' ' ' TYR . 24.3 m -57.68 135.47 56.74 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.026 -1.279 . . . . 0.0 110.056 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -101.14 139.61 36.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.441 -0.787 . . . . 0.0 110.69 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 43.8 p90 -165.78 145.05 6.26 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.75 -0.594 . . . . 28.030000000000001 109.902 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 24.9 pt -102.21 158.11 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.716 -0.615 . . . . 0.0 111.16 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.674 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -119.86 97.6 49.59 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -58.15 143.82 96.19 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 O-C-N 123.835 1.439 . . . . 33.310000000000002 112.166 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.503 HD13 ' CH2' ' A' ' 52' ' ' TRP . 68.7 mt -108.81 122.52 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-N 115.368 -0.833 . . . . 30.59 108.954 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.61 172.81 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.255 0.55 . . . . 30.780000000000001 111.429 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.546 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -100.29 119.93 39.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.583 -0.698 . . . . 0.0 110.753 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 97' ' ' MET . 41.9 p90 -111.99 156.02 22.83 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.244 -1.021 . . . . 30.66 108.244 178.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.672 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.2 t -116.95 153.45 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.177 -0.952 . . . . 0.0 110.886 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.672 HD12 ' C ' ' A' ' 119' ' ' VAL . 7.9 mp -114.52 130.16 56.72 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.141 -0.689 . . . . 39.149999999999999 109.141 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.606 -0.684 . . . . 0.0 110.156 -179.802 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.665 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 91.1 mtm-85 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.772 0.32 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.53 ' CZ ' HG21 ' A' ' 109' ' ' THR . 90.9 m-85 -119.18 105.96 11.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.52 -0.738 . . . . 31.93 110.141 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.474 ' C ' HG23 ' A' ' 9' ' ' VAL . 93.8 mtt-85 -149.03 134.82 18.84 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.615 -0.678 . . . . 0.0 110.07 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.818 HG11 ' SD ' ' A' ' 103' ' ' MET . 97.0 t -151.58 116.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-O 121.554 0.692 . . . . 0.0 109.609 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -105.63 131.24 53.25 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.652 0.739 . . . . 0.0 110.385 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.577 HG11 ' HE2' ' A' ' 101' ' ' TYR . 63.4 t -118.75 136.12 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 109.303 -0.628 . . . . 28.210000000000001 109.303 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -124.02 137.24 54.62 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.306 -0.871 . . . . 0.0 110.136 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 75.8 t -129.22 136.95 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.679 -0.638 . . . . 27.949999999999999 110.523 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.1 m -125.12 105.55 28.72 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.785 -0.572 . . . . 0.0 110.302 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.406 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 49.8 Cg_endo -82.33 164.66 16.87 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.859 1.452 . . . . 33.0 111.255 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -157.47 130.63 7.71 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.667 0.746 . . . . 54.100000000000001 109.722 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.509 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 76.9 t80 -63.95 139.87 58.81 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.663 -0.648 . . . . 0.0 111.585 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.981 HD11 ' HB2' ' A' ' 32' ' ' ALA . 96.0 mt -116.04 80.7 1.49 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.947 0.88 . . . . 0.0 110.453 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.509 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -68.46 -35.75 78.01 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.793 178.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -69.54 -24.02 63.67 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.447 -0.783 . . . . 0.0 110.734 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -120.84 43.1 2.86 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.431 -0.793 . . . . 52.369999999999997 110.735 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.736 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 32.7 t -164.68 146.67 8.32 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.365 -0.834 . . . . 55.189999999999998 110.974 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.59 ' O ' HG23 ' A' ' 23' ' ' THR . 5.1 t -120.38 93.12 48.07 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.552 -0.718 . . . . 0.0 109.146 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.472 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.1 Cg_endo -65.94 -23.09 54.83 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 O-C-N 123.89 1.469 . . . . 51.57 111.573 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -65.61 -23.69 66.88 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.378 -0.826 . . . . 0.0 111.047 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -105.59 23.99 12.93 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.347 -0.845 . . . . 0.0 110.815 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.24 27.82 73.57 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.565 ' HB2' HG23 ' A' ' 23' ' ' THR . 10.5 mtm180 -120.79 94.2 4.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.503 -0.998 . . . . 0.0 110.169 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.472 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 68.2 m-85 -104.45 132.68 50.42 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.601 -0.687 . . . . 46.07 109.313 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.736 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -114.64 120.56 40.58 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.338 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.578 ' CG ' HD23 ' A' ' 120' ' ' LEU . 89.4 m-85 -116.26 134.5 54.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.529 -0.732 . . . . 38.880000000000003 109.841 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.981 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -112.16 132.71 54.73 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.442 -0.947 . . . . 34.060000000000002 108.442 178.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.605 ' HE1' HG23 ' A' ' 88' ' ' VAL . 20.1 p90 -128.05 143.28 51.07 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.078 -1.049 . . . . 29.030000000000001 111.611 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.9 m -106.71 139.69 40.75 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.818 HD12 ' CZ ' ' A' ' 84' ' ' TYR . 87.3 mt -108.8 134.55 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 121.668 0.747 . . . . 0.0 111.671 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.3 mtm105 -124.82 98.65 5.8 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.642 0.734 . . . . 40.240000000000002 109.796 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.563 HG22 ' CD1' ' A' ' 76' ' ' LEU . 85.4 mt -94.13 118.26 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.818 -0.551 . . . . 20.73 110.726 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -116.43 138.61 51.22 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.267 -0.896 . . . . 0.0 109.231 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -90.61 117.97 29.69 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.78 -0.575 . . . . 21.34 110.856 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.51 9.92 15.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.477 -0.765 . . . . 0.0 110.603 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.2 -178.97 52.4 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.417 -1.473 . . . . 29.100000000000001 109.417 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.665 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . . . -94.69 -33.89 12.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.441 -1.034 . . . . 0.0 110.326 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.516 HG13 ' HD2' ' A' ' 44' ' ' PRO . 87.4 t -103.78 139.6 20.26 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.846 -0.533 . . . . 0.0 109.946 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.516 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.9 Cg_endo -52.35 143.22 44.55 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 O-C-N 123.883 1.465 . . . . 21.949999999999999 111.845 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.452 ' HB1' ' HZ ' ' A' ' 111' ' ' PHE . . . -139.88 151.92 46.03 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.498 0.666 . . . . 20.91 110.99 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.438 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 19.6 ptt-85 -128.05 158.96 36.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.824 -0.547 . . . . 0.0 110.017 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.903 HD22 HG13 ' A' ' 69' ' ' VAL . 6.4 tt -97.7 115.28 27.66 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.446 -0.784 . . . . 0.0 109.246 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.444 HG11 HG21 ' A' ' 104' ' ' VAL . 35.1 m -100.54 -26.18 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.632 -0.667 . . . . 0.0 111.175 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.763 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -142.4 163.05 33.9 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.196 -0.94 . . . . 0.0 111.734 -179.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.463 ' HD3' HG12 ' A' ' 69' ' ' VAL . 39.3 ptt85 -145.39 142.26 29.18 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.644 0.735 . . . . 29.050000000000001 110.858 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.608 ' HB3' ' CE1' ' A' ' 100' ' ' HIS . 22.1 t-160 -144.89 115.17 7.54 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.324 -0.621 . . . . 27.969999999999999 109.324 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -98.05 135.6 39.51 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.558 -0.713 . . . . 25.25 111.747 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -115.48 75.98 0.98 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.427 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.8 pt -86.98 131.3 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.412 -0.805 . . . . 36.109999999999999 112.14 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.966 HG23 HG22 ' A' ' 61' ' ' THR . 12.3 m -119.85 132.93 55.72 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.35 -0.982 . . . . 33.979999999999997 108.35 178.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -87.19 169.48 12.31 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.638 0.732 . . . . 45.039999999999999 111.308 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.32 -8.36 12.4 Favored Glycine 0 N--CA 1.494 2.549 0 O-C-N 121.828 -0.545 . . . . 39.469999999999999 112.124 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -101.01 8.15 43.14 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 119.402 1.601 . . . . 0.0 110.859 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.34 -23.07 29.26 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.196 -0.94 . . . . 0.0 110.952 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -60.4 142.16 55.35 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.187 -1.184 . . . . 62.780000000000001 109.806 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.966 HG22 HG23 ' A' ' 55' ' ' THR . 74.3 p -126.05 142.0 51.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.407 -0.808 . . . . 0.0 110.669 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -122.87 119.95 32.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.411 -0.806 . . . . 0.0 109.948 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -104.79 134.47 47.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.657 -0.652 . . . . 0.0 110.7 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.9 t -127.93 130.85 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.625 -0.672 . . . . 37.939999999999998 109.81 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -123.41 126.6 47.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.84 -0.537 . . . . 0.0 110.299 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -147.84 147.45 18.13 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.223 -1.551 . . . . 31.82 109.223 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -72.59 155.63 39.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.51 -0.994 . . . . 0.0 110.15 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.59 -170.65 0.08 OUTLIER Glycine 0 N--CA 1.498 2.824 0 O-C-N 121.49 -0.756 . . . . 22.620000000000001 111.357 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.903 HG13 HD22 ' A' ' 47' ' ' LEU . 13.0 m -129.74 127.96 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.835 -0.803 . . . . 17.510000000000002 108.957 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.517 HG11 ' CE2' ' A' ' 84' ' ' TYR . 12.3 m 41.75 34.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 CA-C-O 121.7 0.762 . . . . 20.550000000000001 111.448 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.4 18.83 61.53 Favored Glycine 0 N--CA 1.497 2.751 0 O-C-N 121.714 -0.616 . . . . 18.289999999999999 113.041 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.425 ' O ' HG22 ' A' ' 69' ' ' VAL . 8.6 pt-20 -147.58 150.67 34.9 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 119.449 1.625 . . . . 0.0 112.675 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -115.24 73.05 3.47 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 108.257 -1.016 . . . . 18.210000000000001 108.257 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -55.5 141.49 82.63 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 O-C-N 123.842 1.443 . . . . 17.609999999999999 112.426 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.438 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 4.7 t90 -102.39 76.88 1.59 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.563 ' CD1' HG22 ' A' ' 37' ' ' ILE . 9.3 mt -60.89 117.49 5.49 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.636 -0.665 . . . . 20.57 111.783 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -88.39 159.12 47.94 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -54.25 129.58 35.3 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 O-C-N 123.535 1.281 . . . . 27.039999999999999 111.134 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.91 -18.9 44.95 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 111.003 -0.839 . . . . 24.739999999999998 111.003 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.93 166.62 14.39 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.117 -1.225 . . . . 29.379999999999999 110.446 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -144.55 146.16 32.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.672 -0.643 . . . . 0.0 110.415 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.512 ' HD2' HD12 ' A' ' 37' ' ' ILE . 89.5 t80 -114.58 141.24 48.01 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.049 -0.722 . . . . 18.559999999999999 109.049 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -147.95 140.98 24.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.298 -0.876 . . . . 0.0 111.101 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.818 ' CZ ' HD12 ' A' ' 35' ' ' ILE . 46.3 p90 -153.33 162.5 41.22 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.621 -0.674 . . . . 26.649999999999999 109.775 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.1 m -99.01 135.78 39.92 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.468 -0.77 . . . . 28.140000000000001 111.211 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 17.2 t -125.16 166.65 16.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.642 -0.661 . . . . 33.880000000000003 109.688 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.26 130.33 5.69 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 119.779 -1.201 . . . . 31.800000000000001 110.536 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.605 HG23 ' HE1' ' A' ' 33' ' ' TYR . 61.2 t -132.77 147.01 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.695 -0.885 . . . . 0.0 109.118 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.2 tp -110.27 143.74 40.0 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.559 -0.713 . . . . 0.0 110.33 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.75 HD12 HD22 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -122.4 144.97 48.7 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.491 -0.756 . . . . 38.68 109.936 -179.683 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -78.24 -26.09 47.17 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.425 -0.797 . . . . 0.0 110.641 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.446 HG22 ' N ' ' A' ' 93' ' ' GLU . 21.5 m -123.41 171.22 9.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.42 -0.8 . . . . 31.629999999999999 110.2 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.446 ' N ' HG22 ' A' ' 92' ' ' THR . 56.8 tt0 -86.21 12.54 9.59 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.415 -0.803 . . . . 0.0 111.579 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 97.0 mt-30 -140.99 144.99 35.38 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.044 -1.035 . . . . 0.0 109.698 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.51 158.94 21.66 Favored Glycine 0 N--CA 1.496 2.673 0 C-N-CA 118.766 -1.683 . . . . 28.050000000000001 112.321 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -119.66 129.96 54.83 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 122.128 -0.631 . . . . 0.0 109.578 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.478 ' HB3' ' HE2' ' A' ' 97' ' ' MET . 90.0 mtp -125.48 117.42 23.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.275 -0.89 . . . . 0.0 111.075 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.496 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 57.1 tt0 -129.21 150.04 50.76 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.36 -177.83 38.04 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 119.108 -1.52 . . . . 29.620000000000001 110.514 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.608 ' CE1' ' HB3' ' A' ' 51' ' ' HIS . 23.1 p80 -140.26 159.93 41.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.698 -0.883 . . . . 0.0 110.676 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.645 ' CD1' HD11 ' A' ' 47' ' ' LEU . 5.2 m-85 -115.3 128.38 56.07 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.753 -0.592 . . . . 27.050000000000001 109.944 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.763 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 42.9 t0 -83.4 122.3 28.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.006 -1.059 . . . . 0.0 108.739 177.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.818 ' SD ' HG11 ' A' ' 9' ' ' VAL . 43.0 mtp -123.51 161.93 23.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.878 -0.513 . . . . 0.0 110.507 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.444 HG21 HG11 ' A' ' 48' ' ' VAL . 6.4 m -140.32 129.47 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.719 -0.613 . . . . 23.280000000000001 110.23 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.21 166.53 22.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.507 -0.745 . . . . 0.0 109.649 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -65.86 -29.27 69.7 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.198 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -76.74 -4.89 45.7 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.395 -0.816 . . . . 0.0 111.347 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.33 -9.52 57.61 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.045 -1.074 . . . . 30.43 110.627 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.53 HG21 ' CZ ' ' A' ' 7' ' ' TYR . 23.9 m -57.42 134.57 56.16 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.047 -1.266 . . . . 0.0 110.104 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -101.68 139.61 37.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.37 -0.831 . . . . 0.0 110.724 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 45.2 p90 -164.08 143.75 7.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.664 -0.648 . . . . 28.030000000000001 109.856 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 102' ' ' ASP . 50.9 mm -98.69 156.11 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.661 -0.649 . . . . 0.0 110.61 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.53 96.92 48.93 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -59.44 141.53 97.63 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.911 1.479 . . . . 33.310000000000002 112.222 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.613 HD11 ' CD2' ' A' ' 101' ' ' TYR . 68.0 mt -107.08 124.05 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.627 -0.879 . . . . 30.59 108.627 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.92 147.52 3.82 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.234 0.54 . . . . 30.780000000000001 111.48 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.496 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -89.65 122.33 32.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.597 -0.689 . . . . 0.0 110.179 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.637 ' CE1' HD11 ' A' ' 120' ' ' LEU . 45.0 p90 -109.1 164.69 12.2 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.934 -0.765 . . . . 30.66 108.934 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.634 ' C ' HD12 ' A' ' 120' ' ' LEU . 57.8 t -114.48 155.4 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.333 -0.854 . . . . 0.0 110.28 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.75 HD22 HD12 ' A' ' 90' ' ' LEU . 7.0 mp -114.11 132.17 56.15 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.264 -0.643 . . . . 39.149999999999999 109.264 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.687 -0.633 . . . . 0.0 110.104 -179.852 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.42 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 38.7 ttm180 . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 120.906 0.384 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.445 ' CZ ' HG21 ' A' ' 109' ' ' THR . 47.7 m-85 -115.83 107.18 14.71 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.559 -0.713 . . . . 31.93 110.167 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.483 ' C ' HG23 ' A' ' 9' ' ' VAL . 9.8 ttt85 -153.44 135.2 14.52 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.561 0.696 . . . . 0.0 110.413 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.729 HG11 ' SD ' ' A' ' 103' ' ' MET . 97.0 t -152.29 116.08 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-O 121.448 0.642 . . . . 0.0 109.499 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -107.36 130.07 54.83 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.622 0.725 . . . . 0.0 110.049 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.0 t -118.1 139.46 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.848 -0.532 . . . . 28.210000000000001 109.817 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -121.81 137.81 54.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.386 -0.822 . . . . 0.0 110.014 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.724 HG22 HD13 ' A' ' 35' ' ' ILE . 58.7 t -128.7 137.11 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.59 -0.694 . . . . 27.949999999999999 110.379 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -125.3 106.9 27.54 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.738 -0.601 . . . . 0.0 110.485 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.439 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 51.0 Cg_endo -82.76 165.66 15.54 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 O-C-N 123.816 1.43 . . . . 33.0 111.119 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -158.05 129.59 6.72 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.595 0.712 . . . . 54.100000000000001 109.588 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.496 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 78.7 t80 -62.98 139.95 58.82 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.753 -0.592 . . . . 0.0 111.543 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.003 HD11 ' HB2' ' A' ' 32' ' ' ALA . 88.9 mt -115.85 81.2 1.56 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.907 0.861 . . . . 0.0 110.381 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.496 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -68.44 -35.77 78.08 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.893 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -69.94 -23.18 63.16 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.415 -0.803 . . . . 0.0 110.823 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -121.23 38.97 3.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.364 -0.835 . . . . 52.369999999999997 110.757 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.738 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 32.9 t -160.01 145.75 15.48 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.335 -0.853 . . . . 55.189999999999998 111.117 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.59 HG23 ' HB2' ' A' ' 28' ' ' ARG . 5.0 t -120.02 92.76 47.24 Favored Pre-proline 0 N--CA 1.496 1.848 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.476 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.8 Cg_endo -66.32 -23.0 52.17 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 O-C-N 123.86 1.453 . . . . 51.57 111.718 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -65.28 -23.45 67.04 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.357 -0.839 . . . . 0.0 110.994 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -105.62 24.15 12.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.306 -0.871 . . . . 0.0 110.846 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.99 28.13 73.68 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.59 ' HB2' HG23 ' A' ' 23' ' ' THR . 13.3 mtp180 -120.98 94.0 4.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.642 -0.916 . . . . 0.0 110.23 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.476 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 69.8 m-85 -104.14 133.56 48.87 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.607 -0.683 . . . . 46.07 109.359 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.738 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -115.21 120.19 38.87 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 119.754 -0.779 . . . . 0.0 111.075 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.83 ' CD1' HD12 ' A' ' 90' ' ' LEU . 91.4 m-85 -115.92 135.26 54.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.512 -0.742 . . . . 38.880000000000003 109.782 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 1.003 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -112.38 132.24 55.12 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.542 -0.91 . . . . 34.060000000000002 108.542 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.621 ' HE1' HG13 ' A' ' 88' ' ' VAL . 18.5 p90 -128.4 143.26 50.97 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.214 -0.995 . . . . 29.030000000000001 111.429 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.5 t -105.77 140.57 38.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.724 -0.61 . . . . 0.0 109.494 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.724 HD13 HG22 ' A' ' 13' ' ' VAL . 45.6 mm -105.11 131.84 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.727 0.775 . . . . 0.0 111.63 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -122.91 96.93 5.21 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.532 0.682 . . . . 40.240000000000002 109.381 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.513 HG22 ' CD1' ' A' ' 76' ' ' LEU . 79.9 mt -92.48 117.83 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.759 -0.588 . . . . 20.73 110.592 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -116.82 134.16 55.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.496 -0.753 . . . . 0.0 109.248 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -92.79 117.57 30.16 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 120.204 -0.598 . . . . 21.34 110.565 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.35 11.96 16.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.49 -0.756 . . . . 0.0 110.575 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.25 -179.26 52.76 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.086 -1.605 . . . . 29.100000000000001 109.086 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . . . -94.99 -32.89 12.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.479 -1.012 . . . . 0.0 110.32 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.526 HG13 ' HD2' ' A' ' 44' ' ' PRO . 85.3 t -104.6 141.2 22.05 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.83 -0.544 . . . . 0.0 109.883 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.526 ' HD2' HG13 ' A' ' 43' ' ' VAL . 40.1 Cg_endo -53.53 143.26 56.82 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 O-C-N 123.809 1.426 . . . . 21.949999999999999 111.91 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.408 ' HB1' ' HZ ' ' A' ' 111' ' ' PHE . . . -139.7 151.69 46.09 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.604 0.716 . . . . 20.91 110.861 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.436 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 18.4 ptt180 -127.96 159.76 33.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.751 -0.593 . . . . 0.0 109.723 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.923 HD22 HG13 ' A' ' 69' ' ' VAL . 6.9 tt -98.14 117.28 32.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.432 -0.792 . . . . 0.0 109.699 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.46 HG21 HG21 ' A' ' 104' ' ' VAL . 62.5 t -99.85 -29.45 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.514 -0.741 . . . . 0.0 110.677 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.696 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -141.38 162.66 34.95 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.949 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.6 ptt85 -143.7 141.59 30.58 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.673 0.749 . . . . 29.050000000000001 110.323 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -144.51 113.97 7.09 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.405 0.622 . . . . 27.969999999999999 109.507 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -98.45 135.2 40.35 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.65 -0.656 . . . . 25.25 111.488 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -115.38 75.85 0.97 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 54' ' ' ILE . 28.3 pt -85.7 130.5 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 121.85 0.833 . . . . 36.109999999999999 111.975 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.596 HG23 HG22 ' A' ' 61' ' ' THR . 86.1 m -121.22 132.93 55.11 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.351 -0.981 . . . . 33.979999999999997 108.351 178.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -87.32 169.74 12.03 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.717 0.77 . . . . 45.039999999999999 111.477 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.29 -7.88 15.93 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 121.819 -0.551 . . . . 39.469999999999999 112.06 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -100.57 8.12 43.63 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 119.345 1.573 . . . . 0.0 110.578 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.7 -21.3 36.77 Favored Glycine 0 N--CA 1.493 2.49 0 O-C-N 121.233 -0.917 . . . . 0.0 111.011 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.19 141.03 56.6 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.169 -1.195 . . . . 62.780000000000001 109.806 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.596 HG22 HG23 ' A' ' 55' ' ' THR . 82.1 p -125.87 140.09 52.94 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.447 -0.783 . . . . 0.0 110.668 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -123.73 120.0 31.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.41 -0.806 . . . . 0.0 110.014 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -104.85 135.26 46.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.686 -0.634 . . . . 0.0 110.859 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.26 130.62 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.58 -0.7 . . . . 37.939999999999998 109.848 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.65 127.57 47.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.817 -0.552 . . . . 0.0 110.42 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.79 150.92 23.06 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.289 -1.524 . . . . 31.82 109.289 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -79.43 156.76 27.75 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.559 -0.965 . . . . 0.0 110.25 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 51.57 -173.49 0.18 Allowed Glycine 0 N--CA 1.497 2.752 0 N-CA-C 111.008 -0.837 . . . . 22.620000000000001 111.008 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.923 HG13 HD22 ' A' ' 47' ' ' LEU . 15.2 m -130.1 127.98 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.793 -0.828 . . . . 17.510000000000002 109.606 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.6 m 41.12 36.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 CA-C-O 121.514 0.673 . . . . 20.550000000000001 111.853 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.13 16.65 68.99 Favored Glycine 0 N--CA 1.499 2.857 0 O-C-N 121.683 -0.636 . . . . 18.289999999999999 113.002 177.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.409 ' O ' HG22 ' A' ' 69' ' ' VAL . 9.9 pt-20 -145.64 150.9 37.19 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 119.164 1.482 . . . . 0.0 112.018 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -115.22 75.12 4.18 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.915 -0.772 . . . . 18.210000000000001 108.915 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -57.67 140.06 92.28 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 O-C-N 123.861 1.453 . . . . 17.609999999999999 112.149 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.436 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 4.1 t90 -103.14 77.57 1.55 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.513 ' CD1' HG22 ' A' ' 37' ' ' ILE . 11.3 mt -60.14 118.31 6.18 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.462 0.649 . . . . 20.57 111.953 -178.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 -85.8 157.19 57.93 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -53.49 128.1 27.99 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 O-C-N 123.561 1.295 . . . . 27.039999999999999 111.15 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.66 -17.13 54.39 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.727 -0.949 . . . . 24.739999999999998 110.727 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -86.89 165.71 15.71 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.058 -1.26 . . . . 29.379999999999999 110.537 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.02 149.1 34.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.66 -0.65 . . . . 0.0 110.041 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.4 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 79.6 t80 -118.9 146.27 45.05 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.47 -0.769 . . . . 18.559999999999999 109.179 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -146.05 141.03 27.22 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.213 -0.929 . . . . 0.0 111.13 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.447 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 50.6 p90 -151.09 160.02 44.14 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.59 -0.693 . . . . 26.649999999999999 109.837 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.2 m -100.04 135.58 41.25 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.391 -0.818 . . . . 28.140000000000001 110.646 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 28.4 t -125.06 167.41 14.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.592 -0.693 . . . . 33.880000000000003 110.048 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.87 129.97 5.48 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.841 -1.171 . . . . 31.800000000000001 110.481 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.621 HG13 ' HE1' ' A' ' 33' ' ' TYR . 15.6 m -134.75 148.61 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.695 -0.885 . . . . 0.0 109.821 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 89' ' ' LEU . 4.9 mp -112.93 144.28 42.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.57 -0.706 . . . . 0.0 110.569 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.83 HD12 ' CD1' ' A' ' 31' ' ' PHE . 31.8 mt -121.98 146.57 47.02 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.639 -0.663 . . . . 38.68 110.004 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -77.6 -26.16 50.45 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.405 -0.809 . . . . 0.0 110.765 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.5 p -122.95 171.33 9.31 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.47 -0.769 . . . . 31.629999999999999 110.522 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -86.13 11.06 12.65 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.636 -0.665 . . . . 0.0 111.549 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 78.1 mt-30 -140.72 146.18 37.42 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.016 -1.053 . . . . 0.0 109.638 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.42 153.21 10.72 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 118.921 -1.609 . . . . 28.050000000000001 112.264 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -118.2 129.84 55.73 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 94.3 mtp -126.8 122.45 34.8 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.39 -0.819 . . . . 0.0 111.63 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.491 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 57.2 tt0 -127.34 149.45 50.04 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.86 -177.68 36.85 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 118.931 -1.604 . . . . 29.620000000000001 110.844 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -142.81 158.81 43.26 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.795 -0.826 . . . . 0.0 110.626 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.703 ' CD2' HD11 ' A' ' 115' ' ' ILE . 4.5 m-85 -116.68 129.18 55.98 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.656 -0.652 . . . . 27.050000000000001 110.076 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.696 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 11.0 t70 -83.06 122.65 28.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.014 -1.054 . . . . 0.0 109.095 177.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.729 ' SD ' HG11 ' A' ' 9' ' ' VAL . 63.3 mtp -123.12 163.01 21.36 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.108 0.48 . . . . 0.0 110.457 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.46 HG21 HG21 ' A' ' 48' ' ' VAL . 7.5 m -142.54 131.55 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.65 -0.656 . . . . 23.280000000000001 110.432 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.531 ' HB3' ' HB ' ' A' ' 109' ' ' THR . . . -70.2 165.03 23.02 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.398 -0.814 . . . . 0.0 109.508 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -65.71 -27.21 68.16 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.519 -0.738 . . . . 0.0 110.46 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -79.93 -1.29 38.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.321 -0.862 . . . . 0.0 111.312 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.03 -10.07 56.79 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.962 -1.113 . . . . 30.43 110.581 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 25.6 m -57.46 134.02 55.71 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.086 -1.244 . . . . 0.0 110.059 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -102.64 139.24 38.48 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.311 -0.868 . . . . 0.0 110.782 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 43.1 p90 -162.82 141.68 8.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.759 -0.588 . . . . 28.030000000000001 110.002 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.8 pt -98.43 156.8 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.715 -0.615 . . . . 0.0 110.77 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -121.33 97.98 46.95 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -59.31 142.11 98.67 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 O-C-N 123.907 1.477 . . . . 33.310000000000002 112.039 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.703 HD11 ' CD2' ' A' ' 101' ' ' TYR . 70.9 mt -107.68 124.13 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.791 -0.818 . . . . 30.59 108.791 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.59 151.18 2.41 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.264 0.554 . . . . 30.780000000000001 111.356 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.491 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -98.67 118.19 34.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.675 -0.641 . . . . 0.0 110.159 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.7 ' CE1' HD11 ' A' ' 120' ' ' LEU . 41.6 p90 -107.95 168.94 8.92 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.944 -0.761 . . . . 30.66 108.944 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.605 ' C ' HD12 ' A' ' 120' ' ' LEU . 57.5 t -114.23 154.14 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.251 -0.906 . . . . 0.0 110.509 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.804 HD22 HD11 ' A' ' 90' ' ' LEU . 7.0 mp -113.65 132.4 55.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.676 -0.64 . . . . 39.149999999999999 109.357 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 79.8 p . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.636 -0.665 . . . . 0.0 110.1 -179.808 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.457 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 76.9 mtp180 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 120.951 0.405 . . . . 0.0 110.111 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -109.97 100.59 9.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.785 -0.572 . . . . 31.93 109.908 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.467 ' C ' HG23 ' A' ' 9' ' ' VAL . 64.7 mtp85 -149.0 137.21 20.86 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.754 0.788 . . . . 0.0 110.314 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.467 HG23 ' C ' ' A' ' 8' ' ' ARG . 82.2 t -151.31 114.79 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -107.55 130.26 54.89 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.574 0.702 . . . . 0.0 110.109 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.9 t -118.53 138.89 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.883 -0.511 . . . . 28.210000000000001 109.639 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -121.24 137.36 54.72 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.477 -0.764 . . . . 0.0 109.85 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.735 HG22 HD13 ' A' ' 35' ' ' ILE . 62.2 t -129.16 136.58 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.555 -0.715 . . . . 27.949999999999999 110.502 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.6 t -125.24 104.43 28.98 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.714 -0.616 . . . . 0.0 110.226 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.441 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 50.2 Cg_endo -83.86 165.81 13.41 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 O-C-N 123.815 1.429 . . . . 33.0 111.095 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -158.02 131.5 7.7 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.527 0.679 . . . . 54.100000000000001 109.737 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.523 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 78.5 t80 -59.29 138.49 57.6 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.737 -0.602 . . . . 0.0 111.2 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.516 HD23 ' HB3' ' A' ' 21' ' ' GLN . 9.1 tp -115.01 80.72 1.46 Allowed 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 122.014 0.912 . . . . 0.0 110.269 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.523 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -70.07 -35.63 74.35 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.366 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -69.22 -22.6 63.86 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.366 -0.834 . . . . 0.0 111.03 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.516 ' HB3' HD23 ' A' ' 18' ' ' LEU . 34.1 tp60 -121.75 36.87 4.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.283 -0.885 . . . . 52.369999999999997 110.596 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.714 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 32.8 t -156.95 146.02 20.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.451 -0.781 . . . . 55.189999999999998 111.02 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.602 ' O ' HG23 ' A' ' 23' ' ' THR . 9.2 t -122.03 92.83 48.82 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.475 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.1 Cg_endo -65.98 -22.39 55.46 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 O-C-N 123.711 1.374 . . . . 51.57 111.928 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -64.87 -23.52 67.26 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.258 -0.901 . . . . 0.0 110.879 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.59 23.48 14.17 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.289 -0.882 . . . . 0.0 110.705 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.61 29.94 72.89 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.602 ' HB2' HG23 ' A' ' 23' ' ' THR . 42.2 mmm-85 -120.87 93.59 4.08 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.596 -0.943 . . . . 0.0 110.181 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.475 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 68.4 m-85 -104.58 130.4 52.56 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.571 -0.705 . . . . 46.07 109.126 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.714 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -117.76 120.31 37.57 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.571 -0.851 . . . . 0.0 111.185 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.667 ' CD1' HD12 ' A' ' 90' ' ' LEU . 68.1 m-85 -115.0 137.28 52.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.583 -0.698 . . . . 38.880000000000003 109.815 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.78 131.61 55.21 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.293 -1.002 . . . . 34.060000000000002 108.293 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.653 ' HE2' HD11 ' A' ' 35' ' ' ILE . 20.6 p90 -128.21 144.08 51.09 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.19 -1.004 . . . . 29.030000000000001 111.534 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.5 t -104.39 141.06 37.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.68 -0.638 . . . . 0.0 109.851 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.735 HD13 HG22 ' A' ' 13' ' ' VAL . 45.6 mm -106.35 132.23 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.822 0.82 . . . . 0.0 111.618 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.7 mtp85 -121.47 96.6 5.14 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.418 0.628 . . . . 40.240000000000002 109.526 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.619 HG22 ' CD1' ' A' ' 76' ' ' LEU . 78.1 mt -92.53 115.74 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.736 -0.603 . . . . 20.73 110.352 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -117.66 136.49 53.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.563 -0.711 . . . . 0.0 109.472 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -91.47 116.11 28.59 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 120.179 -0.608 . . . . 21.34 110.541 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -112.26 9.38 19.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.441 -0.787 . . . . 0.0 110.683 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.96 -176.15 50.96 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.002 -1.639 . . . . 29.100000000000001 109.002 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.457 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . . . -98.75 -30.0 12.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.463 -1.021 . . . . 0.0 110.137 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.517 HG13 ' HD2' ' A' ' 44' ' ' PRO . 84.2 t -105.57 139.83 20.57 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.78 -0.575 . . . . 0.0 109.714 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.517 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.9 Cg_endo -51.18 144.84 28.22 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 O-C-N 123.684 1.36 . . . . 21.949999999999999 111.685 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.5 150.08 49.68 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.736 0.779 . . . . 20.91 111.212 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.499 ' NH2' HG22 ' A' ' 48' ' ' VAL . 35.5 ttt-85 -125.81 153.08 44.58 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.546 HD23 ' C ' ' A' ' 47' ' ' LEU . 7.5 tt -97.57 117.16 31.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.494 -0.754 . . . . 0.0 109.997 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.499 HG22 ' NH2' ' A' ' 46' ' ' ARG . 64.7 t -100.85 -29.45 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.613 -0.68 . . . . 0.0 110.436 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.675 ' HB3' ' HB2' ' A' ' 102' ' ' ASP . . . -141.2 163.7 32.24 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.13 -1.028 . . . . 0.0 112.007 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.6 ptt85 -143.55 141.19 30.59 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.337 0.589 . . . . 29.050000000000001 110.16 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -144.0 114.14 7.38 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.396 0.617 . . . . 27.969999999999999 110.15 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.415 ' CH2' HG21 ' A' ' 115' ' ' ILE . 58.0 m95 -102.05 135.25 43.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.658 -0.651 . . . . 25.25 111.241 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -116.24 81.05 1.55 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.912 HG22 ' HG3' ' A' ' 97' ' ' MET . 17.3 pt -86.04 129.99 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 121.671 0.748 . . . . 36.109999999999999 111.748 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.693 HG23 HG22 ' A' ' 61' ' ' THR . 94.3 m -119.32 130.16 55.24 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.397 -0.964 . . . . 33.979999999999997 108.397 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -89.18 169.9 11.07 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.666 0.746 . . . . 45.039999999999999 111.26 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.25 -7.9 15.8 Favored Glycine 0 N--CA 1.495 2.579 0 O-C-N 121.791 -0.568 . . . . 39.469999999999999 112.071 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -102.15 6.95 41.06 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 119.336 1.568 . . . . 0.0 110.805 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.418 ' O ' HG23 ' A' ' 61' ' ' THR . . . 93.1 -27.94 10.5 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 121.159 -0.963 . . . . 0.0 110.933 178.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -61.6 141.81 57.54 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.19 -1.182 . . . . 62.780000000000001 109.707 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.693 HG22 HG23 ' A' ' 55' ' ' THR . 57.9 p -132.36 150.24 52.2 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.429 -0.794 . . . . 0.0 110.69 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -122.26 122.26 38.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.562 -0.711 . . . . 0.0 109.792 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -102.63 136.04 43.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.613 -0.679 . . . . 0.0 110.83 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.2 t -128.51 131.85 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.504 0.669 . . . . 37.939999999999998 109.925 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -125.02 127.48 47.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.79 -0.569 . . . . 0.0 110.3 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -153.91 173.5 32.54 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.101 -1.599 . . . . 31.82 109.101 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -115.78 159.64 21.18 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.362 -1.081 . . . . 0.0 110.047 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.66 95.35 0.01 OUTLIER Glycine 0 N--CA 1.5 2.94 0 O-C-N 121.423 -0.798 . . . . 22.620000000000001 111.355 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.493 HG13 HD22 ' A' ' 47' ' ' LEU . 16.1 m -46.36 134.02 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.505 0 O-C-N 121.399 -1.059 . . . . 17.510000000000002 111.553 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 69' ' ' VAL . 12.4 m 41.55 37.13 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-O 121.634 0.73 . . . . 20.550000000000001 111.344 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.7 20.02 62.49 Favored Glycine 0 N--CA 1.495 2.598 0 O-C-N 121.752 -0.592 . . . . 18.289999999999999 112.428 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.401 ' OE2' ' CZ ' ' A' ' 82' ' ' PHE . 5.2 pt-20 -146.73 151.81 37.8 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 119.191 1.496 . . . . 0.0 112.57 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -119.06 72.24 11.91 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 108.336 -0.987 . . . . 18.210000000000001 108.336 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -54.31 141.07 72.26 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 O-C-N 123.83 1.437 . . . . 17.609999999999999 112.517 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -99.14 74.4 1.96 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.619 ' CD1' HG22 ' A' ' 37' ' ' ILE . 12.0 mt -60.02 120.2 9.24 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.427 0.632 . . . . 20.57 112.045 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -85.42 157.8 58.29 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -53.81 127.03 23.89 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 O-C-N 123.584 1.307 . . . . 27.039999999999999 110.882 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.89 -15.69 57.02 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.735 -0.946 . . . . 24.739999999999998 110.735 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -87.02 164.27 16.57 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.086 -1.244 . . . . 29.379999999999999 110.435 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.83 151.33 36.93 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.45 -0.781 . . . . 0.0 110.333 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.401 ' CZ ' ' OE2' ' A' ' 72' ' ' GLU . 72.4 t80 -119.2 149.3 41.98 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.868 -0.79 . . . . 18.559999999999999 108.868 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -139.34 137.39 35.73 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.104 -0.997 . . . . 0.0 111.013 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.514 ' CE1' HG21 ' A' ' 35' ' ' ILE . 51.7 p90 -151.57 159.74 43.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.664 -0.648 . . . . 26.649999999999999 109.793 178.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.9 m -104.47 138.59 40.63 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.394 -0.816 . . . . 28.140000000000001 111.107 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 28.3 t -124.79 169.92 11.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.577 -0.702 . . . . 33.880000000000003 109.896 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.43 123.22 2.12 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.798 -1.191 . . . . 31.800000000000001 110.544 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.625 HG23 ' HE1' ' A' ' 33' ' ' TYR . 74.9 t -129.63 148.86 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.61 -0.935 . . . . 0.0 109.272 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.584 HD12 ' HA ' ' A' ' 30' ' ' ALA . 13.1 tp -109.74 143.82 39.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.487 -0.758 . . . . 0.0 110.496 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.667 HD12 ' CD1' ' A' ' 31' ' ' PHE . 84.8 mt -121.62 145.25 48.18 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.516 -0.74 . . . . 38.68 109.963 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.402 ' O ' ' CE1' ' A' ' 29' ' ' TYR . 29.9 tp10 -73.88 -26.06 60.35 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.407 -0.808 . . . . 0.0 110.782 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.1 p -123.34 171.74 9.19 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.39 -0.818 . . . . 31.629999999999999 110.579 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.41 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 54.9 tt0 -87.02 12.38 11.45 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.679 -0.638 . . . . 0.0 111.552 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -142.27 148.64 38.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.099 -1.0 . . . . 0.0 109.912 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.26 162.61 26.86 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 118.908 -1.615 . . . . 28.050000000000001 112.137 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -119.11 129.46 55.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.083 -0.657 . . . . 0.0 109.335 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.912 ' HG3' HG22 ' A' ' 54' ' ' ILE . 54.0 ttm -125.02 117.74 24.66 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.279 -0.888 . . . . 0.0 111.205 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.494 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 57.1 tt0 -129.5 150.34 50.89 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.08 -179.44 38.32 Favored Glycine 0 N--CA 1.499 2.886 0 C-N-CA 118.787 -1.673 . . . . 29.620000000000001 111.017 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.403 ' HB3' ' CG2' ' A' ' 112' ' ' ILE . 63.3 m80 -137.12 155.36 49.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.808 -0.819 . . . . 0.0 110.118 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.663 ' CD2' HD11 ' A' ' 115' ' ' ILE . 4.4 m-85 -117.65 127.06 53.58 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.61 -0.681 . . . . 27.050000000000001 109.668 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.675 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 71.4 m-20 -81.88 122.11 27.32 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.935 -1.103 . . . . 0.0 109.335 178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.443 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 91.8 mmm -120.53 162.84 18.91 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.189 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.458 HG22 HG23 ' A' ' 48' ' ' VAL . 7.9 m -142.51 128.76 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.672 -0.643 . . . . 23.280000000000001 110.503 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.38 167.97 20.16 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.557 -0.714 . . . . 0.0 109.469 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -62.15 -28.14 69.45 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.522 -0.736 . . . . 0.0 110.4 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -72.29 -11.29 60.64 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 111.111 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.45 -6.49 59.29 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.099 -1.048 . . . . 30.43 110.667 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.5 m -59.93 139.5 57.35 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.108 -1.23 . . . . 0.0 109.963 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -99.56 140.48 33.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.463 -0.773 . . . . 0.0 110.892 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.443 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 33.5 p90 -163.64 146.33 9.8 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.376 -0.601 . . . . 28.030000000000001 109.376 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.403 ' CG2' ' HB3' ' A' ' 100' ' ' HIS . 79.9 mt -100.78 155.43 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.61 0.719 . . . . 0.0 111.104 -178.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.92 98.12 47.8 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -59.14 144.17 99.48 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 O-C-N 123.869 1.457 . . . . 33.310000000000002 112.554 -178.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.663 HD11 ' CD2' ' A' ' 101' ' ' TYR . 66.2 mt -108.78 122.63 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.451 -0.944 . . . . 30.59 108.451 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.92 144.97 5.98 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.199 0.523 . . . . 30.780000000000001 111.615 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.494 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -92.65 119.43 32.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.795 -0.565 . . . . 0.0 110.394 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.705 ' CE1' HD11 ' A' ' 120' ' ' LEU . 43.2 p90 -108.92 169.32 8.75 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.815 -0.809 . . . . 30.66 108.815 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.628 ' C ' HD12 ' A' ' 120' ' ' LEU . 7.8 p -113.35 154.66 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.29 -0.881 . . . . 0.0 110.54 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.705 HD11 ' CE1' ' A' ' 118' ' ' PHE . 7.5 mp -113.25 131.91 55.73 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.426 -0.583 . . . . 39.149999999999999 109.426 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 96.6 p . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.654 -0.654 . . . . 0.0 110.092 -179.877 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.1 mtt-85 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 120.807 0.337 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -116.14 108.6 16.37 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.503 -0.748 . . . . 31.93 110.313 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.473 ' C ' HG23 ' A' ' 9' ' ' VAL . 74.8 mtt85 -152.17 134.56 15.22 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.574 0.702 . . . . 0.0 110.192 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.473 HG23 ' C ' ' A' ' 8' ' ' ARG . 80.0 t -151.42 113.84 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -107.85 129.04 55.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.636 -0.665 . . . . 0.0 109.767 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.551 HG11 ' HE2' ' A' ' 101' ' ' TYR . 59.5 t -119.41 139.75 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.863 -0.523 . . . . 28.210000000000001 109.968 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -121.51 136.51 54.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.409 -0.807 . . . . 0.0 109.673 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.761 HG22 HD13 ' A' ' 35' ' ' ILE . 61.0 t -129.47 137.64 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.513 -0.742 . . . . 27.949999999999999 110.434 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.6 t -125.62 104.51 27.6 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.733 -0.605 . . . . 0.0 110.583 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -83.61 165.14 14.1 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 O-C-N 123.851 1.448 . . . . 33.0 110.996 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -157.53 132.84 8.96 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.505 0.669 . . . . 54.100000000000001 109.999 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.537 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 76.5 t80 -59.96 139.47 57.38 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.812 -0.555 . . . . 0.0 111.298 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.0 HD11 ' HB2' ' A' ' 32' ' ' ALA . 77.0 mt -116.34 80.52 1.47 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.901 0.858 . . . . 0.0 110.524 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.537 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -70.01 -33.28 71.81 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.998 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -68.98 -25.97 64.8 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.271 -0.893 . . . . 0.0 111.875 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.423 ' CG ' ' HB3' ' A' ' 18' ' ' LEU . 15.7 pt20 -120.01 29.61 7.44 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.093 -1.004 . . . . 52.369999999999997 111.191 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.609 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 24.1 p -148.07 150.59 34.18 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.316 -0.865 . . . . 55.189999999999998 110.821 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.5 m -117.9 92.52 42.09 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.584 -0.697 . . . . 0.0 109.361 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.459 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 48.3 Cg_endo -65.58 -25.46 54.9 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 O-C-N 123.951 1.5 . . . . 51.57 111.241 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.79 -23.22 65.18 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.462 -0.773 . . . . 0.0 110.843 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.39 23.4 14.22 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.326 -0.859 . . . . 0.0 110.716 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.84 30.03 72.54 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -120.86 92.59 3.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.543 -0.975 . . . . 0.0 110.036 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.459 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 72.3 m-85 -105.68 132.84 51.32 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.405 -0.809 . . . . 46.07 109.247 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.609 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -115.05 119.62 37.07 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.43 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.453 ' CG ' HD23 ' A' ' 120' ' ' LEU . 83.5 m-85 -115.93 129.31 56.34 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.533 -0.729 . . . . 38.880000000000003 109.492 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 1.0 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -115.84 131.18 57.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.139 -0.976 . . . . 34.060000000000002 108.982 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.552 ' CE1' HD11 ' A' ' 35' ' ' ILE . 54.8 p90 -126.99 146.99 50.14 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.293 -0.963 . . . . 29.030000000000001 111.021 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.3 m -100.34 140.18 34.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.646 -0.659 . . . . 0.0 109.378 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.761 HD13 HG22 ' A' ' 13' ' ' VAL . 42.1 mm -104.39 132.01 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 121.734 0.778 . . . . 0.0 111.562 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -123.23 97.4 5.4 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.454 0.645 . . . . 40.240000000000002 109.664 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.658 HG22 HD22 ' A' ' 76' ' ' LEU . 75.7 mt -91.68 117.33 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.777 -0.577 . . . . 20.73 110.504 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -117.54 136.01 53.56 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.548 -0.72 . . . . 0.0 109.554 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.501 ' HB2' HD23 ' A' ' 76' ' ' LEU . 54.9 t-20 -91.72 117.43 29.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.73 -0.606 . . . . 21.34 110.715 -179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.13 9.51 17.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.451 -0.78 . . . . 0.0 110.679 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.61 -178.22 51.25 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.136 -1.586 . . . . 29.100000000000001 109.136 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.05 -31.81 13.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.427 -1.043 . . . . 0.0 110.057 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.51 HG13 ' HD2' ' A' ' 44' ' ' PRO . 85.7 t -104.79 141.16 21.96 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.51 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.9 Cg_endo -53.98 147.17 43.98 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 O-C-N 123.74 1.39 . . . . 21.949999999999999 111.541 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.438 ' HB1' ' HZ ' ' A' ' 111' ' ' PHE . . . -137.41 150.94 48.02 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.776 0.798 . . . . 20.91 111.203 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.434 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 3.0 ttt180 -126.46 154.76 43.26 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.978 HD22 HG13 ' A' ' 69' ' ' VAL . 6.9 tt -98.19 118.17 34.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.444 -0.785 . . . . 0.0 109.755 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.537 HG23 HG22 ' A' ' 104' ' ' VAL . 63.5 t -101.53 -26.73 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.715 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.655 ' HB3' ' HB2' ' A' ' 102' ' ' ASP . . . -141.45 162.83 34.54 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.146 -179.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -142.93 139.4 30.71 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.34 0.59 . . . . 29.050000000000001 110.159 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -143.12 114.1 7.7 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.4 0.619 . . . . 27.969999999999999 109.815 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.539 ' CH2' HD13 ' A' ' 115' ' ' ILE . 88.0 m95 -102.49 134.47 45.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.669 -0.644 . . . . 25.25 110.881 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -115.75 78.76 1.21 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.522 -0.736 . . . . 0.0 109.092 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.728 HG22 ' HG3' ' A' ' 97' ' ' MET . 13.1 pt -83.45 128.63 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.515 -0.741 . . . . 36.109999999999999 111.741 -178.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.704 HG23 ' HB ' ' A' ' 61' ' ' THR . 3.6 m -120.03 131.08 55.0 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.469 -0.937 . . . . 33.979999999999997 108.469 178.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -88.54 170.01 11.24 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.619 0.723 . . . . 45.039999999999999 111.205 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.4 -6.93 12.08 Favored Glycine 0 N--CA 1.496 2.661 0 O-C-N 121.831 -0.543 . . . . 39.469999999999999 112.188 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.35 7.69 42.63 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 119.322 1.561 . . . . 0.0 110.576 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.59 -31.31 6.56 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -62.09 142.72 57.42 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.202 -1.175 . . . . 62.780000000000001 109.778 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.704 ' HB ' HG23 ' A' ' 55' ' ' THR . 7.6 t -135.82 153.3 51.55 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.531 -0.731 . . . . 0.0 110.613 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -121.68 122.95 40.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.635 -0.665 . . . . 0.0 110.02 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -100.55 135.06 42.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.699 -0.625 . . . . 0.0 110.547 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.2 t -128.12 130.59 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.613 0.72 . . . . 37.939999999999998 110.065 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -126.44 127.09 44.86 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.801 -0.562 . . . . 0.0 110.147 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -150.5 154.85 25.88 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.494 -1.442 . . . . 31.82 109.494 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -78.16 154.74 30.92 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.51 -0.994 . . . . 0.0 110.367 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.46 -168.38 0.21 Allowed Glycine 0 N--CA 1.498 2.787 0 O-C-N 121.412 -0.805 . . . . 22.620000000000001 111.598 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.978 HG13 HD22 ' A' ' 47' ' ' LEU . 16.0 m -129.86 129.2 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.864 -0.786 . . . . 17.510000000000002 109.72 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.3 m 41.13 36.77 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 CA-C-O 121.44 0.638 . . . . 20.550000000000001 111.86 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.08 16.47 69.59 Favored Glycine 0 N--CA 1.499 2.893 0 O-C-N 121.645 -0.659 . . . . 18.289999999999999 112.833 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -145.98 151.72 38.25 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-N 119.145 1.472 . . . . 0.0 112.014 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -114.9 75.7 3.98 Favored Pre-proline 0 N--CA 1.492 1.625 0 N-CA-C 109.006 -0.739 . . . . 18.210000000000001 109.006 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -57.66 139.81 91.46 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 O-C-N 123.769 1.405 . . . . 17.609999999999999 111.951 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 46' ' ' ARG . 2.3 t90 -103.36 76.53 1.44 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.658 HD22 HG22 ' A' ' 37' ' ' ILE . 6.6 tp -59.97 117.83 5.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.648 -0.658 . . . . 20.57 111.51 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -86.46 157.99 55.1 Favored Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -53.79 127.57 26.07 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 O-C-N 123.56 1.295 . . . . 27.039999999999999 111.054 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.88 -19.08 39.87 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.761 -0.936 . . . . 24.739999999999998 110.761 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 71.3 tt0 -88.87 166.48 13.95 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.1 -1.235 . . . . 29.379999999999999 110.162 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.624 ' CA ' HD11 ' A' ' 76' ' ' LEU . . . -146.28 150.62 36.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.49 -0.756 . . . . 0.0 110.464 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.45 ' N ' HD11 ' A' ' 76' ' ' LEU . 66.2 t80 -117.71 147.84 42.57 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.044 -0.725 . . . . 18.559999999999999 109.044 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -144.29 140.19 29.03 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.109 -0.994 . . . . 0.0 111.338 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.66 ' CE1' HG21 ' A' ' 35' ' ' ILE . 47.9 p90 -150.78 160.28 43.97 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.653 -0.655 . . . . 26.649999999999999 109.577 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.7 m -102.63 137.67 40.55 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.424 -0.798 . . . . 28.140000000000001 110.949 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.442 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 15.0 t -124.11 167.06 14.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.595 -0.69 . . . . 33.880000000000003 109.957 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -139.83 128.65 3.99 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.882 -1.151 . . . . 31.800000000000001 110.503 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.5 m -134.19 154.27 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.651 -0.911 . . . . 0.0 110.009 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.424 ' N ' HD12 ' A' ' 89' ' ' LEU . 5.0 mp -109.83 144.69 37.93 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.566 -0.709 . . . . 0.0 110.95 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.712 HD23 ' O ' ' A' ' 92' ' ' THR . 12.6 tp -121.43 146.55 46.78 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.656 -0.653 . . . . 38.68 109.762 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -83.9 -27.46 28.6 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.321 -0.862 . . . . 0.0 111.053 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.712 ' O ' HD23 ' A' ' 90' ' ' LEU . 71.9 p -123.44 171.26 9.6 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.341 -0.849 . . . . 31.629999999999999 110.774 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.453 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 96.6 mt-10 -86.48 11.64 12.12 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.646 -0.659 . . . . 0.0 111.609 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -144.05 143.13 31.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.044 -1.035 . . . . 0.0 109.893 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.7 160.37 25.18 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 118.615 -1.755 . . . . 28.050000000000001 112.537 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -118.91 129.79 55.37 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.728 ' HG3' HG22 ' A' ' 54' ' ' ILE . 15.5 ttt -128.69 122.86 31.7 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.306 -0.871 . . . . 0.0 111.641 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.407 ' HG2' ' CB ' ' A' ' 117' ' ' ALA . 39.3 mt-30 -120.27 150.79 40.14 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -151.62 172.21 31.07 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 118.677 -1.725 . . . . 29.620000000000001 111.325 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.858 ' CE1' HD12 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -138.95 154.3 48.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.761 -0.847 . . . . 0.0 109.373 179.121 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.62 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 10.3 m-85 -118.98 126.09 50.94 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.404 -0.81 . . . . 27.050000000000001 110.244 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.655 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 78.3 m-20 -86.31 120.25 27.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.899 -1.125 . . . . 0.0 108.777 177.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.454 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 86.8 mmm -121.87 163.04 19.9 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.228 0.537 . . . . 0.0 110.537 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.537 HG22 HG23 ' A' ' 48' ' ' VAL . 7.5 m -142.17 128.7 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.693 -0.629 . . . . 23.280000000000001 110.421 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.5 166.36 22.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.358 -0.838 . . . . 0.0 109.378 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -63.95 -27.73 69.34 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.324 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -76.41 -10.31 59.3 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.444 -0.785 . . . . 0.0 111.181 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.9 -7.34 48.85 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.45 -1.06 . . . . 30.43 110.45 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.3 m -58.32 135.76 57.23 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.052 -1.263 . . . . 0.0 109.966 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -100.51 139.03 36.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.434 -0.791 . . . . 0.0 110.783 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 37.8 p90 -161.2 141.46 10.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.702 -0.624 . . . . 28.030000000000001 109.889 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.858 HD12 ' CE1' ' A' ' 100' ' ' HIS . 29.9 pt -99.88 156.17 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.661 -0.649 . . . . 0.0 110.923 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.62 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -121.69 98.77 45.41 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.648 -0.658 . . . . 0.0 109.391 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.415 ' HB3' ' CE1' ' A' ' 100' ' ' HIS . 46.3 Cg_endo -59.03 144.0 99.56 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 O-C-N 123.901 1.474 . . . . 33.310000000000002 112.154 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.539 HD13 ' CH2' ' A' ' 52' ' ' TRP . 64.1 mt -108.8 121.71 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.426 -0.953 . . . . 30.59 108.426 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.3 159.13 0.22 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.176 0.512 . . . . 30.780000000000001 111.533 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.407 ' CB ' ' HG2' ' A' ' 98' ' ' GLN . . . -91.12 124.3 35.24 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.738 -0.601 . . . . 0.0 110.874 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 97' ' ' MET . 38.5 p90 -113.64 158.35 20.95 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.347 -0.982 . . . . 30.66 108.347 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.662 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.1 t -116.15 154.89 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.27 -0.894 . . . . 0.0 110.387 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.662 HD12 ' C ' ' A' ' 119' ' ' VAL . 7.9 mp -114.64 130.51 56.81 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.229 -0.656 . . . . 39.149999999999999 109.229 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.744 -0.598 . . . . 0.0 110.069 -179.652 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 120.762 0.315 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.447 ' CE2' HG21 ' A' ' 109' ' ' THR . 49.9 m-85 -118.51 108.42 14.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.433 -0.792 . . . . 31.93 110.209 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.451 ' C ' HG23 ' A' ' 9' ' ' VAL . 66.9 mtt85 -150.15 134.95 17.62 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.57 0.7 . . . . 0.0 110.12 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.808 HG11 ' SD ' ' A' ' 103' ' ' MET . 63.3 t -150.21 116.01 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.507 0.67 . . . . 0.0 109.365 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -107.25 130.69 54.71 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.592 0.711 . . . . 0.0 110.279 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.648 HG11 ' HE2' ' A' ' 101' ' ' TYR . 62.7 t -118.89 137.02 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.809 -0.557 . . . . 28.210000000000001 109.501 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -123.85 137.7 54.61 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.404 -0.81 . . . . 0.0 109.94 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.2 t -128.97 137.02 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.484 0.659 . . . . 27.949999999999999 110.583 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -124.59 105.19 30.47 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.754 -0.591 . . . . 0.0 110.116 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.433 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 50.7 Cg_endo -82.58 163.39 16.62 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 O-C-N 123.869 1.457 . . . . 33.0 111.323 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -156.98 130.77 8.22 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.613 0.721 . . . . 54.100000000000001 109.602 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.442 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 84.8 t80 -61.55 138.48 58.29 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.344 0.592 . . . . 0.0 111.444 -178.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.705 HD23 ' HB3' ' A' ' 21' ' ' GLN . 8.9 tp -114.96 82.65 1.77 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.961 0.886 . . . . 0.0 110.014 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.442 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -65.19 -36.17 83.38 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.575 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -68.89 -22.39 64.18 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.355 -0.84 . . . . 0.0 110.871 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.705 ' HB3' HD23 ' A' ' 18' ' ' LEU . 44.2 tt0 -119.54 23.55 11.13 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.345 -0.847 . . . . 52.369999999999997 110.702 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.719 ' OG ' ' HB3' ' A' ' 30' ' ' ALA . 73.1 m -136.11 137.95 41.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.301 -0.875 . . . . 55.189999999999998 111.16 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.2 m -119.19 90.44 41.8 Favored Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.447 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 48.3 Cg_endo -63.74 -26.83 68.14 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 O-C-N 123.933 1.491 . . . . 51.57 111.686 -178.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -69.04 -22.83 64.02 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.327 -0.858 . . . . 0.0 110.829 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -107.11 19.27 20.64 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.295 -0.878 . . . . 0.0 110.998 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.18 30.37 73.73 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -119.61 94.37 4.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.667 -0.902 . . . . 0.0 110.247 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.447 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 79.0 m-85 -106.51 129.01 54.54 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.391 -0.818 . . . . 46.07 109.386 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.719 ' HB3' ' OG ' ' A' ' 22' ' ' SER . . . -119.42 120.07 35.76 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.31 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.634 ' CD1' HD12 ' A' ' 90' ' ' LEU . 61.9 m-85 -115.79 136.84 52.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.644 -0.66 . . . . 38.880000000000003 109.597 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.27 131.82 54.85 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.727 -0.842 . . . . 34.060000000000002 108.727 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.561 ' HE1' HG23 ' A' ' 88' ' ' VAL . 26.4 p90 -126.54 143.37 51.23 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.212 -0.995 . . . . 29.030000000000001 111.303 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 t -102.81 139.12 38.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.682 -0.636 . . . . 0.0 109.286 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.9 HD13 ' CE2' ' A' ' 84' ' ' TYR . 5.2 mp -104.78 132.04 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.81 0.814 . . . . 0.0 111.247 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.6 mtm180 -122.08 97.35 5.44 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.467 0.651 . . . . 40.240000000000002 109.63 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.651 HG22 HD22 ' A' ' 76' ' ' LEU . 80.2 mt -94.2 116.47 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.765 -0.584 . . . . 20.73 110.507 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -117.46 138.68 51.7 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.486 -0.759 . . . . 0.0 109.455 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.417 ' HB2' HD23 ' A' ' 76' ' ' LEU . 41.5 t-20 -91.61 118.12 30.33 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.67 -0.644 . . . . 21.34 110.851 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.1 9.04 14.63 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.428 -0.795 . . . . 0.0 110.479 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.23 176.63 52.95 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.544 -1.423 . . . . 29.100000000000001 109.544 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.12 -35.71 17.3 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.585 -0.95 . . . . 0.0 110.271 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.518 HG13 ' HD2' ' A' ' 44' ' ' PRO . 86.9 t -102.96 140.31 20.93 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.802 -0.561 . . . . 0.0 110.033 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.518 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.5 Cg_endo -52.87 144.14 45.73 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 O-C-N 123.775 1.408 . . . . 21.949999999999999 111.68 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.09 151.4 46.69 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.659 0.742 . . . . 20.91 111.092 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 1.1 ptt85 -127.73 159.79 33.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.697 -0.627 . . . . 0.0 109.715 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.953 HD22 HG13 ' A' ' 69' ' ' VAL . 6.8 tt -98.04 116.4 30.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.463 -0.773 . . . . 0.0 109.583 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.482 HG23 HG22 ' A' ' 104' ' ' VAL . 57.6 t -98.43 -28.21 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.541 -0.724 . . . . 0.0 110.515 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.679 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -141.62 162.38 35.63 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.439 -0.905 . . . . 0.0 111.758 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.0 ptt85 -142.89 141.56 31.55 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.579 0.704 . . . . 29.050000000000001 110.298 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -144.23 114.86 7.67 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.288 0.566 . . . . 27.969999999999999 109.581 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -95.9 133.68 39.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.646 -0.659 . . . . 25.25 111.037 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -115.84 78.49 1.19 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.879 HG22 ' HG3' ' A' ' 97' ' ' MET . 13.3 pt -86.29 129.24 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-O 121.748 0.785 . . . . 36.109999999999999 111.758 -178.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.687 HG23 HG22 ' A' ' 61' ' ' THR . 90.6 m -120.19 129.98 54.35 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.097 -1.075 . . . . 33.979999999999997 108.097 178.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -91.04 170.32 10.14 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.771 0.796 . . . . 45.039999999999999 111.504 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.62 -6.62 11.97 Favored Glycine 0 N--CA 1.494 2.555 0 O-C-N 121.8 -0.562 . . . . 39.469999999999999 112.122 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -101.73 5.56 41.38 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 119.429 1.614 . . . . 0.0 110.62 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.4 ' O ' HG23 ' A' ' 61' ' ' THR . . . 92.77 -28.5 9.2 Favored Glycine 0 N--CA 1.495 2.613 0 O-C-N 121.25 -0.906 . . . . 0.0 110.894 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.6 142.44 58.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.191 -1.182 . . . . 62.780000000000001 109.621 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.687 HG22 HG23 ' A' ' 55' ' ' THR . 71.5 p -132.23 149.99 52.26 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.455 -0.778 . . . . 0.0 110.67 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -122.4 122.12 38.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.47 -0.769 . . . . 0.0 109.962 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -105.44 136.39 45.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.579 -0.701 . . . . 0.0 110.984 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.6 t -129.23 131.35 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.546 -0.722 . . . . 37.939999999999998 109.818 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.29 127.45 47.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.711 -0.618 . . . . 0.0 110.429 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.24 149.23 21.17 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.412 -1.475 . . . . 31.82 109.412 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -74.42 155.68 37.81 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.448 -1.031 . . . . 0.0 110.274 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 50.4 -171.94 0.14 Allowed Glycine 0 N--CA 1.498 2.817 0 O-C-N 121.336 -0.853 . . . . 22.620000000000001 111.253 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.953 HG13 HD22 ' A' ' 47' ' ' LEU . 14.8 m -129.41 128.11 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.78 -0.835 . . . . 17.510000000000002 109.57 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 69' ' ' VAL . 12.0 m 41.17 36.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 CA-C-O 121.603 0.716 . . . . 20.550000000000001 111.796 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.25 16.25 69.75 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 121.627 -0.67 . . . . 18.289999999999999 112.93 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.415 ' O ' HG22 ' A' ' 69' ' ' VAL . 10.0 pt-20 -145.79 150.76 36.8 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 119.163 1.481 . . . . 0.0 112.028 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -114.97 74.15 3.43 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.895 -0.78 . . . . 18.210000000000001 108.895 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -57.25 140.51 93.11 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 O-C-N 123.793 1.417 . . . . 17.609999999999999 112.225 -178.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.432 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 5.9 t90 -102.11 77.17 1.65 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.651 HD22 HG22 ' A' ' 37' ' ' ILE . 6.9 tp -59.66 117.3 4.77 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.553 -0.717 . . . . 20.57 111.621 -178.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -86.35 156.86 56.66 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -52.76 126.72 22.02 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 O-C-N 123.678 1.357 . . . . 27.039999999999999 110.931 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.6 -17.44 49.25 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.701 -0.96 . . . . 24.739999999999998 110.701 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -88.16 165.5 15.05 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.053 -1.263 . . . . 29.379999999999999 110.196 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.602 ' CA ' HD11 ' A' ' 76' ' ' LEU . . . -147.81 152.8 38.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.513 -0.742 . . . . 0.0 110.372 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.4 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 66.9 t80 -119.34 147.89 43.81 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.93 -0.767 . . . . 18.559999999999999 108.93 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.5 m80 -138.95 138.31 37.21 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.094 -1.004 . . . . 0.0 110.824 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.9 ' CE2' HD13 ' A' ' 35' ' ' ILE . 50.5 p90 -151.0 159.72 44.39 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.527 -0.733 . . . . 26.649999999999999 109.993 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.1 m -104.36 137.61 41.99 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.444 -0.785 . . . . 28.140000000000001 110.811 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 14.6 t -125.14 166.86 15.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.578 -0.701 . . . . 33.880000000000003 110.091 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.43 127.24 4.07 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.886 -1.15 . . . . 31.800000000000001 110.413 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.561 HG23 ' HE1' ' A' ' 33' ' ' TYR . 79.4 t -131.51 148.43 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.577 -0.955 . . . . 0.0 109.375 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.9 tp -110.13 143.54 40.06 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.561 -0.712 . . . . 0.0 110.275 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.668 ' CD1' HD22 ' A' ' 120' ' ' LEU . 84.5 mt -122.97 148.38 45.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.474 -0.766 . . . . 38.68 110.358 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -76.21 -26.41 56.09 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.376 -0.828 . . . . 0.0 110.63 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 93' ' ' GLU . 6.4 m -122.55 171.27 9.24 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.453 -0.78 . . . . 31.629999999999999 110.545 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.423 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 58.0 tt0 -85.87 8.15 21.3 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.678 -0.639 . . . . 0.0 111.754 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -140.71 150.11 43.03 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.059 -1.026 . . . . 0.0 110.064 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.06 164.46 29.14 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 118.867 -1.635 . . . . 28.050000000000001 112.097 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -121.89 131.69 54.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 122.067 -0.667 . . . . 0.0 109.545 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.879 ' HG3' HG22 ' A' ' 54' ' ' ILE . 27.1 ttt -127.27 121.05 30.09 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.256 -0.902 . . . . 0.0 111.424 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.493 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 56.2 tt0 -128.66 147.75 50.76 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.84 -179.86 35.86 Favored Glycine 0 N--CA 1.5 2.945 0 C-N-CA 119.072 -1.537 . . . . 29.620000000000001 110.72 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -140.84 157.97 44.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.697 -0.884 . . . . 0.0 110.75 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.648 ' HE2' HG11 ' A' ' 11' ' ' VAL . 6.9 m-85 -116.72 129.28 56.03 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.606 -0.684 . . . . 27.050000000000001 110.193 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.679 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 42.6 t0 -83.9 122.98 29.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.959 -1.088 . . . . 0.0 109.149 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.808 ' SD ' HG11 ' A' ' 9' ' ' VAL . 24.1 mtp -124.23 162.75 23.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.9 -0.5 . . . . 0.0 110.572 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.482 HG22 HG23 ' A' ' 48' ' ' VAL . 10.6 m -140.45 130.24 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.69 -0.631 . . . . 23.280000000000001 110.208 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.9 166.61 22.66 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.407 -0.808 . . . . 0.0 109.473 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -63.93 -29.97 71.09 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.127 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -74.19 -10.34 59.51 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.524 -0.735 . . . . 0.0 111.129 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.14 -7.43 47.99 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 120.072 -1.061 . . . . 30.43 110.454 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.447 HG21 ' CE2' ' A' ' 7' ' ' TYR . 65.8 m -57.45 136.05 56.63 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.108 -1.231 . . . . 0.0 109.988 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -101.92 140.85 35.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.334 -0.854 . . . . 0.0 110.955 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 46.5 p90 -167.45 147.03 5.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.678 -0.639 . . . . 28.030000000000001 110.06 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.2 pt -102.43 157.53 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.685 -0.634 . . . . 0.0 110.846 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.77 98.33 49.65 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -59.25 142.19 98.84 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 O-C-N 123.935 1.492 . . . . 33.310000000000002 112.236 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.557 HD11 ' CE2' ' A' ' 101' ' ' TYR . 67.3 mt -106.83 123.3 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.52 -0.918 . . . . 30.59 108.52 178.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.18 144.09 7.56 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.243 0.544 . . . . 30.780000000000001 111.365 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.493 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -88.53 121.22 30.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.659 -0.651 . . . . 0.0 110.103 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.493 ' HE1' HD11 ' A' ' 120' ' ' LEU . 36.3 p90 -107.5 165.14 11.62 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.037 -0.727 . . . . 30.66 109.037 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.607 ' C ' HD12 ' A' ' 120' ' ' LEU . 57.3 t -116.94 155.63 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.377 -0.827 . . . . 0.0 110.274 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.668 HD22 ' CD1' ' A' ' 90' ' ' LEU . 7.2 mp -114.06 132.49 56.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.709 -0.619 . . . . 39.149999999999999 109.6 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.657 -0.652 . . . . 0.0 110.138 -179.796 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.034 0.445 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -112.68 79.57 1.24 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.702 -0.624 . . . . 31.93 109.9 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.458 ' C ' HG23 ' A' ' 9' ' ' VAL . 45.9 mtm180 -138.29 142.87 39.79 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.966 0.889 . . . . 0.0 110.333 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.458 HG23 ' C ' ' A' ' 8' ' ' ARG . 85.5 t -150.56 115.75 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.537 0.684 . . . . 0.0 109.215 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -106.02 129.61 54.1 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.557 0.694 . . . . 0.0 109.779 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.453 HG11 ' HE2' ' A' ' 101' ' ' TYR . 66.5 t -116.93 138.87 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.92 -0.487 . . . . 28.210000000000001 109.694 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -121.02 136.6 54.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.466 -0.771 . . . . 0.0 109.798 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.804 HG22 HD13 ' A' ' 35' ' ' ILE . 62.1 t -128.42 136.38 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.669 -0.644 . . . . 27.949999999999999 110.173 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.9 m -124.81 105.05 29.9 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.617 -0.677 . . . . 0.0 110.509 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -82.22 165.06 17.0 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 O-C-N 123.893 1.47 . . . . 33.0 110.768 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -158.01 130.67 7.27 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.587 0.708 . . . . 54.100000000000001 109.844 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.532 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 77.6 t80 -61.16 138.21 58.22 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.761 -0.587 . . . . 0.0 111.327 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.541 ' CD1' ' HB2' ' A' ' 32' ' ' ALA . 6.1 mt -116.62 80.94 1.54 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.086 0.946 . . . . 0.0 110.333 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.532 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -67.37 -35.67 79.82 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.136 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -68.8 -23.25 64.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.275 -0.891 . . . . 0.0 110.818 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -121.96 46.87 2.0 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.36 -0.838 . . . . 52.369999999999997 110.64 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.743 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 53.3 p -167.46 148.74 5.57 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.236 -0.915 . . . . 55.189999999999998 111.112 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.655 HG23 ' HB2' ' A' ' 28' ' ' ARG . 9.8 t -122.02 93.27 48.67 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.475 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.0 Cg_endo -67.26 -22.81 45.86 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 O-C-N 123.673 1.354 . . . . 51.57 111.949 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -65.15 -23.27 67.07 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.283 -0.886 . . . . 0.0 110.961 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -106.14 24.45 12.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.285 -0.884 . . . . 0.0 110.709 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.84 28.91 73.39 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.655 ' HB2' HG23 ' A' ' 23' ' ' THR . 51.8 mtp180 -120.87 93.81 4.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.641 -0.917 . . . . 0.0 110.178 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.475 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 67.8 m-85 -104.26 133.95 48.31 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.533 -0.729 . . . . 46.07 109.126 179.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.743 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -114.28 120.93 42.08 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.107 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.404 ' CD1' HD12 ' A' ' 90' ' ' LEU . 90.4 m-85 -116.12 134.02 55.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.694 -0.629 . . . . 38.880000000000003 109.788 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.541 ' HB2' ' CD1' ' A' ' 18' ' ' LEU . . . -112.43 132.04 55.25 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.463 -0.939 . . . . 34.060000000000002 108.463 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.502 ' CE2' HD11 ' A' ' 35' ' ' ILE . 38.2 p90 -127.67 144.39 51.08 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.073 -1.051 . . . . 29.030000000000001 111.708 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.6 t -104.82 139.98 38.79 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.804 HD13 HG22 ' A' ' 13' ' ' VAL . 41.4 mm -105.77 132.63 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.77 0.795 . . . . 0.0 111.725 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.3 mtp180 -124.04 97.02 5.16 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.49 0.662 . . . . 40.240000000000002 109.799 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.657 HG22 ' CD1' ' A' ' 76' ' ' LEU . 74.1 mt -92.78 116.92 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.706 -0.621 . . . . 20.73 110.433 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -119.77 144.69 47.15 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.455 -0.778 . . . . 0.0 109.919 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -86.06 113.84 22.46 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.514 -0.741 . . . . 21.34 109.47 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 8' ' ' ARG . . . -89.32 -18.79 26.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.788 -0.57 . . . . 0.0 111.715 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.59 -163.93 37.2 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.305 -0.95 . . . . 29.100000000000001 110.942 -178.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -113.89 -17.02 12.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.964 -0.727 . . . . 0.0 111.013 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.491 HG13 ' HD2' ' A' ' 44' ' ' PRO . 95.5 t -103.31 135.59 19.36 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.316 -0.865 . . . . 0.0 109.566 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.491 ' HD2' HG13 ' A' ' 43' ' ' VAL . 41.2 Cg_endo -48.84 140.54 23.09 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 O-C-N 123.757 1.399 . . . . 21.949999999999999 112.219 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -134.23 149.52 50.98 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.703 0.764 . . . . 20.91 110.873 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.428 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 43.2 ttt180 -125.91 151.45 46.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.832 -0.542 . . . . 0.0 109.547 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.836 HD22 HG13 ' A' ' 69' ' ' VAL . 7.2 tt -98.68 117.21 32.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.464 -0.773 . . . . 0.0 109.973 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.476 HG23 HG22 ' A' ' 104' ' ' VAL . 62.4 t -100.98 -30.49 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.6 -0.687 . . . . 0.0 110.649 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -141.4 162.54 35.25 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.08 -1.048 . . . . 0.0 112.334 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.43 ' HD3' HG12 ' A' ' 69' ' ' VAL . 23.2 ptt180 -143.25 140.98 30.91 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.482 0.658 . . . . 29.050000000000001 110.201 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.412 ' HB3' ' CE1' ' A' ' 100' ' ' HIS . 21.7 t-160 -145.86 114.69 6.9 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.353 0.597 . . . . 27.969999999999999 109.987 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.53 ' CH2' HD13 ' A' ' 115' ' ' ILE . 63.2 m95 -100.21 135.97 40.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.579 -0.701 . . . . 25.25 111.42 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -117.06 79.17 1.3 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.711 -0.618 . . . . 0.0 109.417 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 54' ' ' ILE . 28.2 pt -83.31 130.27 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.375 -0.828 . . . . 36.109999999999999 112.208 -178.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.782 HG23 HG22 ' A' ' 61' ' ' THR . 85.3 m -119.48 130.05 55.03 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.209 -1.034 . . . . 33.979999999999997 108.209 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -91.39 170.03 10.31 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.657 0.741 . . . . 45.039999999999999 111.352 -178.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.81 -6.72 12.85 Favored Glycine 0 N--CA 1.495 2.609 0 O-C-N 121.866 -0.521 . . . . 39.469999999999999 112.086 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -102.05 5.83 40.74 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 119.367 1.584 . . . . 0.0 110.6 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 61' ' ' THR . . . 93.27 -28.47 9.71 Favored Glycine 0 N--CA 1.495 2.596 0 C-N-CA 120.352 -0.927 . . . . 0.0 110.859 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.1 141.4 58.15 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.277 -1.131 . . . . 62.780000000000001 109.77 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.782 HG22 HG23 ' A' ' 55' ' ' THR . 66.4 p -132.38 150.05 52.23 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.438 -0.788 . . . . 0.0 110.488 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -122.32 122.29 38.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.566 -0.709 . . . . 0.0 109.903 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -103.28 134.66 46.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.696 -0.627 . . . . 0.0 110.59 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.3 t -128.04 130.07 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.558 0.694 . . . . 37.939999999999998 109.942 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -124.24 126.82 46.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.822 -0.549 . . . . 0.0 110.111 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.96 149.6 21.62 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.35 -1.5 . . . . 31.82 109.35 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -76.72 154.72 33.86 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.492 -1.004 . . . . 0.0 110.078 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.77 -169.48 0.19 Allowed Glycine 0 N--CA 1.498 2.808 0 O-C-N 121.378 -0.826 . . . . 22.620000000000001 111.337 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.836 HG13 HD22 ' A' ' 47' ' ' LEU . 15.9 m -131.05 129.24 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.834 -0.803 . . . . 17.510000000000002 109.648 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.1 m 40.95 35.22 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.456 0 CA-C-O 121.445 0.64 . . . . 20.550000000000001 111.918 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.06 17.13 67.95 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 121.676 -0.64 . . . . 18.289999999999999 112.85 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.404 ' OE1' ' CZ ' ' A' ' 82' ' ' PHE . 11.9 pt-20 -144.97 150.33 36.75 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 119.131 1.466 . . . . 0.0 111.902 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 46' ' ' ARG . 93.4 mt-30 -116.3 75.57 6.37 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 109.019 -0.734 . . . . 18.210000000000001 109.019 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -58.1 142.17 96.83 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 O-C-N 123.956 1.503 . . . . 17.609999999999999 112.411 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.436 ' CH2' ' HB2' ' A' ' 44' ' ' PRO . 5.0 t90 -103.88 75.54 1.3 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.657 ' CD1' HG22 ' A' ' 37' ' ' ILE . 9.7 mt -60.82 121.34 12.08 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.563 -0.711 . . . . 20.57 112.35 -178.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -87.44 158.44 51.72 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -54.22 129.21 33.32 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 O-C-N 123.529 1.279 . . . . 27.039999999999999 111.309 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.92 -16.75 49.8 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 120.481 -0.866 . . . . 24.739999999999998 111.023 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -87.96 166.07 14.77 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.973 -1.31 . . . . 29.379999999999999 110.393 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.33 149.56 35.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.516 -0.74 . . . . 0.0 110.283 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.404 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 65.1 t80 -118.99 147.79 43.7 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.846 -0.798 . . . . 18.559999999999999 108.846 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -143.95 140.19 29.53 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.13 -0.981 . . . . 0.0 111.552 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.53 ' CE1' HG21 ' A' ' 35' ' ' ILE . 52.1 p90 -150.45 159.97 44.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.707 -0.621 . . . . 26.649999999999999 109.526 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.5 m -104.83 138.78 40.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.283 -0.885 . . . . 28.140000000000001 111.353 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.451 ' CB ' ' CZ ' ' A' ' 33' ' ' TYR . 25.2 t -123.95 166.18 16.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.714 -0.616 . . . . 33.880000000000003 109.762 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -143.06 118.89 1.28 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.202 -1.159 . . . . 31.800000000000001 110.202 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 68.2 t -132.57 149.42 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.66 -0.906 . . . . 0.0 109.763 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 pp -107.34 142.36 37.25 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.505 -0.747 . . . . 0.0 110.205 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.404 HD12 ' CD1' ' A' ' 31' ' ' PHE . 31.0 mt -124.57 143.3 50.77 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.486 -0.759 . . . . 38.68 110.502 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.56 -19.26 38.88 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.281 -0.887 . . . . 0.0 110.232 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.431 HG22 ' H ' ' A' ' 94' ' ' GLN . 5.3 m -101.67 133.17 46.79 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.443 -0.786 . . . . 31.629999999999999 109.978 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.415 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 67.9 tt0 -75.7 -4.89 42.85 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.119 -0.988 . . . . 0.0 110.623 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.431 ' H ' HG22 ' A' ' 92' ' ' THR . 15.5 pt20 -138.68 143.31 39.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.207 -0.933 . . . . 0.0 108.803 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -178.05 167.35 38.04 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 118.303 -1.903 . . . . 28.050000000000001 112.639 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -117.71 130.63 56.45 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 122.192 -0.593 . . . . 0.0 109.711 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 98.1 mtp -127.11 121.28 31.01 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.325 -0.859 . . . . 0.0 111.337 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.72 ' HG2' ' HB2' ' A' ' 117' ' ' ALA . 75.6 mt-30 -123.06 152.7 40.76 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.426 ' HA3' ' CE3' ' A' ' 52' ' ' TRP . . . -168.41 174.96 43.18 Favored Glycine 0 N--CA 1.499 2.879 0 C-N-CA 118.561 -1.78 . . . . 29.620000000000001 111.366 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.412 ' CE1' ' HB3' ' A' ' 51' ' ' HIS . 40.7 p-80 -142.86 156.17 44.89 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.876 -0.779 . . . . 0.0 110.078 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.785 ' CD2' HD11 ' A' ' 115' ' ' ILE . 4.8 m-85 -116.82 127.81 54.67 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.503 -0.748 . . . . 27.050000000000001 109.796 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 10.2 t70 -78.88 123.17 26.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.914 -1.116 . . . . 0.0 109.298 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.452 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 92.3 mmm -119.69 163.07 17.96 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.174 0.512 . . . . 0.0 110.062 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.476 HG22 HG23 ' A' ' 48' ' ' VAL . 8.6 m -142.42 129.16 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.588 -0.695 . . . . 23.280000000000001 110.453 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.564 ' HB3' ' OD1' ' A' ' 107' ' ' ASP . . . -72.73 166.03 23.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.492 -0.755 . . . . 0.0 109.408 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -64.36 -28.39 69.67 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.383 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.564 ' OD1' ' HB3' ' A' ' 105' ' ' ALA . 47.0 p-10 -76.29 -4.44 42.04 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.467 -0.77 . . . . 0.0 111.505 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.7 -9.91 60.57 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.056 -1.069 . . . . 30.43 110.915 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 89.7 m -57.5 135.08 56.59 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.03 -1.276 . . . . 0.0 109.985 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -101.36 140.8 35.15 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.335 -0.853 . . . . 0.0 110.877 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.452 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 44.0 p90 -165.9 144.87 6.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.712 -0.618 . . . . 28.030000000000001 109.603 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 84.8 mt -99.15 157.41 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.699 -0.626 . . . . 0.0 110.712 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.82 96.07 49.39 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -60.1 144.88 99.45 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 O-C-N 123.946 1.498 . . . . 33.310000000000002 112.376 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.785 HD11 ' CD2' ' A' ' 101' ' ' TYR . 68.8 mt -111.56 123.32 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.749 -0.834 . . . . 30.59 108.749 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -47.87 170.56 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.246 0.545 . . . . 30.780000000000001 111.636 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.72 ' HB2' ' HG2' ' A' ' 98' ' ' GLN . . . -99.41 123.14 43.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.699 -0.626 . . . . 0.0 110.766 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.47 ' CE1' HD11 ' A' ' 120' ' ' LEU . 48.4 p90 -111.36 156.83 20.97 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.262 -1.014 . . . . 30.66 108.262 178.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.631 ' C ' HD12 ' A' ' 120' ' ' LEU . 8.9 p -115.65 155.31 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.245 -0.909 . . . . 0.0 110.602 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.653 ' N ' HD12 ' A' ' 120' ' ' LEU . 7.8 mp -112.81 132.34 55.3 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.286 -0.635 . . . . 39.149999999999999 109.286 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.735 -0.603 . . . . 0.0 110.114 -179.722 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.554 ' HG3' ' HB3' ' A' ' 42' ' ' ALA . 29.3 ttm-85 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.011 0.434 . . . . 0.0 110.0 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -122.47 84.59 2.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.77 -0.581 . . . . 31.93 110.348 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.47 ' C ' HG23 ' A' ' 9' ' ' VAL . 11.9 ptp180 -148.3 144.26 27.47 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.133 0.968 . . . . 0.0 110.737 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.641 HG11 ' SD ' ' A' ' 103' ' ' MET . 99.3 t -151.02 120.61 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -108.07 134.18 51.32 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.615 0.721 . . . . 0.0 110.127 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 37' ' ' ILE . 60.5 t -119.28 138.55 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.915 -0.491 . . . . 28.210000000000001 109.921 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.412 ' HG3' ' HB2' ' A' ' 36' ' ' ARG . 13.4 pt-20 -122.92 139.71 53.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.502 -0.749 . . . . 0.0 109.422 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.742 HG22 HD13 ' A' ' 35' ' ' ILE . 59.3 t -128.56 140.25 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.645 -0.659 . . . . 27.949999999999999 110.717 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.6 t -122.83 104.04 36.52 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.844 -0.535 . . . . 0.0 109.963 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.433 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 50.0 Cg_endo -82.74 165.79 15.53 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 O-C-N 123.901 1.474 . . . . 33.0 111.26 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 -157.61 132.8 8.86 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.511 0.672 . . . . 54.100000000000001 109.557 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 19' ' ' ALA . 71.9 t80 -60.0 137.77 58.01 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.287 0.565 . . . . 0.0 111.206 -178.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.545 HD21 ' OE1' ' A' ' 21' ' ' GLN . 5.6 tp -114.95 78.71 1.19 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.979 0.895 . . . . 0.0 110.211 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.577 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -70.89 -35.32 72.27 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.567 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -68.14 -25.18 65.16 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.339 -0.851 . . . . 0.0 111.02 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.545 ' OE1' HD21 ' A' ' 18' ' ' LEU . 97.8 mt-30 -119.38 33.7 5.53 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.375 -0.828 . . . . 52.369999999999997 110.38 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.656 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 23.1 t -152.39 143.91 23.43 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.537 -0.727 . . . . 55.189999999999998 110.705 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.577 ' O ' HG23 ' A' ' 23' ' ' THR . 8.0 t -121.05 95.56 48.79 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.468 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.5 Cg_endo -66.46 -23.17 50.92 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 O-C-N 123.79 1.416 . . . . 51.57 112.106 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -65.13 -24.15 67.33 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.295 -0.878 . . . . 0.0 110.995 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -105.4 21.8 16.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.197 -0.939 . . . . 0.0 110.944 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.89 30.3 70.35 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.718 ' HD2' HD21 ' A' ' 89' ' ' LEU . 9.5 tpt180 -121.14 93.13 3.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.619 -0.93 . . . . 0.0 109.943 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.468 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 54.8 m-85 -105.56 130.77 53.54 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.955 -0.757 . . . . 46.07 108.955 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.656 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -117.98 119.62 35.36 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.635 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.677 ' CD1' HD12 ' A' ' 90' ' ' LEU . 79.2 m-85 -114.59 131.39 56.7 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.134 -0.691 . . . . 38.880000000000003 109.134 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.69 131.01 56.32 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.142 -0.974 . . . . 34.060000000000002 109.021 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.482 ' CE1' HD11 ' A' ' 35' ' ' ILE . 52.3 p90 -128.51 147.46 50.69 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.237 -0.985 . . . . 29.030000000000001 111.161 -179.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.7 m -101.07 139.44 36.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.697 -0.627 . . . . 0.0 109.691 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.742 HD13 HG22 ' A' ' 13' ' ' VAL . 47.4 mm -103.22 132.74 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.661 0.743 . . . . 0.0 111.317 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.412 ' HB2' ' HG3' ' A' ' 12' ' ' GLU . 62.7 mtt85 -126.0 97.77 5.24 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.577 0.703 . . . . 40.240000000000002 110.182 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.557 HG22 ' CD1' ' A' ' 76' ' ' LEU . 81.7 mt -93.5 118.05 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.882 -0.511 . . . . 20.73 110.656 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -117.0 135.73 53.47 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.428 -0.795 . . . . 0.0 109.507 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -90.69 118.73 30.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.879 -0.513 . . . . 21.34 110.833 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.56 8.91 17.85 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.558 -0.714 . . . . 0.0 110.706 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.454 ' HA2' ' HG2' ' A' ' 8' ' ' ARG . . . -82.94 178.68 53.13 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.216 -1.554 . . . . 29.100000000000001 109.216 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.554 ' HB3' ' HG3' ' A' ' 6' ' ' ARG . . . -94.62 -30.45 14.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.446 -1.032 . . . . 0.0 110.198 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.515 HG13 ' HD2' ' A' ' 44' ' ' PRO . 86.7 t -103.82 139.89 20.54 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.855 -0.528 . . . . 0.0 109.764 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.515 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.9 Cg_endo -52.75 142.69 50.28 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 O-C-N 123.818 1.43 . . . . 21.949999999999999 111.827 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.4 151.44 46.3 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.53 0.681 . . . . 20.91 110.926 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.43 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 19.3 ptt-85 -127.76 159.14 35.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.721 -0.612 . . . . 0.0 109.893 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.848 HD22 HG13 ' A' ' 69' ' ' VAL . 7.6 tt -97.75 116.22 29.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.449 -0.782 . . . . 0.0 109.737 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.434 HG23 HG22 ' A' ' 104' ' ' VAL . 57.3 t -98.08 -27.54 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.517 -0.739 . . . . 0.0 110.497 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.725 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -140.46 163.61 32.36 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.822 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -143.18 140.65 30.85 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.306 0.574 . . . . 29.050000000000001 110.226 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -145.1 113.46 6.61 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.433 0.635 . . . . 27.969999999999999 110.15 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.473 ' CH2' HG21 ' A' ' 115' ' ' ILE . 63.0 m95 -101.1 136.66 40.59 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.635 -0.666 . . . . 25.25 110.996 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -116.8 78.52 1.22 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.717 -0.614 . . . . 0.0 109.751 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.421 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.0 pt -86.42 131.89 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.361 -0.837 . . . . 36.109999999999999 111.963 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.717 HG23 HG22 ' A' ' 61' ' ' THR . 94.3 m -118.76 132.51 56.14 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.549 -0.908 . . . . 33.979999999999997 108.549 178.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -87.91 169.81 11.69 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.556 0.694 . . . . 45.039999999999999 111.244 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.48 -8.67 20.77 Favored Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.81 -0.556 . . . . 39.469999999999999 112.016 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -101.98 8.29 41.07 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 119.301 1.551 . . . . 0.0 110.797 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.78 -25.61 18.36 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 121.264 -0.898 . . . . 0.0 110.966 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.3 mpp_? -62.0 141.71 57.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.219 -1.165 . . . . 62.780000000000001 109.619 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.717 HG22 HG23 ' A' ' 55' ' ' THR . 63.7 p -129.3 147.83 51.17 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.614 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -122.1 120.49 34.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.549 -0.72 . . . . 0.0 109.809 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -103.92 136.13 44.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.66 -0.65 . . . . 0.0 110.668 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.5 t -128.12 131.11 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.454 0.645 . . . . 37.939999999999998 109.781 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.99 127.85 47.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.827 -0.546 . . . . 0.0 110.472 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -153.0 170.18 31.99 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.165 -1.574 . . . . 31.82 109.165 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -111.13 160.32 17.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.411 -1.052 . . . . 0.0 109.896 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.77 93.81 0.01 OUTLIER Glycine 0 N--CA 1.5 2.919 0 O-C-N 121.284 -0.885 . . . . 22.620000000000001 111.239 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.848 HG13 HD22 ' A' ' 47' ' ' LEU . 16.6 m -44.54 132.53 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.528 0 O-C-N 121.431 -1.041 . . . . 17.510000000000002 111.774 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.9 m 41.77 38.45 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 CA-C-N 115.592 -0.731 . . . . 20.550000000000001 111.605 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.08 18.79 64.19 Favored Glycine 0 N--CA 1.495 2.618 0 O-C-N 121.789 -0.569 . . . . 18.289999999999999 112.521 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 82' ' ' PHE . 5.5 pt-20 -147.41 153.07 39.16 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 119.045 1.422 . . . . 0.0 112.477 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -117.39 73.31 7.58 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.555 -0.906 . . . . 18.210000000000001 108.555 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -54.88 141.39 77.75 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 O-C-N 123.715 1.376 . . . . 17.609999999999999 112.174 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.444 ' CZ3' ' HB2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -100.62 76.93 1.86 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.557 ' CD1' HG22 ' A' ' 37' ' ' ILE . 11.2 mt -60.68 118.18 6.28 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.618 -0.676 . . . . 20.57 111.736 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.08 157.5 56.79 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -53.17 127.6 25.74 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 O-C-N 123.491 1.258 . . . . 27.039999999999999 111.089 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.14 -16.58 55.33 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.799 -0.92 . . . . 24.739999999999998 110.799 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -86.81 165.36 16.06 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.078 -1.248 . . . . 29.379999999999999 110.489 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.14 149.62 35.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.517 -0.739 . . . . 0.0 110.015 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.407 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 64.7 t80 -119.75 148.25 43.64 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.414 -0.804 . . . . 18.559999999999999 109.141 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.8 p80 -143.46 140.23 30.27 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.125 -0.985 . . . . 0.0 111.293 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.61 ' CE1' HG21 ' A' ' 35' ' ' ILE . 51.7 p90 -151.52 160.38 43.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.664 -0.648 . . . . 26.649999999999999 109.618 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.2 m -102.82 137.64 40.75 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.402 -0.812 . . . . 28.140000000000001 111.058 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.436 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 17.0 t -123.99 167.28 14.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.595 -0.691 . . . . 33.880000000000003 109.886 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -143.97 124.35 2.23 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.813 -1.184 . . . . 31.800000000000001 110.572 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.5 m -131.36 154.19 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.632 -0.923 . . . . 0.0 109.939 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.718 HD21 ' HD2' ' A' ' 28' ' ' ARG . 10.6 tp -109.18 144.64 36.99 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.553 -0.717 . . . . 0.0 110.832 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.719 HD11 HD22 ' A' ' 120' ' ' LEU . 74.7 mt -122.14 146.34 47.32 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.597 -0.689 . . . . 38.68 110.314 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.403 ' O ' ' CE1' ' A' ' 29' ' ' TYR . 75.4 tt0 -76.2 -25.62 55.33 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.353 -0.842 . . . . 0.0 110.782 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 68.0 p -125.2 172.06 9.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.361 -0.837 . . . . 31.629999999999999 110.782 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.458 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 50.1 mt-10 -86.81 11.72 12.58 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.593 -0.692 . . . . 0.0 111.654 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 14.4 pt20 -140.85 148.22 40.2 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.06 -1.025 . . . . 0.0 110.057 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.31 160.82 23.78 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 118.907 -1.616 . . . . 28.050000000000001 112.086 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -119.73 129.64 54.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 122.14 -0.624 . . . . 0.0 109.335 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 97.7 mtp -125.3 116.24 21.62 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.344 -0.848 . . . . 0.0 111.116 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.49 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 56.6 tt0 -129.26 149.79 50.91 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.7 -178.49 38.72 Favored Glycine 0 N--CA 1.498 2.822 0 C-N-CA 118.916 -1.611 . . . . 29.620000000000001 110.76 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -140.54 157.96 44.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.703 -0.881 . . . . 0.0 110.752 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.669 ' CE2' HD11 ' A' ' 115' ' ' ILE . 6.3 m-85 -116.79 128.58 55.43 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.645 -0.66 . . . . 27.050000000000001 109.885 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.725 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 41.9 t0 -81.35 123.18 28.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.978 -1.076 . . . . 0.0 109.136 178.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.641 ' SD ' HG11 ' A' ' 9' ' ' VAL . 51.7 mtp -122.19 162.35 21.52 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.118 0.485 . . . . 0.0 110.339 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.434 HG22 HG23 ' A' ' 48' ' ' VAL . 10.0 m -142.91 129.73 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.613 -0.679 . . . . 23.280000000000001 110.325 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.04 167.66 20.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.513 -0.742 . . . . 0.0 109.45 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -64.29 -28.44 69.72 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.142 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -72.92 -12.26 60.89 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.567 -0.708 . . . . 0.0 111.026 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.25 -7.05 47.05 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.484 -1.046 . . . . 30.43 110.484 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 91.3 m -57.66 135.2 56.7 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.051 -1.264 . . . . 0.0 110.049 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -101.29 140.03 36.14 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.457 -0.777 . . . . 0.0 110.796 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.452 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 47.5 p90 -167.16 147.23 5.43 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.781 -0.574 . . . . 28.030000000000001 109.854 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.7 pt -102.55 158.12 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.596 -0.69 . . . . 0.0 111.087 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.63 97.59 49.91 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -59.25 143.13 99.86 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 O-C-N 123.895 1.471 . . . . 33.310000000000002 112.432 -178.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.669 HD11 ' CE2' ' A' ' 101' ' ' TYR . 72.2 mt -108.33 123.24 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.658 -0.867 . . . . 30.59 108.658 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.05 144.21 7.13 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.217 0.532 . . . . 30.780000000000001 111.551 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.49 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -87.37 121.03 29.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.638 -0.664 . . . . 0.0 110.242 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.616 ' CE1' HD11 ' A' ' 120' ' ' LEU . 41.9 p90 -109.42 165.89 11.3 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.879 -0.785 . . . . 30.66 108.879 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.605 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.1 t -114.81 154.0 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.284 -0.885 . . . . 0.0 110.326 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.719 HD22 HD11 ' A' ' 90' ' ' LEU . 7.0 mp -113.2 133.23 55.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.788 -0.57 . . . . 39.149999999999999 109.514 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.673 -0.642 . . . . 0.0 110.071 -179.838 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.961 0.41 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.424 ' CE2' HG21 ' A' ' 109' ' ' THR . 34.3 m-85 -115.93 107.41 14.96 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.542 -0.724 . . . . 31.93 110.029 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.483 ' C ' HG23 ' A' ' 9' ' ' VAL . 4.1 ttp180 -155.87 135.05 12.17 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.588 0.708 . . . . 0.0 110.594 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.629 HG11 ' SD ' ' A' ' 103' ' ' MET . 98.2 t -152.42 116.23 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -108.95 132.6 53.93 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.675 0.75 . . . . 0.0 110.62 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.7 t -119.41 139.08 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.891 -0.506 . . . . 28.210000000000001 109.712 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -119.96 137.92 53.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.505 -0.747 . . . . 0.0 109.709 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.523 HG13 ' HD1' ' A' ' 33' ' ' TYR . 62.6 t -129.26 136.62 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.539 -0.725 . . . . 27.949999999999999 110.509 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.6 p -124.17 103.89 32.65 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.72 -0.612 . . . . 0.0 110.281 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -82.89 165.97 15.13 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 123.841 1.443 . . . . 33.0 111.063 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -157.59 132.12 8.47 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.539 0.685 . . . . 54.100000000000001 109.801 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.483 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 77.3 t80 -60.29 139.52 57.57 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.257 0.551 . . . . 0.0 111.471 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.914 HD11 ' HB2' ' A' ' 32' ' ' ALA . 93.7 mt -115.58 79.15 1.25 Allowed 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.879 0.847 . . . . 0.0 110.279 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.483 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -65.89 -35.62 81.15 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.17 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -69.96 -23.45 63.18 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.365 -0.835 . . . . 0.0 110.985 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -121.07 29.97 7.08 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.366 -0.834 . . . . 52.369999999999997 110.976 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.608 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 19.7 p -152.17 146.37 25.42 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.265 -0.897 . . . . 55.189999999999998 111.099 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.586 ' O ' HG23 ' A' ' 23' ' ' THR . 5.1 t -119.45 92.79 46.45 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.48 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.3 Cg_endo -66.08 -23.15 53.75 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 O-C-N 123.912 1.48 . . . . 51.57 111.566 -178.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.04 -23.19 67.12 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.4 -0.812 . . . . 0.0 110.882 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -105.77 23.83 13.27 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.357 -0.839 . . . . 0.0 110.693 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.43 28.71 73.66 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.569 ' HB2' HG23 ' A' ' 23' ' ' THR . 33.1 mtt180 -121.52 93.9 4.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.646 -0.914 . . . . 0.0 110.311 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.48 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 66.4 m-85 -104.59 134.32 47.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.644 -0.66 . . . . 46.07 109.325 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.608 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -117.17 120.68 39.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.444 -0.785 . . . . 0.0 111.273 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.755 ' CD1' HD12 ' A' ' 90' ' ' LEU . 91.1 m-85 -116.36 133.67 55.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.505 -0.747 . . . . 38.880000000000003 109.853 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.914 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -114.74 132.42 56.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.205 -0.934 . . . . 34.060000000000002 108.74 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.523 ' HD1' HG13 ' A' ' 13' ' ' VAL . 34.0 p90 -127.63 145.99 50.7 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 119.19 -1.004 . . . . 29.030000000000001 111.747 -178.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 53.8 m -104.46 134.15 48.14 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.872 HG21 ' CE2' ' A' ' 84' ' ' TYR . 18.8 tt -105.94 135.76 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 121.807 0.813 . . . . 0.0 112.111 -178.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -124.64 100.88 6.85 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.548 0.689 . . . . 40.240000000000002 109.897 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.632 HG22 HD22 ' A' ' 76' ' ' LEU . 81.6 mt -90.72 118.56 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.808 -0.558 . . . . 20.73 110.69 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -117.35 139.5 50.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.392 -0.817 . . . . 0.0 109.497 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -88.55 117.23 27.36 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.672 -0.642 . . . . 21.34 110.848 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.68 3.31 15.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.551 -0.718 . . . . 0.0 110.633 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.8 -174.88 49.92 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.02 -1.632 . . . . 29.100000000000001 109.02 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.02 -30.67 11.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.439 -1.036 . . . . 0.0 110.277 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.522 HG13 ' HD2' ' A' ' 44' ' ' PRO . 86.3 t -105.33 140.65 21.35 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.796 -0.565 . . . . 0.0 109.646 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.522 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.5 Cg_endo -52.1 141.12 48.93 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 O-C-N 123.718 1.378 . . . . 21.949999999999999 111.991 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.84 151.56 45.8 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.627 0.727 . . . . 20.91 110.883 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 0.5 OUTLIER -127.68 160.5 31.48 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.72 -0.612 . . . . 0.0 109.794 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.958 HD22 HG13 ' A' ' 69' ' ' VAL . 7.1 tt -97.27 117.88 32.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.379 -0.826 . . . . 0.0 109.451 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.452 HG23 HG22 ' A' ' 104' ' ' VAL . 58.8 t -101.32 -27.05 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.542 -0.724 . . . . 0.0 110.627 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.783 ' HB3' ' HB2' ' A' ' 102' ' ' ASP . . . -140.41 162.82 34.4 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.226 -0.989 . . . . 0.0 111.558 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -141.29 138.67 33.34 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.345 0.593 . . . . 29.050000000000001 110.434 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -142.86 113.31 7.32 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.327 0.584 . . . . 27.969999999999999 109.723 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.427 ' CH2' HD13 ' A' ' 115' ' ' ILE . 82.1 m95 -101.15 133.63 45.4 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.632 -0.668 . . . . 25.25 111.049 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -116.28 76.48 1.02 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.635 -0.666 . . . . 0.0 109.345 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 54' ' ' ILE . 28.0 pt -85.59 129.21 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-O 121.776 0.798 . . . . 36.109999999999999 111.774 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.0 m -120.57 131.8 54.84 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.429 -0.952 . . . . 33.979999999999997 108.429 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -88.55 169.99 11.25 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.85 0.833 . . . . 45.039999999999999 111.474 -178.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.04 -7.12 11.57 Favored Glycine 0 N--CA 1.495 2.616 0 O-C-N 121.757 -0.589 . . . . 39.469999999999999 112.205 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -101.0 7.02 43.71 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 119.434 1.617 . . . . 0.0 110.6 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.04 -29.05 8.47 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.79 141.49 58.75 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.23 -1.159 . . . . 62.780000000000001 109.674 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.8 t -134.84 152.96 52.18 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.618 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -121.32 122.08 39.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.542 -0.723 . . . . 0.0 110.155 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -102.82 134.72 45.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.705 -0.622 . . . . 0.0 110.439 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.4 t -128.01 130.82 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.578 -0.701 . . . . 37.939999999999998 110.062 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -125.82 126.87 45.2 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.849 -0.532 . . . . 0.0 110.041 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -151.13 158.37 27.66 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.264 -1.534 . . . . 31.82 109.264 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -80.7 154.35 27.34 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.428 -1.042 . . . . 0.0 110.374 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.88 -167.09 0.2 Allowed Glycine 0 N--CA 1.498 2.767 0 O-C-N 121.493 -0.754 . . . . 22.620000000000001 111.605 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.958 HG13 HD22 ' A' ' 47' ' ' LEU . 16.0 m -131.8 129.61 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.96 -0.729 . . . . 17.510000000000002 109.537 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.4 m 40.91 35.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 CA-C-O 121.517 0.675 . . . . 20.550000000000001 111.779 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.28 17.8 65.98 Favored Glycine 0 N--CA 1.498 2.813 0 O-C-N 121.598 -0.689 . . . . 18.289999999999999 112.988 177.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 69' ' ' VAL . 11.1 pt-20 -145.13 150.59 37.06 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 119.211 1.505 . . . . 0.0 112.025 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -115.21 74.75 4.03 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.923 -0.769 . . . . 18.210000000000001 108.923 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -56.94 140.8 93.12 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 O-C-N 123.785 1.413 . . . . 17.609999999999999 112.189 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.436 ' CZ3' ' HG2' ' A' ' 77' ' ' ARG . 6.3 t90 -104.03 77.55 1.45 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.632 HD22 HG22 ' A' ' 37' ' ' ILE . 5.8 tp -61.38 118.17 6.6 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.516 -0.74 . . . . 20.57 111.623 -178.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.436 ' HG2' ' CZ3' ' A' ' 75' ' ' TRP . 16.0 mtm180 -86.31 159.18 53.98 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -54.61 126.71 23.28 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 O-C-N 123.628 1.331 . . . . 27.039999999999999 111.002 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.64 -18.53 42.34 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.903 -0.879 . . . . 24.739999999999998 110.903 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -87.89 165.77 15.02 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.079 -1.248 . . . . 29.379999999999999 110.255 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.523 ' CA ' HD11 ' A' ' 76' ' ' LEU . . . -145.74 150.45 36.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.545 -0.722 . . . . 0.0 110.388 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.47 ' HD2' HD12 ' A' ' 37' ' ' ILE . 90.7 t80 -118.59 145.68 45.21 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.031 -0.729 . . . . 18.559999999999999 109.031 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.6 p80 -146.14 141.19 27.26 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.226 -0.922 . . . . 0.0 111.367 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.872 ' CE2' HG21 ' A' ' 35' ' ' ILE . 44.9 p90 -151.89 163.28 39.57 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.655 -0.653 . . . . 26.649999999999999 109.557 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.9 m -99.0 138.42 36.12 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.167 -0.958 . . . . 28.140000000000001 111.137 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 15.2 t -125.91 166.35 17.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.615 -0.678 . . . . 33.880000000000003 109.912 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -143.88 124.52 2.27 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 119.774 -1.203 . . . . 31.800000000000001 110.675 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.5 m -132.13 152.8 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.667 -0.902 . . . . 0.0 109.809 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.548 HD23 ' HA ' ' A' ' 30' ' ' ALA . 81.5 mt -111.56 145.15 39.63 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.559 -0.713 . . . . 0.0 110.977 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.755 HD12 ' CD1' ' A' ' 31' ' ' PHE . 78.7 mt -121.2 145.95 47.3 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.691 -0.631 . . . . 38.68 109.886 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -73.39 -25.69 60.67 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.306 -0.871 . . . . 0.0 111.165 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.8 p -123.47 171.71 9.27 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.354 -0.841 . . . . 31.629999999999999 110.756 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.41 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 32.6 tt0 -86.31 7.37 25.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.692 -0.63 . . . . 0.0 111.506 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -138.62 148.62 44.31 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.097 -1.002 . . . . 0.0 109.526 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.62 156.77 14.57 Favored Glycine 0 N--CA 1.496 2.661 0 C-N-CA 118.755 -1.688 . . . . 28.050000000000001 112.254 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -118.41 130.02 55.74 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 94.8 mtp -126.29 120.77 30.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.38 -0.825 . . . . 0.0 111.4 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -130.6 151.83 50.64 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.73 -173.67 33.63 Favored Glycine 0 N--CA 1.5 2.951 0 C-N-CA 118.973 -1.584 . . . . 29.620000000000001 110.806 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -137.13 160.18 39.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.654 -0.909 . . . . 0.0 110.557 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.61 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 8.7 m-85 -116.98 128.42 55.17 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.771 -0.581 . . . . 27.050000000000001 110.181 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.783 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 78.6 m-20 -87.15 121.31 29.43 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.021 -1.05 . . . . 0.0 108.846 177.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.629 ' SD ' HG11 ' A' ' 9' ' ' VAL . 55.1 mtp -126.4 162.76 24.82 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.21 0.529 . . . . 0.0 110.624 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.514 HG12 ' CD ' ' A' ' 110' ' ' GLU . 12.6 m -140.65 131.23 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.551 -0.718 . . . . 23.280000000000001 110.287 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.45 165.58 24.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.35 -0.844 . . . . 0.0 109.402 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -63.7 -29.37 70.6 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.024 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -75.34 -9.69 58.78 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.493 -0.754 . . . . 0.0 111.202 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.99 -7.98 49.29 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.061 -1.066 . . . . 30.43 110.469 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.424 HG21 ' CE2' ' A' ' 7' ' ' TYR . 33.6 m -57.69 135.38 56.74 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.036 -1.273 . . . . 0.0 109.964 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.514 ' CD ' HG12 ' A' ' 104' ' ' VAL . 79.3 mm-40 -101.34 139.77 36.56 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.347 -0.845 . . . . 0.0 110.723 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 47.8 p90 -163.76 143.24 8.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.684 -0.635 . . . . 28.030000000000001 109.993 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 84.3 mt -101.09 156.79 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.424 0.631 . . . . 0.0 110.43 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.61 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -120.86 98.91 47.45 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -58.36 143.22 97.8 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 O-C-N 123.93 1.49 . . . . 33.310000000000002 112.066 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.464 HD11 ' CZ ' ' A' ' 101' ' ' TYR . 70.9 mt -107.97 123.28 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-N 115.375 -0.829 . . . . 30.59 108.907 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -51.84 149.63 4.7 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.175 0.512 . . . . 30.780000000000001 111.207 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -91.29 120.87 32.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.586 -0.696 . . . . 0.0 110.113 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.72 ' CE1' HD11 ' A' ' 120' ' ' LEU . 51.2 p90 -110.29 165.01 12.11 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.678 -0.86 . . . . 30.66 108.678 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.595 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.2 t -116.01 153.13 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.159 -0.963 . . . . 0.0 110.677 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.74 HD22 HD11 ' A' ' 90' ' ' LEU . 7.0 mp -113.32 134.35 54.66 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.283 -0.636 . . . . 39.149999999999999 109.283 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 51.9 m . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.62 -0.675 . . . . 0.0 110.081 -179.819 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.703 0.287 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.415 ' CE2' HG21 ' A' ' 109' ' ' THR . 39.9 m-85 -118.62 105.36 11.53 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.484 -0.76 . . . . 31.93 110.331 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.49 ' C ' HG23 ' A' ' 9' ' ' VAL . 82.4 mtt85 -147.08 132.57 18.67 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.603 -0.685 . . . . 0.0 109.839 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.49 HG23 ' C ' ' A' ' 8' ' ' ARG . 93.4 t -152.1 115.41 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.501 -0.75 . . . . 0.0 109.896 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -105.7 128.42 53.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.662 -0.649 . . . . 0.0 109.823 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.593 HG11 ' HE2' ' A' ' 101' ' ' TYR . 58.4 t -119.32 138.3 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.757 -0.59 . . . . 28.210000000000001 109.793 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -123.57 136.73 54.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.316 -0.865 . . . . 0.0 110.148 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.633 HG22 HD13 ' A' ' 35' ' ' ILE . 60.4 t -129.61 137.11 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.57 -0.706 . . . . 27.949999999999999 110.18 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.4 t -125.61 105.28 27.17 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.688 -0.633 . . . . 0.0 110.887 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.88 165.13 15.51 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.794 1.418 . . . . 33.0 110.886 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.8 ptt-85 -157.98 132.01 8.04 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.664 0.745 . . . . 54.100000000000001 109.947 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.48 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 79.7 t80 -60.02 139.97 57.1 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.725 -0.609 . . . . 0.0 111.604 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.951 HD11 ' HB2' ' A' ' 32' ' ' ALA . 84.5 mt -116.49 80.76 1.51 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.903 0.858 . . . . 0.0 110.422 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.48 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -65.8 -35.74 81.55 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.065 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -69.96 -24.45 63.34 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.282 -0.886 . . . . 0.0 110.881 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.2 tp60 -121.36 49.56 1.5 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.331 -0.856 . . . . 52.369999999999997 110.779 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.699 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 52.5 p -169.59 149.12 3.84 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.228 -0.92 . . . . 55.189999999999998 110.916 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.604 HG23 ' HB2' ' A' ' 28' ' ' ARG . 5.1 t -118.88 92.42 44.77 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.0 Cg_endo -66.86 -24.92 45.88 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 O-C-N 123.818 1.43 . . . . 51.57 112.064 -178.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -66.7 -20.77 66.04 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.236 -0.915 . . . . 0.0 111.022 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -105.6 23.58 13.61 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.145 -0.972 . . . . 0.0 110.739 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.72 27.43 73.27 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.604 ' HB2' HG23 ' A' ' 23' ' ' THR . 30.8 mtt85 -122.08 94.38 4.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.643 -0.916 . . . . 0.0 110.082 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.46 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 63.8 m-85 -104.41 137.15 42.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.582 -0.699 . . . . 46.07 109.209 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.699 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -114.03 120.4 40.47 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.162 -179.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -116.5 131.38 56.96 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.608 -0.683 . . . . 38.880000000000003 109.653 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.951 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -113.39 131.5 55.97 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.282 -0.886 . . . . 34.060000000000002 108.849 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 86' ' ' SER . 53.7 p90 -126.52 145.57 50.46 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.331 -0.948 . . . . 29.030000000000001 111.326 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.5 t -102.41 140.27 36.91 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.633 HD13 HG22 ' A' ' 13' ' ' VAL . 48.5 mm -105.68 132.46 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.783 0.802 . . . . 0.0 111.715 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -123.58 97.77 5.54 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.522 0.677 . . . . 40.240000000000002 109.718 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.531 HG22 ' CD1' ' A' ' 76' ' ' LEU . 81.8 mt -93.17 117.75 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.773 -0.58 . . . . 20.73 110.583 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -117.18 133.72 55.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.439 -0.788 . . . . 0.0 109.319 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -94.59 117.44 30.13 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 120.212 -0.595 . . . . 21.34 110.523 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.27 15.89 15.86 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.39 -0.819 . . . . 0.0 110.45 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.83 -179.72 52.78 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.332 -1.507 . . . . 29.100000000000001 109.332 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.31 -33.26 13.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.56 -0.964 . . . . 0.0 110.267 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.532 HG13 ' HD2' ' A' ' 44' ' ' PRO . 87.2 t -106.45 142.02 24.03 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 122.022 -0.424 . . . . 0.0 109.937 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.532 ' HD2' HG13 ' A' ' 43' ' ' VAL . 38.7 Cg_endo -53.66 146.84 42.28 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 O-C-N 123.792 1.417 . . . . 21.949999999999999 111.428 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.5 151.28 47.23 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.794 0.807 . . . . 20.91 111.506 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 8.1 ttt180 -126.85 152.32 47.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.865 -0.522 . . . . 0.0 109.595 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.852 HD22 HG13 ' A' ' 69' ' ' VAL . 7.0 tt -98.03 118.73 35.28 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.382 -0.824 . . . . 0.0 109.728 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.501 HG23 HG22 ' A' ' 104' ' ' VAL . 58.0 t -100.27 -29.66 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.61 -0.681 . . . . 0.0 111.073 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.602 ' HB3' ' HB2' ' A' ' 102' ' ' ASP . . . -141.68 165.58 27.1 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.078 -1.049 . . . . 0.0 112.296 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.5 ptt85 -142.72 140.69 31.57 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.519 0.676 . . . . 29.050000000000001 110.352 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -143.09 114.59 8.0 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.777 -0.577 . . . . 27.969999999999999 109.628 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.577 ' CH2' HD13 ' A' ' 115' ' ' ILE . 91.6 m95 -99.95 132.92 45.01 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.578 -0.701 . . . . 25.25 111.2 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -116.15 76.05 0.99 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.604 -0.685 . . . . 0.0 109.402 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 54' ' ' ILE . 28.2 pt -85.17 130.13 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.789 0.805 . . . . 36.109999999999999 112.275 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.562 HG23 ' HB ' ' A' ' 61' ' ' THR . 6.9 m -118.64 130.89 56.11 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.983 -1.117 . . . . 33.979999999999997 107.983 178.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.475 ' OD2' HG21 ' A' ' 92' ' ' THR . 26.3 t0 -88.5 169.72 11.51 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.644 0.735 . . . . 45.039999999999999 111.144 -178.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.57 -6.84 12.41 Favored Glycine 0 N--CA 1.496 2.636 0 O-C-N 121.754 -0.591 . . . . 39.469999999999999 112.13 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -101.47 7.69 42.36 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 119.337 1.569 . . . . 0.0 110.596 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.67 -31.63 6.37 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.51 142.72 57.81 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.387 -1.067 . . . . 62.780000000000001 109.944 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.562 ' HB ' HG23 ' A' ' 55' ' ' THR . 7.7 t -134.36 152.93 52.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.531 -0.731 . . . . 0.0 110.451 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -121.92 123.35 41.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.545 -0.722 . . . . 0.0 110.335 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -103.23 134.24 46.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.671 -0.643 . . . . 0.0 110.496 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.8 t -128.37 131.78 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.538 -0.727 . . . . 37.939999999999998 110.043 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -124.86 126.21 45.2 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.822 -0.549 . . . . 0.0 110.148 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.35 149.01 21.0 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.363 -1.495 . . . . 31.82 109.363 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -77.88 155.24 31.07 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.474 -1.015 . . . . 0.0 110.439 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.56 -175.13 0.18 Allowed Glycine 0 N--CA 1.497 2.7 0 N-CA-C 111.049 -0.82 . . . . 22.620000000000001 111.049 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.852 HG13 HD22 ' A' ' 47' ' ' LEU . 14.3 m -128.24 127.52 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.8 -0.824 . . . . 17.510000000000002 109.576 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.4 m 41.21 36.95 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-O 121.599 0.714 . . . . 20.550000000000001 111.809 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.97 15.77 71.7 Favored Glycine 0 N--CA 1.499 2.854 0 O-C-N 121.571 -0.705 . . . . 18.289999999999999 112.957 177.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.416 ' O ' HG22 ' A' ' 69' ' ' VAL . 10.8 pt-20 -146.3 151.33 37.36 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-N 119.136 1.468 . . . . 0.0 112.15 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -115.5 75.36 4.82 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.887 -0.783 . . . . 18.210000000000001 108.887 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -57.71 139.04 88.96 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 O-C-N 123.847 1.446 . . . . 17.609999999999999 112.084 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.432 ' CD1' ' HB2' ' A' ' 46' ' ' ARG . 4.0 t90 -101.68 76.22 1.64 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.531 ' CD1' HG22 ' A' ' 37' ' ' ILE . 10.1 mt -60.25 118.17 6.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.582 -0.699 . . . . 20.57 112.039 -178.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.429 ' HG2' ' CZ3' ' A' ' 75' ' ' TRP . 15.2 mtm180 -86.91 158.45 53.28 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -54.25 129.37 34.2 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 O-C-N 123.461 1.243 . . . . 27.039999999999999 111.227 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.01 -18.59 47.03 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 111.068 -0.813 . . . . 24.739999999999998 111.068 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -88.05 166.17 14.64 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.058 -1.26 . . . . 29.379999999999999 110.618 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.04 147.66 32.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.621 -0.674 . . . . 0.0 110.231 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.514 ' HD2' HD12 ' A' ' 37' ' ' ILE . 84.6 t80 -116.21 144.24 44.45 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.525 -0.734 . . . . 18.559999999999999 109.08 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -144.18 140.58 29.42 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.278 -0.889 . . . . 0.0 111.141 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.455 ' CE1' HG21 ' A' ' 35' ' ' ILE . 51.3 p90 -150.15 159.99 44.01 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.758 -0.589 . . . . 26.649999999999999 109.528 178.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.9 m -103.51 138.77 39.75 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.43 -0.794 . . . . 28.140000000000001 110.875 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.434 ' HB3' ' CE2' ' A' ' 33' ' ' TYR . 15.3 t -124.21 167.36 14.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.689 -0.632 . . . . 33.880000000000003 109.937 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -144.03 119.36 1.29 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 110.136 -1.186 . . . . 31.800000000000001 110.136 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.35 152.83 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.591 -0.947 . . . . 0.0 110.1 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -108.71 142.99 38.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.53 -0.731 . . . . 0.0 110.666 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.438 ' CD1' HD22 ' A' ' 120' ' ' LEU . 36.4 mt -124.64 144.79 49.99 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.484 -0.76 . . . . 38.68 110.38 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -88.71 -19.84 25.59 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.129 -0.982 . . . . 0.0 110.395 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.475 HG21 ' OD2' ' A' ' 56' ' ' ASP . 2.6 p -103.05 134.88 45.74 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.403 -0.811 . . . . 31.629999999999999 110.481 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.456 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 51.3 mt-10 -77.38 -2.88 37.32 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.239 -0.913 . . . . 0.0 110.66 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 97.1 mt-30 -138.59 140.63 39.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.179 -0.951 . . . . 0.0 108.834 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.91 166.57 35.76 Favored Glycine 0 N--CA 1.499 2.885 0 C-N-CA 118.409 -1.853 . . . . 28.050000000000001 112.585 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -117.77 129.98 56.02 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.154 -0.615 . . . . 0.0 109.465 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.452 ' HB3' ' HE2' ' A' ' 97' ' ' MET . 98.0 mtp -126.33 119.97 28.69 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.308 -0.87 . . . . 0.0 111.281 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.572 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 30.1 mt-30 -122.54 152.16 40.65 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.93 173.43 36.61 Favored Glycine 0 N--CA 1.498 2.813 0 C-N-CA 118.783 -1.675 . . . . 29.620000000000001 111.107 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.432 ' CD2' ' HB3' ' A' ' 114' ' ' PRO . 67.5 m80 -136.98 156.77 48.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.702 -0.881 . . . . 0.0 109.892 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.599 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 9.1 m-85 -116.66 127.48 54.47 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.683 -0.635 . . . . 27.050000000000001 109.938 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.602 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 78.4 m-20 -84.07 119.89 25.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.962 -1.086 . . . . 0.0 108.414 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.44 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 4.8 ttm -123.48 162.34 23.08 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.065 0.46 . . . . 0.0 110.685 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.501 HG22 HG23 ' A' ' 48' ' ' VAL . 10.8 m -141.42 129.84 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.699 -0.626 . . . . 23.280000000000001 110.52 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.7 166.45 23.26 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.474 -0.766 . . . . 0.0 109.521 179.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -66.45 -30.55 70.93 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.484 -0.76 . . . . 0.0 110.291 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -74.98 -4.59 39.15 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.494 -0.754 . . . . 0.0 111.233 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.8 -9.99 58.68 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.139 -1.029 . . . . 30.43 110.537 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.415 HG21 ' CE2' ' A' ' 7' ' ' TYR . 43.5 m -57.57 134.59 56.27 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.124 -1.221 . . . . 0.0 109.982 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -101.42 140.02 36.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.354 -0.841 . . . . 0.0 110.776 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 42.8 p90 -164.41 142.98 7.09 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.644 -0.66 . . . . 28.030000000000001 109.822 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 85.7 mt -101.23 158.01 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.633 -0.667 . . . . 0.0 110.495 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.599 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -119.01 95.43 49.35 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.432 ' HB3' ' CD2' ' A' ' 100' ' ' HIS . 46.6 Cg_endo -59.56 146.6 94.72 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 O-C-N 123.933 1.491 . . . . 33.310000000000002 112.082 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.596 HD11 ' CE2' ' A' ' 101' ' ' TYR . 66.5 mt -111.19 120.92 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.594 -0.891 . . . . 30.59 108.594 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.05 168.77 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.152 0.501 . . . . 30.780000000000001 111.467 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.572 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -96.98 122.17 39.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.584 -0.698 . . . . 0.0 110.765 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.552 ' CE1' HD11 ' A' ' 120' ' ' LEU . 47.4 p90 -112.01 157.99 20.07 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.183 -1.043 . . . . 30.66 108.183 178.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.627 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.3 t -114.93 153.73 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.241 -0.912 . . . . 0.0 110.494 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.669 ' N ' HD12 ' A' ' 120' ' ' LEU . 7.3 mp -113.12 131.57 55.78 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.175 -0.676 . . . . 39.149999999999999 109.175 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.836 -0.54 . . . . 0.0 110.068 -179.754 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.742 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 83.1 mtt180 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.864 0.364 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.527 ' CZ ' HG21 ' A' ' 109' ' ' THR . 91.9 m-85 -120.63 98.09 5.86 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.553 -0.717 . . . . 31.93 110.199 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.469 ' C ' HG23 ' A' ' 9' ' ' VAL . 74.4 mtm-85 -142.66 135.11 27.75 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.62 -0.675 . . . . 0.0 109.754 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.469 HG23 ' C ' ' A' ' 8' ' ' ARG . 73.4 t -151.75 117.01 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 121.621 0.724 . . . . 0.0 109.784 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -106.56 128.03 53.79 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.63 -0.669 . . . . 0.0 109.687 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.518 HG11 ' HE2' ' A' ' 101' ' ' TYR . 62.7 t -121.1 136.01 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.759 -0.588 . . . . 28.210000000000001 109.926 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -126.89 137.56 53.17 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.341 -0.85 . . . . 0.0 109.869 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.735 HG22 HD13 ' A' ' 35' ' ' ILE . 67.2 t -128.01 139.81 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.641 -0.662 . . . . 27.949999999999999 110.123 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -123.82 105.39 32.48 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.726 -0.609 . . . . 0.0 110.627 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HG3' ' CE1' ' A' ' 118' ' ' PHE . 49.1 Cg_endo -83.69 165.82 13.72 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 O-C-N 123.898 1.473 . . . . 33.0 110.734 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -157.93 132.47 8.35 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.598 0.713 . . . . 54.100000000000001 109.917 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.571 ' CE2' ' HB2' ' A' ' 19' ' ' ALA . 73.0 t80 -60.03 138.43 57.86 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.797 -0.565 . . . . 0.0 111.197 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.423 HD21 ' OE1' ' A' ' 21' ' ' GLN . 8.8 tp -115.5 79.68 1.32 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 122.039 0.923 . . . . 0.0 110.402 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.571 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -72.17 -35.65 69.07 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.465 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -68.42 -25.75 65.19 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.274 -0.891 . . . . 0.0 110.941 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.423 ' OE1' HD21 ' A' ' 18' ' ' LEU . 80.9 mt-30 -119.42 43.66 2.56 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.379 -0.826 . . . . 52.369999999999997 110.313 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.675 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 22.6 t -162.87 150.27 13.34 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.532 -0.73 . . . . 55.189999999999998 110.93 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.61 ' O ' HG23 ' A' ' 23' ' ' THR . 9.7 t -121.25 93.98 48.78 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.459 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.7 Cg_endo -67.12 -22.85 46.65 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 O-C-N 123.748 1.394 . . . . 51.57 112.004 -178.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -65.44 -22.98 66.82 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.289 -0.882 . . . . 0.0 110.947 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -106.22 23.49 14.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.209 -0.932 . . . . 0.0 110.786 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.97 28.85 73.32 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.608 ' HB2' HG23 ' A' ' 23' ' ' THR . 86.1 mtt180 -120.72 93.93 4.19 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.636 -0.92 . . . . 0.0 110.076 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.459 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 54.1 m-85 -105.45 134.1 49.11 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.542 -0.724 . . . . 46.07 109.202 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.675 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -113.67 119.48 37.56 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.02 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.612 ' CD1' HD12 ' A' ' 90' ' ' LEU . 83.0 m-85 -114.73 133.3 56.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.595 -0.69 . . . . 38.880000000000003 109.614 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.44 130.25 56.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.218 -0.926 . . . . 34.060000000000002 108.726 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.529 ' HE2' HD11 ' A' ' 35' ' ' ILE . 35.7 p90 -126.05 144.27 50.79 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.263 -0.975 . . . . 29.030000000000001 111.176 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.5 m -103.91 137.82 41.35 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.609 -0.682 . . . . 0.0 109.834 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.735 HD13 HG22 ' A' ' 13' ' ' VAL . 43.2 mm -104.62 130.79 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-O 121.696 0.76 . . . . 0.0 111.37 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -122.85 98.81 6.07 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.528 0.68 . . . . 40.240000000000002 109.716 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.577 HG22 ' CD1' ' A' ' 76' ' ' LEU . 82.5 mt -91.82 116.9 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.715 -0.616 . . . . 20.73 110.411 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -117.87 133.29 56.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.536 -0.727 . . . . 0.0 109.486 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -94.4 117.51 30.23 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 120.217 -0.593 . . . . 21.34 110.423 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.72 15.25 17.58 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.358 -0.839 . . . . 0.0 110.534 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.25 -171.36 47.42 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.237 -1.545 . . . . 29.100000000000001 109.237 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.742 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . . . -101.53 -30.17 11.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.497 -1.002 . . . . 0.0 110.169 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.517 HG13 ' HD2' ' A' ' 44' ' ' PRO . 91.5 t -106.18 139.55 20.39 Favored Pre-proline 0 N--CA 1.498 1.951 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.082 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.517 ' HD2' HG13 ' A' ' 43' ' ' VAL . 40.4 Cg_endo -53.2 144.65 47.02 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 O-C-N 123.837 1.441 . . . . 21.949999999999999 111.796 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.489 ' HB1' ' HG2' ' A' ' 103' ' ' MET . . . -141.06 152.21 44.65 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.701 0.762 . . . . 20.91 111.296 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.435 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 22.3 ptt180 -127.42 155.74 43.18 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.898 HD22 HG13 ' A' ' 69' ' ' VAL . 6.5 tt -94.27 118.3 31.39 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.339 -0.851 . . . . 0.0 109.767 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.449 HG23 HG22 ' A' ' 104' ' ' VAL . 58.3 t -100.31 -28.53 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.563 -0.71 . . . . 0.0 110.851 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.692 ' HB3' ' HB2' ' A' ' 102' ' ' ASP . . . -142.13 165.26 27.94 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.098 -1.041 . . . . 0.0 112.24 -179.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -141.62 139.88 33.17 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.463 0.649 . . . . 29.050000000000001 110.251 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -142.62 114.52 8.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.782 -0.574 . . . . 27.969999999999999 109.605 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -99.71 132.17 45.22 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.643 -0.66 . . . . 25.25 111.398 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -115.12 78.25 1.15 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.813 HG22 ' HG3' ' A' ' 97' ' ' MET . 15.2 pt -87.02 128.81 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-O 121.609 0.718 . . . . 36.109999999999999 111.8 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.644 HG23 ' HB ' ' A' ' 61' ' ' THR . 3.6 m -118.6 130.14 55.72 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.874 -1.158 . . . . 33.979999999999997 107.874 177.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.613 ' OD2' HG21 ' A' ' 92' ' ' THR . 43.7 t0 -89.23 169.82 11.12 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.86 0.838 . . . . 45.039999999999999 111.636 -178.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.11 -7.63 13.97 Favored Glycine 0 N--CA 1.495 2.63 0 O-C-N 121.837 -0.54 . . . . 39.469999999999999 112.043 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -101.41 6.98 42.78 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 119.334 1.567 . . . . 0.0 110.561 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.99 -30.25 7.77 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -63.27 142.36 58.42 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.224 -1.163 . . . . 62.780000000000001 109.928 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.644 ' HB ' HG23 ' A' ' 55' ' ' THR . 7.9 t -133.98 151.92 51.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.509 -0.744 . . . . 0.0 110.456 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -121.89 123.61 42.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.565 -0.709 . . . . 0.0 110.409 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -104.47 135.71 45.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.724 -0.61 . . . . 0.0 110.684 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.9 t -129.47 132.43 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.437 -0.789 . . . . 37.939999999999998 110.118 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.76 126.17 45.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.83 -0.544 . . . . 0.0 110.172 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.65 148.26 19.54 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.454 -1.459 . . . . 31.82 109.454 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -78.73 154.83 29.72 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.434 -1.039 . . . . 0.0 110.463 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 54.97 -178.86 0.27 Allowed Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.855 -0.898 . . . . 22.620000000000001 110.855 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.898 HG13 HD22 ' A' ' 47' ' ' LEU . 14.4 m -128.14 127.26 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.749 -0.854 . . . . 17.510000000000002 109.679 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 69' ' ' VAL . 10.9 m 41.4 36.79 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 CA-C-O 121.636 0.732 . . . . 20.550000000000001 111.744 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.06 15.27 72.77 Favored Glycine 0 N--CA 1.499 2.856 0 O-C-N 121.563 -0.71 . . . . 18.289999999999999 112.935 177.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.406 ' O ' HG22 ' A' ' 69' ' ' VAL . 10.1 pt-20 -145.5 150.01 35.68 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 119.131 1.465 . . . . 0.0 112.157 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -116.15 74.52 5.58 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.625 -0.88 . . . . 18.210000000000001 108.625 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -57.49 140.81 94.39 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.904 1.476 . . . . 17.609999999999999 112.229 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.435 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 1.6 t90 -101.81 76.91 1.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.577 ' CD1' HG22 ' A' ' 37' ' ' ILE . 11.1 mt -60.19 117.89 5.7 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.663 -0.648 . . . . 20.57 111.969 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -86.29 157.62 56.04 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -53.41 128.31 28.79 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 O-C-N 123.5 1.263 . . . . 27.039999999999999 111.126 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.97 -16.97 55.68 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.751 -0.94 . . . . 24.739999999999998 110.751 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -87.13 165.18 15.94 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.074 -1.251 . . . . 29.379999999999999 110.555 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.81 150.52 36.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.58 -0.7 . . . . 0.0 110.154 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.423 ' HD2' HD12 ' A' ' 37' ' ' ILE . 50.6 t80 -118.03 147.59 43.07 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.417 -0.802 . . . . 18.559999999999999 109.11 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -142.73 137.45 29.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.238 -0.914 . . . . 0.0 110.878 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.495 ' CE2' HG21 ' A' ' 35' ' ' ILE . 51.6 p90 -150.95 160.21 44.06 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.613 -0.679 . . . . 26.649999999999999 109.709 178.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.9 m -105.16 139.23 40.13 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.43 -0.794 . . . . 28.140000000000001 111.035 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 16.9 t -124.46 166.68 15.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.62 -0.675 . . . . 33.880000000000003 109.834 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.03 120.15 1.58 Allowed Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.923 -1.132 . . . . 31.800000000000001 110.38 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.458 HG23 ' HE1' ' A' ' 33' ' ' TYR . 80.8 t -130.77 152.2 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.628 -0.925 . . . . 0.0 109.862 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 89' ' ' LEU . 5.0 mp -108.41 142.63 38.47 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.556 -0.715 . . . . 0.0 110.177 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.612 HD12 ' CD1' ' A' ' 31' ' ' PHE . 67.0 mt -124.63 145.14 49.8 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.489 -0.757 . . . . 38.68 110.565 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -90.74 -21.63 21.48 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.138 -0.976 . . . . 0.0 110.124 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.613 HG21 ' OD2' ' A' ' 56' ' ' ASP . 3.3 p -102.71 137.0 41.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.525 -0.735 . . . . 31.629999999999999 110.447 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.447 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 66.6 mt-10 -77.66 -1.77 32.69 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.29 -0.881 . . . . 0.0 110.753 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 27.9 pt20 -138.53 141.05 39.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.048 -1.033 . . . . 0.0 108.911 179.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.54 168.66 38.78 Favored Glycine 0 N--CA 1.498 2.83 0 C-N-CA 118.577 -1.773 . . . . 28.050000000000001 112.308 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -118.83 130.2 55.63 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.056 -0.673 . . . . 0.0 109.665 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.813 ' HG3' HG22 ' A' ' 54' ' ' ILE . 35.9 ttm -124.9 117.15 23.44 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.236 -0.915 . . . . 0.0 111.01 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.433 ' HB2' ' HB2' ' A' ' 117' ' ' ALA . 60.7 tt0 -127.82 151.31 49.19 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.88 176.67 37.47 Favored Glycine 0 N--CA 1.499 2.873 0 C-N-CA 119.087 -1.53 . . . . 29.620000000000001 110.895 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.42 ' CD2' ' HB3' ' A' ' 114' ' ' PRO . 66.3 m80 -136.41 156.41 48.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.704 -0.88 . . . . 0.0 110.193 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.578 ' CD2' HD11 ' A' ' 115' ' ' ILE . 5.9 m-85 -117.03 128.12 54.85 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.57 -0.706 . . . . 27.050000000000001 109.972 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.692 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 78.6 m-20 -83.71 120.31 25.85 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.083 -1.011 . . . . 0.0 108.835 177.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.489 ' HG2' ' HB1' ' A' ' 45' ' ' ALA . 7.8 ttm -122.88 161.46 24.06 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.028 0.442 . . . . 0.0 110.222 -179.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.449 HG22 HG23 ' A' ' 48' ' ' VAL . 7.1 m -142.74 130.53 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.554 -0.716 . . . . 23.280000000000001 110.546 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.512 ' HB3' ' OD1' ' A' ' 107' ' ' ASP . . . -73.45 168.14 19.84 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.468 -0.77 . . . . 0.0 109.649 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -67.77 -28.81 67.93 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.516 -0.74 . . . . 0.0 110.374 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.512 ' OD1' ' HB3' ' A' ' 105' ' ' ALA . 46.9 p-10 -76.07 -3.69 37.29 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.338 -0.851 . . . . 0.0 111.422 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.89 -10.51 60.48 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.022 -1.085 . . . . 30.43 110.892 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.527 HG21 ' CZ ' ' A' ' 7' ' ' TYR . 76.5 m -57.9 134.66 56.53 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.998 -1.295 . . . . 0.0 110.053 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -101.16 140.09 35.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.355 -0.841 . . . . 0.0 110.809 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.431 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 37.2 p90 -164.56 143.87 7.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.709 -0.62 . . . . 28.030000000000001 109.708 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 85.5 mt -101.36 157.49 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.714 -0.617 . . . . 0.0 110.556 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.5 96.07 49.58 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.42 ' HB3' ' CD2' ' A' ' 100' ' ' HIS . 46.6 Cg_endo -58.98 142.93 99.85 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 O-C-N 123.966 1.509 . . . . 33.310000000000002 112.147 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.578 HD11 ' CD2' ' A' ' 101' ' ' TYR . 51.7 mt -107.94 122.31 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.465 -0.939 . . . . 30.59 108.465 178.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.01 153.76 0.85 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.894 -0.504 . . . . 30.780000000000001 111.389 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' A' ' 98' ' ' GLN . . . -99.76 117.58 34.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.727 -0.608 . . . . 0.0 110.278 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.684 ' CE1' HD11 ' A' ' 120' ' ' LEU . 41.4 p90 -106.18 169.13 8.68 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.822 -0.807 . . . . 30.66 108.822 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.617 ' C ' HD12 ' A' ' 120' ' ' LEU . 57.5 t -111.95 154.37 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.254 -0.904 . . . . 0.0 110.231 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.684 HD11 ' CE1' ' A' ' 118' ' ' PHE . 7.4 mp -112.21 132.48 54.89 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.259 -0.645 . . . . 39.149999999999999 109.259 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.687 -0.633 . . . . 0.0 110.089 -179.735 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 120.594 0.235 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.567 ' CE2' HG21 ' A' ' 109' ' ' THR . 37.8 m-85 -118.65 112.07 19.35 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.406 -0.808 . . . . 31.93 110.338 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.479 ' C ' HG23 ' A' ' 9' ' ' VAL . 45.2 mtm-85 -153.48 134.23 13.78 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.509 0.671 . . . . 0.0 110.28 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.786 HG11 ' CE ' ' A' ' 103' ' ' MET . 97.0 t -151.74 115.8 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 121.466 0.65 . . . . 0.0 109.57 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -106.19 128.86 54.23 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.542 0.687 . . . . 0.0 109.78 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.3 t -118.02 138.84 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.815 -0.553 . . . . 28.21 109.702 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -122.41 136.32 54.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.444 -0.785 . . . . 0.0 109.944 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.806 HG22 HD13 ' A' ' 35' ' ' ILE . 62.7 t -128.29 136.1 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.605 -0.684 . . . . 27.95 110.33 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 65.3 p -126.37 105.66 24.47 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.689 -0.632 . . . . 0.0 110.526 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.423 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 49.8 Cg_endo -83.46 165.25 14.34 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 O-C-N 123.831 1.438 . . . . 33.0 110.991 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -157.78 131.67 8.03 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.51 0.671 . . . . 54.1 109.793 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.512 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 76.3 t80 -62.28 138.68 58.47 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.767 -0.583 . . . . 0.0 111.55 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.944 HD11 ' HB2' ' A' ' 32' ' ' ALA . 85.7 mt -115.4 79.62 1.31 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.903 0.859 . . . . 0.0 110.309 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.512 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -67.03 -35.32 79.63 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.222 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -69.54 -25.17 63.89 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.288 -0.882 . . . . 0.0 111.003 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -119.07 31.18 6.76 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.363 -0.835 . . . . 52.37 110.927 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.547 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 22.1 p -152.05 146.51 25.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.368 -0.832 . . . . 55.19 110.996 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.601 HG23 ' HB2' ' A' ' 28' ' ' ARG . 8.8 t -122.5 93.2 48.65 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.465 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.2 Cg_endo -66.2 -22.51 53.75 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 O-C-N 123.715 1.376 . . . . 51.57 111.804 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -64.87 -24.31 67.5 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.333 -0.855 . . . . 0.0 110.951 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -105.75 23.72 13.44 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.336 -0.853 . . . . 0.0 110.76 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.21 29.44 72.06 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.601 ' HB2' HG23 ' A' ' 23' ' ' THR . 84.2 mtt-85 -121.02 93.7 4.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.643 -0.916 . . . . 0.0 110.18 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.465 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 67.4 m-85 -104.84 131.28 52.51 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.924 -0.769 . . . . 46.07 108.924 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.547 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -118.43 120.9 38.94 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.528 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.657 ' CD1' HD12 ' A' ' 90' ' ' LEU . 75.4 m-85 -116.74 134.63 54.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.651 -0.656 . . . . 38.88 109.711 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.944 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -111.41 132.54 54.37 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.623 -0.881 . . . . 34.06 108.623 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.594 ' HE1' HG23 ' A' ' 88' ' ' VAL . 24.8 p90 -127.59 144.04 51.11 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.216 -0.994 . . . . 29.03 111.447 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.5 m -103.93 139.7 38.73 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.703 -0.623 . . . . 0.0 109.549 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.806 HD13 HG22 ' A' ' 13' ' ' VAL . 41.8 mm -105.69 132.42 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.784 0.802 . . . . 0.0 111.755 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -122.9 97.89 5.65 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.452 0.644 . . . . 40.24 109.644 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.761 HG22 HD22 ' A' ' 76' ' ' LEU . 78.3 mt -91.98 117.22 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.735 -0.603 . . . . 20.73 110.55 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -117.71 134.96 54.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.44 -0.787 . . . . 0.0 109.47 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.614 ' HB2' HD23 ' A' ' 76' ' ' LEU . 51.7 t-20 -93.35 117.68 30.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.736 -0.602 . . . . 21.34 110.652 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.52 11.58 15.96 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.517 -0.739 . . . . 0.0 110.489 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.34 176.02 51.32 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.429 -1.469 . . . . 29.1 109.429 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.52 -39.36 16.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.482 -1.01 . . . . 0.0 110.214 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.506 HG13 ' HD2' ' A' ' 44' ' ' PRO . 87.9 t -99.32 140.41 21.64 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.923 -0.486 . . . . 0.0 109.805 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.506 ' HD2' HG13 ' A' ' 43' ' ' VAL . 40.6 Cg_endo -53.74 144.63 53.22 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 O-C-N 123.786 1.414 . . . . 21.95 111.722 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.55 151.9 46.46 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.548 0.69 . . . . 20.91 110.953 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.429 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 21.6 ptt-85 -128.11 158.11 38.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.78 -0.575 . . . . 0.0 109.855 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.681 HD22 HG13 ' A' ' 69' ' ' VAL . 6.4 tt -99.0 116.86 32.19 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.472 -0.767 . . . . 0.0 109.123 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.411 HG23 HG22 ' A' ' 104' ' ' VAL . 58.7 t -99.13 -29.63 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.495 -0.753 . . . . 0.0 111.461 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.653 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -139.87 163.72 31.9 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.048 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -142.79 141.45 31.68 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.588 0.708 . . . . 29.05 110.637 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -144.55 112.36 6.25 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.365 0.603 . . . . 27.97 109.403 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -99.44 136.16 39.79 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.559 0.695 . . . . 25.25 111.248 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -114.83 80.87 1.47 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.848 HG22 ' HG3' ' A' ' 97' ' ' MET . 12.3 pt -83.15 127.71 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-O 121.784 0.802 . . . . 36.11 111.59 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.634 HG23 HG22 ' A' ' 61' ' ' THR . 95.8 m -120.78 129.25 53.51 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.21 -1.033 . . . . 33.98 108.21 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -91.64 171.21 9.32 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.706 0.765 . . . . 45.04 111.217 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.92 -6.37 9.38 Favored Glycine 0 N--CA 1.493 2.482 0 O-C-N 121.688 -0.632 . . . . 39.47 112.214 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.6 p30 -101.87 5.88 41.2 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 119.46 1.63 . . . . 0.0 110.94 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 61' ' ' THR . . . 92.36 -32.0 5.73 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.204 -0.935 . . . . 0.0 111.23 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.05 142.71 53.57 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.128 -1.219 . . . . 62.78 109.845 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.634 HG22 HG23 ' A' ' 55' ' ' THR . 60.9 p -132.5 151.16 52.0 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.816 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -123.31 125.12 44.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.579 -0.701 . . . . 0.0 109.865 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -101.68 135.01 43.93 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.554 -0.716 . . . . 0.0 110.763 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.0 t -129.18 133.49 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.582 -0.699 . . . . 37.94 110.021 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -125.2 127.1 46.26 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.923 -0.486 . . . . 0.0 110.533 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.55 -174.16 14.25 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 108.757 -1.737 . . . . 31.82 108.757 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -66.42 -158.28 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.278 -1.131 . . . . 0.0 109.816 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.403 ' HA2' ' CD2' ' A' ' 47' ' ' LEU . . . -51.76 -88.6 0.01 OUTLIER Glycine 0 N--CA 1.498 2.824 0 N-CA-C 110.504 -1.039 . . . . 22.62 110.504 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.681 HG13 HD22 ' A' ' 47' ' ' LEU . 25.0 m -140.17 128.15 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.382 -1.069 . . . . 17.51 110.159 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 69' ' ' VAL . 12.4 m 40.86 35.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 CA-C-O 121.313 0.577 . . . . 20.55 112.248 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.58 21.53 57.93 Favored Glycine 0 N--CA 1.499 2.851 0 O-C-N 121.433 -0.792 . . . . 18.29 112.794 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.664 ' HG3' HG23 ' A' ' 69' ' ' VAL . 1.7 pt-20 -139.38 151.73 46.55 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 119.101 1.45 . . . . 0.0 111.197 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -113.51 74.65 2.28 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 109.278 -0.638 . . . . 18.21 109.278 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -57.58 141.98 95.44 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 O-C-N 123.838 1.441 . . . . 17.61 111.668 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.429 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 1.4 t90 -103.09 77.33 1.54 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.761 HD22 HG22 ' A' ' 37' ' ' ILE . 5.6 tp -62.24 118.18 7.06 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.612 -0.68 . . . . 20.57 111.285 -178.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -86.8 158.73 53.26 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -53.67 127.24 24.65 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 O-C-N 123.564 1.297 . . . . 27.04 110.972 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.64 -18.3 43.83 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.843 -0.903 . . . . 24.74 110.843 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -88.85 165.64 14.52 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.109 -1.23 . . . . 29.38 110.239 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.597 ' C ' HD11 ' A' ' 76' ' ' LEU . . . -146.21 151.08 37.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.498 -0.751 . . . . 0.0 110.43 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.491 ' N ' HD11 ' A' ' 76' ' ' LEU . 64.8 t80 -118.12 144.96 45.23 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.906 -0.775 . . . . 18.56 108.906 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.6 p80 -142.65 140.39 31.58 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.117 -0.989 . . . . 0.0 111.258 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.577 ' CE1' HG21 ' A' ' 35' ' ' ILE . 52.8 p90 -150.93 159.93 44.24 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.57 -0.706 . . . . 26.65 109.732 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.6 m -102.58 136.73 41.87 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.422 -0.799 . . . . 28.14 110.923 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 16.2 t -124.9 168.99 12.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.62 -0.675 . . . . 33.88 110.146 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.2 124.6 2.57 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.885 -1.15 . . . . 31.8 110.364 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.594 HG23 ' HE1' ' A' ' 33' ' ' TYR . 79.9 t -129.83 150.64 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.671 -0.899 . . . . 0.0 109.352 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.532 HD23 ' N ' ' A' ' 90' ' ' LEU . 9.4 tt -111.08 143.58 41.56 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.529 -0.732 . . . . 0.0 110.577 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.657 HD12 ' CD1' ' A' ' 31' ' ' PHE . 84.0 mt -121.9 145.27 48.26 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.576 -0.703 . . . . 38.68 109.978 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.658 ' HG3' HG23 ' A' ' 92' ' ' THR . 7.8 pt-20 -72.88 -24.22 60.82 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.373 -0.829 . . . . 0.0 111.157 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.658 HG23 ' HG3' ' A' ' 91' ' ' GLU . 57.3 p -124.3 171.27 10.02 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.342 -0.849 . . . . 31.63 110.755 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 32.1 tt0 -85.73 6.69 26.66 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.668 -0.645 . . . . 0.0 111.692 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -140.08 149.09 42.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.992 -1.068 . . . . 0.0 109.815 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.62 160.75 23.81 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 118.808 -1.663 . . . . 28.05 112.178 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -121.97 131.66 54.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 122.185 -0.597 . . . . 0.0 109.401 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.848 ' HG3' HG22 ' A' ' 54' ' ' ILE . 54.6 ttm -127.21 123.68 37.16 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.304 -0.872 . . . . 0.0 111.36 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.505 ' HG2' ' HB2' ' A' ' 117' ' ' ALA . 1.8 mp0 -123.8 148.21 46.89 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.76 176.21 39.86 Favored Glycine 0 N--CA 1.501 2.991 0 C-N-CA 118.565 -1.779 . . . . 29.62 111.132 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -140.87 157.6 45.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.804 -0.821 . . . . 0.0 110.663 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.615 ' CE2' HD11 ' A' ' 115' ' ' ILE . 7.2 m-85 -117.07 128.82 55.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.677 -0.639 . . . . 27.05 110.007 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.653 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 26.1 t0 -81.75 123.59 28.89 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.967 -1.083 . . . . 0.0 109.11 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.786 ' CE ' HG11 ' A' ' 9' ' ' VAL . 47.4 mtt -122.58 162.6 21.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.887 -0.508 . . . . 0.0 110.491 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.411 HG22 HG23 ' A' ' 48' ' ' VAL . 11.3 m -141.85 128.72 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.516 -0.74 . . . . 23.28 110.251 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.96 167.55 21.27 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.489 -0.757 . . . . 0.0 109.684 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -64.33 -30.78 71.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.497 -0.752 . . . . 0.0 110.059 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -72.38 -11.7 60.8 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.519 -0.738 . . . . 0.0 110.959 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.23 -7.41 47.6 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.398 -1.081 . . . . 30.43 110.398 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.567 HG21 ' CE2' ' A' ' 7' ' ' TYR . 69.3 m -57.2 135.02 56.4 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.048 -1.266 . . . . 0.0 110.036 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -101.19 139.94 36.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.384 -0.823 . . . . 0.0 110.827 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.458 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 49.8 p90 -167.38 146.92 5.16 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.704 -0.622 . . . . 28.03 110.077 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.3 pt -103.18 159.12 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.675 -0.641 . . . . 0.0 110.954 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.41 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -119.3 96.61 50.04 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -59.23 143.79 99.62 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 O-C-N 123.907 1.477 . . . . 33.31 112.269 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.615 HD11 ' CE2' ' A' ' 101' ' ' TYR . 71.4 mt -107.77 122.15 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.68 -0.859 . . . . 30.59 108.68 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.82 155.69 0.83 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.264 0.554 . . . . 30.78 111.577 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.505 ' HB2' ' HG2' ' A' ' 98' ' ' GLN . . . -91.05 119.99 31.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.724 -0.61 . . . . 0.0 110.675 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.678 ' CE1' HD11 ' A' ' 120' ' ' LEU . 51.5 p90 -111.02 162.66 14.64 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.487 -0.931 . . . . 30.66 108.487 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.625 ' C ' HD12 ' A' ' 120' ' ' LEU . 9.3 p -115.98 154.67 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.204 -0.935 . . . . 0.0 110.882 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.678 HD11 ' CE1' ' A' ' 118' ' ' PHE . 7.3 mp -114.07 132.12 56.14 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.32 -0.622 . . . . 39.15 109.32 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.654 -0.654 . . . . 0.0 110.137 -179.814 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 120.823 0.344 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.456 ' CE1' ' CB ' ' A' ' 105' ' ' ALA . 21.4 m-85 -123.55 101.44 7.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.355 -0.841 . . . . 31.93 110.207 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.458 ' C ' HG23 ' A' ' 9' ' ' VAL . 27.6 mmt180 -144.1 139.19 28.75 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.665 0.745 . . . . 0.0 109.99 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.458 HG23 ' C ' ' A' ' 8' ' ' ARG . 70.7 t -150.94 114.98 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -105.97 129.55 54.08 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.538 0.685 . . . . 0.0 109.836 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.512 HG22 ' HA ' ' A' ' 37' ' ' ILE . 57.6 t -118.23 139.79 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.869 -0.519 . . . . 28.21 109.754 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -120.67 136.65 54.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.438 -0.789 . . . . 0.0 109.817 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.649 HG22 HD13 ' A' ' 35' ' ' ILE . 60.9 t -128.87 137.77 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.586 -0.697 . . . . 27.95 110.219 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.7 m -125.07 105.07 29.12 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.717 -0.614 . . . . 0.0 110.638 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -84.3 165.56 12.69 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 O-C-N 123.85 1.447 . . . . 33.0 110.797 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -157.46 132.06 8.56 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.541 0.686 . . . . 54.1 110.064 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.482 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 80.5 t80 -59.73 139.98 56.84 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.852 -0.53 . . . . 0.0 111.315 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.915 HD11 ' HB2' ' A' ' 32' ' ' ALA . 91.2 mt -115.98 80.16 1.41 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.904 0.859 . . . . 0.0 110.397 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.482 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -66.02 -35.84 81.65 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.912 -0.492 . . . . 0.0 111.063 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -69.77 -23.71 63.4 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.415 -0.803 . . . . 0.0 110.947 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -121.05 34.65 5.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.36 -0.837 . . . . 52.37 111.08 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.654 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 24.4 p -156.47 147.91 22.5 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.312 -0.868 . . . . 55.19 111.109 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.579 HG23 ' O ' ' A' ' 23' ' ' THR . 4.9 t -118.9 92.17 44.36 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.475 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 51.3 Cg_endo -65.74 -23.51 55.86 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 O-C-N 123.853 1.449 . . . . 51.57 111.627 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.83 -22.41 66.55 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.398 -0.813 . . . . 0.0 110.833 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -106.13 23.56 13.85 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.25 -0.906 . . . . 0.0 110.684 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.37 28.0 73.6 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.549 ' HB2' HG23 ' A' ' 23' ' ' THR . 3.2 mtm-85 -121.46 94.13 4.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.591 -0.947 . . . . 0.0 110.175 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.475 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 63.8 m-85 -104.15 135.4 45.71 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.54 -0.725 . . . . 46.07 109.22 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.654 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -114.59 120.54 40.53 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.524 -0.735 . . . . 0.0 111.174 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.459 ' CD1' HD12 ' A' ' 90' ' ' LEU . 89.0 m-85 -116.14 131.56 56.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.555 -0.715 . . . . 38.88 109.795 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.915 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -114.01 131.96 56.16 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.287 -0.883 . . . . 34.06 108.658 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.475 ' CE1' HD11 ' A' ' 35' ' ' ILE . 54.6 p90 -128.22 145.98 50.87 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 119.17 -1.012 . . . . 29.03 111.544 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.6 t -101.97 140.88 35.66 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.649 HD13 HG22 ' A' ' 13' ' ' VAL . 48.1 mm -105.47 132.29 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.819 0.819 . . . . 0.0 111.772 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -123.49 98.97 6.09 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.399 0.619 . . . . 40.24 109.826 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.886 HG22 HD22 ' A' ' 76' ' ' LEU . 80.3 mt -91.23 117.27 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.711 -0.618 . . . . 20.73 110.735 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -117.99 134.06 55.32 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.578 -0.701 . . . . 0.0 109.421 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.466 ' HB2' HD23 ' A' ' 76' ' ' LEU . 42.9 t-20 -94.5 117.36 30.0 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 120.178 -0.609 . . . . 21.34 110.781 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.25 13.37 17.89 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.415 -0.803 . . . . 0.0 110.442 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.89 -176.26 51.17 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.515 -1.434 . . . . 29.1 109.515 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.28 -33.74 10.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.561 -0.964 . . . . 0.0 109.846 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.511 HG13 ' HD2' ' A' ' 44' ' ' PRO . 87.6 t -104.56 141.51 22.68 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.511 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.6 Cg_endo -53.13 144.5 46.9 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 O-C-N 123.693 1.365 . . . . 21.95 111.619 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -136.79 151.37 49.09 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.732 0.777 . . . . 20.91 111.232 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.426 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 47.2 ttp180 -126.6 152.08 47.11 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.775 HD22 HG13 ' A' ' 69' ' ' VAL . 7.1 tt -98.02 117.85 33.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 109.441 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.6 p -100.69 -25.21 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.55 -0.719 . . . . 0.0 110.947 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.665 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -142.12 164.27 30.62 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.039 -1.064 . . . . 0.0 112.034 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -141.69 139.08 32.87 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.334 0.588 . . . . 29.05 109.993 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -142.46 113.84 7.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.703 -0.623 . . . . 27.97 110.016 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.543 ' CH2' HD13 ' A' ' 115' ' ' ILE . 87.8 m95 -101.47 132.66 46.97 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.745 -0.597 . . . . 25.25 110.753 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -116.88 77.42 1.11 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.642 -0.661 . . . . 0.0 109.572 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.459 HD11 ' HB2' ' A' ' 62' ' ' GLU . 28.5 pt -83.59 130.07 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.789 0.804 . . . . 36.11 112.211 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.906 HG23 HG22 ' A' ' 61' ' ' THR . 25.6 m -119.28 129.59 54.98 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.266 -1.013 . . . . 33.98 108.266 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -91.63 170.32 10.02 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.734 0.778 . . . . 45.04 111.364 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.28 -7.21 12.82 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 121.791 -0.568 . . . . 39.47 112.149 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -102.23 5.69 40.23 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 119.431 1.616 . . . . 0.0 110.733 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 61' ' ' THR . . . 93.3 -29.49 8.2 Favored Glycine 0 N--CA 1.495 2.585 0 O-C-N 121.213 -0.929 . . . . 0.0 110.898 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -61.86 142.28 57.46 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.323 -1.104 . . . . 62.78 109.747 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.906 HG22 HG23 ' A' ' 55' ' ' THR . 69.9 p -134.29 151.69 51.4 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.476 -0.765 . . . . 0.0 110.434 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.459 ' HB2' HD11 ' A' ' 54' ' ' ILE . 96.6 mt-10 -121.65 122.12 38.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.509 -0.745 . . . . 0.0 110.074 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -104.19 135.15 46.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.567 -0.708 . . . . 0.0 110.634 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.4 t -128.07 131.75 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.545 -0.722 . . . . 37.94 109.888 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -125.12 127.55 47.05 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.747 -0.596 . . . . 0.0 110.554 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.88 164.82 30.92 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.215 -1.554 . . . . 31.82 109.215 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -106.08 158.31 16.9 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.351 -1.088 . . . . 0.0 110.086 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.96 96.43 0.01 OUTLIER Glycine 0 N--CA 1.5 2.929 0 O-C-N 121.454 -0.778 . . . . 22.62 111.628 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.775 HG13 HD22 ' A' ' 47' ' ' LEU . 25.1 m -45.39 132.89 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.519 0 O-C-N 121.403 -1.057 . . . . 17.51 111.534 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.0 m 41.63 36.01 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 CA-C-O 121.631 0.729 . . . . 20.55 111.413 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.0 21.46 59.16 Favored Glycine 0 N--CA 1.496 2.688 0 O-C-N 121.762 -0.586 . . . . 18.29 112.436 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.421 ' HG3' HG23 ' A' ' 69' ' ' VAL . 4.9 pt-20 -147.6 154.32 40.51 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-N 119.128 1.464 . . . . 0.0 112.457 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -117.55 72.97 7.88 Favored Pre-proline 0 N--CA 1.491 1.6 0 N-CA-C 108.558 -0.904 . . . . 18.21 108.558 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -53.99 139.78 70.1 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 O-C-N 123.735 1.387 . . . . 17.61 112.286 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.426 ' CD1' ' HB2' ' A' ' 46' ' ' ARG . 3.4 t90 -101.45 76.03 1.65 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.886 HD22 HG22 ' A' ' 37' ' ' ILE . 2.5 tp -62.33 117.22 5.82 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.585 -0.697 . . . . 20.57 111.339 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 -85.59 158.71 56.72 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -53.96 126.02 20.64 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 O-C-N 123.537 1.283 . . . . 27.04 110.905 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.94 -18.37 44.69 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.732 -0.947 . . . . 24.74 110.732 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -88.96 164.9 14.91 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.133 -1.216 . . . . 29.38 110.263 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.451 ' C ' HD11 ' A' ' 76' ' ' LEU . . . -146.98 150.4 35.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.541 -0.724 . . . . 0.0 110.331 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.608 ' N ' HD11 ' A' ' 76' ' ' LEU . 64.7 t80 -117.86 145.58 44.5 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.864 -0.791 . . . . 18.56 108.864 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -143.57 140.48 30.23 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.119 -0.988 . . . . 0.0 111.37 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.512 ' CE1' HG21 ' A' ' 35' ' ' ILE . 51.1 p90 -150.14 160.02 43.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.647 -0.658 . . . . 26.65 109.34 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.5 m -102.62 139.08 38.67 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.29 -0.881 . . . . 28.14 110.928 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.437 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 16.8 t -124.06 166.07 16.41 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.647 -0.658 . . . . 33.88 109.97 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -144.53 120.3 1.4 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.076 -1.21 . . . . 31.8 110.076 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.51 152.93 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.686 -0.89 . . . . 0.0 109.927 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.98 142.85 39.03 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.521 -0.737 . . . . 0.0 110.508 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.459 HD12 ' CD1' ' A' ' 31' ' ' PHE . 24.1 mt -124.02 143.08 50.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.542 -0.724 . . . . 38.68 110.291 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -82.23 -22.77 35.71 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.217 -0.927 . . . . 0.0 110.087 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.429 HG22 ' H ' ' A' ' 94' ' ' GLN . 7.2 m -99.55 134.25 42.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.671 -0.643 . . . . 31.63 109.991 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.413 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 58.2 tt0 -75.39 -7.9 55.26 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.171 -0.956 . . . . 0.0 110.833 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.429 ' H ' HG22 ' A' ' 92' ' ' THR . 14.5 pt20 -138.3 147.28 43.41 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.21 -0.931 . . . . 0.0 108.952 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.7 169.64 38.97 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 118.265 -1.922 . . . . 28.05 112.706 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -115.82 130.23 56.75 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 98.3 mtp -126.73 121.27 31.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.349 -0.844 . . . . 0.0 111.316 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.612 ' HG2' ' HB2' ' A' ' 117' ' ' ALA . 55.8 mt-30 -124.39 152.12 43.6 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.27 175.92 36.99 Favored Glycine 0 N--CA 1.499 2.86 0 C-N-CA 118.792 -1.671 . . . . 29.62 111.05 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -137.61 157.85 45.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.8 -0.824 . . . . 0.0 109.678 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.593 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 10.1 m-85 -116.64 127.31 54.32 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.577 -0.702 . . . . 27.05 110.009 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.665 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 42.8 t0 -85.63 119.13 25.62 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.992 -1.068 . . . . 0.0 108.723 177.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.425 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 2.5 tpt -122.49 160.7 25.03 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.141 0.496 . . . . 0.0 110.348 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.0 m -139.08 129.5 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.639 -0.663 . . . . 23.28 110.105 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.456 ' CB ' ' CE1' ' A' ' 7' ' ' TYR . . . -70.01 164.81 23.14 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.571 -0.706 . . . . 0.0 109.633 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -63.76 -28.17 69.69 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.537 -0.727 . . . . 0.0 110.131 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -79.0 -7.6 58.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.487 -0.758 . . . . 0.0 111.294 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.7 -7.63 45.94 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 120.104 -1.046 . . . . 30.43 110.515 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.4 m -57.82 134.98 56.76 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.046 -1.267 . . . . 0.0 109.98 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -101.84 139.38 37.55 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.346 -0.846 . . . . 0.0 110.891 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 43.0 p90 -165.1 143.61 6.42 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.732 -0.605 . . . . 28.03 109.685 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 85.0 mt -101.62 157.69 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.646 -0.659 . . . . 0.0 110.81 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.593 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -120.15 97.33 49.25 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -58.7 143.78 98.44 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 O-C-N 123.847 1.446 . . . . 33.31 112.292 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.543 HD13 ' CH2' ' A' ' 52' ' ' TRP . 52.7 mt -108.71 122.83 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.739 -0.837 . . . . 30.59 108.739 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.42 171.29 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.29 0.567 . . . . 30.78 111.465 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.612 ' HB2' ' HG2' ' A' ' 98' ' ' GLN . . . -101.72 122.01 43.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.657 -0.652 . . . . 0.0 110.825 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.474 ' CE1' HD11 ' A' ' 120' ' ' LEU . 49.1 p90 -110.94 156.45 21.19 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.162 -1.051 . . . . 30.66 108.162 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.613 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.8 t -115.87 154.95 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.174 -0.954 . . . . 0.0 110.587 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.65 ' N ' HD12 ' A' ' 120' ' ' LEU . 7.6 mp -112.49 132.23 55.18 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.099 -0.704 . . . . 39.15 109.099 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 34.7 t . . . . . 0 N--CA 1.493 1.716 0 O-C-N 121.779 -0.576 . . . . 0.0 110.041 -179.782 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.67 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 90.0 mtt180 . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 120.781 0.324 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -121.42 101.95 7.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.437 -0.79 . . . . 31.93 110.16 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.482 ' C ' HG23 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -148.79 131.53 15.98 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.554 -0.716 . . . . 0.0 110.065 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.482 HG23 ' C ' ' A' ' 8' ' ' ARG . 84.0 t -152.11 117.09 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.613 0.72 . . . . 0.0 109.808 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -105.27 129.66 53.58 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.537 0.684 . . . . 0.0 109.825 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.483 HG11 ' HE2' ' A' ' 101' ' ' TYR . 62.2 t -117.97 139.03 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.842 -0.536 . . . . 28.21 109.76 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -121.65 136.93 54.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.456 -0.777 . . . . 0.0 110.116 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.714 HG22 HD13 ' A' ' 35' ' ' ILE . 60.5 t -129.28 136.57 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.581 -0.699 . . . . 27.95 110.139 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.0 m -125.44 103.96 28.57 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.737 -0.602 . . . . 0.0 110.659 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.74 165.05 15.85 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 O-C-N 123.874 1.46 . . . . 33.0 110.835 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -157.85 132.92 8.69 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.661 0.743 . . . . 54.1 110.111 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.495 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 80.4 t80 -60.01 140.1 57.0 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.27 0.557 . . . . 0.0 111.629 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.873 HD11 ' HB2' ' A' ' 32' ' ' ALA . 85.4 mt -117.11 83.44 1.98 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.019 0.914 . . . . 0.0 110.247 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.495 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -68.97 -35.11 76.37 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.317 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -69.92 -22.69 63.18 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.427 -0.795 . . . . 0.0 111.099 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -121.87 34.31 5.22 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.232 -0.918 . . . . 52.37 110.897 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.585 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 24.8 p -154.46 148.8 26.09 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.308 -0.87 . . . . 55.19 110.979 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.619 HG23 ' HB2' ' A' ' 28' ' ' ARG . 8.2 t -121.97 93.84 48.43 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.4 Cg_endo -66.86 -23.2 47.94 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 O-C-N 123.786 1.414 . . . . 51.57 112.068 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -66.05 -22.36 66.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.253 -0.904 . . . . 0.0 111.032 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -106.47 23.22 14.55 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.207 -0.933 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.52 29.16 72.89 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.619 ' HB2' HG23 ' A' ' 23' ' ' THR . 93.6 mtt-85 -121.4 94.18 4.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.551 -0.97 . . . . 0.0 110.178 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.46 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 58.8 m-85 -105.6 133.8 49.75 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.503 -0.748 . . . . 46.07 109.143 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.585 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -115.77 120.64 39.97 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.354 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -116.68 131.04 57.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.553 -0.717 . . . . 38.88 109.642 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.873 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -114.77 131.77 56.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.255 -0.903 . . . . 34.06 109.048 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.489 ' CE1' HD11 ' A' ' 35' ' ' ILE . 53.1 p90 -128.08 148.13 50.55 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.338 -0.945 . . . . 29.03 111.308 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 m -101.27 140.21 35.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.667 -0.646 . . . . 0.0 109.411 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.714 HD13 HG22 ' A' ' 13' ' ' VAL . 46.0 mm -103.69 132.39 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-O 121.841 0.829 . . . . 0.0 111.677 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.0 mmm-85 -124.05 97.22 5.25 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.471 0.653 . . . . 40.24 109.797 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.499 HG22 ' CD1' ' A' ' 76' ' ' LEU . 80.1 mt -92.21 118.17 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.704 -0.623 . . . . 20.73 110.751 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -117.36 132.81 56.52 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.508 -0.745 . . . . 0.0 109.21 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -93.96 117.89 30.73 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.786 -0.571 . . . . 21.34 110.632 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.81 14.12 16.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.527 -0.733 . . . . 0.0 110.539 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.52 -171.89 46.09 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.215 -1.554 . . . . 29.1 109.215 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.67 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . . . -104.64 -29.99 10.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.463 -1.021 . . . . 0.0 110.343 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.539 HG13 ' HD2' ' A' ' 44' ' ' PRO . 88.0 t -108.82 141.36 23.16 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.836 -0.54 . . . . 0.0 110.016 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.539 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.1 Cg_endo -52.52 142.33 49.18 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 O-C-N 123.772 1.406 . . . . 21.95 111.749 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.461 ' HB1' ' SD ' ' A' ' 103' ' ' MET . . . -137.41 151.69 48.82 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.875 0.845 . . . . 20.91 111.418 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.427 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 54.5 ttp180 -125.89 153.45 44.18 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.93 HD22 HG13 ' A' ' 69' ' ' VAL . 7.0 tt -97.53 119.19 35.63 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.574 -0.704 . . . . 0.0 109.464 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.492 HG23 HG22 ' A' ' 104' ' ' VAL . 57.3 t -101.17 -27.15 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.539 -0.726 . . . . 0.0 110.983 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.725 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -142.13 165.06 28.47 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 119.1 -1.04 . . . . 0.0 112.162 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.7 ptt-85 -141.12 139.59 33.99 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.368 0.604 . . . . 29.05 110.214 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -142.79 112.84 7.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.775 -0.578 . . . . 27.97 109.873 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -102.19 134.27 45.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.642 -0.661 . . . . 25.25 111.168 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -116.09 79.15 1.27 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.75 -0.594 . . . . 0.0 109.405 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.433 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.0 pt -86.75 129.24 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 121.833 0.825 . . . . 36.11 111.826 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.722 HG23 HG22 ' A' ' 61' ' ' THR . 99.1 m -120.69 130.38 54.06 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.441 -0.948 . . . . 33.98 108.441 178.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -89.93 170.5 10.32 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.748 0.785 . . . . 45.04 111.251 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.83 -7.06 14.07 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 121.75 -0.594 . . . . 39.47 112.138 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -101.62 6.3 41.99 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 119.344 1.572 . . . . 0.0 110.667 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 61' ' ' THR . . . 92.61 -26.19 15.23 Favored Glycine 0 N--CA 1.494 2.566 0 O-C-N 121.208 -0.933 . . . . 0.0 110.966 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -62.16 141.28 58.25 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.184 -1.186 . . . . 62.78 109.6 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.722 HG22 HG23 ' A' ' 55' ' ' THR . 58.3 p -131.54 148.79 52.65 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.402 -0.812 . . . . 0.0 110.574 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -122.3 120.53 34.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.445 -0.785 . . . . 0.0 109.872 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -103.06 135.0 45.55 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.747 -0.596 . . . . 0.0 110.499 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.2 t -128.29 130.31 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.614 0.721 . . . . 37.94 110.031 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -126.17 126.53 44.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.895 -0.503 . . . . 0.0 109.946 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.78 151.03 23.18 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.555 -1.418 . . . . 31.82 109.555 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -77.38 155.22 32.03 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.431 -1.04 . . . . 0.0 110.241 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.62 -174.52 0.23 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 110.99 -0.844 . . . . 22.62 110.99 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.93 HG13 HD22 ' A' ' 47' ' ' LEU . 13.1 m -128.81 127.43 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.838 -0.801 . . . . 17.51 109.625 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 69' ' ' VAL . 13.2 m 41.32 36.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 CA-C-O 121.603 0.715 . . . . 20.55 111.831 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.37 16.03 70.03 Favored Glycine 0 N--CA 1.499 2.841 0 O-C-N 121.588 -0.695 . . . . 18.29 112.869 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.425 ' O ' HG22 ' A' ' 69' ' ' VAL . 10.1 pt-20 -146.43 151.67 37.81 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 119.158 1.479 . . . . 0.0 112.147 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -115.42 75.55 4.76 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 108.746 -0.835 . . . . 18.21 108.746 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -57.85 137.65 82.12 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 O-C-N 123.811 1.427 . . . . 17.61 112.194 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.434 ' CH2' ' CB ' ' A' ' 44' ' ' PRO . 7.4 t90 -101.34 75.98 1.67 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.499 ' CD1' HG22 ' A' ' 37' ' ' ILE . 10.1 mt -60.3 118.37 6.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.566 -0.709 . . . . 20.57 112.013 -178.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.6 mtp85 -86.59 158.87 53.69 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -54.62 129.14 33.38 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 O-C-N 123.466 1.246 . . . . 27.04 111.126 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.02 -18.3 48.62 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 111.012 -0.835 . . . . 24.74 111.012 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -88.28 166.01 14.62 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.041 -1.27 . . . . 29.38 110.69 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.1 148.68 33.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.594 -0.691 . . . . 0.0 110.024 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.435 ' HD1' HD12 ' A' ' 37' ' ' ILE . 64.6 t80 -117.57 144.67 44.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.466 -0.771 . . . . 18.56 109.13 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -143.62 140.42 30.13 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.234 -0.916 . . . . 0.0 111.279 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.646 ' CE1' HG21 ' A' ' 35' ' ' ILE . 49.5 p90 -150.89 159.96 44.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.591 -0.693 . . . . 26.65 109.62 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.5 m -101.67 137.5 39.9 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.389 -0.819 . . . . 28.14 111.005 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.447 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 15.0 t -124.49 167.63 14.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.641 -0.662 . . . . 33.88 109.918 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.89 124.41 2.45 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.811 -1.185 . . . . 31.8 110.466 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.71 153.5 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.653 -0.91 . . . . 0.0 109.896 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 89' ' ' LEU . 4.9 mp -108.84 144.86 36.15 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.559 -0.713 . . . . 0.0 111.071 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.692 ' CD1' HD22 ' A' ' 120' ' ' LEU . 0.4 OUTLIER -121.09 147.23 45.83 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.685 -0.634 . . . . 38.68 109.591 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.41 ' O ' ' CE1' ' A' ' 29' ' ' TYR . 74.7 tt0 -77.9 -26.6 49.2 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.248 -0.908 . . . . 0.0 111.25 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.8 p -124.99 172.78 9.14 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.268 -0.895 . . . . 31.63 110.936 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.457 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 50.4 mt-10 -86.62 11.55 12.6 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.653 -0.654 . . . . 0.0 111.469 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 97.4 mt-30 -139.99 144.38 36.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.037 -1.039 . . . . 0.0 109.69 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.98 157.03 17.9 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 118.795 -1.669 . . . . 28.05 112.237 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -121.36 131.37 54.15 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.425 ' HE2' ' HB3' ' A' ' 97' ' ' MET . 98.1 mtp -127.24 120.7 29.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.326 -0.859 . . . . 0.0 111.386 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 117' ' ' ALA . 56.0 tt0 -126.41 151.4 47.74 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.12 177.8 39.02 Favored Glycine 0 N--CA 1.499 2.871 0 C-N-CA 118.946 -1.597 . . . . 29.62 110.962 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.406 ' CD2' ' HB3' ' A' ' 114' ' ' PRO . 66.9 m80 -136.17 156.92 47.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.715 -0.874 . . . . 0.0 110.139 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.624 ' CD2' HD11 ' A' ' 115' ' ' ILE . 4.7 m-85 -115.37 127.93 55.73 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.759 -0.588 . . . . 27.05 109.932 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.725 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 11.1 t70 -83.71 121.92 27.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.965 -1.084 . . . . 0.0 108.532 177.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.462 ' SD ' HG21 ' A' ' 9' ' ' VAL . 54.6 ttm -123.92 161.59 25.07 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.297 0.57 . . . . 0.0 110.781 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.492 HG22 HG23 ' A' ' 48' ' ' VAL . 10.5 m -139.99 129.93 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.741 -0.599 . . . . 23.28 110.17 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 107' ' ' ASP . . . -75.3 166.29 23.84 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.509 -0.744 . . . . 0.0 109.811 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -65.33 -31.05 71.98 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.52 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.488 ' OD1' ' HB3' ' A' ' 105' ' ' ALA . 49.4 p-10 -74.57 -7.73 54.05 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.433 -0.792 . . . . 0.0 111.272 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.0 -9.33 54.92 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 120.091 -1.052 . . . . 30.43 110.636 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.4 m -57.55 134.79 56.43 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.021 -1.282 . . . . 0.0 109.935 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -101.92 140.83 35.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.432 -0.792 . . . . 0.0 110.931 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -168.61 146.12 3.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.666 -0.646 . . . . 28.03 109.851 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 84.9 mt -101.23 157.52 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.707 -0.621 . . . . 0.0 110.66 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.27 98.7 50.57 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.406 ' HB3' ' CD2' ' A' ' 100' ' ' HIS . 45.4 Cg_endo -58.08 142.84 97.16 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 O-C-N 123.932 1.491 . . . . 33.31 112.254 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.624 HD11 ' CD2' ' A' ' 101' ' ' TYR . 48.6 mt -109.31 124.28 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.741 -0.837 . . . . 30.59 108.741 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.66 149.99 3.02 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.861 -0.525 . . . . 30.78 111.271 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.438 ' HB2' ' HB2' ' A' ' 98' ' ' GLN . . . -92.86 124.26 36.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.66 -0.65 . . . . 0.0 110.047 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.653 ' HE1' HD11 ' A' ' 120' ' ' LEU . 44.7 p90 -108.8 164.67 12.18 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.046 -0.724 . . . . 30.66 109.046 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.588 ' C ' HD12 ' A' ' 120' ' ' LEU . 8.5 p -116.0 155.41 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.349 -0.845 . . . . 0.0 110.495 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.692 HD22 ' CD1' ' A' ' 90' ' ' LEU . 7.2 mp -112.13 133.07 54.49 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.281 -0.637 . . . . 39.15 109.281 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.627 -0.671 . . . . 0.0 110.094 -179.796 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 120.678 0.275 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -118.23 108.1 14.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.452 -0.78 . . . . 31.93 110.336 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.48 ' C ' HG23 ' A' ' 9' ' ' VAL . 23.5 mtm180 -151.01 132.12 14.37 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.61 -0.681 . . . . 0.0 110.092 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.599 HG11 ' SD ' ' A' ' 103' ' ' MET . 60.9 t -151.67 114.45 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.543 -0.723 . . . . 0.0 109.548 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -106.7 130.36 54.44 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.628 0.727 . . . . 0.0 110.246 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.6 t -117.73 139.23 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.585 -0.524 . . . . 28.21 109.585 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -121.24 138.44 54.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.367 -0.833 . . . . 0.0 110.193 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.833 HG22 HD13 ' A' ' 35' ' ' ILE . 61.8 t -128.56 135.84 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.61 -0.681 . . . . 27.95 110.445 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.6 t -126.61 105.53 23.72 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.694 -0.629 . . . . 0.0 110.474 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -82.95 164.8 15.45 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 O-C-N 123.832 1.438 . . . . 33.0 111.15 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -157.87 131.63 7.92 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.572 0.701 . . . . 54.1 109.697 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.522 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 80.2 t80 -62.13 138.55 58.41 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.651 -0.656 . . . . 0.0 111.691 -178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.985 HD11 ' HB2' ' A' ' 32' ' ' ALA . 86.0 mt -116.66 83.15 1.91 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 122.009 0.909 . . . . 0.0 110.269 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.522 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -68.45 -35.55 77.74 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.303 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -69.8 -23.71 63.37 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.309 -0.869 . . . . 0.0 111.076 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -121.77 43.06 2.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.263 -0.898 . . . . 52.37 110.717 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.734 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 37.8 t -162.64 143.93 10.17 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.399 -0.813 . . . . 55.19 110.883 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.9 m -116.58 92.69 38.21 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.44 -0.787 . . . . 0.0 109.124 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.458 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 47.5 Cg_endo -66.05 -25.16 51.63 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 O-C-N 123.932 1.49 . . . . 51.57 111.553 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -68.49 -22.95 64.51 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.298 -0.876 . . . . 0.0 111.038 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -105.06 22.82 14.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.235 -0.915 . . . . 0.0 110.912 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.41 28.62 73.15 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -120.63 93.59 4.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.652 -0.91 . . . . 0.0 109.804 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.458 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 65.2 m-85 -105.62 130.89 53.56 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.361 -0.837 . . . . 46.07 109.017 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.734 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -116.3 121.14 41.13 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.554 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.653 ' CD1' HD12 ' A' ' 90' ' ' LEU . 85.1 m-85 -116.75 134.3 54.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.624 -0.672 . . . . 38.88 109.459 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.985 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -110.9 132.63 54.04 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.171 -0.956 . . . . 34.06 108.839 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.585 ' HE1' HG23 ' A' ' 88' ' ' VAL . 25.8 p90 -126.98 143.55 51.26 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.376 -0.929 . . . . 29.03 111.294 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.0 t -103.92 139.57 38.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.707 -0.621 . . . . 0.0 109.417 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.833 HD13 HG22 ' A' ' 13' ' ' VAL . 40.9 mm -105.06 132.6 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.811 0.815 . . . . 0.0 111.532 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -123.02 95.74 4.73 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.46 0.647 . . . . 40.24 109.563 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.53 HG22 ' CD1' ' A' ' 76' ' ' LEU . 78.7 mt -90.23 117.5 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.766 -0.583 . . . . 20.73 110.535 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -117.36 134.4 54.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.515 -0.741 . . . . 0.0 109.434 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -92.24 117.43 29.87 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.282 -0.567 . . . . 21.34 110.524 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.85 10.44 16.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.471 -0.768 . . . . 0.0 110.584 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.32 179.55 53.3 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.216 -1.554 . . . . 29.1 109.216 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.11 -30.93 13.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.516 -0.991 . . . . 0.0 110.29 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.523 HG13 ' HD2' ' A' ' 44' ' ' PRO . 84.0 t -106.29 140.15 21.0 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.791 -0.568 . . . . 0.0 109.984 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.523 ' HD2' HG13 ' A' ' 43' ' ' VAL . 38.7 Cg_endo -51.53 141.28 42.74 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 O-C-N 123.8 1.421 . . . . 21.95 112.038 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.34 152.2 45.63 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.709 0.766 . . . . 20.91 111.09 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.2 ptt-85 -127.66 159.46 34.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.706 -0.621 . . . . 0.0 109.471 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.894 HD22 HG13 ' A' ' 69' ' ' VAL . 7.1 tt -96.62 117.56 31.24 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.418 -0.801 . . . . 0.0 109.794 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.444 HG23 HG22 ' A' ' 104' ' ' VAL . 58.6 t -99.48 -28.46 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.519 -0.738 . . . . 0.0 110.636 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.743 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -142.61 162.82 34.46 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.83 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.606 ' HD2' HG12 ' A' ' 69' ' ' VAL . 2.7 ptm180 -143.5 142.12 31.02 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.612 0.72 . . . . 29.05 110.712 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.409 ' HB3' ' NE2' ' A' ' 100' ' ' HIS . 21.6 t-160 -145.27 114.79 7.2 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.289 0.566 . . . . 27.97 109.701 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.464 ' CH2' HG21 ' A' ' 115' ' ' ILE . 67.3 m95 -100.13 136.67 39.69 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.652 -0.655 . . . . 25.25 111.36 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -116.13 78.28 1.18 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.661 -0.649 . . . . 0.0 109.258 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.425 ' O ' HG13 ' A' ' 54' ' ' ILE . 29.9 pt -88.15 131.67 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.771 0.796 . . . . 36.11 112.279 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.449 ' OG1' HG22 ' A' ' 61' ' ' THR . 93.5 m -119.63 133.23 55.73 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.395 -0.965 . . . . 33.98 108.395 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -85.89 169.16 13.55 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.693 0.759 . . . . 45.04 111.265 -178.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.93 -9.35 13.66 Favored Glycine 0 N--CA 1.496 2.644 0 O-C-N 121.827 -0.546 . . . . 39.47 112.078 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -100.78 9.23 42.64 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 119.26 1.53 . . . . 0.0 110.761 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.7 -21.0 38.3 Favored Glycine 0 N--CA 1.495 2.621 0 O-C-N 121.2 -0.938 . . . . 0.0 111.018 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.02 142.33 54.12 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.064 -1.257 . . . . 62.78 109.884 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.449 HG22 ' OG1' ' A' ' 55' ' ' THR . 73.4 p -125.32 140.24 52.99 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.515 -0.741 . . . . 0.0 110.808 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -123.18 117.88 26.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.525 -0.734 . . . . 0.0 109.829 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -103.75 135.32 45.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.717 -0.614 . . . . 0.0 110.768 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.0 t -128.75 130.89 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.657 -0.652 . . . . 37.94 109.947 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.404 ' OD1' ' CG ' ' A' ' 51' ' ' HIS . 64.7 m-20 -124.07 126.77 46.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.929 -0.482 . . . . 0.0 109.959 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.9 145.67 14.26 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.527 -1.429 . . . . 31.82 109.527 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -67.29 153.57 43.36 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.462 -1.022 . . . . 0.0 110.099 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 46.97 -164.73 0.12 Allowed Glycine 0 N--CA 1.501 3.009 0 O-C-N 121.487 -0.758 . . . . 22.62 111.793 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.894 HG13 HD22 ' A' ' 47' ' ' LEU . 15.9 m -130.98 129.37 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.89 -0.771 . . . . 17.51 109.633 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 69' ' ' VAL . 12.5 m 40.98 34.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 CA-C-O 121.513 0.673 . . . . 20.55 111.822 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.57 17.16 66.75 Favored Glycine 0 N--CA 1.499 2.839 0 O-C-N 121.668 -0.645 . . . . 18.29 112.952 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -144.53 150.0 36.81 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 119.2 1.5 . . . . 0.0 111.95 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -116.08 74.92 5.62 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.989 -0.745 . . . . 18.21 108.989 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -56.37 141.32 89.34 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 O-C-N 123.852 1.449 . . . . 17.61 112.06 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -100.34 77.33 1.94 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.53 ' CD1' HG22 ' A' ' 37' ' ' ILE . 11.1 mt -62.88 118.04 7.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.575 -0.703 . . . . 20.57 111.987 -178.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -86.92 159.18 52.23 Favored Pre-proline 0 N--CA 1.489 1.508 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -54.65 128.73 31.53 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 O-C-N 123.512 1.27 . . . . 27.04 111.013 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.49 -17.39 52.49 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.955 -0.858 . . . . 24.74 110.955 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -87.41 166.1 15.08 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.995 -1.297 . . . . 29.38 110.635 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.34 150.08 35.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.659 -0.651 . . . . 0.0 110.112 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -118.94 147.69 43.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.505 -0.747 . . . . 18.56 109.081 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.5 p80 -144.75 140.84 28.79 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.146 -0.971 . . . . 0.0 111.243 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.539 ' CE1' HG21 ' A' ' 35' ' ' ILE . 52.1 p90 -150.95 160.02 44.19 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.633 -0.667 . . . . 26.65 109.812 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.4 m -101.34 137.01 40.24 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.431 -0.793 . . . . 28.14 110.911 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.451 ' HG ' ' HH ' ' A' ' 33' ' ' TYR . 26.6 t -125.23 169.35 12.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.616 -0.677 . . . . 33.88 110.132 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.39 123.33 2.15 Favored Glycine 0 N--CA 1.497 2.725 0 C-N-CA 119.914 -1.136 . . . . 31.8 110.461 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.585 HG23 ' HE1' ' A' ' 33' ' ' TYR . 80.4 t -130.18 152.44 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.532 -0.981 . . . . 0.0 109.48 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.719 HD23 ' N ' ' A' ' 90' ' ' LEU . 5.6 tt -110.56 143.81 40.37 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.532 -0.73 . . . . 0.0 110.508 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.777 HD11 HD22 ' A' ' 120' ' ' LEU . 70.8 mt -122.28 147.57 46.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.578 -0.702 . . . . 38.68 110.193 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -74.74 -25.91 59.43 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.28 -0.887 . . . . 0.0 110.805 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.2 p -125.52 172.9 9.32 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.429 -0.794 . . . . 31.63 110.857 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.452 ' HG2' ' CD2' ' A' ' 29' ' ' TYR . 94.0 mt-10 -86.33 11.91 11.21 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.683 -0.636 . . . . 0.0 111.635 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 97.0 mt-30 -139.93 147.39 40.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.113 -0.992 . . . . 0.0 109.895 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.48 158.88 21.51 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 118.889 -1.624 . . . . 28.05 112.28 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -119.47 129.72 54.88 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 122.108 -0.642 . . . . 0.0 109.357 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.451 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 98.0 mtp -125.61 116.42 21.69 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.371 -0.83 . . . . 0.0 111.124 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.493 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 56.3 tt0 -130.15 151.1 51.05 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -168.77 -177.18 39.5 Favored Glycine 0 N--CA 1.5 2.93 0 C-N-CA 119.017 -1.564 . . . . 29.62 110.748 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.409 ' NE2' ' HB3' ' A' ' 51' ' ' HIS . 6.0 p-80 -140.16 157.99 44.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.682 -0.893 . . . . 0.0 110.958 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.664 ' CD1' HD11 ' A' ' 47' ' ' LEU . 5.6 m-85 -115.77 128.21 55.68 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.68 -0.637 . . . . 27.05 109.647 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.743 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 41.4 t0 -80.78 124.83 29.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.927 -1.108 . . . . 0.0 109.184 178.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.599 ' SD ' HG11 ' A' ' 9' ' ' VAL . 29.5 mtp -124.63 162.37 24.25 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.249 0.547 . . . . 0.0 110.543 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.456 HG12 ' OE2' ' A' ' 110' ' ' GLU . 9.8 m -139.73 128.15 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.654 -0.654 . . . . 23.28 110.285 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.46 168.99 18.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.538 -0.726 . . . . 0.0 109.861 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.61 -31.74 72.63 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.834 -0.747 . . . . 0.0 110.271 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -70.02 -15.67 63.05 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.491 -0.755 . . . . 0.0 110.942 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.9 -5.74 47.01 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.42 -1.072 . . . . 30.43 110.42 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.4 m -57.72 135.6 56.78 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.061 -1.258 . . . . 0.0 110.052 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.456 ' OE2' HG12 ' A' ' 104' ' ' VAL . 77.1 mm-40 -98.63 139.98 33.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.443 -0.786 . . . . 0.0 110.612 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 48.0 p90 -168.39 148.88 4.75 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.703 -0.623 . . . . 28.03 110.121 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.6 pt -102.64 157.9 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.707 -0.621 . . . . 0.0 110.833 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -118.54 99.08 51.51 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -58.68 142.76 98.82 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 O-C-N 123.928 1.489 . . . . 33.31 112.356 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.637 HD11 ' CD2' ' A' ' 101' ' ' TYR . 70.2 mt -108.82 123.6 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.45 -0.945 . . . . 30.59 108.45 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.74 143.98 8.93 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.191 0.52 . . . . 30.78 111.362 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.493 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -85.98 121.6 28.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.619 -0.675 . . . . 0.0 110.186 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.582 ' CE1' HD11 ' A' ' 120' ' ' LEU . 42.4 p90 -109.46 163.95 12.95 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.796 -0.816 . . . . 30.66 108.796 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.606 ' C ' HD12 ' A' ' 120' ' ' LEU . 8.8 p -115.4 154.53 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.186 -0.946 . . . . 0.0 110.476 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.777 HD22 HD11 ' A' ' 90' ' ' LEU . 6.9 mp -113.63 133.47 55.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.733 -0.604 . . . . 39.15 109.384 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.702 -0.624 . . . . 0.0 110.046 -179.792 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.656 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 61.6 mtt180 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.656 0.265 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.476 ' CE2' HG21 ' A' ' 109' ' ' THR . 31.4 m-85 -119.98 108.07 13.87 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.44 -0.788 . . . . 31.93 110.306 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.464 ' C ' HG23 ' A' ' 9' ' ' VAL . 81.4 mtt85 -149.06 132.85 16.97 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.661 -0.65 . . . . 0.0 109.986 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.588 HG11 ' CE ' ' A' ' 103' ' ' MET . 68.0 t -150.61 113.48 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.687 -0.633 . . . . 0.0 109.455 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -107.41 129.19 54.96 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.616 -0.677 . . . . 0.0 109.809 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.585 HG11 ' HE2' ' A' ' 101' ' ' TYR . 58.4 t -118.75 139.56 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.88 -0.512 . . . . 28.21 109.969 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -121.26 137.07 54.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.401 -0.812 . . . . 0.0 109.905 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.715 HG22 HD13 ' A' ' 35' ' ' ILE . 59.1 t -128.81 136.67 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.709 -0.619 . . . . 27.95 110.23 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.9 p -125.38 104.8 28.23 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.719 -0.613 . . . . 0.0 110.55 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.404 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 48.4 Cg_endo -83.7 164.39 14.08 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 O-C-N 123.95 1.5 . . . . 33.0 110.902 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.6 ptt-85 -157.37 132.5 8.9 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.522 0.677 . . . . 54.1 109.843 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.567 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 75.1 t80 -59.43 138.56 57.62 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.337 0.589 . . . . 0.0 111.305 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.3 tp -116.18 79.79 1.36 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.983 0.897 . . . . 0.0 110.386 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.567 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -70.59 -35.58 73.09 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.567 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -68.43 -25.05 64.82 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.279 -0.888 . . . . 0.0 111.117 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -120.08 45.85 2.09 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.27 -0.894 . . . . 52.37 110.63 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.735 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 34.8 p -165.76 150.03 8.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.374 -0.829 . . . . 55.19 110.974 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.628 HG23 ' HB2' ' A' ' 28' ' ' ARG . 9.5 t -120.98 93.24 48.81 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.461 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.3 Cg_endo -66.89 -23.21 47.73 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 O-C-N 123.761 1.401 . . . . 51.57 111.965 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.09 -23.02 67.04 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.287 -0.883 . . . . 0.0 110.927 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -106.39 24.0 13.25 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.295 -0.878 . . . . 0.0 110.641 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.76 29.17 72.68 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.628 ' HB2' HG23 ' A' ' 23' ' ' THR . 99.5 mtt180 -121.85 93.94 4.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.592 -0.946 . . . . 0.0 110.152 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.461 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 58.4 m-85 -104.95 133.8 49.14 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.559 -0.713 . . . . 46.07 109.103 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.735 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -115.04 119.78 37.62 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.163 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.833 ' CD1' HD12 ' A' ' 90' ' ' LEU . 83.2 m-85 -114.73 134.83 54.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.564 -0.71 . . . . 38.88 109.786 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.4 131.54 55.49 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.52 -0.919 . . . . 34.06 108.52 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.633 ' HE1' HG23 ' A' ' 88' ' ' VAL . 21.9 p90 -128.43 144.76 51.19 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.273 -0.971 . . . . 29.03 111.435 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -104.42 139.6 39.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.752 -0.592 . . . . 0.0 109.886 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.715 HD13 HG22 ' A' ' 13' ' ' VAL . 44.7 mm -107.28 133.04 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.707 0.765 . . . . 0.0 111.416 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.13 98.52 5.81 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.394 0.616 . . . . 40.24 109.738 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.58 HG22 ' CD1' ' A' ' 76' ' ' LEU . 77.3 mt -90.27 117.75 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.749 -0.595 . . . . 20.73 110.597 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -118.09 133.45 55.89 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.451 -0.781 . . . . 0.0 109.615 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.41 117.12 29.79 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.822 -0.549 . . . . 21.34 110.434 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.82 14.39 17.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.319 -0.863 . . . . 0.0 110.717 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.58 -177.03 51.5 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.349 -1.501 . . . . 29.1 109.349 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.656 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . . . -95.98 -33.5 12.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.598 -0.943 . . . . 0.0 109.915 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.514 HG13 ' HD2' ' A' ' 44' ' ' PRO . 84.9 t -104.7 140.82 21.45 Favored Pre-proline 0 N--CA 1.494 1.772 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.514 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.1 Cg_endo -52.51 142.24 49.4 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 O-C-N 123.777 1.409 . . . . 21.95 111.711 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.03 152.73 46.47 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.716 0.77 . . . . 20.91 111.101 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.431 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 24.0 ptt-85 -127.88 157.75 39.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.708 -0.62 . . . . 0.0 109.634 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.71 HD22 HG13 ' A' ' 69' ' ' VAL . 6.4 tt -97.46 117.85 32.62 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.381 -0.824 . . . . 0.0 109.084 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.454 HG23 HG22 ' A' ' 104' ' ' VAL . 60.9 t -100.22 -29.32 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.56 -0.712 . . . . 0.0 111.616 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.695 ' HB3' ' HB2' ' A' ' 102' ' ' ASP . . . -140.06 164.47 29.94 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.126 -1.029 . . . . 0.0 112.151 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -142.85 141.14 31.53 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.559 0.695 . . . . 29.05 110.906 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -143.37 113.06 7.0 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.309 -0.626 . . . . 27.97 109.309 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.501 ' CH2' HD13 ' A' ' 115' ' ' ILE . 88.3 m95 -100.05 134.69 42.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.607 -0.683 . . . . 25.25 111.099 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -116.54 77.19 1.08 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.574 -0.704 . . . . 0.0 109.57 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.442 ' O ' HG13 ' A' ' 54' ' ' ILE . 27.6 pt -86.68 130.27 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.416 -0.803 . . . . 36.11 111.855 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.59 HG23 ' HB ' ' A' ' 61' ' ' THR . 6.8 m -119.48 132.67 55.83 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.374 -0.973 . . . . 33.98 108.374 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -88.13 169.57 11.81 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.717 0.77 . . . . 45.04 111.417 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.67 -7.69 12.2 Favored Glycine 0 N--CA 1.495 2.57 0 O-C-N 121.786 -0.571 . . . . 39.47 112.16 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -101.25 7.59 42.89 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 119.307 1.554 . . . . 0.0 110.682 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.13 -29.32 8.26 Favored Glycine 0 N--CA 1.495 2.631 0 O-C-N 121.211 -0.931 . . . . 0.0 110.798 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -63.6 142.45 58.39 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.205 -1.173 . . . . 62.78 109.755 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.59 ' HB ' HG23 ' A' ' 55' ' ' THR . 7.9 t -134.49 152.76 52.0 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.846 -0.741 . . . . 0.0 110.683 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -122.53 125.23 45.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.623 -0.673 . . . . 0.0 110.267 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -102.47 134.72 45.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.671 -0.643 . . . . 0.0 110.512 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.8 t -128.38 132.6 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.548 -0.72 . . . . 37.94 110.038 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -125.49 127.18 46.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.874 -0.516 . . . . 0.0 110.338 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.3 -174.57 15.68 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 108.711 -1.756 . . . . 31.82 108.711 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.24 -157.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.186 -1.185 . . . . 0.0 109.813 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.405 ' HA2' ' CD2' ' A' ' 47' ' ' LEU . . . -51.03 -91.25 0.01 OUTLIER Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.563 -1.015 . . . . 22.62 110.563 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.71 HG13 HD22 ' A' ' 47' ' ' LEU . 27.4 m -140.22 129.13 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.402 -1.057 . . . . 17.51 110.143 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 69' ' ' VAL . 12.0 m 40.81 33.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 CA-C-O 121.268 0.556 . . . . 20.55 112.122 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.97 22.29 55.5 Favored Glycine 0 N--CA 1.499 2.837 0 O-C-N 121.533 -0.729 . . . . 18.29 112.782 177.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.656 ' HG3' HG23 ' A' ' 69' ' ' VAL . 1.6 pt-20 -139.83 150.75 45.05 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 119.142 1.471 . . . . 0.0 111.354 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -113.84 74.83 2.62 Favored Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 109.117 -0.697 . . . . 18.21 109.117 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -57.36 141.7 94.85 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 O-C-N 123.858 1.452 . . . . 17.61 111.887 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.431 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -103.8 76.36 1.37 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.58 ' CD1' HG22 ' A' ' 37' ' ' ILE . 19.0 mt -63.67 121.48 14.04 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.634 -0.666 . . . . 20.57 111.947 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -86.31 158.44 54.99 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -53.6 128.75 30.69 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 O-C-N 123.517 1.272 . . . . 27.04 111.132 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.01 -17.3 54.07 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.805 -0.918 . . . . 24.74 110.805 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -88.62 164.85 15.16 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.121 -1.223 . . . . 29.38 110.585 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.19 150.04 35.08 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.649 -0.657 . . . . 0.0 110.165 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -117.93 144.51 45.41 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.503 -0.748 . . . . 18.56 109.126 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -142.76 140.4 31.4 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.24 -0.912 . . . . 0.0 111.25 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.564 ' CE1' HG21 ' A' ' 35' ' ' ILE . 52.1 p90 -150.65 159.92 44.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.672 -0.642 . . . . 26.65 109.781 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 60.3 m -102.78 136.73 42.07 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.431 -0.793 . . . . 28.14 110.76 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 15.7 t -125.25 169.95 11.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.643 -0.661 . . . . 33.88 110.133 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -139.83 125.87 3.1 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 119.934 -1.127 . . . . 31.8 110.38 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.633 HG23 ' HE1' ' A' ' 33' ' ' TYR . 71.2 t -130.08 152.47 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.594 -0.945 . . . . 0.0 109.462 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.598 HD23 ' N ' ' A' ' 90' ' ' LEU . 8.1 tt -110.51 142.64 42.01 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.642 -0.661 . . . . 0.0 110.488 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.833 HD12 ' CD1' ' A' ' 31' ' ' PHE . 86.1 mt -122.12 145.8 47.83 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.543 -0.723 . . . . 38.68 109.971 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -81.49 -26.3 35.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.299 -0.876 . . . . 0.0 111.036 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 93' ' ' GLU . 27.0 m -123.69 169.34 11.59 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.306 -0.871 . . . . 31.63 110.66 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.453 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 50.6 mt-10 -86.22 11.09 12.8 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.637 -0.664 . . . . 0.0 111.603 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 96.9 mt-30 -140.72 145.31 36.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.16 -0.963 . . . . 0.0 109.853 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.51 157.02 17.52 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 118.747 -1.692 . . . . 28.05 112.315 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -117.28 129.28 55.8 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 99.6 mtp -126.08 117.77 23.88 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.314 -0.866 . . . . 0.0 111.431 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.483 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 56.6 tt0 -126.3 149.18 49.3 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -155.46 -178.91 30.16 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 118.8 -1.667 . . . . 29.62 111.078 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.824 ' CE1' HD12 ' A' ' 112' ' ' ILE . 0.3 OUTLIER -136.92 155.74 49.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.769 -0.842 . . . . 0.0 109.494 179.506 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.585 ' HE2' HG11 ' A' ' 11' ' ' VAL . 6.6 m-85 -118.09 126.95 53.27 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.419 -0.801 . . . . 27.05 110.163 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.695 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 78.6 m-20 -85.49 120.36 26.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.113 -0.992 . . . . 0.0 108.761 177.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.588 ' CE ' HG11 ' A' ' 9' ' ' VAL . 14.2 tpp -123.93 160.67 27.03 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.109 0.48 . . . . 0.0 110.403 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.454 HG22 HG23 ' A' ' 48' ' ' VAL . 9.1 m -140.69 130.04 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.654 -0.654 . . . . 23.28 110.176 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.39 166.62 23.18 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.494 -0.754 . . . . 0.0 109.732 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -65.37 -29.77 70.53 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.546 -0.721 . . . . 0.0 110.153 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -74.64 -6.43 48.59 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.437 -0.789 . . . . 0.0 111.139 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.26 -9.41 59.38 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 120.082 -1.056 . . . . 30.43 110.581 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.476 HG21 ' CE2' ' A' ' 7' ' ' TYR . 27.4 m -57.89 135.01 56.81 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.009 -1.289 . . . . 0.0 110.023 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -101.13 138.86 37.61 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.359 -0.838 . . . . 0.0 110.726 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 41.9 p90 -162.69 143.8 10.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.664 -0.648 . . . . 28.03 109.942 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.824 HD12 ' CE1' ' A' ' 100' ' ' HIS . 30.5 pt -101.01 156.78 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 121.331 0.586 . . . . 0.0 110.877 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.485 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -121.66 100.19 44.19 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.617 -0.677 . . . . 0.0 109.421 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.422 ' HB3' ' CE1' ' A' ' 100' ' ' HIS . 45.3 Cg_endo -58.02 142.85 96.99 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 O-C-N 123.862 1.454 . . . . 33.31 112.176 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.501 HD13 ' CH2' ' A' ' 52' ' ' TRP . 66.9 mt -107.88 123.05 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.677 -0.861 . . . . 30.59 108.677 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.83 145.45 7.08 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.848 -0.532 . . . . 30.78 111.352 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.483 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -93.61 120.36 33.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.745 -0.597 . . . . 0.0 110.012 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.725 ' CE1' HD11 ' A' ' 120' ' ' LEU . 46.1 p90 -108.55 167.75 9.82 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.907 -0.775 . . . . 30.66 108.907 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.615 ' C ' HD12 ' A' ' 120' ' ' LEU . 8.8 p -113.7 154.1 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.349 -0.844 . . . . 0.0 110.498 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.725 HD11 ' CE1' ' A' ' 118' ' ' PHE . 7.1 mp -113.72 132.93 55.63 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.37 -0.604 . . . . 39.15 109.37 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.672 -0.642 . . . . 0.0 110.069 -179.808 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.588 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 28.5 mmt85 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 120.669 0.271 . . . . 0.0 110.741 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.444 ' CE2' HG21 ' A' ' 109' ' ' THR . 40.4 m-85 -121.22 113.34 19.82 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.412 -0.805 . . . . 31.93 110.383 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.461 ' C ' HG23 ' A' ' 9' ' ' VAL . 41.0 mtp85 -152.14 135.93 16.3 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.589 0.709 . . . . 0.0 110.092 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.461 HG23 ' C ' ' A' ' 8' ' ' ARG . 83.7 t -151.28 114.4 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 CA-C-O 121.442 0.639 . . . . 0.0 109.426 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -106.79 129.0 54.72 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.516 0.674 . . . . 0.0 109.907 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.19 138.4 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 109.694 -0.484 . . . . 28.21 109.694 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -121.8 136.66 54.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.416 -0.802 . . . . 0.0 109.931 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.733 HG22 HD13 ' A' ' 35' ' ' ILE . 62.4 t -129.39 136.4 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.484 -0.76 . . . . 27.95 110.375 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -125.71 104.57 27.26 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.732 -0.605 . . . . 0.0 110.443 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.425 ' HG3' ' CE1' ' A' ' 118' ' ' PHE . 49.9 Cg_endo -84.41 165.25 12.57 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 O-C-N 123.843 1.444 . . . . 33.0 110.929 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -158.03 132.61 8.33 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.562 0.696 . . . . 54.1 109.982 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.556 ' CE2' ' HB2' ' A' ' 19' ' ' ALA . 76.8 t80 -58.66 138.25 57.09 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.833 -0.542 . . . . 0.0 111.198 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.438 HD23 ' HB3' ' A' ' 21' ' ' GLN . 8.6 tp -115.47 80.53 1.45 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.028 0.918 . . . . 0.0 110.359 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.556 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -71.12 -35.97 71.95 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.494 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -68.8 -24.2 64.37 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.374 -0.829 . . . . 0.0 111.002 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.438 ' HB3' HD23 ' A' ' 18' ' ' LEU . 54.4 tp60 -121.34 46.82 1.97 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.382 -0.824 . . . . 52.37 110.389 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.739 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 34.3 t -166.05 149.85 7.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.456 -0.777 . . . . 55.19 110.894 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.625 HG23 ' HB2' ' A' ' 28' ' ' ARG . 8.7 t -122.04 92.94 48.81 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.457 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.5 Cg_endo -66.72 -23.1 49.13 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.761 1.401 . . . . 51.57 111.986 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -65.81 -22.68 66.58 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.267 -0.896 . . . . 0.0 110.947 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -105.97 23.59 13.74 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.251 -0.905 . . . . 0.0 110.734 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.33 28.85 73.08 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.625 ' HB2' HG23 ' A' ' 23' ' ' THR . 24.8 mmt85 -121.72 94.19 4.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.599 -0.942 . . . . 0.0 110.154 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.457 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 57.6 m-85 -105.33 131.66 52.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.538 -0.726 . . . . 46.07 109.122 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.739 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -114.7 120.56 40.53 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.609 -0.837 . . . . 0.0 111.043 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.788 ' CD1' HD12 ' A' ' 90' ' ' LEU . 86.8 m-85 -114.59 135.75 53.8 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.578 -0.701 . . . . 38.88 109.581 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.72 131.61 55.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.198 -0.939 . . . . 34.06 108.483 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.645 ' HE1' HG23 ' A' ' 88' ' ' VAL . 20.9 p90 -128.55 144.58 51.17 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.276 -0.969 . . . . 29.03 111.45 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.8 p -104.18 141.1 36.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.647 -0.658 . . . . 0.0 109.877 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.733 HD13 HG22 ' A' ' 13' ' ' VAL . 44.3 mm -106.89 132.24 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.728 0.775 . . . . 0.0 111.352 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -122.95 97.88 5.64 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.427 0.632 . . . . 40.24 109.578 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.608 HG22 ' CD1' ' A' ' 76' ' ' LEU . 77.6 mt -91.65 116.99 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.771 -0.581 . . . . 20.73 110.598 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -118.02 133.5 55.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.437 -0.789 . . . . 0.0 109.468 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -95.5 117.83 31.11 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.225 -0.59 . . . . 21.34 110.634 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.96 14.28 17.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.423 -0.798 . . . . 0.0 110.5 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.68 179.79 53.31 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.316 -1.514 . . . . 29.1 109.316 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.588 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . . . -92.42 -33.81 14.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.536 -0.979 . . . . 0.0 110.056 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.511 HG13 ' HD2' ' A' ' 44' ' ' PRO . 84.3 t -104.6 139.61 20.27 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.965 -0.46 . . . . 0.0 109.771 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.511 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.5 Cg_endo -51.26 146.2 24.7 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 O-C-N 123.709 1.373 . . . . 21.95 111.613 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.49 151.08 48.07 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.861 0.838 . . . . 20.91 111.524 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.437 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 52.6 ttp180 -126.02 153.35 44.51 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.641 HD22 HG13 ' A' ' 69' ' ' VAL . 7.2 tt -96.93 116.97 30.11 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.541 -0.724 . . . . 0.0 109.705 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.44 HG23 HG22 ' A' ' 104' ' ' VAL . 57.3 t -100.51 -27.0 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.607 -0.683 . . . . 0.0 110.516 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.727 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -140.69 162.4 35.49 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.132 -1.027 . . . . 0.0 112.124 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 32.6 ptt85 -140.76 139.0 34.54 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.322 0.582 . . . . 29.05 109.858 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.407 ' NE2' ' CG ' ' A' ' 63' ' ' GLN . 20.0 t-160 -143.32 111.45 6.15 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.653 -0.654 . . . . 27.97 110.264 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.57 ' CH2' HD13 ' A' ' 115' ' ' ILE . 60.5 m95 -105.64 135.85 46.31 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.33 0.586 . . . . 25.25 111.135 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -115.87 82.26 1.74 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.703 -0.623 . . . . 0.0 109.348 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.908 HG22 ' HG3' ' A' ' 97' ' ' MET . 16.3 pt -84.47 128.38 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.43 -0.794 . . . . 36.11 111.668 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.477 HG23 ' HB ' ' A' ' 61' ' ' THR . 17.6 m -120.57 132.13 55.0 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.492 -0.929 . . . . 33.98 108.492 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -88.69 169.89 11.28 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.664 0.745 . . . . 45.04 111.271 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.14 -7.48 13.47 Favored Glycine 0 N--CA 1.495 2.604 0 O-C-N 121.82 -0.55 . . . . 39.47 112.148 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -101.41 7.66 42.5 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 119.369 1.585 . . . . 0.0 110.682 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.07 -28.75 8.99 Favored Glycine 0 N--CA 1.493 2.457 0 O-C-N 121.193 -0.942 . . . . 0.0 110.892 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.26 141.24 58.84 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.232 -1.158 . . . . 62.78 109.617 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.477 ' HB ' HG23 ' A' ' 55' ' ' THR . 7.8 t -135.58 153.18 51.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.446 -0.784 . . . . 0.0 110.745 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -120.98 123.36 42.23 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.536 -0.728 . . . . 0.0 109.735 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.407 ' CG ' ' NE2' ' A' ' 51' ' ' HIS . 50.7 tt0 -99.15 136.6 38.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.659 -0.651 . . . . 0.0 110.827 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.94 131.68 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 CA-C-O 121.681 0.753 . . . . 37.94 110.352 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -126.91 127.45 44.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.955 -0.466 . . . . 0.0 110.055 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.11 172.63 32.74 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.304 -1.518 . . . . 31.82 109.304 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -115.61 159.18 21.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.403 -1.057 . . . . 0.0 110.085 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.65 96.55 0.01 OUTLIER Glycine 0 N--CA 1.501 2.98 0 O-C-N 121.424 -0.797 . . . . 22.62 111.531 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.641 HG13 HD22 ' A' ' 47' ' ' LEU . 23.7 m -45.56 133.31 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 O-C-N 121.338 -1.095 . . . . 17.51 111.589 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.1 m 41.6 35.97 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 CA-C-O 121.619 0.723 . . . . 20.55 111.408 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.4 21.5 58.34 Favored Glycine 0 N--CA 1.495 2.584 0 O-C-N 121.753 -0.592 . . . . 18.29 112.398 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.488 ' HG3' HG23 ' A' ' 69' ' ' VAL . 3.6 pt-20 -146.21 152.85 39.88 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 119.111 1.455 . . . . 0.0 112.473 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -118.56 72.95 10.81 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 108.449 -0.945 . . . . 18.21 108.449 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -55.01 139.64 79.8 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 O-C-N 123.781 1.411 . . . . 17.61 112.284 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.44 ' CZ3' ' HG2' ' A' ' 77' ' ' ARG . 5.2 t90 -99.56 75.54 1.95 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.608 ' CD1' HG22 ' A' ' 37' ' ' ILE . 12.4 mt -61.03 119.77 8.95 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.682 -0.636 . . . . 20.57 112.084 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.44 ' HG2' ' CZ3' ' A' ' 75' ' ' TRP . 18.1 mtm180 -86.48 157.86 55.2 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -53.84 128.28 29.0 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 O-C-N 123.492 1.259 . . . . 27.04 111.093 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.68 -16.59 56.16 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.769 -0.933 . . . . 24.74 110.769 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -88.17 164.75 15.52 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.133 -1.216 . . . . 29.38 110.533 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.18 149.82 34.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.586 -0.696 . . . . 0.0 110.124 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -118.65 147.54 43.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.49 -0.756 . . . . 18.56 109.17 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -143.34 139.85 30.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.168 -0.957 . . . . 0.0 111.124 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.556 ' CE1' HG21 ' A' ' 35' ' ' ILE . 53.2 p90 -150.92 159.73 44.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.614 -0.679 . . . . 26.65 109.716 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.2 m -102.12 136.64 41.6 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.363 -0.836 . . . . 28.14 110.92 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 17.9 t -124.95 170.25 11.29 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.681 -0.637 . . . . 33.88 109.912 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -140.54 125.34 2.85 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.827 -1.177 . . . . 31.8 110.495 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.645 HG23 ' HE1' ' A' ' 33' ' ' TYR . 76.2 t -129.98 152.26 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.592 -0.946 . . . . 0.0 109.293 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.493 HD23 ' N ' ' A' ' 90' ' ' LEU . 7.1 tt -111.01 142.91 42.52 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.627 -0.671 . . . . 0.0 110.712 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.788 HD12 ' CD1' ' A' ' 31' ' ' PHE . 89.4 mt -121.67 145.21 48.24 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.576 -0.703 . . . . 38.68 109.893 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -79.16 -26.73 42.72 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.211 -0.93 . . . . 0.0 110.939 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.9 p -124.43 172.29 9.27 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.361 -0.837 . . . . 31.63 110.729 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.456 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 48.8 mt-10 -86.56 12.38 10.59 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.62 -0.675 . . . . 0.0 111.58 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 15.1 pt20 -141.47 144.89 34.63 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.039 -1.038 . . . . 0.0 109.78 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 178.77 158.89 22.15 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 118.74 -1.695 . . . . 28.05 112.275 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -119.71 129.42 54.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 122.117 -0.637 . . . . 0.0 109.322 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.908 ' HG3' HG22 ' A' ' 54' ' ' ILE . 49.2 ttm -125.14 121.18 33.49 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.249 -0.907 . . . . 0.0 111.155 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.449 ' CD ' ' HB2' ' A' ' 117' ' ' ALA . 35.4 mt-30 -123.82 150.15 44.87 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.56 171.28 36.69 Favored Glycine 0 N--CA 1.5 2.931 0 C-N-CA 118.337 -1.887 . . . . 29.62 111.605 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 114' ' ' PRO . 51.6 m80 -135.3 153.97 51.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.895 -0.767 . . . . 0.0 109.685 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.725 ' CE2' HD11 ' A' ' 115' ' ' ILE . 5.3 m-85 -119.16 126.1 50.78 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.519 -0.738 . . . . 27.05 109.74 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.727 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 41.5 t0 -80.98 121.93 26.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.898 -1.126 . . . . 0.0 109.359 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.447 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 91.6 mmm -119.68 161.47 20.65 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.112 0.482 . . . . 0.0 110.066 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.44 HG22 HG23 ' A' ' 48' ' ' VAL . 8.5 m -140.86 127.62 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.551 -0.718 . . . . 23.28 110.335 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.88 167.47 21.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.585 -0.697 . . . . 0.0 109.581 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -64.06 -29.63 70.76 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.136 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -73.3 -11.19 60.41 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.534 -0.729 . . . . 0.0 111.136 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.91 -7.2 52.56 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 120.075 -1.059 . . . . 30.43 110.54 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.444 HG21 ' CE2' ' A' ' 7' ' ' TYR . 41.2 m -57.47 136.28 56.66 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.015 -1.285 . . . . 0.0 110.106 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -101.57 141.19 34.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.433 -0.792 . . . . 0.0 110.959 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 46.8 p90 -168.54 146.7 4.13 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.677 -0.639 . . . . 28.03 109.883 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.3 pt -102.63 159.27 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.673 -0.642 . . . . 0.0 111.222 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.02 97.13 50.64 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.429 ' HB3' ' CD2' ' A' ' 100' ' ' HIS . 46.0 Cg_endo -59.75 143.44 99.63 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 O-C-N 123.962 1.506 . . . . 33.31 112.332 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.725 HD11 ' CE2' ' A' ' 101' ' ' TYR . 72.7 mt -108.13 120.72 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.301 -0.999 . . . . 30.59 108.301 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -47.36 161.23 0.08 Allowed 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.304 0.573 . . . . 30.78 111.818 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.449 ' HB2' ' CD ' ' A' ' 98' ' ' GLN . . . -99.93 118.05 35.53 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.78 -0.575 . . . . 0.0 110.778 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.755 ' CE1' HD11 ' A' ' 120' ' ' LEU . 50.5 p90 -110.68 166.24 11.18 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.359 -0.978 . . . . 30.66 108.359 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.633 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.2 t -113.18 153.98 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.172 -0.955 . . . . 0.0 110.48 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.755 HD11 ' CE1' ' A' ' 118' ' ' PHE . 7.4 mp -113.35 130.57 56.25 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.169 -0.678 . . . . 39.15 109.169 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.4 m . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.668 -0.645 . . . . 0.0 110.062 -179.801 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.666 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 60.0 mtt180 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 120.734 0.302 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.683 ' CE2' HG21 ' A' ' 109' ' ' THR . 44.6 m-85 -123.77 119.56 30.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.505 -0.747 . . . . 31.93 110.501 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.489 ' C ' HG23 ' A' ' 9' ' ' VAL . 21.3 ttm180 -156.86 132.89 9.65 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.43 0.633 . . . . 0.0 110.081 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.489 HG23 ' C ' ' A' ' 8' ' ' ARG . 95.5 t -151.74 115.45 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.618 -0.676 . . . . 0.0 109.755 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -106.15 128.8 54.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.667 -0.646 . . . . 0.0 109.82 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.487 HG22 ' HA ' ' A' ' 37' ' ' ILE . 61.8 t -118.9 138.99 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.92 -0.487 . . . . 28.21 109.896 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -122.5 135.82 54.74 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.39 -0.818 . . . . 0.0 109.935 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.9 t -129.29 136.88 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.639 -0.663 . . . . 27.95 110.36 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -126.79 105.08 23.21 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.687 -0.633 . . . . 0.0 110.758 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -82.9 165.01 15.5 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 O-C-N 123.796 1.419 . . . . 33.0 110.808 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -157.69 131.62 8.07 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.725 0.774 . . . . 54.1 110.219 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.516 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 79.9 t80 -61.22 140.12 58.0 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.718 -0.614 . . . . 0.0 111.507 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.005 HD11 ' HB2' ' A' ' 32' ' ' ALA . 88.7 mt -116.95 82.39 1.8 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.944 0.878 . . . . 0.0 110.373 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.516 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -68.99 -34.64 75.62 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.137 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -69.9 -23.37 63.23 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.315 -0.865 . . . . 0.0 111.15 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -121.46 39.12 3.92 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.274 -0.892 . . . . 52.37 110.983 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.613 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 44.1 p -158.92 149.78 20.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.292 -0.88 . . . . 55.19 111.015 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.603 HG23 ' HB2' ' A' ' 28' ' ' ARG . 4.8 t -120.33 92.9 47.83 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.46 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 48.6 Cg_endo -66.23 -23.05 52.82 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 O-C-N 123.913 1.481 . . . . 51.57 111.894 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -67.25 -22.15 65.69 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.257 -0.902 . . . . 0.0 111.141 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -105.6 23.22 14.18 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.261 -0.9 . . . . 0.0 110.937 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.08 27.38 73.43 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.603 ' HB2' HG23 ' A' ' 23' ' ' THR . 29.6 mtt85 -121.0 94.48 4.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.533 -0.98 . . . . 0.0 110.023 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.46 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 61.3 m-85 -105.24 134.91 47.56 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.498 -0.751 . . . . 46.07 109.26 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -115.51 121.18 41.9 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.082 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.867 ' CD1' HD12 ' A' ' 90' ' ' LEU . 87.8 m-85 -116.64 133.3 56.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.509 -0.744 . . . . 38.88 109.727 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 1.005 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -112.51 131.66 55.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.279 -0.888 . . . . 34.06 108.619 178.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.588 ' HE1' HG23 ' A' ' 88' ' ' VAL . 25.0 p90 -127.05 144.47 51.02 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.307 -0.957 . . . . 29.03 111.386 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.3 t -104.21 139.04 39.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.695 -0.628 . . . . 0.0 109.388 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.831 HD12 ' CZ ' ' A' ' 84' ' ' TYR . 79.3 mt -108.4 133.94 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.714 0.768 . . . . 0.0 111.493 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -123.91 99.01 6.05 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.526 0.679 . . . . 40.24 109.718 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.559 HG22 ' CD1' ' A' ' 76' ' ' LEU . 83.9 mt -91.15 117.73 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.875 -0.515 . . . . 20.73 110.492 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -117.32 131.5 56.79 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.442 -0.786 . . . . 0.0 109.35 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -96.43 117.61 31.24 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 120.261 -0.575 . . . . 21.34 110.235 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -118.0 17.42 14.12 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.318 -0.864 . . . . 0.0 110.525 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.3 178.28 53.95 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.519 -1.432 . . . . 29.1 109.519 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.666 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . . . -86.96 -42.55 13.06 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.572 -0.958 . . . . 0.0 110.282 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.515 HG13 ' HD2' ' A' ' 44' ' ' PRO . 86.4 t -98.69 139.96 21.46 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.954 -0.466 . . . . 0.0 109.982 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.515 ' HD2' HG13 ' A' ' 43' ' ' VAL . 40.3 Cg_endo -53.03 145.65 40.86 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 O-C-N 123.805 1.423 . . . . 21.95 111.67 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.421 ' HB1' ' HG2' ' A' ' 103' ' ' MET . . . -140.56 152.24 45.36 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.687 0.756 . . . . 20.91 111.22 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.444 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 18.2 ptt-85 -127.76 153.85 46.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.803 -0.561 . . . . 0.0 109.665 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.761 HD22 HG13 ' A' ' 69' ' ' VAL . 6.5 tt -94.66 117.05 29.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.384 -0.823 . . . . 0.0 109.247 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.7 m -100.93 -24.44 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.732 -0.605 . . . . 0.0 111.194 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.766 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -142.44 163.1 33.76 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.19 -1.004 . . . . 0.0 112.081 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.499 ' HD2' HG12 ' A' ' 69' ' ' VAL . 1.8 ptm180 -142.06 140.05 32.46 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.542 0.687 . . . . 29.05 110.517 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.406 ' CD2' ' OD1' ' A' ' 65' ' ' ASP . 20.8 t-160 -144.39 112.93 6.59 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.42 0.628 . . . . 27.97 109.809 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -103.61 135.93 44.28 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.499 0.666 . . . . 25.25 111.532 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -115.8 82.31 1.74 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.78 HG22 ' HG3' ' A' ' 97' ' ' MET . 13.1 pt -83.1 127.11 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 121.75 0.786 . . . . 36.11 111.567 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.983 HG23 HG22 ' A' ' 61' ' ' THR . 95.4 m -122.0 130.03 52.96 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.732 -0.84 . . . . 33.98 108.732 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -91.56 169.77 10.48 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.757 0.789 . . . . 45.04 111.493 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.98 -5.91 16.52 Favored Glycine 0 N--CA 1.496 2.683 0 O-C-N 121.856 -0.527 . . . . 39.47 112.345 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -100.26 5.58 44.61 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 119.501 1.65 . . . . 0.0 110.636 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.449 ' O ' HG23 ' A' ' 61' ' ' THR . . . 91.91 -27.34 10.2 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.48 141.43 58.77 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.164 -1.198 . . . . 62.78 109.228 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.983 HG22 HG23 ' A' ' 55' ' ' THR . 61.8 p -133.73 150.06 51.49 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.664 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -121.93 121.86 38.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.498 -0.751 . . . . 0.0 109.601 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.401 ' CG ' ' NE2' ' A' ' 51' ' ' HIS . 51.9 tt0 -100.53 134.86 42.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.667 -0.646 . . . . 0.0 110.705 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.7 t -128.93 129.97 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.714 0.768 . . . . 37.94 110.214 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.406 ' OD1' ' CD2' ' A' ' 51' ' ' HIS . 58.9 m-20 -125.58 126.87 45.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.86 -0.525 . . . . 0.0 109.808 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.03 146.27 15.49 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.51 -1.436 . . . . 31.82 109.51 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -71.84 154.26 41.38 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.607 -0.937 . . . . 0.0 110.196 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 50.05 -170.63 0.17 Allowed Glycine 0 N--CA 1.497 2.762 0 O-C-N 121.373 -0.829 . . . . 22.62 111.268 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.761 HG13 HD22 ' A' ' 47' ' ' LEU . 13.3 m -129.92 128.0 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.89 -0.77 . . . . 17.51 109.155 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.639 HG11 ' CE2' ' A' ' 84' ' ' TYR . 11.5 m 41.49 33.48 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 CA-C-O 121.649 0.738 . . . . 20.55 111.397 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.59 18.76 61.32 Favored Glycine 0 N--CA 1.498 2.767 0 O-C-N 121.769 -0.582 . . . . 18.29 113.101 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.416 ' O ' HG22 ' A' ' 69' ' ' VAL . 9.8 pt-20 -146.59 150.2 35.02 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 119.386 1.593 . . . . 0.0 112.618 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -116.14 72.85 4.85 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.257 -1.016 . . . . 18.21 108.257 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -55.1 142.49 77.3 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 O-C-N 123.761 1.401 . . . . 17.61 112.331 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.444 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 3.1 t90 -101.87 76.54 1.63 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.559 ' CD1' HG22 ' A' ' 37' ' ' ILE . 10.4 mt -61.84 117.87 6.45 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.612 -0.68 . . . . 20.57 111.921 -178.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -87.83 159.04 49.8 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -54.0 129.07 32.45 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 O-C-N 123.579 1.305 . . . . 27.04 111.119 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.62 -18.03 49.0 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.929 -0.868 . . . . 24.74 110.929 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -87.33 165.07 15.89 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.005 -1.291 . . . . 29.38 110.458 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.22 148.69 33.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.586 -0.696 . . . . 0.0 110.289 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.506 ' HD2' HD12 ' A' ' 37' ' ' ILE . 89.4 t80 -117.71 143.47 46.17 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.085 -0.709 . . . . 18.56 109.085 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -146.99 140.89 25.89 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.2 -0.938 . . . . 0.0 111.314 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.831 ' CZ ' HD12 ' A' ' 35' ' ' ILE . 42.7 p90 -152.8 162.3 41.45 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.539 -0.725 . . . . 26.65 109.653 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 54.2 m -98.61 136.63 38.42 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.439 -0.788 . . . . 28.14 111.248 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.478 ' HG ' ' HH ' ' A' ' 33' ' ' TYR . 15.2 t -125.06 169.11 12.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.639 -0.663 . . . . 33.88 109.774 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -139.85 126.3 3.22 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.769 -1.205 . . . . 31.8 110.487 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.588 HG23 ' HE1' ' A' ' 33' ' ' TYR . 77.9 t -131.28 151.7 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.63 -0.923 . . . . 0.0 109.31 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.18 144.39 40.41 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.582 -0.699 . . . . 0.0 110.862 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.867 HD12 ' CD1' ' A' ' 31' ' ' PHE . 94.6 mt -122.33 148.07 45.49 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.621 -0.674 . . . . 38.68 110.026 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.408 ' O ' ' CE1' ' A' ' 29' ' ' TYR . 38.6 tp10 -79.01 -26.4 43.24 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.39 -0.819 . . . . 0.0 110.757 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.2 p -124.09 172.1 9.26 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.336 -0.853 . . . . 31.63 110.621 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.457 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 50.4 mt-10 -85.42 10.67 12.18 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.607 -0.683 . . . . 0.0 111.63 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 14.4 pt20 -141.39 145.49 35.42 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.125 -0.984 . . . . 0.0 109.811 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.6 155.46 15.24 Favored Glycine 0 N--CA 1.496 2.682 0 C-N-CA 118.871 -1.633 . . . . 28.05 112.219 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -120.47 130.2 54.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 122.125 -0.632 . . . . 0.0 109.374 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.78 ' HG3' HG22 ' A' ' 54' ' ' ILE . 56.1 ttm -126.82 123.77 38.1 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.37 -0.831 . . . . 0.0 111.533 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.61 ' CD ' ' HB2' ' A' ' 117' ' ' ALA . 40.7 mt-30 -123.1 148.93 45.13 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.67 175.52 41.33 Favored Glycine 0 N--CA 1.499 2.842 0 C-N-CA 118.738 -1.696 . . . . 29.62 111.05 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.4 ' NE2' ' HB3' ' A' ' 51' ' ' HIS . 11.7 p-80 -140.04 157.79 45.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.828 -0.807 . . . . 0.0 110.675 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.606 ' CE2' HD11 ' A' ' 115' ' ' ILE . 6.0 m-85 -114.62 130.01 56.74 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.673 -0.642 . . . . 27.05 109.787 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.766 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 11.2 t70 -82.02 121.81 27.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 108.928 178.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.434 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 2.0 ttm -121.93 161.92 21.98 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.204 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.5 m -141.65 130.34 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.639 -0.663 . . . . 23.28 110.486 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.479 ' HB3' ' HB ' ' A' ' 109' ' ' THR . . . -72.14 166.73 21.73 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.51 -0.744 . . . . 0.0 109.609 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -66.92 -29.36 69.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.533 -0.729 . . . . 0.0 110.284 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -77.36 -4.29 44.43 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.426 -0.796 . . . . 0.0 111.359 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.27 -9.7 54.02 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.087 -1.054 . . . . 30.43 110.519 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.683 HG21 ' CE2' ' A' ' 7' ' ' TYR . 57.6 m -57.02 133.61 55.09 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.045 -1.268 . . . . 0.0 110.093 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -102.32 139.44 37.93 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -0.866 . . . . 0.0 110.668 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.434 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 38.9 p90 -165.26 144.05 6.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.705 -0.622 . . . . 28.03 109.886 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.8 pt -101.85 158.89 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.636 -0.665 . . . . 0.0 110.874 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.01 95.12 49.1 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -60.48 144.73 99.54 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 O-C-N 123.958 1.504 . . . . 33.31 112.24 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.606 HD11 ' CE2' ' A' ' 101' ' ' TYR . 71.7 mt -108.65 121.55 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.698 -0.852 . . . . 30.59 108.698 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.61 167.05 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.258 0.552 . . . . 30.78 111.578 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.61 ' HB2' ' CD ' ' A' ' 98' ' ' GLN . . . -95.03 118.92 32.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.65 -0.656 . . . . 0.0 110.759 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.45 ' CE1' HD11 ' A' ' 120' ' ' LEU . 38.9 p90 -112.59 160.34 17.95 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.343 -0.984 . . . . 30.66 108.343 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.634 ' C ' HD12 ' A' ' 120' ' ' LEU . 59.1 t -116.86 152.98 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.169 -0.957 . . . . 0.0 110.753 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.747 HD22 HD11 ' A' ' 90' ' ' LEU . 7.3 mp -114.16 131.26 56.5 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.098 -0.704 . . . . 39.15 109.098 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 40.4 p . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.607 -0.683 . . . . 0.0 110.033 -179.831 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.9 0.381 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.439 ' CE2' HG21 ' A' ' 109' ' ' THR . 37.1 m-85 -112.24 104.65 12.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.546 -0.721 . . . . 31.93 110.158 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.478 ' C ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -150.29 131.58 14.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.655 -0.653 . . . . 0.0 109.982 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.746 HG11 ' SD ' ' A' ' 103' ' ' MET . 69.2 t -151.98 114.53 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.519 -0.738 . . . . 0.0 109.522 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -107.58 129.88 54.94 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.636 0.731 . . . . 0.0 109.954 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.535 HG11 ' HE2' ' A' ' 101' ' ' TYR . 57.3 t -117.35 139.69 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 109.562 -0.533 . . . . 28.21 109.562 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -120.49 137.19 54.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.409 -0.807 . . . . 0.0 110.017 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.763 HG22 HD13 ' A' ' 35' ' ' ILE . 60.7 t -127.46 135.99 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.304 0.573 . . . . 27.95 110.056 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.2 m -125.0 104.03 30.07 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.77 -0.581 . . . . 0.0 110.392 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -84.16 164.31 13.21 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 O-C-N 123.927 1.488 . . . . 33.0 110.907 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -156.62 131.86 9.22 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.592 0.711 . . . . 54.1 109.723 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 19' ' ' ALA . 69.8 t80 -60.1 138.99 57.77 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.279 0.562 . . . . 0.0 111.146 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.444 ' HA ' HD12 ' A' ' 18' ' ' LEU . 8.8 tp -116.01 78.05 1.15 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 122.075 0.941 . . . . 0.0 110.476 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.572 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -71.82 -35.45 69.93 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.119 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -68.01 -24.05 65.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.358 -0.839 . . . . 0.0 110.895 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -121.77 41.66 3.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.365 -0.835 . . . . 52.37 110.416 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.679 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 21.7 t -163.69 150.98 12.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.506 -0.747 . . . . 55.19 110.789 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 23' ' ' THR . 8.2 t -122.49 94.52 47.65 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.593 -0.692 . . . . 0.0 109.246 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.469 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.8 Cg_endo -66.17 -22.91 53.39 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.773 1.407 . . . . 51.57 111.466 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.59 -23.95 67.43 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.341 -0.849 . . . . 0.0 110.819 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -105.96 23.13 14.48 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.357 -0.84 . . . . 0.0 110.705 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.33 29.44 73.15 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.51 ' HB3' HG23 ' A' ' 23' ' ' THR . 54.9 ttt85 -121.5 93.05 3.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.634 -0.921 . . . . 0.0 110.13 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.469 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 56.6 m-85 -104.53 133.19 49.81 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.035 -0.728 . . . . 46.07 109.035 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.679 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -116.0 118.87 34.11 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.938 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -114.05 134.25 54.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.629 -0.669 . . . . 38.88 109.72 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.91 132.08 55.47 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.228 -0.92 . . . . 34.06 108.563 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.586 ' HE1' HG23 ' A' ' 88' ' ' VAL . 22.9 p90 -129.06 144.56 51.24 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.175 -1.01 . . . . 29.03 111.476 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.2 m -104.4 139.95 38.62 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.717 -0.614 . . . . 0.0 109.788 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.763 HD13 HG22 ' A' ' 13' ' ' VAL . 43.7 mm -105.55 132.29 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.735 0.779 . . . . 0.0 111.535 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -123.49 98.02 5.66 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.482 0.658 . . . . 40.24 109.722 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.776 HG22 HD22 ' A' ' 76' ' ' LEU . 78.8 mt -91.18 117.27 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.762 -0.586 . . . . 20.73 110.458 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -117.99 135.56 54.07 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.512 -0.742 . . . . 0.0 109.453 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.606 ' HB2' HD23 ' A' ' 76' ' ' LEU . 42.7 t-20 -92.67 117.76 30.33 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.721 -0.612 . . . . 21.34 110.867 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.16 9.34 17.14 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.435 -0.79 . . . . 0.0 110.456 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.9 173.71 49.13 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.348 -1.501 . . . . 29.1 109.348 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.38 -31.01 21.71 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.583 -0.951 . . . . 0.0 110.216 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.512 HG13 ' HD2' ' A' ' 44' ' ' PRO . 87.2 t -106.71 140.6 21.51 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.853 -0.529 . . . . 0.0 110.076 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.512 ' HD2' HG13 ' A' ' 43' ' ' VAL . 40.3 Cg_endo -53.52 148.38 34.82 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 O-C-N 123.752 1.396 . . . . 21.95 111.673 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.499 ' HB1' ' HZ ' ' A' ' 111' ' ' PHE . . . -138.29 151.12 47.3 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.68 0.752 . . . . 20.91 111.377 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.429 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 45.5 ttp180 -126.06 155.31 41.75 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.851 HD22 HG13 ' A' ' 69' ' ' VAL . 7.0 tt -99.29 117.78 34.5 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.554 -0.716 . . . . 0.0 109.711 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.558 HG23 HG22 ' A' ' 104' ' ' VAL . 62.3 t -100.48 -29.4 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.547 -0.72 . . . . 0.0 111.015 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 102' ' ' ASP . . . -142.27 164.76 29.27 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 118.981 -1.088 . . . . 0.0 112.42 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -142.72 140.54 31.53 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.425 0.631 . . . . 29.05 110.223 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -142.92 114.06 7.76 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.315 0.578 . . . . 27.97 109.759 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.6 ' CH2' HD13 ' A' ' 115' ' ' ILE . 86.6 m95 -100.38 133.4 44.85 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.676 -0.64 . . . . 25.25 110.971 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -115.51 77.14 1.05 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.589 -0.694 . . . . 0.0 109.139 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.811 HG22 ' CG ' ' A' ' 97' ' ' MET . 17.1 pt -82.85 127.99 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.468 -0.77 . . . . 36.11 111.881 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.5 m -120.79 130.09 53.85 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.329 -0.989 . . . . 33.98 108.329 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -89.06 169.98 11.04 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.701 0.762 . . . . 45.04 111.553 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.06 -5.74 8.37 Favored Glycine 0 N--CA 1.495 2.588 0 O-C-N 121.88 -0.513 . . . . 39.47 112.246 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -101.54 6.58 42.3 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 119.417 1.608 . . . . 0.0 110.516 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.75 -31.13 6.74 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -62.99 141.95 58.56 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.316 -1.108 . . . . 62.78 110.019 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.1 t -135.31 153.2 51.95 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.574 -0.704 . . . . 0.0 110.653 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -121.97 124.36 43.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.535 -0.728 . . . . 0.0 110.184 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -102.27 134.79 44.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.674 -0.641 . . . . 0.0 110.593 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.2 t -128.49 131.57 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.587 -0.696 . . . . 37.94 110.086 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -125.59 126.72 45.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.813 -0.554 . . . . 0.0 110.137 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.12 148.84 20.71 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.463 -1.455 . . . . 31.82 109.463 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -75.27 154.7 37.31 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.528 -0.984 . . . . 0.0 110.505 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.09 -170.38 0.1 Allowed Glycine 0 N--CA 1.499 2.896 0 O-C-N 121.46 -0.775 . . . . 22.62 111.454 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.851 HG13 HD22 ' A' ' 47' ' ' LEU . 15.5 m -130.85 128.88 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.862 -0.787 . . . . 17.51 109.331 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 69' ' ' VAL . 10.9 m 41.14 33.77 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 CA-C-O 121.485 0.66 . . . . 20.55 111.844 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.93 17.45 67.52 Favored Glycine 0 N--CA 1.498 2.799 0 O-C-N 121.456 -0.777 . . . . 18.29 112.957 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 69' ' ' VAL . 15.4 pt-20 -145.23 150.45 36.71 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-N 119.275 1.537 . . . . 0.0 111.856 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -115.37 75.57 4.68 Favored Pre-proline 0 N--CA 1.492 1.637 0 N-CA-C 108.932 -0.766 . . . . 18.21 108.932 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -57.49 138.07 84.42 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 O-C-N 123.885 1.466 . . . . 17.61 112.043 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.429 ' CD1' ' HB2' ' A' ' 46' ' ' ARG . 4.3 t90 -100.82 75.89 1.74 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.776 HD22 HG22 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -58.95 116.56 3.87 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.545 -0.722 . . . . 20.57 111.239 -178.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.427 ' HG2' ' CZ3' ' A' ' 75' ' ' TRP . 4.5 mtt180 -86.83 159.25 52.3 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -54.39 125.87 20.36 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 O-C-N 123.585 1.308 . . . . 27.04 110.75 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.51 -18.21 43.8 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.732 -0.947 . . . . 24.74 110.732 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -89.24 165.64 14.3 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.996 -1.297 . . . . 29.38 110.243 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 37' ' ' ILE . . . -148.27 151.79 36.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.494 -0.753 . . . . 0.0 110.5 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.494 ' N ' HD11 ' A' ' 76' ' ' LEU . 65.3 t80 -118.17 147.53 43.26 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.479 -0.763 . . . . 18.56 109.042 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -144.42 140.73 29.17 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.192 -0.943 . . . . 0.0 111.082 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.443 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 47.2 p90 -150.16 160.0 44.0 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.653 -0.654 . . . . 26.65 109.671 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 62.8 m -100.37 136.54 40.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.464 -0.772 . . . . 28.14 110.651 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 29.2 t -124.04 167.9 13.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.578 -0.701 . . . . 33.88 110.033 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.15 122.46 2.09 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.876 -1.154 . . . . 31.8 110.274 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.586 HG23 ' HE1' ' A' ' 33' ' ' TYR . 80.3 t -129.72 148.19 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.575 -0.956 . . . . 0.0 109.352 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 30' ' ' ALA . 87.0 mt -107.97 144.49 35.19 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.522 -0.736 . . . . 0.0 110.408 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.2 tp -121.57 144.07 48.94 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.581 -0.699 . . . . 38.68 109.787 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -105.15 -2.19 24.55 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.329 -0.857 . . . . 0.0 111.332 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.584 HG22 ' HG2' ' A' ' 94' ' ' GLN . 29.6 m -109.29 -35.96 6.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.068 -1.02 . . . . 31.63 110.931 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.51 ' CB ' ' O ' ' A' ' 92' ' ' THR . 33.3 tt0 87.72 -14.07 0.44 Allowed 'General case' 0 N--CA 1.524 3.266 0 C-N-CA 123.196 0.598 . . . . 0.0 111.059 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.584 ' HG2' HG22 ' A' ' 92' ' ' THR . 14.3 pt20 -139.97 146.41 39.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.119 -0.988 . . . . 0.0 109.832 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 160.79 179.85 35.81 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 118.421 -1.847 . . . . 28.05 112.643 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -121.66 130.79 53.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 122.237 -0.567 . . . . 0.0 109.668 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.811 ' CG ' HG22 ' A' ' 54' ' ' ILE . 0.5 OUTLIER -126.58 124.61 40.36 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.314 -0.866 . . . . 0.0 111.543 -178.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.803 ' HG2' ' HB2' ' A' ' 117' ' ' ALA . 88.7 mt-30 -118.05 151.4 37.59 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.434 ' HA3' ' CE3' ' A' ' 52' ' ' TRP . . . -156.02 167.58 33.31 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 118.873 -1.632 . . . . 29.62 110.902 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -137.75 156.87 47.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.73 -0.865 . . . . 0.0 109.846 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.688 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 12.2 m-85 -117.94 127.21 53.62 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.546 -0.721 . . . . 27.05 110.154 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.581 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 80.4 m-20 -85.64 121.45 28.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.929 -1.107 . . . . 0.0 108.732 177.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.746 ' SD ' HG11 ' A' ' 9' ' ' VAL . 76.8 mtp -123.87 164.06 20.01 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.239 0.543 . . . . 0.0 110.672 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.558 HG22 HG23 ' A' ' 48' ' ' VAL . 9.1 m -142.8 129.21 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.678 -0.639 . . . . 23.28 110.377 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.52 166.85 22.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.431 -0.793 . . . . 0.0 109.229 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -63.65 -28.94 70.26 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.108 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -74.01 -12.96 60.79 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.455 -0.778 . . . . 0.0 111.044 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.06 -6.34 43.09 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.351 -1.099 . . . . 30.43 110.351 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.439 HG21 ' CE2' ' A' ' 7' ' ' TYR . 48.0 m -58.62 137.36 57.56 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.082 -1.246 . . . . 0.0 109.952 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -101.42 139.77 36.63 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.362 -0.836 . . . . 0.0 110.947 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.499 ' HZ ' ' HB1' ' A' ' 45' ' ' ALA . 45.1 p90 -163.02 141.81 8.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.715 -0.616 . . . . 28.03 109.782 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 84.9 mt -101.74 157.92 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.738 -0.601 . . . . 0.0 110.813 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.688 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -120.01 95.82 49.22 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -60.14 146.14 96.9 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 O-C-N 124.013 1.533 . . . . 33.31 112.201 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.638 HD11 ' CZ ' ' A' ' 101' ' ' TYR . 69.0 mt -111.43 121.55 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.731 -0.84 . . . . 30.59 108.731 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -47.58 161.66 0.08 Allowed 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 121.199 0.524 . . . . 30.78 111.641 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.803 ' HB2' ' HG2' ' A' ' 98' ' ' GLN . . . -98.71 122.95 42.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.584 -0.698 . . . . 0.0 110.807 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.61 ' HE1' HD11 ' A' ' 120' ' ' LEU . 46.3 p90 -109.86 162.91 14.03 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.409 -0.959 . . . . 30.66 108.409 178.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.583 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.0 t -114.22 155.34 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.338 -0.851 . . . . 0.0 110.253 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.637 ' N ' HD12 ' A' ' 120' ' ' LEU . 7.9 mp -110.63 131.98 54.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.684 -0.635 . . . . 39.15 109.422 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.8 p . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.807 -0.558 . . . . 0.0 110.126 -179.772 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.463 ' HG3' ' HB3' ' A' ' 42' ' ' ALA . 32.4 ttp180 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 120.833 0.349 . . . . 0.0 110.377 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.475 ' CE2' HG21 ' A' ' 109' ' ' THR . 34.3 m-85 -115.42 109.13 17.42 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.566 -0.709 . . . . 31.93 110.154 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.451 ' C ' HG23 ' A' ' 9' ' ' VAL . 58.8 mtp85 -151.89 135.63 16.3 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.666 0.746 . . . . 0.0 110.347 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.735 HG11 ' CE ' ' A' ' 103' ' ' MET . 62.4 t -150.68 116.08 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.478 0.656 . . . . 0.0 109.415 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -107.07 128.93 54.81 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.551 0.691 . . . . 0.0 109.916 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.5 t -118.93 137.27 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.813 -0.554 . . . . 28.21 109.844 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -123.6 136.61 54.61 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.351 -0.843 . . . . 0.0 109.649 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.827 HG22 HD13 ' A' ' 35' ' ' ILE . 57.9 t -129.05 137.67 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.621 -0.674 . . . . 27.95 110.688 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.3 t -126.34 105.66 24.59 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.77 -0.581 . . . . 0.0 110.44 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.442 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 51.1 Cg_endo -83.8 166.89 13.18 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 O-C-N 123.799 1.42 . . . . 33.0 111.236 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -157.77 130.19 7.24 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.474 0.654 . . . . 54.1 109.732 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.471 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 81.5 t80 -60.54 140.03 57.51 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.788 -0.57 . . . . 0.0 111.407 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.073 HD11 ' HB2' ' A' ' 32' ' ' ALA . 92.6 mt -116.46 81.39 1.61 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.9 0.857 . . . . 0.0 110.462 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.471 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -66.58 -36.08 81.77 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.968 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -69.98 -22.99 63.09 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.366 -0.834 . . . . 0.0 111.127 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -121.33 38.42 4.09 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.218 -0.926 . . . . 52.37 111.258 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.714 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 45.4 p -160.09 146.47 15.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.269 -0.895 . . . . 55.19 111.161 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.2 m -117.7 92.09 40.34 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.517 -0.739 . . . . 0.0 109.043 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.454 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.3 Cg_endo -66.91 -25.36 45.09 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 O-C-N 123.925 1.487 . . . . 51.57 111.374 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -66.35 -23.93 66.43 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.552 -0.717 . . . . 0.0 110.846 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -106.84 24.51 12.63 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.334 -0.854 . . . . 0.0 110.581 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.5 30.57 73.17 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -120.02 92.37 3.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.602 -0.94 . . . . 0.0 110.111 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.454 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 81.2 m-85 -105.06 131.21 52.87 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.47 -0.769 . . . . 46.07 109.296 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.714 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -118.32 120.76 38.59 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.406 -0.809 . . . . 0.0 111.34 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.811 ' CD1' HD12 ' A' ' 90' ' ' LEU . 67.2 m-85 -116.44 134.6 54.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.459 -0.776 . . . . 38.88 109.819 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 1.073 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -110.92 131.42 55.06 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.379 -0.971 . . . . 34.06 108.379 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.619 ' HE1' HG23 ' A' ' 88' ' ' VAL . 23.9 p90 -127.58 143.69 51.15 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.112 -1.035 . . . . 29.03 111.559 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.2 m -103.25 139.24 38.97 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.827 HD13 HG22 ' A' ' 13' ' ' VAL . 40.6 mm -106.66 133.75 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.626 0.727 . . . . 0.0 111.488 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -123.25 98.78 6.03 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.422 0.63 . . . . 40.24 109.751 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.792 HG22 HD22 ' A' ' 76' ' ' LEU . 81.3 mt -90.33 116.11 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.653 -0.654 . . . . 20.73 110.408 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -117.91 134.76 54.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.517 -0.739 . . . . 0.0 109.53 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.569 ' HB2' HD23 ' A' ' 76' ' ' LEU . 22.3 t-20 -92.82 117.64 30.23 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 120.234 -0.586 . . . . 21.34 110.503 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.1 11.06 17.53 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.404 -0.81 . . . . 0.0 110.482 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.27 171.62 48.25 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.907 -1.677 . . . . 29.1 108.907 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.463 ' HB3' ' HG3' ' A' ' 6' ' ' ARG . . . -84.53 -31.89 24.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.442 -1.034 . . . . 0.0 110.09 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.51 HG13 ' HD2' ' A' ' 44' ' ' PRO . 87.1 t -103.15 139.67 20.33 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.813 -0.555 . . . . 0.0 109.873 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.51 ' HD2' HG13 ' A' ' 43' ' ' VAL . 40.1 Cg_endo -53.21 145.09 45.32 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 O-C-N 123.891 1.469 . . . . 21.95 111.748 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.02 151.8 45.74 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.674 0.75 . . . . 20.91 111.112 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.439 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 2.1 ptt85 -127.36 158.68 36.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.768 -0.583 . . . . 0.0 109.596 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.908 HD22 HG13 ' A' ' 69' ' ' VAL . 6.4 tt -96.68 118.06 32.34 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.486 -0.759 . . . . 0.0 109.5 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.1 p -101.2 -24.41 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.589 -0.695 . . . . 0.0 111.071 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.794 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -142.3 163.88 31.65 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.213 -0.929 . . . . 0.0 111.901 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.5 ptt85 -138.16 137.65 37.85 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.437 0.636 . . . . 29.05 110.201 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.403 ' CD2' ' OD1' ' A' ' 65' ' ' ASP . 20.4 t-160 -142.11 111.29 6.41 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.417 0.627 . . . . 27.97 109.852 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.415 ' CH2' HG21 ' A' ' 115' ' ' ILE . 66.2 m95 -103.35 133.8 47.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.682 -0.637 . . . . 25.25 111.396 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -115.77 80.76 1.49 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.892 HG22 ' HG3' ' A' ' 97' ' ' MET . 17.2 pt -86.0 129.14 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.49 -0.756 . . . . 36.11 111.755 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.812 HG23 HG22 ' A' ' 61' ' ' THR . 86.6 m -120.04 129.96 54.48 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.362 -0.977 . . . . 33.98 108.362 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -91.15 169.99 10.39 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.582 0.706 . . . . 45.04 111.309 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.12 -6.72 14.24 Favored Glycine 0 N--CA 1.495 2.633 0 O-C-N 121.848 -0.533 . . . . 39.47 112.066 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -101.71 6.84 42.04 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 119.357 1.579 . . . . 0.0 110.771 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 61' ' ' THR . . . 92.75 -33.11 5.18 Favored Glycine 0 N--CA 1.496 2.644 0 C-N-CA 120.329 -0.939 . . . . 0.0 110.983 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.29 142.34 54.82 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.146 -1.208 . . . . 62.78 109.835 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.812 HG22 HG23 ' A' ' 55' ' ' THR . 69.3 p -133.49 152.4 51.9 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.599 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.415 ' HB2' HD11 ' A' ' 54' ' ' ILE . 49.3 mt-10 -121.15 121.89 38.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.584 -0.698 . . . . 0.0 109.833 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.403 ' CG ' ' NE2' ' A' ' 51' ' ' HIS . 46.9 tt0 -102.4 135.3 44.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.577 -0.702 . . . . 0.0 110.658 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.2 t -129.52 130.44 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.705 0.764 . . . . 37.94 110.484 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.403 ' OD1' ' CD2' ' A' ' 51' ' ' HIS . 77.9 m-20 -127.41 126.46 42.46 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.06 148.53 20.0 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.806 -1.318 . . . . 31.82 109.806 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -71.09 152.31 43.61 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.447 -1.031 . . . . 0.0 110.22 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 50.52 -172.17 0.14 Allowed Glycine 0 N--CA 1.498 2.812 0 O-C-N 121.403 -0.811 . . . . 22.62 111.345 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.908 HG13 HD22 ' A' ' 47' ' ' LEU . 14.4 m -129.79 128.53 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.87 -0.782 . . . . 17.51 109.631 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 69' ' ' VAL . 10.6 m 41.32 34.62 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 CA-C-O 121.578 0.704 . . . . 20.55 111.733 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.51 17.06 67.12 Favored Glycine 0 N--CA 1.499 2.837 0 O-C-N 121.658 -0.651 . . . . 18.29 112.991 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -145.67 150.36 36.16 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 119.179 1.489 . . . . 0.0 112.118 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -115.75 73.15 4.33 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.85 -0.796 . . . . 18.21 108.85 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -55.87 141.37 85.57 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 O-C-N 123.876 1.461 . . . . 17.61 112.281 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.439 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 2.9 t90 -103.43 77.17 1.48 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.792 HD22 HG22 ' A' ' 37' ' ' ILE . 8.0 tp -61.4 117.68 5.97 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.553 -0.717 . . . . 20.57 111.857 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.4 mtm180 -88.12 159.63 47.68 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -54.69 129.2 33.74 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 O-C-N 123.549 1.289 . . . . 27.04 111.185 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.11 -19.21 40.03 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 111.045 -0.822 . . . . 24.74 111.045 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -89.13 166.42 13.85 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.098 -1.236 . . . . 29.38 110.53 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.543 ' CA ' HD11 ' A' ' 76' ' ' LEU . . . -147.0 149.88 34.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.556 -0.715 . . . . 0.0 110.384 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -117.27 148.16 41.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.471 -0.768 . . . . 18.56 109.221 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -144.37 139.77 28.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.229 -0.919 . . . . 0.0 111.258 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.513 ' CE1' HG21 ' A' ' 35' ' ' ILE . 43.3 p90 -150.6 159.98 44.12 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.549 -0.719 . . . . 26.65 109.667 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.0 m -102.44 136.79 41.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.388 -0.82 . . . . 28.14 110.846 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 21.3 t -125.35 169.47 12.29 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.586 -0.696 . . . . 33.88 110.081 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.16 124.71 2.6 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.834 -1.174 . . . . 31.8 110.433 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.619 HG23 ' HE1' ' A' ' 33' ' ' TYR . 75.6 t -129.46 150.83 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.699 -0.883 . . . . 0.0 109.272 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 48.3 mt -110.35 143.73 40.14 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.526 -0.734 . . . . 0.0 110.729 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.811 HD12 ' CD1' ' A' ' 31' ' ' PHE . 98.1 mt -122.13 146.12 47.52 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.644 -0.66 . . . . 38.68 109.941 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -73.19 -25.96 60.98 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.379 -0.826 . . . . 0.0 110.773 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 94' ' ' GLN . 7.7 t -123.81 173.04 8.42 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.461 -0.774 . . . . 31.63 110.618 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.42 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 37.2 tt0 -85.72 10.28 13.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.665 -0.647 . . . . 0.0 111.576 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.458 ' O ' HG23 ' A' ' 92' ' ' THR . 27.7 pt20 -142.12 150.04 40.61 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.125 -0.984 . . . . 0.0 109.919 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.05 165.52 31.45 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 118.868 -1.634 . . . . 28.05 112.244 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -119.08 129.86 55.3 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 122.173 -0.604 . . . . 0.0 109.444 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.892 ' HG3' HG22 ' A' ' 54' ' ' ILE . 48.4 ttm -125.29 116.44 21.94 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.314 -0.866 . . . . 0.0 111.055 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.501 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 56.7 tt0 -129.5 150.58 50.78 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -162.2 178.51 37.99 Favored Glycine 0 N--CA 1.499 2.889 0 C-N-CA 118.743 -1.694 . . . . 29.62 111.104 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.418 ' CD2' ' HB3' ' A' ' 114' ' ' PRO . 50.9 m80 -134.72 154.0 51.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.73 -0.865 . . . . 0.0 109.972 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.655 ' CD2' HD11 ' A' ' 115' ' ' ILE . 4.4 m-85 -117.9 127.69 54.1 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.599 -0.688 . . . . 27.05 109.718 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.794 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 41.1 t0 -81.26 122.11 27.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.971 -1.08 . . . . 0.0 109.053 178.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.735 ' CE ' HG11 ' A' ' 9' ' ' VAL . 13.1 tpp -121.61 159.82 25.65 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.078 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.403 HG23 ' CG ' ' A' ' 46' ' ' ARG . 11.1 m -140.54 129.06 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.517 -0.74 . . . . 23.28 110.269 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.32 167.34 21.43 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.568 -0.708 . . . . 0.0 109.618 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -64.03 -29.61 70.75 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.95 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -72.39 -12.04 60.95 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.607 -0.683 . . . . 0.0 111.059 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.5 -7.34 50.48 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.415 -1.074 . . . . 30.43 110.415 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.475 HG21 ' CE2' ' A' ' 7' ' ' TYR . 30.4 m -57.55 135.99 56.7 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.098 -1.236 . . . . 0.0 110.038 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -101.74 141.48 34.53 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.412 -0.805 . . . . 0.0 110.985 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 42.7 p90 -169.39 148.78 3.9 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.65 -0.656 . . . . 28.03 109.865 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.2 pt -101.98 157.71 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.597 -0.69 . . . . 0.0 111.252 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -118.92 96.89 50.52 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.418 ' HB3' ' CD2' ' A' ' 100' ' ' HIS . 46.3 Cg_endo -58.1 143.3 96.81 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 O-C-N 123.939 1.494 . . . . 33.31 112.453 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.655 HD11 ' CD2' ' A' ' 101' ' ' TYR . 70.4 mt -107.51 121.89 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.352 -0.981 . . . . 30.59 108.352 178.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.17 144.61 6.9 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.157 0.503 . . . . 30.78 111.441 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.501 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -91.08 119.4 31.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.718 -0.613 . . . . 0.0 110.313 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.573 ' HE1' HD11 ' A' ' 120' ' ' LEU . 34.2 p90 -109.11 168.44 9.37 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.717 -0.845 . . . . 30.66 108.717 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.594 ' C ' HD12 ' A' ' 120' ' ' LEU . 57.9 t -114.21 154.67 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.304 -0.873 . . . . 0.0 110.542 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 120' ' ' LEU . 7.4 mp -112.4 133.64 54.38 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.342 -0.614 . . . . 39.15 109.342 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 95.6 p . . . . . 0 N--CA 1.494 1.754 0 O-C-N 121.681 -0.637 . . . . 0.0 110.046 -179.719 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.424 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 82.7 mtt85 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.024 0.44 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.453 ' CE2' HG21 ' A' ' 109' ' ' THR . 29.2 m-85 -114.82 98.96 7.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.56 -0.713 . . . . 31.93 110.109 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.484 ' C ' HG23 ' A' ' 9' ' ' VAL . 80.2 mtt85 -146.59 137.19 23.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.602 0.715 . . . . 0.0 110.216 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.535 HG11 ' CE ' ' A' ' 103' ' ' MET . 97.6 t -152.94 114.12 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.433 0.635 . . . . 0.0 109.305 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -109.06 130.16 55.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.539 -0.726 . . . . 0.0 109.981 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.48 HG22 ' HA ' ' A' ' 37' ' ' ILE . 60.2 t -118.34 141.55 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.811 -0.556 . . . . 28.21 109.97 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -120.1 137.66 54.01 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.465 -0.772 . . . . 0.0 109.817 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.765 HG22 HD13 ' A' ' 35' ' ' ILE . 61.1 t -128.65 137.4 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.607 -0.683 . . . . 27.95 110.45 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -125.97 106.11 25.67 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.778 -0.576 . . . . 0.0 110.624 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -84.52 165.83 12.22 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 O-C-N 123.923 1.486 . . . . 33.0 111.091 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -158.14 131.09 7.36 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.52 0.676 . . . . 54.1 109.953 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.474 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 79.8 t80 -61.5 139.97 58.15 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.766 -0.584 . . . . 0.0 111.563 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.0 HD11 ' HB2' ' A' ' 32' ' ' ALA . 73.8 mt -116.32 80.81 1.51 Allowed 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.912 0.863 . . . . 0.0 110.349 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.474 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -66.03 -35.88 81.75 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.901 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -69.93 -22.83 63.16 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.375 -0.828 . . . . 0.0 111.107 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -122.23 43.38 2.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.382 -0.824 . . . . 52.37 110.959 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.639 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 51.6 p -164.98 147.42 8.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.299 -0.876 . . . . 55.19 111.043 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.3 m -116.37 91.43 33.16 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.0 Cg_endo -65.09 -24.85 59.04 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 O-C-N 123.877 1.462 . . . . 51.57 111.229 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -67.94 -22.82 65.03 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.381 -0.824 . . . . 0.0 110.834 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -106.51 23.34 14.37 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.265 -0.897 . . . . 0.0 110.615 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.98 29.28 73.44 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -120.41 94.07 4.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.596 -0.943 . . . . 0.0 110.171 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.46 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 77.3 m-85 -105.48 132.18 51.97 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.495 -0.753 . . . . 46.07 109.278 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.639 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -114.72 120.62 40.7 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.093 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.598 ' CG ' HD23 ' A' ' 120' ' ' LEU . 87.7 m-85 -116.01 134.78 54.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.55 -0.718 . . . . 38.88 109.784 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 1.0 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -111.62 132.02 54.86 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.436 -0.95 . . . . 34.06 108.436 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.627 ' HE1' HG23 ' A' ' 88' ' ' VAL . 20.2 p90 -127.72 142.85 51.21 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.083 -1.047 . . . . 29.03 111.262 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.5 p -105.2 140.65 38.03 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.765 HD13 HG22 ' A' ' 13' ' ' VAL . 44.6 mm -105.3 131.8 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.841 0.829 . . . . 0.0 111.604 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -122.46 95.74 4.76 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.183 -0.673 . . . . 40.24 109.183 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.535 HG22 ' CD1' ' A' ' 76' ' ' LEU . 75.4 mt -90.84 117.81 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.792 -0.567 . . . . 20.73 110.657 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.556 ' OE1' ' HB2' ' A' ' 81' ' ' ALA . 71.6 tp60 -117.06 135.72 53.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.543 -0.723 . . . . 0.0 109.398 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -91.46 117.23 29.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.801 -0.562 . . . . 21.34 110.651 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.51 9.29 18.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.536 -0.728 . . . . 0.0 110.579 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.27 -177.08 51.7 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.182 -1.567 . . . . 29.1 109.182 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . . . -100.39 -30.99 11.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.492 -1.005 . . . . 0.0 110.063 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.519 HG13 ' HD2' ' A' ' 44' ' ' PRO . 86.2 t -105.4 140.56 21.27 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.8 -0.563 . . . . 0.0 109.545 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.519 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.2 Cg_endo -51.4 141.89 39.64 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 O-C-N 123.731 1.385 . . . . 21.95 111.9 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.7 151.73 46.12 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.488 0.661 . . . . 20.91 110.937 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -127.57 158.89 36.26 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.827 -0.546 . . . . 0.0 109.844 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.805 HD22 HG13 ' A' ' 69' ' ' VAL . 7.7 tt -97.88 117.12 31.48 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.449 -0.782 . . . . 0.0 109.404 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.439 HG21 HG21 ' A' ' 104' ' ' VAL . 62.1 t -100.69 -27.76 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.666 -0.646 . . . . 0.0 110.569 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.714 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -140.11 162.83 34.3 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.833 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.7 ptt85 -142.41 139.97 31.83 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.44 0.638 . . . . 29.05 110.206 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -142.24 113.67 7.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.72 -0.613 . . . . 27.97 109.699 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.503 ' CH2' HD13 ' A' ' 115' ' ' ILE . 92.4 m95 -101.92 133.5 46.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.74 -0.6 . . . . 25.25 110.792 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -116.33 77.33 1.09 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.633 -0.667 . . . . 0.0 109.338 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.44 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.4 pt -84.17 129.19 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.922 0.868 . . . . 36.11 112.149 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.5 m -121.0 130.99 54.02 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.325 -0.991 . . . . 33.98 108.325 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -88.64 170.59 10.69 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.725 0.774 . . . . 45.04 111.427 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.55 -7.67 8.18 Favored Glycine 0 N--CA 1.494 2.542 0 O-C-N 121.823 -0.548 . . . . 39.47 112.299 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -101.21 6.92 43.21 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 119.411 1.605 . . . . 0.0 110.691 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.77 -28.33 9.47 Favored Glycine 0 N--CA 1.495 2.587 0 O-C-N 121.204 -0.935 . . . . 0.0 110.955 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.76 142.0 58.56 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.256 -1.143 . . . . 62.78 109.779 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.7 t -135.06 153.16 52.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.489 -0.757 . . . . 0.0 110.756 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -121.51 123.33 41.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.535 -0.728 . . . . 0.0 110.076 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -102.36 135.61 43.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.75 -0.594 . . . . 0.0 110.742 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.9 t -128.67 132.9 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.628 -0.67 . . . . 37.94 109.85 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -124.64 127.48 47.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.828 -0.545 . . . . 0.0 110.452 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -153.94 170.32 32.56 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.215 -1.554 . . . . 31.82 109.215 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -114.99 159.98 20.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.374 -1.074 . . . . 0.0 110.141 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.44 96.25 0.01 OUTLIER Glycine 0 N--CA 1.5 2.957 0 O-C-N 121.328 -0.857 . . . . 22.62 111.444 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.805 HG13 HD22 ' A' ' 47' ' ' LEU . 30.4 m -46.32 133.37 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.453 0 O-C-N 121.365 -1.079 . . . . 17.51 111.425 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.0 m 41.45 34.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 CA-C-O 121.587 0.708 . . . . 20.55 111.312 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.62 23.14 54.42 Favored Glycine 0 N--CA 1.495 2.603 0 O-C-N 121.714 -0.616 . . . . 18.29 112.301 178.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.53 ' HG3' HG23 ' A' ' 69' ' ' VAL . 2.2 pt-20 -144.21 151.25 39.22 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 119.125 1.463 . . . . 0.0 112.335 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -117.86 72.19 8.33 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.152 -1.055 . . . . 18.21 108.152 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -54.8 141.79 75.78 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 O-C-N 123.757 1.399 . . . . 17.61 112.385 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -103.75 75.32 1.3 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.535 ' CD1' HG22 ' A' ' 37' ' ' ILE . 15.0 mt -60.43 119.66 8.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.706 -0.621 . . . . 20.57 111.915 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -86.05 158.45 55.72 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -53.48 127.4 25.16 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 O-C-N 123.539 1.284 . . . . 27.04 111.167 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.76 -16.48 56.55 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.74 -0.944 . . . . 24.74 110.74 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -87.25 164.36 16.36 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.089 -1.242 . . . . 29.38 110.427 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.556 ' HB2' ' OE1' ' A' ' 38' ' ' GLN . . . -145.45 149.33 34.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.568 -0.708 . . . . 0.0 110.199 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -119.2 144.63 46.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.499 -0.751 . . . . 18.56 109.212 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 -144.14 140.93 29.67 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.163 -0.96 . . . . 0.0 111.236 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.462 ' CE1' HG21 ' A' ' 35' ' ' ILE . 51.0 p90 -150.8 160.05 44.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.646 -0.659 . . . . 26.65 109.74 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 60.3 m -100.8 136.08 41.23 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.445 -0.785 . . . . 28.14 110.848 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 23.3 t -126.38 168.08 14.65 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.554 -0.716 . . . . 33.88 110.115 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -135.67 129.11 4.88 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.926 -1.13 . . . . 31.8 110.496 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.627 HG23 ' HE1' ' A' ' 33' ' ' TYR . 54.2 t -133.01 148.76 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.592 -0.946 . . . . 0.0 109.248 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 29' ' ' TYR . 15.9 tp -109.81 143.79 39.18 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.552 -0.718 . . . . 0.0 110.542 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.746 HD23 ' O ' ' A' ' 92' ' ' THR . 11.4 tp -121.49 144.26 48.8 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.574 -0.704 . . . . 38.68 109.767 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -75.98 -25.41 55.79 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.25 -0.906 . . . . 0.0 111.096 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.746 ' O ' HD23 ' A' ' 90' ' ' LEU . 5.8 m -124.04 171.97 9.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.332 -0.855 . . . . 31.63 110.512 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.428 ' H ' HG22 ' A' ' 92' ' ' THR . 52.6 tt0 -86.28 11.45 12.13 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.612 -0.68 . . . . 0.0 111.592 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -142.89 142.98 31.86 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.2 -0.937 . . . . 0.0 109.626 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -177.47 152.73 12.29 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 118.751 -1.69 . . . . 28.05 112.198 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -118.05 130.33 56.1 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 90.7 mtp -128.0 124.02 36.18 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.457 -0.777 . . . . 0.0 111.597 -178.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.546 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 62.8 mt-30 -125.49 152.19 45.29 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.89 179.88 38.59 Favored Glycine 0 N--CA 1.5 2.958 0 C-N-CA 118.665 -1.731 . . . . 29.62 111.211 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -134.62 159.07 42.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.843 -0.798 . . . . 0.0 110.031 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.674 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 8.2 m-85 -116.71 127.35 54.31 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.589 -0.694 . . . . 27.05 109.959 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.714 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 40.4 t0 -85.99 118.51 25.51 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.06 -1.025 . . . . 0.0 108.815 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.535 ' CE ' HG11 ' A' ' 9' ' ' VAL . 18.3 tpp -124.73 160.78 27.83 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.294 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.439 HG21 HG21 ' A' ' 48' ' ' VAL . 7.2 m -140.93 131.19 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.614 -0.679 . . . . 23.28 110.328 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.04 166.86 22.28 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.437 -0.789 . . . . 0.0 109.606 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -64.64 -29.45 70.45 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.94 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -73.72 -11.24 60.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.519 -0.738 . . . . 0.0 111.059 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.24 -7.3 47.43 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.411 -1.076 . . . . 30.43 110.411 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.453 HG21 ' CE2' ' A' ' 7' ' ' TYR . 24.3 m -57.68 135.47 56.74 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.026 -1.279 . . . . 0.0 110.056 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -101.14 139.61 36.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.441 -0.787 . . . . 0.0 110.69 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 43.8 p90 -165.78 145.05 6.26 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.75 -0.594 . . . . 28.03 109.902 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 24.9 pt -102.21 158.11 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.716 -0.615 . . . . 0.0 111.16 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.674 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -119.86 97.6 49.59 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -58.15 143.82 96.19 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 O-C-N 123.835 1.439 . . . . 33.31 112.166 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.503 HD13 ' CH2' ' A' ' 52' ' ' TRP . 68.7 mt -108.81 122.52 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-N 115.368 -0.833 . . . . 30.59 108.954 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.61 172.81 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.255 0.55 . . . . 30.78 111.429 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.546 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -100.29 119.93 39.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.583 -0.698 . . . . 0.0 110.753 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 97' ' ' MET . 41.9 p90 -111.99 156.02 22.83 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.244 -1.021 . . . . 30.66 108.244 178.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.672 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.2 t -116.95 153.45 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.177 -0.952 . . . . 0.0 110.886 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.672 HD12 ' C ' ' A' ' 119' ' ' VAL . 7.9 mp -114.52 130.16 56.72 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.141 -0.689 . . . . 39.15 109.141 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.606 -0.684 . . . . 0.0 110.156 -179.802 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.665 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 91.1 mtm-85 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.772 0.32 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.53 ' CZ ' HG21 ' A' ' 109' ' ' THR . 90.9 m-85 -119.18 105.96 11.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.52 -0.738 . . . . 31.93 110.141 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.474 ' C ' HG23 ' A' ' 9' ' ' VAL . 93.8 mtt-85 -149.03 134.82 18.84 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.615 -0.678 . . . . 0.0 110.07 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.818 HG11 ' SD ' ' A' ' 103' ' ' MET . 97.0 t -151.58 116.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-O 121.554 0.692 . . . . 0.0 109.609 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -105.63 131.24 53.25 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.652 0.739 . . . . 0.0 110.385 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.577 HG11 ' HE2' ' A' ' 101' ' ' TYR . 63.4 t -118.75 136.12 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 109.303 -0.628 . . . . 28.21 109.303 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -124.02 137.24 54.62 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.306 -0.871 . . . . 0.0 110.136 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 75.8 t -129.22 136.95 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.679 -0.638 . . . . 27.95 110.523 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.1 m -125.12 105.55 28.72 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.785 -0.572 . . . . 0.0 110.302 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.406 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 49.8 Cg_endo -82.33 164.66 16.87 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.859 1.452 . . . . 33.0 111.255 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -157.47 130.63 7.71 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.667 0.746 . . . . 54.1 109.722 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.509 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 76.9 t80 -63.95 139.87 58.81 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.663 -0.648 . . . . 0.0 111.585 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.981 HD11 ' HB2' ' A' ' 32' ' ' ALA . 96.0 mt -116.04 80.7 1.49 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.947 0.88 . . . . 0.0 110.453 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.509 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -68.46 -35.75 78.01 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.793 178.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -69.54 -24.02 63.67 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.447 -0.783 . . . . 0.0 110.734 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -120.84 43.1 2.86 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.431 -0.793 . . . . 52.37 110.735 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.736 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 32.7 t -164.68 146.67 8.32 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.365 -0.834 . . . . 55.19 110.974 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 23' ' ' THR . 5.1 t -120.38 93.12 48.07 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.552 -0.718 . . . . 0.0 109.146 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.472 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.1 Cg_endo -65.94 -23.09 54.83 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 O-C-N 123.89 1.469 . . . . 51.57 111.573 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -65.61 -23.69 66.88 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.378 -0.826 . . . . 0.0 111.047 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -105.59 23.99 12.93 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.347 -0.845 . . . . 0.0 110.815 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.24 27.82 73.57 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.565 ' HB2' HG23 ' A' ' 23' ' ' THR . 10.5 mtm180 -120.79 94.2 4.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.503 -0.998 . . . . 0.0 110.169 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.472 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 68.2 m-85 -104.45 132.68 50.42 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.601 -0.687 . . . . 46.07 109.313 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.736 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -114.64 120.56 40.58 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.338 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.578 ' CG ' HD23 ' A' ' 120' ' ' LEU . 89.4 m-85 -116.26 134.5 54.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.529 -0.732 . . . . 38.88 109.841 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.981 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -112.16 132.71 54.73 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.442 -0.947 . . . . 34.06 108.442 178.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.605 ' HE1' HG23 ' A' ' 88' ' ' VAL . 20.1 p90 -128.05 143.28 51.07 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.078 -1.049 . . . . 29.03 111.611 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.9 m -106.71 139.69 40.75 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.818 HD12 ' CZ ' ' A' ' 84' ' ' TYR . 87.3 mt -108.8 134.55 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 121.668 0.747 . . . . 0.0 111.671 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.3 mtm105 -124.82 98.65 5.8 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.642 0.734 . . . . 40.24 109.796 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.563 HG22 ' CD1' ' A' ' 76' ' ' LEU . 85.4 mt -94.13 118.26 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.818 -0.551 . . . . 20.73 110.726 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -116.43 138.61 51.22 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.267 -0.896 . . . . 0.0 109.231 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -90.61 117.97 29.69 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.78 -0.575 . . . . 21.34 110.856 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.51 9.92 15.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.477 -0.765 . . . . 0.0 110.603 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.2 -178.97 52.4 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.417 -1.473 . . . . 29.1 109.417 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.665 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . . . -94.69 -33.89 12.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.441 -1.034 . . . . 0.0 110.326 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.516 HG13 ' HD2' ' A' ' 44' ' ' PRO . 87.4 t -103.78 139.6 20.26 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.846 -0.533 . . . . 0.0 109.946 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.516 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.9 Cg_endo -52.35 143.22 44.55 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 O-C-N 123.883 1.465 . . . . 21.95 111.845 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.452 ' HB1' ' HZ ' ' A' ' 111' ' ' PHE . . . -139.88 151.92 46.03 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.498 0.666 . . . . 20.91 110.99 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.438 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 19.6 ptt-85 -128.05 158.96 36.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.824 -0.547 . . . . 0.0 110.017 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.903 HD22 HG13 ' A' ' 69' ' ' VAL . 6.4 tt -97.7 115.28 27.66 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.446 -0.784 . . . . 0.0 109.246 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.444 HG11 HG21 ' A' ' 104' ' ' VAL . 35.1 m -100.54 -26.18 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.632 -0.667 . . . . 0.0 111.175 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.763 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -142.4 163.05 33.9 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.196 -0.94 . . . . 0.0 111.734 -179.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.463 ' HD3' HG12 ' A' ' 69' ' ' VAL . 39.3 ptt85 -145.39 142.26 29.18 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.644 0.735 . . . . 29.05 110.858 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.406 ' HB3' ' NE2' ' A' ' 100' ' ' HIS . 22.1 t-160 -144.89 115.17 7.54 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.324 -0.621 . . . . 27.97 109.324 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -98.05 135.6 39.51 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.558 -0.713 . . . . 25.25 111.747 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -115.48 75.98 0.98 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.427 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.8 pt -86.98 131.3 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.412 -0.805 . . . . 36.11 112.14 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.966 HG23 HG22 ' A' ' 61' ' ' THR . 12.3 m -119.85 132.93 55.72 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.35 -0.982 . . . . 33.98 108.35 178.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -87.19 169.48 12.31 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.638 0.732 . . . . 45.04 111.308 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.32 -8.36 12.4 Favored Glycine 0 N--CA 1.494 2.549 0 O-C-N 121.828 -0.545 . . . . 39.47 112.124 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -101.01 8.15 43.14 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 119.402 1.601 . . . . 0.0 110.859 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.34 -23.07 29.26 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.196 -0.94 . . . . 0.0 110.952 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -60.4 142.16 55.35 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.187 -1.184 . . . . 62.78 109.806 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.966 HG22 HG23 ' A' ' 55' ' ' THR . 74.3 p -126.05 142.0 51.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.407 -0.808 . . . . 0.0 110.669 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -122.87 119.95 32.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.411 -0.806 . . . . 0.0 109.948 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -104.79 134.47 47.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.657 -0.652 . . . . 0.0 110.7 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.9 t -127.93 130.85 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.625 -0.672 . . . . 37.94 109.81 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -123.41 126.6 47.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.84 -0.537 . . . . 0.0 110.299 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -147.84 147.45 18.13 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.223 -1.551 . . . . 31.82 109.223 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -72.59 155.63 39.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.51 -0.994 . . . . 0.0 110.15 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.59 -170.65 0.08 OUTLIER Glycine 0 N--CA 1.498 2.824 0 O-C-N 121.49 -0.756 . . . . 22.62 111.357 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.903 HG13 HD22 ' A' ' 47' ' ' LEU . 13.0 m -129.74 127.96 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.835 -0.803 . . . . 17.51 108.957 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.517 HG11 ' CE2' ' A' ' 84' ' ' TYR . 12.3 m 41.75 34.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 CA-C-O 121.7 0.762 . . . . 20.55 111.448 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.4 18.83 61.53 Favored Glycine 0 N--CA 1.497 2.751 0 O-C-N 121.714 -0.616 . . . . 18.29 113.041 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.425 ' O ' HG22 ' A' ' 69' ' ' VAL . 8.6 pt-20 -147.58 150.67 34.9 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 119.449 1.625 . . . . 0.0 112.675 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -115.24 73.05 3.47 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 108.257 -1.016 . . . . 18.21 108.257 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -55.5 141.49 82.63 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 O-C-N 123.842 1.443 . . . . 17.61 112.426 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.438 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 4.7 t90 -102.39 76.88 1.59 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.563 ' CD1' HG22 ' A' ' 37' ' ' ILE . 9.3 mt -60.89 117.49 5.49 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.636 -0.665 . . . . 20.57 111.783 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -88.39 159.12 47.94 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -54.25 129.58 35.3 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 O-C-N 123.535 1.281 . . . . 27.04 111.134 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.91 -18.9 44.95 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 111.003 -0.839 . . . . 24.74 111.003 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.93 166.62 14.39 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.117 -1.225 . . . . 29.38 110.446 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -144.55 146.16 32.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.672 -0.643 . . . . 0.0 110.415 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.512 ' HD2' HD12 ' A' ' 37' ' ' ILE . 89.5 t80 -114.58 141.24 48.01 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.049 -0.722 . . . . 18.56 109.049 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -147.95 140.98 24.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.298 -0.876 . . . . 0.0 111.101 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.818 ' CZ ' HD12 ' A' ' 35' ' ' ILE . 46.3 p90 -153.33 162.5 41.22 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.621 -0.674 . . . . 26.65 109.775 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.1 m -99.01 135.78 39.92 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.468 -0.77 . . . . 28.14 111.211 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 17.2 t -125.16 166.65 16.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.642 -0.661 . . . . 33.88 109.688 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.26 130.33 5.69 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 119.779 -1.201 . . . . 31.8 110.536 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.605 HG23 ' HE1' ' A' ' 33' ' ' TYR . 61.2 t -132.77 147.01 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.695 -0.885 . . . . 0.0 109.118 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.2 tp -110.27 143.74 40.0 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.559 -0.713 . . . . 0.0 110.33 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.75 HD12 HD22 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -122.4 144.97 48.7 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.491 -0.756 . . . . 38.68 109.936 -179.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -78.24 -26.09 47.17 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.425 -0.797 . . . . 0.0 110.641 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.446 HG22 ' N ' ' A' ' 93' ' ' GLU . 21.5 m -123.41 171.22 9.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.42 -0.8 . . . . 31.63 110.2 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.446 ' N ' HG22 ' A' ' 92' ' ' THR . 56.8 tt0 -86.21 12.54 9.59 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.415 -0.803 . . . . 0.0 111.579 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 97.0 mt-30 -140.99 144.99 35.38 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.044 -1.035 . . . . 0.0 109.698 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.51 158.94 21.66 Favored Glycine 0 N--CA 1.496 2.673 0 C-N-CA 118.766 -1.683 . . . . 28.05 112.321 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -119.66 129.96 54.83 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 122.128 -0.631 . . . . 0.0 109.578 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.478 ' HE2' ' HB3' ' A' ' 97' ' ' MET . 90.0 mtp -125.48 117.42 23.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.275 -0.89 . . . . 0.0 111.075 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.496 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 57.1 tt0 -129.21 150.04 50.76 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.36 -177.83 38.04 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 119.108 -1.52 . . . . 29.62 110.514 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.406 ' NE2' ' HB3' ' A' ' 51' ' ' HIS . 44.5 p-80 -140.26 159.93 41.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.698 -0.883 . . . . 0.0 110.676 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.645 ' CD1' HD11 ' A' ' 47' ' ' LEU . 5.2 m-85 -115.3 128.38 56.07 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.753 -0.592 . . . . 27.05 109.944 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.763 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 42.9 t0 -83.4 122.3 28.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.006 -1.059 . . . . 0.0 108.739 177.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.818 ' SD ' HG11 ' A' ' 9' ' ' VAL . 43.0 mtp -123.51 161.93 23.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.878 -0.513 . . . . 0.0 110.507 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.444 HG21 HG11 ' A' ' 48' ' ' VAL . 6.4 m -140.32 129.47 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.719 -0.613 . . . . 23.28 110.23 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.21 166.53 22.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.507 -0.745 . . . . 0.0 109.649 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -65.86 -29.27 69.7 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.198 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -76.74 -4.89 45.7 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.395 -0.816 . . . . 0.0 111.347 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.33 -9.52 57.61 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.045 -1.074 . . . . 30.43 110.627 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.53 HG21 ' CZ ' ' A' ' 7' ' ' TYR . 23.9 m -57.42 134.57 56.16 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.047 -1.266 . . . . 0.0 110.104 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -101.68 139.61 37.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.37 -0.831 . . . . 0.0 110.724 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 45.2 p90 -164.08 143.75 7.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.664 -0.648 . . . . 28.03 109.856 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 102' ' ' ASP . 50.9 mm -98.69 156.11 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.661 -0.649 . . . . 0.0 110.61 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.53 96.92 48.93 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -59.44 141.53 97.63 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.911 1.479 . . . . 33.31 112.222 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.613 HD11 ' CD2' ' A' ' 101' ' ' TYR . 68.0 mt -107.08 124.05 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.627 -0.879 . . . . 30.59 108.627 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.92 147.52 3.82 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.234 0.54 . . . . 30.78 111.48 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.496 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -89.65 122.33 32.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.597 -0.689 . . . . 0.0 110.179 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.637 ' CE1' HD11 ' A' ' 120' ' ' LEU . 45.0 p90 -109.1 164.69 12.2 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.934 -0.765 . . . . 30.66 108.934 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.634 ' C ' HD12 ' A' ' 120' ' ' LEU . 57.8 t -114.48 155.4 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.333 -0.854 . . . . 0.0 110.28 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.75 HD22 HD12 ' A' ' 90' ' ' LEU . 7.0 mp -114.11 132.17 56.15 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.264 -0.643 . . . . 39.15 109.264 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.687 -0.633 . . . . 0.0 110.104 -179.852 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.42 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 38.7 ttm180 . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 120.906 0.384 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.445 ' CZ ' HG21 ' A' ' 109' ' ' THR . 47.7 m-85 -115.83 107.18 14.71 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.559 -0.713 . . . . 31.93 110.167 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.483 ' C ' HG23 ' A' ' 9' ' ' VAL . 9.8 ttt85 -153.44 135.2 14.52 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.561 0.696 . . . . 0.0 110.413 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.729 HG11 ' SD ' ' A' ' 103' ' ' MET . 97.0 t -152.29 116.08 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-O 121.448 0.642 . . . . 0.0 109.499 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -107.36 130.07 54.83 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.622 0.725 . . . . 0.0 110.049 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.0 t -118.1 139.46 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.848 -0.532 . . . . 28.21 109.817 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -121.81 137.81 54.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.386 -0.822 . . . . 0.0 110.014 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.724 HG22 HD13 ' A' ' 35' ' ' ILE . 58.7 t -128.7 137.11 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.59 -0.694 . . . . 27.95 110.379 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -125.3 106.9 27.54 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.738 -0.601 . . . . 0.0 110.485 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.439 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 51.0 Cg_endo -82.76 165.66 15.54 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 O-C-N 123.816 1.43 . . . . 33.0 111.119 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -158.05 129.59 6.72 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.595 0.712 . . . . 54.1 109.588 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.496 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 78.7 t80 -62.98 139.95 58.82 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.753 -0.592 . . . . 0.0 111.543 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.003 HD11 ' HB2' ' A' ' 32' ' ' ALA . 88.9 mt -115.85 81.2 1.56 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.907 0.861 . . . . 0.0 110.381 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.496 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -68.44 -35.77 78.08 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.893 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -69.94 -23.18 63.16 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.415 -0.803 . . . . 0.0 110.823 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -121.23 38.97 3.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.364 -0.835 . . . . 52.37 110.757 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.738 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 32.9 t -160.01 145.75 15.48 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.335 -0.853 . . . . 55.19 111.117 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.59 HG23 ' HB2' ' A' ' 28' ' ' ARG . 5.0 t -120.02 92.76 47.24 Favored Pre-proline 0 N--CA 1.496 1.848 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.476 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.8 Cg_endo -66.32 -23.0 52.17 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 O-C-N 123.86 1.453 . . . . 51.57 111.718 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -65.28 -23.45 67.04 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.357 -0.839 . . . . 0.0 110.994 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -105.62 24.15 12.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.306 -0.871 . . . . 0.0 110.846 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.99 28.13 73.68 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.59 ' HB2' HG23 ' A' ' 23' ' ' THR . 13.3 mtp180 -120.98 94.0 4.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.642 -0.916 . . . . 0.0 110.23 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.476 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 69.8 m-85 -104.14 133.56 48.87 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.607 -0.683 . . . . 46.07 109.359 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.738 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -115.21 120.19 38.87 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 119.754 -0.779 . . . . 0.0 111.075 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.83 ' CD1' HD12 ' A' ' 90' ' ' LEU . 91.4 m-85 -115.92 135.26 54.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.512 -0.742 . . . . 38.88 109.782 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 1.003 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -112.38 132.24 55.12 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.542 -0.91 . . . . 34.06 108.542 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.621 ' HE1' HG13 ' A' ' 88' ' ' VAL . 18.5 p90 -128.4 143.26 50.97 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.214 -0.995 . . . . 29.03 111.429 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.5 t -105.77 140.57 38.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.724 -0.61 . . . . 0.0 109.494 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.724 HD13 HG22 ' A' ' 13' ' ' VAL . 45.6 mm -105.11 131.84 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.727 0.775 . . . . 0.0 111.63 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -122.91 96.93 5.21 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.532 0.682 . . . . 40.24 109.381 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.513 HG22 ' CD1' ' A' ' 76' ' ' LEU . 79.9 mt -92.48 117.83 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.759 -0.588 . . . . 20.73 110.592 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -116.82 134.16 55.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.496 -0.753 . . . . 0.0 109.248 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -92.79 117.57 30.16 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 120.204 -0.598 . . . . 21.34 110.565 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.35 11.96 16.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.49 -0.756 . . . . 0.0 110.575 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.25 -179.26 52.76 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.086 -1.605 . . . . 29.1 109.086 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . . . -94.99 -32.89 12.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.479 -1.012 . . . . 0.0 110.32 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.526 HG13 ' HD2' ' A' ' 44' ' ' PRO . 85.3 t -104.6 141.2 22.05 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.83 -0.544 . . . . 0.0 109.883 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.526 ' HD2' HG13 ' A' ' 43' ' ' VAL . 40.1 Cg_endo -53.53 143.26 56.82 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 O-C-N 123.809 1.426 . . . . 21.95 111.91 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.408 ' HB1' ' HZ ' ' A' ' 111' ' ' PHE . . . -139.7 151.69 46.09 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.604 0.716 . . . . 20.91 110.861 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.436 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 18.4 ptt180 -127.96 159.76 33.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.751 -0.593 . . . . 0.0 109.723 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.923 HD22 HG13 ' A' ' 69' ' ' VAL . 6.9 tt -98.14 117.28 32.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.432 -0.792 . . . . 0.0 109.699 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.46 HG21 HG21 ' A' ' 104' ' ' VAL . 62.5 t -99.85 -29.45 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.514 -0.741 . . . . 0.0 110.677 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.696 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -141.38 162.66 34.95 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.949 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.6 ptt85 -143.7 141.59 30.58 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.673 0.749 . . . . 29.05 110.323 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -144.51 113.97 7.09 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.405 0.622 . . . . 27.97 109.507 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -98.45 135.2 40.35 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.65 -0.656 . . . . 25.25 111.488 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -115.38 75.85 0.97 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.431 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.3 pt -85.7 130.5 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 121.85 0.833 . . . . 36.11 111.975 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.596 HG23 HG22 ' A' ' 61' ' ' THR . 86.1 m -121.22 132.93 55.11 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.351 -0.981 . . . . 33.98 108.351 178.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -87.32 169.74 12.03 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.717 0.77 . . . . 45.04 111.477 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.29 -7.88 15.93 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 121.819 -0.551 . . . . 39.47 112.06 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -100.57 8.12 43.63 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 119.345 1.573 . . . . 0.0 110.578 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.7 -21.3 36.77 Favored Glycine 0 N--CA 1.493 2.49 0 O-C-N 121.233 -0.917 . . . . 0.0 111.011 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.19 141.03 56.6 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.169 -1.195 . . . . 62.78 109.806 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.596 HG22 HG23 ' A' ' 55' ' ' THR . 82.1 p -125.87 140.09 52.94 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.447 -0.783 . . . . 0.0 110.668 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -123.73 120.0 31.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.41 -0.806 . . . . 0.0 110.014 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -104.85 135.26 46.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.686 -0.634 . . . . 0.0 110.859 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.26 130.62 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.58 -0.7 . . . . 37.94 109.848 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.65 127.57 47.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.817 -0.552 . . . . 0.0 110.42 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.79 150.92 23.06 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.289 -1.524 . . . . 31.82 109.289 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -79.43 156.76 27.75 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.559 -0.965 . . . . 0.0 110.25 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 51.57 -173.49 0.18 Allowed Glycine 0 N--CA 1.497 2.752 0 N-CA-C 111.008 -0.837 . . . . 22.62 111.008 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.923 HG13 HD22 ' A' ' 47' ' ' LEU . 15.2 m -130.1 127.98 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.793 -0.828 . . . . 17.51 109.606 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.6 m 41.12 36.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 CA-C-O 121.514 0.673 . . . . 20.55 111.853 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.13 16.65 68.99 Favored Glycine 0 N--CA 1.499 2.857 0 O-C-N 121.683 -0.636 . . . . 18.29 113.002 177.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.409 ' O ' HG22 ' A' ' 69' ' ' VAL . 9.9 pt-20 -145.64 150.9 37.19 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 119.164 1.482 . . . . 0.0 112.018 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -115.22 75.12 4.18 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.915 -0.772 . . . . 18.21 108.915 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -57.67 140.06 92.28 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 O-C-N 123.861 1.453 . . . . 17.61 112.149 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.436 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 4.1 t90 -103.14 77.57 1.55 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.513 ' CD1' HG22 ' A' ' 37' ' ' ILE . 11.3 mt -60.14 118.31 6.18 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.462 0.649 . . . . 20.57 111.953 -178.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 -85.8 157.19 57.93 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -53.49 128.1 27.99 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 O-C-N 123.561 1.295 . . . . 27.04 111.15 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.66 -17.13 54.39 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.727 -0.949 . . . . 24.74 110.727 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -86.89 165.71 15.71 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.058 -1.26 . . . . 29.38 110.537 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.02 149.1 34.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.66 -0.65 . . . . 0.0 110.041 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.4 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 79.6 t80 -118.9 146.27 45.05 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.47 -0.769 . . . . 18.56 109.179 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -146.05 141.03 27.22 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.213 -0.929 . . . . 0.0 111.13 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.447 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 50.6 p90 -151.09 160.02 44.14 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.59 -0.693 . . . . 26.65 109.837 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.2 m -100.04 135.58 41.25 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.391 -0.818 . . . . 28.14 110.646 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 28.4 t -125.06 167.41 14.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.592 -0.693 . . . . 33.88 110.048 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.87 129.97 5.48 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.841 -1.171 . . . . 31.8 110.481 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.621 HG13 ' HE1' ' A' ' 33' ' ' TYR . 15.6 m -134.75 148.61 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.695 -0.885 . . . . 0.0 109.821 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 89' ' ' LEU . 4.9 mp -112.93 144.28 42.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.57 -0.706 . . . . 0.0 110.569 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.83 HD12 ' CD1' ' A' ' 31' ' ' PHE . 31.8 mt -121.98 146.57 47.02 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.639 -0.663 . . . . 38.68 110.004 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -77.6 -26.16 50.45 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.405 -0.809 . . . . 0.0 110.765 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.5 p -122.95 171.33 9.31 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.47 -0.769 . . . . 31.63 110.522 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -86.13 11.06 12.65 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.636 -0.665 . . . . 0.0 111.549 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 78.1 mt-30 -140.72 146.18 37.42 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.016 -1.053 . . . . 0.0 109.638 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.42 153.21 10.72 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 118.921 -1.609 . . . . 28.05 112.264 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -118.2 129.84 55.73 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 94.3 mtp -126.8 122.45 34.8 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.39 -0.819 . . . . 0.0 111.63 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.491 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 57.2 tt0 -127.34 149.45 50.04 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.86 -177.68 36.85 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 118.931 -1.604 . . . . 29.62 110.844 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -142.81 158.81 43.26 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.795 -0.826 . . . . 0.0 110.626 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.703 ' CD2' HD11 ' A' ' 115' ' ' ILE . 4.5 m-85 -116.68 129.18 55.98 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.656 -0.652 . . . . 27.05 110.076 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.696 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 11.0 t70 -83.06 122.65 28.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.014 -1.054 . . . . 0.0 109.095 177.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.729 ' SD ' HG11 ' A' ' 9' ' ' VAL . 63.3 mtp -123.12 163.01 21.36 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.108 0.48 . . . . 0.0 110.457 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.46 HG21 HG21 ' A' ' 48' ' ' VAL . 7.5 m -142.54 131.55 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.65 -0.656 . . . . 23.28 110.432 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.531 ' HB3' ' HB ' ' A' ' 109' ' ' THR . . . -70.2 165.03 23.02 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.398 -0.814 . . . . 0.0 109.508 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -65.71 -27.21 68.16 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.519 -0.738 . . . . 0.0 110.46 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -79.93 -1.29 38.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.321 -0.862 . . . . 0.0 111.312 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.03 -10.07 56.79 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.962 -1.113 . . . . 30.43 110.581 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 25.6 m -57.46 134.02 55.71 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.086 -1.244 . . . . 0.0 110.059 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -102.64 139.24 38.48 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.311 -0.868 . . . . 0.0 110.782 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 43.1 p90 -162.82 141.68 8.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.759 -0.588 . . . . 28.03 110.002 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.8 pt -98.43 156.8 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.715 -0.615 . . . . 0.0 110.77 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -121.33 97.98 46.95 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -59.31 142.11 98.67 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 O-C-N 123.907 1.477 . . . . 33.31 112.039 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.703 HD11 ' CD2' ' A' ' 101' ' ' TYR . 70.9 mt -107.68 124.13 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.791 -0.818 . . . . 30.59 108.791 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.59 151.18 2.41 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.264 0.554 . . . . 30.78 111.356 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.491 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -98.67 118.19 34.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.675 -0.641 . . . . 0.0 110.159 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.7 ' CE1' HD11 ' A' ' 120' ' ' LEU . 41.6 p90 -107.95 168.94 8.92 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.944 -0.761 . . . . 30.66 108.944 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.605 ' C ' HD12 ' A' ' 120' ' ' LEU . 57.5 t -114.23 154.14 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.251 -0.906 . . . . 0.0 110.509 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.804 HD22 HD11 ' A' ' 90' ' ' LEU . 7.0 mp -113.65 132.4 55.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.676 -0.64 . . . . 39.15 109.357 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 79.8 p . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.636 -0.665 . . . . 0.0 110.1 -179.808 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.457 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 76.9 mtp180 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 120.951 0.405 . . . . 0.0 110.111 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -109.97 100.59 9.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.785 -0.572 . . . . 31.93 109.908 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.467 ' C ' HG23 ' A' ' 9' ' ' VAL . 64.7 mtp85 -149.0 137.21 20.86 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.754 0.788 . . . . 0.0 110.314 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.467 HG23 ' C ' ' A' ' 8' ' ' ARG . 82.2 t -151.31 114.79 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -107.55 130.26 54.89 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.574 0.702 . . . . 0.0 110.109 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.9 t -118.53 138.89 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.883 -0.511 . . . . 28.21 109.639 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -121.24 137.36 54.72 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.477 -0.764 . . . . 0.0 109.85 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.735 HG22 HD13 ' A' ' 35' ' ' ILE . 62.2 t -129.16 136.58 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.555 -0.715 . . . . 27.95 110.502 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.6 t -125.24 104.43 28.98 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.714 -0.616 . . . . 0.0 110.226 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.441 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 50.2 Cg_endo -83.86 165.81 13.41 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 O-C-N 123.815 1.429 . . . . 33.0 111.095 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -158.02 131.5 7.7 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.527 0.679 . . . . 54.1 109.737 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.523 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 78.5 t80 -59.29 138.49 57.6 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.737 -0.602 . . . . 0.0 111.2 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.516 HD23 ' HB3' ' A' ' 21' ' ' GLN . 9.1 tp -115.01 80.72 1.46 Allowed 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 122.014 0.912 . . . . 0.0 110.269 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.523 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -70.07 -35.63 74.35 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.366 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -69.22 -22.6 63.86 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.366 -0.834 . . . . 0.0 111.03 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.516 ' HB3' HD23 ' A' ' 18' ' ' LEU . 34.1 tp60 -121.75 36.87 4.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.283 -0.885 . . . . 52.37 110.596 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.714 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 32.8 t -156.95 146.02 20.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.451 -0.781 . . . . 55.19 111.02 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.602 HG23 ' O ' ' A' ' 23' ' ' THR . 9.2 t -122.03 92.83 48.82 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.475 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.1 Cg_endo -65.98 -22.39 55.46 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 O-C-N 123.711 1.374 . . . . 51.57 111.928 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -64.87 -23.52 67.26 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.258 -0.901 . . . . 0.0 110.879 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.59 23.48 14.17 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.289 -0.882 . . . . 0.0 110.705 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.61 29.94 72.89 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.602 ' HB2' HG23 ' A' ' 23' ' ' THR . 42.2 mmm-85 -120.87 93.59 4.08 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.596 -0.943 . . . . 0.0 110.181 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.475 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 68.4 m-85 -104.58 130.4 52.56 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.571 -0.705 . . . . 46.07 109.126 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.714 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -117.76 120.31 37.57 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.571 -0.851 . . . . 0.0 111.185 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.667 ' CD1' HD12 ' A' ' 90' ' ' LEU . 68.1 m-85 -115.0 137.28 52.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.583 -0.698 . . . . 38.88 109.815 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.78 131.61 55.21 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.293 -1.002 . . . . 34.06 108.293 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.653 ' HE2' HD11 ' A' ' 35' ' ' ILE . 20.6 p90 -128.21 144.08 51.09 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.19 -1.004 . . . . 29.03 111.534 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.5 t -104.39 141.06 37.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.68 -0.638 . . . . 0.0 109.851 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.735 HD13 HG22 ' A' ' 13' ' ' VAL . 45.6 mm -106.35 132.23 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.822 0.82 . . . . 0.0 111.618 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.7 mtp85 -121.47 96.6 5.14 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.418 0.628 . . . . 40.24 109.526 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.619 HG22 ' CD1' ' A' ' 76' ' ' LEU . 78.1 mt -92.53 115.74 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.736 -0.603 . . . . 20.73 110.352 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -117.66 136.49 53.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.563 -0.711 . . . . 0.0 109.472 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -91.47 116.11 28.59 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 120.179 -0.608 . . . . 21.34 110.541 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -112.26 9.38 19.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.441 -0.787 . . . . 0.0 110.683 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.96 -176.15 50.96 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.002 -1.639 . . . . 29.1 109.002 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.457 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . . . -98.75 -30.0 12.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.463 -1.021 . . . . 0.0 110.137 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.517 HG13 ' HD2' ' A' ' 44' ' ' PRO . 84.2 t -105.57 139.83 20.57 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.78 -0.575 . . . . 0.0 109.714 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.517 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.9 Cg_endo -51.18 144.84 28.22 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 O-C-N 123.684 1.36 . . . . 21.95 111.685 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.5 150.08 49.68 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.736 0.779 . . . . 20.91 111.212 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.499 ' NH2' HG22 ' A' ' 48' ' ' VAL . 35.5 ttt-85 -125.81 153.08 44.58 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.546 HD23 ' C ' ' A' ' 47' ' ' LEU . 7.5 tt -97.57 117.16 31.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.494 -0.754 . . . . 0.0 109.997 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.499 HG22 ' NH2' ' A' ' 46' ' ' ARG . 64.7 t -100.85 -29.45 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.613 -0.68 . . . . 0.0 110.436 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.675 ' HB3' ' HB2' ' A' ' 102' ' ' ASP . . . -141.2 163.7 32.24 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.13 -1.028 . . . . 0.0 112.007 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.6 ptt85 -143.55 141.19 30.59 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.337 0.589 . . . . 29.05 110.16 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -144.0 114.14 7.38 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.396 0.617 . . . . 27.97 110.15 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.415 ' CH2' HG21 ' A' ' 115' ' ' ILE . 58.0 m95 -102.05 135.25 43.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.658 -0.651 . . . . 25.25 111.241 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -116.24 81.05 1.55 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.912 HG22 ' HG3' ' A' ' 97' ' ' MET . 17.3 pt -86.04 129.99 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 121.671 0.748 . . . . 36.11 111.748 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.693 HG23 HG22 ' A' ' 61' ' ' THR . 94.3 m -119.32 130.16 55.24 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.397 -0.964 . . . . 33.98 108.397 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -89.18 169.9 11.07 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.666 0.746 . . . . 45.04 111.26 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.25 -7.9 15.8 Favored Glycine 0 N--CA 1.495 2.579 0 O-C-N 121.791 -0.568 . . . . 39.47 112.071 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -102.15 6.95 41.06 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 119.336 1.568 . . . . 0.0 110.805 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.418 ' O ' HG23 ' A' ' 61' ' ' THR . . . 93.1 -27.94 10.5 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 121.159 -0.963 . . . . 0.0 110.933 178.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -61.6 141.81 57.54 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.19 -1.182 . . . . 62.78 109.707 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.693 HG22 HG23 ' A' ' 55' ' ' THR . 57.9 p -132.36 150.24 52.2 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.429 -0.794 . . . . 0.0 110.69 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -122.26 122.26 38.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.562 -0.711 . . . . 0.0 109.792 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -102.63 136.04 43.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.613 -0.679 . . . . 0.0 110.83 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.2 t -128.51 131.85 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.504 0.669 . . . . 37.94 109.925 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -125.02 127.48 47.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.79 -0.569 . . . . 0.0 110.3 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -153.91 173.5 32.54 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.101 -1.599 . . . . 31.82 109.101 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -115.78 159.64 21.18 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.362 -1.081 . . . . 0.0 110.047 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.66 95.35 0.01 OUTLIER Glycine 0 N--CA 1.5 2.94 0 O-C-N 121.423 -0.798 . . . . 22.62 111.355 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.493 HG13 HD22 ' A' ' 47' ' ' LEU . 16.1 m -46.36 134.02 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.505 0 O-C-N 121.399 -1.059 . . . . 17.51 111.553 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 69' ' ' VAL . 12.4 m 41.55 37.13 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-O 121.634 0.73 . . . . 20.55 111.344 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.7 20.02 62.49 Favored Glycine 0 N--CA 1.495 2.598 0 O-C-N 121.752 -0.592 . . . . 18.29 112.428 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.401 ' OE2' ' CZ ' ' A' ' 82' ' ' PHE . 5.2 pt-20 -146.73 151.81 37.8 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 119.191 1.496 . . . . 0.0 112.57 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -119.06 72.24 11.91 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 108.336 -0.987 . . . . 18.21 108.336 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -54.31 141.07 72.26 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 O-C-N 123.83 1.437 . . . . 17.61 112.517 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -99.14 74.4 1.96 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.619 ' CD1' HG22 ' A' ' 37' ' ' ILE . 12.0 mt -60.02 120.2 9.24 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.427 0.632 . . . . 20.57 112.045 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -85.42 157.8 58.29 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -53.81 127.03 23.89 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 O-C-N 123.584 1.307 . . . . 27.04 110.882 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.89 -15.69 57.02 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.735 -0.946 . . . . 24.74 110.735 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -87.02 164.27 16.57 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.086 -1.244 . . . . 29.38 110.435 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.83 151.33 36.93 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.45 -0.781 . . . . 0.0 110.333 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.401 ' CZ ' ' OE2' ' A' ' 72' ' ' GLU . 72.4 t80 -119.2 149.3 41.98 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.868 -0.79 . . . . 18.56 108.868 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -139.34 137.39 35.73 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.104 -0.997 . . . . 0.0 111.013 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.514 ' CE1' HG21 ' A' ' 35' ' ' ILE . 51.7 p90 -151.57 159.74 43.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.664 -0.648 . . . . 26.65 109.793 178.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.9 m -104.47 138.59 40.63 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.394 -0.816 . . . . 28.14 111.107 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 28.3 t -124.79 169.92 11.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.577 -0.702 . . . . 33.88 109.896 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.43 123.22 2.12 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.798 -1.191 . . . . 31.8 110.544 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.625 HG23 ' HE1' ' A' ' 33' ' ' TYR . 74.9 t -129.63 148.86 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.61 -0.935 . . . . 0.0 109.272 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.584 HD12 ' HA ' ' A' ' 30' ' ' ALA . 13.1 tp -109.74 143.82 39.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.487 -0.758 . . . . 0.0 110.496 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.667 HD12 ' CD1' ' A' ' 31' ' ' PHE . 84.8 mt -121.62 145.25 48.18 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.516 -0.74 . . . . 38.68 109.963 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.402 ' O ' ' CE1' ' A' ' 29' ' ' TYR . 29.9 tp10 -73.88 -26.06 60.35 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.407 -0.808 . . . . 0.0 110.782 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.1 p -123.34 171.74 9.19 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.39 -0.818 . . . . 31.63 110.579 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.41 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 54.9 tt0 -87.02 12.38 11.45 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.679 -0.638 . . . . 0.0 111.552 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -142.27 148.64 38.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.099 -1.0 . . . . 0.0 109.912 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.26 162.61 26.86 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 118.908 -1.615 . . . . 28.05 112.137 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -119.11 129.46 55.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.083 -0.657 . . . . 0.0 109.335 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.912 ' HG3' HG22 ' A' ' 54' ' ' ILE . 54.0 ttm -125.02 117.74 24.66 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.279 -0.888 . . . . 0.0 111.205 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.494 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 57.1 tt0 -129.5 150.34 50.89 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.08 -179.44 38.32 Favored Glycine 0 N--CA 1.499 2.886 0 C-N-CA 118.787 -1.673 . . . . 29.62 111.017 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.403 ' HB3' ' CG2' ' A' ' 112' ' ' ILE . 63.3 m80 -137.12 155.36 49.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.808 -0.819 . . . . 0.0 110.118 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.663 ' CD2' HD11 ' A' ' 115' ' ' ILE . 4.4 m-85 -117.65 127.06 53.58 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.61 -0.681 . . . . 27.05 109.668 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.675 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 71.4 m-20 -81.88 122.11 27.32 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.935 -1.103 . . . . 0.0 109.335 178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.443 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 91.8 mmm -120.53 162.84 18.91 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.189 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.458 HG22 HG23 ' A' ' 48' ' ' VAL . 7.9 m -142.51 128.76 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.672 -0.643 . . . . 23.28 110.503 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.38 167.97 20.16 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.557 -0.714 . . . . 0.0 109.469 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -62.15 -28.14 69.45 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.522 -0.736 . . . . 0.0 110.4 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -72.29 -11.29 60.64 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 111.111 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.45 -6.49 59.29 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.099 -1.048 . . . . 30.43 110.667 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.5 m -59.93 139.5 57.35 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.108 -1.23 . . . . 0.0 109.963 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -99.56 140.48 33.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.463 -0.773 . . . . 0.0 110.892 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.443 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 33.5 p90 -163.64 146.33 9.8 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.376 -0.601 . . . . 28.03 109.376 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.403 ' CG2' ' HB3' ' A' ' 100' ' ' HIS . 79.9 mt -100.78 155.43 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.61 0.719 . . . . 0.0 111.104 -178.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.92 98.12 47.8 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -59.14 144.17 99.48 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 O-C-N 123.869 1.457 . . . . 33.31 112.554 -178.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.663 HD11 ' CD2' ' A' ' 101' ' ' TYR . 66.2 mt -108.78 122.63 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.451 -0.944 . . . . 30.59 108.451 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.92 144.97 5.98 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.199 0.523 . . . . 30.78 111.615 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.494 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -92.65 119.43 32.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.795 -0.565 . . . . 0.0 110.394 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.705 ' CE1' HD11 ' A' ' 120' ' ' LEU . 43.2 p90 -108.92 169.32 8.75 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.815 -0.809 . . . . 30.66 108.815 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.628 ' C ' HD12 ' A' ' 120' ' ' LEU . 7.8 p -113.35 154.66 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.29 -0.881 . . . . 0.0 110.54 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.705 HD11 ' CE1' ' A' ' 118' ' ' PHE . 7.5 mp -113.25 131.91 55.73 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.426 -0.583 . . . . 39.15 109.426 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 96.6 p . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.654 -0.654 . . . . 0.0 110.092 -179.877 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.1 mtt-85 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 120.807 0.337 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -116.14 108.6 16.37 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.503 -0.748 . . . . 31.93 110.313 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.473 ' C ' HG23 ' A' ' 9' ' ' VAL . 74.8 mtt85 -152.17 134.56 15.22 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.574 0.702 . . . . 0.0 110.192 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.473 HG23 ' C ' ' A' ' 8' ' ' ARG . 80.0 t -151.42 113.84 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -107.85 129.04 55.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.636 -0.665 . . . . 0.0 109.767 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.551 HG11 ' HE2' ' A' ' 101' ' ' TYR . 59.5 t -119.41 139.75 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.863 -0.523 . . . . 28.21 109.968 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -121.51 136.51 54.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.409 -0.807 . . . . 0.0 109.673 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.761 HG22 HD13 ' A' ' 35' ' ' ILE . 61.0 t -129.47 137.64 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.513 -0.742 . . . . 27.95 110.434 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.6 t -125.62 104.51 27.6 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.733 -0.605 . . . . 0.0 110.583 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -83.61 165.14 14.1 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 O-C-N 123.851 1.448 . . . . 33.0 110.996 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -157.53 132.84 8.96 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.505 0.669 . . . . 54.1 109.999 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.537 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 76.5 t80 -59.96 139.47 57.38 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.812 -0.555 . . . . 0.0 111.298 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.0 HD11 ' HB2' ' A' ' 32' ' ' ALA . 77.0 mt -116.34 80.52 1.47 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.901 0.858 . . . . 0.0 110.524 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.537 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -70.01 -33.28 71.81 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.998 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -68.98 -25.97 64.8 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.271 -0.893 . . . . 0.0 111.875 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.423 ' CG ' ' HB3' ' A' ' 18' ' ' LEU . 15.7 pt20 -120.01 29.61 7.44 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.093 -1.004 . . . . 52.37 111.191 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.609 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 24.1 p -148.07 150.59 34.18 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.316 -0.865 . . . . 55.19 110.821 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.5 m -117.9 92.52 42.09 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.584 -0.697 . . . . 0.0 109.361 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.459 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 48.3 Cg_endo -65.58 -25.46 54.9 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 O-C-N 123.951 1.5 . . . . 51.57 111.241 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.79 -23.22 65.18 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.462 -0.773 . . . . 0.0 110.843 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.39 23.4 14.22 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.326 -0.859 . . . . 0.0 110.716 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.84 30.03 72.54 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -120.86 92.59 3.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.543 -0.975 . . . . 0.0 110.036 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.459 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 72.3 m-85 -105.68 132.84 51.32 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.405 -0.809 . . . . 46.07 109.247 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.609 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -115.05 119.62 37.07 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.43 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.453 ' CG ' HD23 ' A' ' 120' ' ' LEU . 83.5 m-85 -115.93 129.31 56.34 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.533 -0.729 . . . . 38.88 109.492 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 1.0 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -115.84 131.18 57.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.139 -0.976 . . . . 34.06 108.982 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.552 ' CE1' HD11 ' A' ' 35' ' ' ILE . 54.8 p90 -126.99 146.99 50.14 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.293 -0.963 . . . . 29.03 111.021 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.3 m -100.34 140.18 34.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.646 -0.659 . . . . 0.0 109.378 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.761 HD13 HG22 ' A' ' 13' ' ' VAL . 42.1 mm -104.39 132.01 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 121.734 0.778 . . . . 0.0 111.562 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -123.23 97.4 5.4 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.454 0.645 . . . . 40.24 109.664 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.658 HG22 HD22 ' A' ' 76' ' ' LEU . 75.7 mt -91.68 117.33 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.777 -0.577 . . . . 20.73 110.504 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -117.54 136.01 53.56 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.548 -0.72 . . . . 0.0 109.554 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.501 ' HB2' HD23 ' A' ' 76' ' ' LEU . 54.9 t-20 -91.72 117.43 29.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.73 -0.606 . . . . 21.34 110.715 -179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.13 9.51 17.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.451 -0.78 . . . . 0.0 110.679 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.61 -178.22 51.25 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.136 -1.586 . . . . 29.1 109.136 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.05 -31.81 13.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.427 -1.043 . . . . 0.0 110.057 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.51 HG13 ' HD2' ' A' ' 44' ' ' PRO . 85.7 t -104.79 141.16 21.96 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.51 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.9 Cg_endo -53.98 147.17 43.98 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 O-C-N 123.74 1.39 . . . . 21.95 111.541 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.438 ' HB1' ' HZ ' ' A' ' 111' ' ' PHE . . . -137.41 150.94 48.02 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.776 0.798 . . . . 20.91 111.203 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.434 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 3.0 ttt180 -126.46 154.76 43.26 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.978 HD22 HG13 ' A' ' 69' ' ' VAL . 6.9 tt -98.19 118.17 34.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.444 -0.785 . . . . 0.0 109.755 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.537 HG23 HG22 ' A' ' 104' ' ' VAL . 63.5 t -101.53 -26.73 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.715 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.655 ' HB3' ' HB2' ' A' ' 102' ' ' ASP . . . -141.45 162.83 34.54 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.146 -179.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -142.93 139.4 30.71 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.34 0.59 . . . . 29.05 110.159 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -143.12 114.1 7.7 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.4 0.619 . . . . 27.97 109.815 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.539 ' CH2' HD13 ' A' ' 115' ' ' ILE . 88.0 m95 -102.49 134.47 45.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.669 -0.644 . . . . 25.25 110.881 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -115.75 78.76 1.21 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.522 -0.736 . . . . 0.0 109.092 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.728 HG22 ' HG3' ' A' ' 97' ' ' MET . 13.1 pt -83.45 128.63 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.515 -0.741 . . . . 36.11 111.741 -178.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.704 HG23 ' HB ' ' A' ' 61' ' ' THR . 3.6 m -120.03 131.08 55.0 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.469 -0.937 . . . . 33.98 108.469 178.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -88.54 170.01 11.24 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.619 0.723 . . . . 45.04 111.205 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.4 -6.93 12.08 Favored Glycine 0 N--CA 1.496 2.661 0 O-C-N 121.831 -0.543 . . . . 39.47 112.188 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.35 7.69 42.63 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 119.322 1.561 . . . . 0.0 110.576 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.59 -31.31 6.56 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -62.09 142.72 57.42 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.202 -1.175 . . . . 62.78 109.778 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.704 ' HB ' HG23 ' A' ' 55' ' ' THR . 7.6 t -135.82 153.3 51.55 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.531 -0.731 . . . . 0.0 110.613 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -121.68 122.95 40.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.635 -0.665 . . . . 0.0 110.02 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -100.55 135.06 42.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.699 -0.625 . . . . 0.0 110.547 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.2 t -128.12 130.59 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.613 0.72 . . . . 37.94 110.065 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -126.44 127.09 44.86 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.801 -0.562 . . . . 0.0 110.147 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -150.5 154.85 25.88 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.494 -1.442 . . . . 31.82 109.494 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -78.16 154.74 30.92 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.51 -0.994 . . . . 0.0 110.367 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.46 -168.38 0.21 Allowed Glycine 0 N--CA 1.498 2.787 0 O-C-N 121.412 -0.805 . . . . 22.62 111.598 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.978 HG13 HD22 ' A' ' 47' ' ' LEU . 16.0 m -129.86 129.2 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.864 -0.786 . . . . 17.51 109.72 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.3 m 41.13 36.77 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 CA-C-O 121.44 0.638 . . . . 20.55 111.86 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.08 16.47 69.59 Favored Glycine 0 N--CA 1.499 2.893 0 O-C-N 121.645 -0.659 . . . . 18.29 112.833 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -145.98 151.72 38.25 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-N 119.145 1.472 . . . . 0.0 112.014 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -114.9 75.7 3.98 Favored Pre-proline 0 N--CA 1.492 1.625 0 N-CA-C 109.006 -0.739 . . . . 18.21 109.006 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -57.66 139.81 91.46 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 O-C-N 123.769 1.405 . . . . 17.61 111.951 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 46' ' ' ARG . 2.3 t90 -103.36 76.53 1.44 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.658 HD22 HG22 ' A' ' 37' ' ' ILE . 6.6 tp -59.97 117.83 5.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.648 -0.658 . . . . 20.57 111.51 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -86.46 157.99 55.1 Favored Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -53.79 127.57 26.07 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 O-C-N 123.56 1.295 . . . . 27.04 111.054 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.88 -19.08 39.87 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.761 -0.936 . . . . 24.74 110.761 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 71.3 tt0 -88.87 166.48 13.95 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.1 -1.235 . . . . 29.38 110.162 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.624 ' CA ' HD11 ' A' ' 76' ' ' LEU . . . -146.28 150.62 36.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.49 -0.756 . . . . 0.0 110.464 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.45 ' N ' HD11 ' A' ' 76' ' ' LEU . 66.2 t80 -117.71 147.84 42.57 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.044 -0.725 . . . . 18.56 109.044 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -144.29 140.19 29.03 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.109 -0.994 . . . . 0.0 111.338 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.66 ' CE1' HG21 ' A' ' 35' ' ' ILE . 47.9 p90 -150.78 160.28 43.97 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.653 -0.655 . . . . 26.65 109.577 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.7 m -102.63 137.67 40.55 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.424 -0.798 . . . . 28.14 110.949 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.442 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 15.0 t -124.11 167.06 14.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.595 -0.69 . . . . 33.88 109.957 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -139.83 128.65 3.99 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.882 -1.151 . . . . 31.8 110.503 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.5 m -134.19 154.27 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.651 -0.911 . . . . 0.0 110.009 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 89' ' ' LEU . 5.0 mp -109.83 144.69 37.93 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.566 -0.709 . . . . 0.0 110.95 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.712 HD23 ' O ' ' A' ' 92' ' ' THR . 12.6 tp -121.43 146.55 46.78 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.656 -0.653 . . . . 38.68 109.762 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -83.9 -27.46 28.6 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.321 -0.862 . . . . 0.0 111.053 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.712 ' O ' HD23 ' A' ' 90' ' ' LEU . 71.9 p -123.44 171.26 9.6 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.341 -0.849 . . . . 31.63 110.774 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.453 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 96.6 mt-10 -86.48 11.64 12.12 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.646 -0.659 . . . . 0.0 111.609 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -144.05 143.13 31.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.044 -1.035 . . . . 0.0 109.893 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.7 160.37 25.18 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 118.615 -1.755 . . . . 28.05 112.537 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -118.91 129.79 55.37 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.728 ' HG3' HG22 ' A' ' 54' ' ' ILE . 15.5 ttt -128.69 122.86 31.7 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.306 -0.871 . . . . 0.0 111.641 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.407 ' HG2' ' CB ' ' A' ' 117' ' ' ALA . 39.3 mt-30 -120.27 150.79 40.14 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -151.62 172.21 31.07 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 118.677 -1.725 . . . . 29.62 111.325 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.858 ' CE1' HD12 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -138.95 154.3 48.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.761 -0.847 . . . . 0.0 109.373 179.121 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.62 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 10.3 m-85 -118.98 126.09 50.94 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.404 -0.81 . . . . 27.05 110.244 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.655 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 78.3 m-20 -86.31 120.25 27.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.899 -1.125 . . . . 0.0 108.777 177.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.454 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 86.8 mmm -121.87 163.04 19.9 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.228 0.537 . . . . 0.0 110.537 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.537 HG22 HG23 ' A' ' 48' ' ' VAL . 7.5 m -142.17 128.7 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.693 -0.629 . . . . 23.28 110.421 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.5 166.36 22.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.358 -0.838 . . . . 0.0 109.378 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -63.95 -27.73 69.34 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.324 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -76.41 -10.31 59.3 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.444 -0.785 . . . . 0.0 111.181 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.9 -7.34 48.85 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.45 -1.06 . . . . 30.43 110.45 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.3 m -58.32 135.76 57.23 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.052 -1.263 . . . . 0.0 109.966 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -100.51 139.03 36.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.434 -0.791 . . . . 0.0 110.783 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 37.8 p90 -161.2 141.46 10.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.702 -0.624 . . . . 28.03 109.889 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.858 HD12 ' CE1' ' A' ' 100' ' ' HIS . 29.9 pt -99.88 156.17 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.661 -0.649 . . . . 0.0 110.923 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.62 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -121.69 98.77 45.41 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.648 -0.658 . . . . 0.0 109.391 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.415 ' HB3' ' CE1' ' A' ' 100' ' ' HIS . 46.3 Cg_endo -59.03 144.0 99.56 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 O-C-N 123.901 1.474 . . . . 33.31 112.154 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.539 HD13 ' CH2' ' A' ' 52' ' ' TRP . 64.1 mt -108.8 121.71 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.426 -0.953 . . . . 30.59 108.426 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.3 159.13 0.22 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.176 0.512 . . . . 30.78 111.533 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.407 ' CB ' ' HG2' ' A' ' 98' ' ' GLN . . . -91.12 124.3 35.24 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.738 -0.601 . . . . 0.0 110.874 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 97' ' ' MET . 38.5 p90 -113.64 158.35 20.95 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.347 -0.982 . . . . 30.66 108.347 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.662 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.1 t -116.15 154.89 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.27 -0.894 . . . . 0.0 110.387 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.662 HD12 ' C ' ' A' ' 119' ' ' VAL . 7.9 mp -114.64 130.51 56.81 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.229 -0.656 . . . . 39.15 109.229 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.744 -0.598 . . . . 0.0 110.069 -179.652 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 120.762 0.315 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.447 ' CE2' HG21 ' A' ' 109' ' ' THR . 49.9 m-85 -118.51 108.42 14.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.433 -0.792 . . . . 31.93 110.209 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.451 ' C ' HG23 ' A' ' 9' ' ' VAL . 66.9 mtt85 -150.15 134.95 17.62 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.57 0.7 . . . . 0.0 110.12 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.808 HG11 ' SD ' ' A' ' 103' ' ' MET . 63.3 t -150.21 116.01 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.507 0.67 . . . . 0.0 109.365 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -107.25 130.69 54.71 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.592 0.711 . . . . 0.0 110.279 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.648 HG11 ' HE2' ' A' ' 101' ' ' TYR . 62.7 t -118.89 137.02 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.809 -0.557 . . . . 28.21 109.501 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -123.85 137.7 54.61 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.404 -0.81 . . . . 0.0 109.94 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.2 t -128.97 137.02 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.484 0.659 . . . . 27.95 110.583 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -124.59 105.19 30.47 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.754 -0.591 . . . . 0.0 110.116 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.433 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 50.7 Cg_endo -82.58 163.39 16.62 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 O-C-N 123.869 1.457 . . . . 33.0 111.323 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -156.98 130.77 8.22 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.613 0.721 . . . . 54.1 109.602 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.442 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 84.8 t80 -61.55 138.48 58.29 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.344 0.592 . . . . 0.0 111.444 -178.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.705 HD23 ' HB3' ' A' ' 21' ' ' GLN . 8.9 tp -114.96 82.65 1.77 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.961 0.886 . . . . 0.0 110.014 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.442 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -65.19 -36.17 83.38 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.575 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -68.89 -22.39 64.18 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.355 -0.84 . . . . 0.0 110.871 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.705 ' HB3' HD23 ' A' ' 18' ' ' LEU . 44.2 tt0 -119.54 23.55 11.13 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.345 -0.847 . . . . 52.37 110.702 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.719 ' OG ' ' HB3' ' A' ' 30' ' ' ALA . 73.1 m -136.11 137.95 41.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.301 -0.875 . . . . 55.19 111.16 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.2 m -119.19 90.44 41.8 Favored Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.447 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 48.3 Cg_endo -63.74 -26.83 68.14 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 O-C-N 123.933 1.491 . . . . 51.57 111.686 -178.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -69.04 -22.83 64.02 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.327 -0.858 . . . . 0.0 110.829 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -107.11 19.27 20.64 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.295 -0.878 . . . . 0.0 110.998 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.18 30.37 73.73 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -119.61 94.37 4.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.667 -0.902 . . . . 0.0 110.247 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.447 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 79.0 m-85 -106.51 129.01 54.54 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.391 -0.818 . . . . 46.07 109.386 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.719 ' HB3' ' OG ' ' A' ' 22' ' ' SER . . . -119.42 120.07 35.76 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.31 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.634 ' CD1' HD12 ' A' ' 90' ' ' LEU . 61.9 m-85 -115.79 136.84 52.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.644 -0.66 . . . . 38.88 109.597 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.27 131.82 54.85 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.727 -0.842 . . . . 34.06 108.727 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.561 ' HE1' HG23 ' A' ' 88' ' ' VAL . 26.4 p90 -126.54 143.37 51.23 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.212 -0.995 . . . . 29.03 111.303 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 t -102.81 139.12 38.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.682 -0.636 . . . . 0.0 109.286 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.9 HD13 ' CE2' ' A' ' 84' ' ' TYR . 5.2 mp -104.78 132.04 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.81 0.814 . . . . 0.0 111.247 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.6 mtm180 -122.08 97.35 5.44 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.467 0.651 . . . . 40.24 109.63 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.651 HG22 HD22 ' A' ' 76' ' ' LEU . 80.2 mt -94.2 116.47 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.765 -0.584 . . . . 20.73 110.507 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -117.46 138.68 51.7 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.486 -0.759 . . . . 0.0 109.455 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.417 ' HB2' HD23 ' A' ' 76' ' ' LEU . 41.5 t-20 -91.61 118.12 30.33 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.67 -0.644 . . . . 21.34 110.851 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.1 9.04 14.63 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.428 -0.795 . . . . 0.0 110.479 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.23 176.63 52.95 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.544 -1.423 . . . . 29.1 109.544 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.12 -35.71 17.3 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.585 -0.95 . . . . 0.0 110.271 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.518 HG13 ' HD2' ' A' ' 44' ' ' PRO . 86.9 t -102.96 140.31 20.93 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.802 -0.561 . . . . 0.0 110.033 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.518 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.5 Cg_endo -52.87 144.14 45.73 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 O-C-N 123.775 1.408 . . . . 21.95 111.68 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.09 151.4 46.69 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.659 0.742 . . . . 20.91 111.092 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 1.1 ptt85 -127.73 159.79 33.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.697 -0.627 . . . . 0.0 109.715 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.953 HD22 HG13 ' A' ' 69' ' ' VAL . 6.8 tt -98.04 116.4 30.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.463 -0.773 . . . . 0.0 109.583 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.482 HG23 HG22 ' A' ' 104' ' ' VAL . 57.6 t -98.43 -28.21 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.541 -0.724 . . . . 0.0 110.515 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.679 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -141.62 162.38 35.63 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.439 -0.905 . . . . 0.0 111.758 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.0 ptt85 -142.89 141.56 31.55 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.579 0.704 . . . . 29.05 110.298 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -144.23 114.86 7.67 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.288 0.566 . . . . 27.97 109.581 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -95.9 133.68 39.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.646 -0.659 . . . . 25.25 111.037 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -115.84 78.49 1.19 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.879 HG22 ' HG3' ' A' ' 97' ' ' MET . 13.3 pt -86.29 129.24 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-O 121.748 0.785 . . . . 36.11 111.758 -178.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.687 HG23 HG22 ' A' ' 61' ' ' THR . 90.6 m -120.19 129.98 54.35 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.097 -1.075 . . . . 33.98 108.097 178.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -91.04 170.32 10.14 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.771 0.796 . . . . 45.04 111.504 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.62 -6.62 11.97 Favored Glycine 0 N--CA 1.494 2.555 0 O-C-N 121.8 -0.562 . . . . 39.47 112.122 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -101.73 5.56 41.38 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 119.429 1.614 . . . . 0.0 110.62 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.4 ' O ' HG23 ' A' ' 61' ' ' THR . . . 92.77 -28.5 9.2 Favored Glycine 0 N--CA 1.495 2.613 0 O-C-N 121.25 -0.906 . . . . 0.0 110.894 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.6 142.44 58.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.191 -1.182 . . . . 62.78 109.621 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.687 HG22 HG23 ' A' ' 55' ' ' THR . 71.5 p -132.23 149.99 52.26 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.455 -0.778 . . . . 0.0 110.67 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -122.4 122.12 38.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.47 -0.769 . . . . 0.0 109.962 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -105.44 136.39 45.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.579 -0.701 . . . . 0.0 110.984 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.6 t -129.23 131.35 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.546 -0.722 . . . . 37.94 109.818 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.29 127.45 47.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.711 -0.618 . . . . 0.0 110.429 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.24 149.23 21.17 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.412 -1.475 . . . . 31.82 109.412 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -74.42 155.68 37.81 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.448 -1.031 . . . . 0.0 110.274 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 50.4 -171.94 0.14 Allowed Glycine 0 N--CA 1.498 2.817 0 O-C-N 121.336 -0.853 . . . . 22.62 111.253 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.953 HG13 HD22 ' A' ' 47' ' ' LEU . 14.8 m -129.41 128.11 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.78 -0.835 . . . . 17.51 109.57 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 69' ' ' VAL . 12.0 m 41.17 36.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 CA-C-O 121.603 0.716 . . . . 20.55 111.796 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.25 16.25 69.75 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 121.627 -0.67 . . . . 18.29 112.93 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.415 ' O ' HG22 ' A' ' 69' ' ' VAL . 10.0 pt-20 -145.79 150.76 36.8 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 119.163 1.481 . . . . 0.0 112.028 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -114.97 74.15 3.43 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.895 -0.78 . . . . 18.21 108.895 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -57.25 140.51 93.11 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 O-C-N 123.793 1.417 . . . . 17.61 112.225 -178.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.432 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 5.9 t90 -102.11 77.17 1.65 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.651 HD22 HG22 ' A' ' 37' ' ' ILE . 6.9 tp -59.66 117.3 4.77 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.553 -0.717 . . . . 20.57 111.621 -178.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -86.35 156.86 56.66 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -52.76 126.72 22.02 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 O-C-N 123.678 1.357 . . . . 27.04 110.931 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.6 -17.44 49.25 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.701 -0.96 . . . . 24.74 110.701 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -88.16 165.5 15.05 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.053 -1.263 . . . . 29.38 110.196 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.602 ' CA ' HD11 ' A' ' 76' ' ' LEU . . . -147.81 152.8 38.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.513 -0.742 . . . . 0.0 110.372 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.4 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 66.9 t80 -119.34 147.89 43.81 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.93 -0.767 . . . . 18.56 108.93 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.5 m80 -138.95 138.31 37.21 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.094 -1.004 . . . . 0.0 110.824 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.9 ' CE2' HD13 ' A' ' 35' ' ' ILE . 50.5 p90 -151.0 159.72 44.39 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.527 -0.733 . . . . 26.65 109.993 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.1 m -104.36 137.61 41.99 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.444 -0.785 . . . . 28.14 110.811 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 14.6 t -125.14 166.86 15.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.578 -0.701 . . . . 33.88 110.091 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.43 127.24 4.07 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.886 -1.15 . . . . 31.8 110.413 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.561 HG23 ' HE1' ' A' ' 33' ' ' TYR . 79.4 t -131.51 148.43 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.577 -0.955 . . . . 0.0 109.375 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.9 tp -110.13 143.54 40.06 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.561 -0.712 . . . . 0.0 110.275 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.668 ' CD1' HD22 ' A' ' 120' ' ' LEU . 84.5 mt -122.97 148.38 45.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.474 -0.766 . . . . 38.68 110.358 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -76.21 -26.41 56.09 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.376 -0.828 . . . . 0.0 110.63 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 93' ' ' GLU . 6.4 m -122.55 171.27 9.24 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.453 -0.78 . . . . 31.63 110.545 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.423 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 58.0 tt0 -85.87 8.15 21.3 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.678 -0.639 . . . . 0.0 111.754 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -140.71 150.11 43.03 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.059 -1.026 . . . . 0.0 110.064 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.06 164.46 29.14 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 118.867 -1.635 . . . . 28.05 112.097 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -121.89 131.69 54.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 122.067 -0.667 . . . . 0.0 109.545 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.879 ' HG3' HG22 ' A' ' 54' ' ' ILE . 27.1 ttt -127.27 121.05 30.09 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.256 -0.902 . . . . 0.0 111.424 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.493 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 56.2 tt0 -128.66 147.75 50.76 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.84 -179.86 35.86 Favored Glycine 0 N--CA 1.5 2.945 0 C-N-CA 119.072 -1.537 . . . . 29.62 110.72 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -140.84 157.97 44.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.697 -0.884 . . . . 0.0 110.75 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.648 ' HE2' HG11 ' A' ' 11' ' ' VAL . 6.9 m-85 -116.72 129.28 56.03 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.606 -0.684 . . . . 27.05 110.193 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.679 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 42.6 t0 -83.9 122.98 29.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.959 -1.088 . . . . 0.0 109.149 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.808 ' SD ' HG11 ' A' ' 9' ' ' VAL . 24.1 mtp -124.23 162.75 23.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.9 -0.5 . . . . 0.0 110.572 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.482 HG22 HG23 ' A' ' 48' ' ' VAL . 10.6 m -140.45 130.24 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.69 -0.631 . . . . 23.28 110.208 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.9 166.61 22.66 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.407 -0.808 . . . . 0.0 109.473 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -63.93 -29.97 71.09 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.127 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -74.19 -10.34 59.51 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.524 -0.735 . . . . 0.0 111.129 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.14 -7.43 47.99 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 120.072 -1.061 . . . . 30.43 110.454 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.447 HG21 ' CE2' ' A' ' 7' ' ' TYR . 65.8 m -57.45 136.05 56.63 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.108 -1.231 . . . . 0.0 109.988 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -101.92 140.85 35.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.334 -0.854 . . . . 0.0 110.955 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 46.5 p90 -167.45 147.03 5.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.678 -0.639 . . . . 28.03 110.06 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.2 pt -102.43 157.53 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.685 -0.634 . . . . 0.0 110.846 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.77 98.33 49.65 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -59.25 142.19 98.84 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 O-C-N 123.935 1.492 . . . . 33.31 112.236 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.557 HD11 ' CE2' ' A' ' 101' ' ' TYR . 67.3 mt -106.83 123.3 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.52 -0.918 . . . . 30.59 108.52 178.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.18 144.09 7.56 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.243 0.544 . . . . 30.78 111.365 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.493 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -88.53 121.22 30.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.659 -0.651 . . . . 0.0 110.103 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.493 ' HE1' HD11 ' A' ' 120' ' ' LEU . 36.3 p90 -107.5 165.14 11.62 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.037 -0.727 . . . . 30.66 109.037 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.607 ' C ' HD12 ' A' ' 120' ' ' LEU . 57.3 t -116.94 155.63 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.377 -0.827 . . . . 0.0 110.274 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.668 HD22 ' CD1' ' A' ' 90' ' ' LEU . 7.2 mp -114.06 132.49 56.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.709 -0.619 . . . . 39.15 109.6 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.657 -0.652 . . . . 0.0 110.138 -179.796 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.034 0.445 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -112.68 79.57 1.24 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.702 -0.624 . . . . 31.93 109.9 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.458 ' C ' HG23 ' A' ' 9' ' ' VAL . 45.9 mtm180 -138.29 142.87 39.79 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.966 0.889 . . . . 0.0 110.333 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.458 HG23 ' C ' ' A' ' 8' ' ' ARG . 85.5 t -150.56 115.75 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.537 0.684 . . . . 0.0 109.215 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -106.02 129.61 54.1 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.557 0.694 . . . . 0.0 109.779 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.453 HG11 ' HE2' ' A' ' 101' ' ' TYR . 66.5 t -116.93 138.87 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.92 -0.487 . . . . 28.21 109.694 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -121.02 136.6 54.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.466 -0.771 . . . . 0.0 109.798 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.804 HG22 HD13 ' A' ' 35' ' ' ILE . 62.1 t -128.42 136.38 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.669 -0.644 . . . . 27.95 110.173 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.9 m -124.81 105.05 29.9 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.617 -0.677 . . . . 0.0 110.509 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -82.22 165.06 17.0 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 O-C-N 123.893 1.47 . . . . 33.0 110.768 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -158.01 130.67 7.27 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.587 0.708 . . . . 54.1 109.844 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.532 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 77.6 t80 -61.16 138.21 58.22 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.761 -0.587 . . . . 0.0 111.327 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.541 ' CD1' ' HB2' ' A' ' 32' ' ' ALA . 6.1 mt -116.62 80.94 1.54 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.086 0.946 . . . . 0.0 110.333 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.532 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -67.37 -35.67 79.82 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.136 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -68.8 -23.25 64.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.275 -0.891 . . . . 0.0 110.818 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -121.96 46.87 2.0 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.36 -0.838 . . . . 52.37 110.64 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.743 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 53.3 p -167.46 148.74 5.57 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.236 -0.915 . . . . 55.19 111.112 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.655 HG23 ' HB2' ' A' ' 28' ' ' ARG . 9.8 t -122.02 93.27 48.67 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.475 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.0 Cg_endo -67.26 -22.81 45.86 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 O-C-N 123.673 1.354 . . . . 51.57 111.949 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -65.15 -23.27 67.07 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.283 -0.886 . . . . 0.0 110.961 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -106.14 24.45 12.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.285 -0.884 . . . . 0.0 110.709 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.84 28.91 73.39 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.655 ' HB2' HG23 ' A' ' 23' ' ' THR . 51.8 mtp180 -120.87 93.81 4.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.641 -0.917 . . . . 0.0 110.178 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.475 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 67.8 m-85 -104.26 133.95 48.31 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.533 -0.729 . . . . 46.07 109.126 179.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.743 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -114.28 120.93 42.08 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.107 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.404 ' CD1' HD12 ' A' ' 90' ' ' LEU . 90.4 m-85 -116.12 134.02 55.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.694 -0.629 . . . . 38.88 109.788 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.541 ' HB2' ' CD1' ' A' ' 18' ' ' LEU . . . -112.43 132.04 55.25 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.463 -0.939 . . . . 34.06 108.463 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.502 ' CE2' HD11 ' A' ' 35' ' ' ILE . 38.2 p90 -127.67 144.39 51.08 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.073 -1.051 . . . . 29.03 111.708 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.6 t -104.82 139.98 38.79 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.804 HD13 HG22 ' A' ' 13' ' ' VAL . 41.4 mm -105.77 132.63 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.77 0.795 . . . . 0.0 111.725 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.3 mtp180 -124.04 97.02 5.16 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.49 0.662 . . . . 40.24 109.799 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.657 HG22 ' CD1' ' A' ' 76' ' ' LEU . 74.1 mt -92.78 116.92 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.706 -0.621 . . . . 20.73 110.433 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -119.77 144.69 47.15 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.455 -0.778 . . . . 0.0 109.919 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.06 113.84 22.46 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.514 -0.741 . . . . 21.34 109.47 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 8' ' ' ARG . . . -89.32 -18.79 26.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.788 -0.57 . . . . 0.0 111.715 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.59 -163.93 37.2 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.305 -0.95 . . . . 29.1 110.942 -178.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -113.89 -17.02 12.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.964 -0.727 . . . . 0.0 111.013 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.491 HG13 ' HD2' ' A' ' 44' ' ' PRO . 95.5 t -103.31 135.59 19.36 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.316 -0.865 . . . . 0.0 109.566 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.491 ' HD2' HG13 ' A' ' 43' ' ' VAL . 41.2 Cg_endo -48.84 140.54 23.09 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 O-C-N 123.757 1.399 . . . . 21.95 112.219 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -134.23 149.52 50.98 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.703 0.764 . . . . 20.91 110.873 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.428 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 43.2 ttt180 -125.91 151.45 46.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.832 -0.542 . . . . 0.0 109.547 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.836 HD22 HG13 ' A' ' 69' ' ' VAL . 7.2 tt -98.68 117.21 32.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.464 -0.773 . . . . 0.0 109.973 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.476 HG23 HG22 ' A' ' 104' ' ' VAL . 62.4 t -100.98 -30.49 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.6 -0.687 . . . . 0.0 110.649 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -141.4 162.54 35.25 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.08 -1.048 . . . . 0.0 112.334 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.43 ' HD3' HG12 ' A' ' 69' ' ' VAL . 23.2 ptt180 -143.25 140.98 30.91 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.482 0.658 . . . . 29.05 110.201 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.412 ' HB3' ' CE1' ' A' ' 100' ' ' HIS . 21.7 t-160 -145.86 114.69 6.9 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.353 0.597 . . . . 27.97 109.987 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.53 ' CH2' HD13 ' A' ' 115' ' ' ILE . 63.2 m95 -100.21 135.97 40.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.579 -0.701 . . . . 25.25 111.42 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -117.06 79.17 1.3 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.711 -0.618 . . . . 0.0 109.417 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.447 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.2 pt -83.31 130.27 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.375 -0.828 . . . . 36.11 112.208 -178.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.782 HG23 HG22 ' A' ' 61' ' ' THR . 85.3 m -119.48 130.05 55.03 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.209 -1.034 . . . . 33.98 108.209 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -91.39 170.03 10.31 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.657 0.741 . . . . 45.04 111.352 -178.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.81 -6.72 12.85 Favored Glycine 0 N--CA 1.495 2.609 0 O-C-N 121.866 -0.521 . . . . 39.47 112.086 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -102.05 5.83 40.74 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 119.367 1.584 . . . . 0.0 110.6 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 61' ' ' THR . . . 93.27 -28.47 9.71 Favored Glycine 0 N--CA 1.495 2.596 0 C-N-CA 120.352 -0.927 . . . . 0.0 110.859 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.1 141.4 58.15 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.277 -1.131 . . . . 62.78 109.77 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.782 HG22 HG23 ' A' ' 55' ' ' THR . 66.4 p -132.38 150.05 52.23 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.438 -0.788 . . . . 0.0 110.488 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -122.32 122.29 38.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.566 -0.709 . . . . 0.0 109.903 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -103.28 134.66 46.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.696 -0.627 . . . . 0.0 110.59 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.3 t -128.04 130.07 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.558 0.694 . . . . 37.94 109.942 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -124.24 126.82 46.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.822 -0.549 . . . . 0.0 110.111 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.96 149.6 21.62 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.35 -1.5 . . . . 31.82 109.35 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -76.72 154.72 33.86 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.492 -1.004 . . . . 0.0 110.078 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.77 -169.48 0.19 Allowed Glycine 0 N--CA 1.498 2.808 0 O-C-N 121.378 -0.826 . . . . 22.62 111.337 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.836 HG13 HD22 ' A' ' 47' ' ' LEU . 15.9 m -131.05 129.24 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.834 -0.803 . . . . 17.51 109.648 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.1 m 40.95 35.22 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.456 0 CA-C-O 121.445 0.64 . . . . 20.55 111.918 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.06 17.13 67.95 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 121.676 -0.64 . . . . 18.29 112.85 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.404 ' OE1' ' CZ ' ' A' ' 82' ' ' PHE . 11.9 pt-20 -144.97 150.33 36.75 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 119.131 1.466 . . . . 0.0 111.902 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 46' ' ' ARG . 93.4 mt-30 -116.3 75.57 6.37 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 109.019 -0.734 . . . . 18.21 109.019 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -58.1 142.17 96.83 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 O-C-N 123.956 1.503 . . . . 17.61 112.411 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.436 ' CH2' ' HB2' ' A' ' 44' ' ' PRO . 5.0 t90 -103.88 75.54 1.3 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.657 ' CD1' HG22 ' A' ' 37' ' ' ILE . 9.7 mt -60.82 121.34 12.08 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.563 -0.711 . . . . 20.57 112.35 -178.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -87.44 158.44 51.72 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -54.22 129.21 33.32 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 O-C-N 123.529 1.279 . . . . 27.04 111.309 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.92 -16.75 49.8 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 120.481 -0.866 . . . . 24.74 111.023 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -87.96 166.07 14.77 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.973 -1.31 . . . . 29.38 110.393 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.33 149.56 35.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.516 -0.74 . . . . 0.0 110.283 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.404 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 65.1 t80 -118.99 147.79 43.7 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.846 -0.798 . . . . 18.56 108.846 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -143.95 140.19 29.53 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.13 -0.981 . . . . 0.0 111.552 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.53 ' CE1' HG21 ' A' ' 35' ' ' ILE . 52.1 p90 -150.45 159.97 44.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.707 -0.621 . . . . 26.65 109.526 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.5 m -104.83 138.78 40.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.283 -0.885 . . . . 28.14 111.353 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.451 ' CB ' ' CZ ' ' A' ' 33' ' ' TYR . 25.2 t -123.95 166.18 16.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.714 -0.616 . . . . 33.88 109.762 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -143.06 118.89 1.28 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.202 -1.159 . . . . 31.8 110.202 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 68.2 t -132.57 149.42 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.66 -0.906 . . . . 0.0 109.763 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 pp -107.34 142.36 37.25 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.505 -0.747 . . . . 0.0 110.205 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.404 HD12 ' CD1' ' A' ' 31' ' ' PHE . 31.0 mt -124.57 143.3 50.77 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.486 -0.759 . . . . 38.68 110.502 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.56 -19.26 38.88 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.281 -0.887 . . . . 0.0 110.232 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.431 HG22 ' H ' ' A' ' 94' ' ' GLN . 5.3 m -101.67 133.17 46.79 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.443 -0.786 . . . . 31.63 109.978 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.415 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 67.9 tt0 -75.7 -4.89 42.85 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.119 -0.988 . . . . 0.0 110.623 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.431 ' H ' HG22 ' A' ' 92' ' ' THR . 15.5 pt20 -138.68 143.31 39.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.207 -0.933 . . . . 0.0 108.803 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -178.05 167.35 38.04 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 118.303 -1.903 . . . . 28.05 112.639 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -117.71 130.63 56.45 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 122.192 -0.593 . . . . 0.0 109.711 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 98.1 mtp -127.11 121.28 31.01 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.325 -0.859 . . . . 0.0 111.337 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.72 ' HG2' ' HB2' ' A' ' 117' ' ' ALA . 75.6 mt-30 -123.06 152.7 40.76 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.426 ' HA3' ' CE3' ' A' ' 52' ' ' TRP . . . -168.41 174.96 43.18 Favored Glycine 0 N--CA 1.499 2.879 0 C-N-CA 118.561 -1.78 . . . . 29.62 111.366 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.412 ' CE1' ' HB3' ' A' ' 51' ' ' HIS . 40.7 p-80 -142.86 156.17 44.89 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.876 -0.779 . . . . 0.0 110.078 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.785 ' CD2' HD11 ' A' ' 115' ' ' ILE . 4.8 m-85 -116.82 127.81 54.67 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.503 -0.748 . . . . 27.05 109.796 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 10.2 t70 -78.88 123.17 26.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.914 -1.116 . . . . 0.0 109.298 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.452 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 92.3 mmm -119.69 163.07 17.96 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.174 0.512 . . . . 0.0 110.062 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.476 HG22 HG23 ' A' ' 48' ' ' VAL . 8.6 m -142.42 129.16 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.588 -0.695 . . . . 23.28 110.453 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.564 ' HB3' ' OD1' ' A' ' 107' ' ' ASP . . . -72.73 166.03 23.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.492 -0.755 . . . . 0.0 109.408 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -64.36 -28.39 69.67 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.383 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.564 ' OD1' ' HB3' ' A' ' 105' ' ' ALA . 47.0 p-10 -76.29 -4.44 42.04 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.467 -0.77 . . . . 0.0 111.505 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.7 -9.91 60.57 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.056 -1.069 . . . . 30.43 110.915 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 89.7 m -57.5 135.08 56.59 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.03 -1.276 . . . . 0.0 109.985 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -101.36 140.8 35.15 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.335 -0.853 . . . . 0.0 110.877 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.452 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 44.0 p90 -165.9 144.87 6.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.712 -0.618 . . . . 28.03 109.603 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 84.8 mt -99.15 157.41 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.699 -0.626 . . . . 0.0 110.712 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.82 96.07 49.39 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -60.1 144.88 99.45 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 O-C-N 123.946 1.498 . . . . 33.31 112.376 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.785 HD11 ' CD2' ' A' ' 101' ' ' TYR . 68.8 mt -111.56 123.32 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.749 -0.834 . . . . 30.59 108.749 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -47.87 170.56 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.246 0.545 . . . . 30.78 111.636 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.72 ' HB2' ' HG2' ' A' ' 98' ' ' GLN . . . -99.41 123.14 43.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.699 -0.626 . . . . 0.0 110.766 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.47 ' CE1' HD11 ' A' ' 120' ' ' LEU . 48.4 p90 -111.36 156.83 20.97 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.262 -1.014 . . . . 30.66 108.262 178.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.631 ' C ' HD12 ' A' ' 120' ' ' LEU . 8.9 p -115.65 155.31 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.245 -0.909 . . . . 0.0 110.602 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.653 ' N ' HD12 ' A' ' 120' ' ' LEU . 7.8 mp -112.81 132.34 55.3 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.286 -0.635 . . . . 39.15 109.286 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.735 -0.603 . . . . 0.0 110.114 -179.722 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.554 ' HG3' ' HB3' ' A' ' 42' ' ' ALA . 29.3 ttm-85 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.011 0.434 . . . . 0.0 110.0 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -122.47 84.59 2.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.77 -0.581 . . . . 31.93 110.348 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.47 ' C ' HG23 ' A' ' 9' ' ' VAL . 11.9 ptp180 -148.3 144.26 27.47 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.133 0.968 . . . . 0.0 110.737 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.641 HG11 ' SD ' ' A' ' 103' ' ' MET . 99.3 t -151.02 120.61 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -108.07 134.18 51.32 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.615 0.721 . . . . 0.0 110.127 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 37' ' ' ILE . 60.5 t -119.28 138.55 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.915 -0.491 . . . . 28.21 109.921 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.412 ' HG3' ' HB2' ' A' ' 36' ' ' ARG . 13.4 pt-20 -122.92 139.71 53.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.502 -0.749 . . . . 0.0 109.422 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.742 HG22 HD13 ' A' ' 35' ' ' ILE . 59.3 t -128.56 140.25 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.645 -0.659 . . . . 27.95 110.717 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.6 t -122.83 104.04 36.52 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.844 -0.535 . . . . 0.0 109.963 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.433 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 50.0 Cg_endo -82.74 165.79 15.53 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 O-C-N 123.901 1.474 . . . . 33.0 111.26 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 -157.61 132.8 8.86 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.511 0.672 . . . . 54.1 109.557 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 19' ' ' ALA . 71.9 t80 -60.0 137.77 58.01 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.287 0.565 . . . . 0.0 111.206 -178.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.545 HD21 ' OE1' ' A' ' 21' ' ' GLN . 5.6 tp -114.95 78.71 1.19 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.979 0.895 . . . . 0.0 110.211 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.577 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -70.89 -35.32 72.27 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.567 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -68.14 -25.18 65.16 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.339 -0.851 . . . . 0.0 111.02 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.545 ' OE1' HD21 ' A' ' 18' ' ' LEU . 97.8 mt-30 -119.38 33.7 5.53 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.375 -0.828 . . . . 52.37 110.38 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.656 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 23.1 t -152.39 143.91 23.43 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.537 -0.727 . . . . 55.19 110.705 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 23' ' ' THR . 8.0 t -121.05 95.56 48.79 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.468 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.5 Cg_endo -66.46 -23.17 50.92 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 O-C-N 123.79 1.416 . . . . 51.57 112.106 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -65.13 -24.15 67.33 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.295 -0.878 . . . . 0.0 110.995 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -105.4 21.8 16.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.197 -0.939 . . . . 0.0 110.944 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.89 30.3 70.35 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.718 ' HD2' HD21 ' A' ' 89' ' ' LEU . 9.5 tpt180 -121.14 93.13 3.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.619 -0.93 . . . . 0.0 109.943 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.468 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 54.8 m-85 -105.56 130.77 53.54 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.955 -0.757 . . . . 46.07 108.955 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.656 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -117.98 119.62 35.36 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.635 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.677 ' CD1' HD12 ' A' ' 90' ' ' LEU . 79.2 m-85 -114.59 131.39 56.7 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.134 -0.691 . . . . 38.88 109.134 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.69 131.01 56.32 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.142 -0.974 . . . . 34.06 109.021 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.482 ' CE1' HD11 ' A' ' 35' ' ' ILE . 52.3 p90 -128.51 147.46 50.69 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.237 -0.985 . . . . 29.03 111.161 -179.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.7 m -101.07 139.44 36.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.697 -0.627 . . . . 0.0 109.691 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.742 HD13 HG22 ' A' ' 13' ' ' VAL . 47.4 mm -103.22 132.74 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.661 0.743 . . . . 0.0 111.317 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.412 ' HB2' ' HG3' ' A' ' 12' ' ' GLU . 62.7 mtt85 -126.0 97.77 5.24 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.577 0.703 . . . . 40.24 110.182 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.557 HG22 ' CD1' ' A' ' 76' ' ' LEU . 81.7 mt -93.5 118.05 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.882 -0.511 . . . . 20.73 110.656 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -117.0 135.73 53.47 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.428 -0.795 . . . . 0.0 109.507 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -90.69 118.73 30.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.879 -0.513 . . . . 21.34 110.833 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.56 8.91 17.85 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.558 -0.714 . . . . 0.0 110.706 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.454 ' HA2' ' HG2' ' A' ' 8' ' ' ARG . . . -82.94 178.68 53.13 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.216 -1.554 . . . . 29.1 109.216 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.554 ' HB3' ' HG3' ' A' ' 6' ' ' ARG . . . -94.62 -30.45 14.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.446 -1.032 . . . . 0.0 110.198 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.515 HG13 ' HD2' ' A' ' 44' ' ' PRO . 86.7 t -103.82 139.89 20.54 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.855 -0.528 . . . . 0.0 109.764 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.515 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.9 Cg_endo -52.75 142.69 50.28 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 O-C-N 123.818 1.43 . . . . 21.95 111.827 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.4 151.44 46.3 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.53 0.681 . . . . 20.91 110.926 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.43 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 19.3 ptt-85 -127.76 159.14 35.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.721 -0.612 . . . . 0.0 109.893 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.848 HD22 HG13 ' A' ' 69' ' ' VAL . 7.6 tt -97.75 116.22 29.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.449 -0.782 . . . . 0.0 109.737 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.434 HG23 HG22 ' A' ' 104' ' ' VAL . 57.3 t -98.08 -27.54 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.517 -0.739 . . . . 0.0 110.497 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.725 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -140.46 163.61 32.36 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.822 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -143.18 140.65 30.85 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.306 0.574 . . . . 29.05 110.226 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -145.1 113.46 6.61 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.433 0.635 . . . . 27.97 110.15 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.473 ' CH2' HG21 ' A' ' 115' ' ' ILE . 63.0 m95 -101.1 136.66 40.59 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.635 -0.666 . . . . 25.25 110.996 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -116.8 78.52 1.22 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.717 -0.614 . . . . 0.0 109.751 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.421 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.0 pt -86.42 131.89 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.361 -0.837 . . . . 36.11 111.963 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.717 HG23 HG22 ' A' ' 61' ' ' THR . 94.3 m -118.76 132.51 56.14 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.549 -0.908 . . . . 33.98 108.549 178.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -87.91 169.81 11.69 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.556 0.694 . . . . 45.04 111.244 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.48 -8.67 20.77 Favored Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.81 -0.556 . . . . 39.47 112.016 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -101.98 8.29 41.07 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 119.301 1.551 . . . . 0.0 110.797 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.78 -25.61 18.36 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 121.264 -0.898 . . . . 0.0 110.966 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.3 mpp_? -62.0 141.71 57.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.219 -1.165 . . . . 62.78 109.619 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.717 HG22 HG23 ' A' ' 55' ' ' THR . 63.7 p -129.3 147.83 51.17 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.614 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -122.1 120.49 34.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.549 -0.72 . . . . 0.0 109.809 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -103.92 136.13 44.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.66 -0.65 . . . . 0.0 110.668 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.5 t -128.12 131.11 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.454 0.645 . . . . 37.94 109.781 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.99 127.85 47.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.827 -0.546 . . . . 0.0 110.472 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -153.0 170.18 31.99 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.165 -1.574 . . . . 31.82 109.165 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -111.13 160.32 17.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.411 -1.052 . . . . 0.0 109.896 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.77 93.81 0.01 OUTLIER Glycine 0 N--CA 1.5 2.919 0 O-C-N 121.284 -0.885 . . . . 22.62 111.239 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.848 HG13 HD22 ' A' ' 47' ' ' LEU . 16.6 m -44.54 132.53 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.528 0 O-C-N 121.431 -1.041 . . . . 17.51 111.774 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.9 m 41.77 38.45 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 CA-C-N 115.592 -0.731 . . . . 20.55 111.605 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.08 18.79 64.19 Favored Glycine 0 N--CA 1.495 2.618 0 O-C-N 121.789 -0.569 . . . . 18.29 112.521 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 82' ' ' PHE . 5.5 pt-20 -147.41 153.07 39.16 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 119.045 1.422 . . . . 0.0 112.477 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -117.39 73.31 7.58 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.555 -0.906 . . . . 18.21 108.555 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -54.88 141.39 77.75 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 O-C-N 123.715 1.376 . . . . 17.61 112.174 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.444 ' CZ3' ' HB2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -100.62 76.93 1.86 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.557 ' CD1' HG22 ' A' ' 37' ' ' ILE . 11.2 mt -60.68 118.18 6.28 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.618 -0.676 . . . . 20.57 111.736 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.08 157.5 56.79 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -53.17 127.6 25.74 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 O-C-N 123.491 1.258 . . . . 27.04 111.089 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.14 -16.58 55.33 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.799 -0.92 . . . . 24.74 110.799 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -86.81 165.36 16.06 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.078 -1.248 . . . . 29.38 110.489 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.14 149.62 35.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.517 -0.739 . . . . 0.0 110.015 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.407 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 64.7 t80 -119.75 148.25 43.64 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.414 -0.804 . . . . 18.56 109.141 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.8 p80 -143.46 140.23 30.27 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.125 -0.985 . . . . 0.0 111.293 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.61 ' CE1' HG21 ' A' ' 35' ' ' ILE . 51.7 p90 -151.52 160.38 43.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.664 -0.648 . . . . 26.65 109.618 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.2 m -102.82 137.64 40.75 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.402 -0.812 . . . . 28.14 111.058 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.436 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 17.0 t -123.99 167.28 14.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.595 -0.691 . . . . 33.88 109.886 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -143.97 124.35 2.23 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.813 -1.184 . . . . 31.8 110.572 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.5 m -131.36 154.19 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.632 -0.923 . . . . 0.0 109.939 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.718 HD21 ' HD2' ' A' ' 28' ' ' ARG . 10.6 tp -109.18 144.64 36.99 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.553 -0.717 . . . . 0.0 110.832 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.719 HD11 HD22 ' A' ' 120' ' ' LEU . 74.7 mt -122.14 146.34 47.32 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.597 -0.689 . . . . 38.68 110.314 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.403 ' O ' ' CE1' ' A' ' 29' ' ' TYR . 75.4 tt0 -76.2 -25.62 55.33 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.353 -0.842 . . . . 0.0 110.782 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 68.0 p -125.2 172.06 9.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.361 -0.837 . . . . 31.63 110.782 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.458 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 50.1 mt-10 -86.81 11.72 12.58 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.593 -0.692 . . . . 0.0 111.654 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 14.4 pt20 -140.85 148.22 40.2 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.06 -1.025 . . . . 0.0 110.057 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.31 160.82 23.78 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 118.907 -1.616 . . . . 28.05 112.086 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -119.73 129.64 54.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 122.14 -0.624 . . . . 0.0 109.335 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 97.7 mtp -125.3 116.24 21.62 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.344 -0.848 . . . . 0.0 111.116 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.49 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 56.6 tt0 -129.26 149.79 50.91 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.7 -178.49 38.72 Favored Glycine 0 N--CA 1.498 2.822 0 C-N-CA 118.916 -1.611 . . . . 29.62 110.76 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -140.54 157.96 44.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.703 -0.881 . . . . 0.0 110.752 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.669 ' CE2' HD11 ' A' ' 115' ' ' ILE . 6.3 m-85 -116.79 128.58 55.43 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.645 -0.66 . . . . 27.05 109.885 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.725 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 41.9 t0 -81.35 123.18 28.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.978 -1.076 . . . . 0.0 109.136 178.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.641 ' SD ' HG11 ' A' ' 9' ' ' VAL . 51.7 mtp -122.19 162.35 21.52 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.118 0.485 . . . . 0.0 110.339 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.434 HG22 HG23 ' A' ' 48' ' ' VAL . 10.0 m -142.91 129.73 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.613 -0.679 . . . . 23.28 110.325 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.04 167.66 20.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.513 -0.742 . . . . 0.0 109.45 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -64.29 -28.44 69.72 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.142 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -72.92 -12.26 60.89 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.567 -0.708 . . . . 0.0 111.026 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.25 -7.05 47.05 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.484 -1.046 . . . . 30.43 110.484 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 91.3 m -57.66 135.2 56.7 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.051 -1.264 . . . . 0.0 110.049 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -101.29 140.03 36.14 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.457 -0.777 . . . . 0.0 110.796 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.452 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 47.5 p90 -167.16 147.23 5.43 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.781 -0.574 . . . . 28.03 109.854 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.7 pt -102.55 158.12 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.596 -0.69 . . . . 0.0 111.087 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.63 97.59 49.91 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -59.25 143.13 99.86 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 O-C-N 123.895 1.471 . . . . 33.31 112.432 -178.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.669 HD11 ' CE2' ' A' ' 101' ' ' TYR . 72.2 mt -108.33 123.24 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.658 -0.867 . . . . 30.59 108.658 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.05 144.21 7.13 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.217 0.532 . . . . 30.78 111.551 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.49 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -87.37 121.03 29.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.638 -0.664 . . . . 0.0 110.242 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.616 ' CE1' HD11 ' A' ' 120' ' ' LEU . 41.9 p90 -109.42 165.89 11.3 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.879 -0.785 . . . . 30.66 108.879 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.605 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.1 t -114.81 154.0 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.284 -0.885 . . . . 0.0 110.326 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.719 HD22 HD11 ' A' ' 90' ' ' LEU . 7.0 mp -113.2 133.23 55.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.788 -0.57 . . . . 39.15 109.514 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.673 -0.642 . . . . 0.0 110.071 -179.838 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.961 0.41 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.424 ' CE2' HG21 ' A' ' 109' ' ' THR . 34.3 m-85 -115.93 107.41 14.96 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.542 -0.724 . . . . 31.93 110.029 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.483 ' C ' HG23 ' A' ' 9' ' ' VAL . 4.1 ttp180 -155.87 135.05 12.17 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.588 0.708 . . . . 0.0 110.594 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.629 HG11 ' SD ' ' A' ' 103' ' ' MET . 98.2 t -152.42 116.23 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -108.95 132.6 53.93 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.675 0.75 . . . . 0.0 110.62 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.7 t -119.41 139.08 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.891 -0.506 . . . . 28.21 109.712 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -119.96 137.92 53.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.505 -0.747 . . . . 0.0 109.709 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.523 HG13 ' HD1' ' A' ' 33' ' ' TYR . 62.6 t -129.26 136.62 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.539 -0.725 . . . . 27.95 110.509 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.6 p -124.17 103.89 32.65 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.72 -0.612 . . . . 0.0 110.281 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -82.89 165.97 15.13 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 123.841 1.443 . . . . 33.0 111.063 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -157.59 132.12 8.47 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.539 0.685 . . . . 54.1 109.801 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.483 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 77.3 t80 -60.29 139.52 57.57 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.257 0.551 . . . . 0.0 111.471 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.914 HD11 ' HB2' ' A' ' 32' ' ' ALA . 93.7 mt -115.58 79.15 1.25 Allowed 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.879 0.847 . . . . 0.0 110.279 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.483 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -65.89 -35.62 81.15 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.17 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -69.96 -23.45 63.18 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.365 -0.835 . . . . 0.0 110.985 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -121.07 29.97 7.08 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.366 -0.834 . . . . 52.37 110.976 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.608 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 19.7 p -152.17 146.37 25.42 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.265 -0.897 . . . . 55.19 111.099 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.586 HG23 ' O ' ' A' ' 23' ' ' THR . 5.1 t -119.45 92.79 46.45 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.48 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.3 Cg_endo -66.08 -23.15 53.75 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 O-C-N 123.912 1.48 . . . . 51.57 111.566 -178.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.04 -23.19 67.12 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.4 -0.812 . . . . 0.0 110.882 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -105.77 23.83 13.27 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.357 -0.839 . . . . 0.0 110.693 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.43 28.71 73.66 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.569 ' HB2' HG23 ' A' ' 23' ' ' THR . 33.1 mtt180 -121.52 93.9 4.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.646 -0.914 . . . . 0.0 110.311 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.48 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 66.4 m-85 -104.59 134.32 47.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.644 -0.66 . . . . 46.07 109.325 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.608 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -117.17 120.68 39.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.444 -0.785 . . . . 0.0 111.273 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.755 ' CD1' HD12 ' A' ' 90' ' ' LEU . 91.1 m-85 -116.36 133.67 55.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.505 -0.747 . . . . 38.88 109.853 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.914 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -114.74 132.42 56.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.205 -0.934 . . . . 34.06 108.74 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.523 ' HD1' HG13 ' A' ' 13' ' ' VAL . 34.0 p90 -127.63 145.99 50.7 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 119.19 -1.004 . . . . 29.03 111.747 -178.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 53.8 m -104.46 134.15 48.14 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.872 HG21 ' CE2' ' A' ' 84' ' ' TYR . 18.8 tt -105.94 135.76 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 121.807 0.813 . . . . 0.0 112.111 -178.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -124.64 100.88 6.85 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.548 0.689 . . . . 40.24 109.897 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.632 HG22 HD22 ' A' ' 76' ' ' LEU . 81.6 mt -90.72 118.56 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.808 -0.558 . . . . 20.73 110.69 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -117.35 139.5 50.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.392 -0.817 . . . . 0.0 109.497 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -88.55 117.23 27.36 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.672 -0.642 . . . . 21.34 110.848 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.68 3.31 15.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.551 -0.718 . . . . 0.0 110.633 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.8 -174.88 49.92 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.02 -1.632 . . . . 29.1 109.02 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.02 -30.67 11.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.439 -1.036 . . . . 0.0 110.277 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.522 HG13 ' HD2' ' A' ' 44' ' ' PRO . 86.3 t -105.33 140.65 21.35 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.796 -0.565 . . . . 0.0 109.646 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.522 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.5 Cg_endo -52.1 141.12 48.93 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 O-C-N 123.718 1.378 . . . . 21.95 111.991 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.84 151.56 45.8 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.627 0.727 . . . . 20.91 110.883 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 0.5 OUTLIER -127.68 160.5 31.48 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.72 -0.612 . . . . 0.0 109.794 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.958 HD22 HG13 ' A' ' 69' ' ' VAL . 7.1 tt -97.27 117.88 32.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.379 -0.826 . . . . 0.0 109.451 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.452 HG23 HG22 ' A' ' 104' ' ' VAL . 58.8 t -101.32 -27.05 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.542 -0.724 . . . . 0.0 110.627 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.783 ' HB3' ' HB2' ' A' ' 102' ' ' ASP . . . -140.41 162.82 34.4 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.226 -0.989 . . . . 0.0 111.558 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -141.29 138.67 33.34 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.345 0.593 . . . . 29.05 110.434 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -142.86 113.31 7.32 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.327 0.584 . . . . 27.97 109.723 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.427 ' CH2' HD13 ' A' ' 115' ' ' ILE . 82.1 m95 -101.15 133.63 45.4 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.632 -0.668 . . . . 25.25 111.049 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -116.28 76.48 1.02 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.635 -0.666 . . . . 0.0 109.345 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.441 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.0 pt -85.59 129.21 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-O 121.776 0.798 . . . . 36.11 111.774 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.0 m -120.57 131.8 54.84 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.429 -0.952 . . . . 33.98 108.429 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -88.55 169.99 11.25 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.85 0.833 . . . . 45.04 111.474 -178.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.04 -7.12 11.57 Favored Glycine 0 N--CA 1.495 2.616 0 O-C-N 121.757 -0.589 . . . . 39.47 112.205 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -101.0 7.02 43.71 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 119.434 1.617 . . . . 0.0 110.6 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.04 -29.05 8.47 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.79 141.49 58.75 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.23 -1.159 . . . . 62.78 109.674 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.8 t -134.84 152.96 52.18 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.618 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -121.32 122.08 39.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.542 -0.723 . . . . 0.0 110.155 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -102.82 134.72 45.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.705 -0.622 . . . . 0.0 110.439 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.4 t -128.01 130.82 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.578 -0.701 . . . . 37.94 110.062 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -125.82 126.87 45.2 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.849 -0.532 . . . . 0.0 110.041 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -151.13 158.37 27.66 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.264 -1.534 . . . . 31.82 109.264 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -80.7 154.35 27.34 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.428 -1.042 . . . . 0.0 110.374 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.88 -167.09 0.2 Allowed Glycine 0 N--CA 1.498 2.767 0 O-C-N 121.493 -0.754 . . . . 22.62 111.605 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.958 HG13 HD22 ' A' ' 47' ' ' LEU . 16.0 m -131.8 129.61 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.96 -0.729 . . . . 17.51 109.537 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.4 m 40.91 35.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 CA-C-O 121.517 0.675 . . . . 20.55 111.779 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.28 17.8 65.98 Favored Glycine 0 N--CA 1.498 2.813 0 O-C-N 121.598 -0.689 . . . . 18.29 112.988 177.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 69' ' ' VAL . 11.1 pt-20 -145.13 150.59 37.06 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 119.211 1.505 . . . . 0.0 112.025 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -115.21 74.75 4.03 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.923 -0.769 . . . . 18.21 108.923 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -56.94 140.8 93.12 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 O-C-N 123.785 1.413 . . . . 17.61 112.189 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.436 ' CZ3' ' HG2' ' A' ' 77' ' ' ARG . 6.3 t90 -104.03 77.55 1.45 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.632 HD22 HG22 ' A' ' 37' ' ' ILE . 5.8 tp -61.38 118.17 6.6 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.516 -0.74 . . . . 20.57 111.623 -178.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.436 ' HG2' ' CZ3' ' A' ' 75' ' ' TRP . 16.0 mtm180 -86.31 159.18 53.98 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -54.61 126.71 23.28 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 O-C-N 123.628 1.331 . . . . 27.04 111.002 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.64 -18.53 42.34 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.903 -0.879 . . . . 24.74 110.903 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -87.89 165.77 15.02 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.079 -1.248 . . . . 29.38 110.255 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.523 ' CA ' HD11 ' A' ' 76' ' ' LEU . . . -145.74 150.45 36.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.545 -0.722 . . . . 0.0 110.388 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.47 ' HD2' HD12 ' A' ' 37' ' ' ILE . 90.7 t80 -118.59 145.68 45.21 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.031 -0.729 . . . . 18.56 109.031 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.6 p80 -146.14 141.19 27.26 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.226 -0.922 . . . . 0.0 111.367 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.872 ' CE2' HG21 ' A' ' 35' ' ' ILE . 44.9 p90 -151.89 163.28 39.57 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.655 -0.653 . . . . 26.65 109.557 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.9 m -99.0 138.42 36.12 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.167 -0.958 . . . . 28.14 111.137 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 15.2 t -125.91 166.35 17.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.615 -0.678 . . . . 33.88 109.912 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -143.88 124.52 2.27 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 119.774 -1.203 . . . . 31.8 110.675 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.5 m -132.13 152.8 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.667 -0.902 . . . . 0.0 109.809 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.548 HD23 ' HA ' ' A' ' 30' ' ' ALA . 81.5 mt -111.56 145.15 39.63 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.559 -0.713 . . . . 0.0 110.977 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.755 HD12 ' CD1' ' A' ' 31' ' ' PHE . 78.7 mt -121.2 145.95 47.3 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.691 -0.631 . . . . 38.68 109.886 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -73.39 -25.69 60.67 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.306 -0.871 . . . . 0.0 111.165 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.8 p -123.47 171.71 9.27 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.354 -0.841 . . . . 31.63 110.756 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.41 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 32.6 tt0 -86.31 7.37 25.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.692 -0.63 . . . . 0.0 111.506 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -138.62 148.62 44.31 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.097 -1.002 . . . . 0.0 109.526 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.62 156.77 14.57 Favored Glycine 0 N--CA 1.496 2.661 0 C-N-CA 118.755 -1.688 . . . . 28.05 112.254 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -118.41 130.02 55.74 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 94.8 mtp -126.29 120.77 30.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.38 -0.825 . . . . 0.0 111.4 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -130.6 151.83 50.64 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.73 -173.67 33.63 Favored Glycine 0 N--CA 1.5 2.951 0 C-N-CA 118.973 -1.584 . . . . 29.62 110.806 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -137.13 160.18 39.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.654 -0.909 . . . . 0.0 110.557 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.61 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 8.7 m-85 -116.98 128.42 55.17 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.771 -0.581 . . . . 27.05 110.181 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.783 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 78.6 m-20 -87.15 121.31 29.43 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.021 -1.05 . . . . 0.0 108.846 177.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.629 ' SD ' HG11 ' A' ' 9' ' ' VAL . 55.1 mtp -126.4 162.76 24.82 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.21 0.529 . . . . 0.0 110.624 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.514 HG12 ' CD ' ' A' ' 110' ' ' GLU . 12.6 m -140.65 131.23 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.551 -0.718 . . . . 23.28 110.287 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.45 165.58 24.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.35 -0.844 . . . . 0.0 109.402 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -63.7 -29.37 70.6 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.024 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -75.34 -9.69 58.78 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.493 -0.754 . . . . 0.0 111.202 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.99 -7.98 49.29 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.061 -1.066 . . . . 30.43 110.469 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.424 HG21 ' CE2' ' A' ' 7' ' ' TYR . 33.6 m -57.69 135.38 56.74 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.036 -1.273 . . . . 0.0 109.964 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.514 ' CD ' HG12 ' A' ' 104' ' ' VAL . 79.3 mm-40 -101.34 139.77 36.56 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.347 -0.845 . . . . 0.0 110.723 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 47.8 p90 -163.76 143.24 8.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.684 -0.635 . . . . 28.03 109.993 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 84.3 mt -101.09 156.79 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.424 0.631 . . . . 0.0 110.43 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.61 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -120.86 98.91 47.45 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -58.36 143.22 97.8 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 O-C-N 123.93 1.49 . . . . 33.31 112.066 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.464 HD11 ' CZ ' ' A' ' 101' ' ' TYR . 70.9 mt -107.97 123.28 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-N 115.375 -0.829 . . . . 30.59 108.907 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -51.84 149.63 4.7 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.175 0.512 . . . . 30.78 111.207 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -91.29 120.87 32.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.586 -0.696 . . . . 0.0 110.113 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.72 ' CE1' HD11 ' A' ' 120' ' ' LEU . 51.2 p90 -110.29 165.01 12.11 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.678 -0.86 . . . . 30.66 108.678 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.595 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.2 t -116.01 153.13 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.159 -0.963 . . . . 0.0 110.677 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.74 HD22 HD11 ' A' ' 90' ' ' LEU . 7.0 mp -113.32 134.35 54.66 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.283 -0.636 . . . . 39.15 109.283 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 51.9 m . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.62 -0.675 . . . . 0.0 110.081 -179.819 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.703 0.287 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.415 ' CE2' HG21 ' A' ' 109' ' ' THR . 39.9 m-85 -118.62 105.36 11.53 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.484 -0.76 . . . . 31.93 110.331 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.49 ' C ' HG23 ' A' ' 9' ' ' VAL . 82.4 mtt85 -147.08 132.57 18.67 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.603 -0.685 . . . . 0.0 109.839 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.49 HG23 ' C ' ' A' ' 8' ' ' ARG . 93.4 t -152.1 115.41 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.501 -0.75 . . . . 0.0 109.896 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -105.7 128.42 53.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.662 -0.649 . . . . 0.0 109.823 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.593 HG11 ' HE2' ' A' ' 101' ' ' TYR . 58.4 t -119.32 138.3 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.757 -0.59 . . . . 28.21 109.793 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -123.57 136.73 54.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.316 -0.865 . . . . 0.0 110.148 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.633 HG22 HD13 ' A' ' 35' ' ' ILE . 60.4 t -129.61 137.11 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.57 -0.706 . . . . 27.95 110.18 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.4 t -125.61 105.28 27.17 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.688 -0.633 . . . . 0.0 110.887 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.88 165.13 15.51 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.794 1.418 . . . . 33.0 110.886 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.8 ptt-85 -157.98 132.01 8.04 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.664 0.745 . . . . 54.1 109.947 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.48 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 79.7 t80 -60.02 139.97 57.1 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.725 -0.609 . . . . 0.0 111.604 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.951 HD11 ' HB2' ' A' ' 32' ' ' ALA . 84.5 mt -116.49 80.76 1.51 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.903 0.858 . . . . 0.0 110.422 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.48 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -65.8 -35.74 81.55 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.065 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -69.96 -24.45 63.34 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.282 -0.886 . . . . 0.0 110.881 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.2 tp60 -121.36 49.56 1.5 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.331 -0.856 . . . . 52.37 110.779 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.699 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 52.5 p -169.59 149.12 3.84 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.228 -0.92 . . . . 55.19 110.916 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.604 HG23 ' HB2' ' A' ' 28' ' ' ARG . 5.1 t -118.88 92.42 44.77 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.0 Cg_endo -66.86 -24.92 45.88 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 O-C-N 123.818 1.43 . . . . 51.57 112.064 -178.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -66.7 -20.77 66.04 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.236 -0.915 . . . . 0.0 111.022 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -105.6 23.58 13.61 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.145 -0.972 . . . . 0.0 110.739 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.72 27.43 73.27 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.604 ' HB2' HG23 ' A' ' 23' ' ' THR . 30.8 mtt85 -122.08 94.38 4.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.643 -0.916 . . . . 0.0 110.082 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.46 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 63.8 m-85 -104.41 137.15 42.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.582 -0.699 . . . . 46.07 109.209 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.699 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -114.03 120.4 40.47 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.162 -179.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -116.5 131.38 56.96 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.608 -0.683 . . . . 38.88 109.653 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.951 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -113.39 131.5 55.97 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.282 -0.886 . . . . 34.06 108.849 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 86' ' ' SER . 53.7 p90 -126.52 145.57 50.46 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.331 -0.948 . . . . 29.03 111.326 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.5 t -102.41 140.27 36.91 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.633 HD13 HG22 ' A' ' 13' ' ' VAL . 48.5 mm -105.68 132.46 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.783 0.802 . . . . 0.0 111.715 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -123.58 97.77 5.54 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.522 0.677 . . . . 40.24 109.718 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.531 HG22 ' CD1' ' A' ' 76' ' ' LEU . 81.8 mt -93.17 117.75 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.773 -0.58 . . . . 20.73 110.583 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -117.18 133.72 55.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.439 -0.788 . . . . 0.0 109.319 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -94.59 117.44 30.13 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 120.212 -0.595 . . . . 21.34 110.523 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.27 15.89 15.86 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.39 -0.819 . . . . 0.0 110.45 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.83 -179.72 52.78 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.332 -1.507 . . . . 29.1 109.332 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.31 -33.26 13.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.56 -0.964 . . . . 0.0 110.267 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.532 HG13 ' HD2' ' A' ' 44' ' ' PRO . 87.2 t -106.45 142.02 24.03 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 122.022 -0.424 . . . . 0.0 109.937 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.532 ' HD2' HG13 ' A' ' 43' ' ' VAL . 38.7 Cg_endo -53.66 146.84 42.28 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 O-C-N 123.792 1.417 . . . . 21.95 111.428 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.5 151.28 47.23 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.794 0.807 . . . . 20.91 111.506 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 8.1 ttt180 -126.85 152.32 47.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.865 -0.522 . . . . 0.0 109.595 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.852 HD22 HG13 ' A' ' 69' ' ' VAL . 7.0 tt -98.03 118.73 35.28 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.382 -0.824 . . . . 0.0 109.728 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.501 HG23 HG22 ' A' ' 104' ' ' VAL . 58.0 t -100.27 -29.66 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.61 -0.681 . . . . 0.0 111.073 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.602 ' HB3' ' HB2' ' A' ' 102' ' ' ASP . . . -141.68 165.58 27.1 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.078 -1.049 . . . . 0.0 112.296 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.5 ptt85 -142.72 140.69 31.57 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.519 0.676 . . . . 29.05 110.352 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -143.09 114.59 8.0 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.777 -0.577 . . . . 27.97 109.628 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.577 ' CH2' HD13 ' A' ' 115' ' ' ILE . 91.6 m95 -99.95 132.92 45.01 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.578 -0.701 . . . . 25.25 111.2 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -116.15 76.05 0.99 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.604 -0.685 . . . . 0.0 109.402 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.442 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.2 pt -85.17 130.13 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.789 0.805 . . . . 36.11 112.275 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.562 HG23 ' HB ' ' A' ' 61' ' ' THR . 6.9 m -118.64 130.89 56.11 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.983 -1.117 . . . . 33.98 107.983 178.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.475 ' OD2' HG21 ' A' ' 92' ' ' THR . 26.3 t0 -88.5 169.72 11.51 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.644 0.735 . . . . 45.04 111.144 -178.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.57 -6.84 12.41 Favored Glycine 0 N--CA 1.496 2.636 0 O-C-N 121.754 -0.591 . . . . 39.47 112.13 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -101.47 7.69 42.36 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 119.337 1.569 . . . . 0.0 110.596 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.67 -31.63 6.37 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.51 142.72 57.81 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.387 -1.067 . . . . 62.78 109.944 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.562 ' HB ' HG23 ' A' ' 55' ' ' THR . 7.7 t -134.36 152.93 52.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.531 -0.731 . . . . 0.0 110.451 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -121.92 123.35 41.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.545 -0.722 . . . . 0.0 110.335 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -103.23 134.24 46.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.671 -0.643 . . . . 0.0 110.496 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.8 t -128.37 131.78 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.538 -0.727 . . . . 37.94 110.043 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -124.86 126.21 45.2 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.822 -0.549 . . . . 0.0 110.148 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.35 149.01 21.0 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.363 -1.495 . . . . 31.82 109.363 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -77.88 155.24 31.07 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.474 -1.015 . . . . 0.0 110.439 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.56 -175.13 0.18 Allowed Glycine 0 N--CA 1.497 2.7 0 N-CA-C 111.049 -0.82 . . . . 22.62 111.049 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.852 HG13 HD22 ' A' ' 47' ' ' LEU . 14.3 m -128.24 127.52 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.8 -0.824 . . . . 17.51 109.576 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.4 m 41.21 36.95 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-O 121.599 0.714 . . . . 20.55 111.809 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.97 15.77 71.7 Favored Glycine 0 N--CA 1.499 2.854 0 O-C-N 121.571 -0.705 . . . . 18.29 112.957 177.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.416 ' O ' HG22 ' A' ' 69' ' ' VAL . 10.8 pt-20 -146.3 151.33 37.36 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-N 119.136 1.468 . . . . 0.0 112.15 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -115.5 75.36 4.82 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.887 -0.783 . . . . 18.21 108.887 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -57.71 139.04 88.96 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 O-C-N 123.847 1.446 . . . . 17.61 112.084 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.432 ' CD1' ' HB2' ' A' ' 46' ' ' ARG . 4.0 t90 -101.68 76.22 1.64 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.531 ' CD1' HG22 ' A' ' 37' ' ' ILE . 10.1 mt -60.25 118.17 6.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.582 -0.699 . . . . 20.57 112.039 -178.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.429 ' HG2' ' CZ3' ' A' ' 75' ' ' TRP . 15.2 mtm180 -86.91 158.45 53.28 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -54.25 129.37 34.2 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 O-C-N 123.461 1.243 . . . . 27.04 111.227 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.01 -18.59 47.03 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 111.068 -0.813 . . . . 24.74 111.068 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -88.05 166.17 14.64 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.058 -1.26 . . . . 29.38 110.618 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.04 147.66 32.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.621 -0.674 . . . . 0.0 110.231 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.514 ' HD2' HD12 ' A' ' 37' ' ' ILE . 84.6 t80 -116.21 144.24 44.45 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.525 -0.734 . . . . 18.56 109.08 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -144.18 140.58 29.42 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.278 -0.889 . . . . 0.0 111.141 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.455 ' CE1' HG21 ' A' ' 35' ' ' ILE . 51.3 p90 -150.15 159.99 44.01 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.758 -0.589 . . . . 26.65 109.528 178.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.9 m -103.51 138.77 39.75 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.43 -0.794 . . . . 28.14 110.875 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.434 ' HB3' ' CE2' ' A' ' 33' ' ' TYR . 15.3 t -124.21 167.36 14.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.689 -0.632 . . . . 33.88 109.937 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -144.03 119.36 1.29 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 110.136 -1.186 . . . . 31.8 110.136 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.35 152.83 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.591 -0.947 . . . . 0.0 110.1 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -108.71 142.99 38.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.53 -0.731 . . . . 0.0 110.666 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.438 ' CD1' HD22 ' A' ' 120' ' ' LEU . 36.4 mt -124.64 144.79 49.99 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.484 -0.76 . . . . 38.68 110.38 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -88.71 -19.84 25.59 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.129 -0.982 . . . . 0.0 110.395 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.475 HG21 ' OD2' ' A' ' 56' ' ' ASP . 2.6 p -103.05 134.88 45.74 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.403 -0.811 . . . . 31.63 110.481 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.456 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 51.3 mt-10 -77.38 -2.88 37.32 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.239 -0.913 . . . . 0.0 110.66 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 97.1 mt-30 -138.59 140.63 39.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.179 -0.951 . . . . 0.0 108.834 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.91 166.57 35.76 Favored Glycine 0 N--CA 1.499 2.885 0 C-N-CA 118.409 -1.853 . . . . 28.05 112.585 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -117.77 129.98 56.02 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.154 -0.615 . . . . 0.0 109.465 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.452 ' HB3' ' HE2' ' A' ' 97' ' ' MET . 98.0 mtp -126.33 119.97 28.69 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.308 -0.87 . . . . 0.0 111.281 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.572 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 69.4 mt-30 -122.54 152.16 40.65 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.93 173.43 36.61 Favored Glycine 0 N--CA 1.498 2.813 0 C-N-CA 118.783 -1.675 . . . . 29.62 111.107 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.432 ' CD2' ' HB3' ' A' ' 114' ' ' PRO . 67.5 m80 -136.98 156.77 48.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.702 -0.881 . . . . 0.0 109.892 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.599 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 9.1 m-85 -116.66 127.48 54.47 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.683 -0.635 . . . . 27.05 109.938 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.602 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 78.4 m-20 -84.07 119.89 25.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.962 -1.086 . . . . 0.0 108.414 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.44 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 4.8 ttm -123.48 162.34 23.08 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.065 0.46 . . . . 0.0 110.685 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.501 HG22 HG23 ' A' ' 48' ' ' VAL . 10.8 m -141.42 129.84 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.699 -0.626 . . . . 23.28 110.52 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.7 166.45 23.26 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.474 -0.766 . . . . 0.0 109.521 179.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -66.45 -30.55 70.93 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.484 -0.76 . . . . 0.0 110.291 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -74.98 -4.59 39.15 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.494 -0.754 . . . . 0.0 111.233 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.8 -9.99 58.68 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.139 -1.029 . . . . 30.43 110.537 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.415 HG21 ' CE2' ' A' ' 7' ' ' TYR . 43.5 m -57.57 134.59 56.27 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.124 -1.221 . . . . 0.0 109.982 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -101.42 140.02 36.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.354 -0.841 . . . . 0.0 110.776 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 42.8 p90 -164.41 142.98 7.09 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.644 -0.66 . . . . 28.03 109.822 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 85.7 mt -101.23 158.01 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.633 -0.667 . . . . 0.0 110.495 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.599 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -119.01 95.43 49.35 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.432 ' HB3' ' CD2' ' A' ' 100' ' ' HIS . 46.6 Cg_endo -59.56 146.6 94.72 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 O-C-N 123.933 1.491 . . . . 33.31 112.082 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.596 HD11 ' CE2' ' A' ' 101' ' ' TYR . 66.5 mt -111.19 120.92 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.594 -0.891 . . . . 30.59 108.594 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.05 168.77 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.152 0.501 . . . . 30.78 111.467 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.572 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -96.98 122.17 39.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.584 -0.698 . . . . 0.0 110.765 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.552 ' CE1' HD11 ' A' ' 120' ' ' LEU . 47.4 p90 -112.01 157.99 20.07 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.183 -1.043 . . . . 30.66 108.183 178.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.627 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.3 t -114.93 153.73 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.241 -0.912 . . . . 0.0 110.494 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.669 ' N ' HD12 ' A' ' 120' ' ' LEU . 7.3 mp -113.12 131.57 55.78 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.175 -0.676 . . . . 39.15 109.175 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.836 -0.54 . . . . 0.0 110.068 -179.754 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.742 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 83.1 mtt180 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.864 0.364 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.527 ' CZ ' HG21 ' A' ' 109' ' ' THR . 91.9 m-85 -120.63 98.09 5.86 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.553 -0.717 . . . . 31.93 110.199 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.469 ' C ' HG23 ' A' ' 9' ' ' VAL . 74.4 mtm-85 -142.66 135.11 27.75 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.62 -0.675 . . . . 0.0 109.754 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.469 HG23 ' C ' ' A' ' 8' ' ' ARG . 73.4 t -151.75 117.01 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 121.621 0.724 . . . . 0.0 109.784 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -106.56 128.03 53.79 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.63 -0.669 . . . . 0.0 109.687 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.518 HG11 ' HE2' ' A' ' 101' ' ' TYR . 62.7 t -121.1 136.01 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.759 -0.588 . . . . 28.21 109.926 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -126.89 137.56 53.17 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.341 -0.85 . . . . 0.0 109.869 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.735 HG22 HD13 ' A' ' 35' ' ' ILE . 67.2 t -128.01 139.81 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.641 -0.662 . . . . 27.95 110.123 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -123.82 105.39 32.48 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.726 -0.609 . . . . 0.0 110.627 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HG3' ' CE1' ' A' ' 118' ' ' PHE . 49.1 Cg_endo -83.69 165.82 13.72 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 O-C-N 123.898 1.473 . . . . 33.0 110.734 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -157.93 132.47 8.35 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.598 0.713 . . . . 54.1 109.917 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.571 ' CE2' ' HB2' ' A' ' 19' ' ' ALA . 73.0 t80 -60.03 138.43 57.86 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.797 -0.565 . . . . 0.0 111.197 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.423 HD21 ' OE1' ' A' ' 21' ' ' GLN . 8.8 tp -115.5 79.68 1.32 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 122.039 0.923 . . . . 0.0 110.402 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.571 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -72.17 -35.65 69.07 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.465 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -68.42 -25.75 65.19 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.274 -0.891 . . . . 0.0 110.941 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.423 ' OE1' HD21 ' A' ' 18' ' ' LEU . 80.9 mt-30 -119.42 43.66 2.56 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.379 -0.826 . . . . 52.37 110.313 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.675 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 22.6 t -162.87 150.27 13.34 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.532 -0.73 . . . . 55.19 110.93 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 23' ' ' THR . 9.7 t -121.25 93.98 48.78 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.459 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.7 Cg_endo -67.12 -22.85 46.65 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 O-C-N 123.748 1.394 . . . . 51.57 112.004 -178.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -65.44 -22.98 66.82 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.289 -0.882 . . . . 0.0 110.947 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -106.22 23.49 14.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.209 -0.932 . . . . 0.0 110.786 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.97 28.85 73.32 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.608 ' HB2' HG23 ' A' ' 23' ' ' THR . 86.1 mtt180 -120.72 93.93 4.19 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.636 -0.92 . . . . 0.0 110.076 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.459 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 54.1 m-85 -105.45 134.1 49.11 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.542 -0.724 . . . . 46.07 109.202 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.675 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -113.67 119.48 37.56 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.02 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.612 ' CD1' HD12 ' A' ' 90' ' ' LEU . 83.0 m-85 -114.73 133.3 56.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.595 -0.69 . . . . 38.88 109.614 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.44 130.25 56.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.218 -0.926 . . . . 34.06 108.726 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.529 ' HE2' HD11 ' A' ' 35' ' ' ILE . 35.7 p90 -126.05 144.27 50.79 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.263 -0.975 . . . . 29.03 111.176 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.5 m -103.91 137.82 41.35 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.609 -0.682 . . . . 0.0 109.834 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.735 HD13 HG22 ' A' ' 13' ' ' VAL . 43.2 mm -104.62 130.79 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-O 121.696 0.76 . . . . 0.0 111.37 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -122.85 98.81 6.07 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.528 0.68 . . . . 40.24 109.716 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.577 HG22 ' CD1' ' A' ' 76' ' ' LEU . 82.5 mt -91.82 116.9 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.715 -0.616 . . . . 20.73 110.411 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -117.87 133.29 56.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.536 -0.727 . . . . 0.0 109.486 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.4 117.51 30.23 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 120.217 -0.593 . . . . 21.34 110.423 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.72 15.25 17.58 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.358 -0.839 . . . . 0.0 110.534 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.25 -171.36 47.42 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.237 -1.545 . . . . 29.1 109.237 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.742 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . . . -101.53 -30.17 11.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.497 -1.002 . . . . 0.0 110.169 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.517 HG13 ' HD2' ' A' ' 44' ' ' PRO . 91.5 t -106.18 139.55 20.39 Favored Pre-proline 0 N--CA 1.498 1.951 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.082 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.517 ' HD2' HG13 ' A' ' 43' ' ' VAL . 40.4 Cg_endo -53.2 144.65 47.02 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 O-C-N 123.837 1.441 . . . . 21.95 111.796 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.489 ' HB1' ' HG2' ' A' ' 103' ' ' MET . . . -141.06 152.21 44.65 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.701 0.762 . . . . 20.91 111.296 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.435 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 22.3 ptt180 -127.42 155.74 43.18 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.898 HD22 HG13 ' A' ' 69' ' ' VAL . 6.5 tt -94.27 118.3 31.39 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.339 -0.851 . . . . 0.0 109.767 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.449 HG23 HG22 ' A' ' 104' ' ' VAL . 58.3 t -100.31 -28.53 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.563 -0.71 . . . . 0.0 110.851 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.692 ' HB3' ' HB2' ' A' ' 102' ' ' ASP . . . -142.13 165.26 27.94 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.098 -1.041 . . . . 0.0 112.24 -179.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -141.62 139.88 33.17 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.463 0.649 . . . . 29.05 110.251 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -142.62 114.52 8.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.782 -0.574 . . . . 27.97 109.605 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -99.71 132.17 45.22 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.643 -0.66 . . . . 25.25 111.398 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -115.12 78.25 1.15 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.813 HG22 ' HG3' ' A' ' 97' ' ' MET . 15.2 pt -87.02 128.81 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-O 121.609 0.718 . . . . 36.11 111.8 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.644 HG23 ' HB ' ' A' ' 61' ' ' THR . 3.6 m -118.6 130.14 55.72 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.874 -1.158 . . . . 33.98 107.874 177.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.613 ' OD2' HG21 ' A' ' 92' ' ' THR . 43.7 t0 -89.23 169.82 11.12 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.86 0.838 . . . . 45.04 111.636 -178.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.11 -7.63 13.97 Favored Glycine 0 N--CA 1.495 2.63 0 O-C-N 121.837 -0.54 . . . . 39.47 112.043 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -101.41 6.98 42.78 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 119.334 1.567 . . . . 0.0 110.561 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.99 -30.25 7.77 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -63.27 142.36 58.42 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.224 -1.163 . . . . 62.78 109.928 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.644 ' HB ' HG23 ' A' ' 55' ' ' THR . 7.9 t -133.98 151.92 51.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.509 -0.744 . . . . 0.0 110.456 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -121.89 123.61 42.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.565 -0.709 . . . . 0.0 110.409 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -104.47 135.71 45.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.724 -0.61 . . . . 0.0 110.684 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.9 t -129.47 132.43 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.437 -0.789 . . . . 37.94 110.118 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.76 126.17 45.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.83 -0.544 . . . . 0.0 110.172 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.65 148.26 19.54 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.454 -1.459 . . . . 31.82 109.454 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -78.73 154.83 29.72 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.434 -1.039 . . . . 0.0 110.463 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 54.97 -178.86 0.27 Allowed Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.855 -0.898 . . . . 22.62 110.855 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.898 HG13 HD22 ' A' ' 47' ' ' LEU . 14.4 m -128.14 127.26 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.749 -0.854 . . . . 17.51 109.679 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 69' ' ' VAL . 10.9 m 41.4 36.79 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 CA-C-O 121.636 0.732 . . . . 20.55 111.744 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.06 15.27 72.77 Favored Glycine 0 N--CA 1.499 2.856 0 O-C-N 121.563 -0.71 . . . . 18.29 112.935 177.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.406 ' O ' HG22 ' A' ' 69' ' ' VAL . 10.1 pt-20 -145.5 150.01 35.68 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 119.131 1.465 . . . . 0.0 112.157 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -116.15 74.52 5.58 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.625 -0.88 . . . . 18.21 108.625 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -57.49 140.81 94.39 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.904 1.476 . . . . 17.61 112.229 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.435 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 1.6 t90 -101.81 76.91 1.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.577 ' CD1' HG22 ' A' ' 37' ' ' ILE . 11.1 mt -60.19 117.89 5.7 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.663 -0.648 . . . . 20.57 111.969 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -86.29 157.62 56.04 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -53.41 128.31 28.79 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 O-C-N 123.5 1.263 . . . . 27.04 111.126 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.97 -16.97 55.68 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.751 -0.94 . . . . 24.74 110.751 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -87.13 165.18 15.94 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.074 -1.251 . . . . 29.38 110.555 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.81 150.52 36.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.58 -0.7 . . . . 0.0 110.154 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.423 ' HD2' HD12 ' A' ' 37' ' ' ILE . 50.6 t80 -118.03 147.59 43.07 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.417 -0.802 . . . . 18.56 109.11 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -142.73 137.45 29.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.238 -0.914 . . . . 0.0 110.878 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.495 ' CE2' HG21 ' A' ' 35' ' ' ILE . 51.6 p90 -150.95 160.21 44.06 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.613 -0.679 . . . . 26.65 109.709 178.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.9 m -105.16 139.23 40.13 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.43 -0.794 . . . . 28.14 111.035 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 16.9 t -124.46 166.68 15.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.62 -0.675 . . . . 33.88 109.834 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.03 120.15 1.58 Allowed Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.923 -1.132 . . . . 31.8 110.38 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.458 HG23 ' HE1' ' A' ' 33' ' ' TYR . 80.8 t -130.77 152.2 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.628 -0.925 . . . . 0.0 109.862 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 89' ' ' LEU . 5.0 mp -108.41 142.63 38.47 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.556 -0.715 . . . . 0.0 110.177 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.612 HD12 ' CD1' ' A' ' 31' ' ' PHE . 67.0 mt -124.63 145.14 49.8 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.489 -0.757 . . . . 38.68 110.565 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -90.74 -21.63 21.48 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.138 -0.976 . . . . 0.0 110.124 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.613 HG21 ' OD2' ' A' ' 56' ' ' ASP . 3.3 p -102.71 137.0 41.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.525 -0.735 . . . . 31.63 110.447 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.447 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 66.6 mt-10 -77.66 -1.77 32.69 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.29 -0.881 . . . . 0.0 110.753 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 27.9 pt20 -138.53 141.05 39.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.048 -1.033 . . . . 0.0 108.911 179.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.54 168.66 38.78 Favored Glycine 0 N--CA 1.498 2.83 0 C-N-CA 118.577 -1.773 . . . . 28.05 112.308 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -118.83 130.2 55.63 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.056 -0.673 . . . . 0.0 109.665 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.813 ' HG3' HG22 ' A' ' 54' ' ' ILE . 35.9 ttm -124.9 117.15 23.44 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.236 -0.915 . . . . 0.0 111.01 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.433 ' HB2' ' HB2' ' A' ' 117' ' ' ALA . 60.7 tt0 -127.82 151.31 49.19 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.88 176.67 37.47 Favored Glycine 0 N--CA 1.499 2.873 0 C-N-CA 119.087 -1.53 . . . . 29.62 110.895 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.42 ' CD2' ' HB3' ' A' ' 114' ' ' PRO . 66.3 m80 -136.41 156.41 48.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.704 -0.88 . . . . 0.0 110.193 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.578 ' CD2' HD11 ' A' ' 115' ' ' ILE . 5.9 m-85 -117.03 128.12 54.85 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.57 -0.706 . . . . 27.05 109.972 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.692 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 78.6 m-20 -83.71 120.31 25.85 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.083 -1.011 . . . . 0.0 108.835 177.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.489 ' HG2' ' HB1' ' A' ' 45' ' ' ALA . 7.8 ttm -122.88 161.46 24.06 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.028 0.442 . . . . 0.0 110.222 -179.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.449 HG22 HG23 ' A' ' 48' ' ' VAL . 7.1 m -142.74 130.53 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.554 -0.716 . . . . 23.28 110.546 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.512 ' HB3' ' OD1' ' A' ' 107' ' ' ASP . . . -73.45 168.14 19.84 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.468 -0.77 . . . . 0.0 109.649 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -67.77 -28.81 67.93 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.516 -0.74 . . . . 0.0 110.374 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.512 ' OD1' ' HB3' ' A' ' 105' ' ' ALA . 46.9 p-10 -76.07 -3.69 37.29 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.338 -0.851 . . . . 0.0 111.422 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.89 -10.51 60.48 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.022 -1.085 . . . . 30.43 110.892 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.527 HG21 ' CZ ' ' A' ' 7' ' ' TYR . 76.5 m -57.9 134.66 56.53 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.998 -1.295 . . . . 0.0 110.053 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -101.16 140.09 35.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.355 -0.841 . . . . 0.0 110.809 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.431 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 37.2 p90 -164.56 143.87 7.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.709 -0.62 . . . . 28.03 109.708 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 85.5 mt -101.36 157.49 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.714 -0.617 . . . . 0.0 110.556 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.5 96.07 49.58 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.42 ' HB3' ' CD2' ' A' ' 100' ' ' HIS . 46.6 Cg_endo -58.98 142.93 99.85 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 O-C-N 123.966 1.509 . . . . 33.31 112.147 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.578 HD11 ' CD2' ' A' ' 101' ' ' TYR . 51.7 mt -107.94 122.31 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.465 -0.939 . . . . 30.59 108.465 178.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.01 153.76 0.85 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.894 -0.504 . . . . 30.78 111.389 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' A' ' 98' ' ' GLN . . . -99.76 117.58 34.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.727 -0.608 . . . . 0.0 110.278 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.684 ' CE1' HD11 ' A' ' 120' ' ' LEU . 41.4 p90 -106.18 169.13 8.68 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.822 -0.807 . . . . 30.66 108.822 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.617 ' C ' HD12 ' A' ' 120' ' ' LEU . 57.5 t -111.95 154.37 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.254 -0.904 . . . . 0.0 110.231 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.684 HD11 ' CE1' ' A' ' 118' ' ' PHE . 7.4 mp -112.21 132.48 54.89 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.259 -0.645 . . . . 39.15 109.259 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.687 -0.633 . . . . 0.0 110.089 -179.735 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 120.594 0.235 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.567 ' CE2' HG21 ' A' ' 109' ' ' THR . 37.8 m-85 -118.65 112.07 19.35 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.406 -0.808 . . . . 31.93 110.338 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.479 ' C ' HG23 ' A' ' 9' ' ' VAL . 45.2 mtm-85 -153.48 134.23 13.78 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.509 0.671 . . . . 0.0 110.28 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.786 HG11 ' CE ' ' A' ' 103' ' ' MET . 97.0 t -151.74 115.8 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 121.466 0.65 . . . . 0.0 109.57 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -106.19 128.86 54.23 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.542 0.687 . . . . 0.0 109.78 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.3 t -118.02 138.84 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.815 -0.553 . . . . 28.21 109.702 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -122.41 136.32 54.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.444 -0.785 . . . . 0.0 109.944 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.806 HG22 HD13 ' A' ' 35' ' ' ILE . 62.7 t -128.29 136.1 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.605 -0.684 . . . . 27.95 110.33 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 65.3 p -126.37 105.66 24.47 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.689 -0.632 . . . . 0.0 110.526 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.423 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 49.8 Cg_endo -83.46 165.25 14.34 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 O-C-N 123.831 1.438 . . . . 33.0 110.991 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -157.78 131.67 8.03 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.51 0.671 . . . . 54.1 109.793 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.512 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 76.3 t80 -62.28 138.68 58.47 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.767 -0.583 . . . . 0.0 111.55 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.944 HD11 ' HB2' ' A' ' 32' ' ' ALA . 85.7 mt -115.4 79.62 1.31 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.903 0.859 . . . . 0.0 110.309 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.512 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -67.03 -35.32 79.63 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.222 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -69.54 -25.17 63.89 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.288 -0.882 . . . . 0.0 111.003 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -119.07 31.18 6.76 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.363 -0.835 . . . . 52.37 110.927 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.547 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 22.1 p -152.05 146.51 25.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.368 -0.832 . . . . 55.19 110.996 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.601 HG23 ' HB2' ' A' ' 28' ' ' ARG . 8.8 t -122.5 93.2 48.65 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.465 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.2 Cg_endo -66.2 -22.51 53.75 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 O-C-N 123.715 1.376 . . . . 51.57 111.804 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -64.87 -24.31 67.5 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.333 -0.855 . . . . 0.0 110.951 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -105.75 23.72 13.44 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.336 -0.853 . . . . 0.0 110.76 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.21 29.44 72.06 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.601 ' HB2' HG23 ' A' ' 23' ' ' THR . 84.2 mtt-85 -121.02 93.7 4.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.643 -0.916 . . . . 0.0 110.18 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.465 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 67.4 m-85 -104.84 131.28 52.51 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.924 -0.769 . . . . 46.07 108.924 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.547 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -118.43 120.9 38.94 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.528 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.657 ' CD1' HD12 ' A' ' 90' ' ' LEU . 75.4 m-85 -116.74 134.63 54.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.651 -0.656 . . . . 38.88 109.711 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.944 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -111.41 132.54 54.37 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.623 -0.881 . . . . 34.06 108.623 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.594 ' HE1' HG23 ' A' ' 88' ' ' VAL . 24.8 p90 -127.59 144.04 51.11 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.216 -0.994 . . . . 29.03 111.447 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.5 m -103.93 139.7 38.73 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.703 -0.623 . . . . 0.0 109.549 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.806 HD13 HG22 ' A' ' 13' ' ' VAL . 41.8 mm -105.69 132.42 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.784 0.802 . . . . 0.0 111.755 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -122.9 97.89 5.65 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.452 0.644 . . . . 40.24 109.644 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.761 HG22 HD22 ' A' ' 76' ' ' LEU . 78.3 mt -91.98 117.22 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.735 -0.603 . . . . 20.73 110.55 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -117.71 134.96 54.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.44 -0.787 . . . . 0.0 109.47 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.614 ' HB2' HD23 ' A' ' 76' ' ' LEU . 51.7 t-20 -93.35 117.68 30.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.736 -0.602 . . . . 21.34 110.652 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.52 11.58 15.96 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.517 -0.739 . . . . 0.0 110.489 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.34 176.02 51.32 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.429 -1.469 . . . . 29.1 109.429 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.52 -39.36 16.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.482 -1.01 . . . . 0.0 110.214 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.506 HG13 ' HD2' ' A' ' 44' ' ' PRO . 87.9 t -99.32 140.41 21.64 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.923 -0.486 . . . . 0.0 109.805 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.506 ' HD2' HG13 ' A' ' 43' ' ' VAL . 40.6 Cg_endo -53.74 144.63 53.22 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 O-C-N 123.786 1.414 . . . . 21.95 111.722 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.55 151.9 46.46 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.548 0.69 . . . . 20.91 110.953 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.429 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 21.6 ptt-85 -128.11 158.11 38.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.78 -0.575 . . . . 0.0 109.855 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.681 HD22 HG13 ' A' ' 69' ' ' VAL . 6.4 tt -99.0 116.86 32.19 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.472 -0.767 . . . . 0.0 109.123 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.411 HG23 HG22 ' A' ' 104' ' ' VAL . 58.7 t -99.13 -29.63 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.495 -0.753 . . . . 0.0 111.461 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.653 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -139.87 163.72 31.9 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.048 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -142.79 141.45 31.68 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.588 0.708 . . . . 29.05 110.637 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -144.55 112.36 6.25 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.365 0.603 . . . . 27.97 109.403 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -99.44 136.16 39.79 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.559 0.695 . . . . 25.25 111.248 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -114.83 80.87 1.47 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.848 HG22 ' HG3' ' A' ' 97' ' ' MET . 12.3 pt -83.15 127.71 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-O 121.784 0.802 . . . . 36.11 111.59 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.634 HG23 HG22 ' A' ' 61' ' ' THR . 95.8 m -120.78 129.25 53.51 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.21 -1.033 . . . . 33.98 108.21 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -91.64 171.21 9.32 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.706 0.765 . . . . 45.04 111.217 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.92 -6.37 9.38 Favored Glycine 0 N--CA 1.493 2.482 0 O-C-N 121.688 -0.632 . . . . 39.47 112.214 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.6 p30 -101.87 5.88 41.2 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 119.46 1.63 . . . . 0.0 110.94 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 61' ' ' THR . . . 92.36 -32.0 5.73 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.204 -0.935 . . . . 0.0 111.23 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.05 142.71 53.57 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.128 -1.219 . . . . 62.78 109.845 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.634 HG22 HG23 ' A' ' 55' ' ' THR . 60.9 p -132.5 151.16 52.0 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.816 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -123.31 125.12 44.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.579 -0.701 . . . . 0.0 109.865 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -101.68 135.01 43.93 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.554 -0.716 . . . . 0.0 110.763 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.0 t -129.18 133.49 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.582 -0.699 . . . . 37.94 110.021 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -125.2 127.1 46.26 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.923 -0.486 . . . . 0.0 110.533 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.55 -174.16 14.25 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 108.757 -1.737 . . . . 31.82 108.757 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -66.42 -158.28 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.278 -1.131 . . . . 0.0 109.816 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.403 ' HA2' ' CD2' ' A' ' 47' ' ' LEU . . . -51.76 -88.6 0.01 OUTLIER Glycine 0 N--CA 1.498 2.824 0 N-CA-C 110.504 -1.039 . . . . 22.62 110.504 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.681 HG13 HD22 ' A' ' 47' ' ' LEU . 25.0 m -140.17 128.15 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.382 -1.069 . . . . 17.51 110.159 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 69' ' ' VAL . 12.4 m 40.86 35.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 CA-C-O 121.313 0.577 . . . . 20.55 112.248 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.58 21.53 57.93 Favored Glycine 0 N--CA 1.499 2.851 0 O-C-N 121.433 -0.792 . . . . 18.29 112.794 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.664 ' HG3' HG23 ' A' ' 69' ' ' VAL . 1.7 pt-20 -139.38 151.73 46.55 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 119.101 1.45 . . . . 0.0 111.197 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -113.51 74.65 2.28 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 109.278 -0.638 . . . . 18.21 109.278 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -57.58 141.98 95.44 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 O-C-N 123.838 1.441 . . . . 17.61 111.668 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.429 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 1.4 t90 -103.09 77.33 1.54 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.761 HD22 HG22 ' A' ' 37' ' ' ILE . 5.6 tp -62.24 118.18 7.06 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.612 -0.68 . . . . 20.57 111.285 -178.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -86.8 158.73 53.26 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -53.67 127.24 24.65 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 O-C-N 123.564 1.297 . . . . 27.04 110.972 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.64 -18.3 43.83 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.843 -0.903 . . . . 24.74 110.843 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -88.85 165.64 14.52 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.109 -1.23 . . . . 29.38 110.239 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.597 ' C ' HD11 ' A' ' 76' ' ' LEU . . . -146.21 151.08 37.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.498 -0.751 . . . . 0.0 110.43 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.491 ' N ' HD11 ' A' ' 76' ' ' LEU . 64.8 t80 -118.12 144.96 45.23 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.906 -0.775 . . . . 18.56 108.906 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.6 p80 -142.65 140.39 31.58 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.117 -0.989 . . . . 0.0 111.258 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.577 ' CE1' HG21 ' A' ' 35' ' ' ILE . 52.8 p90 -150.93 159.93 44.24 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.57 -0.706 . . . . 26.65 109.732 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.6 m -102.58 136.73 41.87 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.422 -0.799 . . . . 28.14 110.923 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 16.2 t -124.9 168.99 12.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.62 -0.675 . . . . 33.88 110.146 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.2 124.6 2.57 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.885 -1.15 . . . . 31.8 110.364 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.594 HG23 ' HE1' ' A' ' 33' ' ' TYR . 79.9 t -129.83 150.64 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.671 -0.899 . . . . 0.0 109.352 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.532 HD23 ' N ' ' A' ' 90' ' ' LEU . 9.4 tt -111.08 143.58 41.56 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.529 -0.732 . . . . 0.0 110.577 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.657 HD12 ' CD1' ' A' ' 31' ' ' PHE . 84.0 mt -121.9 145.27 48.26 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.576 -0.703 . . . . 38.68 109.978 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.658 ' HG3' HG23 ' A' ' 92' ' ' THR . 7.8 pt-20 -72.88 -24.22 60.82 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.373 -0.829 . . . . 0.0 111.157 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.658 HG23 ' HG3' ' A' ' 91' ' ' GLU . 57.3 p -124.3 171.27 10.02 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.342 -0.849 . . . . 31.63 110.755 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 32.1 tt0 -85.73 6.69 26.66 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.668 -0.645 . . . . 0.0 111.692 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -140.08 149.09 42.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.992 -1.068 . . . . 0.0 109.815 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.62 160.75 23.81 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 118.808 -1.663 . . . . 28.05 112.178 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -121.97 131.66 54.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 122.185 -0.597 . . . . 0.0 109.401 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.848 ' HG3' HG22 ' A' ' 54' ' ' ILE . 54.6 ttm -127.21 123.68 37.16 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.304 -0.872 . . . . 0.0 111.36 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.505 ' HG2' ' HB2' ' A' ' 117' ' ' ALA . 1.8 mp0 -123.8 148.21 46.89 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.76 176.21 39.86 Favored Glycine 0 N--CA 1.501 2.991 0 C-N-CA 118.565 -1.779 . . . . 29.62 111.132 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -140.87 157.6 45.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.804 -0.821 . . . . 0.0 110.663 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.615 ' CE2' HD11 ' A' ' 115' ' ' ILE . 7.2 m-85 -117.07 128.82 55.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.677 -0.639 . . . . 27.05 110.007 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.653 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 26.1 t0 -81.75 123.59 28.89 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.967 -1.083 . . . . 0.0 109.11 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.786 ' CE ' HG11 ' A' ' 9' ' ' VAL . 47.4 mtt -122.58 162.6 21.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.887 -0.508 . . . . 0.0 110.491 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.411 HG22 HG23 ' A' ' 48' ' ' VAL . 11.3 m -141.85 128.72 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.516 -0.74 . . . . 23.28 110.251 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.96 167.55 21.27 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.489 -0.757 . . . . 0.0 109.684 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -64.33 -30.78 71.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.497 -0.752 . . . . 0.0 110.059 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -72.38 -11.7 60.8 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.519 -0.738 . . . . 0.0 110.959 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.23 -7.41 47.6 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.398 -1.081 . . . . 30.43 110.398 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.567 HG21 ' CE2' ' A' ' 7' ' ' TYR . 69.3 m -57.2 135.02 56.4 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.048 -1.266 . . . . 0.0 110.036 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -101.19 139.94 36.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.384 -0.823 . . . . 0.0 110.827 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.458 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 49.8 p90 -167.38 146.92 5.16 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.704 -0.622 . . . . 28.03 110.077 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.3 pt -103.18 159.12 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.675 -0.641 . . . . 0.0 110.954 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.41 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -119.3 96.61 50.04 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -59.23 143.79 99.62 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 O-C-N 123.907 1.477 . . . . 33.31 112.269 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.615 HD11 ' CE2' ' A' ' 101' ' ' TYR . 71.4 mt -107.77 122.15 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.68 -0.859 . . . . 30.59 108.68 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.82 155.69 0.83 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.264 0.554 . . . . 30.78 111.577 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.505 ' HB2' ' HG2' ' A' ' 98' ' ' GLN . . . -91.05 119.99 31.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.724 -0.61 . . . . 0.0 110.675 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.678 ' CE1' HD11 ' A' ' 120' ' ' LEU . 51.5 p90 -111.02 162.66 14.64 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.487 -0.931 . . . . 30.66 108.487 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.625 ' C ' HD12 ' A' ' 120' ' ' LEU . 9.3 p -115.98 154.67 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.204 -0.935 . . . . 0.0 110.882 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.678 HD11 ' CE1' ' A' ' 118' ' ' PHE . 7.3 mp -114.07 132.12 56.14 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.32 -0.622 . . . . 39.15 109.32 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.654 -0.654 . . . . 0.0 110.137 -179.814 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 120.823 0.344 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.456 ' CE1' ' CB ' ' A' ' 105' ' ' ALA . 21.4 m-85 -123.55 101.44 7.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.355 -0.841 . . . . 31.93 110.207 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.458 ' C ' HG23 ' A' ' 9' ' ' VAL . 27.6 mmt180 -144.1 139.19 28.75 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.665 0.745 . . . . 0.0 109.99 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.458 HG23 ' C ' ' A' ' 8' ' ' ARG . 70.7 t -150.94 114.98 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -105.97 129.55 54.08 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.538 0.685 . . . . 0.0 109.836 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.512 HG22 ' HA ' ' A' ' 37' ' ' ILE . 57.6 t -118.23 139.79 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.869 -0.519 . . . . 28.21 109.754 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -120.67 136.65 54.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.438 -0.789 . . . . 0.0 109.817 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.649 HG22 HD13 ' A' ' 35' ' ' ILE . 60.9 t -128.87 137.77 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.586 -0.697 . . . . 27.95 110.219 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.7 m -125.07 105.07 29.12 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.717 -0.614 . . . . 0.0 110.638 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -84.3 165.56 12.69 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 O-C-N 123.85 1.447 . . . . 33.0 110.797 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -157.46 132.06 8.56 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.541 0.686 . . . . 54.1 110.064 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.482 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 80.5 t80 -59.73 139.98 56.84 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.852 -0.53 . . . . 0.0 111.315 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.915 HD11 ' HB2' ' A' ' 32' ' ' ALA . 91.2 mt -115.98 80.16 1.41 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.904 0.859 . . . . 0.0 110.397 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.482 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -66.02 -35.84 81.65 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.912 -0.492 . . . . 0.0 111.063 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -69.77 -23.71 63.4 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.415 -0.803 . . . . 0.0 110.947 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -121.05 34.65 5.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.36 -0.837 . . . . 52.37 111.08 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.654 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 24.4 p -156.47 147.91 22.5 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.312 -0.868 . . . . 55.19 111.109 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.579 HG23 ' O ' ' A' ' 23' ' ' THR . 4.9 t -118.9 92.17 44.36 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.475 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 51.3 Cg_endo -65.74 -23.51 55.86 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 O-C-N 123.853 1.449 . . . . 51.57 111.627 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.83 -22.41 66.55 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.398 -0.813 . . . . 0.0 110.833 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -106.13 23.56 13.85 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.25 -0.906 . . . . 0.0 110.684 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.37 28.0 73.6 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.549 ' HB2' HG23 ' A' ' 23' ' ' THR . 3.2 mtm-85 -121.46 94.13 4.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.591 -0.947 . . . . 0.0 110.175 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.475 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 63.8 m-85 -104.15 135.4 45.71 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.54 -0.725 . . . . 46.07 109.22 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.654 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -114.59 120.54 40.53 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.524 -0.735 . . . . 0.0 111.174 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.459 ' CD1' HD12 ' A' ' 90' ' ' LEU . 89.0 m-85 -116.14 131.56 56.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.555 -0.715 . . . . 38.88 109.795 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.915 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -114.01 131.96 56.16 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.287 -0.883 . . . . 34.06 108.658 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.475 ' CE1' HD11 ' A' ' 35' ' ' ILE . 54.6 p90 -128.22 145.98 50.87 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 119.17 -1.012 . . . . 29.03 111.544 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.6 t -101.97 140.88 35.66 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.649 HD13 HG22 ' A' ' 13' ' ' VAL . 48.1 mm -105.47 132.29 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.819 0.819 . . . . 0.0 111.772 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -123.49 98.97 6.09 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.399 0.619 . . . . 40.24 109.826 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.886 HG22 HD22 ' A' ' 76' ' ' LEU . 80.3 mt -91.23 117.27 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.711 -0.618 . . . . 20.73 110.735 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -117.99 134.06 55.32 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.578 -0.701 . . . . 0.0 109.421 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.466 ' HB2' HD23 ' A' ' 76' ' ' LEU . 42.9 t-20 -94.5 117.36 30.0 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 120.178 -0.609 . . . . 21.34 110.781 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.25 13.37 17.89 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.415 -0.803 . . . . 0.0 110.442 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.89 -176.26 51.17 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.515 -1.434 . . . . 29.1 109.515 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.28 -33.74 10.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.561 -0.964 . . . . 0.0 109.846 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.511 HG13 ' HD2' ' A' ' 44' ' ' PRO . 87.6 t -104.56 141.51 22.68 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.511 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.6 Cg_endo -53.13 144.5 46.9 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 O-C-N 123.693 1.365 . . . . 21.95 111.619 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -136.79 151.37 49.09 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.732 0.777 . . . . 20.91 111.232 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.426 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 47.2 ttp180 -126.6 152.08 47.11 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.775 HD22 HG13 ' A' ' 69' ' ' VAL . 7.1 tt -98.02 117.85 33.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 109.441 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.6 p -100.69 -25.21 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.55 -0.719 . . . . 0.0 110.947 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.665 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -142.12 164.27 30.62 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.039 -1.064 . . . . 0.0 112.034 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -141.69 139.08 32.87 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.334 0.588 . . . . 29.05 109.993 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -142.46 113.84 7.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.703 -0.623 . . . . 27.97 110.016 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.543 ' CH2' HD13 ' A' ' 115' ' ' ILE . 87.8 m95 -101.47 132.66 46.97 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.745 -0.597 . . . . 25.25 110.753 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -116.88 77.42 1.11 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.642 -0.661 . . . . 0.0 109.572 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.459 HD11 ' HB2' ' A' ' 62' ' ' GLU . 28.5 pt -83.59 130.07 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.789 0.804 . . . . 36.11 112.211 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.906 HG23 HG22 ' A' ' 61' ' ' THR . 25.6 m -119.28 129.59 54.98 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.266 -1.013 . . . . 33.98 108.266 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -91.63 170.32 10.02 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.734 0.778 . . . . 45.04 111.364 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.28 -7.21 12.82 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 121.791 -0.568 . . . . 39.47 112.149 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -102.23 5.69 40.23 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 119.431 1.616 . . . . 0.0 110.733 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 61' ' ' THR . . . 93.3 -29.49 8.2 Favored Glycine 0 N--CA 1.495 2.585 0 O-C-N 121.213 -0.929 . . . . 0.0 110.898 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -61.86 142.28 57.46 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.323 -1.104 . . . . 62.78 109.747 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.906 HG22 HG23 ' A' ' 55' ' ' THR . 69.9 p -134.29 151.69 51.4 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.476 -0.765 . . . . 0.0 110.434 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.459 ' HB2' HD11 ' A' ' 54' ' ' ILE . 96.6 mt-10 -121.65 122.12 38.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.509 -0.745 . . . . 0.0 110.074 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -104.19 135.15 46.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.567 -0.708 . . . . 0.0 110.634 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.4 t -128.07 131.75 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.545 -0.722 . . . . 37.94 109.888 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -125.12 127.55 47.05 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.747 -0.596 . . . . 0.0 110.554 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.88 164.82 30.92 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.215 -1.554 . . . . 31.82 109.215 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -106.08 158.31 16.9 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.351 -1.088 . . . . 0.0 110.086 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.96 96.43 0.01 OUTLIER Glycine 0 N--CA 1.5 2.929 0 O-C-N 121.454 -0.778 . . . . 22.62 111.628 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.775 HG13 HD22 ' A' ' 47' ' ' LEU . 25.1 m -45.39 132.89 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.519 0 O-C-N 121.403 -1.057 . . . . 17.51 111.534 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.0 m 41.63 36.01 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 CA-C-O 121.631 0.729 . . . . 20.55 111.413 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.0 21.46 59.16 Favored Glycine 0 N--CA 1.496 2.688 0 O-C-N 121.762 -0.586 . . . . 18.29 112.436 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.421 ' HG3' HG23 ' A' ' 69' ' ' VAL . 4.9 pt-20 -147.6 154.32 40.51 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-N 119.128 1.464 . . . . 0.0 112.457 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -117.55 72.97 7.88 Favored Pre-proline 0 N--CA 1.491 1.6 0 N-CA-C 108.558 -0.904 . . . . 18.21 108.558 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -53.99 139.78 70.1 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 O-C-N 123.735 1.387 . . . . 17.61 112.286 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.426 ' CD1' ' HB2' ' A' ' 46' ' ' ARG . 3.4 t90 -101.45 76.03 1.65 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.886 HD22 HG22 ' A' ' 37' ' ' ILE . 2.5 tp -62.33 117.22 5.82 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.585 -0.697 . . . . 20.57 111.339 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 -85.59 158.71 56.72 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -53.96 126.02 20.64 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 O-C-N 123.537 1.283 . . . . 27.04 110.905 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.94 -18.37 44.69 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.732 -0.947 . . . . 24.74 110.732 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -88.96 164.9 14.91 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.133 -1.216 . . . . 29.38 110.263 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.451 ' C ' HD11 ' A' ' 76' ' ' LEU . . . -146.98 150.4 35.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.541 -0.724 . . . . 0.0 110.331 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.608 ' N ' HD11 ' A' ' 76' ' ' LEU . 64.7 t80 -117.86 145.58 44.5 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.864 -0.791 . . . . 18.56 108.864 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -143.57 140.48 30.23 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.119 -0.988 . . . . 0.0 111.37 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.512 ' CE1' HG21 ' A' ' 35' ' ' ILE . 51.1 p90 -150.14 160.02 43.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.647 -0.658 . . . . 26.65 109.34 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.5 m -102.62 139.08 38.67 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.29 -0.881 . . . . 28.14 110.928 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.437 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 16.8 t -124.06 166.07 16.41 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.647 -0.658 . . . . 33.88 109.97 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -144.53 120.3 1.4 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.076 -1.21 . . . . 31.8 110.076 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.51 152.93 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.686 -0.89 . . . . 0.0 109.927 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.98 142.85 39.03 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.521 -0.737 . . . . 0.0 110.508 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.459 HD12 ' CD1' ' A' ' 31' ' ' PHE . 24.1 mt -124.02 143.08 50.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.542 -0.724 . . . . 38.68 110.291 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -82.23 -22.77 35.71 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.217 -0.927 . . . . 0.0 110.087 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.429 HG22 ' H ' ' A' ' 94' ' ' GLN . 7.2 m -99.55 134.25 42.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.671 -0.643 . . . . 31.63 109.991 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.413 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 58.2 tt0 -75.39 -7.9 55.26 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.171 -0.956 . . . . 0.0 110.833 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.429 ' H ' HG22 ' A' ' 92' ' ' THR . 14.5 pt20 -138.3 147.28 43.41 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.21 -0.931 . . . . 0.0 108.952 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.7 169.64 38.97 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 118.265 -1.922 . . . . 28.05 112.706 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -115.82 130.23 56.75 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 98.3 mtp -126.73 121.27 31.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.349 -0.844 . . . . 0.0 111.316 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.612 ' HG2' ' HB2' ' A' ' 117' ' ' ALA . 55.8 mt-30 -124.39 152.12 43.6 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.27 175.92 36.99 Favored Glycine 0 N--CA 1.499 2.86 0 C-N-CA 118.792 -1.671 . . . . 29.62 111.05 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -137.61 157.85 45.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.8 -0.824 . . . . 0.0 109.678 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.593 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 10.1 m-85 -116.64 127.31 54.32 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.577 -0.702 . . . . 27.05 110.009 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.665 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 42.8 t0 -85.63 119.13 25.62 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.992 -1.068 . . . . 0.0 108.723 177.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.425 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 2.5 tpt -122.49 160.7 25.03 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.141 0.496 . . . . 0.0 110.348 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.0 m -139.08 129.5 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.639 -0.663 . . . . 23.28 110.105 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.456 ' CB ' ' CE1' ' A' ' 7' ' ' TYR . . . -70.01 164.81 23.14 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.571 -0.706 . . . . 0.0 109.633 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -63.76 -28.17 69.69 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.537 -0.727 . . . . 0.0 110.131 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -79.0 -7.6 58.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.487 -0.758 . . . . 0.0 111.294 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.7 -7.63 45.94 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 120.104 -1.046 . . . . 30.43 110.515 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.4 m -57.82 134.98 56.76 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.046 -1.267 . . . . 0.0 109.98 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -101.84 139.38 37.55 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.346 -0.846 . . . . 0.0 110.891 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 43.0 p90 -165.1 143.61 6.42 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.732 -0.605 . . . . 28.03 109.685 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 85.0 mt -101.62 157.69 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.646 -0.659 . . . . 0.0 110.81 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.593 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -120.15 97.33 49.25 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -58.7 143.78 98.44 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 O-C-N 123.847 1.446 . . . . 33.31 112.292 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.543 HD13 ' CH2' ' A' ' 52' ' ' TRP . 52.7 mt -108.71 122.83 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.739 -0.837 . . . . 30.59 108.739 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.42 171.29 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.29 0.567 . . . . 30.78 111.465 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.612 ' HB2' ' HG2' ' A' ' 98' ' ' GLN . . . -101.72 122.01 43.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.657 -0.652 . . . . 0.0 110.825 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.474 ' CE1' HD11 ' A' ' 120' ' ' LEU . 49.1 p90 -110.94 156.45 21.19 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.162 -1.051 . . . . 30.66 108.162 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.613 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.8 t -115.87 154.95 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.174 -0.954 . . . . 0.0 110.587 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.65 ' N ' HD12 ' A' ' 120' ' ' LEU . 7.6 mp -112.49 132.23 55.18 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.099 -0.704 . . . . 39.15 109.099 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 34.7 t . . . . . 0 N--CA 1.493 1.716 0 O-C-N 121.779 -0.576 . . . . 0.0 110.041 -179.782 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.67 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 90.0 mtt180 . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 120.781 0.324 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -121.42 101.95 7.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.437 -0.79 . . . . 31.93 110.16 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.482 ' C ' HG23 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -148.79 131.53 15.98 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.554 -0.716 . . . . 0.0 110.065 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.482 HG23 ' C ' ' A' ' 8' ' ' ARG . 84.0 t -152.11 117.09 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.613 0.72 . . . . 0.0 109.808 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -105.27 129.66 53.58 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.537 0.684 . . . . 0.0 109.825 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.483 HG11 ' HE2' ' A' ' 101' ' ' TYR . 62.2 t -117.97 139.03 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.842 -0.536 . . . . 28.21 109.76 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -121.65 136.93 54.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.456 -0.777 . . . . 0.0 110.116 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.714 HG22 HD13 ' A' ' 35' ' ' ILE . 60.5 t -129.28 136.57 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.581 -0.699 . . . . 27.95 110.139 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.0 m -125.44 103.96 28.57 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.737 -0.602 . . . . 0.0 110.659 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.74 165.05 15.85 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 O-C-N 123.874 1.46 . . . . 33.0 110.835 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -157.85 132.92 8.69 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.661 0.743 . . . . 54.1 110.111 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.495 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 80.4 t80 -60.01 140.1 57.0 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.27 0.557 . . . . 0.0 111.629 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.873 HD11 ' HB2' ' A' ' 32' ' ' ALA . 85.4 mt -117.11 83.44 1.98 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.019 0.914 . . . . 0.0 110.247 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.495 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -68.97 -35.11 76.37 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.317 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -69.92 -22.69 63.18 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.427 -0.795 . . . . 0.0 111.099 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -121.87 34.31 5.22 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.232 -0.918 . . . . 52.37 110.897 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.585 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 24.8 p -154.46 148.8 26.09 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.308 -0.87 . . . . 55.19 110.979 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.619 HG23 ' HB2' ' A' ' 28' ' ' ARG . 8.2 t -121.97 93.84 48.43 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.4 Cg_endo -66.86 -23.2 47.94 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 O-C-N 123.786 1.414 . . . . 51.57 112.068 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -66.05 -22.36 66.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.253 -0.904 . . . . 0.0 111.032 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -106.47 23.22 14.55 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.207 -0.933 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.52 29.16 72.89 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.619 ' HB2' HG23 ' A' ' 23' ' ' THR . 93.6 mtt-85 -121.4 94.18 4.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.551 -0.97 . . . . 0.0 110.178 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.46 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 58.8 m-85 -105.6 133.8 49.75 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.503 -0.748 . . . . 46.07 109.143 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.585 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -115.77 120.64 39.97 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.354 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -116.68 131.04 57.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.553 -0.717 . . . . 38.88 109.642 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.873 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -114.77 131.77 56.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.255 -0.903 . . . . 34.06 109.048 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.489 ' CE1' HD11 ' A' ' 35' ' ' ILE . 53.1 p90 -128.08 148.13 50.55 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.338 -0.945 . . . . 29.03 111.308 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 m -101.27 140.21 35.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.667 -0.646 . . . . 0.0 109.411 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.714 HD13 HG22 ' A' ' 13' ' ' VAL . 46.0 mm -103.69 132.39 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-O 121.841 0.829 . . . . 0.0 111.677 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.0 mmm-85 -124.05 97.22 5.25 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.471 0.653 . . . . 40.24 109.797 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.499 HG22 ' CD1' ' A' ' 76' ' ' LEU . 80.1 mt -92.21 118.17 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.704 -0.623 . . . . 20.73 110.751 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -117.36 132.81 56.52 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.508 -0.745 . . . . 0.0 109.21 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -93.96 117.89 30.73 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.786 -0.571 . . . . 21.34 110.632 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.81 14.12 16.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.527 -0.733 . . . . 0.0 110.539 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.52 -171.89 46.09 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.215 -1.554 . . . . 29.1 109.215 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.67 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . . . -104.64 -29.99 10.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.463 -1.021 . . . . 0.0 110.343 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.539 HG13 ' HD2' ' A' ' 44' ' ' PRO . 88.0 t -108.82 141.36 23.16 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.836 -0.54 . . . . 0.0 110.016 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.539 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.1 Cg_endo -52.52 142.33 49.18 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 O-C-N 123.772 1.406 . . . . 21.95 111.749 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.461 ' HB1' ' SD ' ' A' ' 103' ' ' MET . . . -137.41 151.69 48.82 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.875 0.845 . . . . 20.91 111.418 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.427 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 54.5 ttp180 -125.89 153.45 44.18 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.93 HD22 HG13 ' A' ' 69' ' ' VAL . 7.0 tt -97.53 119.19 35.63 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.574 -0.704 . . . . 0.0 109.464 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.492 HG23 HG22 ' A' ' 104' ' ' VAL . 57.3 t -101.17 -27.15 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.539 -0.726 . . . . 0.0 110.983 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.725 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -142.13 165.06 28.47 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 119.1 -1.04 . . . . 0.0 112.162 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.7 ptt-85 -141.12 139.59 33.99 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.368 0.604 . . . . 29.05 110.214 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -142.79 112.84 7.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.775 -0.578 . . . . 27.97 109.873 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -102.19 134.27 45.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.642 -0.661 . . . . 25.25 111.168 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -116.09 79.15 1.27 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.75 -0.594 . . . . 0.0 109.405 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.433 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.0 pt -86.75 129.24 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 121.833 0.825 . . . . 36.11 111.826 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.722 HG23 HG22 ' A' ' 61' ' ' THR . 99.1 m -120.69 130.38 54.06 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.441 -0.948 . . . . 33.98 108.441 178.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -89.93 170.5 10.32 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.748 0.785 . . . . 45.04 111.251 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.83 -7.06 14.07 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 121.75 -0.594 . . . . 39.47 112.138 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -101.62 6.3 41.99 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 119.344 1.572 . . . . 0.0 110.667 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 61' ' ' THR . . . 92.61 -26.19 15.23 Favored Glycine 0 N--CA 1.494 2.566 0 O-C-N 121.208 -0.933 . . . . 0.0 110.966 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -62.16 141.28 58.25 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.184 -1.186 . . . . 62.78 109.6 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.722 HG22 HG23 ' A' ' 55' ' ' THR . 58.3 p -131.54 148.79 52.65 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.402 -0.812 . . . . 0.0 110.574 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -122.3 120.53 34.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.445 -0.785 . . . . 0.0 109.872 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -103.06 135.0 45.55 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.747 -0.596 . . . . 0.0 110.499 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.2 t -128.29 130.31 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.614 0.721 . . . . 37.94 110.031 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -126.17 126.53 44.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.895 -0.503 . . . . 0.0 109.946 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.78 151.03 23.18 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.555 -1.418 . . . . 31.82 109.555 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -77.38 155.22 32.03 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.431 -1.04 . . . . 0.0 110.241 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.62 -174.52 0.23 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 110.99 -0.844 . . . . 22.62 110.99 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.93 HG13 HD22 ' A' ' 47' ' ' LEU . 13.1 m -128.81 127.43 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.838 -0.801 . . . . 17.51 109.625 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 69' ' ' VAL . 13.2 m 41.32 36.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 CA-C-O 121.603 0.715 . . . . 20.55 111.831 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.37 16.03 70.03 Favored Glycine 0 N--CA 1.499 2.841 0 O-C-N 121.588 -0.695 . . . . 18.29 112.869 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.425 ' O ' HG22 ' A' ' 69' ' ' VAL . 10.1 pt-20 -146.43 151.67 37.81 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 119.158 1.479 . . . . 0.0 112.147 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -115.42 75.55 4.76 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 108.746 -0.835 . . . . 18.21 108.746 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -57.85 137.65 82.12 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 O-C-N 123.811 1.427 . . . . 17.61 112.194 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.434 ' CH2' ' CB ' ' A' ' 44' ' ' PRO . 7.4 t90 -101.34 75.98 1.67 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.499 ' CD1' HG22 ' A' ' 37' ' ' ILE . 10.1 mt -60.3 118.37 6.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.566 -0.709 . . . . 20.57 112.013 -178.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.6 mtp85 -86.59 158.87 53.69 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -54.62 129.14 33.38 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 O-C-N 123.466 1.246 . . . . 27.04 111.126 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.02 -18.3 48.62 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 111.012 -0.835 . . . . 24.74 111.012 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -88.28 166.01 14.62 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.041 -1.27 . . . . 29.38 110.69 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.1 148.68 33.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.594 -0.691 . . . . 0.0 110.024 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.435 ' HD1' HD12 ' A' ' 37' ' ' ILE . 64.6 t80 -117.57 144.67 44.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.466 -0.771 . . . . 18.56 109.13 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -143.62 140.42 30.13 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.234 -0.916 . . . . 0.0 111.279 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.646 ' CE1' HG21 ' A' ' 35' ' ' ILE . 49.5 p90 -150.89 159.96 44.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.591 -0.693 . . . . 26.65 109.62 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.5 m -101.67 137.5 39.9 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.389 -0.819 . . . . 28.14 111.005 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.447 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 15.0 t -124.49 167.63 14.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.641 -0.662 . . . . 33.88 109.918 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.89 124.41 2.45 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.811 -1.185 . . . . 31.8 110.466 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.71 153.5 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.653 -0.91 . . . . 0.0 109.896 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 89' ' ' LEU . 4.9 mp -108.84 144.86 36.15 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.559 -0.713 . . . . 0.0 111.071 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.692 ' CD1' HD22 ' A' ' 120' ' ' LEU . 0.4 OUTLIER -121.09 147.23 45.83 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.685 -0.634 . . . . 38.68 109.591 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.41 ' O ' ' CE1' ' A' ' 29' ' ' TYR . 74.7 tt0 -77.9 -26.6 49.2 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.248 -0.908 . . . . 0.0 111.25 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.8 p -124.99 172.78 9.14 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.268 -0.895 . . . . 31.63 110.936 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.457 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 50.4 mt-10 -86.62 11.55 12.6 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.653 -0.654 . . . . 0.0 111.469 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 97.4 mt-30 -139.99 144.38 36.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.037 -1.039 . . . . 0.0 109.69 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.98 157.03 17.9 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 118.795 -1.669 . . . . 28.05 112.237 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -121.36 131.37 54.15 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.425 ' HE2' ' HB3' ' A' ' 97' ' ' MET . 98.1 mtp -127.24 120.7 29.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.326 -0.859 . . . . 0.0 111.386 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 117' ' ' ALA . 56.0 tt0 -126.41 151.4 47.74 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.12 177.8 39.02 Favored Glycine 0 N--CA 1.499 2.871 0 C-N-CA 118.946 -1.597 . . . . 29.62 110.962 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.406 ' CD2' ' HB3' ' A' ' 114' ' ' PRO . 66.9 m80 -136.17 156.92 47.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.715 -0.874 . . . . 0.0 110.139 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.624 ' CD2' HD11 ' A' ' 115' ' ' ILE . 4.7 m-85 -115.37 127.93 55.73 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.759 -0.588 . . . . 27.05 109.932 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.725 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 11.1 t70 -83.71 121.92 27.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.965 -1.084 . . . . 0.0 108.532 177.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.462 ' SD ' HG21 ' A' ' 9' ' ' VAL . 54.6 ttm -123.92 161.59 25.07 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.297 0.57 . . . . 0.0 110.781 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.492 HG22 HG23 ' A' ' 48' ' ' VAL . 10.5 m -139.99 129.93 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.741 -0.599 . . . . 23.28 110.17 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 107' ' ' ASP . . . -75.3 166.29 23.84 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.509 -0.744 . . . . 0.0 109.811 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -65.33 -31.05 71.98 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.52 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.488 ' OD1' ' HB3' ' A' ' 105' ' ' ALA . 49.4 p-10 -74.57 -7.73 54.05 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.433 -0.792 . . . . 0.0 111.272 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.0 -9.33 54.92 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 120.091 -1.052 . . . . 30.43 110.636 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.4 m -57.55 134.79 56.43 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.021 -1.282 . . . . 0.0 109.935 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -101.92 140.83 35.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.432 -0.792 . . . . 0.0 110.931 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -168.61 146.12 3.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.666 -0.646 . . . . 28.03 109.851 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 84.9 mt -101.23 157.52 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.707 -0.621 . . . . 0.0 110.66 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.27 98.7 50.57 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.406 ' HB3' ' CD2' ' A' ' 100' ' ' HIS . 45.4 Cg_endo -58.08 142.84 97.16 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 O-C-N 123.932 1.491 . . . . 33.31 112.254 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.624 HD11 ' CD2' ' A' ' 101' ' ' TYR . 48.6 mt -109.31 124.28 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.741 -0.837 . . . . 30.59 108.741 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.66 149.99 3.02 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.861 -0.525 . . . . 30.78 111.271 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.438 ' HB2' ' HB2' ' A' ' 98' ' ' GLN . . . -92.86 124.26 36.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.66 -0.65 . . . . 0.0 110.047 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.653 ' HE1' HD11 ' A' ' 120' ' ' LEU . 44.7 p90 -108.8 164.67 12.18 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.046 -0.724 . . . . 30.66 109.046 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.588 ' C ' HD12 ' A' ' 120' ' ' LEU . 8.5 p -116.0 155.41 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.349 -0.845 . . . . 0.0 110.495 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.692 HD22 ' CD1' ' A' ' 90' ' ' LEU . 7.2 mp -112.13 133.07 54.49 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.281 -0.637 . . . . 39.15 109.281 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.627 -0.671 . . . . 0.0 110.094 -179.796 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 120.678 0.275 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -118.23 108.1 14.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.452 -0.78 . . . . 31.93 110.336 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.48 ' C ' HG23 ' A' ' 9' ' ' VAL . 23.5 mtm180 -151.01 132.12 14.37 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.61 -0.681 . . . . 0.0 110.092 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.599 HG11 ' SD ' ' A' ' 103' ' ' MET . 60.9 t -151.67 114.45 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.543 -0.723 . . . . 0.0 109.548 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -106.7 130.36 54.44 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.628 0.727 . . . . 0.0 110.246 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.6 t -117.73 139.23 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.585 -0.524 . . . . 28.21 109.585 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -121.24 138.44 54.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.367 -0.833 . . . . 0.0 110.193 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.833 HG22 HD13 ' A' ' 35' ' ' ILE . 61.8 t -128.56 135.84 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.61 -0.681 . . . . 27.95 110.445 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.6 t -126.61 105.53 23.72 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.694 -0.629 . . . . 0.0 110.474 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -82.95 164.8 15.45 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 O-C-N 123.832 1.438 . . . . 33.0 111.15 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -157.87 131.63 7.92 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.572 0.701 . . . . 54.1 109.697 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.522 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 80.2 t80 -62.13 138.55 58.41 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.651 -0.656 . . . . 0.0 111.691 -178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.985 HD11 ' HB2' ' A' ' 32' ' ' ALA . 86.0 mt -116.66 83.15 1.91 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 122.009 0.909 . . . . 0.0 110.269 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.522 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -68.45 -35.55 77.74 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.303 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -69.8 -23.71 63.37 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.309 -0.869 . . . . 0.0 111.076 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -121.77 43.06 2.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.263 -0.898 . . . . 52.37 110.717 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.734 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 37.8 t -162.64 143.93 10.17 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.399 -0.813 . . . . 55.19 110.883 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.9 m -116.58 92.69 38.21 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.44 -0.787 . . . . 0.0 109.124 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.458 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 47.5 Cg_endo -66.05 -25.16 51.63 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 O-C-N 123.932 1.49 . . . . 51.57 111.553 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -68.49 -22.95 64.51 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.298 -0.876 . . . . 0.0 111.038 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -105.06 22.82 14.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.235 -0.915 . . . . 0.0 110.912 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.41 28.62 73.15 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -120.63 93.59 4.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.652 -0.91 . . . . 0.0 109.804 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.458 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 65.2 m-85 -105.62 130.89 53.56 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.361 -0.837 . . . . 46.07 109.017 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.734 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -116.3 121.14 41.13 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.554 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.653 ' CD1' HD12 ' A' ' 90' ' ' LEU . 85.1 m-85 -116.75 134.3 54.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.624 -0.672 . . . . 38.88 109.459 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.985 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -110.9 132.63 54.04 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.171 -0.956 . . . . 34.06 108.839 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.585 ' HE1' HG23 ' A' ' 88' ' ' VAL . 25.8 p90 -126.98 143.55 51.26 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.376 -0.929 . . . . 29.03 111.294 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.0 t -103.92 139.57 38.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.707 -0.621 . . . . 0.0 109.417 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.833 HD13 HG22 ' A' ' 13' ' ' VAL . 40.9 mm -105.06 132.6 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.811 0.815 . . . . 0.0 111.532 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -123.02 95.74 4.73 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.46 0.647 . . . . 40.24 109.563 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.53 HG22 ' CD1' ' A' ' 76' ' ' LEU . 78.7 mt -90.23 117.5 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.766 -0.583 . . . . 20.73 110.535 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -117.36 134.4 54.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.515 -0.741 . . . . 0.0 109.434 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -92.24 117.43 29.87 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.282 -0.567 . . . . 21.34 110.524 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.85 10.44 16.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.471 -0.768 . . . . 0.0 110.584 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.32 179.55 53.3 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.216 -1.554 . . . . 29.1 109.216 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.11 -30.93 13.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.516 -0.991 . . . . 0.0 110.29 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.523 HG13 ' HD2' ' A' ' 44' ' ' PRO . 84.0 t -106.29 140.15 21.0 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.791 -0.568 . . . . 0.0 109.984 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.523 ' HD2' HG13 ' A' ' 43' ' ' VAL . 38.7 Cg_endo -51.53 141.28 42.74 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 O-C-N 123.8 1.421 . . . . 21.95 112.038 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.34 152.2 45.63 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.709 0.766 . . . . 20.91 111.09 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.2 ptt-85 -127.66 159.46 34.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.706 -0.621 . . . . 0.0 109.471 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.894 HD22 HG13 ' A' ' 69' ' ' VAL . 7.1 tt -96.62 117.56 31.24 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.418 -0.801 . . . . 0.0 109.794 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.444 HG23 HG22 ' A' ' 104' ' ' VAL . 58.6 t -99.48 -28.46 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.519 -0.738 . . . . 0.0 110.636 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.743 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -142.61 162.82 34.46 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.83 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.606 ' HD2' HG12 ' A' ' 69' ' ' VAL . 2.7 ptm180 -143.5 142.12 31.02 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.612 0.72 . . . . 29.05 110.712 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.409 ' HB3' ' NE2' ' A' ' 100' ' ' HIS . 21.6 t-160 -145.27 114.79 7.2 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.289 0.566 . . . . 27.97 109.701 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.464 ' CH2' HG21 ' A' ' 115' ' ' ILE . 67.3 m95 -100.13 136.67 39.69 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.652 -0.655 . . . . 25.25 111.36 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -116.13 78.28 1.18 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.661 -0.649 . . . . 0.0 109.258 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.425 ' O ' HG13 ' A' ' 54' ' ' ILE . 29.9 pt -88.15 131.67 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.771 0.796 . . . . 36.11 112.279 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.449 ' OG1' HG22 ' A' ' 61' ' ' THR . 93.5 m -119.63 133.23 55.73 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.395 -0.965 . . . . 33.98 108.395 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -85.89 169.16 13.55 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.693 0.759 . . . . 45.04 111.265 -178.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.93 -9.35 13.66 Favored Glycine 0 N--CA 1.496 2.644 0 O-C-N 121.827 -0.546 . . . . 39.47 112.078 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -100.78 9.23 42.64 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 119.26 1.53 . . . . 0.0 110.761 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.7 -21.0 38.3 Favored Glycine 0 N--CA 1.495 2.621 0 O-C-N 121.2 -0.938 . . . . 0.0 111.018 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.02 142.33 54.12 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.064 -1.257 . . . . 62.78 109.884 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.449 HG22 ' OG1' ' A' ' 55' ' ' THR . 73.4 p -125.32 140.24 52.99 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.515 -0.741 . . . . 0.0 110.808 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -123.18 117.88 26.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.525 -0.734 . . . . 0.0 109.829 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -103.75 135.32 45.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.717 -0.614 . . . . 0.0 110.768 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.0 t -128.75 130.89 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.657 -0.652 . . . . 37.94 109.947 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.404 ' OD1' ' CG ' ' A' ' 51' ' ' HIS . 64.7 m-20 -124.07 126.77 46.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.929 -0.482 . . . . 0.0 109.959 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.9 145.67 14.26 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.527 -1.429 . . . . 31.82 109.527 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -67.29 153.57 43.36 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.462 -1.022 . . . . 0.0 110.099 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 46.97 -164.73 0.12 Allowed Glycine 0 N--CA 1.501 3.009 0 O-C-N 121.487 -0.758 . . . . 22.62 111.793 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.894 HG13 HD22 ' A' ' 47' ' ' LEU . 15.9 m -130.98 129.37 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.89 -0.771 . . . . 17.51 109.633 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 69' ' ' VAL . 12.5 m 40.98 34.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 CA-C-O 121.513 0.673 . . . . 20.55 111.822 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.57 17.16 66.75 Favored Glycine 0 N--CA 1.499 2.839 0 O-C-N 121.668 -0.645 . . . . 18.29 112.952 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -144.53 150.0 36.81 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 119.2 1.5 . . . . 0.0 111.95 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -116.08 74.92 5.62 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.989 -0.745 . . . . 18.21 108.989 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -56.37 141.32 89.34 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 O-C-N 123.852 1.449 . . . . 17.61 112.06 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -100.34 77.33 1.94 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.53 ' CD1' HG22 ' A' ' 37' ' ' ILE . 11.1 mt -62.88 118.04 7.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.575 -0.703 . . . . 20.57 111.987 -178.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -86.92 159.18 52.23 Favored Pre-proline 0 N--CA 1.489 1.508 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -54.65 128.73 31.53 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 O-C-N 123.512 1.27 . . . . 27.04 111.013 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.49 -17.39 52.49 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.955 -0.858 . . . . 24.74 110.955 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -87.41 166.1 15.08 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.995 -1.297 . . . . 29.38 110.635 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.34 150.08 35.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.659 -0.651 . . . . 0.0 110.112 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -118.94 147.69 43.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.505 -0.747 . . . . 18.56 109.081 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.5 p80 -144.75 140.84 28.79 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.146 -0.971 . . . . 0.0 111.243 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.539 ' CE1' HG21 ' A' ' 35' ' ' ILE . 52.1 p90 -150.95 160.02 44.19 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.633 -0.667 . . . . 26.65 109.812 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.4 m -101.34 137.01 40.24 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.431 -0.793 . . . . 28.14 110.911 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.451 ' HG ' ' HH ' ' A' ' 33' ' ' TYR . 26.6 t -125.23 169.35 12.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.616 -0.677 . . . . 33.88 110.132 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.39 123.33 2.15 Favored Glycine 0 N--CA 1.497 2.725 0 C-N-CA 119.914 -1.136 . . . . 31.8 110.461 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.585 HG23 ' HE1' ' A' ' 33' ' ' TYR . 80.4 t -130.18 152.44 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.532 -0.981 . . . . 0.0 109.48 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.719 HD23 ' N ' ' A' ' 90' ' ' LEU . 5.6 tt -110.56 143.81 40.37 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.532 -0.73 . . . . 0.0 110.508 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.777 HD11 HD22 ' A' ' 120' ' ' LEU . 70.8 mt -122.28 147.57 46.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.578 -0.702 . . . . 38.68 110.193 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -74.74 -25.91 59.43 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.28 -0.887 . . . . 0.0 110.805 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.2 p -125.52 172.9 9.32 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.429 -0.794 . . . . 31.63 110.857 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.452 ' HG2' ' CD2' ' A' ' 29' ' ' TYR . 94.0 mt-10 -86.33 11.91 11.21 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.683 -0.636 . . . . 0.0 111.635 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 97.0 mt-30 -139.93 147.39 40.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.113 -0.992 . . . . 0.0 109.895 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.48 158.88 21.51 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 118.889 -1.624 . . . . 28.05 112.28 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -119.47 129.72 54.88 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 122.108 -0.642 . . . . 0.0 109.357 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.451 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 98.0 mtp -125.61 116.42 21.69 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.371 -0.83 . . . . 0.0 111.124 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.493 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 56.3 tt0 -130.15 151.1 51.05 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -168.77 -177.18 39.5 Favored Glycine 0 N--CA 1.5 2.93 0 C-N-CA 119.017 -1.564 . . . . 29.62 110.748 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.409 ' NE2' ' HB3' ' A' ' 51' ' ' HIS . 6.0 p-80 -140.16 157.99 44.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.682 -0.893 . . . . 0.0 110.958 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.664 ' CD1' HD11 ' A' ' 47' ' ' LEU . 5.6 m-85 -115.77 128.21 55.68 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.68 -0.637 . . . . 27.05 109.647 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.743 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 41.4 t0 -80.78 124.83 29.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.927 -1.108 . . . . 0.0 109.184 178.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.599 ' SD ' HG11 ' A' ' 9' ' ' VAL . 29.5 mtp -124.63 162.37 24.25 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.249 0.547 . . . . 0.0 110.543 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.456 HG12 ' OE2' ' A' ' 110' ' ' GLU . 9.8 m -139.73 128.15 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.654 -0.654 . . . . 23.28 110.285 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.46 168.99 18.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.538 -0.726 . . . . 0.0 109.861 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.61 -31.74 72.63 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.834 -0.747 . . . . 0.0 110.271 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -70.02 -15.67 63.05 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.491 -0.755 . . . . 0.0 110.942 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.9 -5.74 47.01 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.42 -1.072 . . . . 30.43 110.42 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.4 m -57.72 135.6 56.78 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.061 -1.258 . . . . 0.0 110.052 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.456 ' OE2' HG12 ' A' ' 104' ' ' VAL . 77.1 mm-40 -98.63 139.98 33.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.443 -0.786 . . . . 0.0 110.612 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 48.0 p90 -168.39 148.88 4.75 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.703 -0.623 . . . . 28.03 110.121 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.6 pt -102.64 157.9 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.707 -0.621 . . . . 0.0 110.833 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -118.54 99.08 51.51 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -58.68 142.76 98.82 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 O-C-N 123.928 1.489 . . . . 33.31 112.356 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.637 HD11 ' CD2' ' A' ' 101' ' ' TYR . 70.2 mt -108.82 123.6 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.45 -0.945 . . . . 30.59 108.45 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.74 143.98 8.93 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.191 0.52 . . . . 30.78 111.362 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.493 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -85.98 121.6 28.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.619 -0.675 . . . . 0.0 110.186 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.582 ' CE1' HD11 ' A' ' 120' ' ' LEU . 42.4 p90 -109.46 163.95 12.95 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.796 -0.816 . . . . 30.66 108.796 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.606 ' C ' HD12 ' A' ' 120' ' ' LEU . 8.8 p -115.4 154.53 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.186 -0.946 . . . . 0.0 110.476 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.777 HD22 HD11 ' A' ' 90' ' ' LEU . 6.9 mp -113.63 133.47 55.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.733 -0.604 . . . . 39.15 109.384 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.702 -0.624 . . . . 0.0 110.046 -179.792 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.656 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 61.6 mtt180 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.656 0.265 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.476 ' CE2' HG21 ' A' ' 109' ' ' THR . 31.4 m-85 -119.98 108.07 13.87 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.44 -0.788 . . . . 31.93 110.306 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.464 ' C ' HG23 ' A' ' 9' ' ' VAL . 81.4 mtt85 -149.06 132.85 16.97 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.661 -0.65 . . . . 0.0 109.986 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.588 HG11 ' CE ' ' A' ' 103' ' ' MET . 68.0 t -150.61 113.48 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.687 -0.633 . . . . 0.0 109.455 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -107.41 129.19 54.96 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.616 -0.677 . . . . 0.0 109.809 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.585 HG11 ' HE2' ' A' ' 101' ' ' TYR . 58.4 t -118.75 139.56 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.88 -0.512 . . . . 28.21 109.969 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -121.26 137.07 54.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.401 -0.812 . . . . 0.0 109.905 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.715 HG22 HD13 ' A' ' 35' ' ' ILE . 59.1 t -128.81 136.67 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.709 -0.619 . . . . 27.95 110.23 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.9 p -125.38 104.8 28.23 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.719 -0.613 . . . . 0.0 110.55 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.404 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 48.4 Cg_endo -83.7 164.39 14.08 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 O-C-N 123.95 1.5 . . . . 33.0 110.902 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.6 ptt-85 -157.37 132.5 8.9 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.522 0.677 . . . . 54.1 109.843 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.567 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 75.1 t80 -59.43 138.56 57.62 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.337 0.589 . . . . 0.0 111.305 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.3 tp -116.18 79.79 1.36 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.983 0.897 . . . . 0.0 110.386 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.567 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -70.59 -35.58 73.09 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.567 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -68.43 -25.05 64.82 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.279 -0.888 . . . . 0.0 111.117 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -120.08 45.85 2.09 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.27 -0.894 . . . . 52.37 110.63 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.735 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 34.8 p -165.76 150.03 8.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.374 -0.829 . . . . 55.19 110.974 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.628 HG23 ' HB2' ' A' ' 28' ' ' ARG . 9.5 t -120.98 93.24 48.81 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.461 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.3 Cg_endo -66.89 -23.21 47.73 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 O-C-N 123.761 1.401 . . . . 51.57 111.965 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.09 -23.02 67.04 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.287 -0.883 . . . . 0.0 110.927 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -106.39 24.0 13.25 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.295 -0.878 . . . . 0.0 110.641 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.76 29.17 72.68 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.628 ' HB2' HG23 ' A' ' 23' ' ' THR . 99.5 mtt180 -121.85 93.94 4.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.592 -0.946 . . . . 0.0 110.152 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.461 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 58.4 m-85 -104.95 133.8 49.14 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.559 -0.713 . . . . 46.07 109.103 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.735 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -115.04 119.78 37.62 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.163 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.833 ' CD1' HD12 ' A' ' 90' ' ' LEU . 83.2 m-85 -114.73 134.83 54.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.564 -0.71 . . . . 38.88 109.786 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.4 131.54 55.49 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.52 -0.919 . . . . 34.06 108.52 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.633 ' HE1' HG23 ' A' ' 88' ' ' VAL . 21.9 p90 -128.43 144.76 51.19 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.273 -0.971 . . . . 29.03 111.435 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -104.42 139.6 39.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.752 -0.592 . . . . 0.0 109.886 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.715 HD13 HG22 ' A' ' 13' ' ' VAL . 44.7 mm -107.28 133.04 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.707 0.765 . . . . 0.0 111.416 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.13 98.52 5.81 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.394 0.616 . . . . 40.24 109.738 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.58 HG22 ' CD1' ' A' ' 76' ' ' LEU . 77.3 mt -90.27 117.75 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.749 -0.595 . . . . 20.73 110.597 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -118.09 133.45 55.89 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.451 -0.781 . . . . 0.0 109.615 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.41 117.12 29.79 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.822 -0.549 . . . . 21.34 110.434 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.82 14.39 17.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.319 -0.863 . . . . 0.0 110.717 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.58 -177.03 51.5 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.349 -1.501 . . . . 29.1 109.349 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.656 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . . . -95.98 -33.5 12.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.598 -0.943 . . . . 0.0 109.915 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.514 HG13 ' HD2' ' A' ' 44' ' ' PRO . 84.9 t -104.7 140.82 21.45 Favored Pre-proline 0 N--CA 1.494 1.772 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.514 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.1 Cg_endo -52.51 142.24 49.4 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 O-C-N 123.777 1.409 . . . . 21.95 111.711 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.03 152.73 46.47 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.716 0.77 . . . . 20.91 111.101 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.431 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 24.0 ptt-85 -127.88 157.75 39.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.708 -0.62 . . . . 0.0 109.634 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.71 HD22 HG13 ' A' ' 69' ' ' VAL . 6.4 tt -97.46 117.85 32.62 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.381 -0.824 . . . . 0.0 109.084 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.454 HG23 HG22 ' A' ' 104' ' ' VAL . 60.9 t -100.22 -29.32 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.56 -0.712 . . . . 0.0 111.616 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.695 ' HB3' ' HB2' ' A' ' 102' ' ' ASP . . . -140.06 164.47 29.94 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.126 -1.029 . . . . 0.0 112.151 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -142.85 141.14 31.53 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.559 0.695 . . . . 29.05 110.906 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -143.37 113.06 7.0 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.309 -0.626 . . . . 27.97 109.309 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.501 ' CH2' HD13 ' A' ' 115' ' ' ILE . 88.3 m95 -100.05 134.69 42.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.607 -0.683 . . . . 25.25 111.099 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -116.54 77.19 1.08 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.574 -0.704 . . . . 0.0 109.57 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.442 ' O ' HG13 ' A' ' 54' ' ' ILE . 27.6 pt -86.68 130.27 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.416 -0.803 . . . . 36.11 111.855 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.59 HG23 ' HB ' ' A' ' 61' ' ' THR . 6.8 m -119.48 132.67 55.83 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.374 -0.973 . . . . 33.98 108.374 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -88.13 169.57 11.81 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.717 0.77 . . . . 45.04 111.417 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.67 -7.69 12.2 Favored Glycine 0 N--CA 1.495 2.57 0 O-C-N 121.786 -0.571 . . . . 39.47 112.16 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -101.25 7.59 42.89 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 119.307 1.554 . . . . 0.0 110.682 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.13 -29.32 8.26 Favored Glycine 0 N--CA 1.495 2.631 0 O-C-N 121.211 -0.931 . . . . 0.0 110.798 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -63.6 142.45 58.39 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.205 -1.173 . . . . 62.78 109.755 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.59 ' HB ' HG23 ' A' ' 55' ' ' THR . 7.9 t -134.49 152.76 52.0 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.846 -0.741 . . . . 0.0 110.683 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -122.53 125.23 45.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.623 -0.673 . . . . 0.0 110.267 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -102.47 134.72 45.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.671 -0.643 . . . . 0.0 110.512 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.8 t -128.38 132.6 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.548 -0.72 . . . . 37.94 110.038 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -125.49 127.18 46.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.874 -0.516 . . . . 0.0 110.338 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.3 -174.57 15.68 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 108.711 -1.756 . . . . 31.82 108.711 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.24 -157.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.186 -1.185 . . . . 0.0 109.813 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.405 ' HA2' ' CD2' ' A' ' 47' ' ' LEU . . . -51.03 -91.25 0.01 OUTLIER Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.563 -1.015 . . . . 22.62 110.563 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.71 HG13 HD22 ' A' ' 47' ' ' LEU . 27.4 m -140.22 129.13 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.402 -1.057 . . . . 17.51 110.143 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 69' ' ' VAL . 12.0 m 40.81 33.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 CA-C-O 121.268 0.556 . . . . 20.55 112.122 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.97 22.29 55.5 Favored Glycine 0 N--CA 1.499 2.837 0 O-C-N 121.533 -0.729 . . . . 18.29 112.782 177.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.656 ' HG3' HG23 ' A' ' 69' ' ' VAL . 1.6 pt-20 -139.83 150.75 45.05 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 119.142 1.471 . . . . 0.0 111.354 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -113.84 74.83 2.62 Favored Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 109.117 -0.697 . . . . 18.21 109.117 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -57.36 141.7 94.85 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 O-C-N 123.858 1.452 . . . . 17.61 111.887 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.431 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -103.8 76.36 1.37 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.58 ' CD1' HG22 ' A' ' 37' ' ' ILE . 19.0 mt -63.67 121.48 14.04 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.634 -0.666 . . . . 20.57 111.947 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -86.31 158.44 54.99 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -53.6 128.75 30.69 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 O-C-N 123.517 1.272 . . . . 27.04 111.132 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.01 -17.3 54.07 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.805 -0.918 . . . . 24.74 110.805 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -88.62 164.85 15.16 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.121 -1.223 . . . . 29.38 110.585 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.19 150.04 35.08 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.649 -0.657 . . . . 0.0 110.165 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -117.93 144.51 45.41 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.503 -0.748 . . . . 18.56 109.126 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -142.76 140.4 31.4 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.24 -0.912 . . . . 0.0 111.25 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.564 ' CE1' HG21 ' A' ' 35' ' ' ILE . 52.1 p90 -150.65 159.92 44.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.672 -0.642 . . . . 26.65 109.781 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 60.3 m -102.78 136.73 42.07 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.431 -0.793 . . . . 28.14 110.76 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 15.7 t -125.25 169.95 11.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.643 -0.661 . . . . 33.88 110.133 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -139.83 125.87 3.1 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 119.934 -1.127 . . . . 31.8 110.38 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.633 HG23 ' HE1' ' A' ' 33' ' ' TYR . 71.2 t -130.08 152.47 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.594 -0.945 . . . . 0.0 109.462 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.598 HD23 ' N ' ' A' ' 90' ' ' LEU . 8.1 tt -110.51 142.64 42.01 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.642 -0.661 . . . . 0.0 110.488 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.833 HD12 ' CD1' ' A' ' 31' ' ' PHE . 86.1 mt -122.12 145.8 47.83 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.543 -0.723 . . . . 38.68 109.971 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -81.49 -26.3 35.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.299 -0.876 . . . . 0.0 111.036 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 93' ' ' GLU . 27.0 m -123.69 169.34 11.59 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.306 -0.871 . . . . 31.63 110.66 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.453 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 50.6 mt-10 -86.22 11.09 12.8 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.637 -0.664 . . . . 0.0 111.603 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 96.9 mt-30 -140.72 145.31 36.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.16 -0.963 . . . . 0.0 109.853 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.51 157.02 17.52 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 118.747 -1.692 . . . . 28.05 112.315 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -117.28 129.28 55.8 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 99.6 mtp -126.08 117.77 23.88 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.314 -0.866 . . . . 0.0 111.431 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.483 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 56.6 tt0 -126.3 149.18 49.3 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -155.46 -178.91 30.16 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 118.8 -1.667 . . . . 29.62 111.078 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.824 ' CE1' HD12 ' A' ' 112' ' ' ILE . 0.3 OUTLIER -136.92 155.74 49.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.769 -0.842 . . . . 0.0 109.494 179.506 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.585 ' HE2' HG11 ' A' ' 11' ' ' VAL . 6.6 m-85 -118.09 126.95 53.27 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.419 -0.801 . . . . 27.05 110.163 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.695 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 78.6 m-20 -85.49 120.36 26.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.113 -0.992 . . . . 0.0 108.761 177.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.588 ' CE ' HG11 ' A' ' 9' ' ' VAL . 14.2 tpp -123.93 160.67 27.03 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.109 0.48 . . . . 0.0 110.403 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.454 HG22 HG23 ' A' ' 48' ' ' VAL . 9.1 m -140.69 130.04 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.654 -0.654 . . . . 23.28 110.176 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.39 166.62 23.18 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.494 -0.754 . . . . 0.0 109.732 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -65.37 -29.77 70.53 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.546 -0.721 . . . . 0.0 110.153 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -74.64 -6.43 48.59 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.437 -0.789 . . . . 0.0 111.139 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.26 -9.41 59.38 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 120.082 -1.056 . . . . 30.43 110.581 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.476 HG21 ' CE2' ' A' ' 7' ' ' TYR . 27.4 m -57.89 135.01 56.81 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.009 -1.289 . . . . 0.0 110.023 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -101.13 138.86 37.61 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.359 -0.838 . . . . 0.0 110.726 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 41.9 p90 -162.69 143.8 10.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.664 -0.648 . . . . 28.03 109.942 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.824 HD12 ' CE1' ' A' ' 100' ' ' HIS . 30.5 pt -101.01 156.78 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 121.331 0.586 . . . . 0.0 110.877 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.485 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -121.66 100.19 44.19 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.617 -0.677 . . . . 0.0 109.421 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.422 ' HB3' ' CE1' ' A' ' 100' ' ' HIS . 45.3 Cg_endo -58.02 142.85 96.99 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 O-C-N 123.862 1.454 . . . . 33.31 112.176 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.501 HD13 ' CH2' ' A' ' 52' ' ' TRP . 66.9 mt -107.88 123.05 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.677 -0.861 . . . . 30.59 108.677 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.83 145.45 7.08 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.848 -0.532 . . . . 30.78 111.352 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.483 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -93.61 120.36 33.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.745 -0.597 . . . . 0.0 110.012 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.725 ' CE1' HD11 ' A' ' 120' ' ' LEU . 46.1 p90 -108.55 167.75 9.82 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.907 -0.775 . . . . 30.66 108.907 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.615 ' C ' HD12 ' A' ' 120' ' ' LEU . 8.8 p -113.7 154.1 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.349 -0.844 . . . . 0.0 110.498 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.725 HD11 ' CE1' ' A' ' 118' ' ' PHE . 7.1 mp -113.72 132.93 55.63 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.37 -0.604 . . . . 39.15 109.37 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.672 -0.642 . . . . 0.0 110.069 -179.808 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.588 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 28.5 mmt85 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 120.669 0.271 . . . . 0.0 110.741 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.444 ' CE2' HG21 ' A' ' 109' ' ' THR . 40.4 m-85 -121.22 113.34 19.82 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.412 -0.805 . . . . 31.93 110.383 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.461 ' C ' HG23 ' A' ' 9' ' ' VAL . 41.0 mtp85 -152.14 135.93 16.3 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.589 0.709 . . . . 0.0 110.092 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.461 HG23 ' C ' ' A' ' 8' ' ' ARG . 83.7 t -151.28 114.4 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 CA-C-O 121.442 0.639 . . . . 0.0 109.426 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -106.79 129.0 54.72 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.516 0.674 . . . . 0.0 109.907 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.19 138.4 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 109.694 -0.484 . . . . 28.21 109.694 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -121.8 136.66 54.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.416 -0.802 . . . . 0.0 109.931 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.733 HG22 HD13 ' A' ' 35' ' ' ILE . 62.4 t -129.39 136.4 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.484 -0.76 . . . . 27.95 110.375 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -125.71 104.57 27.26 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.732 -0.605 . . . . 0.0 110.443 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.425 ' HG3' ' CE1' ' A' ' 118' ' ' PHE . 49.9 Cg_endo -84.41 165.25 12.57 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 O-C-N 123.843 1.444 . . . . 33.0 110.929 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -158.03 132.61 8.33 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.562 0.696 . . . . 54.1 109.982 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.556 ' CE2' ' HB2' ' A' ' 19' ' ' ALA . 76.8 t80 -58.66 138.25 57.09 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.833 -0.542 . . . . 0.0 111.198 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.438 HD23 ' HB3' ' A' ' 21' ' ' GLN . 8.6 tp -115.47 80.53 1.45 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.028 0.918 . . . . 0.0 110.359 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.556 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -71.12 -35.97 71.95 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.494 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -68.8 -24.2 64.37 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.374 -0.829 . . . . 0.0 111.002 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.438 ' HB3' HD23 ' A' ' 18' ' ' LEU . 54.4 tp60 -121.34 46.82 1.97 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.382 -0.824 . . . . 52.37 110.389 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.739 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 34.3 t -166.05 149.85 7.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.456 -0.777 . . . . 55.19 110.894 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.625 HG23 ' HB2' ' A' ' 28' ' ' ARG . 8.7 t -122.04 92.94 48.81 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.457 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.5 Cg_endo -66.72 -23.1 49.13 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.761 1.401 . . . . 51.57 111.986 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -65.81 -22.68 66.58 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.267 -0.896 . . . . 0.0 110.947 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -105.97 23.59 13.74 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.251 -0.905 . . . . 0.0 110.734 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.33 28.85 73.08 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.625 ' HB2' HG23 ' A' ' 23' ' ' THR . 24.8 mmt85 -121.72 94.19 4.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.599 -0.942 . . . . 0.0 110.154 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.457 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 57.6 m-85 -105.33 131.66 52.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.538 -0.726 . . . . 46.07 109.122 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.739 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -114.7 120.56 40.53 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.609 -0.837 . . . . 0.0 111.043 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.788 ' CD1' HD12 ' A' ' 90' ' ' LEU . 86.8 m-85 -114.59 135.75 53.8 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.578 -0.701 . . . . 38.88 109.581 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.72 131.61 55.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.198 -0.939 . . . . 34.06 108.483 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.645 ' HE1' HG23 ' A' ' 88' ' ' VAL . 20.9 p90 -128.55 144.58 51.17 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.276 -0.969 . . . . 29.03 111.45 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.8 p -104.18 141.1 36.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.647 -0.658 . . . . 0.0 109.877 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.733 HD13 HG22 ' A' ' 13' ' ' VAL . 44.3 mm -106.89 132.24 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.728 0.775 . . . . 0.0 111.352 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -122.95 97.88 5.64 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.427 0.632 . . . . 40.24 109.578 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.608 HG22 ' CD1' ' A' ' 76' ' ' LEU . 77.6 mt -91.65 116.99 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.771 -0.581 . . . . 20.73 110.598 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -118.02 133.5 55.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.437 -0.789 . . . . 0.0 109.468 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -95.5 117.83 31.11 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.225 -0.59 . . . . 21.34 110.634 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.96 14.28 17.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.423 -0.798 . . . . 0.0 110.5 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.68 179.79 53.31 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.316 -1.514 . . . . 29.1 109.316 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.588 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . . . -92.42 -33.81 14.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.536 -0.979 . . . . 0.0 110.056 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.511 HG13 ' HD2' ' A' ' 44' ' ' PRO . 84.3 t -104.6 139.61 20.27 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.965 -0.46 . . . . 0.0 109.771 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.511 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.5 Cg_endo -51.26 146.2 24.7 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 O-C-N 123.709 1.373 . . . . 21.95 111.613 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.49 151.08 48.07 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.861 0.838 . . . . 20.91 111.524 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.437 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 52.6 ttp180 -126.02 153.35 44.51 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.641 HD22 HG13 ' A' ' 69' ' ' VAL . 7.2 tt -96.93 116.97 30.11 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.541 -0.724 . . . . 0.0 109.705 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.44 HG23 HG22 ' A' ' 104' ' ' VAL . 57.3 t -100.51 -27.0 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.607 -0.683 . . . . 0.0 110.516 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.727 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -140.69 162.4 35.49 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.132 -1.027 . . . . 0.0 112.124 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 32.6 ptt85 -140.76 139.0 34.54 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.322 0.582 . . . . 29.05 109.858 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.407 ' NE2' ' CG ' ' A' ' 63' ' ' GLN . 20.0 t-160 -143.32 111.45 6.15 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.653 -0.654 . . . . 27.97 110.264 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.57 ' CH2' HD13 ' A' ' 115' ' ' ILE . 60.5 m95 -105.64 135.85 46.31 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.33 0.586 . . . . 25.25 111.135 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -115.87 82.26 1.74 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.703 -0.623 . . . . 0.0 109.348 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.908 HG22 ' HG3' ' A' ' 97' ' ' MET . 16.3 pt -84.47 128.38 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.43 -0.794 . . . . 36.11 111.668 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.477 HG23 ' HB ' ' A' ' 61' ' ' THR . 17.6 m -120.57 132.13 55.0 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.492 -0.929 . . . . 33.98 108.492 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -88.69 169.89 11.28 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.664 0.745 . . . . 45.04 111.271 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.14 -7.48 13.47 Favored Glycine 0 N--CA 1.495 2.604 0 O-C-N 121.82 -0.55 . . . . 39.47 112.148 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -101.41 7.66 42.5 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 119.369 1.585 . . . . 0.0 110.682 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.07 -28.75 8.99 Favored Glycine 0 N--CA 1.493 2.457 0 O-C-N 121.193 -0.942 . . . . 0.0 110.892 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.26 141.24 58.84 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.232 -1.158 . . . . 62.78 109.617 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.477 ' HB ' HG23 ' A' ' 55' ' ' THR . 7.8 t -135.58 153.18 51.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.446 -0.784 . . . . 0.0 110.745 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -120.98 123.36 42.23 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.536 -0.728 . . . . 0.0 109.735 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.407 ' CG ' ' NE2' ' A' ' 51' ' ' HIS . 50.7 tt0 -99.15 136.6 38.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.659 -0.651 . . . . 0.0 110.827 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.94 131.68 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 CA-C-O 121.681 0.753 . . . . 37.94 110.352 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -126.91 127.45 44.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.955 -0.466 . . . . 0.0 110.055 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.11 172.63 32.74 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.304 -1.518 . . . . 31.82 109.304 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -115.61 159.18 21.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.403 -1.057 . . . . 0.0 110.085 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.65 96.55 0.01 OUTLIER Glycine 0 N--CA 1.501 2.98 0 O-C-N 121.424 -0.797 . . . . 22.62 111.531 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.641 HG13 HD22 ' A' ' 47' ' ' LEU . 23.7 m -45.56 133.31 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 O-C-N 121.338 -1.095 . . . . 17.51 111.589 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.1 m 41.6 35.97 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 CA-C-O 121.619 0.723 . . . . 20.55 111.408 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.4 21.5 58.34 Favored Glycine 0 N--CA 1.495 2.584 0 O-C-N 121.753 -0.592 . . . . 18.29 112.398 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.488 ' HG3' HG23 ' A' ' 69' ' ' VAL . 3.6 pt-20 -146.21 152.85 39.88 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 119.111 1.455 . . . . 0.0 112.473 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -118.56 72.95 10.81 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 108.449 -0.945 . . . . 18.21 108.449 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -55.01 139.64 79.8 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 O-C-N 123.781 1.411 . . . . 17.61 112.284 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.44 ' CZ3' ' HG2' ' A' ' 77' ' ' ARG . 5.2 t90 -99.56 75.54 1.95 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.608 ' CD1' HG22 ' A' ' 37' ' ' ILE . 12.4 mt -61.03 119.77 8.95 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.682 -0.636 . . . . 20.57 112.084 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.44 ' HG2' ' CZ3' ' A' ' 75' ' ' TRP . 18.1 mtm180 -86.48 157.86 55.2 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -53.84 128.28 29.0 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 O-C-N 123.492 1.259 . . . . 27.04 111.093 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.68 -16.59 56.16 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.769 -0.933 . . . . 24.74 110.769 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -88.17 164.75 15.52 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.133 -1.216 . . . . 29.38 110.533 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.18 149.82 34.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.586 -0.696 . . . . 0.0 110.124 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -118.65 147.54 43.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.49 -0.756 . . . . 18.56 109.17 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -143.34 139.85 30.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.168 -0.957 . . . . 0.0 111.124 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.556 ' CE1' HG21 ' A' ' 35' ' ' ILE . 53.2 p90 -150.92 159.73 44.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.614 -0.679 . . . . 26.65 109.716 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.2 m -102.12 136.64 41.6 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.363 -0.836 . . . . 28.14 110.92 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 17.9 t -124.95 170.25 11.29 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.681 -0.637 . . . . 33.88 109.912 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -140.54 125.34 2.85 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.827 -1.177 . . . . 31.8 110.495 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.645 HG23 ' HE1' ' A' ' 33' ' ' TYR . 76.2 t -129.98 152.26 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.592 -0.946 . . . . 0.0 109.293 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.493 HD23 ' N ' ' A' ' 90' ' ' LEU . 7.1 tt -111.01 142.91 42.52 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.627 -0.671 . . . . 0.0 110.712 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.788 HD12 ' CD1' ' A' ' 31' ' ' PHE . 89.4 mt -121.67 145.21 48.24 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.576 -0.703 . . . . 38.68 109.893 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -79.16 -26.73 42.72 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.211 -0.93 . . . . 0.0 110.939 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.9 p -124.43 172.29 9.27 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.361 -0.837 . . . . 31.63 110.729 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.456 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 48.8 mt-10 -86.56 12.38 10.59 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.62 -0.675 . . . . 0.0 111.58 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 15.1 pt20 -141.47 144.89 34.63 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.039 -1.038 . . . . 0.0 109.78 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 178.77 158.89 22.15 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 118.74 -1.695 . . . . 28.05 112.275 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -119.71 129.42 54.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 122.117 -0.637 . . . . 0.0 109.322 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.908 ' HG3' HG22 ' A' ' 54' ' ' ILE . 49.2 ttm -125.14 121.18 33.49 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.249 -0.907 . . . . 0.0 111.155 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.449 ' CD ' ' HB2' ' A' ' 117' ' ' ALA . 35.4 mt-30 -123.82 150.15 44.87 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.56 171.28 36.69 Favored Glycine 0 N--CA 1.5 2.931 0 C-N-CA 118.337 -1.887 . . . . 29.62 111.605 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 114' ' ' PRO . 51.6 m80 -135.3 153.97 51.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.895 -0.767 . . . . 0.0 109.685 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.725 ' CE2' HD11 ' A' ' 115' ' ' ILE . 5.3 m-85 -119.16 126.1 50.78 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.519 -0.738 . . . . 27.05 109.74 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.727 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 41.5 t0 -80.98 121.93 26.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.898 -1.126 . . . . 0.0 109.359 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.447 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 91.6 mmm -119.68 161.47 20.65 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.112 0.482 . . . . 0.0 110.066 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.44 HG22 HG23 ' A' ' 48' ' ' VAL . 8.5 m -140.86 127.62 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.551 -0.718 . . . . 23.28 110.335 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.88 167.47 21.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.585 -0.697 . . . . 0.0 109.581 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -64.06 -29.63 70.76 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.136 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -73.3 -11.19 60.41 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.534 -0.729 . . . . 0.0 111.136 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.91 -7.2 52.56 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 120.075 -1.059 . . . . 30.43 110.54 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.444 HG21 ' CE2' ' A' ' 7' ' ' TYR . 41.2 m -57.47 136.28 56.66 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.015 -1.285 . . . . 0.0 110.106 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -101.57 141.19 34.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.433 -0.792 . . . . 0.0 110.959 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 46.8 p90 -168.54 146.7 4.13 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.677 -0.639 . . . . 28.03 109.883 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.3 pt -102.63 159.27 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.673 -0.642 . . . . 0.0 111.222 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.02 97.13 50.64 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.429 ' HB3' ' CD2' ' A' ' 100' ' ' HIS . 46.0 Cg_endo -59.75 143.44 99.63 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 O-C-N 123.962 1.506 . . . . 33.31 112.332 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.725 HD11 ' CE2' ' A' ' 101' ' ' TYR . 72.7 mt -108.13 120.72 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.301 -0.999 . . . . 30.59 108.301 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -47.36 161.23 0.08 Allowed 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.304 0.573 . . . . 30.78 111.818 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.449 ' HB2' ' CD ' ' A' ' 98' ' ' GLN . . . -99.93 118.05 35.53 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.78 -0.575 . . . . 0.0 110.778 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.755 ' CE1' HD11 ' A' ' 120' ' ' LEU . 50.5 p90 -110.68 166.24 11.18 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.359 -0.978 . . . . 30.66 108.359 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.633 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.2 t -113.18 153.98 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.172 -0.955 . . . . 0.0 110.48 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.755 HD11 ' CE1' ' A' ' 118' ' ' PHE . 7.4 mp -113.35 130.57 56.25 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.169 -0.678 . . . . 39.15 109.169 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.4 m . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.668 -0.645 . . . . 0.0 110.062 -179.801 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.666 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 60.0 mtt180 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 120.734 0.302 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.683 ' CE2' HG21 ' A' ' 109' ' ' THR . 44.6 m-85 -123.77 119.56 30.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.505 -0.747 . . . . 31.93 110.501 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.489 ' C ' HG23 ' A' ' 9' ' ' VAL . 21.3 ttm180 -156.86 132.89 9.65 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.43 0.633 . . . . 0.0 110.081 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.489 HG23 ' C ' ' A' ' 8' ' ' ARG . 95.5 t -151.74 115.45 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.618 -0.676 . . . . 0.0 109.755 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -106.15 128.8 54.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.667 -0.646 . . . . 0.0 109.82 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.487 HG22 ' HA ' ' A' ' 37' ' ' ILE . 61.8 t -118.9 138.99 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.92 -0.487 . . . . 28.21 109.896 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -122.5 135.82 54.74 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.39 -0.818 . . . . 0.0 109.935 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.9 t -129.29 136.88 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.639 -0.663 . . . . 27.95 110.36 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -126.79 105.08 23.21 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.687 -0.633 . . . . 0.0 110.758 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -82.9 165.01 15.5 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 O-C-N 123.796 1.419 . . . . 33.0 110.808 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -157.69 131.62 8.07 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.725 0.774 . . . . 54.1 110.219 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.516 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 79.9 t80 -61.22 140.12 58.0 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.718 -0.614 . . . . 0.0 111.507 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.005 HD11 ' HB2' ' A' ' 32' ' ' ALA . 88.7 mt -116.95 82.39 1.8 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.944 0.878 . . . . 0.0 110.373 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.516 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -68.99 -34.64 75.62 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.137 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -69.9 -23.37 63.23 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.315 -0.865 . . . . 0.0 111.15 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -121.46 39.12 3.92 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.274 -0.892 . . . . 52.37 110.983 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.613 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 44.1 p -158.92 149.78 20.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.292 -0.88 . . . . 55.19 111.015 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.603 HG23 ' HB2' ' A' ' 28' ' ' ARG . 4.8 t -120.33 92.9 47.83 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.46 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 48.6 Cg_endo -66.23 -23.05 52.82 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 O-C-N 123.913 1.481 . . . . 51.57 111.894 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -67.25 -22.15 65.69 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.257 -0.902 . . . . 0.0 111.141 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -105.6 23.22 14.18 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.261 -0.9 . . . . 0.0 110.937 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.08 27.38 73.43 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.603 ' HB2' HG23 ' A' ' 23' ' ' THR . 29.6 mtt85 -121.0 94.48 4.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.533 -0.98 . . . . 0.0 110.023 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.46 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 61.3 m-85 -105.24 134.91 47.56 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.498 -0.751 . . . . 46.07 109.26 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -115.51 121.18 41.9 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.082 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.867 ' CD1' HD12 ' A' ' 90' ' ' LEU . 87.8 m-85 -116.64 133.3 56.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.509 -0.744 . . . . 38.88 109.727 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 1.005 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -112.51 131.66 55.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.279 -0.888 . . . . 34.06 108.619 178.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.588 ' HE1' HG23 ' A' ' 88' ' ' VAL . 25.0 p90 -127.05 144.47 51.02 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.307 -0.957 . . . . 29.03 111.386 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.3 t -104.21 139.04 39.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.695 -0.628 . . . . 0.0 109.388 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.831 HD12 ' CZ ' ' A' ' 84' ' ' TYR . 79.3 mt -108.4 133.94 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.714 0.768 . . . . 0.0 111.493 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -123.91 99.01 6.05 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.526 0.679 . . . . 40.24 109.718 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.559 HG22 ' CD1' ' A' ' 76' ' ' LEU . 83.9 mt -91.15 117.73 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.875 -0.515 . . . . 20.73 110.492 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -117.32 131.5 56.79 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.442 -0.786 . . . . 0.0 109.35 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -96.43 117.61 31.24 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 120.261 -0.575 . . . . 21.34 110.235 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -118.0 17.42 14.12 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.318 -0.864 . . . . 0.0 110.525 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.3 178.28 53.95 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.519 -1.432 . . . . 29.1 109.519 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.666 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . . . -86.96 -42.55 13.06 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.572 -0.958 . . . . 0.0 110.282 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.515 HG13 ' HD2' ' A' ' 44' ' ' PRO . 86.4 t -98.69 139.96 21.46 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.954 -0.466 . . . . 0.0 109.982 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.515 ' HD2' HG13 ' A' ' 43' ' ' VAL . 40.3 Cg_endo -53.03 145.65 40.86 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 O-C-N 123.805 1.423 . . . . 21.95 111.67 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.421 ' HB1' ' HG2' ' A' ' 103' ' ' MET . . . -140.56 152.24 45.36 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.687 0.756 . . . . 20.91 111.22 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.444 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 18.2 ptt-85 -127.76 153.85 46.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.803 -0.561 . . . . 0.0 109.665 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.761 HD22 HG13 ' A' ' 69' ' ' VAL . 6.5 tt -94.66 117.05 29.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.384 -0.823 . . . . 0.0 109.247 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.7 m -100.93 -24.44 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.732 -0.605 . . . . 0.0 111.194 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.766 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -142.44 163.1 33.76 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.19 -1.004 . . . . 0.0 112.081 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.499 ' HD2' HG12 ' A' ' 69' ' ' VAL . 1.8 ptm180 -142.06 140.05 32.46 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.542 0.687 . . . . 29.05 110.517 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.406 ' CD2' ' OD1' ' A' ' 65' ' ' ASP . 20.8 t-160 -144.39 112.93 6.59 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.42 0.628 . . . . 27.97 109.809 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -103.61 135.93 44.28 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.499 0.666 . . . . 25.25 111.532 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -115.8 82.31 1.74 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.78 HG22 ' HG3' ' A' ' 97' ' ' MET . 13.1 pt -83.1 127.11 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 121.75 0.786 . . . . 36.11 111.567 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.983 HG23 HG22 ' A' ' 61' ' ' THR . 95.4 m -122.0 130.03 52.96 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.732 -0.84 . . . . 33.98 108.732 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -91.56 169.77 10.48 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.757 0.789 . . . . 45.04 111.493 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.98 -5.91 16.52 Favored Glycine 0 N--CA 1.496 2.683 0 O-C-N 121.856 -0.527 . . . . 39.47 112.345 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -100.26 5.58 44.61 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 119.501 1.65 . . . . 0.0 110.636 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.449 ' O ' HG23 ' A' ' 61' ' ' THR . . . 91.91 -27.34 10.2 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.48 141.43 58.77 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.164 -1.198 . . . . 62.78 109.228 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.983 HG22 HG23 ' A' ' 55' ' ' THR . 61.8 p -133.73 150.06 51.49 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.664 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -121.93 121.86 38.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.498 -0.751 . . . . 0.0 109.601 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.401 ' CG ' ' NE2' ' A' ' 51' ' ' HIS . 51.9 tt0 -100.53 134.86 42.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.667 -0.646 . . . . 0.0 110.705 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.7 t -128.93 129.97 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.714 0.768 . . . . 37.94 110.214 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.406 ' OD1' ' CD2' ' A' ' 51' ' ' HIS . 58.9 m-20 -125.58 126.87 45.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.86 -0.525 . . . . 0.0 109.808 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.03 146.27 15.49 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.51 -1.436 . . . . 31.82 109.51 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -71.84 154.26 41.38 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.607 -0.937 . . . . 0.0 110.196 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 50.05 -170.63 0.17 Allowed Glycine 0 N--CA 1.497 2.762 0 O-C-N 121.373 -0.829 . . . . 22.62 111.268 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.761 HG13 HD22 ' A' ' 47' ' ' LEU . 13.3 m -129.92 128.0 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.89 -0.77 . . . . 17.51 109.155 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.639 HG11 ' CE2' ' A' ' 84' ' ' TYR . 11.5 m 41.49 33.48 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 CA-C-O 121.649 0.738 . . . . 20.55 111.397 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.59 18.76 61.32 Favored Glycine 0 N--CA 1.498 2.767 0 O-C-N 121.769 -0.582 . . . . 18.29 113.101 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.416 ' O ' HG22 ' A' ' 69' ' ' VAL . 9.8 pt-20 -146.59 150.2 35.02 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 119.386 1.593 . . . . 0.0 112.618 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -116.14 72.85 4.85 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.257 -1.016 . . . . 18.21 108.257 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -55.1 142.49 77.3 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 O-C-N 123.761 1.401 . . . . 17.61 112.331 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.444 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 3.1 t90 -101.87 76.54 1.63 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.559 ' CD1' HG22 ' A' ' 37' ' ' ILE . 10.4 mt -61.84 117.87 6.45 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.612 -0.68 . . . . 20.57 111.921 -178.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -87.83 159.04 49.8 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -54.0 129.07 32.45 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 O-C-N 123.579 1.305 . . . . 27.04 111.119 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.62 -18.03 49.0 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.929 -0.868 . . . . 24.74 110.929 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -87.33 165.07 15.89 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.005 -1.291 . . . . 29.38 110.458 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.22 148.69 33.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.586 -0.696 . . . . 0.0 110.289 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.506 ' HD2' HD12 ' A' ' 37' ' ' ILE . 89.4 t80 -117.71 143.47 46.17 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.085 -0.709 . . . . 18.56 109.085 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -146.99 140.89 25.89 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.2 -0.938 . . . . 0.0 111.314 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.831 ' CZ ' HD12 ' A' ' 35' ' ' ILE . 42.7 p90 -152.8 162.3 41.45 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.539 -0.725 . . . . 26.65 109.653 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 54.2 m -98.61 136.63 38.42 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.439 -0.788 . . . . 28.14 111.248 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.478 ' HG ' ' HH ' ' A' ' 33' ' ' TYR . 15.2 t -125.06 169.11 12.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.639 -0.663 . . . . 33.88 109.774 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -139.85 126.3 3.22 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.769 -1.205 . . . . 31.8 110.487 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.588 HG23 ' HE1' ' A' ' 33' ' ' TYR . 77.9 t -131.28 151.7 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.63 -0.923 . . . . 0.0 109.31 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.18 144.39 40.41 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.582 -0.699 . . . . 0.0 110.862 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.867 HD12 ' CD1' ' A' ' 31' ' ' PHE . 94.6 mt -122.33 148.07 45.49 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.621 -0.674 . . . . 38.68 110.026 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.408 ' O ' ' CE1' ' A' ' 29' ' ' TYR . 38.6 tp10 -79.01 -26.4 43.24 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.39 -0.819 . . . . 0.0 110.757 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.2 p -124.09 172.1 9.26 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.336 -0.853 . . . . 31.63 110.621 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.457 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 50.4 mt-10 -85.42 10.67 12.18 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.607 -0.683 . . . . 0.0 111.63 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 14.4 pt20 -141.39 145.49 35.42 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.125 -0.984 . . . . 0.0 109.811 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.6 155.46 15.24 Favored Glycine 0 N--CA 1.496 2.682 0 C-N-CA 118.871 -1.633 . . . . 28.05 112.219 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -120.47 130.2 54.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 122.125 -0.632 . . . . 0.0 109.374 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.78 ' HG3' HG22 ' A' ' 54' ' ' ILE . 56.1 ttm -126.82 123.77 38.1 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.37 -0.831 . . . . 0.0 111.533 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.61 ' CD ' ' HB2' ' A' ' 117' ' ' ALA . 40.7 mt-30 -123.1 148.93 45.13 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.67 175.52 41.33 Favored Glycine 0 N--CA 1.499 2.842 0 C-N-CA 118.738 -1.696 . . . . 29.62 111.05 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.4 ' NE2' ' HB3' ' A' ' 51' ' ' HIS . 11.7 p-80 -140.04 157.79 45.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.828 -0.807 . . . . 0.0 110.675 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.606 ' CE2' HD11 ' A' ' 115' ' ' ILE . 6.0 m-85 -114.62 130.01 56.74 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.673 -0.642 . . . . 27.05 109.787 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.766 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 11.2 t70 -82.02 121.81 27.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 108.928 178.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.434 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 2.0 ttm -121.93 161.92 21.98 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.204 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.5 m -141.65 130.34 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.639 -0.663 . . . . 23.28 110.486 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.479 ' HB3' ' HB ' ' A' ' 109' ' ' THR . . . -72.14 166.73 21.73 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.51 -0.744 . . . . 0.0 109.609 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -66.92 -29.36 69.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.533 -0.729 . . . . 0.0 110.284 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -77.36 -4.29 44.43 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.426 -0.796 . . . . 0.0 111.359 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.27 -9.7 54.02 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.087 -1.054 . . . . 30.43 110.519 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.683 HG21 ' CE2' ' A' ' 7' ' ' TYR . 57.6 m -57.02 133.61 55.09 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.045 -1.268 . . . . 0.0 110.093 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -102.32 139.44 37.93 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -0.866 . . . . 0.0 110.668 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.434 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 38.9 p90 -165.26 144.05 6.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.705 -0.622 . . . . 28.03 109.886 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.8 pt -101.85 158.89 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.636 -0.665 . . . . 0.0 110.874 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.01 95.12 49.1 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -60.48 144.73 99.54 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 O-C-N 123.958 1.504 . . . . 33.31 112.24 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.606 HD11 ' CE2' ' A' ' 101' ' ' TYR . 71.7 mt -108.65 121.55 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.698 -0.852 . . . . 30.59 108.698 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.61 167.05 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.258 0.552 . . . . 30.78 111.578 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.61 ' HB2' ' CD ' ' A' ' 98' ' ' GLN . . . -95.03 118.92 32.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.65 -0.656 . . . . 0.0 110.759 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.45 ' CE1' HD11 ' A' ' 120' ' ' LEU . 38.9 p90 -112.59 160.34 17.95 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.343 -0.984 . . . . 30.66 108.343 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.634 ' C ' HD12 ' A' ' 120' ' ' LEU . 59.1 t -116.86 152.98 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.169 -0.957 . . . . 0.0 110.753 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.747 HD22 HD11 ' A' ' 90' ' ' LEU . 7.3 mp -114.16 131.26 56.5 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.098 -0.704 . . . . 39.15 109.098 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 40.4 p . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.607 -0.683 . . . . 0.0 110.033 -179.831 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.9 0.381 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.439 ' CE2' HG21 ' A' ' 109' ' ' THR . 37.1 m-85 -112.24 104.65 12.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.546 -0.721 . . . . 31.93 110.158 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.478 ' C ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -150.29 131.58 14.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.655 -0.653 . . . . 0.0 109.982 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.746 HG11 ' SD ' ' A' ' 103' ' ' MET . 69.2 t -151.98 114.53 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.519 -0.738 . . . . 0.0 109.522 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -107.58 129.88 54.94 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.636 0.731 . . . . 0.0 109.954 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.535 HG11 ' HE2' ' A' ' 101' ' ' TYR . 57.3 t -117.35 139.69 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 109.562 -0.533 . . . . 28.21 109.562 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -120.49 137.19 54.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.409 -0.807 . . . . 0.0 110.017 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.763 HG22 HD13 ' A' ' 35' ' ' ILE . 60.7 t -127.46 135.99 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.304 0.573 . . . . 27.95 110.056 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.2 m -125.0 104.03 30.07 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.77 -0.581 . . . . 0.0 110.392 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -84.16 164.31 13.21 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 O-C-N 123.927 1.488 . . . . 33.0 110.907 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -156.62 131.86 9.22 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.592 0.711 . . . . 54.1 109.723 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 19' ' ' ALA . 69.8 t80 -60.1 138.99 57.77 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.279 0.562 . . . . 0.0 111.146 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.444 ' HA ' HD12 ' A' ' 18' ' ' LEU . 8.8 tp -116.01 78.05 1.15 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 122.075 0.941 . . . . 0.0 110.476 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.572 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -71.82 -35.45 69.93 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.119 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -68.01 -24.05 65.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.358 -0.839 . . . . 0.0 110.895 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -121.77 41.66 3.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.365 -0.835 . . . . 52.37 110.416 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.679 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 21.7 t -163.69 150.98 12.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.506 -0.747 . . . . 55.19 110.789 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 23' ' ' THR . 8.2 t -122.49 94.52 47.65 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.593 -0.692 . . . . 0.0 109.246 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.469 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.8 Cg_endo -66.17 -22.91 53.39 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.773 1.407 . . . . 51.57 111.466 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.59 -23.95 67.43 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.341 -0.849 . . . . 0.0 110.819 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -105.96 23.13 14.48 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.357 -0.84 . . . . 0.0 110.705 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.33 29.44 73.15 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.51 ' HB3' HG23 ' A' ' 23' ' ' THR . 54.9 ttt85 -121.5 93.05 3.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.634 -0.921 . . . . 0.0 110.13 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.469 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 56.6 m-85 -104.53 133.19 49.81 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.035 -0.728 . . . . 46.07 109.035 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.679 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -116.0 118.87 34.11 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.938 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -114.05 134.25 54.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.629 -0.669 . . . . 38.88 109.72 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.91 132.08 55.47 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.228 -0.92 . . . . 34.06 108.563 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.586 ' HE1' HG23 ' A' ' 88' ' ' VAL . 22.9 p90 -129.06 144.56 51.24 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.175 -1.01 . . . . 29.03 111.476 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.2 m -104.4 139.95 38.62 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.717 -0.614 . . . . 0.0 109.788 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.763 HD13 HG22 ' A' ' 13' ' ' VAL . 43.7 mm -105.55 132.29 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.735 0.779 . . . . 0.0 111.535 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -123.49 98.02 5.66 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.482 0.658 . . . . 40.24 109.722 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.776 HG22 HD22 ' A' ' 76' ' ' LEU . 78.8 mt -91.18 117.27 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.762 -0.586 . . . . 20.73 110.458 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -117.99 135.56 54.07 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.512 -0.742 . . . . 0.0 109.453 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.606 ' HB2' HD23 ' A' ' 76' ' ' LEU . 42.7 t-20 -92.67 117.76 30.33 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.721 -0.612 . . . . 21.34 110.867 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.16 9.34 17.14 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.435 -0.79 . . . . 0.0 110.456 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.9 173.71 49.13 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.348 -1.501 . . . . 29.1 109.348 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.38 -31.01 21.71 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.583 -0.951 . . . . 0.0 110.216 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.512 HG13 ' HD2' ' A' ' 44' ' ' PRO . 87.2 t -106.71 140.6 21.51 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.853 -0.529 . . . . 0.0 110.076 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.512 ' HD2' HG13 ' A' ' 43' ' ' VAL . 40.3 Cg_endo -53.52 148.38 34.82 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 O-C-N 123.752 1.396 . . . . 21.95 111.673 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.499 ' HB1' ' HZ ' ' A' ' 111' ' ' PHE . . . -138.29 151.12 47.3 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.68 0.752 . . . . 20.91 111.377 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.429 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 45.5 ttp180 -126.06 155.31 41.75 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.851 HD22 HG13 ' A' ' 69' ' ' VAL . 7.0 tt -99.29 117.78 34.5 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.554 -0.716 . . . . 0.0 109.711 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.558 HG23 HG22 ' A' ' 104' ' ' VAL . 62.3 t -100.48 -29.4 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.547 -0.72 . . . . 0.0 111.015 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 102' ' ' ASP . . . -142.27 164.76 29.27 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 118.981 -1.088 . . . . 0.0 112.42 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -142.72 140.54 31.53 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.425 0.631 . . . . 29.05 110.223 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -142.92 114.06 7.76 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.315 0.578 . . . . 27.97 109.759 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.6 ' CH2' HD13 ' A' ' 115' ' ' ILE . 86.6 m95 -100.38 133.4 44.85 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.676 -0.64 . . . . 25.25 110.971 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -115.51 77.14 1.05 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.589 -0.694 . . . . 0.0 109.139 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.811 HG22 ' CG ' ' A' ' 97' ' ' MET . 17.1 pt -82.85 127.99 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.468 -0.77 . . . . 36.11 111.881 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.5 m -120.79 130.09 53.85 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.329 -0.989 . . . . 33.98 108.329 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -89.06 169.98 11.04 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.701 0.762 . . . . 45.04 111.553 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.06 -5.74 8.37 Favored Glycine 0 N--CA 1.495 2.588 0 O-C-N 121.88 -0.513 . . . . 39.47 112.246 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -101.54 6.58 42.3 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 119.417 1.608 . . . . 0.0 110.516 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.75 -31.13 6.74 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -62.99 141.95 58.56 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.316 -1.108 . . . . 62.78 110.019 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.1 t -135.31 153.2 51.95 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.574 -0.704 . . . . 0.0 110.653 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -121.97 124.36 43.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.535 -0.728 . . . . 0.0 110.184 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -102.27 134.79 44.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.674 -0.641 . . . . 0.0 110.593 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.2 t -128.49 131.57 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.587 -0.696 . . . . 37.94 110.086 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -125.59 126.72 45.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.813 -0.554 . . . . 0.0 110.137 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.12 148.84 20.71 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.463 -1.455 . . . . 31.82 109.463 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -75.27 154.7 37.31 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.528 -0.984 . . . . 0.0 110.505 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.09 -170.38 0.1 Allowed Glycine 0 N--CA 1.499 2.896 0 O-C-N 121.46 -0.775 . . . . 22.62 111.454 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.851 HG13 HD22 ' A' ' 47' ' ' LEU . 15.5 m -130.85 128.88 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.862 -0.787 . . . . 17.51 109.331 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 69' ' ' VAL . 10.9 m 41.14 33.77 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 CA-C-O 121.485 0.66 . . . . 20.55 111.844 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.93 17.45 67.52 Favored Glycine 0 N--CA 1.498 2.799 0 O-C-N 121.456 -0.777 . . . . 18.29 112.957 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 69' ' ' VAL . 15.4 pt-20 -145.23 150.45 36.71 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-N 119.275 1.537 . . . . 0.0 111.856 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -115.37 75.57 4.68 Favored Pre-proline 0 N--CA 1.492 1.637 0 N-CA-C 108.932 -0.766 . . . . 18.21 108.932 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -57.49 138.07 84.42 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 O-C-N 123.885 1.466 . . . . 17.61 112.043 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.429 ' CD1' ' HB2' ' A' ' 46' ' ' ARG . 4.3 t90 -100.82 75.89 1.74 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.776 HD22 HG22 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -58.95 116.56 3.87 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.545 -0.722 . . . . 20.57 111.239 -178.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.427 ' HG2' ' CZ3' ' A' ' 75' ' ' TRP . 4.5 mtt180 -86.83 159.25 52.3 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -54.39 125.87 20.36 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 O-C-N 123.585 1.308 . . . . 27.04 110.75 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.51 -18.21 43.8 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.732 -0.947 . . . . 24.74 110.732 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -89.24 165.64 14.3 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.996 -1.297 . . . . 29.38 110.243 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 37' ' ' ILE . . . -148.27 151.79 36.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.494 -0.753 . . . . 0.0 110.5 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.494 ' N ' HD11 ' A' ' 76' ' ' LEU . 65.3 t80 -118.17 147.53 43.26 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.479 -0.763 . . . . 18.56 109.042 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -144.42 140.73 29.17 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.192 -0.943 . . . . 0.0 111.082 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.443 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 47.2 p90 -150.16 160.0 44.0 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.653 -0.654 . . . . 26.65 109.671 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 62.8 m -100.37 136.54 40.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.464 -0.772 . . . . 28.14 110.651 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 29.2 t -124.04 167.9 13.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.578 -0.701 . . . . 33.88 110.033 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.15 122.46 2.09 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.876 -1.154 . . . . 31.8 110.274 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.586 HG23 ' HE1' ' A' ' 33' ' ' TYR . 80.3 t -129.72 148.19 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.575 -0.956 . . . . 0.0 109.352 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 30' ' ' ALA . 87.0 mt -107.97 144.49 35.19 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.522 -0.736 . . . . 0.0 110.408 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.2 tp -121.57 144.07 48.94 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.581 -0.699 . . . . 38.68 109.787 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -105.15 -2.19 24.55 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.329 -0.857 . . . . 0.0 111.332 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.584 HG22 ' HG2' ' A' ' 94' ' ' GLN . 29.6 m -109.29 -35.96 6.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.068 -1.02 . . . . 31.63 110.931 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.51 ' CB ' ' O ' ' A' ' 92' ' ' THR . 33.3 tt0 87.72 -14.07 0.44 Allowed 'General case' 0 N--CA 1.524 3.266 0 C-N-CA 123.196 0.598 . . . . 0.0 111.059 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.584 ' HG2' HG22 ' A' ' 92' ' ' THR . 14.3 pt20 -139.97 146.41 39.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.119 -0.988 . . . . 0.0 109.832 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 160.79 179.85 35.81 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 118.421 -1.847 . . . . 28.05 112.643 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -121.66 130.79 53.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 122.237 -0.567 . . . . 0.0 109.668 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.811 ' CG ' HG22 ' A' ' 54' ' ' ILE . 0.5 OUTLIER -126.58 124.61 40.36 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.314 -0.866 . . . . 0.0 111.543 -178.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.803 ' HG2' ' HB2' ' A' ' 117' ' ' ALA . 88.7 mt-30 -118.05 151.4 37.59 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.434 ' HA3' ' CE3' ' A' ' 52' ' ' TRP . . . -156.02 167.58 33.31 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 118.873 -1.632 . . . . 29.62 110.902 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -137.75 156.87 47.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.73 -0.865 . . . . 0.0 109.846 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.688 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 12.2 m-85 -117.94 127.21 53.62 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.546 -0.721 . . . . 27.05 110.154 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.581 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 80.4 m-20 -85.64 121.45 28.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.929 -1.107 . . . . 0.0 108.732 177.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.746 ' SD ' HG11 ' A' ' 9' ' ' VAL . 76.8 mtp -123.87 164.06 20.01 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.239 0.543 . . . . 0.0 110.672 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.558 HG22 HG23 ' A' ' 48' ' ' VAL . 9.1 m -142.8 129.21 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.678 -0.639 . . . . 23.28 110.377 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.52 166.85 22.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.431 -0.793 . . . . 0.0 109.229 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -63.65 -28.94 70.26 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.108 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -74.01 -12.96 60.79 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.455 -0.778 . . . . 0.0 111.044 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.06 -6.34 43.09 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.351 -1.099 . . . . 30.43 110.351 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.439 HG21 ' CE2' ' A' ' 7' ' ' TYR . 48.0 m -58.62 137.36 57.56 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.082 -1.246 . . . . 0.0 109.952 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -101.42 139.77 36.63 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.362 -0.836 . . . . 0.0 110.947 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.499 ' HZ ' ' HB1' ' A' ' 45' ' ' ALA . 45.1 p90 -163.02 141.81 8.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.715 -0.616 . . . . 28.03 109.782 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 84.9 mt -101.74 157.92 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.738 -0.601 . . . . 0.0 110.813 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.688 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -120.01 95.82 49.22 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -60.14 146.14 96.9 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 O-C-N 124.013 1.533 . . . . 33.31 112.201 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.638 HD11 ' CZ ' ' A' ' 101' ' ' TYR . 69.0 mt -111.43 121.55 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.731 -0.84 . . . . 30.59 108.731 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -47.58 161.66 0.08 Allowed 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 121.199 0.524 . . . . 30.78 111.641 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.803 ' HB2' ' HG2' ' A' ' 98' ' ' GLN . . . -98.71 122.95 42.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.584 -0.698 . . . . 0.0 110.807 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.61 ' HE1' HD11 ' A' ' 120' ' ' LEU . 46.3 p90 -109.86 162.91 14.03 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.409 -0.959 . . . . 30.66 108.409 178.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.583 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.0 t -114.22 155.34 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.338 -0.851 . . . . 0.0 110.253 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.637 ' N ' HD12 ' A' ' 120' ' ' LEU . 7.9 mp -110.63 131.98 54.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.684 -0.635 . . . . 39.15 109.422 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.8 p . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.807 -0.558 . . . . 0.0 110.126 -179.772 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.463 ' HG3' ' HB3' ' A' ' 42' ' ' ALA . 32.4 ttp180 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 120.833 0.349 . . . . 0.0 110.377 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.475 ' CE2' HG21 ' A' ' 109' ' ' THR . 34.3 m-85 -115.42 109.13 17.42 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.566 -0.709 . . . . 31.93 110.154 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.451 ' C ' HG23 ' A' ' 9' ' ' VAL . 58.8 mtp85 -151.89 135.63 16.3 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.666 0.746 . . . . 0.0 110.347 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.735 HG11 ' CE ' ' A' ' 103' ' ' MET . 62.4 t -150.68 116.08 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.478 0.656 . . . . 0.0 109.415 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -107.07 128.93 54.81 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.551 0.691 . . . . 0.0 109.916 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.5 t -118.93 137.27 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.813 -0.554 . . . . 28.21 109.844 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -123.6 136.61 54.61 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.351 -0.843 . . . . 0.0 109.649 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.827 HG22 HD13 ' A' ' 35' ' ' ILE . 57.9 t -129.05 137.67 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.621 -0.674 . . . . 27.95 110.688 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.3 t -126.34 105.66 24.59 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.77 -0.581 . . . . 0.0 110.44 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.442 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 51.1 Cg_endo -83.8 166.89 13.18 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 O-C-N 123.799 1.42 . . . . 33.0 111.236 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -157.77 130.19 7.24 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.474 0.654 . . . . 54.1 109.732 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.471 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 81.5 t80 -60.54 140.03 57.51 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.788 -0.57 . . . . 0.0 111.407 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.073 HD11 ' HB2' ' A' ' 32' ' ' ALA . 92.6 mt -116.46 81.39 1.61 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.9 0.857 . . . . 0.0 110.462 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.471 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -66.58 -36.08 81.77 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.968 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -69.98 -22.99 63.09 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.366 -0.834 . . . . 0.0 111.127 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -121.33 38.42 4.09 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.218 -0.926 . . . . 52.37 111.258 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.714 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 45.4 p -160.09 146.47 15.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.269 -0.895 . . . . 55.19 111.161 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.2 m -117.7 92.09 40.34 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.517 -0.739 . . . . 0.0 109.043 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.454 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.3 Cg_endo -66.91 -25.36 45.09 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 O-C-N 123.925 1.487 . . . . 51.57 111.374 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -66.35 -23.93 66.43 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.552 -0.717 . . . . 0.0 110.846 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -106.84 24.51 12.63 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.334 -0.854 . . . . 0.0 110.581 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.5 30.57 73.17 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -120.02 92.37 3.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.602 -0.94 . . . . 0.0 110.111 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.454 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 81.2 m-85 -105.06 131.21 52.87 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.47 -0.769 . . . . 46.07 109.296 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.714 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -118.32 120.76 38.59 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.406 -0.809 . . . . 0.0 111.34 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.811 ' CD1' HD12 ' A' ' 90' ' ' LEU . 67.2 m-85 -116.44 134.6 54.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.459 -0.776 . . . . 38.88 109.819 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 1.073 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -110.92 131.42 55.06 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.379 -0.971 . . . . 34.06 108.379 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.619 ' HE1' HG23 ' A' ' 88' ' ' VAL . 23.9 p90 -127.58 143.69 51.15 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.112 -1.035 . . . . 29.03 111.559 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.2 m -103.25 139.24 38.97 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.827 HD13 HG22 ' A' ' 13' ' ' VAL . 40.6 mm -106.66 133.75 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.626 0.727 . . . . 0.0 111.488 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -123.25 98.78 6.03 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.422 0.63 . . . . 40.24 109.751 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.792 HG22 HD22 ' A' ' 76' ' ' LEU . 81.3 mt -90.33 116.11 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.653 -0.654 . . . . 20.73 110.408 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -117.91 134.76 54.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.517 -0.739 . . . . 0.0 109.53 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.569 ' HB2' HD23 ' A' ' 76' ' ' LEU . 22.3 t-20 -92.82 117.64 30.23 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 120.234 -0.586 . . . . 21.34 110.503 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.1 11.06 17.53 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.404 -0.81 . . . . 0.0 110.482 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.27 171.62 48.25 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.907 -1.677 . . . . 29.1 108.907 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.463 ' HB3' ' HG3' ' A' ' 6' ' ' ARG . . . -84.53 -31.89 24.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.442 -1.034 . . . . 0.0 110.09 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.51 HG13 ' HD2' ' A' ' 44' ' ' PRO . 87.1 t -103.15 139.67 20.33 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.813 -0.555 . . . . 0.0 109.873 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.51 ' HD2' HG13 ' A' ' 43' ' ' VAL . 40.1 Cg_endo -53.21 145.09 45.32 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 O-C-N 123.891 1.469 . . . . 21.95 111.748 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.02 151.8 45.74 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.674 0.75 . . . . 20.91 111.112 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.439 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 2.1 ptt85 -127.36 158.68 36.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.768 -0.583 . . . . 0.0 109.596 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.908 HD22 HG13 ' A' ' 69' ' ' VAL . 6.4 tt -96.68 118.06 32.34 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.486 -0.759 . . . . 0.0 109.5 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.1 p -101.2 -24.41 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.589 -0.695 . . . . 0.0 111.071 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.794 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -142.3 163.88 31.65 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.213 -0.929 . . . . 0.0 111.901 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.5 ptt85 -138.16 137.65 37.85 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.437 0.636 . . . . 29.05 110.201 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.403 ' CD2' ' OD1' ' A' ' 65' ' ' ASP . 20.4 t-160 -142.11 111.29 6.41 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.417 0.627 . . . . 27.97 109.852 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.415 ' CH2' HG21 ' A' ' 115' ' ' ILE . 66.2 m95 -103.35 133.8 47.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.682 -0.637 . . . . 25.25 111.396 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -115.77 80.76 1.49 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.892 HG22 ' HG3' ' A' ' 97' ' ' MET . 17.2 pt -86.0 129.14 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.49 -0.756 . . . . 36.11 111.755 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.812 HG23 HG22 ' A' ' 61' ' ' THR . 86.6 m -120.04 129.96 54.48 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.362 -0.977 . . . . 33.98 108.362 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -91.15 169.99 10.39 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.582 0.706 . . . . 45.04 111.309 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.12 -6.72 14.24 Favored Glycine 0 N--CA 1.495 2.633 0 O-C-N 121.848 -0.533 . . . . 39.47 112.066 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -101.71 6.84 42.04 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 119.357 1.579 . . . . 0.0 110.771 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 61' ' ' THR . . . 92.75 -33.11 5.18 Favored Glycine 0 N--CA 1.496 2.644 0 C-N-CA 120.329 -0.939 . . . . 0.0 110.983 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.29 142.34 54.82 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.146 -1.208 . . . . 62.78 109.835 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.812 HG22 HG23 ' A' ' 55' ' ' THR . 69.3 p -133.49 152.4 51.9 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.599 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.415 ' HB2' HD11 ' A' ' 54' ' ' ILE . 49.3 mt-10 -121.15 121.89 38.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.584 -0.698 . . . . 0.0 109.833 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.403 ' CG ' ' NE2' ' A' ' 51' ' ' HIS . 46.9 tt0 -102.4 135.3 44.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.577 -0.702 . . . . 0.0 110.658 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.2 t -129.52 130.44 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.705 0.764 . . . . 37.94 110.484 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.403 ' OD1' ' CD2' ' A' ' 51' ' ' HIS . 77.9 m-20 -127.41 126.46 42.46 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.06 148.53 20.0 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.806 -1.318 . . . . 31.82 109.806 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -71.09 152.31 43.61 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.447 -1.031 . . . . 0.0 110.22 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 50.52 -172.17 0.14 Allowed Glycine 0 N--CA 1.498 2.812 0 O-C-N 121.403 -0.811 . . . . 22.62 111.345 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.908 HG13 HD22 ' A' ' 47' ' ' LEU . 14.4 m -129.79 128.53 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.87 -0.782 . . . . 17.51 109.631 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 69' ' ' VAL . 10.6 m 41.32 34.62 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 CA-C-O 121.578 0.704 . . . . 20.55 111.733 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.51 17.06 67.12 Favored Glycine 0 N--CA 1.499 2.837 0 O-C-N 121.658 -0.651 . . . . 18.29 112.991 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -145.67 150.36 36.16 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 119.179 1.489 . . . . 0.0 112.118 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -115.75 73.15 4.33 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.85 -0.796 . . . . 18.21 108.85 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -55.87 141.37 85.57 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 O-C-N 123.876 1.461 . . . . 17.61 112.281 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.439 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 2.9 t90 -103.43 77.17 1.48 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.792 HD22 HG22 ' A' ' 37' ' ' ILE . 8.0 tp -61.4 117.68 5.97 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.553 -0.717 . . . . 20.57 111.857 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.4 mtm180 -88.12 159.63 47.68 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -54.69 129.2 33.74 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 O-C-N 123.549 1.289 . . . . 27.04 111.185 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.11 -19.21 40.03 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 111.045 -0.822 . . . . 24.74 111.045 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -89.13 166.42 13.85 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.098 -1.236 . . . . 29.38 110.53 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.543 ' CA ' HD11 ' A' ' 76' ' ' LEU . . . -147.0 149.88 34.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.556 -0.715 . . . . 0.0 110.384 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -117.27 148.16 41.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.471 -0.768 . . . . 18.56 109.221 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -144.37 139.77 28.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.229 -0.919 . . . . 0.0 111.258 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.513 ' CE1' HG21 ' A' ' 35' ' ' ILE . 43.3 p90 -150.6 159.98 44.12 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.549 -0.719 . . . . 26.65 109.667 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.0 m -102.44 136.79 41.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.388 -0.82 . . . . 28.14 110.846 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 21.3 t -125.35 169.47 12.29 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.586 -0.696 . . . . 33.88 110.081 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.16 124.71 2.6 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.834 -1.174 . . . . 31.8 110.433 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.619 HG23 ' HE1' ' A' ' 33' ' ' TYR . 75.6 t -129.46 150.83 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.699 -0.883 . . . . 0.0 109.272 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 48.3 mt -110.35 143.73 40.14 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.526 -0.734 . . . . 0.0 110.729 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.811 HD12 ' CD1' ' A' ' 31' ' ' PHE . 98.1 mt -122.13 146.12 47.52 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.644 -0.66 . . . . 38.68 109.941 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -73.19 -25.96 60.98 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.379 -0.826 . . . . 0.0 110.773 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 94' ' ' GLN . 7.7 t -123.81 173.04 8.42 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.461 -0.774 . . . . 31.63 110.618 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.42 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 37.2 tt0 -85.72 10.28 13.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.665 -0.647 . . . . 0.0 111.576 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.458 ' O ' HG23 ' A' ' 92' ' ' THR . 27.7 pt20 -142.12 150.04 40.61 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.125 -0.984 . . . . 0.0 109.919 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.05 165.52 31.45 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 118.868 -1.634 . . . . 28.05 112.244 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -119.08 129.86 55.3 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 122.173 -0.604 . . . . 0.0 109.444 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.892 ' HG3' HG22 ' A' ' 54' ' ' ILE . 48.4 ttm -125.29 116.44 21.94 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.314 -0.866 . . . . 0.0 111.055 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.501 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 56.7 tt0 -129.5 150.58 50.78 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -162.2 178.51 37.99 Favored Glycine 0 N--CA 1.499 2.889 0 C-N-CA 118.743 -1.694 . . . . 29.62 111.104 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.418 ' CD2' ' HB3' ' A' ' 114' ' ' PRO . 50.9 m80 -134.72 154.0 51.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.73 -0.865 . . . . 0.0 109.972 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.655 ' CD2' HD11 ' A' ' 115' ' ' ILE . 4.4 m-85 -117.9 127.69 54.1 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.599 -0.688 . . . . 27.05 109.718 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.794 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 41.1 t0 -81.26 122.11 27.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.971 -1.08 . . . . 0.0 109.053 178.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.735 ' CE ' HG11 ' A' ' 9' ' ' VAL . 13.1 tpp -121.61 159.82 25.65 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.078 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.403 HG23 ' CG ' ' A' ' 46' ' ' ARG . 11.1 m -140.54 129.06 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.517 -0.74 . . . . 23.28 110.269 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.32 167.34 21.43 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.568 -0.708 . . . . 0.0 109.618 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -64.03 -29.61 70.75 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.95 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -72.39 -12.04 60.95 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.607 -0.683 . . . . 0.0 111.059 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.5 -7.34 50.48 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.415 -1.074 . . . . 30.43 110.415 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.475 HG21 ' CE2' ' A' ' 7' ' ' TYR . 30.4 m -57.55 135.99 56.7 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.098 -1.236 . . . . 0.0 110.038 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -101.74 141.48 34.53 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.412 -0.805 . . . . 0.0 110.985 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 42.7 p90 -169.39 148.78 3.9 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.65 -0.656 . . . . 28.03 109.865 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.2 pt -101.98 157.71 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.597 -0.69 . . . . 0.0 111.252 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -118.92 96.89 50.52 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.418 ' HB3' ' CD2' ' A' ' 100' ' ' HIS . 46.3 Cg_endo -58.1 143.3 96.81 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 O-C-N 123.939 1.494 . . . . 33.31 112.453 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.655 HD11 ' CD2' ' A' ' 101' ' ' TYR . 70.4 mt -107.51 121.89 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.352 -0.981 . . . . 30.59 108.352 178.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.17 144.61 6.9 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.157 0.503 . . . . 30.78 111.441 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.501 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -91.08 119.4 31.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.718 -0.613 . . . . 0.0 110.313 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.573 ' HE1' HD11 ' A' ' 120' ' ' LEU . 34.2 p90 -109.11 168.44 9.37 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.717 -0.845 . . . . 30.66 108.717 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.594 ' C ' HD12 ' A' ' 120' ' ' LEU . 57.9 t -114.21 154.67 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.304 -0.873 . . . . 0.0 110.542 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 120' ' ' LEU . 7.4 mp -112.4 133.64 54.38 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.342 -0.614 . . . . 39.15 109.342 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 95.6 p . . . . . 0 N--CA 1.494 1.754 0 O-C-N 121.681 -0.637 . . . . 0.0 110.046 -179.719 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.424 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 82.7 mtt85 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.024 0.44 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.453 ' CE2' HG21 ' A' ' 109' ' ' THR . 29.2 m-85 -114.82 98.96 7.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.56 -0.713 . . . . 31.93 110.109 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.484 ' C ' HG23 ' A' ' 9' ' ' VAL . 80.2 mtt85 -146.59 137.19 23.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.602 0.715 . . . . 0.0 110.216 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.535 HG11 ' CE ' ' A' ' 103' ' ' MET . 97.6 t -152.94 114.12 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.433 0.635 . . . . 0.0 109.305 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -109.06 130.16 55.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.539 -0.726 . . . . 0.0 109.981 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.48 HG22 ' HA ' ' A' ' 37' ' ' ILE . 60.2 t -118.34 141.55 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.811 -0.556 . . . . 28.21 109.97 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -120.1 137.66 54.01 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.465 -0.772 . . . . 0.0 109.817 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.765 HG22 HD13 ' A' ' 35' ' ' ILE . 61.1 t -128.65 137.4 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.607 -0.683 . . . . 27.95 110.45 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -125.97 106.11 25.67 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.778 -0.576 . . . . 0.0 110.624 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -84.52 165.83 12.22 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 O-C-N 123.923 1.486 . . . . 33.0 111.091 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -158.14 131.09 7.36 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.52 0.676 . . . . 54.1 109.953 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.474 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 79.8 t80 -61.5 139.97 58.15 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.766 -0.584 . . . . 0.0 111.563 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.0 HD11 ' HB2' ' A' ' 32' ' ' ALA . 73.8 mt -116.32 80.81 1.51 Allowed 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.912 0.863 . . . . 0.0 110.349 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.474 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -66.03 -35.88 81.75 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.901 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -69.93 -22.83 63.16 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.375 -0.828 . . . . 0.0 111.107 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -122.23 43.38 2.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.382 -0.824 . . . . 52.37 110.959 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.639 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 51.6 p -164.98 147.42 8.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.299 -0.876 . . . . 55.19 111.043 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.3 m -116.37 91.43 33.16 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.0 Cg_endo -65.09 -24.85 59.04 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 O-C-N 123.877 1.462 . . . . 51.57 111.229 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -67.94 -22.82 65.03 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.381 -0.824 . . . . 0.0 110.834 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -106.51 23.34 14.37 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.265 -0.897 . . . . 0.0 110.615 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.98 29.28 73.44 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -120.41 94.07 4.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.596 -0.943 . . . . 0.0 110.171 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.46 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 77.3 m-85 -105.48 132.18 51.97 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.495 -0.753 . . . . 46.07 109.278 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.639 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -114.72 120.62 40.7 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.093 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.598 ' CG ' HD23 ' A' ' 120' ' ' LEU . 87.7 m-85 -116.01 134.78 54.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.55 -0.718 . . . . 38.88 109.784 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 1.0 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -111.62 132.02 54.86 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.436 -0.95 . . . . 34.06 108.436 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.627 ' HE1' HG23 ' A' ' 88' ' ' VAL . 20.2 p90 -127.72 142.85 51.21 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.083 -1.047 . . . . 29.03 111.262 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.5 p -105.2 140.65 38.03 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.765 HD13 HG22 ' A' ' 13' ' ' VAL . 44.6 mm -105.3 131.8 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.841 0.829 . . . . 0.0 111.604 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -122.46 95.74 4.76 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.183 -0.673 . . . . 40.24 109.183 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.535 HG22 ' CD1' ' A' ' 76' ' ' LEU . 75.4 mt -90.84 117.81 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.792 -0.567 . . . . 20.73 110.657 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.556 ' OE1' ' HB2' ' A' ' 81' ' ' ALA . 71.6 tp60 -117.06 135.72 53.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.543 -0.723 . . . . 0.0 109.398 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -91.46 117.23 29.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.801 -0.562 . . . . 21.34 110.651 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.51 9.29 18.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.536 -0.728 . . . . 0.0 110.579 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.27 -177.08 51.7 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.182 -1.567 . . . . 29.1 109.182 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . . . -100.39 -30.99 11.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.492 -1.005 . . . . 0.0 110.063 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.519 HG13 ' HD2' ' A' ' 44' ' ' PRO . 86.2 t -105.4 140.56 21.27 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.8 -0.563 . . . . 0.0 109.545 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.519 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.2 Cg_endo -51.4 141.89 39.64 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 O-C-N 123.731 1.385 . . . . 21.95 111.9 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.7 151.73 46.12 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.488 0.661 . . . . 20.91 110.937 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -127.57 158.89 36.26 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.827 -0.546 . . . . 0.0 109.844 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.805 HD22 HG13 ' A' ' 69' ' ' VAL . 7.7 tt -97.88 117.12 31.48 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.449 -0.782 . . . . 0.0 109.404 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.439 HG21 HG21 ' A' ' 104' ' ' VAL . 62.1 t -100.69 -27.76 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.666 -0.646 . . . . 0.0 110.569 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.714 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -140.11 162.83 34.3 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.833 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.7 ptt85 -142.41 139.97 31.83 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.44 0.638 . . . . 29.05 110.206 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -142.24 113.67 7.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.72 -0.613 . . . . 27.97 109.699 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.503 ' CH2' HD13 ' A' ' 115' ' ' ILE . 92.4 m95 -101.92 133.5 46.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.74 -0.6 . . . . 25.25 110.792 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -116.33 77.33 1.09 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.633 -0.667 . . . . 0.0 109.338 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.44 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.4 pt -84.17 129.19 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.922 0.868 . . . . 36.11 112.149 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.5 m -121.0 130.99 54.02 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.325 -0.991 . . . . 33.98 108.325 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -88.64 170.59 10.69 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.725 0.774 . . . . 45.04 111.427 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.55 -7.67 8.18 Favored Glycine 0 N--CA 1.494 2.542 0 O-C-N 121.823 -0.548 . . . . 39.47 112.299 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -101.21 6.92 43.21 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 119.411 1.605 . . . . 0.0 110.691 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.77 -28.33 9.47 Favored Glycine 0 N--CA 1.495 2.587 0 O-C-N 121.204 -0.935 . . . . 0.0 110.955 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.76 142.0 58.56 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.256 -1.143 . . . . 62.78 109.779 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.7 t -135.06 153.16 52.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.489 -0.757 . . . . 0.0 110.756 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -121.51 123.33 41.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.535 -0.728 . . . . 0.0 110.076 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -102.36 135.61 43.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.75 -0.594 . . . . 0.0 110.742 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.9 t -128.67 132.9 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.628 -0.67 . . . . 37.94 109.85 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -124.64 127.48 47.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.828 -0.545 . . . . 0.0 110.452 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -153.94 170.32 32.56 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.215 -1.554 . . . . 31.82 109.215 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -114.99 159.98 20.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.374 -1.074 . . . . 0.0 110.141 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.44 96.25 0.01 OUTLIER Glycine 0 N--CA 1.5 2.957 0 O-C-N 121.328 -0.857 . . . . 22.62 111.444 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.805 HG13 HD22 ' A' ' 47' ' ' LEU . 30.4 m -46.32 133.37 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.453 0 O-C-N 121.365 -1.079 . . . . 17.51 111.425 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.0 m 41.45 34.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 CA-C-O 121.587 0.708 . . . . 20.55 111.312 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.62 23.14 54.42 Favored Glycine 0 N--CA 1.495 2.603 0 O-C-N 121.714 -0.616 . . . . 18.29 112.301 178.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.53 ' HG3' HG23 ' A' ' 69' ' ' VAL . 2.2 pt-20 -144.21 151.25 39.22 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 119.125 1.463 . . . . 0.0 112.335 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -117.86 72.19 8.33 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.152 -1.055 . . . . 18.21 108.152 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -54.8 141.79 75.78 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 O-C-N 123.757 1.399 . . . . 17.61 112.385 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -103.75 75.32 1.3 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.535 ' CD1' HG22 ' A' ' 37' ' ' ILE . 15.0 mt -60.43 119.66 8.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.706 -0.621 . . . . 20.57 111.915 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -86.05 158.45 55.72 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -53.48 127.4 25.16 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 O-C-N 123.539 1.284 . . . . 27.04 111.167 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.76 -16.48 56.55 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.74 -0.944 . . . . 24.74 110.74 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -87.25 164.36 16.36 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.089 -1.242 . . . . 29.38 110.427 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.556 ' HB2' ' OE1' ' A' ' 38' ' ' GLN . . . -145.45 149.33 34.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.568 -0.708 . . . . 0.0 110.199 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -119.2 144.63 46.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.499 -0.751 . . . . 18.56 109.212 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 -144.14 140.93 29.67 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.163 -0.96 . . . . 0.0 111.236 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.462 ' CE1' HG21 ' A' ' 35' ' ' ILE . 51.0 p90 -150.8 160.05 44.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.646 -0.659 . . . . 26.65 109.74 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 60.3 m -100.8 136.08 41.23 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.445 -0.785 . . . . 28.14 110.848 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 23.3 t -126.38 168.08 14.65 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.554 -0.716 . . . . 33.88 110.115 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -135.67 129.11 4.88 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.926 -1.13 . . . . 31.8 110.496 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.627 HG23 ' HE1' ' A' ' 33' ' ' TYR . 54.2 t -133.01 148.76 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.592 -0.946 . . . . 0.0 109.248 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 29' ' ' TYR . 15.9 tp -109.81 143.79 39.18 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.552 -0.718 . . . . 0.0 110.542 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.746 HD23 ' O ' ' A' ' 92' ' ' THR . 11.4 tp -121.49 144.26 48.8 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.574 -0.704 . . . . 38.68 109.767 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -75.98 -25.41 55.79 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.25 -0.906 . . . . 0.0 111.096 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.746 ' O ' HD23 ' A' ' 90' ' ' LEU . 5.8 m -124.04 171.97 9.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.332 -0.855 . . . . 31.63 110.512 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.428 ' H ' HG22 ' A' ' 92' ' ' THR . 52.6 tt0 -86.28 11.45 12.13 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.612 -0.68 . . . . 0.0 111.592 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -142.89 142.98 31.86 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.2 -0.937 . . . . 0.0 109.626 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -177.47 152.73 12.29 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 118.751 -1.69 . . . . 28.05 112.198 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -118.05 130.33 56.1 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 90.7 mtp -128.0 124.02 36.18 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.457 -0.777 . . . . 0.0 111.597 -178.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.546 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 62.8 mt-30 -125.49 152.19 45.29 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.89 179.88 38.59 Favored Glycine 0 N--CA 1.5 2.958 0 C-N-CA 118.665 -1.731 . . . . 29.62 111.211 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -134.62 159.07 42.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.843 -0.798 . . . . 0.0 110.031 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.674 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 8.2 m-85 -116.71 127.35 54.31 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.589 -0.694 . . . . 27.05 109.959 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.714 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 40.4 t0 -85.99 118.51 25.51 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.06 -1.025 . . . . 0.0 108.815 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.535 ' CE ' HG11 ' A' ' 9' ' ' VAL . 18.3 tpp -124.73 160.78 27.83 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.294 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.439 HG21 HG21 ' A' ' 48' ' ' VAL . 7.2 m -140.93 131.19 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.614 -0.679 . . . . 23.28 110.328 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.04 166.86 22.28 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.437 -0.789 . . . . 0.0 109.606 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -64.64 -29.45 70.45 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.94 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -73.72 -11.24 60.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.519 -0.738 . . . . 0.0 111.059 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.24 -7.3 47.43 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.411 -1.076 . . . . 30.43 110.411 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.453 HG21 ' CE2' ' A' ' 7' ' ' TYR . 24.3 m -57.68 135.47 56.74 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.026 -1.279 . . . . 0.0 110.056 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -101.14 139.61 36.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.441 -0.787 . . . . 0.0 110.69 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 43.8 p90 -165.78 145.05 6.26 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.75 -0.594 . . . . 28.03 109.902 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 24.9 pt -102.21 158.11 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.716 -0.615 . . . . 0.0 111.16 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.674 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -119.86 97.6 49.59 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -58.15 143.82 96.19 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 O-C-N 123.835 1.439 . . . . 33.31 112.166 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.503 HD13 ' CH2' ' A' ' 52' ' ' TRP . 68.7 mt -108.81 122.52 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-N 115.368 -0.833 . . . . 30.59 108.954 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.61 172.81 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.255 0.55 . . . . 30.78 111.429 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.546 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -100.29 119.93 39.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.583 -0.698 . . . . 0.0 110.753 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 97' ' ' MET . 41.9 p90 -111.99 156.02 22.83 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.244 -1.021 . . . . 30.66 108.244 178.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.672 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.2 t -116.95 153.45 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.177 -0.952 . . . . 0.0 110.886 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.672 HD12 ' C ' ' A' ' 119' ' ' VAL . 7.9 mp -114.52 130.16 56.72 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.141 -0.689 . . . . 39.15 109.141 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.606 -0.684 . . . . 0.0 110.156 -179.802 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.665 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 91.1 mtm-85 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.772 0.32 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.53 ' CZ ' HG21 ' A' ' 109' ' ' THR . 90.9 m-85 -119.18 105.96 11.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.52 -0.738 . . . . 31.93 110.141 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.474 ' C ' HG23 ' A' ' 9' ' ' VAL . 93.8 mtt-85 -149.03 134.82 18.84 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.615 -0.678 . . . . 0.0 110.07 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.818 HG11 ' SD ' ' A' ' 103' ' ' MET . 97.0 t -151.58 116.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-O 121.554 0.692 . . . . 0.0 109.609 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -105.63 131.24 53.25 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.652 0.739 . . . . 0.0 110.385 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.577 HG11 ' HE2' ' A' ' 101' ' ' TYR . 63.4 t -118.75 136.12 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 109.303 -0.628 . . . . 28.21 109.303 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -124.02 137.24 54.62 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.306 -0.871 . . . . 0.0 110.136 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 75.8 t -129.22 136.95 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.679 -0.638 . . . . 27.95 110.523 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.1 m -125.12 105.55 28.72 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.785 -0.572 . . . . 0.0 110.302 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.406 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 49.8 Cg_endo -82.33 164.66 16.87 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.859 1.452 . . . . 33.0 111.255 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -157.47 130.63 7.71 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.667 0.746 . . . . 54.1 109.722 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.509 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 76.9 t80 -63.95 139.87 58.81 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.663 -0.648 . . . . 0.0 111.585 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.981 HD11 ' HB2' ' A' ' 32' ' ' ALA . 96.0 mt -116.04 80.7 1.49 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.947 0.88 . . . . 0.0 110.453 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.509 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -68.46 -35.75 78.01 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.793 178.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -69.54 -24.02 63.67 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.447 -0.783 . . . . 0.0 110.734 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -120.84 43.1 2.86 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.431 -0.793 . . . . 52.37 110.735 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.736 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 32.7 t -164.68 146.67 8.32 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.365 -0.834 . . . . 55.19 110.974 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 23' ' ' THR . 5.1 t -120.38 93.12 48.07 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.552 -0.718 . . . . 0.0 109.146 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.472 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.1 Cg_endo -65.94 -23.09 54.83 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 O-C-N 123.89 1.469 . . . . 51.57 111.573 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -65.61 -23.69 66.88 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.378 -0.826 . . . . 0.0 111.047 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -105.59 23.99 12.93 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.347 -0.845 . . . . 0.0 110.815 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.24 27.82 73.57 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.565 ' HB2' HG23 ' A' ' 23' ' ' THR . 10.5 mtm180 -120.79 94.2 4.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.503 -0.998 . . . . 0.0 110.169 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.472 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 68.2 m-85 -104.45 132.68 50.42 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.601 -0.687 . . . . 46.07 109.313 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.736 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -114.64 120.56 40.58 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.338 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.578 ' CG ' HD23 ' A' ' 120' ' ' LEU . 89.4 m-85 -116.26 134.5 54.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.529 -0.732 . . . . 38.88 109.841 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.981 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -112.16 132.71 54.73 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.442 -0.947 . . . . 34.06 108.442 178.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.605 ' HE1' HG23 ' A' ' 88' ' ' VAL . 20.1 p90 -128.05 143.28 51.07 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.078 -1.049 . . . . 29.03 111.611 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.9 m -106.71 139.69 40.75 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.818 HD12 ' CZ ' ' A' ' 84' ' ' TYR . 87.3 mt -108.8 134.55 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 121.668 0.747 . . . . 0.0 111.671 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.3 mtm105 -124.82 98.65 5.8 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.642 0.734 . . . . 40.24 109.796 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.563 HG22 ' CD1' ' A' ' 76' ' ' LEU . 85.4 mt -94.13 118.26 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.818 -0.551 . . . . 20.73 110.726 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -116.43 138.61 51.22 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.267 -0.896 . . . . 0.0 109.231 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -90.61 117.97 29.69 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.78 -0.575 . . . . 21.34 110.856 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.51 9.92 15.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.477 -0.765 . . . . 0.0 110.603 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.2 -178.97 52.4 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.417 -1.473 . . . . 29.1 109.417 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.665 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . . . -94.69 -33.89 12.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.441 -1.034 . . . . 0.0 110.326 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.516 HG13 ' HD2' ' A' ' 44' ' ' PRO . 87.4 t -103.78 139.6 20.26 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.846 -0.533 . . . . 0.0 109.946 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.516 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.9 Cg_endo -52.35 143.22 44.55 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 O-C-N 123.883 1.465 . . . . 21.95 111.845 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.452 ' HB1' ' HZ ' ' A' ' 111' ' ' PHE . . . -139.88 151.92 46.03 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.498 0.666 . . . . 20.91 110.99 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.438 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 19.6 ptt-85 -128.05 158.96 36.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.824 -0.547 . . . . 0.0 110.017 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.903 HD22 HG13 ' A' ' 69' ' ' VAL . 6.4 tt -97.7 115.28 27.66 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.446 -0.784 . . . . 0.0 109.246 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.444 HG11 HG21 ' A' ' 104' ' ' VAL . 35.1 m -100.54 -26.18 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.632 -0.667 . . . . 0.0 111.175 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.763 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -142.4 163.05 33.9 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.196 -0.94 . . . . 0.0 111.734 -179.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.463 ' HD3' HG12 ' A' ' 69' ' ' VAL . 39.3 ptt85 -145.39 142.26 29.18 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.644 0.735 . . . . 29.05 110.858 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.406 ' HB3' ' NE2' ' A' ' 100' ' ' HIS . 22.1 t-160 -144.89 115.17 7.54 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.324 -0.621 . . . . 27.97 109.324 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -98.05 135.6 39.51 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.558 -0.713 . . . . 25.25 111.747 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -115.48 75.98 0.98 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.427 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.8 pt -86.98 131.3 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.412 -0.805 . . . . 36.11 112.14 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.966 HG23 HG22 ' A' ' 61' ' ' THR . 12.3 m -119.85 132.93 55.72 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.35 -0.982 . . . . 33.98 108.35 178.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -87.19 169.48 12.31 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.638 0.732 . . . . 45.04 111.308 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.32 -8.36 12.4 Favored Glycine 0 N--CA 1.494 2.549 0 O-C-N 121.828 -0.545 . . . . 39.47 112.124 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -101.01 8.15 43.14 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 119.402 1.601 . . . . 0.0 110.859 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.34 -23.07 29.26 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.196 -0.94 . . . . 0.0 110.952 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -60.4 142.16 55.35 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.187 -1.184 . . . . 62.78 109.806 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.966 HG22 HG23 ' A' ' 55' ' ' THR . 74.3 p -126.05 142.0 51.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.407 -0.808 . . . . 0.0 110.669 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -122.87 119.95 32.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.411 -0.806 . . . . 0.0 109.948 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -104.79 134.47 47.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.657 -0.652 . . . . 0.0 110.7 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.9 t -127.93 130.85 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.625 -0.672 . . . . 37.94 109.81 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -123.41 126.6 47.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.84 -0.537 . . . . 0.0 110.299 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -147.84 147.45 18.13 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.223 -1.551 . . . . 31.82 109.223 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -72.59 155.63 39.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.51 -0.994 . . . . 0.0 110.15 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.59 -170.65 0.08 OUTLIER Glycine 0 N--CA 1.498 2.824 0 O-C-N 121.49 -0.756 . . . . 22.62 111.357 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.903 HG13 HD22 ' A' ' 47' ' ' LEU . 13.0 m -129.74 127.96 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.835 -0.803 . . . . 17.51 108.957 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.517 HG11 ' CE2' ' A' ' 84' ' ' TYR . 12.3 m 41.75 34.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 CA-C-O 121.7 0.762 . . . . 20.55 111.448 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.4 18.83 61.53 Favored Glycine 0 N--CA 1.497 2.751 0 O-C-N 121.714 -0.616 . . . . 18.29 113.041 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.425 ' O ' HG22 ' A' ' 69' ' ' VAL . 8.6 pt-20 -147.58 150.67 34.9 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 119.449 1.625 . . . . 0.0 112.675 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -115.24 73.05 3.47 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 108.257 -1.016 . . . . 18.21 108.257 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -55.5 141.49 82.63 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 O-C-N 123.842 1.443 . . . . 17.61 112.426 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.438 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 4.7 t90 -102.39 76.88 1.59 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.563 ' CD1' HG22 ' A' ' 37' ' ' ILE . 9.3 mt -60.89 117.49 5.49 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.636 -0.665 . . . . 20.57 111.783 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -88.39 159.12 47.94 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -54.25 129.58 35.3 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 O-C-N 123.535 1.281 . . . . 27.04 111.134 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.91 -18.9 44.95 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 111.003 -0.839 . . . . 24.74 111.003 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.93 166.62 14.39 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.117 -1.225 . . . . 29.38 110.446 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -144.55 146.16 32.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.672 -0.643 . . . . 0.0 110.415 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.512 ' HD2' HD12 ' A' ' 37' ' ' ILE . 89.5 t80 -114.58 141.24 48.01 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.049 -0.722 . . . . 18.56 109.049 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -147.95 140.98 24.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.298 -0.876 . . . . 0.0 111.101 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.818 ' CZ ' HD12 ' A' ' 35' ' ' ILE . 46.3 p90 -153.33 162.5 41.22 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.621 -0.674 . . . . 26.65 109.775 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.1 m -99.01 135.78 39.92 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.468 -0.77 . . . . 28.14 111.211 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 17.2 t -125.16 166.65 16.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.642 -0.661 . . . . 33.88 109.688 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.26 130.33 5.69 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 119.779 -1.201 . . . . 31.8 110.536 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.605 HG23 ' HE1' ' A' ' 33' ' ' TYR . 61.2 t -132.77 147.01 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.695 -0.885 . . . . 0.0 109.118 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.2 tp -110.27 143.74 40.0 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.559 -0.713 . . . . 0.0 110.33 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.75 HD12 HD22 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -122.4 144.97 48.7 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.491 -0.756 . . . . 38.68 109.936 -179.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -78.24 -26.09 47.17 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.425 -0.797 . . . . 0.0 110.641 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.446 HG22 ' N ' ' A' ' 93' ' ' GLU . 21.5 m -123.41 171.22 9.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.42 -0.8 . . . . 31.63 110.2 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.446 ' N ' HG22 ' A' ' 92' ' ' THR . 56.8 tt0 -86.21 12.54 9.59 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.415 -0.803 . . . . 0.0 111.579 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 97.0 mt-30 -140.99 144.99 35.38 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.044 -1.035 . . . . 0.0 109.698 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.51 158.94 21.66 Favored Glycine 0 N--CA 1.496 2.673 0 C-N-CA 118.766 -1.683 . . . . 28.05 112.321 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -119.66 129.96 54.83 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 122.128 -0.631 . . . . 0.0 109.578 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.478 ' HE2' ' HB3' ' A' ' 97' ' ' MET . 90.0 mtp -125.48 117.42 23.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.275 -0.89 . . . . 0.0 111.075 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.496 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 57.1 tt0 -129.21 150.04 50.76 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.36 -177.83 38.04 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 119.108 -1.52 . . . . 29.62 110.514 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.406 ' NE2' ' HB3' ' A' ' 51' ' ' HIS . 44.5 p-80 -140.26 159.93 41.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.698 -0.883 . . . . 0.0 110.676 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.645 ' CD1' HD11 ' A' ' 47' ' ' LEU . 5.2 m-85 -115.3 128.38 56.07 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.753 -0.592 . . . . 27.05 109.944 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.763 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 42.9 t0 -83.4 122.3 28.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.006 -1.059 . . . . 0.0 108.739 177.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.818 ' SD ' HG11 ' A' ' 9' ' ' VAL . 43.0 mtp -123.51 161.93 23.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.878 -0.513 . . . . 0.0 110.507 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.444 HG21 HG11 ' A' ' 48' ' ' VAL . 6.4 m -140.32 129.47 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.719 -0.613 . . . . 23.28 110.23 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.21 166.53 22.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.507 -0.745 . . . . 0.0 109.649 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -65.86 -29.27 69.7 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.198 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -76.74 -4.89 45.7 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.395 -0.816 . . . . 0.0 111.347 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.33 -9.52 57.61 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.045 -1.074 . . . . 30.43 110.627 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.53 HG21 ' CZ ' ' A' ' 7' ' ' TYR . 23.9 m -57.42 134.57 56.16 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.047 -1.266 . . . . 0.0 110.104 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -101.68 139.61 37.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.37 -0.831 . . . . 0.0 110.724 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 45.2 p90 -164.08 143.75 7.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.664 -0.648 . . . . 28.03 109.856 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 102' ' ' ASP . 50.9 mm -98.69 156.11 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.661 -0.649 . . . . 0.0 110.61 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.53 96.92 48.93 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -59.44 141.53 97.63 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.911 1.479 . . . . 33.31 112.222 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.613 HD11 ' CD2' ' A' ' 101' ' ' TYR . 68.0 mt -107.08 124.05 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.627 -0.879 . . . . 30.59 108.627 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.92 147.52 3.82 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.234 0.54 . . . . 30.78 111.48 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.496 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -89.65 122.33 32.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.597 -0.689 . . . . 0.0 110.179 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.637 ' CE1' HD11 ' A' ' 120' ' ' LEU . 45.0 p90 -109.1 164.69 12.2 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.934 -0.765 . . . . 30.66 108.934 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.634 ' C ' HD12 ' A' ' 120' ' ' LEU . 57.8 t -114.48 155.4 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.333 -0.854 . . . . 0.0 110.28 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.75 HD22 HD12 ' A' ' 90' ' ' LEU . 7.0 mp -114.11 132.17 56.15 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.264 -0.643 . . . . 39.15 109.264 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.687 -0.633 . . . . 0.0 110.104 -179.852 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.42 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 38.7 ttm180 . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 120.906 0.384 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.445 ' CZ ' HG21 ' A' ' 109' ' ' THR . 47.7 m-85 -115.83 107.18 14.71 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.559 -0.713 . . . . 31.93 110.167 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.483 ' C ' HG23 ' A' ' 9' ' ' VAL . 9.8 ttt85 -153.44 135.2 14.52 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.561 0.696 . . . . 0.0 110.413 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.729 HG11 ' SD ' ' A' ' 103' ' ' MET . 97.0 t -152.29 116.08 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-O 121.448 0.642 . . . . 0.0 109.499 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -107.36 130.07 54.83 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.622 0.725 . . . . 0.0 110.049 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.0 t -118.1 139.46 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.848 -0.532 . . . . 28.21 109.817 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -121.81 137.81 54.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.386 -0.822 . . . . 0.0 110.014 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.724 HG22 HD13 ' A' ' 35' ' ' ILE . 58.7 t -128.7 137.11 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.59 -0.694 . . . . 27.95 110.379 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -125.3 106.9 27.54 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.738 -0.601 . . . . 0.0 110.485 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.439 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 51.0 Cg_endo -82.76 165.66 15.54 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 O-C-N 123.816 1.43 . . . . 33.0 111.119 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -158.05 129.59 6.72 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.595 0.712 . . . . 54.1 109.588 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.496 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 78.7 t80 -62.98 139.95 58.82 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.753 -0.592 . . . . 0.0 111.543 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.003 HD11 ' HB2' ' A' ' 32' ' ' ALA . 88.9 mt -115.85 81.2 1.56 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.907 0.861 . . . . 0.0 110.381 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.496 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -68.44 -35.77 78.08 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.893 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -69.94 -23.18 63.16 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.415 -0.803 . . . . 0.0 110.823 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -121.23 38.97 3.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.364 -0.835 . . . . 52.37 110.757 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.738 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 32.9 t -160.01 145.75 15.48 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.335 -0.853 . . . . 55.19 111.117 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.59 HG23 ' HB2' ' A' ' 28' ' ' ARG . 5.0 t -120.02 92.76 47.24 Favored Pre-proline 0 N--CA 1.496 1.848 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.476 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.8 Cg_endo -66.32 -23.0 52.17 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 O-C-N 123.86 1.453 . . . . 51.57 111.718 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -65.28 -23.45 67.04 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.357 -0.839 . . . . 0.0 110.994 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -105.62 24.15 12.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.306 -0.871 . . . . 0.0 110.846 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.99 28.13 73.68 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.59 ' HB2' HG23 ' A' ' 23' ' ' THR . 13.3 mtp180 -120.98 94.0 4.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.642 -0.916 . . . . 0.0 110.23 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.476 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 69.8 m-85 -104.14 133.56 48.87 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.607 -0.683 . . . . 46.07 109.359 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.738 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -115.21 120.19 38.87 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 119.754 -0.779 . . . . 0.0 111.075 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.83 ' CD1' HD12 ' A' ' 90' ' ' LEU . 91.4 m-85 -115.92 135.26 54.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.512 -0.742 . . . . 38.88 109.782 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 1.003 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -112.38 132.24 55.12 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.542 -0.91 . . . . 34.06 108.542 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.621 ' HE1' HG13 ' A' ' 88' ' ' VAL . 18.5 p90 -128.4 143.26 50.97 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.214 -0.995 . . . . 29.03 111.429 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.5 t -105.77 140.57 38.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.724 -0.61 . . . . 0.0 109.494 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.724 HD13 HG22 ' A' ' 13' ' ' VAL . 45.6 mm -105.11 131.84 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.727 0.775 . . . . 0.0 111.63 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -122.91 96.93 5.21 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.532 0.682 . . . . 40.24 109.381 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.513 HG22 ' CD1' ' A' ' 76' ' ' LEU . 79.9 mt -92.48 117.83 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.759 -0.588 . . . . 20.73 110.592 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -116.82 134.16 55.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.496 -0.753 . . . . 0.0 109.248 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -92.79 117.57 30.16 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 120.204 -0.598 . . . . 21.34 110.565 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.35 11.96 16.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.49 -0.756 . . . . 0.0 110.575 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.25 -179.26 52.76 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.086 -1.605 . . . . 29.1 109.086 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . . . -94.99 -32.89 12.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.479 -1.012 . . . . 0.0 110.32 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.526 HG13 ' HD2' ' A' ' 44' ' ' PRO . 85.3 t -104.6 141.2 22.05 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.83 -0.544 . . . . 0.0 109.883 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.526 ' HD2' HG13 ' A' ' 43' ' ' VAL . 40.1 Cg_endo -53.53 143.26 56.82 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 O-C-N 123.809 1.426 . . . . 21.95 111.91 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.408 ' HB1' ' HZ ' ' A' ' 111' ' ' PHE . . . -139.7 151.69 46.09 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.604 0.716 . . . . 20.91 110.861 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.436 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 18.4 ptt180 -127.96 159.76 33.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.751 -0.593 . . . . 0.0 109.723 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.923 HD22 HG13 ' A' ' 69' ' ' VAL . 6.9 tt -98.14 117.28 32.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.432 -0.792 . . . . 0.0 109.699 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.46 HG21 HG21 ' A' ' 104' ' ' VAL . 62.5 t -99.85 -29.45 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.514 -0.741 . . . . 0.0 110.677 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.696 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -141.38 162.66 34.95 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.949 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.6 ptt85 -143.7 141.59 30.58 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.673 0.749 . . . . 29.05 110.323 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -144.51 113.97 7.09 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.405 0.622 . . . . 27.97 109.507 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -98.45 135.2 40.35 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.65 -0.656 . . . . 25.25 111.488 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -115.38 75.85 0.97 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.431 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.3 pt -85.7 130.5 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 121.85 0.833 . . . . 36.11 111.975 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.596 HG23 HG22 ' A' ' 61' ' ' THR . 86.1 m -121.22 132.93 55.11 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.351 -0.981 . . . . 33.98 108.351 178.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -87.32 169.74 12.03 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.717 0.77 . . . . 45.04 111.477 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.29 -7.88 15.93 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 121.819 -0.551 . . . . 39.47 112.06 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -100.57 8.12 43.63 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 119.345 1.573 . . . . 0.0 110.578 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.7 -21.3 36.77 Favored Glycine 0 N--CA 1.493 2.49 0 O-C-N 121.233 -0.917 . . . . 0.0 111.011 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.19 141.03 56.6 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.169 -1.195 . . . . 62.78 109.806 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.596 HG22 HG23 ' A' ' 55' ' ' THR . 82.1 p -125.87 140.09 52.94 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.447 -0.783 . . . . 0.0 110.668 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -123.73 120.0 31.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.41 -0.806 . . . . 0.0 110.014 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -104.85 135.26 46.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.686 -0.634 . . . . 0.0 110.859 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.26 130.62 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.58 -0.7 . . . . 37.94 109.848 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.65 127.57 47.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.817 -0.552 . . . . 0.0 110.42 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.79 150.92 23.06 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.289 -1.524 . . . . 31.82 109.289 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -79.43 156.76 27.75 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.559 -0.965 . . . . 0.0 110.25 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 51.57 -173.49 0.18 Allowed Glycine 0 N--CA 1.497 2.752 0 N-CA-C 111.008 -0.837 . . . . 22.62 111.008 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.923 HG13 HD22 ' A' ' 47' ' ' LEU . 15.2 m -130.1 127.98 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.793 -0.828 . . . . 17.51 109.606 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.6 m 41.12 36.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 CA-C-O 121.514 0.673 . . . . 20.55 111.853 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.13 16.65 68.99 Favored Glycine 0 N--CA 1.499 2.857 0 O-C-N 121.683 -0.636 . . . . 18.29 113.002 177.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.409 ' O ' HG22 ' A' ' 69' ' ' VAL . 9.9 pt-20 -145.64 150.9 37.19 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 119.164 1.482 . . . . 0.0 112.018 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -115.22 75.12 4.18 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.915 -0.772 . . . . 18.21 108.915 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -57.67 140.06 92.28 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 O-C-N 123.861 1.453 . . . . 17.61 112.149 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.436 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 4.1 t90 -103.14 77.57 1.55 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.513 ' CD1' HG22 ' A' ' 37' ' ' ILE . 11.3 mt -60.14 118.31 6.18 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.462 0.649 . . . . 20.57 111.953 -178.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 -85.8 157.19 57.93 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -53.49 128.1 27.99 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 O-C-N 123.561 1.295 . . . . 27.04 111.15 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.66 -17.13 54.39 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.727 -0.949 . . . . 24.74 110.727 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -86.89 165.71 15.71 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.058 -1.26 . . . . 29.38 110.537 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.02 149.1 34.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.66 -0.65 . . . . 0.0 110.041 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.4 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 79.6 t80 -118.9 146.27 45.05 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.47 -0.769 . . . . 18.56 109.179 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -146.05 141.03 27.22 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.213 -0.929 . . . . 0.0 111.13 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.447 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 50.6 p90 -151.09 160.02 44.14 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.59 -0.693 . . . . 26.65 109.837 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.2 m -100.04 135.58 41.25 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.391 -0.818 . . . . 28.14 110.646 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 28.4 t -125.06 167.41 14.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.592 -0.693 . . . . 33.88 110.048 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.87 129.97 5.48 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.841 -1.171 . . . . 31.8 110.481 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.621 HG13 ' HE1' ' A' ' 33' ' ' TYR . 15.6 m -134.75 148.61 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.695 -0.885 . . . . 0.0 109.821 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 89' ' ' LEU . 4.9 mp -112.93 144.28 42.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.57 -0.706 . . . . 0.0 110.569 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.83 HD12 ' CD1' ' A' ' 31' ' ' PHE . 31.8 mt -121.98 146.57 47.02 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.639 -0.663 . . . . 38.68 110.004 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -77.6 -26.16 50.45 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.405 -0.809 . . . . 0.0 110.765 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.5 p -122.95 171.33 9.31 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.47 -0.769 . . . . 31.63 110.522 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -86.13 11.06 12.65 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.636 -0.665 . . . . 0.0 111.549 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 78.1 mt-30 -140.72 146.18 37.42 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.016 -1.053 . . . . 0.0 109.638 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.42 153.21 10.72 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 118.921 -1.609 . . . . 28.05 112.264 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -118.2 129.84 55.73 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 94.3 mtp -126.8 122.45 34.8 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.39 -0.819 . . . . 0.0 111.63 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.491 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 57.2 tt0 -127.34 149.45 50.04 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.86 -177.68 36.85 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 118.931 -1.604 . . . . 29.62 110.844 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -142.81 158.81 43.26 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.795 -0.826 . . . . 0.0 110.626 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.703 ' CD2' HD11 ' A' ' 115' ' ' ILE . 4.5 m-85 -116.68 129.18 55.98 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.656 -0.652 . . . . 27.05 110.076 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.696 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 11.0 t70 -83.06 122.65 28.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.014 -1.054 . . . . 0.0 109.095 177.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.729 ' SD ' HG11 ' A' ' 9' ' ' VAL . 63.3 mtp -123.12 163.01 21.36 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.108 0.48 . . . . 0.0 110.457 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.46 HG21 HG21 ' A' ' 48' ' ' VAL . 7.5 m -142.54 131.55 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.65 -0.656 . . . . 23.28 110.432 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.531 ' HB3' ' HB ' ' A' ' 109' ' ' THR . . . -70.2 165.03 23.02 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.398 -0.814 . . . . 0.0 109.508 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -65.71 -27.21 68.16 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.519 -0.738 . . . . 0.0 110.46 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -79.93 -1.29 38.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.321 -0.862 . . . . 0.0 111.312 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.03 -10.07 56.79 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.962 -1.113 . . . . 30.43 110.581 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 25.6 m -57.46 134.02 55.71 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.086 -1.244 . . . . 0.0 110.059 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -102.64 139.24 38.48 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.311 -0.868 . . . . 0.0 110.782 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 43.1 p90 -162.82 141.68 8.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.759 -0.588 . . . . 28.03 110.002 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.8 pt -98.43 156.8 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.715 -0.615 . . . . 0.0 110.77 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -121.33 97.98 46.95 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -59.31 142.11 98.67 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 O-C-N 123.907 1.477 . . . . 33.31 112.039 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.703 HD11 ' CD2' ' A' ' 101' ' ' TYR . 70.9 mt -107.68 124.13 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.791 -0.818 . . . . 30.59 108.791 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.59 151.18 2.41 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.264 0.554 . . . . 30.78 111.356 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.491 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -98.67 118.19 34.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.675 -0.641 . . . . 0.0 110.159 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.7 ' CE1' HD11 ' A' ' 120' ' ' LEU . 41.6 p90 -107.95 168.94 8.92 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.944 -0.761 . . . . 30.66 108.944 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.605 ' C ' HD12 ' A' ' 120' ' ' LEU . 57.5 t -114.23 154.14 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.251 -0.906 . . . . 0.0 110.509 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.804 HD22 HD11 ' A' ' 90' ' ' LEU . 7.0 mp -113.65 132.4 55.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.676 -0.64 . . . . 39.15 109.357 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 79.8 p . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.636 -0.665 . . . . 0.0 110.1 -179.808 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.457 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 76.9 mtp180 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 120.951 0.405 . . . . 0.0 110.111 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -109.97 100.59 9.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.785 -0.572 . . . . 31.93 109.908 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.467 ' C ' HG23 ' A' ' 9' ' ' VAL . 64.7 mtp85 -149.0 137.21 20.86 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.754 0.788 . . . . 0.0 110.314 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.467 HG23 ' C ' ' A' ' 8' ' ' ARG . 82.2 t -151.31 114.79 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -107.55 130.26 54.89 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.574 0.702 . . . . 0.0 110.109 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.9 t -118.53 138.89 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.883 -0.511 . . . . 28.21 109.639 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -121.24 137.36 54.72 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.477 -0.764 . . . . 0.0 109.85 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.735 HG22 HD13 ' A' ' 35' ' ' ILE . 62.2 t -129.16 136.58 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.555 -0.715 . . . . 27.95 110.502 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.6 t -125.24 104.43 28.98 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.714 -0.616 . . . . 0.0 110.226 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.441 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 50.2 Cg_endo -83.86 165.81 13.41 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 O-C-N 123.815 1.429 . . . . 33.0 111.095 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -158.02 131.5 7.7 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.527 0.679 . . . . 54.1 109.737 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.523 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 78.5 t80 -59.29 138.49 57.6 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.737 -0.602 . . . . 0.0 111.2 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.516 HD23 ' HB3' ' A' ' 21' ' ' GLN . 9.1 tp -115.01 80.72 1.46 Allowed 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 122.014 0.912 . . . . 0.0 110.269 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.523 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -70.07 -35.63 74.35 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.366 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -69.22 -22.6 63.86 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.366 -0.834 . . . . 0.0 111.03 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.516 ' HB3' HD23 ' A' ' 18' ' ' LEU . 34.1 tp60 -121.75 36.87 4.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.283 -0.885 . . . . 52.37 110.596 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.714 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 32.8 t -156.95 146.02 20.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.451 -0.781 . . . . 55.19 111.02 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.602 HG23 ' O ' ' A' ' 23' ' ' THR . 9.2 t -122.03 92.83 48.82 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.475 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.1 Cg_endo -65.98 -22.39 55.46 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 O-C-N 123.711 1.374 . . . . 51.57 111.928 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -64.87 -23.52 67.26 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.258 -0.901 . . . . 0.0 110.879 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.59 23.48 14.17 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.289 -0.882 . . . . 0.0 110.705 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.61 29.94 72.89 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.602 ' HB2' HG23 ' A' ' 23' ' ' THR . 42.2 mmm-85 -120.87 93.59 4.08 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.596 -0.943 . . . . 0.0 110.181 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.475 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 68.4 m-85 -104.58 130.4 52.56 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.571 -0.705 . . . . 46.07 109.126 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.714 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -117.76 120.31 37.57 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.571 -0.851 . . . . 0.0 111.185 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.667 ' CD1' HD12 ' A' ' 90' ' ' LEU . 68.1 m-85 -115.0 137.28 52.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.583 -0.698 . . . . 38.88 109.815 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.78 131.61 55.21 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.293 -1.002 . . . . 34.06 108.293 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.653 ' HE2' HD11 ' A' ' 35' ' ' ILE . 20.6 p90 -128.21 144.08 51.09 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.19 -1.004 . . . . 29.03 111.534 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.5 t -104.39 141.06 37.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.68 -0.638 . . . . 0.0 109.851 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.735 HD13 HG22 ' A' ' 13' ' ' VAL . 45.6 mm -106.35 132.23 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.822 0.82 . . . . 0.0 111.618 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.7 mtp85 -121.47 96.6 5.14 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.418 0.628 . . . . 40.24 109.526 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.619 HG22 ' CD1' ' A' ' 76' ' ' LEU . 78.1 mt -92.53 115.74 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.736 -0.603 . . . . 20.73 110.352 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -117.66 136.49 53.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.563 -0.711 . . . . 0.0 109.472 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -91.47 116.11 28.59 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 120.179 -0.608 . . . . 21.34 110.541 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -112.26 9.38 19.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.441 -0.787 . . . . 0.0 110.683 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.96 -176.15 50.96 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.002 -1.639 . . . . 29.1 109.002 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.457 ' HB3' ' HA ' ' A' ' 6' ' ' ARG . . . -98.75 -30.0 12.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.463 -1.021 . . . . 0.0 110.137 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.517 HG13 ' HD2' ' A' ' 44' ' ' PRO . 84.2 t -105.57 139.83 20.57 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.78 -0.575 . . . . 0.0 109.714 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.517 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.9 Cg_endo -51.18 144.84 28.22 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 O-C-N 123.684 1.36 . . . . 21.95 111.685 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.5 150.08 49.68 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.736 0.779 . . . . 20.91 111.212 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.499 ' NH2' HG22 ' A' ' 48' ' ' VAL . 35.5 ttt-85 -125.81 153.08 44.58 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.546 HD23 ' C ' ' A' ' 47' ' ' LEU . 7.5 tt -97.57 117.16 31.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.494 -0.754 . . . . 0.0 109.997 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.499 HG22 ' NH2' ' A' ' 46' ' ' ARG . 64.7 t -100.85 -29.45 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.613 -0.68 . . . . 0.0 110.436 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.675 ' HB3' ' HB2' ' A' ' 102' ' ' ASP . . . -141.2 163.7 32.24 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.13 -1.028 . . . . 0.0 112.007 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.6 ptt85 -143.55 141.19 30.59 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.337 0.589 . . . . 29.05 110.16 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -144.0 114.14 7.38 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.396 0.617 . . . . 27.97 110.15 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.415 ' CH2' HG21 ' A' ' 115' ' ' ILE . 58.0 m95 -102.05 135.25 43.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.658 -0.651 . . . . 25.25 111.241 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -116.24 81.05 1.55 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.912 HG22 ' HG3' ' A' ' 97' ' ' MET . 17.3 pt -86.04 129.99 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 121.671 0.748 . . . . 36.11 111.748 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.693 HG23 HG22 ' A' ' 61' ' ' THR . 94.3 m -119.32 130.16 55.24 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.397 -0.964 . . . . 33.98 108.397 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -89.18 169.9 11.07 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.666 0.746 . . . . 45.04 111.26 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.25 -7.9 15.8 Favored Glycine 0 N--CA 1.495 2.579 0 O-C-N 121.791 -0.568 . . . . 39.47 112.071 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -102.15 6.95 41.06 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 119.336 1.568 . . . . 0.0 110.805 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.418 ' O ' HG23 ' A' ' 61' ' ' THR . . . 93.1 -27.94 10.5 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 121.159 -0.963 . . . . 0.0 110.933 178.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -61.6 141.81 57.54 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.19 -1.182 . . . . 62.78 109.707 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.693 HG22 HG23 ' A' ' 55' ' ' THR . 57.9 p -132.36 150.24 52.2 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.429 -0.794 . . . . 0.0 110.69 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -122.26 122.26 38.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.562 -0.711 . . . . 0.0 109.792 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -102.63 136.04 43.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.613 -0.679 . . . . 0.0 110.83 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.2 t -128.51 131.85 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.504 0.669 . . . . 37.94 109.925 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -125.02 127.48 47.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.79 -0.569 . . . . 0.0 110.3 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -153.91 173.5 32.54 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.101 -1.599 . . . . 31.82 109.101 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -115.78 159.64 21.18 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.362 -1.081 . . . . 0.0 110.047 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.66 95.35 0.01 OUTLIER Glycine 0 N--CA 1.5 2.94 0 O-C-N 121.423 -0.798 . . . . 22.62 111.355 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.493 HG13 HD22 ' A' ' 47' ' ' LEU . 16.1 m -46.36 134.02 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.505 0 O-C-N 121.399 -1.059 . . . . 17.51 111.553 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 69' ' ' VAL . 12.4 m 41.55 37.13 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-O 121.634 0.73 . . . . 20.55 111.344 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.7 20.02 62.49 Favored Glycine 0 N--CA 1.495 2.598 0 O-C-N 121.752 -0.592 . . . . 18.29 112.428 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.401 ' OE2' ' CZ ' ' A' ' 82' ' ' PHE . 5.2 pt-20 -146.73 151.81 37.8 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 119.191 1.496 . . . . 0.0 112.57 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -119.06 72.24 11.91 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 108.336 -0.987 . . . . 18.21 108.336 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -54.31 141.07 72.26 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 O-C-N 123.83 1.437 . . . . 17.61 112.517 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -99.14 74.4 1.96 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.619 ' CD1' HG22 ' A' ' 37' ' ' ILE . 12.0 mt -60.02 120.2 9.24 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.427 0.632 . . . . 20.57 112.045 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -85.42 157.8 58.29 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -53.81 127.03 23.89 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 O-C-N 123.584 1.307 . . . . 27.04 110.882 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.89 -15.69 57.02 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.735 -0.946 . . . . 24.74 110.735 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -87.02 164.27 16.57 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.086 -1.244 . . . . 29.38 110.435 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.83 151.33 36.93 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.45 -0.781 . . . . 0.0 110.333 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.401 ' CZ ' ' OE2' ' A' ' 72' ' ' GLU . 72.4 t80 -119.2 149.3 41.98 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.868 -0.79 . . . . 18.56 108.868 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -139.34 137.39 35.73 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.104 -0.997 . . . . 0.0 111.013 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.514 ' CE1' HG21 ' A' ' 35' ' ' ILE . 51.7 p90 -151.57 159.74 43.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.664 -0.648 . . . . 26.65 109.793 178.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.9 m -104.47 138.59 40.63 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.394 -0.816 . . . . 28.14 111.107 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 28.3 t -124.79 169.92 11.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.577 -0.702 . . . . 33.88 109.896 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.43 123.22 2.12 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.798 -1.191 . . . . 31.8 110.544 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.625 HG23 ' HE1' ' A' ' 33' ' ' TYR . 74.9 t -129.63 148.86 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.61 -0.935 . . . . 0.0 109.272 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.584 HD12 ' HA ' ' A' ' 30' ' ' ALA . 13.1 tp -109.74 143.82 39.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.487 -0.758 . . . . 0.0 110.496 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.667 HD12 ' CD1' ' A' ' 31' ' ' PHE . 84.8 mt -121.62 145.25 48.18 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.516 -0.74 . . . . 38.68 109.963 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.402 ' O ' ' CE1' ' A' ' 29' ' ' TYR . 29.9 tp10 -73.88 -26.06 60.35 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.407 -0.808 . . . . 0.0 110.782 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.1 p -123.34 171.74 9.19 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.39 -0.818 . . . . 31.63 110.579 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.41 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 54.9 tt0 -87.02 12.38 11.45 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.679 -0.638 . . . . 0.0 111.552 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -142.27 148.64 38.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.099 -1.0 . . . . 0.0 109.912 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.26 162.61 26.86 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 118.908 -1.615 . . . . 28.05 112.137 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -119.11 129.46 55.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.083 -0.657 . . . . 0.0 109.335 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.912 ' HG3' HG22 ' A' ' 54' ' ' ILE . 54.0 ttm -125.02 117.74 24.66 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.279 -0.888 . . . . 0.0 111.205 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.494 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 57.1 tt0 -129.5 150.34 50.89 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.08 -179.44 38.32 Favored Glycine 0 N--CA 1.499 2.886 0 C-N-CA 118.787 -1.673 . . . . 29.62 111.017 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.403 ' HB3' ' CG2' ' A' ' 112' ' ' ILE . 63.3 m80 -137.12 155.36 49.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.808 -0.819 . . . . 0.0 110.118 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.663 ' CD2' HD11 ' A' ' 115' ' ' ILE . 4.4 m-85 -117.65 127.06 53.58 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.61 -0.681 . . . . 27.05 109.668 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.675 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 71.4 m-20 -81.88 122.11 27.32 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.935 -1.103 . . . . 0.0 109.335 178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.443 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 91.8 mmm -120.53 162.84 18.91 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.189 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.458 HG22 HG23 ' A' ' 48' ' ' VAL . 7.9 m -142.51 128.76 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.672 -0.643 . . . . 23.28 110.503 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.38 167.97 20.16 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.557 -0.714 . . . . 0.0 109.469 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -62.15 -28.14 69.45 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.522 -0.736 . . . . 0.0 110.4 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -72.29 -11.29 60.64 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 111.111 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.45 -6.49 59.29 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.099 -1.048 . . . . 30.43 110.667 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.5 m -59.93 139.5 57.35 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.108 -1.23 . . . . 0.0 109.963 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -99.56 140.48 33.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.463 -0.773 . . . . 0.0 110.892 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.443 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 33.5 p90 -163.64 146.33 9.8 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.376 -0.601 . . . . 28.03 109.376 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.403 ' CG2' ' HB3' ' A' ' 100' ' ' HIS . 79.9 mt -100.78 155.43 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.61 0.719 . . . . 0.0 111.104 -178.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.92 98.12 47.8 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -59.14 144.17 99.48 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 O-C-N 123.869 1.457 . . . . 33.31 112.554 -178.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.663 HD11 ' CD2' ' A' ' 101' ' ' TYR . 66.2 mt -108.78 122.63 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.451 -0.944 . . . . 30.59 108.451 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.92 144.97 5.98 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.199 0.523 . . . . 30.78 111.615 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.494 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -92.65 119.43 32.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.795 -0.565 . . . . 0.0 110.394 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.705 ' CE1' HD11 ' A' ' 120' ' ' LEU . 43.2 p90 -108.92 169.32 8.75 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.815 -0.809 . . . . 30.66 108.815 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.628 ' C ' HD12 ' A' ' 120' ' ' LEU . 7.8 p -113.35 154.66 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.29 -0.881 . . . . 0.0 110.54 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.705 HD11 ' CE1' ' A' ' 118' ' ' PHE . 7.5 mp -113.25 131.91 55.73 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.426 -0.583 . . . . 39.15 109.426 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 96.6 p . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.654 -0.654 . . . . 0.0 110.092 -179.877 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.1 mtt-85 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 120.807 0.337 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -116.14 108.6 16.37 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.503 -0.748 . . . . 31.93 110.313 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.473 ' C ' HG23 ' A' ' 9' ' ' VAL . 74.8 mtt85 -152.17 134.56 15.22 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.574 0.702 . . . . 0.0 110.192 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.473 HG23 ' C ' ' A' ' 8' ' ' ARG . 80.0 t -151.42 113.84 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -107.85 129.04 55.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.636 -0.665 . . . . 0.0 109.767 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.551 HG11 ' HE2' ' A' ' 101' ' ' TYR . 59.5 t -119.41 139.75 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.863 -0.523 . . . . 28.21 109.968 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -121.51 136.51 54.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.409 -0.807 . . . . 0.0 109.673 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.761 HG22 HD13 ' A' ' 35' ' ' ILE . 61.0 t -129.47 137.64 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.513 -0.742 . . . . 27.95 110.434 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.6 t -125.62 104.51 27.6 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.733 -0.605 . . . . 0.0 110.583 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -83.61 165.14 14.1 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 O-C-N 123.851 1.448 . . . . 33.0 110.996 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -157.53 132.84 8.96 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.505 0.669 . . . . 54.1 109.999 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.537 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 76.5 t80 -59.96 139.47 57.38 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.812 -0.555 . . . . 0.0 111.298 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.0 HD11 ' HB2' ' A' ' 32' ' ' ALA . 77.0 mt -116.34 80.52 1.47 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.901 0.858 . . . . 0.0 110.524 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.537 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -70.01 -33.28 71.81 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.998 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -68.98 -25.97 64.8 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.271 -0.893 . . . . 0.0 111.875 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.423 ' CG ' ' HB3' ' A' ' 18' ' ' LEU . 15.7 pt20 -120.01 29.61 7.44 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.093 -1.004 . . . . 52.37 111.191 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.609 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 24.1 p -148.07 150.59 34.18 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.316 -0.865 . . . . 55.19 110.821 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.5 m -117.9 92.52 42.09 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.584 -0.697 . . . . 0.0 109.361 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.459 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . 48.3 Cg_endo -65.58 -25.46 54.9 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 O-C-N 123.951 1.5 . . . . 51.57 111.241 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.79 -23.22 65.18 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.462 -0.773 . . . . 0.0 110.843 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.39 23.4 14.22 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.326 -0.859 . . . . 0.0 110.716 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.84 30.03 72.54 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -120.86 92.59 3.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.543 -0.975 . . . . 0.0 110.036 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.459 ' CE2' ' CB ' ' A' ' 24' ' ' PRO . 72.3 m-85 -105.68 132.84 51.32 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.405 -0.809 . . . . 46.07 109.247 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.609 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -115.05 119.62 37.07 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.43 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.453 ' CG ' HD23 ' A' ' 120' ' ' LEU . 83.5 m-85 -115.93 129.31 56.34 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.533 -0.729 . . . . 38.88 109.492 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 1.0 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -115.84 131.18 57.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.139 -0.976 . . . . 34.06 108.982 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.552 ' CE1' HD11 ' A' ' 35' ' ' ILE . 54.8 p90 -126.99 146.99 50.14 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.293 -0.963 . . . . 29.03 111.021 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.3 m -100.34 140.18 34.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.646 -0.659 . . . . 0.0 109.378 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.761 HD13 HG22 ' A' ' 13' ' ' VAL . 42.1 mm -104.39 132.01 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 121.734 0.778 . . . . 0.0 111.562 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -123.23 97.4 5.4 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.454 0.645 . . . . 40.24 109.664 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.658 HG22 HD22 ' A' ' 76' ' ' LEU . 75.7 mt -91.68 117.33 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.777 -0.577 . . . . 20.73 110.504 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -117.54 136.01 53.56 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.548 -0.72 . . . . 0.0 109.554 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.501 ' HB2' HD23 ' A' ' 76' ' ' LEU . 54.9 t-20 -91.72 117.43 29.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.73 -0.606 . . . . 21.34 110.715 -179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.13 9.51 17.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.451 -0.78 . . . . 0.0 110.679 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.61 -178.22 51.25 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.136 -1.586 . . . . 29.1 109.136 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.05 -31.81 13.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.427 -1.043 . . . . 0.0 110.057 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.51 HG13 ' HD2' ' A' ' 44' ' ' PRO . 85.7 t -104.79 141.16 21.96 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.51 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.9 Cg_endo -53.98 147.17 43.98 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 O-C-N 123.74 1.39 . . . . 21.95 111.541 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.438 ' HB1' ' HZ ' ' A' ' 111' ' ' PHE . . . -137.41 150.94 48.02 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.776 0.798 . . . . 20.91 111.203 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.434 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 3.0 ttt180 -126.46 154.76 43.26 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.978 HD22 HG13 ' A' ' 69' ' ' VAL . 6.9 tt -98.19 118.17 34.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.444 -0.785 . . . . 0.0 109.755 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.537 HG23 HG22 ' A' ' 104' ' ' VAL . 63.5 t -101.53 -26.73 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.715 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.655 ' HB3' ' HB2' ' A' ' 102' ' ' ASP . . . -141.45 162.83 34.54 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.146 -179.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -142.93 139.4 30.71 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.34 0.59 . . . . 29.05 110.159 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -143.12 114.1 7.7 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.4 0.619 . . . . 27.97 109.815 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.539 ' CH2' HD13 ' A' ' 115' ' ' ILE . 88.0 m95 -102.49 134.47 45.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.669 -0.644 . . . . 25.25 110.881 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -115.75 78.76 1.21 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.522 -0.736 . . . . 0.0 109.092 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.728 HG22 ' HG3' ' A' ' 97' ' ' MET . 13.1 pt -83.45 128.63 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.515 -0.741 . . . . 36.11 111.741 -178.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.704 HG23 ' HB ' ' A' ' 61' ' ' THR . 3.6 m -120.03 131.08 55.0 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.469 -0.937 . . . . 33.98 108.469 178.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -88.54 170.01 11.24 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.619 0.723 . . . . 45.04 111.205 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.4 -6.93 12.08 Favored Glycine 0 N--CA 1.496 2.661 0 O-C-N 121.831 -0.543 . . . . 39.47 112.188 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.35 7.69 42.63 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 119.322 1.561 . . . . 0.0 110.576 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.59 -31.31 6.56 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -62.09 142.72 57.42 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.202 -1.175 . . . . 62.78 109.778 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.704 ' HB ' HG23 ' A' ' 55' ' ' THR . 7.6 t -135.82 153.3 51.55 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.531 -0.731 . . . . 0.0 110.613 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -121.68 122.95 40.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.635 -0.665 . . . . 0.0 110.02 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -100.55 135.06 42.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.699 -0.625 . . . . 0.0 110.547 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.2 t -128.12 130.59 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.613 0.72 . . . . 37.94 110.065 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -126.44 127.09 44.86 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.801 -0.562 . . . . 0.0 110.147 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -150.5 154.85 25.88 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.494 -1.442 . . . . 31.82 109.494 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -78.16 154.74 30.92 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.51 -0.994 . . . . 0.0 110.367 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.46 -168.38 0.21 Allowed Glycine 0 N--CA 1.498 2.787 0 O-C-N 121.412 -0.805 . . . . 22.62 111.598 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.978 HG13 HD22 ' A' ' 47' ' ' LEU . 16.0 m -129.86 129.2 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.864 -0.786 . . . . 17.51 109.72 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.3 m 41.13 36.77 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 CA-C-O 121.44 0.638 . . . . 20.55 111.86 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.08 16.47 69.59 Favored Glycine 0 N--CA 1.499 2.893 0 O-C-N 121.645 -0.659 . . . . 18.29 112.833 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -145.98 151.72 38.25 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-N 119.145 1.472 . . . . 0.0 112.014 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -114.9 75.7 3.98 Favored Pre-proline 0 N--CA 1.492 1.625 0 N-CA-C 109.006 -0.739 . . . . 18.21 109.006 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -57.66 139.81 91.46 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 O-C-N 123.769 1.405 . . . . 17.61 111.951 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 46' ' ' ARG . 2.3 t90 -103.36 76.53 1.44 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.658 HD22 HG22 ' A' ' 37' ' ' ILE . 6.6 tp -59.97 117.83 5.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.648 -0.658 . . . . 20.57 111.51 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -86.46 157.99 55.1 Favored Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -53.79 127.57 26.07 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 O-C-N 123.56 1.295 . . . . 27.04 111.054 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.88 -19.08 39.87 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.761 -0.936 . . . . 24.74 110.761 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 71.3 tt0 -88.87 166.48 13.95 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.1 -1.235 . . . . 29.38 110.162 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.624 ' CA ' HD11 ' A' ' 76' ' ' LEU . . . -146.28 150.62 36.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.49 -0.756 . . . . 0.0 110.464 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.45 ' N ' HD11 ' A' ' 76' ' ' LEU . 66.2 t80 -117.71 147.84 42.57 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.044 -0.725 . . . . 18.56 109.044 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -144.29 140.19 29.03 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.109 -0.994 . . . . 0.0 111.338 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.66 ' CE1' HG21 ' A' ' 35' ' ' ILE . 47.9 p90 -150.78 160.28 43.97 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.653 -0.655 . . . . 26.65 109.577 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.7 m -102.63 137.67 40.55 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.424 -0.798 . . . . 28.14 110.949 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.442 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 15.0 t -124.11 167.06 14.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.595 -0.69 . . . . 33.88 109.957 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -139.83 128.65 3.99 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.882 -1.151 . . . . 31.8 110.503 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.5 m -134.19 154.27 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.651 -0.911 . . . . 0.0 110.009 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 89' ' ' LEU . 5.0 mp -109.83 144.69 37.93 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.566 -0.709 . . . . 0.0 110.95 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.712 HD23 ' O ' ' A' ' 92' ' ' THR . 12.6 tp -121.43 146.55 46.78 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.656 -0.653 . . . . 38.68 109.762 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -83.9 -27.46 28.6 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.321 -0.862 . . . . 0.0 111.053 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.712 ' O ' HD23 ' A' ' 90' ' ' LEU . 71.9 p -123.44 171.26 9.6 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.341 -0.849 . . . . 31.63 110.774 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.453 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 96.6 mt-10 -86.48 11.64 12.12 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.646 -0.659 . . . . 0.0 111.609 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -144.05 143.13 31.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.044 -1.035 . . . . 0.0 109.893 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.7 160.37 25.18 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 118.615 -1.755 . . . . 28.05 112.537 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -118.91 129.79 55.37 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.728 ' HG3' HG22 ' A' ' 54' ' ' ILE . 15.5 ttt -128.69 122.86 31.7 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.306 -0.871 . . . . 0.0 111.641 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.407 ' HG2' ' CB ' ' A' ' 117' ' ' ALA . 39.3 mt-30 -120.27 150.79 40.14 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -151.62 172.21 31.07 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 118.677 -1.725 . . . . 29.62 111.325 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.858 ' CE1' HD12 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -138.95 154.3 48.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.761 -0.847 . . . . 0.0 109.373 179.121 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.62 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 10.3 m-85 -118.98 126.09 50.94 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.404 -0.81 . . . . 27.05 110.244 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.655 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 78.3 m-20 -86.31 120.25 27.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.899 -1.125 . . . . 0.0 108.777 177.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.454 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 86.8 mmm -121.87 163.04 19.9 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.228 0.537 . . . . 0.0 110.537 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.537 HG22 HG23 ' A' ' 48' ' ' VAL . 7.5 m -142.17 128.7 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.693 -0.629 . . . . 23.28 110.421 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.5 166.36 22.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.358 -0.838 . . . . 0.0 109.378 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -63.95 -27.73 69.34 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.324 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -76.41 -10.31 59.3 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.444 -0.785 . . . . 0.0 111.181 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.9 -7.34 48.85 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.45 -1.06 . . . . 30.43 110.45 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.3 m -58.32 135.76 57.23 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.052 -1.263 . . . . 0.0 109.966 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -100.51 139.03 36.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.434 -0.791 . . . . 0.0 110.783 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 37.8 p90 -161.2 141.46 10.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.702 -0.624 . . . . 28.03 109.889 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.858 HD12 ' CE1' ' A' ' 100' ' ' HIS . 29.9 pt -99.88 156.17 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.661 -0.649 . . . . 0.0 110.923 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.62 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -121.69 98.77 45.41 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.648 -0.658 . . . . 0.0 109.391 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.415 ' HB3' ' CE1' ' A' ' 100' ' ' HIS . 46.3 Cg_endo -59.03 144.0 99.56 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 O-C-N 123.901 1.474 . . . . 33.31 112.154 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.539 HD13 ' CH2' ' A' ' 52' ' ' TRP . 64.1 mt -108.8 121.71 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.426 -0.953 . . . . 30.59 108.426 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.3 159.13 0.22 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.176 0.512 . . . . 30.78 111.533 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.407 ' CB ' ' HG2' ' A' ' 98' ' ' GLN . . . -91.12 124.3 35.24 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.738 -0.601 . . . . 0.0 110.874 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 97' ' ' MET . 38.5 p90 -113.64 158.35 20.95 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.347 -0.982 . . . . 30.66 108.347 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.662 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.1 t -116.15 154.89 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.27 -0.894 . . . . 0.0 110.387 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.662 HD12 ' C ' ' A' ' 119' ' ' VAL . 7.9 mp -114.64 130.51 56.81 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.229 -0.656 . . . . 39.15 109.229 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.744 -0.598 . . . . 0.0 110.069 -179.652 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 120.762 0.315 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.447 ' CE2' HG21 ' A' ' 109' ' ' THR . 49.9 m-85 -118.51 108.42 14.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.433 -0.792 . . . . 31.93 110.209 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.451 ' C ' HG23 ' A' ' 9' ' ' VAL . 66.9 mtt85 -150.15 134.95 17.62 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.57 0.7 . . . . 0.0 110.12 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.808 HG11 ' SD ' ' A' ' 103' ' ' MET . 63.3 t -150.21 116.01 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.507 0.67 . . . . 0.0 109.365 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -107.25 130.69 54.71 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.592 0.711 . . . . 0.0 110.279 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.648 HG11 ' HE2' ' A' ' 101' ' ' TYR . 62.7 t -118.89 137.02 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.809 -0.557 . . . . 28.21 109.501 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -123.85 137.7 54.61 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.404 -0.81 . . . . 0.0 109.94 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.2 t -128.97 137.02 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.484 0.659 . . . . 27.95 110.583 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -124.59 105.19 30.47 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.754 -0.591 . . . . 0.0 110.116 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.433 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 50.7 Cg_endo -82.58 163.39 16.62 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 O-C-N 123.869 1.457 . . . . 33.0 111.323 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -156.98 130.77 8.22 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.613 0.721 . . . . 54.1 109.602 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.442 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 84.8 t80 -61.55 138.48 58.29 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.344 0.592 . . . . 0.0 111.444 -178.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.705 HD23 ' HB3' ' A' ' 21' ' ' GLN . 8.9 tp -114.96 82.65 1.77 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.961 0.886 . . . . 0.0 110.014 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.442 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -65.19 -36.17 83.38 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.575 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -68.89 -22.39 64.18 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.355 -0.84 . . . . 0.0 110.871 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.705 ' HB3' HD23 ' A' ' 18' ' ' LEU . 44.2 tt0 -119.54 23.55 11.13 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.345 -0.847 . . . . 52.37 110.702 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.719 ' OG ' ' HB3' ' A' ' 30' ' ' ALA . 73.1 m -136.11 137.95 41.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.301 -0.875 . . . . 55.19 111.16 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.2 m -119.19 90.44 41.8 Favored Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.447 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 48.3 Cg_endo -63.74 -26.83 68.14 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 O-C-N 123.933 1.491 . . . . 51.57 111.686 -178.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -69.04 -22.83 64.02 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.327 -0.858 . . . . 0.0 110.829 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -107.11 19.27 20.64 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.295 -0.878 . . . . 0.0 110.998 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.18 30.37 73.73 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -119.61 94.37 4.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.667 -0.902 . . . . 0.0 110.247 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.447 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 79.0 m-85 -106.51 129.01 54.54 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.391 -0.818 . . . . 46.07 109.386 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.719 ' HB3' ' OG ' ' A' ' 22' ' ' SER . . . -119.42 120.07 35.76 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.31 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.634 ' CD1' HD12 ' A' ' 90' ' ' LEU . 61.9 m-85 -115.79 136.84 52.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.644 -0.66 . . . . 38.88 109.597 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.27 131.82 54.85 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.727 -0.842 . . . . 34.06 108.727 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.561 ' HE1' HG23 ' A' ' 88' ' ' VAL . 26.4 p90 -126.54 143.37 51.23 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.212 -0.995 . . . . 29.03 111.303 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 t -102.81 139.12 38.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.682 -0.636 . . . . 0.0 109.286 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.9 HD13 ' CE2' ' A' ' 84' ' ' TYR . 5.2 mp -104.78 132.04 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.81 0.814 . . . . 0.0 111.247 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.6 mtm180 -122.08 97.35 5.44 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.467 0.651 . . . . 40.24 109.63 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.651 HG22 HD22 ' A' ' 76' ' ' LEU . 80.2 mt -94.2 116.47 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.765 -0.584 . . . . 20.73 110.507 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -117.46 138.68 51.7 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.486 -0.759 . . . . 0.0 109.455 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.417 ' HB2' HD23 ' A' ' 76' ' ' LEU . 41.5 t-20 -91.61 118.12 30.33 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.67 -0.644 . . . . 21.34 110.851 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.1 9.04 14.63 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.428 -0.795 . . . . 0.0 110.479 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.23 176.63 52.95 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.544 -1.423 . . . . 29.1 109.544 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.12 -35.71 17.3 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.585 -0.95 . . . . 0.0 110.271 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.518 HG13 ' HD2' ' A' ' 44' ' ' PRO . 86.9 t -102.96 140.31 20.93 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.802 -0.561 . . . . 0.0 110.033 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.518 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.5 Cg_endo -52.87 144.14 45.73 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 O-C-N 123.775 1.408 . . . . 21.95 111.68 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.09 151.4 46.69 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.659 0.742 . . . . 20.91 111.092 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 1.1 ptt85 -127.73 159.79 33.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.697 -0.627 . . . . 0.0 109.715 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.953 HD22 HG13 ' A' ' 69' ' ' VAL . 6.8 tt -98.04 116.4 30.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.463 -0.773 . . . . 0.0 109.583 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.482 HG23 HG22 ' A' ' 104' ' ' VAL . 57.6 t -98.43 -28.21 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.541 -0.724 . . . . 0.0 110.515 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.679 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -141.62 162.38 35.63 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.439 -0.905 . . . . 0.0 111.758 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.0 ptt85 -142.89 141.56 31.55 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.579 0.704 . . . . 29.05 110.298 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -144.23 114.86 7.67 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.288 0.566 . . . . 27.97 109.581 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -95.9 133.68 39.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.646 -0.659 . . . . 25.25 111.037 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -115.84 78.49 1.19 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.879 HG22 ' HG3' ' A' ' 97' ' ' MET . 13.3 pt -86.29 129.24 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-O 121.748 0.785 . . . . 36.11 111.758 -178.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.687 HG23 HG22 ' A' ' 61' ' ' THR . 90.6 m -120.19 129.98 54.35 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.097 -1.075 . . . . 33.98 108.097 178.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -91.04 170.32 10.14 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.771 0.796 . . . . 45.04 111.504 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.62 -6.62 11.97 Favored Glycine 0 N--CA 1.494 2.555 0 O-C-N 121.8 -0.562 . . . . 39.47 112.122 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -101.73 5.56 41.38 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 119.429 1.614 . . . . 0.0 110.62 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.4 ' O ' HG23 ' A' ' 61' ' ' THR . . . 92.77 -28.5 9.2 Favored Glycine 0 N--CA 1.495 2.613 0 O-C-N 121.25 -0.906 . . . . 0.0 110.894 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.6 142.44 58.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.191 -1.182 . . . . 62.78 109.621 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.687 HG22 HG23 ' A' ' 55' ' ' THR . 71.5 p -132.23 149.99 52.26 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.455 -0.778 . . . . 0.0 110.67 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -122.4 122.12 38.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.47 -0.769 . . . . 0.0 109.962 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -105.44 136.39 45.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.579 -0.701 . . . . 0.0 110.984 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.6 t -129.23 131.35 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.546 -0.722 . . . . 37.94 109.818 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.29 127.45 47.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.711 -0.618 . . . . 0.0 110.429 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.24 149.23 21.17 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.412 -1.475 . . . . 31.82 109.412 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -74.42 155.68 37.81 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.448 -1.031 . . . . 0.0 110.274 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 50.4 -171.94 0.14 Allowed Glycine 0 N--CA 1.498 2.817 0 O-C-N 121.336 -0.853 . . . . 22.62 111.253 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.953 HG13 HD22 ' A' ' 47' ' ' LEU . 14.8 m -129.41 128.11 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.78 -0.835 . . . . 17.51 109.57 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 69' ' ' VAL . 12.0 m 41.17 36.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 CA-C-O 121.603 0.716 . . . . 20.55 111.796 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.25 16.25 69.75 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 121.627 -0.67 . . . . 18.29 112.93 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.415 ' O ' HG22 ' A' ' 69' ' ' VAL . 10.0 pt-20 -145.79 150.76 36.8 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 119.163 1.481 . . . . 0.0 112.028 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -114.97 74.15 3.43 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.895 -0.78 . . . . 18.21 108.895 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -57.25 140.51 93.11 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 O-C-N 123.793 1.417 . . . . 17.61 112.225 -178.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.432 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 5.9 t90 -102.11 77.17 1.65 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.651 HD22 HG22 ' A' ' 37' ' ' ILE . 6.9 tp -59.66 117.3 4.77 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.553 -0.717 . . . . 20.57 111.621 -178.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -86.35 156.86 56.66 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -52.76 126.72 22.02 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 O-C-N 123.678 1.357 . . . . 27.04 110.931 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.6 -17.44 49.25 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.701 -0.96 . . . . 24.74 110.701 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -88.16 165.5 15.05 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.053 -1.263 . . . . 29.38 110.196 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.602 ' CA ' HD11 ' A' ' 76' ' ' LEU . . . -147.81 152.8 38.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.513 -0.742 . . . . 0.0 110.372 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.4 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 66.9 t80 -119.34 147.89 43.81 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.93 -0.767 . . . . 18.56 108.93 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.5 m80 -138.95 138.31 37.21 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.094 -1.004 . . . . 0.0 110.824 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.9 ' CE2' HD13 ' A' ' 35' ' ' ILE . 50.5 p90 -151.0 159.72 44.39 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.527 -0.733 . . . . 26.65 109.993 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.1 m -104.36 137.61 41.99 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.444 -0.785 . . . . 28.14 110.811 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 14.6 t -125.14 166.86 15.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.578 -0.701 . . . . 33.88 110.091 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.43 127.24 4.07 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.886 -1.15 . . . . 31.8 110.413 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.561 HG23 ' HE1' ' A' ' 33' ' ' TYR . 79.4 t -131.51 148.43 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.577 -0.955 . . . . 0.0 109.375 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.9 tp -110.13 143.54 40.06 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.561 -0.712 . . . . 0.0 110.275 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.668 ' CD1' HD22 ' A' ' 120' ' ' LEU . 84.5 mt -122.97 148.38 45.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.474 -0.766 . . . . 38.68 110.358 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -76.21 -26.41 56.09 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.376 -0.828 . . . . 0.0 110.63 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 93' ' ' GLU . 6.4 m -122.55 171.27 9.24 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.453 -0.78 . . . . 31.63 110.545 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.423 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 58.0 tt0 -85.87 8.15 21.3 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.678 -0.639 . . . . 0.0 111.754 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -140.71 150.11 43.03 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.059 -1.026 . . . . 0.0 110.064 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.06 164.46 29.14 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 118.867 -1.635 . . . . 28.05 112.097 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -121.89 131.69 54.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 122.067 -0.667 . . . . 0.0 109.545 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.879 ' HG3' HG22 ' A' ' 54' ' ' ILE . 27.1 ttt -127.27 121.05 30.09 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.256 -0.902 . . . . 0.0 111.424 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.493 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 56.2 tt0 -128.66 147.75 50.76 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.84 -179.86 35.86 Favored Glycine 0 N--CA 1.5 2.945 0 C-N-CA 119.072 -1.537 . . . . 29.62 110.72 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -140.84 157.97 44.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.697 -0.884 . . . . 0.0 110.75 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.648 ' HE2' HG11 ' A' ' 11' ' ' VAL . 6.9 m-85 -116.72 129.28 56.03 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.606 -0.684 . . . . 27.05 110.193 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.679 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 42.6 t0 -83.9 122.98 29.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.959 -1.088 . . . . 0.0 109.149 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.808 ' SD ' HG11 ' A' ' 9' ' ' VAL . 24.1 mtp -124.23 162.75 23.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.9 -0.5 . . . . 0.0 110.572 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.482 HG22 HG23 ' A' ' 48' ' ' VAL . 10.6 m -140.45 130.24 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.69 -0.631 . . . . 23.28 110.208 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.9 166.61 22.66 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.407 -0.808 . . . . 0.0 109.473 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -63.93 -29.97 71.09 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.127 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -74.19 -10.34 59.51 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.524 -0.735 . . . . 0.0 111.129 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.14 -7.43 47.99 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 120.072 -1.061 . . . . 30.43 110.454 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.447 HG21 ' CE2' ' A' ' 7' ' ' TYR . 65.8 m -57.45 136.05 56.63 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.108 -1.231 . . . . 0.0 109.988 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -101.92 140.85 35.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.334 -0.854 . . . . 0.0 110.955 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 46.5 p90 -167.45 147.03 5.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.678 -0.639 . . . . 28.03 110.06 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.2 pt -102.43 157.53 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.685 -0.634 . . . . 0.0 110.846 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.77 98.33 49.65 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -59.25 142.19 98.84 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 O-C-N 123.935 1.492 . . . . 33.31 112.236 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.557 HD11 ' CE2' ' A' ' 101' ' ' TYR . 67.3 mt -106.83 123.3 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.52 -0.918 . . . . 30.59 108.52 178.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.18 144.09 7.56 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.243 0.544 . . . . 30.78 111.365 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.493 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -88.53 121.22 30.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.659 -0.651 . . . . 0.0 110.103 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.493 ' HE1' HD11 ' A' ' 120' ' ' LEU . 36.3 p90 -107.5 165.14 11.62 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.037 -0.727 . . . . 30.66 109.037 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.607 ' C ' HD12 ' A' ' 120' ' ' LEU . 57.3 t -116.94 155.63 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.377 -0.827 . . . . 0.0 110.274 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.668 HD22 ' CD1' ' A' ' 90' ' ' LEU . 7.2 mp -114.06 132.49 56.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.709 -0.619 . . . . 39.15 109.6 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.657 -0.652 . . . . 0.0 110.138 -179.796 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.034 0.445 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -112.68 79.57 1.24 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.702 -0.624 . . . . 31.93 109.9 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.458 ' C ' HG23 ' A' ' 9' ' ' VAL . 45.9 mtm180 -138.29 142.87 39.79 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.966 0.889 . . . . 0.0 110.333 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.458 HG23 ' C ' ' A' ' 8' ' ' ARG . 85.5 t -150.56 115.75 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.537 0.684 . . . . 0.0 109.215 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -106.02 129.61 54.1 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.557 0.694 . . . . 0.0 109.779 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.453 HG11 ' HE2' ' A' ' 101' ' ' TYR . 66.5 t -116.93 138.87 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.92 -0.487 . . . . 28.21 109.694 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -121.02 136.6 54.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.466 -0.771 . . . . 0.0 109.798 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.804 HG22 HD13 ' A' ' 35' ' ' ILE . 62.1 t -128.42 136.38 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.669 -0.644 . . . . 27.95 110.173 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.9 m -124.81 105.05 29.9 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.617 -0.677 . . . . 0.0 110.509 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -82.22 165.06 17.0 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 O-C-N 123.893 1.47 . . . . 33.0 110.768 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -158.01 130.67 7.27 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.587 0.708 . . . . 54.1 109.844 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.532 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 77.6 t80 -61.16 138.21 58.22 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.761 -0.587 . . . . 0.0 111.327 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.541 ' CD1' ' HB2' ' A' ' 32' ' ' ALA . 6.1 mt -116.62 80.94 1.54 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.086 0.946 . . . . 0.0 110.333 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.532 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -67.37 -35.67 79.82 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.136 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -68.8 -23.25 64.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.275 -0.891 . . . . 0.0 110.818 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -121.96 46.87 2.0 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.36 -0.838 . . . . 52.37 110.64 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.743 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 53.3 p -167.46 148.74 5.57 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.236 -0.915 . . . . 55.19 111.112 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.655 HG23 ' HB2' ' A' ' 28' ' ' ARG . 9.8 t -122.02 93.27 48.67 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.475 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.0 Cg_endo -67.26 -22.81 45.86 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 O-C-N 123.673 1.354 . . . . 51.57 111.949 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -65.15 -23.27 67.07 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.283 -0.886 . . . . 0.0 110.961 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -106.14 24.45 12.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.285 -0.884 . . . . 0.0 110.709 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.84 28.91 73.39 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.655 ' HB2' HG23 ' A' ' 23' ' ' THR . 51.8 mtp180 -120.87 93.81 4.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.641 -0.917 . . . . 0.0 110.178 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.475 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 67.8 m-85 -104.26 133.95 48.31 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.533 -0.729 . . . . 46.07 109.126 179.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.743 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -114.28 120.93 42.08 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.107 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.404 ' CD1' HD12 ' A' ' 90' ' ' LEU . 90.4 m-85 -116.12 134.02 55.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.694 -0.629 . . . . 38.88 109.788 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.541 ' HB2' ' CD1' ' A' ' 18' ' ' LEU . . . -112.43 132.04 55.25 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.463 -0.939 . . . . 34.06 108.463 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.502 ' CE2' HD11 ' A' ' 35' ' ' ILE . 38.2 p90 -127.67 144.39 51.08 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.073 -1.051 . . . . 29.03 111.708 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.6 t -104.82 139.98 38.79 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.804 HD13 HG22 ' A' ' 13' ' ' VAL . 41.4 mm -105.77 132.63 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.77 0.795 . . . . 0.0 111.725 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.3 mtp180 -124.04 97.02 5.16 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.49 0.662 . . . . 40.24 109.799 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.657 HG22 ' CD1' ' A' ' 76' ' ' LEU . 74.1 mt -92.78 116.92 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.706 -0.621 . . . . 20.73 110.433 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -119.77 144.69 47.15 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.455 -0.778 . . . . 0.0 109.919 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.06 113.84 22.46 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.514 -0.741 . . . . 21.34 109.47 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 8' ' ' ARG . . . -89.32 -18.79 26.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.788 -0.57 . . . . 0.0 111.715 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.59 -163.93 37.2 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.305 -0.95 . . . . 29.1 110.942 -178.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -113.89 -17.02 12.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.964 -0.727 . . . . 0.0 111.013 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.491 HG13 ' HD2' ' A' ' 44' ' ' PRO . 95.5 t -103.31 135.59 19.36 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.316 -0.865 . . . . 0.0 109.566 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.491 ' HD2' HG13 ' A' ' 43' ' ' VAL . 41.2 Cg_endo -48.84 140.54 23.09 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 O-C-N 123.757 1.399 . . . . 21.95 112.219 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -134.23 149.52 50.98 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.703 0.764 . . . . 20.91 110.873 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.428 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 43.2 ttt180 -125.91 151.45 46.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.832 -0.542 . . . . 0.0 109.547 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.836 HD22 HG13 ' A' ' 69' ' ' VAL . 7.2 tt -98.68 117.21 32.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.464 -0.773 . . . . 0.0 109.973 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.476 HG23 HG22 ' A' ' 104' ' ' VAL . 62.4 t -100.98 -30.49 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.6 -0.687 . . . . 0.0 110.649 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -141.4 162.54 35.25 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.08 -1.048 . . . . 0.0 112.334 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.43 ' HD3' HG12 ' A' ' 69' ' ' VAL . 23.2 ptt180 -143.25 140.98 30.91 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.482 0.658 . . . . 29.05 110.201 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.412 ' HB3' ' CE1' ' A' ' 100' ' ' HIS . 21.7 t-160 -145.86 114.69 6.9 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.353 0.597 . . . . 27.97 109.987 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.53 ' CH2' HD13 ' A' ' 115' ' ' ILE . 63.2 m95 -100.21 135.97 40.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.579 -0.701 . . . . 25.25 111.42 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -117.06 79.17 1.3 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.711 -0.618 . . . . 0.0 109.417 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.447 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.2 pt -83.31 130.27 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.375 -0.828 . . . . 36.11 112.208 -178.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.782 HG23 HG22 ' A' ' 61' ' ' THR . 85.3 m -119.48 130.05 55.03 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.209 -1.034 . . . . 33.98 108.209 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -91.39 170.03 10.31 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.657 0.741 . . . . 45.04 111.352 -178.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.81 -6.72 12.85 Favored Glycine 0 N--CA 1.495 2.609 0 O-C-N 121.866 -0.521 . . . . 39.47 112.086 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -102.05 5.83 40.74 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 119.367 1.584 . . . . 0.0 110.6 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 61' ' ' THR . . . 93.27 -28.47 9.71 Favored Glycine 0 N--CA 1.495 2.596 0 C-N-CA 120.352 -0.927 . . . . 0.0 110.859 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.1 141.4 58.15 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.277 -1.131 . . . . 62.78 109.77 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.782 HG22 HG23 ' A' ' 55' ' ' THR . 66.4 p -132.38 150.05 52.23 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.438 -0.788 . . . . 0.0 110.488 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -122.32 122.29 38.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.566 -0.709 . . . . 0.0 109.903 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -103.28 134.66 46.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.696 -0.627 . . . . 0.0 110.59 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.3 t -128.04 130.07 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.558 0.694 . . . . 37.94 109.942 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -124.24 126.82 46.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.822 -0.549 . . . . 0.0 110.111 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.96 149.6 21.62 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.35 -1.5 . . . . 31.82 109.35 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -76.72 154.72 33.86 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.492 -1.004 . . . . 0.0 110.078 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.77 -169.48 0.19 Allowed Glycine 0 N--CA 1.498 2.808 0 O-C-N 121.378 -0.826 . . . . 22.62 111.337 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.836 HG13 HD22 ' A' ' 47' ' ' LEU . 15.9 m -131.05 129.24 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.834 -0.803 . . . . 17.51 109.648 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.1 m 40.95 35.22 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.456 0 CA-C-O 121.445 0.64 . . . . 20.55 111.918 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.06 17.13 67.95 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 121.676 -0.64 . . . . 18.29 112.85 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.404 ' OE1' ' CZ ' ' A' ' 82' ' ' PHE . 11.9 pt-20 -144.97 150.33 36.75 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 119.131 1.466 . . . . 0.0 111.902 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 46' ' ' ARG . 93.4 mt-30 -116.3 75.57 6.37 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 109.019 -0.734 . . . . 18.21 109.019 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -58.1 142.17 96.83 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 O-C-N 123.956 1.503 . . . . 17.61 112.411 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.436 ' CH2' ' HB2' ' A' ' 44' ' ' PRO . 5.0 t90 -103.88 75.54 1.3 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.657 ' CD1' HG22 ' A' ' 37' ' ' ILE . 9.7 mt -60.82 121.34 12.08 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.563 -0.711 . . . . 20.57 112.35 -178.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -87.44 158.44 51.72 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -54.22 129.21 33.32 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 O-C-N 123.529 1.279 . . . . 27.04 111.309 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.92 -16.75 49.8 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 120.481 -0.866 . . . . 24.74 111.023 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -87.96 166.07 14.77 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.973 -1.31 . . . . 29.38 110.393 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.33 149.56 35.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.516 -0.74 . . . . 0.0 110.283 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.404 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 65.1 t80 -118.99 147.79 43.7 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.846 -0.798 . . . . 18.56 108.846 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -143.95 140.19 29.53 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.13 -0.981 . . . . 0.0 111.552 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.53 ' CE1' HG21 ' A' ' 35' ' ' ILE . 52.1 p90 -150.45 159.97 44.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.707 -0.621 . . . . 26.65 109.526 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.5 m -104.83 138.78 40.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.283 -0.885 . . . . 28.14 111.353 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.451 ' CB ' ' CZ ' ' A' ' 33' ' ' TYR . 25.2 t -123.95 166.18 16.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.714 -0.616 . . . . 33.88 109.762 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -143.06 118.89 1.28 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.202 -1.159 . . . . 31.8 110.202 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 68.2 t -132.57 149.42 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.66 -0.906 . . . . 0.0 109.763 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 pp -107.34 142.36 37.25 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.505 -0.747 . . . . 0.0 110.205 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.404 HD12 ' CD1' ' A' ' 31' ' ' PHE . 31.0 mt -124.57 143.3 50.77 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.486 -0.759 . . . . 38.68 110.502 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.56 -19.26 38.88 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.281 -0.887 . . . . 0.0 110.232 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.431 HG22 ' H ' ' A' ' 94' ' ' GLN . 5.3 m -101.67 133.17 46.79 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.443 -0.786 . . . . 31.63 109.978 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.415 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 67.9 tt0 -75.7 -4.89 42.85 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.119 -0.988 . . . . 0.0 110.623 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.431 ' H ' HG22 ' A' ' 92' ' ' THR . 15.5 pt20 -138.68 143.31 39.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.207 -0.933 . . . . 0.0 108.803 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -178.05 167.35 38.04 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 118.303 -1.903 . . . . 28.05 112.639 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -117.71 130.63 56.45 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 122.192 -0.593 . . . . 0.0 109.711 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 98.1 mtp -127.11 121.28 31.01 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.325 -0.859 . . . . 0.0 111.337 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.72 ' HG2' ' HB2' ' A' ' 117' ' ' ALA . 75.6 mt-30 -123.06 152.7 40.76 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.426 ' HA3' ' CE3' ' A' ' 52' ' ' TRP . . . -168.41 174.96 43.18 Favored Glycine 0 N--CA 1.499 2.879 0 C-N-CA 118.561 -1.78 . . . . 29.62 111.366 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.412 ' CE1' ' HB3' ' A' ' 51' ' ' HIS . 40.7 p-80 -142.86 156.17 44.89 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.876 -0.779 . . . . 0.0 110.078 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.785 ' CD2' HD11 ' A' ' 115' ' ' ILE . 4.8 m-85 -116.82 127.81 54.67 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.503 -0.748 . . . . 27.05 109.796 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 10.2 t70 -78.88 123.17 26.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.914 -1.116 . . . . 0.0 109.298 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.452 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 92.3 mmm -119.69 163.07 17.96 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.174 0.512 . . . . 0.0 110.062 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.476 HG22 HG23 ' A' ' 48' ' ' VAL . 8.6 m -142.42 129.16 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.588 -0.695 . . . . 23.28 110.453 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.564 ' HB3' ' OD1' ' A' ' 107' ' ' ASP . . . -72.73 166.03 23.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.492 -0.755 . . . . 0.0 109.408 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -64.36 -28.39 69.67 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.383 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.564 ' OD1' ' HB3' ' A' ' 105' ' ' ALA . 47.0 p-10 -76.29 -4.44 42.04 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.467 -0.77 . . . . 0.0 111.505 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.7 -9.91 60.57 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.056 -1.069 . . . . 30.43 110.915 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 89.7 m -57.5 135.08 56.59 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.03 -1.276 . . . . 0.0 109.985 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -101.36 140.8 35.15 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.335 -0.853 . . . . 0.0 110.877 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.452 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 44.0 p90 -165.9 144.87 6.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.712 -0.618 . . . . 28.03 109.603 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 84.8 mt -99.15 157.41 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.699 -0.626 . . . . 0.0 110.712 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.82 96.07 49.39 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -60.1 144.88 99.45 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 O-C-N 123.946 1.498 . . . . 33.31 112.376 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.785 HD11 ' CD2' ' A' ' 101' ' ' TYR . 68.8 mt -111.56 123.32 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.749 -0.834 . . . . 30.59 108.749 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -47.87 170.56 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.246 0.545 . . . . 30.78 111.636 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.72 ' HB2' ' HG2' ' A' ' 98' ' ' GLN . . . -99.41 123.14 43.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.699 -0.626 . . . . 0.0 110.766 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.47 ' CE1' HD11 ' A' ' 120' ' ' LEU . 48.4 p90 -111.36 156.83 20.97 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.262 -1.014 . . . . 30.66 108.262 178.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.631 ' C ' HD12 ' A' ' 120' ' ' LEU . 8.9 p -115.65 155.31 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.245 -0.909 . . . . 0.0 110.602 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.653 ' N ' HD12 ' A' ' 120' ' ' LEU . 7.8 mp -112.81 132.34 55.3 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.286 -0.635 . . . . 39.15 109.286 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.735 -0.603 . . . . 0.0 110.114 -179.722 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.554 ' HG3' ' HB3' ' A' ' 42' ' ' ALA . 29.3 ttm-85 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.011 0.434 . . . . 0.0 110.0 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -122.47 84.59 2.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.77 -0.581 . . . . 31.93 110.348 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.47 ' C ' HG23 ' A' ' 9' ' ' VAL . 11.9 ptp180 -148.3 144.26 27.47 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.133 0.968 . . . . 0.0 110.737 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.641 HG11 ' SD ' ' A' ' 103' ' ' MET . 99.3 t -151.02 120.61 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -108.07 134.18 51.32 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.615 0.721 . . . . 0.0 110.127 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 37' ' ' ILE . 60.5 t -119.28 138.55 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.915 -0.491 . . . . 28.21 109.921 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.412 ' HG3' ' HB2' ' A' ' 36' ' ' ARG . 13.4 pt-20 -122.92 139.71 53.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.502 -0.749 . . . . 0.0 109.422 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.742 HG22 HD13 ' A' ' 35' ' ' ILE . 59.3 t -128.56 140.25 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.645 -0.659 . . . . 27.95 110.717 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.6 t -122.83 104.04 36.52 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.844 -0.535 . . . . 0.0 109.963 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.433 ' HG3' ' CD1' ' A' ' 118' ' ' PHE . 50.0 Cg_endo -82.74 165.79 15.53 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 O-C-N 123.901 1.474 . . . . 33.0 111.26 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 -157.61 132.8 8.86 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.511 0.672 . . . . 54.1 109.557 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 19' ' ' ALA . 71.9 t80 -60.0 137.77 58.01 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.287 0.565 . . . . 0.0 111.206 -178.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.545 HD21 ' OE1' ' A' ' 21' ' ' GLN . 5.6 tp -114.95 78.71 1.19 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.979 0.895 . . . . 0.0 110.211 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.577 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -70.89 -35.32 72.27 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.567 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -68.14 -25.18 65.16 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.339 -0.851 . . . . 0.0 111.02 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.545 ' OE1' HD21 ' A' ' 18' ' ' LEU . 97.8 mt-30 -119.38 33.7 5.53 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.375 -0.828 . . . . 52.37 110.38 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.656 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 23.1 t -152.39 143.91 23.43 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.537 -0.727 . . . . 55.19 110.705 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 23' ' ' THR . 8.0 t -121.05 95.56 48.79 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.468 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.5 Cg_endo -66.46 -23.17 50.92 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 O-C-N 123.79 1.416 . . . . 51.57 112.106 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -65.13 -24.15 67.33 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.295 -0.878 . . . . 0.0 110.995 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -105.4 21.8 16.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.197 -0.939 . . . . 0.0 110.944 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.89 30.3 70.35 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.718 ' HD2' HD21 ' A' ' 89' ' ' LEU . 9.5 tpt180 -121.14 93.13 3.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.619 -0.93 . . . . 0.0 109.943 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.468 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 54.8 m-85 -105.56 130.77 53.54 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.955 -0.757 . . . . 46.07 108.955 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.656 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -117.98 119.62 35.36 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.635 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.677 ' CD1' HD12 ' A' ' 90' ' ' LEU . 79.2 m-85 -114.59 131.39 56.7 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.134 -0.691 . . . . 38.88 109.134 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.69 131.01 56.32 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.142 -0.974 . . . . 34.06 109.021 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.482 ' CE1' HD11 ' A' ' 35' ' ' ILE . 52.3 p90 -128.51 147.46 50.69 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.237 -0.985 . . . . 29.03 111.161 -179.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.7 m -101.07 139.44 36.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.697 -0.627 . . . . 0.0 109.691 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.742 HD13 HG22 ' A' ' 13' ' ' VAL . 47.4 mm -103.22 132.74 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.661 0.743 . . . . 0.0 111.317 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.412 ' HB2' ' HG3' ' A' ' 12' ' ' GLU . 62.7 mtt85 -126.0 97.77 5.24 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.577 0.703 . . . . 40.24 110.182 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.557 HG22 ' CD1' ' A' ' 76' ' ' LEU . 81.7 mt -93.5 118.05 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.882 -0.511 . . . . 20.73 110.656 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -117.0 135.73 53.47 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.428 -0.795 . . . . 0.0 109.507 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -90.69 118.73 30.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.879 -0.513 . . . . 21.34 110.833 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.56 8.91 17.85 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.558 -0.714 . . . . 0.0 110.706 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.454 ' HA2' ' HG2' ' A' ' 8' ' ' ARG . . . -82.94 178.68 53.13 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.216 -1.554 . . . . 29.1 109.216 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.554 ' HB3' ' HG3' ' A' ' 6' ' ' ARG . . . -94.62 -30.45 14.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.446 -1.032 . . . . 0.0 110.198 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.515 HG13 ' HD2' ' A' ' 44' ' ' PRO . 86.7 t -103.82 139.89 20.54 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.855 -0.528 . . . . 0.0 109.764 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.515 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.9 Cg_endo -52.75 142.69 50.28 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 O-C-N 123.818 1.43 . . . . 21.95 111.827 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.4 151.44 46.3 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.53 0.681 . . . . 20.91 110.926 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.43 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 19.3 ptt-85 -127.76 159.14 35.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.721 -0.612 . . . . 0.0 109.893 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.848 HD22 HG13 ' A' ' 69' ' ' VAL . 7.6 tt -97.75 116.22 29.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.449 -0.782 . . . . 0.0 109.737 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.434 HG23 HG22 ' A' ' 104' ' ' VAL . 57.3 t -98.08 -27.54 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.517 -0.739 . . . . 0.0 110.497 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.725 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . . . -140.46 163.61 32.36 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.822 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -143.18 140.65 30.85 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.306 0.574 . . . . 29.05 110.226 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -145.1 113.46 6.61 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.433 0.635 . . . . 27.97 110.15 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.473 ' CH2' HG21 ' A' ' 115' ' ' ILE . 63.0 m95 -101.1 136.66 40.59 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.635 -0.666 . . . . 25.25 110.996 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -116.8 78.52 1.22 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.717 -0.614 . . . . 0.0 109.751 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.421 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.0 pt -86.42 131.89 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.361 -0.837 . . . . 36.11 111.963 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.717 HG23 HG22 ' A' ' 61' ' ' THR . 94.3 m -118.76 132.51 56.14 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.549 -0.908 . . . . 33.98 108.549 178.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -87.91 169.81 11.69 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.556 0.694 . . . . 45.04 111.244 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.48 -8.67 20.77 Favored Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.81 -0.556 . . . . 39.47 112.016 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -101.98 8.29 41.07 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 119.301 1.551 . . . . 0.0 110.797 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.78 -25.61 18.36 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 121.264 -0.898 . . . . 0.0 110.966 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.3 mpp_? -62.0 141.71 57.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.219 -1.165 . . . . 62.78 109.619 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.717 HG22 HG23 ' A' ' 55' ' ' THR . 63.7 p -129.3 147.83 51.17 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.614 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -122.1 120.49 34.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.549 -0.72 . . . . 0.0 109.809 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -103.92 136.13 44.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.66 -0.65 . . . . 0.0 110.668 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.5 t -128.12 131.11 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.454 0.645 . . . . 37.94 109.781 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.99 127.85 47.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.827 -0.546 . . . . 0.0 110.472 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -153.0 170.18 31.99 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.165 -1.574 . . . . 31.82 109.165 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -111.13 160.32 17.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.411 -1.052 . . . . 0.0 109.896 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.77 93.81 0.01 OUTLIER Glycine 0 N--CA 1.5 2.919 0 O-C-N 121.284 -0.885 . . . . 22.62 111.239 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.848 HG13 HD22 ' A' ' 47' ' ' LEU . 16.6 m -44.54 132.53 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.528 0 O-C-N 121.431 -1.041 . . . . 17.51 111.774 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.9 m 41.77 38.45 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 CA-C-N 115.592 -0.731 . . . . 20.55 111.605 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.08 18.79 64.19 Favored Glycine 0 N--CA 1.495 2.618 0 O-C-N 121.789 -0.569 . . . . 18.29 112.521 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 82' ' ' PHE . 5.5 pt-20 -147.41 153.07 39.16 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 119.045 1.422 . . . . 0.0 112.477 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -117.39 73.31 7.58 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.555 -0.906 . . . . 18.21 108.555 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -54.88 141.39 77.75 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 O-C-N 123.715 1.376 . . . . 17.61 112.174 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.444 ' CZ3' ' HB2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -100.62 76.93 1.86 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.557 ' CD1' HG22 ' A' ' 37' ' ' ILE . 11.2 mt -60.68 118.18 6.28 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.618 -0.676 . . . . 20.57 111.736 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.08 157.5 56.79 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -53.17 127.6 25.74 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 O-C-N 123.491 1.258 . . . . 27.04 111.089 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.14 -16.58 55.33 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.799 -0.92 . . . . 24.74 110.799 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -86.81 165.36 16.06 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.078 -1.248 . . . . 29.38 110.489 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.14 149.62 35.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.517 -0.739 . . . . 0.0 110.015 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.407 ' CZ ' ' OE1' ' A' ' 72' ' ' GLU . 64.7 t80 -119.75 148.25 43.64 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.414 -0.804 . . . . 18.56 109.141 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.8 p80 -143.46 140.23 30.27 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.125 -0.985 . . . . 0.0 111.293 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.61 ' CE1' HG21 ' A' ' 35' ' ' ILE . 51.7 p90 -151.52 160.38 43.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.664 -0.648 . . . . 26.65 109.618 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.2 m -102.82 137.64 40.75 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.402 -0.812 . . . . 28.14 111.058 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.436 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 17.0 t -123.99 167.28 14.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.595 -0.691 . . . . 33.88 109.886 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -143.97 124.35 2.23 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.813 -1.184 . . . . 31.8 110.572 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.5 m -131.36 154.19 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.632 -0.923 . . . . 0.0 109.939 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.718 HD21 ' HD2' ' A' ' 28' ' ' ARG . 10.6 tp -109.18 144.64 36.99 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.553 -0.717 . . . . 0.0 110.832 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.719 HD11 HD22 ' A' ' 120' ' ' LEU . 74.7 mt -122.14 146.34 47.32 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.597 -0.689 . . . . 38.68 110.314 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.403 ' O ' ' CE1' ' A' ' 29' ' ' TYR . 75.4 tt0 -76.2 -25.62 55.33 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.353 -0.842 . . . . 0.0 110.782 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 68.0 p -125.2 172.06 9.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.361 -0.837 . . . . 31.63 110.782 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.458 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 50.1 mt-10 -86.81 11.72 12.58 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.593 -0.692 . . . . 0.0 111.654 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 14.4 pt20 -140.85 148.22 40.2 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.06 -1.025 . . . . 0.0 110.057 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.31 160.82 23.78 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 118.907 -1.616 . . . . 28.05 112.086 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -119.73 129.64 54.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 122.14 -0.624 . . . . 0.0 109.335 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 118' ' ' PHE . 97.7 mtp -125.3 116.24 21.62 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.344 -0.848 . . . . 0.0 111.116 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.49 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 56.6 tt0 -129.26 149.79 50.91 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.7 -178.49 38.72 Favored Glycine 0 N--CA 1.498 2.822 0 C-N-CA 118.916 -1.611 . . . . 29.62 110.76 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -140.54 157.96 44.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.703 -0.881 . . . . 0.0 110.752 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.669 ' CE2' HD11 ' A' ' 115' ' ' ILE . 6.3 m-85 -116.79 128.58 55.43 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.645 -0.66 . . . . 27.05 109.885 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.725 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 41.9 t0 -81.35 123.18 28.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.978 -1.076 . . . . 0.0 109.136 178.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.641 ' SD ' HG11 ' A' ' 9' ' ' VAL . 51.7 mtp -122.19 162.35 21.52 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.118 0.485 . . . . 0.0 110.339 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.434 HG22 HG23 ' A' ' 48' ' ' VAL . 10.0 m -142.91 129.73 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.613 -0.679 . . . . 23.28 110.325 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.04 167.66 20.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.513 -0.742 . . . . 0.0 109.45 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -64.29 -28.44 69.72 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.142 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -72.92 -12.26 60.89 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.567 -0.708 . . . . 0.0 111.026 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.25 -7.05 47.05 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.484 -1.046 . . . . 30.43 110.484 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 91.3 m -57.66 135.2 56.7 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.051 -1.264 . . . . 0.0 110.049 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -101.29 140.03 36.14 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.457 -0.777 . . . . 0.0 110.796 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.452 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 47.5 p90 -167.16 147.23 5.43 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.781 -0.574 . . . . 28.03 109.854 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.7 pt -102.55 158.12 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.596 -0.69 . . . . 0.0 111.087 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.63 97.59 49.91 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -59.25 143.13 99.86 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 O-C-N 123.895 1.471 . . . . 33.31 112.432 -178.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.669 HD11 ' CE2' ' A' ' 101' ' ' TYR . 72.2 mt -108.33 123.24 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.658 -0.867 . . . . 30.59 108.658 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.05 144.21 7.13 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.217 0.532 . . . . 30.78 111.551 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.49 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -87.37 121.03 29.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.638 -0.664 . . . . 0.0 110.242 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.616 ' CE1' HD11 ' A' ' 120' ' ' LEU . 41.9 p90 -109.42 165.89 11.3 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.879 -0.785 . . . . 30.66 108.879 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.605 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.1 t -114.81 154.0 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.284 -0.885 . . . . 0.0 110.326 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.719 HD22 HD11 ' A' ' 90' ' ' LEU . 7.0 mp -113.2 133.23 55.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.788 -0.57 . . . . 39.15 109.514 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.673 -0.642 . . . . 0.0 110.071 -179.838 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.961 0.41 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.424 ' CE2' HG21 ' A' ' 109' ' ' THR . 34.3 m-85 -115.93 107.41 14.96 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.542 -0.724 . . . . 31.93 110.029 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.483 ' C ' HG23 ' A' ' 9' ' ' VAL . 4.1 ttp180 -155.87 135.05 12.17 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.588 0.708 . . . . 0.0 110.594 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.629 HG11 ' SD ' ' A' ' 103' ' ' MET . 98.2 t -152.42 116.23 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -108.95 132.6 53.93 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.675 0.75 . . . . 0.0 110.62 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.7 t -119.41 139.08 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.891 -0.506 . . . . 28.21 109.712 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -119.96 137.92 53.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.505 -0.747 . . . . 0.0 109.709 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.523 HG13 ' HD1' ' A' ' 33' ' ' TYR . 62.6 t -129.26 136.62 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.539 -0.725 . . . . 27.95 110.509 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.6 p -124.17 103.89 32.65 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.72 -0.612 . . . . 0.0 110.281 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -82.89 165.97 15.13 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 123.841 1.443 . . . . 33.0 111.063 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -157.59 132.12 8.47 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.539 0.685 . . . . 54.1 109.801 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.483 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 77.3 t80 -60.29 139.52 57.57 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.257 0.551 . . . . 0.0 111.471 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.914 HD11 ' HB2' ' A' ' 32' ' ' ALA . 93.7 mt -115.58 79.15 1.25 Allowed 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.879 0.847 . . . . 0.0 110.279 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.483 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -65.89 -35.62 81.15 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.17 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -69.96 -23.45 63.18 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.365 -0.835 . . . . 0.0 110.985 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -121.07 29.97 7.08 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.366 -0.834 . . . . 52.37 110.976 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.608 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 19.7 p -152.17 146.37 25.42 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.265 -0.897 . . . . 55.19 111.099 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.586 HG23 ' O ' ' A' ' 23' ' ' THR . 5.1 t -119.45 92.79 46.45 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.48 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 50.3 Cg_endo -66.08 -23.15 53.75 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 O-C-N 123.912 1.48 . . . . 51.57 111.566 -178.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.04 -23.19 67.12 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.4 -0.812 . . . . 0.0 110.882 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -105.77 23.83 13.27 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.357 -0.839 . . . . 0.0 110.693 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.43 28.71 73.66 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.569 ' HB2' HG23 ' A' ' 23' ' ' THR . 33.1 mtt180 -121.52 93.9 4.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.646 -0.914 . . . . 0.0 110.311 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.48 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 66.4 m-85 -104.59 134.32 47.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.644 -0.66 . . . . 46.07 109.325 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.608 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -117.17 120.68 39.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.444 -0.785 . . . . 0.0 111.273 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.755 ' CD1' HD12 ' A' ' 90' ' ' LEU . 91.1 m-85 -116.36 133.67 55.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.505 -0.747 . . . . 38.88 109.853 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.914 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -114.74 132.42 56.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.205 -0.934 . . . . 34.06 108.74 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.523 ' HD1' HG13 ' A' ' 13' ' ' VAL . 34.0 p90 -127.63 145.99 50.7 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 119.19 -1.004 . . . . 29.03 111.747 -178.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 53.8 m -104.46 134.15 48.14 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.872 HG21 ' CE2' ' A' ' 84' ' ' TYR . 18.8 tt -105.94 135.76 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 121.807 0.813 . . . . 0.0 112.111 -178.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -124.64 100.88 6.85 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.548 0.689 . . . . 40.24 109.897 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.632 HG22 HD22 ' A' ' 76' ' ' LEU . 81.6 mt -90.72 118.56 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.808 -0.558 . . . . 20.73 110.69 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -117.35 139.5 50.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.392 -0.817 . . . . 0.0 109.497 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -88.55 117.23 27.36 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.672 -0.642 . . . . 21.34 110.848 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.68 3.31 15.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.551 -0.718 . . . . 0.0 110.633 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.8 -174.88 49.92 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.02 -1.632 . . . . 29.1 109.02 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.02 -30.67 11.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.439 -1.036 . . . . 0.0 110.277 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.522 HG13 ' HD2' ' A' ' 44' ' ' PRO . 86.3 t -105.33 140.65 21.35 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.796 -0.565 . . . . 0.0 109.646 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.522 ' HD2' HG13 ' A' ' 43' ' ' VAL . 39.5 Cg_endo -52.1 141.12 48.93 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 O-C-N 123.718 1.378 . . . . 21.95 111.991 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.84 151.56 45.8 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.627 0.727 . . . . 20.91 110.883 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 0.5 OUTLIER -127.68 160.5 31.48 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.72 -0.612 . . . . 0.0 109.794 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.958 HD22 HG13 ' A' ' 69' ' ' VAL . 7.1 tt -97.27 117.88 32.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.379 -0.826 . . . . 0.0 109.451 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.452 HG23 HG22 ' A' ' 104' ' ' VAL . 58.8 t -101.32 -27.05 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.542 -0.724 . . . . 0.0 110.627 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.783 ' HB3' ' HB2' ' A' ' 102' ' ' ASP . . . -140.41 162.82 34.4 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.226 -0.989 . . . . 0.0 111.558 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -141.29 138.67 33.34 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.345 0.593 . . . . 29.05 110.434 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -142.86 113.31 7.32 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.327 0.584 . . . . 27.97 109.723 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.427 ' CH2' HD13 ' A' ' 115' ' ' ILE . 82.1 m95 -101.15 133.63 45.4 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.632 -0.668 . . . . 25.25 111.049 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -116.28 76.48 1.02 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.635 -0.666 . . . . 0.0 109.345 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.441 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.0 pt -85.59 129.21 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-O 121.776 0.798 . . . . 36.11 111.774 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.0 m -120.57 131.8 54.84 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.429 -0.952 . . . . 33.98 108.429 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -88.55 169.99 11.25 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.85 0.833 . . . . 45.04 111.474 -178.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.04 -7.12 11.57 Favored Glycine 0 N--CA 1.495 2.616 0 O-C-N 121.757 -0.589 . . . . 39.47 112.205 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -101.0 7.02 43.71 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 119.434 1.617 . . . . 0.0 110.6 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.04 -29.05 8.47 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.79 141.49 58.75 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.23 -1.159 . . . . 62.78 109.674 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.8 t -134.84 152.96 52.18 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.618 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -121.32 122.08 39.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.542 -0.723 . . . . 0.0 110.155 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -102.82 134.72 45.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.705 -0.622 . . . . 0.0 110.439 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.4 t -128.01 130.82 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.578 -0.701 . . . . 37.94 110.062 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -125.82 126.87 45.2 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.849 -0.532 . . . . 0.0 110.041 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -151.13 158.37 27.66 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.264 -1.534 . . . . 31.82 109.264 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -80.7 154.35 27.34 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.428 -1.042 . . . . 0.0 110.374 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.88 -167.09 0.2 Allowed Glycine 0 N--CA 1.498 2.767 0 O-C-N 121.493 -0.754 . . . . 22.62 111.605 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.958 HG13 HD22 ' A' ' 47' ' ' LEU . 16.0 m -131.8 129.61 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.96 -0.729 . . . . 17.51 109.537 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.4 m 40.91 35.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 CA-C-O 121.517 0.675 . . . . 20.55 111.779 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.28 17.8 65.98 Favored Glycine 0 N--CA 1.498 2.813 0 O-C-N 121.598 -0.689 . . . . 18.29 112.988 177.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 69' ' ' VAL . 11.1 pt-20 -145.13 150.59 37.06 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 119.211 1.505 . . . . 0.0 112.025 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -115.21 74.75 4.03 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.923 -0.769 . . . . 18.21 108.923 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -56.94 140.8 93.12 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 O-C-N 123.785 1.413 . . . . 17.61 112.189 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.436 ' CZ3' ' HG2' ' A' ' 77' ' ' ARG . 6.3 t90 -104.03 77.55 1.45 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.632 HD22 HG22 ' A' ' 37' ' ' ILE . 5.8 tp -61.38 118.17 6.6 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.516 -0.74 . . . . 20.57 111.623 -178.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.436 ' HG2' ' CZ3' ' A' ' 75' ' ' TRP . 16.0 mtm180 -86.31 159.18 53.98 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -54.61 126.71 23.28 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 O-C-N 123.628 1.331 . . . . 27.04 111.002 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.64 -18.53 42.34 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.903 -0.879 . . . . 24.74 110.903 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -87.89 165.77 15.02 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.079 -1.248 . . . . 29.38 110.255 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.523 ' CA ' HD11 ' A' ' 76' ' ' LEU . . . -145.74 150.45 36.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.545 -0.722 . . . . 0.0 110.388 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.47 ' HD2' HD12 ' A' ' 37' ' ' ILE . 90.7 t80 -118.59 145.68 45.21 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.031 -0.729 . . . . 18.56 109.031 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.6 p80 -146.14 141.19 27.26 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.226 -0.922 . . . . 0.0 111.367 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.872 ' CE2' HG21 ' A' ' 35' ' ' ILE . 44.9 p90 -151.89 163.28 39.57 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.655 -0.653 . . . . 26.65 109.557 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.9 m -99.0 138.42 36.12 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.167 -0.958 . . . . 28.14 111.137 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 15.2 t -125.91 166.35 17.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.615 -0.678 . . . . 33.88 109.912 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -143.88 124.52 2.27 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 119.774 -1.203 . . . . 31.8 110.675 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.5 m -132.13 152.8 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.667 -0.902 . . . . 0.0 109.809 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.548 HD23 ' HA ' ' A' ' 30' ' ' ALA . 81.5 mt -111.56 145.15 39.63 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.559 -0.713 . . . . 0.0 110.977 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.755 HD12 ' CD1' ' A' ' 31' ' ' PHE . 78.7 mt -121.2 145.95 47.3 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.691 -0.631 . . . . 38.68 109.886 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -73.39 -25.69 60.67 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.306 -0.871 . . . . 0.0 111.165 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.8 p -123.47 171.71 9.27 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.354 -0.841 . . . . 31.63 110.756 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.41 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 32.6 tt0 -86.31 7.37 25.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.692 -0.63 . . . . 0.0 111.506 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -138.62 148.62 44.31 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.097 -1.002 . . . . 0.0 109.526 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.62 156.77 14.57 Favored Glycine 0 N--CA 1.496 2.661 0 C-N-CA 118.755 -1.688 . . . . 28.05 112.254 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -118.41 130.02 55.74 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 94.8 mtp -126.29 120.77 30.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.38 -0.825 . . . . 0.0 111.4 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -130.6 151.83 50.64 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.73 -173.67 33.63 Favored Glycine 0 N--CA 1.5 2.951 0 C-N-CA 118.973 -1.584 . . . . 29.62 110.806 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -137.13 160.18 39.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.654 -0.909 . . . . 0.0 110.557 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.61 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 8.7 m-85 -116.98 128.42 55.17 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.771 -0.581 . . . . 27.05 110.181 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.783 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 78.6 m-20 -87.15 121.31 29.43 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.021 -1.05 . . . . 0.0 108.846 177.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.629 ' SD ' HG11 ' A' ' 9' ' ' VAL . 55.1 mtp -126.4 162.76 24.82 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.21 0.529 . . . . 0.0 110.624 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.514 HG12 ' CD ' ' A' ' 110' ' ' GLU . 12.6 m -140.65 131.23 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.551 -0.718 . . . . 23.28 110.287 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.45 165.58 24.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.35 -0.844 . . . . 0.0 109.402 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -63.7 -29.37 70.6 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.024 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -75.34 -9.69 58.78 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.493 -0.754 . . . . 0.0 111.202 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.99 -7.98 49.29 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.061 -1.066 . . . . 30.43 110.469 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.424 HG21 ' CE2' ' A' ' 7' ' ' TYR . 33.6 m -57.69 135.38 56.74 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.036 -1.273 . . . . 0.0 109.964 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.514 ' CD ' HG12 ' A' ' 104' ' ' VAL . 79.3 mm-40 -101.34 139.77 36.56 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.347 -0.845 . . . . 0.0 110.723 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 103' ' ' MET . 47.8 p90 -163.76 143.24 8.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.684 -0.635 . . . . 28.03 109.993 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 84.3 mt -101.09 156.79 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.424 0.631 . . . . 0.0 110.43 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.61 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -120.86 98.91 47.45 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -58.36 143.22 97.8 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 O-C-N 123.93 1.49 . . . . 33.31 112.066 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.464 HD11 ' CZ ' ' A' ' 101' ' ' TYR . 70.9 mt -107.97 123.28 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-N 115.375 -0.829 . . . . 30.59 108.907 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -51.84 149.63 4.7 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.175 0.512 . . . . 30.78 111.207 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -91.29 120.87 32.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.586 -0.696 . . . . 0.0 110.113 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.72 ' CE1' HD11 ' A' ' 120' ' ' LEU . 51.2 p90 -110.29 165.01 12.11 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.678 -0.86 . . . . 30.66 108.678 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.595 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.2 t -116.01 153.13 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.159 -0.963 . . . . 0.0 110.677 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.74 HD22 HD11 ' A' ' 90' ' ' LEU . 7.0 mp -113.32 134.35 54.66 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.283 -0.636 . . . . 39.15 109.283 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 51.9 m . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.62 -0.675 . . . . 0.0 110.081 -179.819 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.703 0.287 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.415 ' CE2' HG21 ' A' ' 109' ' ' THR . 39.9 m-85 -118.62 105.36 11.53 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.484 -0.76 . . . . 31.93 110.331 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.49 ' C ' HG23 ' A' ' 9' ' ' VAL . 82.4 mtt85 -147.08 132.57 18.67 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.603 -0.685 . . . . 0.0 109.839 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.49 HG23 ' C ' ' A' ' 8' ' ' ARG . 93.4 t -152.1 115.41 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.501 -0.75 . . . . 0.0 109.896 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -105.7 128.42 53.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.662 -0.649 . . . . 0.0 109.823 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.593 HG11 ' HE2' ' A' ' 101' ' ' TYR . 58.4 t -119.32 138.3 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.757 -0.59 . . . . 28.21 109.793 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -123.57 136.73 54.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.316 -0.865 . . . . 0.0 110.148 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.633 HG22 HD13 ' A' ' 35' ' ' ILE . 60.4 t -129.61 137.11 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.57 -0.706 . . . . 27.95 110.18 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.4 t -125.61 105.28 27.17 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.688 -0.633 . . . . 0.0 110.887 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.88 165.13 15.51 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.794 1.418 . . . . 33.0 110.886 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.8 ptt-85 -157.98 132.01 8.04 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.664 0.745 . . . . 54.1 109.947 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.48 ' HE2' ' HB2' ' A' ' 19' ' ' ALA . 79.7 t80 -60.02 139.97 57.1 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.725 -0.609 . . . . 0.0 111.604 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.951 HD11 ' HB2' ' A' ' 32' ' ' ALA . 84.5 mt -116.49 80.76 1.51 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.903 0.858 . . . . 0.0 110.422 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.48 ' HB2' ' HE2' ' A' ' 17' ' ' PHE . . . -65.8 -35.74 81.55 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.065 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -69.96 -24.45 63.34 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.282 -0.886 . . . . 0.0 110.881 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.2 tp60 -121.36 49.56 1.5 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.331 -0.856 . . . . 52.37 110.779 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.699 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 52.5 p -169.59 149.12 3.84 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.228 -0.92 . . . . 55.19 110.916 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.604 HG23 ' HB2' ' A' ' 28' ' ' ARG . 5.1 t -118.88 92.42 44.77 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.0 Cg_endo -66.86 -24.92 45.88 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 O-C-N 123.818 1.43 . . . . 51.57 112.064 -178.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -66.7 -20.77 66.04 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.236 -0.915 . . . . 0.0 111.022 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -105.6 23.58 13.61 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.145 -0.972 . . . . 0.0 110.739 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.72 27.43 73.27 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.604 ' HB2' HG23 ' A' ' 23' ' ' THR . 30.8 mtt85 -122.08 94.38 4.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.643 -0.916 . . . . 0.0 110.082 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.46 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 63.8 m-85 -104.41 137.15 42.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.582 -0.699 . . . . 46.07 109.209 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.699 ' HB3' ' HB3' ' A' ' 22' ' ' SER . . . -114.03 120.4 40.47 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.162 -179.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -116.5 131.38 56.96 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.608 -0.683 . . . . 38.88 109.653 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.951 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -113.39 131.5 55.97 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.282 -0.886 . . . . 34.06 108.849 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 86' ' ' SER . 53.7 p90 -126.52 145.57 50.46 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.331 -0.948 . . . . 29.03 111.326 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.5 t -102.41 140.27 36.91 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.633 HD13 HG22 ' A' ' 13' ' ' VAL . 48.5 mm -105.68 132.46 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.783 0.802 . . . . 0.0 111.715 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -123.58 97.77 5.54 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.522 0.677 . . . . 40.24 109.718 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.531 HG22 ' CD1' ' A' ' 76' ' ' LEU . 81.8 mt -93.17 117.75 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.773 -0.58 . . . . 20.73 110.583 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -117.18 133.72 55.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.439 -0.788 . . . . 0.0 109.319 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -94.59 117.44 30.13 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 120.212 -0.595 . . . . 21.34 110.523 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.27 15.89 15.86 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.39 -0.819 . . . . 0.0 110.45 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.83 -179.72 52.78 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.332 -1.507 . . . . 29.1 109.332 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.31 -33.26 13.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.56 -0.964 . . . . 0.0 110.267 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.532 HG13 ' HD2' ' A' ' 44' ' ' PRO . 87.2 t -106.45 142.02 24.03 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 122.022 -0.424 . . . . 0.0 109.937 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.532 ' HD2' HG13 ' A' ' 43' ' ' VAL . 38.7 Cg_endo -53.66 146.84 42.28 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 O-C-N 123.792 1.417 . . . . 21.95 111.428 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.5 151.28 47.23 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.794 0.807 . . . . 20.91 111.506 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 8.1 ttt180 -126.85 152.32 47.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.865 -0.522 . . . . 0.0 109.595 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.852 HD22 HG13 ' A' ' 69' ' ' VAL . 7.0 tt -98.03 118.73 35.28 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.382 -0.824 . . . . 0.0 109.728 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.501 HG23 HG22 ' A' ' 104' ' ' VAL . 58.0 t -100.27 -29.66 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.61 -0.681 . . . . 0.0 111.073 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.602 ' HB3' ' HB2' ' A' ' 102' ' ' ASP . . . -141.68 165.58 27.1 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.078 -1.049 . . . . 0.0 112.296 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.5 ptt85 -142.72 140.69 31.57 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.519 0.676 . . . . 29.05 110.352 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -143.09 114.59 8.0 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.777 -0.577 . . . . 27.97 109.628 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.577 ' CH2' HD13 ' A' ' 115' ' ' ILE . 91.6 m95 -99.95 132.92 45.01 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.578 -0.701 . . . . 25.25 111.2 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -116.15 76.05 0.99 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.604 -0.685 . . . . 0.0 109.402 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.442 ' O ' HG13 ' A' ' 54' ' ' ILE . 28.2 pt -85.17 130.13 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.789 0.805 . . . . 36.11 112.275 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.562 HG23 ' HB ' ' A' ' 61' ' ' THR . 6.9 m -118.64 130.89 56.11 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.983 -1.117 . . . . 33.98 107.983 178.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.475 ' OD2' HG21 ' A' ' 92' ' ' THR . 26.3 t0 -88.5 169.72 11.51 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.644 0.735 . . . . 45.04 111.144 -178.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.57 -6.84 12.41 Favored Glycine 0 N--CA 1.496 2.636 0 O-C-N 121.754 -0.591 . . . . 39.47 112.13 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -101.47 7.69 42.36 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 119.337 1.569 . . . . 0.0 110.596 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.67 -31.63 6.37 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.51 142.72 57.81 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.387 -1.067 . . . . 62.78 109.944 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.562 ' HB ' HG23 ' A' ' 55' ' ' THR . 7.7 t -134.36 152.93 52.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.531 -0.731 . . . . 0.0 110.451 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -121.92 123.35 41.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.545 -0.722 . . . . 0.0 110.335 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -103.23 134.24 46.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.671 -0.643 . . . . 0.0 110.496 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.8 t -128.37 131.78 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.538 -0.727 . . . . 37.94 110.043 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -124.86 126.21 45.2 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.822 -0.549 . . . . 0.0 110.148 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.35 149.01 21.0 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.363 -1.495 . . . . 31.82 109.363 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -77.88 155.24 31.07 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.474 -1.015 . . . . 0.0 110.439 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.56 -175.13 0.18 Allowed Glycine 0 N--CA 1.497 2.7 0 N-CA-C 111.049 -0.82 . . . . 22.62 111.049 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.852 HG13 HD22 ' A' ' 47' ' ' LEU . 14.3 m -128.24 127.52 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.8 -0.824 . . . . 17.51 109.576 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 69' ' ' VAL . 11.4 m 41.21 36.95 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-O 121.599 0.714 . . . . 20.55 111.809 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.97 15.77 71.7 Favored Glycine 0 N--CA 1.499 2.854 0 O-C-N 121.571 -0.705 . . . . 18.29 112.957 177.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.416 ' O ' HG22 ' A' ' 69' ' ' VAL . 10.8 pt-20 -146.3 151.33 37.36 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-N 119.136 1.468 . . . . 0.0 112.15 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -115.5 75.36 4.82 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.887 -0.783 . . . . 18.21 108.887 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -57.71 139.04 88.96 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 O-C-N 123.847 1.446 . . . . 17.61 112.084 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.432 ' CD1' ' HB2' ' A' ' 46' ' ' ARG . 4.0 t90 -101.68 76.22 1.64 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.531 ' CD1' HG22 ' A' ' 37' ' ' ILE . 10.1 mt -60.25 118.17 6.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.582 -0.699 . . . . 20.57 112.039 -178.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.429 ' HG2' ' CZ3' ' A' ' 75' ' ' TRP . 15.2 mtm180 -86.91 158.45 53.28 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -54.25 129.37 34.2 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 O-C-N 123.461 1.243 . . . . 27.04 111.227 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.01 -18.59 47.03 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 111.068 -0.813 . . . . 24.74 111.068 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -88.05 166.17 14.64 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.058 -1.26 . . . . 29.38 110.618 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.04 147.66 32.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.621 -0.674 . . . . 0.0 110.231 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.514 ' HD2' HD12 ' A' ' 37' ' ' ILE . 84.6 t80 -116.21 144.24 44.45 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.525 -0.734 . . . . 18.56 109.08 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -144.18 140.58 29.42 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.278 -0.889 . . . . 0.0 111.141 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.455 ' CE1' HG21 ' A' ' 35' ' ' ILE . 51.3 p90 -150.15 159.99 44.01 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.758 -0.589 . . . . 26.65 109.528 178.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.9 m -103.51 138.77 39.75 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.43 -0.794 . . . . 28.14 110.875 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.434 ' HB3' ' CE2' ' A' ' 33' ' ' TYR . 15.3 t -124.21 167.36 14.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.689 -0.632 . . . . 33.88 109.937 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -144.03 119.36 1.29 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 110.136 -1.186 . . . . 31.8 110.136 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.35 152.83 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.591 -0.947 . . . . 0.0 110.1 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -108.71 142.99 38.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.53 -0.731 . . . . 0.0 110.666 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.438 ' CD1' HD22 ' A' ' 120' ' ' LEU . 36.4 mt -124.64 144.79 49.99 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.484 -0.76 . . . . 38.68 110.38 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -88.71 -19.84 25.59 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.129 -0.982 . . . . 0.0 110.395 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.475 HG21 ' OD2' ' A' ' 56' ' ' ASP . 2.6 p -103.05 134.88 45.74 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.403 -0.811 . . . . 31.63 110.481 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.456 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 51.3 mt-10 -77.38 -2.88 37.32 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.239 -0.913 . . . . 0.0 110.66 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 97.1 mt-30 -138.59 140.63 39.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.179 -0.951 . . . . 0.0 108.834 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.91 166.57 35.76 Favored Glycine 0 N--CA 1.499 2.885 0 C-N-CA 118.409 -1.853 . . . . 28.05 112.585 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -117.77 129.98 56.02 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.154 -0.615 . . . . 0.0 109.465 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.452 ' HB3' ' HE2' ' A' ' 97' ' ' MET . 98.0 mtp -126.33 119.97 28.69 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.308 -0.87 . . . . 0.0 111.281 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.572 ' CG ' ' HB2' ' A' ' 117' ' ' ALA . 69.4 mt-30 -122.54 152.16 40.65 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.93 173.43 36.61 Favored Glycine 0 N--CA 1.498 2.813 0 C-N-CA 118.783 -1.675 . . . . 29.62 111.107 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.432 ' CD2' ' HB3' ' A' ' 114' ' ' PRO . 67.5 m80 -136.98 156.77 48.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.702 -0.881 . . . . 0.0 109.892 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.599 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 9.1 m-85 -116.66 127.48 54.47 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.683 -0.635 . . . . 27.05 109.938 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.602 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 78.4 m-20 -84.07 119.89 25.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.962 -1.086 . . . . 0.0 108.414 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.44 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 4.8 ttm -123.48 162.34 23.08 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.065 0.46 . . . . 0.0 110.685 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.501 HG22 HG23 ' A' ' 48' ' ' VAL . 10.8 m -141.42 129.84 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.699 -0.626 . . . . 23.28 110.52 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.7 166.45 23.26 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.474 -0.766 . . . . 0.0 109.521 179.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -66.45 -30.55 70.93 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.484 -0.76 . . . . 0.0 110.291 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -74.98 -4.59 39.15 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.494 -0.754 . . . . 0.0 111.233 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.8 -9.99 58.68 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.139 -1.029 . . . . 30.43 110.537 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.415 HG21 ' CE2' ' A' ' 7' ' ' TYR . 43.5 m -57.57 134.59 56.27 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.124 -1.221 . . . . 0.0 109.982 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -101.42 140.02 36.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.354 -0.841 . . . . 0.0 110.776 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 42.8 p90 -164.41 142.98 7.09 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.644 -0.66 . . . . 28.03 109.822 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 85.7 mt -101.23 158.01 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.633 -0.667 . . . . 0.0 110.495 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.599 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -119.01 95.43 49.35 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.432 ' HB3' ' CD2' ' A' ' 100' ' ' HIS . 46.6 Cg_endo -59.56 146.6 94.72 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 O-C-N 123.933 1.491 . . . . 33.31 112.082 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.596 HD11 ' CE2' ' A' ' 101' ' ' TYR . 66.5 mt -111.19 120.92 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.594 -0.891 . . . . 30.59 108.594 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.05 168.77 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.152 0.501 . . . . 30.78 111.467 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.572 ' HB2' ' CG ' ' A' ' 98' ' ' GLN . . . -96.98 122.17 39.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.584 -0.698 . . . . 0.0 110.765 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.552 ' CE1' HD11 ' A' ' 120' ' ' LEU . 47.4 p90 -112.01 157.99 20.07 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.183 -1.043 . . . . 30.66 108.183 178.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.627 ' C ' HD12 ' A' ' 120' ' ' LEU . 58.3 t -114.93 153.73 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.241 -0.912 . . . . 0.0 110.494 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.669 ' N ' HD12 ' A' ' 120' ' ' LEU . 7.3 mp -113.12 131.57 55.78 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.175 -0.676 . . . . 39.15 109.175 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.836 -0.54 . . . . 0.0 110.068 -179.754 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.742 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 83.1 mtt180 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.864 0.364 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.527 ' CZ ' HG21 ' A' ' 109' ' ' THR . 91.9 m-85 -120.63 98.09 5.86 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.553 -0.717 . . . . 31.93 110.199 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.469 ' C ' HG23 ' A' ' 9' ' ' VAL . 74.4 mtm-85 -142.66 135.11 27.75 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.62 -0.675 . . . . 0.0 109.754 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.469 HG23 ' C ' ' A' ' 8' ' ' ARG . 73.4 t -151.75 117.01 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 121.621 0.724 . . . . 0.0 109.784 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -106.56 128.03 53.79 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.63 -0.669 . . . . 0.0 109.687 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.518 HG11 ' HE2' ' A' ' 101' ' ' TYR . 62.7 t -121.1 136.01 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.759 -0.588 . . . . 28.21 109.926 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -126.89 137.56 53.17 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.341 -0.85 . . . . 0.0 109.869 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.735 HG22 HD13 ' A' ' 35' ' ' ILE . 67.2 t -128.01 139.81 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.641 -0.662 . . . . 27.95 110.123 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t -123.82 105.39 32.48 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.726 -0.609 . . . . 0.0 110.627 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HG3' ' CE1' ' A' ' 118' ' ' PHE . 49.1 Cg_endo -83.69 165.82 13.72 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 O-C-N 123.898 1.473 . . . . 33.0 110.734 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -157.93 132.47 8.35 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.598 0.713 . . . . 54.1 109.917 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.571 ' CE2' ' HB2' ' A' ' 19' ' ' ALA . 73.0 t80 -60.03 138.43 57.86 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.797 -0.565 . . . . 0.0 111.197 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.423 HD21 ' OE1' ' A' ' 21' ' ' GLN . 8.8 tp -115.5 79.68 1.32 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 122.039 0.923 . . . . 0.0 110.402 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.571 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -72.17 -35.65 69.07 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.465 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -68.42 -25.75 65.19 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.274 -0.891 . . . . 0.0 110.941 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.423 ' OE1' HD21 ' A' ' 18' ' ' LEU . 80.9 mt-30 -119.42 43.66 2.56 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.379 -0.826 . . . . 52.37 110.313 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.675 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 22.6 t -162.87 150.27 13.34 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.532 -0.73 . . . . 55.19 110.93 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 23' ' ' THR . 9.7 t -121.25 93.98 48.78 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.459 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 49.7 Cg_endo -67.12 -22.85 46.65 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 O-C-N 123.748 1.394 . . . . 51.57 112.004 -178.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -65.44 -22.98 66.82 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.289 -0.882 . . . . 0.0 110.947 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -106.22 23.49 14.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.209 -0.932 . . . . 0.0 110.786 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.97 28.85 73.32 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.608 ' HB2' HG23 ' A' ' 23' ' ' THR . 86.1 mtt180 -120.72 93.93 4.19 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.636 -0.92 . . . . 0.0 110.076 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.459 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 54.1 m-85 -105.45 134.1 49.11 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.542 -0.724 . . . . 46.07 109.202 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.675 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -113.67 119.48 37.56 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.02 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.612 ' CD1' HD12 ' A' ' 90' ' ' LEU . 83.0 m-85 -114.73 133.3 56.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.595 -0.69 . . . . 38.88 109.614 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.44 130.25 56.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.218 -0.926 . . . . 34.06 108.726 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.529 ' HE2' HD11 ' A' ' 35' ' ' ILE . 35.7 p90 -126.05 144.27 50.79 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.263 -0.975 . . . . 29.03 111.176 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.5 m -103.91 137.82 41.35 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.609 -0.682 . . . . 0.0 109.834 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.735 HD13 HG22 ' A' ' 13' ' ' VAL . 43.2 mm -104.62 130.79 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-O 121.696 0.76 . . . . 0.0 111.37 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -122.85 98.81 6.07 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.528 0.68 . . . . 40.24 109.716 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.577 HG22 ' CD1' ' A' ' 76' ' ' LEU . 82.5 mt -91.82 116.9 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.715 -0.616 . . . . 20.73 110.411 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -117.87 133.29 56.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.536 -0.727 . . . . 0.0 109.486 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.4 117.51 30.23 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 120.217 -0.593 . . . . 21.34 110.423 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.72 15.25 17.58 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.358 -0.839 . . . . 0.0 110.534 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.25 -171.36 47.42 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.237 -1.545 . . . . 29.1 109.237 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.742 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . . . -101.53 -30.17 11.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.497 -1.002 . . . . 0.0 110.169 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.517 HG13 ' HD2' ' A' ' 44' ' ' PRO . 91.5 t -106.18 139.55 20.39 Favored Pre-proline 0 N--CA 1.498 1.951 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.082 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.517 ' HD2' HG13 ' A' ' 43' ' ' VAL . 40.4 Cg_endo -53.2 144.65 47.02 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 O-C-N 123.837 1.441 . . . . 21.95 111.796 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.489 ' HB1' ' HG2' ' A' ' 103' ' ' MET . . . -141.06 152.21 44.65 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.701 0.762 . . . . 20.91 111.296 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.435 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 22.3 ptt180 -127.42 155.74 43.18 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.898 HD22 HG13 ' A' ' 69' ' ' VAL . 6.5 tt -94.27 118.3 31.39 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.339 -0.851 . . . . 0.0 109.767 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.449 HG23 HG22 ' A' ' 104' ' ' VAL . 58.3 t -100.31 -28.53 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.563 -0.71 . . . . 0.0 110.851 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.692 ' HB3' ' HB2' ' A' ' 102' ' ' ASP . . . -142.13 165.26 27.94 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.098 -1.041 . . . . 0.0 112.24 -179.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -141.62 139.88 33.17 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.463 0.649 . . . . 29.05 110.251 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -142.62 114.52 8.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.782 -0.574 . . . . 27.97 109.605 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -99.71 132.17 45.22 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.643 -0.66 . . . . 25.25 111.398 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -115.12 78.25 1.15 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.813 HG22 ' HG3' ' A' ' 97' ' ' MET . 15.2 pt -87.02 128.81 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-O 121.609 0.718 . . . . 36.11 111.8 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.644 HG23 ' HB ' ' A' ' 61' ' ' THR . 3.6 m -118.6 130.14 55.72 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.874 -1.158 . . . . 33.98 107.874 177.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.613 ' OD2' HG21 ' A' ' 92' ' ' THR . 43.7 t0 -89.23 169.82 11.12 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.86 0.838 . . . . 45.04 111.636 -178.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.11 -7.63 13.97 Favored Glycine 0 N--CA 1.495 2.63 0 O-C-N 121.837 -0.54 . . . . 39.47 112.043 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -101.41 6.98 42.78 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 119.334 1.567 . . . . 0.0 110.561 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.99 -30.25 7.77 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -63.27 142.36 58.42 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.224 -1.163 . . . . 62.78 109.928 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.644 ' HB ' HG23 ' A' ' 55' ' ' THR . 7.9 t -133.98 151.92 51.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.509 -0.744 . . . . 0.0 110.456 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -121.89 123.61 42.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.565 -0.709 . . . . 0.0 110.409 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -104.47 135.71 45.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.724 -0.61 . . . . 0.0 110.684 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.9 t -129.47 132.43 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.437 -0.789 . . . . 37.94 110.118 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.76 126.17 45.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.83 -0.544 . . . . 0.0 110.172 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.65 148.26 19.54 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.454 -1.459 . . . . 31.82 109.454 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -78.73 154.83 29.72 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.434 -1.039 . . . . 0.0 110.463 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 54.97 -178.86 0.27 Allowed Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.855 -0.898 . . . . 22.62 110.855 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.898 HG13 HD22 ' A' ' 47' ' ' LEU . 14.4 m -128.14 127.26 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.749 -0.854 . . . . 17.51 109.679 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 69' ' ' VAL . 10.9 m 41.4 36.79 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 CA-C-O 121.636 0.732 . . . . 20.55 111.744 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.06 15.27 72.77 Favored Glycine 0 N--CA 1.499 2.856 0 O-C-N 121.563 -0.71 . . . . 18.29 112.935 177.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.406 ' O ' HG22 ' A' ' 69' ' ' VAL . 10.1 pt-20 -145.5 150.01 35.68 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 119.131 1.465 . . . . 0.0 112.157 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -116.15 74.52 5.58 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.625 -0.88 . . . . 18.21 108.625 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -57.49 140.81 94.39 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.904 1.476 . . . . 17.61 112.229 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.435 ' CD1' ' HB3' ' A' ' 46' ' ' ARG . 1.6 t90 -101.81 76.91 1.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.577 ' CD1' HG22 ' A' ' 37' ' ' ILE . 11.1 mt -60.19 117.89 5.7 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.663 -0.648 . . . . 20.57 111.969 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -86.29 157.62 56.04 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -53.41 128.31 28.79 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 O-C-N 123.5 1.263 . . . . 27.04 111.126 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.97 -16.97 55.68 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.751 -0.94 . . . . 24.74 110.751 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -87.13 165.18 15.94 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.074 -1.251 . . . . 29.38 110.555 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.81 150.52 36.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.58 -0.7 . . . . 0.0 110.154 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.423 ' HD2' HD12 ' A' ' 37' ' ' ILE . 50.6 t80 -118.03 147.59 43.07 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.417 -0.802 . . . . 18.56 109.11 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -142.73 137.45 29.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.238 -0.914 . . . . 0.0 110.878 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.495 ' CE2' HG21 ' A' ' 35' ' ' ILE . 51.6 p90 -150.95 160.21 44.06 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.613 -0.679 . . . . 26.65 109.709 178.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.9 m -105.16 139.23 40.13 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.43 -0.794 . . . . 28.14 111.035 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 16.9 t -124.46 166.68 15.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.62 -0.675 . . . . 33.88 109.834 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.03 120.15 1.58 Allowed Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.923 -1.132 . . . . 31.8 110.38 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.458 HG23 ' HE1' ' A' ' 33' ' ' TYR . 80.8 t -130.77 152.2 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.628 -0.925 . . . . 0.0 109.862 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 89' ' ' LEU . 5.0 mp -108.41 142.63 38.47 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.556 -0.715 . . . . 0.0 110.177 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.612 HD12 ' CD1' ' A' ' 31' ' ' PHE . 67.0 mt -124.63 145.14 49.8 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.489 -0.757 . . . . 38.68 110.565 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -90.74 -21.63 21.48 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.138 -0.976 . . . . 0.0 110.124 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.613 HG21 ' OD2' ' A' ' 56' ' ' ASP . 3.3 p -102.71 137.0 41.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.525 -0.735 . . . . 31.63 110.447 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.447 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . 66.6 mt-10 -77.66 -1.77 32.69 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.29 -0.881 . . . . 0.0 110.753 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 27.9 pt20 -138.53 141.05 39.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.048 -1.033 . . . . 0.0 108.911 179.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.54 168.66 38.78 Favored Glycine 0 N--CA 1.498 2.83 0 C-N-CA 118.577 -1.773 . . . . 28.05 112.308 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -118.83 130.2 55.63 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.056 -0.673 . . . . 0.0 109.665 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.813 ' HG3' HG22 ' A' ' 54' ' ' ILE . 35.9 ttm -124.9 117.15 23.44 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.236 -0.915 . . . . 0.0 111.01 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.433 ' HB2' ' HB2' ' A' ' 117' ' ' ALA . 60.7 tt0 -127.82 151.31 49.19 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.88 176.67 37.47 Favored Glycine 0 N--CA 1.499 2.873 0 C-N-CA 119.087 -1.53 . . . . 29.62 110.895 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.42 ' CD2' ' HB3' ' A' ' 114' ' ' PRO . 66.3 m80 -136.41 156.41 48.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.704 -0.88 . . . . 0.0 110.193 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.578 ' CD2' HD11 ' A' ' 115' ' ' ILE . 5.9 m-85 -117.03 128.12 54.85 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.57 -0.706 . . . . 27.05 109.972 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.692 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 78.6 m-20 -83.71 120.31 25.85 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.083 -1.011 . . . . 0.0 108.835 177.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.489 ' HG2' ' HB1' ' A' ' 45' ' ' ALA . 7.8 ttm -122.88 161.46 24.06 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.028 0.442 . . . . 0.0 110.222 -179.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.449 HG22 HG23 ' A' ' 48' ' ' VAL . 7.1 m -142.74 130.53 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.554 -0.716 . . . . 23.28 110.546 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.512 ' HB3' ' OD1' ' A' ' 107' ' ' ASP . . . -73.45 168.14 19.84 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.468 -0.77 . . . . 0.0 109.649 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -67.77 -28.81 67.93 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.516 -0.74 . . . . 0.0 110.374 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.512 ' OD1' ' HB3' ' A' ' 105' ' ' ALA . 46.9 p-10 -76.07 -3.69 37.29 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.338 -0.851 . . . . 0.0 111.422 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.89 -10.51 60.48 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.022 -1.085 . . . . 30.43 110.892 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.527 HG21 ' CZ ' ' A' ' 7' ' ' TYR . 76.5 m -57.9 134.66 56.53 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.998 -1.295 . . . . 0.0 110.053 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -101.16 140.09 35.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.355 -0.841 . . . . 0.0 110.809 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.431 ' CE2' ' HB3' ' A' ' 103' ' ' MET . 37.2 p90 -164.56 143.87 7.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.709 -0.62 . . . . 28.03 109.708 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 85.5 mt -101.36 157.49 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.714 -0.617 . . . . 0.0 110.556 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.5 96.07 49.58 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.42 ' HB3' ' CD2' ' A' ' 100' ' ' HIS . 46.6 Cg_endo -58.98 142.93 99.85 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 O-C-N 123.966 1.509 . . . . 33.31 112.147 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.578 HD11 ' CD2' ' A' ' 101' ' ' TYR . 51.7 mt -107.94 122.31 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.465 -0.939 . . . . 30.59 108.465 178.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.01 153.76 0.85 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.894 -0.504 . . . . 30.78 111.389 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' A' ' 98' ' ' GLN . . . -99.76 117.58 34.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.727 -0.608 . . . . 0.0 110.278 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.684 ' CE1' HD11 ' A' ' 120' ' ' LEU . 41.4 p90 -106.18 169.13 8.68 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.822 -0.807 . . . . 30.66 108.822 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.617 ' C ' HD12 ' A' ' 120' ' ' LEU . 57.5 t -111.95 154.37 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.254 -0.904 . . . . 0.0 110.231 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.684 HD11 ' CE1' ' A' ' 118' ' ' PHE . 7.4 mp -112.21 132.48 54.89 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.259 -0.645 . . . . 39.15 109.259 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.687 -0.633 . . . . 0.0 110.089 -179.735 . . . . . . . . 0 0 . 1 stop_ save_